Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABITRAM "C9orf6, CG-8, FAM206A, FLJ20457, Simiate" ENSG00000119328 "Actin binding transcription modulator" Q9NX38 9 108934400-108950744 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 20.7;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 10.6;Fibroblasts: 4.3;Hofbauer cells: 7.8;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035917, HPA035918" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA No "Cluster 31: Non-specific - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 21: OE19 - Mitochondria" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA035917: AB_2674860, HPA035918: AB_10670593" "unprognostic (4.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.85e-1)" "unprognostic (4.00e-3)" "unprognostic (1.05e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.42e-1)" "unprognostic (1.16e-2)" "unprognostic (3.50e-2)" "unprognostic (1.57e-2)" "unprognostic (3.25e-2)" "unprognostic (2.03e-1)" "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 14.2 11.9 17.2 10.0 18.7 15.6 17.2 16.8 21.9 12.5 18.7 14.9 14.4 13.6 25.1 16.4 21.5 10.9 15.8 17.7 17.3 13.6 14.6 12.7 9.0 16.8 17.1 13.5 13.3 23.2 13.9 12.5 17.2 12.1 16.2 24.7 15.3 14.2 13.2 24.5 13.1 12.5 17.5 8.5 14.5 20.2 17.5 11.9 19.0 11.8 12.0 11.9 11.4 18.3 18.5 19.8 19.5 23.4 36.2 44.6 28.1 17.1 20.0 17.0 13.9 29.5 9.7 17.0 9.8 16.6 22.3 41.3 17.2 18.3 16.0 10.4 17.6 10.5 25.8 27.0 30.7 40.4 13.3 25.3 33.6 20.7 47.6 20.9 23.7 26.1 39.7 16.6 20.3 53.0 28.9 16.3 22.6 55.9 28.7 13.9 33.9 18.9 22.5 19.2 26.7 13.7 27.0 23.3 30.1 20.0 31.6 21.4 14.9 9.2 16.9 39.3 21.7 14.7 38.5 12.6 30.1 15.6 13.4 38.8 31.2 31.0 14.8 33.4 22.6 16.5 23.1 19.6 35.5 10.8 22.9 17.6 37.4 21.1 34.6 37.0 21.1 20.1 17.2 18.7 16.8 21.9 17.7 17.3 16.8 17.1 17.2 17.5 17.5 18.3 2.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 6.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 10.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 AC004556.3 ENSG00000276345 "39S ribosomal protein L23, mitochondrial" Unmapped 2585-11802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 24.0" "Group enriched" "Detected in some" 6 "Extravillous trophoblasts: 35.6;Hofbauer cells: 23.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 94.7;K-562: 75.5;MOLT-4: 85.4;NB-4: 160.6;PC-3: 141.1;WM-115: 113.7" HPA050406 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" 3.8 0.0 2.5 4.0 3.0 0.0 19.4 2.8 3.2 0.0 2.6 10.3 0.1 5.0 14.3 0.0 4.9 5.9 24.0 2.4 2.7 6.7 8.5 1.6 0.0 3.1 3.7 6.3 6.8 0.0 2.1 3.4 5.0 0.0 1.2 7.5 0.3 14.5 5.1 9.9 0.5 2.4 4.1 5.0 2.4 2.8 9.9 2.6 0.0 0.1 4.5 2.8 0.2 0.0 0.1 0.1 0.0 0.0 42.0 27.8 43.4 46.5 33.2 94.7 0.8 0.1 0.1 0.0 0.0 0.6 0.7 0.3 18.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 51.1 0.0 31.4 48.3 75.5 42.5 0.4 0.4 85.4 160.6 0.0 0.2 141.1 0.5 22.8 0.2 44.0 27.1 0.2 0.6 0.0 0.2 0.1 0.0 70.4 0.0 0.0 0.0 0.1 0.3 0.4 0.5 0.3 0.1 0.8 0.3 113.7 12.3 3.4 2.2 1.7 6.2 1.4 1.7 2.5 3.5 3.0 2.0 2.6 2.9 1.0 2.1 2.8 2.8 4.0 2.1 2.5 3.0 2.8 3.2 2.4 2.7 3.1 3.7 3.4 2.4 2.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 35.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 AC004922.1 ENSG00000284292 "Novel protein, ARPC1A and ARPC1B readthrough" 7 99325879-99394653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Club cells: 2.5;Exocrine glandular cells: 1.5;granulocytes: 1.3;Pancreatic endocrine cells: 1.1" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004334 Uncertain Approved "Cell Junctions,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 11: Alveolar cells - Smell perception" "Cell Junctions" Cytosol "HPA004334: AB_1078215" 1.5 1.2 0.1 0.9 0.1 0.5 1.2 0.1 0.3 1.1 0.0 1.4 0.9 0.9 0.0 1.3 1.0 0.1 1.0 0.2 0.1 1.0 1.2 1.8 0.8 0.5 0.2 0.8 0.9 0.1 0.8 0.2 0.3 0.9 0.0 0.0 1.2 0.0 0.4 0.7 1.9 0.2 0.1 2.9 1.2 0.5 0.2 0.2 1.2 0.0 0.1 1.2 1.0 0.0 1.9 2.1 0.4 0.2 0.3 1.0 2.5 1.6 0.7 0.9 1.0 4.1 3.5 2.5 4.8 1.5 1.7 1.6 0.1 1.1 0.2 1.0 1.7 1.2 1.3 0.9 0.2 1.4 1.4 1.4 0.7 1.3 0.6 0.3 1.0 0.8 1.6 2.2 1.0 5.1 3.8 0.1 0.7 0.7 2.8 1.4 0.3 0.7 0.2 1.0 0.4 0.3 1.3 2.7 6.0 0.3 0.8 0.7 2.0 3.3 1.3 3.6 2.4 0.0 1.0 2.4 1.7 2.5 3.5 11.8 20.7 23.7 8.7 20.4 6.2 9.3 8.5 8.7 16.6 11.1 7.1 6.9 16.9 7.1 18.7 11.2 16.5 31.5 0.1 0.1 0.1 0.3 0.2 0.1 0.5 0.2 0.3 0.1 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.5 0.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ACAA1 ENSG00000060971 "Acetyl-CoA acyltransferase 1" P09110 3 38103129-38137242 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 212.6;liver: 659.3" "Cell type enhanced" "Detected in all" "Distal enterocytes: 356.8;Hepatocytes: 686.0;Proximal enterocytes: 441.1;Proximal tubular cells: 721.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 224.0;SK-BR-3: 342.9" "Low region specificity" "Detected in all" "HPA006764, HPA007244" Enhanced Supported Peroxisomes NA NA 4700000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Peroxisomes "HPA006764: AB_1078085, HPA007244: AB_1078084" "prognostic favorable (3.00e-4)" "unprognostic (5.57e-2)" "unprognostic (4.54e-2)" "prognostic favorable (7.53e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.23e-4)" "unprognostic (9.35e-3)" "unprognostic (2.91e-2)" "unprognostic (8.11e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.90e-1)" "prognostic favorable (6.99e-9)" "unprognostic (1.72e-1)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (1.65e-2)" 42.8 54.1 47.5 24.0 54.4 44.7 41.2 54.3 49.5 28.3 42.3 56.9 101.0 20.8 44.6 56.7 19.4 29.8 84.8 44.6 48.7 212.6 659.3 34.9 26.1 54.2 50.4 20.9 59.3 47.9 24.8 17.2 53.0 55.1 51.2 4.9 38.9 25.3 48.2 30.7 89.5 18.7 50.9 41.3 42.1 15.5 53.6 28.0 32.1 53.8 30.0 43.7 33.5 54.9 35.5 39.8 13.0 40.7 55.6 32.2 44.6 32.2 47.0 36.3 34.5 52.8 38.8 21.1 22.6 52.0 17.4 24.5 34.9 54.0 20.0 31.0 37.2 27.0 35.4 155.5 35.3 63.3 59.8 59.0 39.3 31.2 22.5 23.9 49.9 49.7 26.2 24.2 41.3 49.2 60.3 45.3 13.3 224.0 47.0 13.9 25.0 34.3 103.4 110.4 10.9 16.5 31.7 342.9 23.7 18.0 35.1 48.9 36.8 21.9 21.1 43.2 44.2 31.9 21.7 16.1 34.8 54.4 34.7 79.9 114.4 130.4 48.8 159.1 41.2 33.9 45.7 47.4 178.1 36.0 45.2 42.5 76.3 71.9 187.7 104.5 77.2 82.1 47.5 54.4 54.3 49.5 44.6 48.7 54.2 50.4 53.0 50.9 53.6 54.9 30.7 41.7 38.7 50.6 45.6 33.3 56.5 57.6 40.9 36.9 48.7 37.1 3.2 98.7 44.3 66.2 14.6 91.6 61.7 356.8 166.3 98.0 4.5 40.7 38.6 25.4 55.1 40.4 25.6 78.4 64.5 34.4 76.5 39.1 19.0 32.5 37.1 686.0 81.7 8.4 24.7 73.1 48.8 93.5 86.8 9.6 35.8 83.2 58.7 14.0 89.5 43.1 53.5 12.5 30.9 100.9 270.6 33.1 44.5 60.6 441.1 721.8 26.3 16.7 32.9 28.5 27.4 19.8 11.7 48.1 35.5 99.3 44.4 186.7 84.3 87.0 ACOT8 "hACTE-III, hTE, NAP1, PTE-2, PTE1" ENSG00000101473 "Acyl-CoA thioesterase 8" O14734 20 45841721-45857405 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 104.2;Late spermatids: 90.3;Proximal enterocytes: 105.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010261 Approved Supported Vesicles,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles Mitochondria "CAB010261: AB_2221664" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (4.27e-1)" "unprognostic (1.03e-3)" "unprognostic (2.92e-2)" "unprognostic (4.70e-1)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" "unprognostic (2.03e-2)" "prognostic favorable (3.18e-4)" "unprognostic (2.79e-1)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (2.98e-1)" 8.3 31.7 27.8 8.6 29.8 18.1 7.6 28.2 35.2 9.3 24.3 18.5 21.1 8.5 11.0 17.5 10.7 9.2 28.1 29.8 28.6 21.3 26.0 11.0 12.6 27.0 28.5 8.0 15.6 15.1 15.4 7.1 28.7 12.7 12.8 9.2 12.8 5.9 28.7 17.0 20.5 6.4 26.0 12.3 21.3 20.2 28.7 13.1 11.4 17.8 9.7 11.0 10.4 28.1 16.8 20.2 6.8 13.4 18.3 11.0 11.7 11.1 9.5 15.1 13.7 29.2 22.7 20.8 48.2 16.3 35.4 32.3 13.0 27.8 6.6 15.5 22.3 21.2 25.1 28.5 16.9 19.9 19.3 12.9 21.3 15.1 10.9 22.6 9.4 23.6 18.8 24.2 11.0 47.4 28.7 27.0 11.8 32.4 52.2 14.0 12.2 37.6 16.5 19.1 23.1 10.8 24.9 61.7 39.5 10.6 34.4 48.8 11.6 37.9 8.5 19.5 18.9 20.7 33.8 14.0 46.3 21.2 20.8 34.3 34.3 43.6 24.8 34.6 21.8 27.5 23.2 21.9 36.7 27.9 20.0 21.6 25.0 16.3 34.2 23.3 31.9 26.7 27.8 29.8 28.2 35.2 29.8 28.6 27.0 28.5 28.7 26.0 28.7 28.1 8.2 35.3 14.1 5.9 17.9 6.1 12.3 21.9 8.6 19.2 9.8 10.9 9.3 11.5 17.7 12.9 16.7 34.2 11.8 104.2 64.6 21.6 38.5 14.2 10.4 10.9 19.2 17.0 12.3 21.0 20.9 11.4 19.9 14.0 14.0 27.6 11.4 25.5 27.8 8.4 12.0 37.3 10.2 18.6 7.1 90.3 9.9 17.5 10.6 3.7 27.5 17.8 34.0 5.0 9.6 21.6 68.4 8.6 21.3 11.3 105.4 81.5 27.1 22.8 13.1 5.8 12.8 27.0 10.2 16.1 8.0 19.4 13.9 37.6 30.3 16.0 AL034430.2 ENSG00000285723 "Novel protein" 20 10420546-10420737 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 47.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 26: Non-specific - Cell cycle regulation" 25.9 8.9 0.6 14.4 2.1 18.2 0.0 0.6 9.5 0.0 7.1 14.3 31.0 2.3 0.0 0.0 0.0 0.0 8.9 4.2 0.9 6.5 17.3 5.1 3.0 0.8 1.1 1.1 11.0 9.4 3.0 4.6 6.5 0.0 21.5 6.9 0.0 47.7 0.0 21.9 0.0 0.9 7.3 9.5 12.3 1.6 0.3 0.0 0.0 0.0 2.0 2.0 77.2 33.4 72.7 62.0 0.0 0.0 22.5 111.4 8.2 2.1 0.0 4.3 70.5 42.7 37.2 7.5 77.6 86.2 0.0 0.0 0.0 3.6 16.6 116.4 23.5 135.7 1.2 131.9 36.0 6.3 0.0 6.1 0.0 19.6 0.0 35.5 17.2 58.8 0.0 9.8 94.9 62.5 79.1 54.2 21.4 49.5 161.5 41.9 0.0 35.4 16.4 31.9 96.4 135.8 165.8 27.6 52.7 56.2 68.3 41.6 73.9 48.6 85.7 51.9 76.3 98.5 27.5 86.3 50.3 52.4 33.8 41.6 17.3 43.5 18.5 26.1 20.1 24.3 39.5 24.5 20.8 21.6 22.1 18.0 41.6 67.0 25.0 25.8 0.6 2.1 0.6 9.5 4.2 0.9 0.8 1.1 4.6 0.9 1.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALDH9A1 "ALDH4, ALDH7, ALDH9, E3" ENSG00000143149 "Aldehyde dehydrogenase 9 family member A1" P49189 1 165662216-165698863 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 311.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA006077, HPA010873" Approved Approved Cytosol "Intracellular and membrane" NA NA 2000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 43: THP-1 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA006077: , HPA010873: AB_1078126" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (4.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.21e-2)" "unprognostic (1.25e-1)" "unprognostic (4.14e-2)" "unprognostic (4.87e-2)" "unprognostic (2.30e-1)" "unprognostic (1.83e-1)" "prognostic favorable (4.56e-4)" "unprognostic (5.51e-2)" "unprognostic (9.05e-2)" "unprognostic (1.67e-1)" "unprognostic (1.49e-1)" "unprognostic (1.43e-1)" "unprognostic (2.15e-1)" 119.2 105.5 49.6 29.8 51.0 24.8 76.8 49.3 60.3 51.5 62.5 45.7 54.8 38.6 93.4 105.6 50.2 32.0 48.2 47.4 57.5 142.4 206.5 38.5 40.3 50.5 52.1 53.6 44.0 81.9 39.9 38.0 51.4 65.3 50.6 46.4 104.1 45.6 93.6 54.7 48.6 42.0 50.7 37.9 39.5 63.4 49.3 39.0 123.0 56.4 60.1 39.4 43.9 55.6 55.7 53.5 48.7 44.1 152.1 132.8 40.7 71.9 101.5 70.8 61.0 33.4 40.7 0.1 67.1 64.8 34.9 42.8 40.0 70.3 83.0 25.9 50.6 35.3 34.7 36.5 78.2 56.0 36.1 86.0 34.8 75.2 62.5 97.8 62.2 45.9 56.9 48.4 111.7 33.4 37.6 57.6 71.3 145.1 64.7 31.7 62.0 74.3 92.5 52.0 57.7 39.8 51.4 57.1 67.4 65.6 108.8 84.0 61.9 42.5 41.5 52.4 37.1 44.7 62.5 54.8 47.9 52.6 41.7 61.8 35.2 50.9 45.5 37.7 48.8 49.9 43.8 49.6 34.5 46.8 43.8 50.4 51.3 43.0 45.3 21.6 69.8 45.6 49.6 51.0 49.3 60.3 47.4 57.5 50.5 52.1 51.4 50.7 49.3 55.6 56.2 16.0 47.6 12.7 43.3 32.6 43.3 43.8 68.3 25.0 83.0 54.6 46.5 55.8 36.8 51.5 22.9 48.5 39.3 43.9 97.8 42.9 45.4 27.7 39.1 49.4 55.8 28.2 5.6 37.0 76.4 60.6 36.2 20.4 38.0 60.9 59.3 158.8 61.9 13.5 8.3 56.9 32.6 59.1 24.9 39.8 95.4 43.8 56.9 6.5 34.6 311.5 39.1 12.1 12.2 32.2 33.1 115.5 34.8 39.6 80.3 204.4 59.4 28.9 26.3 32.5 40.1 85.6 49.9 123.8 51.9 38.2 43.7 148.4 63.6 28.3 AMDHD2 CGI-14 ENSG00000162066 "Amidohydrolase domain containing 2" Q9Y303 16 2520357-2531422 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 64.1;Hofbauer cells: 127.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041184, HPA041321" Enhanced Approved Nucleoli,Cytosol No No 110000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Cytosol" "HPA041184: AB_10803998, HPA041321: AB_10795588" "unprognostic (1.20e-1)" "prognostic favorable (5.19e-4)" "unprognostic (7.86e-3)" "unprognostic (2.39e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-2)" "unprognostic (8.68e-2)" "unprognostic (1.30e-1)" "unprognostic (8.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" 14.7 20.2 2.7 5.6 3.4 5.5 13.7 2.4 4.8 12.9 2.8 12.6 9.1 12.2 0.7 10.6 10.8 4.3 7.0 3.3 2.0 18.7 13.8 12.2 7.9 3.4 3.1 9.3 8.2 3.1 8.5 4.5 2.8 10.8 0.8 0.4 13.7 3.2 8.8 15.4 17.3 1.4 2.4 26.1 9.9 37.0 4.2 3.7 12.1 1.3 1.9 10.9 9.8 4.3 9.6 11.7 3.1 6.7 3.5 2.5 15.4 9.0 3.4 7.4 9.0 8.7 16.9 4.4 4.4 1.7 14.0 9.3 1.7 2.5 0.2 6.0 7.8 6.6 13.8 12.7 12.9 4.6 16.8 6.6 2.5 4.9 0.8 1.8 4.0 12.5 14.3 9.3 3.1 19.0 7.8 11.7 6.7 0.8 10.1 29.6 4.4 14.0 2.4 5.4 10.3 9.9 5.7 13.1 21.4 0.5 13.1 1.5 6.9 7.4 11.3 14.3 4.7 15.7 14.1 8.9 8.1 9.5 7.4 9.5 3.3 9.6 4.8 7.5 3.8 6.4 3.5 2.9 1.2 4.1 2.7 2.4 8.4 3.1 9.9 9.9 3.8 2.9 2.7 3.4 2.4 4.8 3.3 2.0 3.4 3.1 2.8 2.4 4.2 4.3 8.0 3.2 11.6 1.3 16.7 8.9 5.2 3.2 4.0 10.3 13.6 11.6 2.5 10.0 5.2 5.5 6.2 16.7 16.4 16.2 5.9 30.3 64.1 6.0 4.1 8.3 12.6 11.0 1.6 17.0 27.1 9.9 7.1 5.2 7.0 13.1 18.2 11.9 127.0 23.5 1.1 12.8 6.1 47.6 12.1 27.4 10.5 28.9 19.6 1.9 26.9 11.0 20.6 0.5 0.8 14.5 26.4 6.4 11.5 4.1 59.4 48.9 9.1 13.0 0.0 7.8 8.4 52.9 16.3 5.1 8.9 27.9 13.2 7.6 10.4 4.2 AMZ2 ENSG00000196704 "Archaelysin family metallopeptidase 2" Q86W34 17 68205481-68257712 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 477.3;Early spermatids: 736.8;Late spermatids: 1665.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023299, HPA052406" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies, Cytosol" "HPA023299: AB_2226909, HPA052406: AB_2681818" "unprognostic (3.04e-1)" "unprognostic (3.68e-2)" "unprognostic (3.93e-2)" "unprognostic (3.27e-3)" "unprognostic (3.32e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.43e-1)" "unprognostic (3.92e-2)" "unprognostic (2.83e-3)" "unprognostic (3.59e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.37e-1)" "unprognostic (2.95e-1)" "unprognostic (3.28e-1)" "unprognostic (7.62e-2)" 52.3 51.8 54.5 32.6 66.4 36.4 45.0 57.1 87.2 41.2 50.0 57.8 26.2 44.5 53.4 38.4 52.5 37.9 77.0 59.5 56.6 59.2 38.1 32.9 54.0 58.8 56.7 48.7 45.3 64.4 59.1 29.5 58.0 41.6 32.9 78.5 40.0 51.2 95.6 43.1 36.9 41.7 55.3 43.3 39.7 194.4 60.0 53.2 53.3 86.8 51.7 48.5 36.5 61.4 94.6 98.9 87.5 72.9 65.6 113.4 140.0 71.0 88.3 116.1 93.7 42.3 60.4 142.6 74.9 104.8 107.0 46.0 68.6 198.5 154.0 50.2 67.7 52.8 38.6 83.1 124.9 49.8 86.9 96.9 213.9 107.5 206.2 113.0 118.9 121.7 54.6 86.5 150.9 67.3 110.2 45.4 43.5 51.1 98.5 41.3 238.9 106.7 71.2 50.1 85.7 67.2 64.8 125.5 130.9 184.6 100.7 33.5 65.2 143.8 72.0 55.8 74.8 121.9 121.9 255.7 105.1 69.0 79.1 76.6 25.2 35.3 34.8 30.3 46.2 30.7 43.2 46.0 30.3 41.3 37.8 40.4 45.1 63.7 40.9 28.1 58.3 36.9 54.5 66.4 57.1 87.2 59.5 56.6 58.8 56.7 58.0 55.3 60.0 61.4 18.5 12.8 15.6 477.3 38.7 18.6 31.6 58.4 30.1 13.8 29.7 34.3 81.4 21.5 32.8 23.9 8.4 64.0 58.0 9.4 109.5 28.8 736.8 28.4 17.2 24.4 21.1 21.0 36.4 26.0 66.9 28.2 14.8 18.5 34.1 28.9 21.4 15.5 41.8 18.5 30.0 16.7 40.7 26.1 71.0 1665.0 36.1 39.0 56.9 27.2 46.4 65.7 69.0 56.8 47.7 25.4 10.8 32.7 46.2 17.7 15.2 69.0 61.8 12.8 19.7 26.5 26.8 274.4 59.4 26.4 22.6 34.2 49.3 26.1 15.1 24.5 ANAPC11 "APC11, Apc11p, HSPC214, MGC882" ENSG00000141552 "Anaphase promoting complex subunit 11" Q9NYG5 17 81890790-81900991 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1161.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021989, HPA027838" Approved Enhanced Nucleoplasm,Nucleoli Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Nucleoli "HPA021989: AB_1844915, HPA027838: AB_10600978" "unprognostic (9.00e-3)" "unprognostic (1.24e-2)" "unprognostic (3.76e-1)" "unprognostic (4.93e-2)" "unprognostic (8.76e-2)" "unprognostic (1.67e-1)" "unprognostic (5.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.65e-1)" "unprognostic (2.17e-3)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (8.07e-2)" "unprognostic (9.08e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-1)" 112.1 120.5 104.8 52.1 108.6 109.3 103.4 110.9 149.5 85.9 100.7 126.0 61.0 86.4 39.0 125.8 80.3 58.0 231.3 106.4 106.8 127.3 185.7 89.3 73.0 110.0 105.1 76.4 108.1 59.0 92.0 54.8 105.0 105.7 27.3 19.3 117.6 42.0 272.8 99.7 83.4 36.5 110.4 86.7 117.9 189.7 113.0 50.1 90.6 126.5 34.0 95.9 94.7 118.1 262.4 605.0 139.0 209.7 118.7 132.8 164.3 123.4 100.6 111.4 127.1 248.6 226.9 82.1 133.3 114.4 121.8 148.9 58.1 166.4 40.5 122.5 437.1 126.8 257.9 379.0 131.3 95.3 103.6 145.6 151.8 120.4 98.2 73.4 184.9 111.9 173.7 233.8 120.8 474.1 225.5 150.6 131.2 259.2 448.7 92.3 136.2 168.0 104.9 229.3 175.8 282.6 133.5 205.7 253.8 96.7 254.1 222.7 108.4 215.0 169.5 229.4 234.1 110.5 52.1 107.0 228.7 144.5 177.7 495.1 419.8 418.8 229.7 359.9 218.7 309.0 232.0 252.9 348.0 296.2 223.0 212.3 212.1 258.5 345.4 581.1 297.9 506.0 104.8 108.6 110.9 149.5 106.4 106.8 110.0 105.1 105.0 110.4 113.0 118.1 137.2 128.2 157.2 11.4 110.5 148.6 215.0 406.1 145.7 59.5 272.5 332.7 360.2 201.6 272.3 198.6 20.9 467.8 119.5 239.6 522.3 260.6 451.9 157.0 151.3 152.9 190.3 201.6 9.8 337.7 524.6 182.9 124.4 169.5 108.3 158.3 159.2 496.4 448.2 33.7 10.2 272.6 319.4 174.6 194.3 1161.0 181.7 170.1 261.5 13.1 251.4 227.7 176.1 7.1 17.0 324.3 274.0 164.7 226.8 334.2 290.7 548.0 199.8 78.9 105.2 115.9 245.0 435.8 252.5 257.4 186.7 508.7 117.3 156.0 271.4 307.0 ANXA7 ANX7 ENSG00000138279 "Annexin A7" P20073 10 73375101-73414076 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 693.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004312, HPA064290" Approved Uncertain Nucleoplasm,Cytosol NA NA 290000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 3: Monocytes - Immune response regulation" Nucleoplasm Cytosol "CAB004312: AB_626681, HPA064290: AB_2685233" "unprognostic (1.48e-1)" "unprognostic (4.70e-2)" "unprognostic (1.90e-1)" "unprognostic (2.23e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (2.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.47e-1)" "unprognostic (2.67e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (6.93e-2)" "unprognostic (3.06e-2)" 79.0 72.1 60.1 58.6 61.1 85.2 75.5 55.9 67.8 69.9 57.1 64.3 39.4 57.6 80.5 69.3 57.0 51.8 113.4 62.6 64.8 116.4 126.0 60.4 60.8 55.4 57.0 67.1 55.9 240.7 55.6 57.2 58.1 69.2 74.4 32.3 70.2 70.6 200.1 61.2 44.9 68.4 60.8 53.4 51.7 26.3 62.5 55.4 83.1 139.6 84.1 75.2 57.4 63.9 143.4 101.4 38.8 95.3 148.9 145.2 84.3 93.2 244.7 119.9 100.6 149.2 164.8 56.6 92.2 177.2 78.8 116.9 73.2 110.9 118.1 140.8 54.5 80.4 46.5 133.9 130.6 115.7 35.4 90.8 105.7 149.2 265.1 104.7 108.0 60.8 106.2 156.4 154.4 114.5 66.1 74.4 43.5 85.1 693.9 53.9 110.1 103.4 209.3 86.5 30.9 42.8 105.1 239.4 90.3 54.3 149.7 61.0 100.8 48.5 87.9 148.1 122.5 100.5 153.2 79.5 114.4 147.4 38.4 188.6 98.1 129.8 57.5 74.9 78.9 96.5 88.8 72.2 101.3 75.1 80.0 71.4 98.0 97.2 77.5 43.2 127.8 137.2 60.1 61.1 55.9 67.8 62.6 64.8 55.4 57.0 58.1 60.8 62.5 63.9 85.0 67.3 61.8 24.8 68.4 86.2 137.9 189.8 40.9 33.0 56.7 40.9 131.9 62.9 120.6 93.8 14.6 210.6 61.2 76.2 193.7 167.2 9.7 82.9 43.8 82.4 191.8 119.3 44.8 150.9 112.0 85.3 51.5 60.4 108.3 69.0 56.4 122.7 119.9 10.1 50.7 82.8 193.3 83.0 87.3 6.5 137.0 91.4 85.4 15.0 301.5 66.4 36.0 26.7 46.2 133.1 47.5 174.5 73.0 125.3 57.9 262.8 161.1 26.3 26.3 82.1 92.9 24.0 42.3 72.5 92.5 177.3 78.4 46.9 76.9 146.1 AP2M1 "AP50, CLAPM1, mu2" ENSG00000161203 "Adaptor related protein complex 2 subunit mu 1" Q96CW1 3 184174689-184184091 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036849, HPA069870" Uncertain Supported "Plasma membrane" NA NA 7500 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane" "HPA036849: AB_10672101, HPA069870: AB_2686217" "unprognostic (1.16e-1)" "unprognostic (1.35e-2)" "unprognostic (5.28e-3)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (9.12e-4)" "unprognostic (3.80e-3)" "unprognostic (2.09e-1)" "unprognostic (5.53e-2)" "unprognostic (4.11e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (7.45e-6)" "unprognostic (2.61e-2)" "unprognostic (4.09e-2)" "unprognostic (1.60e-2)" "unprognostic (1.28e-1)" 191.8 364.2 233.5 164.7 250.3 231.3 164.6 211.3 257.3 222.8 196.3 232.4 167.5 216.4 104.2 218.1 178.6 166.5 366.2 261.1 249.0 196.0 140.9 180.0 148.2 234.8 211.1 198.6 106.4 224.8 224.9 243.3 248.9 183.2 141.1 230.4 167.2 231.8 181.2 157.2 156.2 243.7 200.9 162.5 156.3 106.4 235.4 158.4 148.0 194.0 157.6 223.7 192.4 225.6 436.3 327.5 275.7 311.8 432.1 450.8 284.3 714.3 412.5 788.5 550.5 355.1 309.9 198.2 851.3 1076.1 516.1 480.0 376.3 482.9 647.1 409.8 470.4 512.2 365.8 317.9 508.9 254.8 311.5 577.0 269.4 501.1 318.5 711.0 595.3 258.3 250.0 377.1 750.1 993.6 330.1 151.2 674.1 388.1 484.7 302.7 351.5 393.7 489.7 389.3 292.0 212.6 561.3 696.4 335.1 427.5 934.4 305.7 645.0 497.1 400.1 492.4 960.2 336.9 318.7 441.6 937.1 369.9 331.7 194.4 294.8 244.9 137.5 238.8 136.2 114.3 127.6 134.0 268.7 112.7 107.7 111.8 127.7 170.2 206.8 134.1 185.4 441.0 233.5 250.3 211.3 257.3 261.1 249.0 234.8 211.1 248.9 200.9 235.4 225.6 146.8 54.5 50.7 41.4 84.8 124.9 177.2 275.1 97.9 174.2 108.0 98.2 195.9 112.9 133.5 114.0 70.9 400.9 117.3 155.9 375.6 243.7 326.6 69.3 131.2 172.2 140.8 277.8 62.0 161.3 327.1 161.5 71.4 78.5 149.1 173.6 182.4 78.0 576.9 277.6 63.4 119.0 201.4 137.1 162.9 347.8 164.7 185.1 199.3 34.7 369.4 199.4 130.7 26.2 46.1 232.1 153.1 214.8 100.2 138.8 253.8 290.7 58.3 125.9 197.2 106.9 278.0 83.3 101.7 128.5 126.6 513.6 102.6 278.1 154.1 185.1 AP2S1 "CLAPS2, FBH3, FBHOk, HHC3" ENSG00000042753 "Adaptor related protein complex 2 subunit sigma 1" P53680 19 46838136-46850846 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 991.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (1.34e-1)" "unprognostic (5.93e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-1)" "unprognostic (1.30e-1)" "unprognostic (6.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.11e-2)" "unprognostic (9.54e-2)" "unprognostic (2.19e-1)" "unprognostic (5.25e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (5.79e-2)" "unprognostic (3.56e-1)" "unprognostic (3.07e-1)" "unprognostic (6.05e-2)" 120.2 136.5 110.7 80.6 119.9 126.5 95.9 104.9 138.5 83.0 99.6 91.5 67.3 62.1 41.0 188.9 58.6 46.1 107.5 122.1 117.7 106.8 148.9 90.2 62.4 108.0 103.9 52.3 77.2 51.9 72.4 79.1 111.9 90.8 57.4 27.6 99.8 48.8 101.6 125.8 79.8 60.1 106.0 124.6 85.1 69.2 111.3 67.2 61.5 63.7 67.6 82.9 103.4 112.5 380.3 363.2 181.6 198.7 227.1 248.7 122.2 311.0 383.2 349.2 411.0 277.1 189.3 121.1 168.6 476.2 153.6 178.8 144.9 450.6 263.9 115.1 418.6 210.4 220.6 204.0 306.7 142.1 150.0 317.9 259.0 337.9 281.1 259.0 471.1 199.5 186.1 180.4 331.1 403.2 181.1 1060.2 295.7 341.8 268.8 142.8 167.0 170.8 269.2 299.9 177.2 258.8 239.1 298.4 377.0 113.9 248.6 336.4 343.2 246.0 293.8 135.3 375.7 130.8 302.0 134.8 439.0 292.3 437.6 278.6 640.3 406.6 174.3 708.8 145.2 211.5 167.3 174.5 716.8 198.4 153.1 156.3 204.6 188.5 544.6 431.5 233.8 673.1 110.7 119.9 104.9 138.5 122.1 117.7 108.0 103.9 111.9 106.0 111.3 112.5 129.0 38.5 57.2 10.4 85.9 171.6 103.9 341.6 73.4 39.5 179.0 227.8 79.4 137.2 163.9 95.6 16.7 415.2 100.9 397.7 348.3 215.6 80.7 67.8 106.7 190.6 163.7 250.7 14.6 247.2 257.4 130.2 95.8 82.5 92.7 176.1 396.9 308.4 991.6 45.4 13.3 259.6 164.8 515.0 389.5 232.8 92.6 389.5 200.9 4.7 661.1 109.4 160.6 4.5 14.8 249.8 333.9 95.5 94.8 157.6 442.9 432.4 89.0 42.5 98.6 59.1 173.9 78.9 52.5 252.2 253.3 440.5 87.9 230.6 282.1 164.3 AP3S1 CLAPS3 ENSG00000177879 "Adaptor related protein complex 3 subunit sigma 1" Q92572 5 115841592-115914081 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "HPA049270: AB_2680696" "prognostic unfavorable (1.22e-4)" "unprognostic (2.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.68e-2)" "prognostic unfavorable (3.33e-4)" "unprognostic (2.60e-2)" "unprognostic (3.83e-3)" "unprognostic (4.42e-3)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.57e-8)" "unprognostic (2.73e-2)" "unprognostic (3.62e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-1)" 63.1 44.5 57.0 38.7 59.7 133.3 60.1 55.2 84.5 70.1 54.6 53.7 61.9 55.1 113.6 65.8 46.1 49.2 52.6 61.5 60.7 37.4 74.7 38.1 64.6 62.3 60.3 69.6 63.2 24.9 19.7 60.1 62.8 43.6 60.1 34.0 59.4 85.6 21.9 60.7 81.5 64.1 59.1 39.0 37.7 57.3 58.4 41.1 49.3 34.4 61.1 60.2 25.4 59.5 134.3 44.8 95.2 63.4 257.4 369.1 89.2 142.6 132.4 94.1 152.0 98.9 121.4 107.5 68.4 162.8 115.4 38.1 58.8 230.4 157.6 320.3 114.4 45.1 43.8 146.2 139.8 76.2 84.6 168.6 177.9 100.2 112.1 123.5 109.4 122.1 47.1 80.9 150.3 49.9 87.3 129.0 71.1 65.5 74.4 85.0 141.9 172.0 123.2 58.8 35.1 53.8 222.8 42.7 146.3 86.2 70.3 116.1 115.4 173.1 116.5 127.1 113.4 71.6 47.3 91.8 129.9 144.2 73.5 81.9 70.7 174.8 37.6 79.2 63.7 67.1 47.1 52.3 54.5 47.3 39.9 41.6 110.0 48.3 75.8 94.8 60.3 70.6 57.0 59.7 55.2 84.5 61.5 60.7 62.3 60.3 62.8 59.1 58.4 59.5 75.6 22.4 21.9 31.3 90.1 203.0 92.8 308.5 95.0 68.0 72.9 59.3 26.4 67.2 115.0 46.0 25.0 74.1 95.0 129.7 70.5 93.6 130.2 37.8 62.1 73.9 76.1 31.7 83.1 86.5 309.4 158.3 43.8 35.1 83.6 39.6 81.8 87.2 152.6 26.9 61.2 131.5 105.8 111.7 185.7 217.4 173.1 88.4 115.6 68.4 103.9 19.6 74.2 46.3 49.9 111.4 105.5 111.3 103.6 118.3 361.1 156.7 59.8 77.7 32.9 48.2 118.0 108.8 104.7 131.5 227.9 128.7 79.0 60.7 74.9 112.5 ARHGAP18 "bA307O14.2, MacGAP" ENSG00000146376 "Rho GTPase activating protein 18" Q8N392 6 129576132-129710177 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 253.6;Respiratory ciliated cells: 265.3;Syncytiotrophoblasts: 212.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 395.8;LHCN-M2: 113.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031595 Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA 1900000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "Nuclear speckles, Plasma membrane" "HPA031595: AB_10959905" "unprognostic (6.39e-2)" "unprognostic (1.60e-1)" "unprognostic (5.45e-2)" "unprognostic (5.49e-2)" "unprognostic (3.05e-1)" "unprognostic (3.17e-1)" "unprognostic (9.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.98e-2)" "unprognostic (3.12e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (4.08e-1)" "unprognostic (2.29e-3)" "unprognostic (2.22e-1)" "unprognostic (3.05e-2)" "unprognostic (5.52e-2)" "unprognostic (1.08e-1)" 20.5 37.2 3.4 13.0 2.5 4.3 13.4 2.4 2.8 14.9 15.1 14.8 24.8 6.7 20.2 6.0 28.3 15.4 6.0 2.9 4.1 28.4 6.3 28.7 9.4 4.7 5.7 6.0 33.2 14.2 6.7 20.8 4.3 9.9 15.0 2.6 14.6 8.4 10.6 4.0 27.3 10.6 3.5 9.0 27.9 8.3 6.4 6.1 23.0 13.0 7.9 12.6 4.1 3.7 8.6 18.8 1.9 2.6 17.8 25.0 15.1 64.0 48.8 27.7 18.5 10.0 14.1 7.1 30.6 43.2 8.8 11.0 13.4 20.9 51.3 7.0 5.7 46.7 13.8 57.3 25.4 6.9 395.8 15.9 3.2 50.4 44.7 57.8 79.8 0.0 25.3 17.4 113.1 2.3 0.1 6.8 2.0 16.0 4.5 0.3 8.5 13.7 84.6 4.8 0.0 0.1 5.3 8.8 32.3 9.3 9.7 8.1 61.6 28.8 4.1 2.3 51.8 7.8 6.0 4.8 9.7 12.7 40.9 12.0 5.1 13.5 4.9 5.8 3.1 2.9 2.5 5.5 4.8 1.7 0.4 2.6 3.9 2.5 3.2 11.8 2.8 6.0 3.4 2.5 2.4 2.8 2.9 4.1 4.7 5.7 4.3 3.5 6.4 3.7 139.5 57.7 33.3 1.6 13.0 13.0 17.7 15.7 10.8 0.7 53.4 14.7 4.1 17.2 39.5 38.6 2.1 92.7 31.0 19.0 150.6 48.2 20.7 176.1 5.8 89.2 13.1 10.9 16.8 120.5 24.9 45.3 63.2 35.7 253.6 34.7 11.0 5.0 110.4 0.0 23.1 22.1 63.1 48.4 112.4 21.2 3.7 163.9 7.2 43.1 23.9 16.4 28.8 12.5 2.2 102.4 25.0 1.2 26.4 18.5 69.8 31.7 265.3 0.9 26.3 38.9 32.5 10.6 1.1 11.2 12.9 212.3 35.9 69.1 31.3 19.1 ARHGDIB "GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2" ENSG00000111348 "Rho GDP dissociation inhibitor beta" P52566 12 14942031-14961728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 1579.9;lymphoid tissue: 1075.8" "Cell type enhanced" "Detected in many" "dendritic cells: 703.8;Extravillous trophoblasts: 667.6;granulocytes: 700.2;Hofbauer cells: 915.2;Kupffer cells: 742.6;Macrophages: 672.9;NK-cells: 999.0;T-cells: 895.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 1636.5;HL-60: 1927.3;HMC-1: 2070.0;JURKAT: 1421.7;MOLT-4: 2313.6;REH: 1912.5;U-698: 1750.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018584, HPA051235" Enhanced Supported Cytosol NA NA 61000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB018584: AB_647972, HPA051235: AB_2681398" "unprognostic (2.29e-3)" "unprognostic (8.10e-2)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (9.16e-2)" "unprognostic (1.90e-2)" "unprognostic (2.44e-1)" "unprognostic (1.47e-2)" "unprognostic (3.46e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (4.42e-3)" "unprognostic (4.97e-2)" "prognostic favorable (3.42e-4)" 188.8 74.1 48.7 521.0 51.2 1579.9 170.4 56.0 77.6 85.4 57.9 112.9 79.6 68.0 48.4 82.9 85.3 165.9 110.7 49.4 56.4 95.9 139.0 280.3 905.3 68.5 65.4 27.6 32.2 54.1 35.4 143.8 68.4 68.8 142.4 5.3 122.3 66.3 56.3 74.2 201.6 144.3 61.8 592.6 108.1 19.5 65.6 1075.8 110.6 79.0 1036.8 290.4 67.4 79.6 147.8 5.5 5.8 327.3 23.7 17.6 2.1 6.0 1.8 2.3 1.6 19.3 156.9 1210.9 74.3 28.0 1.9 171.1 0.0 270.8 17.9 2.3 0.0 1636.5 3.5 0.7 5.2 1927.3 2070.0 2.5 37.5 0.8 24.2 5.6 929.0 1421.7 8.7 454.5 28.8 0.8 2313.6 1382.4 7.1 3.3 1.7 1912.5 21.3 540.3 52.7 845.5 1.3 1.4 1.8 205.7 2.5 14.1 10.9 1385.1 1171.8 4.6 11.5 2.2 36.2 74.5 13.0 1750.9 5.3 1339.7 2.4 5890.8 2659.3 6464.2 2731.2 3085.1 2695.1 2676.3 3099.3 3090.3 2210.1 2532.9 2986.0 3120.5 5422.5 2408.4 3802.9 955.6 5589.7 9860.2 48.7 51.2 56.0 77.6 49.4 56.4 68.5 65.4 68.4 61.8 65.6 79.6 189.6 60.9 143.0 0.7 575.2 68.2 51.9 11.1 5.7 0.6 99.7 64.5 14.0 11.5 79.5 58.8 0.0 89.6 703.8 5.3 17.6 21.9 1.5 3.2 6.1 175.6 1.2 182.1 0.7 342.7 667.6 47.3 42.3 3.6 700.2 0.4 342.3 11.1 915.2 0.0 0.2 2.2 8.2 742.6 487.7 4.1 53.4 672.9 90.7 26.2 451.3 3.3 999.0 0.5 0.1 53.5 16.3 58.6 292.5 6.9 0.2 9.2 39.0 1.2 243.3 10.3 187.9 1.2 2.3 5.5 56.1 68.0 895.2 14.9 6.7 94.7 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 128.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 3: HMC-1 - Innate immune response" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: AB_2679123" "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 20.8 14.3 14.6 18.0 16.6 60.6 16.4 41.2 18.5 14.7 25.6 16.8 12.0 17.6 12.2 21.0 15.7 15.3 17.4 13.3 16.9 18.9 16.9 16.3 21.2 16.0 15.8 16.0 14.2 21.3 12.3 19.8 17.5 16.5 18.3 26.2 12.5 17.5 38.7 12.8 13.5 24.4 15.9 15.9 15.4 18.4 16.7 22.2 21.3 34.8 22.9 22.2 13.4 19.4 46.2 22.0 28.5 23.2 35.2 30.7 37.9 34.8 33.4 46.7 45.3 34.3 23.7 43.2 35.0 30.2 54.6 23.5 37.1 33.9 57.4 29.3 25.7 77.2 14.3 23.9 44.3 60.6 82.5 46.2 21.2 30.0 42.9 25.4 37.0 37.0 29.3 23.8 58.6 40.5 42.7 28.6 39.2 34.8 19.1 33.0 45.7 34.6 30.7 42.3 33.0 24.0 50.0 17.2 29.1 36.8 33.8 31.6 40.4 24.8 20.2 33.1 25.9 45.0 37.5 65.2 22.4 28.4 25.2 79.7 39.7 74.8 38.6 43.5 44.6 48.8 35.2 41.1 45.9 43.3 41.1 40.6 27.9 48.8 46.0 20.3 50.4 37.4 14.6 16.6 41.2 18.5 13.3 16.9 16.0 15.8 17.5 15.9 16.7 19.4 25.0 28.9 14.1 56.2 38.2 31.0 31.9 29.0 25.0 34.9 17.7 14.9 23.1 24.3 27.2 12.9 33.3 29.9 35.6 25.1 11.7 20.2 7.3 16.2 22.3 23.4 23.4 59.6 101.9 14.6 27.6 23.4 31.1 19.5 35.4 24.1 24.3 24.6 22.5 43.7 93.6 16.9 30.5 32.7 39.2 7.3 30.4 35.2 19.6 70.3 27.2 25.0 39.1 128.2 120.8 14.8 17.2 22.2 26.8 28.1 17.0 26.1 17.4 47.0 13.1 30.2 31.5 43.4 32.2 22.3 28.4 34.1 30.9 19.6 17.4 28.3 ARPC1B "ARC41, p40-ARC, p41-ARC" ENSG00000130429 "Actin related protein 2/3 complex subunit 1B" O15143 7 99374249-99394816 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 317.3" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 948.7;Hofbauer cells: 1088.1;Kupffer cells: 1035.5;monocytes: 1029.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 899.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004832 Enhanced Supported Vesicles,Cytosol NA NA 13000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 51: Myeloid cells - Hemostasis" "Vesicles, Cytosol" "HPA004832: AB_1845044" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (2.84e-3)" "unprognostic (2.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (2.57e-4)" "unprognostic (4.37e-2)" "unprognostic (7.76e-2)" "unprognostic (1.02e-2)" "unprognostic (1.56e-1)" "unprognostic (4.86e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (1.18e-1)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (7.27e-2)" 132.2 71.6 19.6 173.3 20.4 209.8 99.1 20.5 25.9 71.7 23.9 104.4 106.6 71.0 14.2 51.6 73.9 48.9 70.1 18.2 21.7 84.4 81.7 169.5 202.1 28.9 23.5 30.1 51.4 14.3 52.4 66.4 26.8 67.4 32.5 1.1 72.4 30.1 18.6 43.2 160.2 39.4 27.3 317.3 66.2 20.4 33.3 62.2 90.1 19.5 95.5 85.1 57.5 28.4 124.3 219.3 16.1 47.5 62.9 225.0 167.9 165.8 170.5 68.7 60.5 146.3 477.8 215.4 308.2 188.5 146.9 93.1 22.4 152.5 27.5 175.5 59.9 157.0 61.6 98.4 179.7 159.5 515.8 125.7 77.3 96.2 94.3 134.6 181.5 113.3 177.9 508.0 100.2 574.5 158.8 332.5 59.6 148.9 435.5 139.5 14.6 536.2 141.2 59.7 13.2 42.1 116.4 506.3 899.5 54.4 119.7 322.4 262.0 190.1 155.8 339.0 216.6 91.4 190.1 263.5 189.9 411.0 350.4 1026.1 2400.1 1973.2 770.3 2458.8 723.9 786.7 883.0 857.2 2054.4 699.1 510.2 680.0 1963.4 633.5 2382.6 1172.9 1315.9 4198.2 19.6 20.4 20.5 25.9 18.2 21.7 28.9 23.5 26.8 27.3 33.3 28.4 182.2 41.7 86.6 1.0 279.2 60.5 141.3 587.9 58.1 9.6 50.8 34.3 9.1 107.2 260.2 130.6 8.4 588.4 416.3 264.9 25.4 407.1 3.2 37.7 37.2 265.5 112.7 84.9 3.2 414.5 948.7 99.7 62.7 41.3 192.2 31.0 226.3 54.5 1088.1 1.7 2.3 97.6 203.4 1035.5 422.8 8.4 37.3 789.1 179.7 28.1 1029.7 21.4 498.5 0.5 1.6 405.1 268.7 18.0 154.0 132.4 516.0 110.9 214.0 14.7 92.1 29.5 238.5 2.7 15.5 26.3 37.1 303.2 324.4 20.4 161.1 187.6 ASL ASAL ENSG00000126522 "Argininosuccinate lyase" P04424 7 66075800-66094697 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 396.4" "Cell type enhanced" "Detected in all" "Distal enterocytes: 294.6;Exocrine glandular cells: 218.6;Hepatocytes: 578.0;Paneth cells: 240.4;Proximal enterocytes: 259.9;Proximal tubular cells: 243.1" "Cancer enhanced" "Detected in all" "liver cancer: 52.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003696, HPA016646" Enhanced Approved Cytosol NA NA 12000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB003696: AB_425316, HPA016646: AB_1845096" "unprognostic (2.95e-2)" "prognostic unfavorable (4.05e-6)" "unprognostic (4.83e-1)" "unprognostic (4.18e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (2.07e-1)" "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (7.25e-2)" "unprognostic (4.95e-2)" "unprognostic (2.07e-2)" "unprognostic (3.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-1)" "unprognostic (8.40e-3)" 21.7 16.1 5.9 16.7 6.0 23.9 22.0 6.6 8.5 18.2 8.7 53.8 60.7 17.0 6.7 28.7 18.1 27.7 16.9 5.9 8.0 61.2 396.4 27.4 10.3 7.4 7.1 19.7 37.1 15.1 19.8 9.1 9.8 19.5 35.7 2.4 18.3 9.8 8.7 15.1 45.6 10.1 6.2 30.5 43.9 4.5 7.6 5.3 24.9 6.9 8.8 19.3 19.8 6.7 48.4 18.9 11.2 36.7 26.3 18.1 22.1 34.0 31.8 49.5 43.6 43.7 59.0 15.9 53.7 48.5 36.6 13.4 7.1 59.1 11.1 10.5 8.9 18.8 17.9 77.2 48.8 24.0 51.3 38.3 19.5 31.8 51.8 12.5 48.1 11.3 34.4 27.8 25.4 36.6 4.8 28.9 15.8 65.5 26.1 12.1 11.0 51.6 31.9 31.6 18.4 24.3 32.3 109.7 12.3 11.4 46.0 19.7 55.1 53.7 30.8 23.5 45.2 30.2 16.9 19.0 55.0 41.5 49.5 34.2 42.6 50.8 16.9 46.6 15.1 21.8 11.5 13.4 46.2 13.8 8.2 8.5 7.3 73.7 36.1 2.5 23.4 27.3 5.9 6.0 6.6 8.5 5.9 8.0 7.4 7.1 9.8 6.2 7.6 6.7 34.5 19.2 61.4 5.2 20.4 5.5 21.4 24.2 9.1 12.7 24.5 20.4 9.2 124.4 25.8 31.3 22.9 20.7 25.4 294.6 52.8 73.7 4.0 41.2 12.1 30.7 54.0 47.1 9.4 218.6 45.7 14.4 115.7 34.1 44.5 12.0 42.8 578.0 46.0 15.2 9.7 126.5 16.2 41.2 17.6 6.3 9.3 22.3 8.8 1.9 48.3 7.2 34.0 2.5 4.8 118.3 240.4 8.2 23.4 14.9 259.9 243.1 42.8 13.2 13.1 16.9 17.5 3.2 5.7 19.5 4.3 22.3 18.0 13.5 189.4 22.0 ASMTL ENSG00000169093 "Acetylserotonin O-methyltransferase like" O95671 X 1403139-1453762 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 92.5;monocytes: 106.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 131.0" "Low region specificity" "Detected in all" "HPA003630, HPA021865" Supported Enhanced Cytosol NA NA 17000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 3: Monocytes - Immune response regulation" Cytosol "HPA003630: AB_1078230, HPA021865: AB_1845099" "unprognostic (3.89e-2)" "unprognostic (1.14e-3)" "unprognostic (2.28e-1)" "unprognostic (1.87e-2)" "unprognostic (7.99e-2)" "unprognostic (9.05e-2)" "unprognostic (8.17e-2)" "unprognostic (5.23e-2)" "unprognostic (8.40e-2)" "unprognostic (1.24e-1)" "unprognostic (1.91e-3)" "unprognostic (7.24e-2)" "unprognostic (3.26e-3)" "unprognostic (9.70e-2)" "unprognostic (8.38e-2)" "unprognostic (2.91e-1)" "unprognostic (2.20e-1)" 28.1 21.8 15.6 15.7 15.1 17.4 26.8 15.1 20.3 29.1 23.0 30.8 11.7 29.4 14.3 15.1 28.6 13.6 34.5 15.7 16.5 23.1 32.1 18.3 21.4 20.4 18.4 33.9 23.6 22.4 31.0 11.2 18.3 26.8 7.8 9.4 24.8 23.4 23.8 27.7 20.6 12.2 15.9 24.1 23.1 13.0 16.6 20.0 29.5 15.3 12.4 25.1 22.9 18.0 14.0 24.0 28.0 21.4 16.5 25.5 38.9 16.3 21.3 18.2 23.2 22.0 16.5 24.6 9.0 21.5 19.7 5.1 7.4 7.9 11.4 36.7 23.9 21.4 17.0 26.6 37.5 10.1 131.0 33.9 13.4 13.9 13.4 20.3 21.7 18.7 11.0 19.3 14.6 52.4 43.5 39.6 33.9 12.9 15.0 35.2 26.7 60.0 12.8 7.6 1.1 13.2 21.9 27.8 20.7 18.9 6.4 13.4 28.6 15.2 16.5 29.0 6.1 24.8 8.0 62.9 19.3 14.5 4.6 45.7 25.5 65.9 28.8 30.9 25.6 24.2 26.1 26.9 22.0 37.7 22.5 17.7 37.2 52.9 22.5 42.1 31.4 23.2 15.6 15.1 15.1 20.3 15.7 16.5 20.4 18.4 18.3 15.9 16.6 18.0 20.6 12.8 9.4 5.2 19.3 18.4 25.3 17.2 23.3 17.7 16.4 17.4 21.3 10.0 9.9 14.7 4.2 33.4 28.8 16.1 27.4 15.2 0.9 8.8 14.3 19.5 14.4 7.4 8.3 17.1 24.1 23.8 14.8 10.4 54.6 27.0 17.9 30.8 20.3 92.5 6.7 17.9 8.2 12.3 31.0 2.8 26.1 18.8 12.4 9.4 106.2 17.1 26.8 5.0 7.1 10.9 18.3 43.2 21.8 22.1 19.9 34.2 11.1 12.6 32.9 21.4 23.2 2.5 8.2 22.3 15.6 66.4 20.4 21.9 20.4 18.4 ATOX1 HAH1 ENSG00000177556 "Antioxidant 1 copper chaperone" O00244 5 151742316-151772532 "Predicted intracellular proteins" "Copper transport, Ion transport, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 932.7;Proximal tubular cells: 1449.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055036 Approved "Nucleoplasm,Plasma membrane" NA NA 790000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Plasma membrane" "HPA055036: " "unprognostic (5.55e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (3.34e-2)" "unprognostic (2.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.58e-2)" "unprognostic (2.53e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.72e-1)" "unprognostic (7.15e-2)" "unprognostic (8.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.87e-1)" "unprognostic (2.22e-1)" 102.0 136.9 173.3 65.9 183.6 73.8 100.1 180.8 201.1 84.4 181.9 84.7 81.8 73.7 98.0 112.1 64.6 63.6 107.4 170.0 189.7 217.1 260.9 80.3 142.9 181.9 184.7 57.8 57.1 180.6 81.2 69.8 183.6 100.2 64.3 24.9 93.0 74.6 53.6 102.8 83.0 75.9 184.9 124.4 76.1 72.9 185.6 82.6 119.3 39.5 128.2 91.7 84.2 192.8 112.0 181.9 104.4 73.1 275.1 224.2 136.6 197.7 225.8 197.2 267.3 248.2 235.8 224.9 233.3 345.7 437.1 102.4 129.2 502.5 161.3 143.9 220.3 98.7 118.4 255.1 254.1 137.5 108.5 291.3 105.0 246.0 161.1 144.7 295.3 138.5 83.4 642.7 305.1 276.6 102.3 304.0 59.8 249.8 382.3 61.4 120.0 350.0 190.6 98.1 136.2 80.0 169.3 476.6 763.4 117.2 234.2 165.3 328.5 201.0 159.4 246.9 345.9 522.6 513.4 136.2 271.7 92.3 846.1 154.6 207.9 199.4 75.1 247.6 69.0 98.6 67.3 66.2 171.3 68.3 53.0 58.0 155.3 97.0 177.2 217.8 103.5 117.3 173.3 183.6 180.8 201.1 170.0 189.7 181.9 184.7 183.6 184.9 185.6 192.8 209.1 57.7 56.6 8.1 93.2 67.7 79.8 204.5 70.0 22.7 250.1 246.5 112.1 165.8 102.2 211.5 14.6 146.0 65.6 213.6 541.9 207.6 178.9 121.1 171.1 183.2 150.7 104.1 6.4 159.1 218.7 127.3 96.8 135.3 73.0 117.8 236.7 932.7 671.2 25.2 9.1 171.1 164.8 221.4 166.0 321.1 83.0 230.4 238.3 4.7 436.7 185.7 88.6 5.5 22.7 318.1 238.7 103.4 170.4 124.2 727.0 1449.1 108.5 24.9 92.1 69.0 235.2 81.9 156.0 153.1 106.4 118.8 55.4 96.6 152.7 122.2 ATP5F1E ATP5E ENSG00000124172 "ATP synthase F1 subunit epsilon" P56381 20 59025475-59032345 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" Hydrolase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 3414.2;Hofbauer cells: 2765.4;Proximal tubular cells: 4125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" "unprognostic (1.73e-1)" "unprognostic (6.30e-2)" "unprognostic (8.16e-2)" "unprognostic (9.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.92e-3)" "unprognostic (7.88e-3)" "unprognostic (2.51e-1)" "unprognostic (5.01e-2)" "unprognostic (6.41e-2)" "unprognostic (4.35e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (3.98e-1)" "unprognostic (3.21e-1)" "unprognostic (1.67e-1)" "unprognostic (2.44e-2)" 81.4 88.3 92.2 98.5 94.5 125.6 62.3 95.3 135.8 49.3 95.7 77.2 80.1 51.2 25.3 77.0 45.2 13.9 162.8 92.7 95.7 128.5 80.2 69.3 69.8 94.2 94.0 42.1 44.9 52.9 104.8 34.0 94.4 50.6 33.1 42.8 62.7 23.7 240.1 42.8 78.9 25.6 95.4 93.5 69.5 47.7 93.7 64.7 64.1 107.0 40.0 63.4 55.5 97.1 150.0 49.6 98.1 90.0 94.0 87.2 65.2 155.9 60.6 102.2 66.0 156.3 143.5 81.1 184.7 82.7 159.6 141.5 70.3 123.7 67.0 66.7 76.4 271.4 107.2 136.5 86.4 193.2 234.6 95.0 105.3 62.5 77.8 99.8 76.9 107.6 103.6 113.8 59.4 144.4 247.8 299.1 32.9 220.4 203.4 120.2 138.3 156.8 107.5 83.0 98.0 146.6 261.6 273.9 328.4 83.5 182.5 312.8 264.3 208.3 222.0 138.9 213.7 180.2 245.9 238.1 201.5 117.9 117.1 613.1 420.6 757.3 237.5 463.8 224.9 351.4 285.8 268.7 356.0 291.7 227.8 259.4 713.9 243.1 470.7 601.7 393.3 781.7 92.2 94.5 95.3 135.8 92.7 95.7 94.2 94.0 94.4 95.4 93.7 97.1 1036.3 516.0 530.8 0.0 331.5 0.0 0.0 0.0 0.0 0.0 1042.4 1138.3 0.0 0.0 289.7 1121.9 0.0 705.8 812.6 0.0 3414.2 998.0 0.0 1145.2 1007.1 436.6 0.0 0.0 0.0 1202.6 956.9 341.7 0.0 1410.3 352.0 594.0 0.0 0.0 2765.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 998.4 0.0 0.0 1473.1 0.0 0.0 0.0 0.0 1427.7 0.0 0.0 132.5 0.0 0.0 4125.3 392.8 0.0 0.0 0.0 334.0 0.0 0.0 0.0 0.0 590.5 431.2 731.9 0.0 0.0 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396492 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1340.2;Ductal cells: 705.9;Exocrine glandular cells: 723.1;Pancreatic endocrine cells: 884.5;Proximal tubular cells: 1879.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria NA NA 55000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA044798: AB_2679091" "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 332.3 343.0 502.9 155.1 517.7 193.0 324.6 514.9 721.8 215.1 515.2 484.6 273.5 176.9 410.2 426.1 194.3 140.8 1229.7 526.1 539.0 546.7 587.1 215.3 180.3 501.2 501.9 157.5 321.4 519.2 309.2 157.4 506.1 254.2 449.6 245.3 234.8 236.4 1019.3 204.6 261.7 229.8 511.8 185.4 369.8 142.5 509.3 319.0 191.2 1325.5 251.0 284.7 258.9 518.0 557.8 559.4 528.4 648.2 570.2 696.0 348.3 523.2 612.7 501.0 556.6 925.2 605.3 312.4 288.9 575.3 398.6 559.4 502.2 522.7 697.9 414.7 887.3 331.8 682.1 1057.7 545.7 688.3 491.3 569.2 801.1 456.4 715.7 849.2 661.5 470.0 441.5 517.5 849.4 842.0 552.0 1167.5 397.8 830.1 959.1 355.8 326.0 495.3 1218.4 878.4 203.7 464.8 269.4 419.7 824.9 723.5 373.4 619.9 388.6 255.2 394.2 394.0 692.8 537.2 958.4 543.5 545.2 678.2 200.3 575.3 271.2 395.8 214.7 384.0 248.0 301.6 296.3 259.8 314.1 219.1 251.4 256.7 231.1 230.5 375.3 456.3 307.9 304.4 502.9 517.7 514.9 721.8 526.1 539.0 501.2 501.9 506.1 511.8 509.3 518.0 169.1 211.5 173.2 0.0 40.9 0.0 0.0 0.0 0.0 0.0 323.4 417.6 0.0 0.0 91.0 388.1 0.0 298.0 76.3 0.0 1340.2 705.9 0.0 406.0 245.4 114.5 0.0 0.0 0.0 723.1 439.4 81.8 0.0 424.5 118.6 176.9 0.0 0.0 543.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.4 0.0 0.0 432.6 0.0 0.0 0.0 0.0 884.5 0.0 0.0 0.0 0.0 0.0 1879.7 121.0 0.0 0.0 0.0 127.9 0.0 0.0 0.0 0.0 305.8 69.4 209.9 0.0 0.0 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466186 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 777.4;Distal tubular cells: 1430.2;Exocrine glandular cells: 578.8;Extravillous trophoblasts: 636.3;Hofbauer cells: 787.4;Pancreatic endocrine cells: 589.5;Proximal tubular cells: 1616.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 60000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 328.8 423.5 636.9 268.7 655.2 404.4 310.8 658.3 868.4 247.8 671.0 470.9 442.7 188.3 299.1 526.6 191.7 143.8 1184.8 658.1 663.7 559.3 561.2 241.8 293.1 657.5 648.0 179.1 271.6 509.6 332.1 235.7 647.0 315.5 367.9 320.7 317.8 205.9 1337.1 287.0 384.6 192.0 637.6 281.8 354.7 310.5 652.7 439.3 241.4 1439.0 301.2 303.1 303.5 641.3 1251.5 1130.6 905.3 1400.5 752.1 739.2 561.1 799.3 705.9 947.2 994.6 1226.2 1091.7 1161.7 822.7 548.5 1513.9 735.7 1064.0 981.3 1021.4 831.0 1333.6 800.1 1584.6 1555.4 530.7 1324.4 824.4 835.6 944.9 766.6 858.9 760.5 919.8 1009.4 1681.6 1213.0 1057.4 3128.1 1984.5 2396.1 1228.2 2594.9 1410.9 874.9 741.6 1985.9 1936.7 1376.1 845.3 925.9 1073.7 2519.4 773.1 1365.1 644.9 1687.5 703.0 706.0 1142.1 1197.3 1181.5 685.7 1795.6 2432.4 829.7 1325.8 1131.8 1020.3 904.1 1069.1 440.2 912.7 425.6 597.7 508.3 494.8 1122.9 512.2 445.1 468.3 428.0 555.2 731.2 890.5 754.9 1505.3 636.9 655.2 658.3 868.4 658.1 663.7 657.5 648.0 647.0 637.6 652.7 641.3 147.7 22.4 44.9 0.0 57.9 0.0 0.0 0.0 0.0 0.0 252.4 289.6 0.0 0.0 36.5 386.2 0.0 777.4 125.6 0.0 1430.2 460.9 0.0 302.6 225.3 82.0 0.0 0.0 0.0 578.8 636.3 110.5 0.0 278.3 64.3 188.1 0.0 0.0 787.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 190.2 0.0 0.0 339.1 0.0 0.0 0.0 0.0 589.5 0.0 0.0 18.6 0.0 0.0 1616.3 51.0 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 436.3 64.0 206.4 0.0 0.0 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1602.3;Extravillous trophoblasts: 671.4;Hofbauer cells: 920.9;Proximal tubular cells: 1883.7;Syncytiotrophoblasts: 710.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA058978: AB_2683867, HPA060520: AB_2684302" "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favorable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 107.8 166.9 304.6 75.7 318.3 177.4 127.5 305.8 446.6 94.9 306.0 165.2 165.1 80.5 139.6 159.4 87.0 48.8 548.2 321.9 313.4 205.2 181.9 79.9 94.4 301.2 297.7 98.3 113.8 257.3 159.9 77.1 302.4 108.5 167.5 169.9 100.9 87.8 489.6 106.1 128.9 78.9 303.1 108.7 135.6 83.4 305.5 135.0 111.5 471.6 122.5 103.0 101.1 304.1 244.6 278.5 233.6 222.8 275.0 284.2 228.5 185.2 211.7 228.6 199.5 240.6 167.4 254.4 187.9 191.2 183.4 201.1 306.4 225.3 310.0 207.9 306.8 280.4 227.5 380.4 180.4 346.2 188.4 298.6 301.5 155.7 164.2 260.8 264.4 330.6 176.7 264.7 253.7 730.8 333.1 493.9 182.1 560.5 523.7 211.5 202.7 231.2 358.4 345.0 201.2 238.4 155.9 289.0 371.4 256.2 355.3 401.7 142.7 87.9 137.9 242.0 153.2 199.3 372.5 360.2 207.8 195.7 152.3 405.1 512.8 336.0 204.9 409.1 232.9 309.5 261.1 234.1 367.0 261.9 295.5 260.0 517.5 206.2 401.4 355.4 282.2 656.9 304.6 318.3 305.8 446.6 321.9 313.4 301.2 297.7 302.4 303.1 305.5 304.1 88.0 221.2 225.1 0.0 47.9 0.0 0.0 0.0 0.0 0.0 369.7 334.4 0.0 0.0 92.2 413.8 0.0 609.1 63.1 0.0 1602.3 504.6 0.0 341.3 245.9 104.1 0.0 0.0 0.0 572.6 671.4 113.8 0.0 297.7 93.4 207.9 0.0 0.0 920.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 210.3 0.0 0.0 335.5 0.0 0.0 0.0 0.0 570.5 0.0 0.0 0.0 0.0 0.0 1883.7 146.5 0.0 0.0 0.0 104.8 0.0 0.0 0.0 0.0 710.1 70.2 228.6 0.0 0.0 ATP6AP1 "16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3" ENSG00000071553 "ATPase H+ transporting accessory protein 1" Q15904 X 154428633-154436516 "Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015218 Uncertain NA NA 700000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 4: Macrophages - Innate immune response" "CAB015218: " "prognostic unfavorable (2.40e-4)" "unprognostic (1.95e-2)" "unprognostic (2.06e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (1.84e-3)" "unprognostic (4.99e-3)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" "unprognostic (1.84e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.07e-1)" "prognostic favorable (5.26e-8)" "unprognostic (2.45e-1)" "unprognostic (4.66e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" 56.3 93.5 108.3 43.1 109.2 59.1 56.7 99.6 118.0 59.6 123.6 61.5 48.4 54.2 145.1 85.2 60.0 46.0 92.7 116.2 115.4 104.3 51.4 96.8 46.9 114.0 96.8 63.3 86.6 176.0 110.4 77.9 121.6 85.1 57.0 74.0 87.4 54.8 53.8 83.6 57.4 49.0 104.6 94.7 70.4 47.5 104.2 40.9 81.9 54.4 42.5 63.7 60.9 121.6 110.1 101.6 88.2 146.2 145.7 77.4 162.2 78.5 116.6 122.5 176.1 93.4 135.1 64.7 337.8 177.1 216.5 112.3 133.8 71.9 76.6 58.6 135.1 37.5 113.7 100.0 170.6 60.9 260.2 98.1 126.7 112.4 68.2 139.5 177.0 47.8 45.6 176.4 84.7 158.1 43.6 96.8 32.1 171.0 100.8 66.6 59.1 170.7 139.9 87.3 84.6 89.7 72.6 289.7 159.3 87.3 123.1 157.8 135.5 87.4 79.0 151.1 135.6 256.3 311.8 77.0 104.4 132.8 90.2 246.6 295.1 363.9 147.3 313.8 148.6 91.7 118.4 127.8 376.7 113.6 107.1 117.8 326.9 140.3 255.6 215.9 155.2 216.9 108.3 109.2 99.6 118.0 116.2 115.4 114.0 96.8 121.6 104.6 104.2 121.6 39.4 38.5 57.5 17.0 32.3 30.2 42.7 122.4 25.6 105.8 58.5 42.2 37.7 54.3 102.1 97.5 47.9 145.1 40.1 84.3 19.6 65.4 3.1 52.5 33.7 50.1 89.0 35.8 17.0 52.5 104.5 48.8 36.7 57.4 77.3 51.8 54.3 46.6 246.3 129.5 24.2 59.0 160.7 143.6 88.2 5.5 41.3 130.3 72.9 15.0 79.9 68.4 27.8 22.1 26.4 42.4 67.5 42.5 61.7 34.1 63.7 49.1 112.5 69.2 65.7 35.7 45.5 64.4 10.7 31.6 32.8 196.5 36.3 74.1 54.6 47.2 ATP6AP2 "APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR" ENSG00000182220 "ATPase H+ transporting accessory protein 2" O75787 X 40579372-40606848 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Congenital disorder of glycosylation, Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 765.1" "Cell type enhanced" "Detected in all" "Hofbauer cells: 702.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003156 Approved NA NA 140000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "HPA003156: AB_1078245" "unprognostic (1.45e-1)" "unprognostic (3.80e-3)" "unprognostic (1.30e-1)" "unprognostic (7.19e-2)" "unprognostic (8.58e-3)" "unprognostic (1.29e-1)" "unprognostic (1.63e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-1)" "unprognostic (4.15e-2)" "unprognostic (1.45e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.01e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-1)" "unprognostic (1.62e-2)" "unprognostic (2.86e-2)" 81.2 71.5 85.6 60.6 86.5 124.4 95.1 76.4 116.9 106.1 72.4 82.9 32.1 86.6 91.3 70.1 75.6 79.7 55.1 90.8 90.2 165.6 96.8 87.3 67.4 80.4 79.8 68.9 53.3 765.1 30.7 106.9 83.4 86.6 89.0 99.3 39.4 97.9 18.4 71.9 47.8 124.7 84.6 69.0 49.1 40.4 87.6 72.0 177.1 40.1 72.5 97.7 41.4 98.7 83.9 117.5 78.7 106.7 472.6 312.4 47.9 182.4 274.1 127.0 152.9 68.0 142.6 48.4 88.1 257.0 141.3 86.6 114.0 136.0 168.2 92.7 97.7 57.5 100.2 66.5 172.0 104.6 111.6 259.6 175.2 154.2 121.4 200.3 168.1 46.1 63.8 130.7 201.7 109.8 45.5 93.7 73.4 140.8 112.7 43.8 132.6 161.6 182.8 96.8 55.2 51.9 185.8 111.7 118.4 284.2 147.8 97.1 172.5 175.0 91.3 207.7 62.8 38.0 70.7 46.2 139.1 93.0 138.5 269.0 511.1 404.8 156.1 364.9 164.3 106.7 157.3 161.9 341.3 110.3 174.8 159.3 255.9 141.2 378.6 124.2 167.2 692.9 85.6 86.5 76.4 116.9 90.8 90.2 80.4 79.8 83.4 84.6 87.6 98.7 102.3 57.7 65.6 36.2 65.4 97.3 135.4 254.3 46.1 155.8 74.1 61.2 30.4 94.4 175.4 138.0 54.2 173.4 109.6 70.3 62.6 146.6 3.6 97.2 115.5 94.7 57.1 62.3 44.8 59.1 106.3 156.5 34.7 124.5 87.5 63.7 96.0 64.0 702.2 188.4 56.3 54.6 349.9 279.5 263.3 9.5 117.4 222.0 149.4 28.1 185.4 193.0 72.1 40.2 40.6 64.0 58.9 151.2 74.8 97.9 61.0 106.4 127.4 93.3 105.2 116.7 138.7 106.7 43.1 60.0 99.9 174.4 100.3 188.2 63.6 121.1 ATP6V0E1 "ATP6H, ATP6V0E, M9.2" ENSG00000113732 "ATPase H+ transporting V0 subunit e1" O15342 5 172983771-173035445 "Metabolic proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (2.24e-1)" "unprognostic (3.08e-1)" "unprognostic (3.61e-1)" "unprognostic (1.51e-1)" "unprognostic (5.34e-2)" "unprognostic (1.54e-3)" "unprognostic (2.25e-3)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (6.63e-2)" "unprognostic (1.47e-1)" "unprognostic (8.33e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-1)" "unprognostic (2.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.02e-1)" 265.1 267.9 135.7 158.7 142.2 89.7 223.2 145.3 192.0 220.8 181.0 204.6 127.0 199.1 634.0 228.9 193.3 163.3 262.4 133.0 154.4 338.2 237.0 253.3 191.4 156.2 145.1 189.3 179.4 145.9 314.2 171.7 154.5 232.3 154.6 45.8 245.0 154.1 225.0 178.9 189.5 157.9 150.3 270.1 233.3 93.4 144.5 130.1 241.2 137.6 188.3 227.2 199.1 158.3 249.4 263.6 85.5 259.5 777.8 310.6 200.6 475.7 444.6 235.3 361.6 299.2 376.6 107.0 663.0 567.4 622.2 174.6 173.4 342.2 260.6 741.8 170.9 100.8 242.1 287.3 379.5 192.9 340.6 413.0 413.3 270.7 149.1 284.0 287.0 116.9 67.3 306.3 519.3 487.6 121.7 278.0 99.2 195.8 228.5 128.8 121.9 193.0 471.5 312.4 123.9 82.8 208.6 255.7 400.5 235.1 282.5 265.5 430.2 553.0 125.9 397.8 405.3 263.2 587.5 120.2 299.5 318.6 185.2 2395.6 1150.2 1781.5 671.3 865.7 620.8 1088.5 761.2 706.6 734.6 951.6 734.7 761.7 2193.1 655.2 852.2 1099.7 853.8 2168.0 135.7 142.2 145.3 192.0 133.0 154.4 156.2 145.1 154.5 150.3 144.5 158.3 226.2 131.4 226.0 23.5 271.9 293.2 327.6 796.7 177.0 17.7 261.1 275.0 199.9 248.8 444.4 518.6 6.2 492.6 279.9 279.8 324.8 619.5 24.0 296.8 188.8 269.7 213.1 138.2 22.9 366.4 553.7 308.2 112.7 394.7 254.1 217.1 258.5 373.6 720.3 37.0 21.6 206.2 565.6 452.1 606.7 40.8 342.3 439.7 368.2 37.5 897.8 295.3 409.9 22.6 44.8 555.1 375.0 335.9 185.1 463.0 362.9 687.5 332.6 21.5 243.3 110.2 238.4 124.6 138.2 219.4 284.6 842.7 275.9 214.7 205.2 405.9 ATP6V1D "ATP6M, VATD, VMA8" ENSG00000100554 "ATPase H+ transporting V1 subunit D" Q9Y5K8 14 67294371-67360265 "Metabolic proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 365.9;Proximal tubular cells: 365.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031515, HPA057316" Enhanced Approved Nucleoplasm Yes No 19000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA031515: AB_10600785, HPA057316: AB_2683409" "unprognostic (1.10e-1)" "unprognostic (7.35e-2)" "unprognostic (1.59e-1)" "unprognostic (7.10e-3)" "unprognostic (1.52e-1)" "unprognostic (7.64e-2)" "unprognostic (7.78e-3)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.05e-2)" "unprognostic (1.13e-2)" "unprognostic (3.08e-2)" "prognostic favorable (7.60e-13)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.41e-2)" "unprognostic (1.44e-2)" 43.4 116.2 98.0 32.2 103.2 28.8 43.8 91.8 119.7 40.3 101.8 52.9 40.4 34.3 72.5 96.7 48.1 38.7 136.6 107.2 103.5 129.8 51.7 37.5 33.3 96.1 98.4 26.1 36.2 88.8 65.8 43.4 106.7 55.7 57.5 78.0 45.1 49.8 78.5 40.4 41.7 46.4 95.1 24.3 43.8 42.5 99.7 52.4 89.5 108.5 46.3 54.5 54.1 99.6 242.5 64.7 96.2 62.4 80.2 82.8 73.5 199.1 109.4 145.8 109.1 76.2 85.2 24.8 73.9 155.1 105.3 89.2 72.6 117.9 195.7 82.5 50.8 23.4 74.5 51.0 144.0 24.9 64.8 65.1 77.7 105.4 73.1 131.4 97.6 58.6 50.2 55.3 206.6 78.5 66.5 46.2 60.7 104.6 83.3 48.8 84.2 32.8 171.2 104.3 120.2 49.8 122.9 65.4 145.6 96.2 98.3 53.4 123.8 162.4 121.6 77.6 120.1 55.8 46.1 33.4 150.2 44.1 96.1 106.7 77.5 92.8 48.5 78.8 40.8 39.9 53.2 52.7 83.4 42.0 41.6 41.7 94.0 48.9 83.5 73.9 78.8 65.0 98.0 103.2 91.8 119.7 107.2 103.5 96.1 98.4 106.7 95.1 99.7 99.6 31.3 54.5 63.0 13.4 27.6 96.2 66.6 112.3 26.2 60.0 44.8 41.8 160.8 55.8 85.0 82.8 54.2 92.3 51.4 91.6 365.9 125.9 190.3 120.8 44.1 40.7 54.4 78.1 22.7 48.9 85.5 51.5 42.3 71.8 41.2 39.8 27.5 45.8 132.0 87.5 21.0 49.4 175.0 44.6 61.0 97.9 32.9 62.2 80.0 6.5 58.5 89.4 47.4 9.5 22.1 121.5 78.7 50.8 21.3 65.9 80.9 365.5 184.1 94.2 13.1 44.5 64.1 100.1 61.5 78.4 138.4 205.9 40.8 71.6 40.6 113.8 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "bone marrow: 78.1" "Cell type enriched" "Detected in many" 6 "Microglial cells: 248.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 15.2;NK-cell: 11.0" "Group enriched" "Detected in many" 5 "granulocytes: 15.2;NK-cells: 11.0" "Cell line enhanced" "Detected in some" "HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 1.4 1.1 2.3 2.5 2.4 78.1 0.7 3.5 6.5 1.5 3.0 1.1 0.7 6.4 4.2 0.5 3.1 2.2 0.4 4.5 2.9 1.2 1.6 1.1 1.0 2.5 2.6 0.4 0.5 0.2 0.3 3.5 2.8 0.6 1.7 0.1 0.5 0.8 0.1 0.3 1.3 3.1 3.1 2.6 0.6 0.4 2.4 0.5 0.1 0.1 1.0 1.4 0.4 4.9 0.1 0.6 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.5 0.5 0.2 0.0 0.2 12.2 0.0 7.3 1.7 0.1 0.0 13.6 40.2 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 19.2 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.1 1.2 0.0 0.0 0.1 0.0 26.7 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 1.3 103.7 0.0 15.2 2.0 3.8 0.4 1.2 0.1 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.8 11.0 0.4 0.0 0.0 0.9 2.3 2.4 3.5 6.5 4.5 2.9 2.5 2.6 2.8 3.1 2.4 4.9 1.7 0.0 1.9 1.6 0.8 1.5 0.1 0.2 0.6 0.6 0.2 0.6 1.3 0.0 0.1 0.0 0.0 5.4 12.5 0.3 0.0 0.0 27.6 0.3 1.7 1.0 0.0 12.2 20.3 0.0 1.8 8.1 3.1 0.2 19.7 0.0 1.1 3.7 16.4 0.0 17.5 0.3 2.0 37.0 17.7 25.3 1.8 27.0 1.8 248.3 6.3 0.5 15.5 1.0 2.1 0.0 0.1 0.7 4.8 2.3 0.7 1.2 0.7 0.2 0.0 1.0 7.0 0.5 0.6 0.6 0.3 2.9 13.4 1.1 0.2 0.3 AURKAIP1 "AIP, AKIP, FLJ20608" ENSG00000175756 "Aurora kinase A interacting protein 1" Q9NWT8 1 1373730-1375495 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1314.3;Late spermatids: 3668.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031821 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Mitochondria" "HPA031821: AB_10601458" "unprognostic (9.54e-2)" "unprognostic (1.86e-2)" "unprognostic (2.77e-1)" "unprognostic (4.77e-2)" "unprognostic (2.68e-1)" "unprognostic (2.98e-2)" "unprognostic (3.31e-1)" "unprognostic (9.52e-2)" "unprognostic (2.76e-1)" "unprognostic (9.91e-2)" "unprognostic (3.39e-2)" "unprognostic (3.34e-1)" "prognostic favorable (8.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.18e-2)" "unprognostic (1.84e-1)" 98.0 129.1 116.2 43.4 117.6 51.5 90.0 125.2 142.4 64.9 130.2 110.5 71.7 70.0 23.5 118.0 64.1 26.1 260.8 113.4 116.3 151.8 215.8 67.2 41.4 125.6 116.8 58.2 120.1 73.4 92.3 35.8 116.1 85.9 27.5 23.6 88.2 38.7 281.3 91.0 85.6 22.4 116.9 85.8 121.4 300.6 128.4 37.9 83.1 171.3 27.2 87.2 72.9 118.4 197.8 116.9 62.9 113.6 54.6 68.2 115.7 116.8 76.8 180.7 127.6 206.3 177.5 103.2 169.3 79.6 90.7 142.4 86.5 154.6 51.9 124.7 245.8 83.6 156.1 194.0 106.7 109.0 109.0 90.4 68.6 127.1 51.3 52.8 99.2 96.3 167.2 138.5 106.6 150.3 134.7 386.9 119.1 123.2 329.1 154.8 77.5 222.7 145.9 51.6 200.7 150.6 83.7 288.4 295.1 38.1 125.0 250.7 75.5 111.3 144.4 134.1 175.7 179.1 177.0 223.4 155.3 159.2 77.1 279.1 231.8 266.6 171.6 200.3 162.7 190.6 178.4 181.7 207.4 202.7 166.6 161.1 291.7 142.4 177.7 294.0 230.1 225.6 116.2 117.6 125.2 142.4 113.4 116.3 125.6 116.8 116.1 116.9 128.4 118.4 118.9 48.1 73.5 18.9 137.4 162.3 166.4 271.4 87.0 109.8 228.1 240.2 231.3 180.1 149.6 165.5 64.6 384.1 134.7 642.0 677.0 310.2 1314.3 145.6 119.3 127.6 203.9 125.2 11.2 418.4 458.6 121.0 178.4 141.8 87.5 144.6 121.1 390.5 294.6 104.3 12.8 415.1 238.0 154.8 175.5 3668.5 136.1 149.7 217.1 5.6 208.1 299.8 166.9 13.0 17.9 425.2 484.3 118.5 240.5 272.5 607.4 780.2 142.2 124.5 157.8 104.4 152.4 572.4 149.2 190.4 197.6 438.1 116.3 181.0 414.3 270.1 AZI2 "AZ2, FLJ21939, NAP1" ENSG00000163512 "5-azacytidine induced 2" Q9H6S1 3 28315003-28349050 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035258 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "HPA035258: AB_10602329" "unprognostic (1.86e-2)" "unprognostic (2.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.05e-1)" "unprognostic (2.38e-1)" "unprognostic (3.60e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (3.76e-2)" "unprognostic (1.44e-1)" "unprognostic (7.48e-3)" "unprognostic (2.72e-1)" "unprognostic (1.17e-1)" "unprognostic (3.30e-3)" "unprognostic (1.66e-1)" "unprognostic (3.34e-1)" "unprognostic (2.92e-3)" "prognostic unfavorable (2.77e-4)" 27.1 11.6 17.1 9.1 17.4 20.8 12.7 17.5 19.8 12.5 18.4 10.4 12.0 12.0 10.7 9.7 10.6 13.1 14.7 16.2 19.0 14.9 11.3 12.5 9.9 17.1 17.2 13.1 11.2 12.8 13.9 12.3 17.6 12.4 9.8 13.6 17.8 10.5 14.1 9.8 11.3 11.8 16.3 10.0 10.9 16.5 18.8 14.0 14.0 12.0 8.6 11.7 8.6 17.8 20.5 20.6 27.4 16.4 43.0 69.0 40.3 25.5 52.6 44.3 52.7 18.3 20.2 12.6 15.5 36.0 29.7 8.4 21.2 42.4 35.9 34.2 23.7 23.8 20.6 25.4 64.4 24.6 14.5 69.9 57.1 35.7 61.9 28.9 24.6 26.6 36.0 22.9 41.1 19.4 31.3 19.4 19.1 13.5 30.0 14.6 29.5 13.0 19.3 11.5 14.6 35.8 22.3 25.6 52.3 24.7 17.7 25.6 17.0 29.4 24.2 24.9 31.3 26.5 27.6 18.3 31.1 51.4 27.2 74.7 37.8 26.3 13.3 31.2 16.1 6.3 12.6 15.5 16.7 8.4 12.0 11.0 10.4 11.0 28.1 13.5 18.9 19.1 17.1 17.4 17.5 19.8 16.2 19.0 17.1 17.2 17.6 16.3 18.8 17.8 31.6 64.1 49.5 21.9 17.0 24.9 34.4 53.6 34.7 29.3 33.0 28.6 23.1 24.3 46.9 23.9 37.5 32.4 34.9 33.1 45.0 26.4 26.9 49.0 46.8 28.1 26.9 31.8 28.2 28.2 57.0 55.6 16.8 30.2 19.6 27.5 32.9 38.3 33.7 15.2 43.6 29.0 38.7 63.0 11.0 28.1 46.9 57.6 8.8 16.9 61.8 30.5 22.6 32.6 32.6 30.5 28.8 41.0 32.8 28.8 34.8 50.0 57.9 30.9 46.0 44.4 34.6 68.0 61.3 32.0 34.7 62.7 28.7 32.0 24.5 28.3 B2M ENSG00000166710 Beta-2-microglobulin P61769 15 44711487-44718851 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Immunity "Amyloidosis, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 31919.3;NK-cells: 24726.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002572, HPA006361" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1790000000 2100000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 3: Monocytes - Immune response regulation" "Golgi apparatus, Plasma membrane" Cytosol "CAB002572: AB_563434, HPA006361: AB_1078278" "unprognostic (9.45e-2)" "unprognostic (5.63e-2)" "unprognostic (3.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.18e-1)" "unprognostic (4.82e-2)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (2.44e-3)" "unprognostic (2.02e-2)" "unprognostic (4.77e-2)" "unprognostic (2.39e-1)" "unprognostic (5.25e-2)" "unprognostic (1.97e-2)" "unprognostic (2.17e-2)" 3160.2 3214.7 697.6 5686.5 705.1 7839.2 2606.9 711.8 1145.0 2539.9 789.6 5139.0 5180.7 2192.2 1735.6 2283.9 1648.3 4948.8 2327.2 651.0 769.9 2462.6 6206.2 6159.2 9311.8 889.5 763.2 1945.7 1310.9 1940.5 318.4 3502.0 815.3 2345.0 5593.5 139.3 5657.1 1784.5 931.7 3015.6 5693.3 2545.3 838.3 7896.1 4878.2 615.6 771.9 4217.4 2340.8 2026.5 5333.4 5753.1 549.4 909.5 1735.4 378.9 226.0 633.6 4348.7 4719.4 1662.5 2045.5 4961.9 3609.7 6561.4 425.3 5417.9 554.8 2567.9 1948.8 2410.2 2537.0 497.2 878.7 1226.2 4762.2 435.9 2956.9 2263.6 600.3 3609.3 2074.5 3328.6 2735.9 609.8 1075.7 1044.4 2442.6 1884.1 965.4 611.9 3649.1 2195.5 476.9 1518.4 3213.8 206.5 629.8 1014.3 2240.2 1926.6 4789.2 2425.5 3486.4 254.1 179.1 1288.4 1571.2 1338.5 394.3 655.3 6180.6 2548.7 4531.4 676.5 5389.2 2193.3 4771.7 7118.6 1683.1 5384.6 3783.6 2567.3 48105.4 18117.1 33178.9 20639.1 17775.0 20836.8 15768.0 23783.0 22245.1 9978.8 11988.4 17122.9 22791.8 50453.6 18779.6 19034.9 12052.6 29659.1 56957.2 697.6 705.1 711.8 1145.0 651.0 769.9 889.5 763.2 815.3 838.3 771.9 909.5 12048.3 3387.8 3505.1 28.7 8472.8 7843.7 3197.1 8420.8 1628.8 33.3 2399.5 2015.2 1068.8 3593.1 5347.4 2100.3 27.1 1354.6 14028.8 8753.6 1038.9 13898.6 43.1 2073.7 2414.0 8385.6 2266.0 2087.2 7.3 9034.5 4397.5 3691.1 1981.7 2282.2 3029.5 1270.6 6835.7 3832.6 11985.7 5.0 22.0 5982.6 8701.4 12536.8 14507.0 158.8 3018.0 10687.9 6744.8 368.2 31919.3 322.0 24726.3 95.0 129.2 10115.7 7085.6 1688.8 11026.6 5300.4 18327.7 3122.5 8367.9 52.5 4016.7 2055.2 4107.1 64.2 72.1 1541.4 8619.8 804.8 14266.2 3229.8 3063.4 8248.6 B3GAT3 GlcAT-I ENSG00000149541 "Beta-1,3-glucuronyltransferase 3" O94766 11 62615296-62622154 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051328 Approved "Intracellular and membrane" NA NA 990000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 4: Macrophages - Innate immune response" "HPA051328: AB_2681444" "unprognostic (1.55e-1)" "unprognostic (3.93e-2)" "unprognostic (8.45e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (3.80e-2)" "prognostic unfavorable (5.11e-6)" "unprognostic (4.94e-2)" "unprognostic (2.42e-1)" "unprognostic (3.66e-2)" "unprognostic (1.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.58e-3)" "unprognostic (1.46e-3)" "unprognostic (6.00e-2)" "unprognostic (4.48e-2)" "unprognostic (2.58e-2)" 28.2 30.0 63.4 17.0 63.8 18.2 27.4 67.0 81.8 33.7 65.9 27.8 17.2 30.0 11.5 21.0 30.0 15.3 23.1 64.0 66.7 52.1 48.7 29.0 26.2 72.3 64.3 32.3 30.7 19.1 55.7 19.1 76.5 37.1 6.9 16.0 25.9 18.2 14.3 33.9 27.8 14.0 63.3 40.0 28.9 23.9 67.1 18.5 30.1 6.8 10.8 30.5 25.7 69.7 36.0 57.3 32.0 55.0 40.0 38.7 23.4 28.3 38.9 26.7 29.4 25.4 52.3 33.4 91.1 29.5 70.6 24.5 30.8 28.7 6.2 71.5 61.3 17.0 25.9 32.8 96.8 21.4 34.8 69.1 47.6 35.0 15.3 42.4 25.3 37.9 51.5 76.7 33.9 89.1 38.1 76.7 47.5 18.9 55.1 36.7 22.5 175.4 55.0 7.2 33.6 53.1 32.6 38.2 134.6 10.6 52.9 41.6 18.6 28.6 20.8 75.2 54.4 79.3 28.7 37.6 82.3 41.0 56.0 32.0 29.3 27.4 21.6 31.8 14.0 18.5 14.9 17.7 25.8 15.3 14.8 17.2 8.6 41.0 33.8 15.5 19.9 16.4 63.4 63.8 67.0 81.8 64.0 66.7 72.3 64.3 76.5 63.3 67.1 69.7 33.2 6.4 13.2 22.2 36.8 19.8 39.0 53.3 51.2 52.3 33.1 44.4 4.2 31.5 26.1 40.5 33.3 77.0 45.3 26.5 15.6 33.8 0.4 20.0 36.3 22.8 25.2 24.4 19.1 46.3 61.3 34.8 25.5 24.1 1.3 45.3 23.2 28.4 67.8 48.8 25.3 23.9 57.0 35.2 17.5 3.2 36.1 34.4 44.4 8.4 45.3 52.5 49.4 14.6 19.5 36.4 31.2 22.6 51.0 30.6 27.3 16.2 15.2 49.6 26.3 22.3 33.7 6.8 25.8 21.9 19.5 43.5 41.7 31.9 28.3 21.0 BAD "BBC2, BCL2L8" ENSG00000002330 "BCL2 associated agonist of cell death" Q92934 11 64269830-64284704 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004205, HPA028185, HPA062105" Approved Enhanced Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684" "unprognostic (1.47e-1)" "unprognostic (3.08e-2)" "unprognostic (1.17e-1)" "unprognostic (8.24e-3)" "unprognostic (2.60e-1)" "unprognostic (6.73e-2)" "unprognostic (1.24e-3)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (9.04e-2)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (7.95e-2)" 60.8 85.1 94.0 13.2 91.1 23.3 58.8 89.0 133.1 64.9 86.6 81.7 26.5 64.8 12.7 72.9 58.8 15.5 118.0 93.1 87.8 87.6 96.1 58.7 14.7 93.4 92.7 55.2 53.7 35.6 55.3 21.7 89.4 79.7 15.1 17.2 57.7 27.6 50.7 70.6 44.7 14.0 89.9 45.0 87.1 55.1 98.9 17.2 75.8 15.1 12.4 65.9 57.7 92.7 95.0 85.1 25.2 38.3 30.0 36.4 36.9 38.2 45.9 60.0 47.5 54.8 53.1 19.5 67.7 37.4 46.9 49.9 16.8 62.7 11.9 77.6 58.7 24.9 81.4 26.1 45.9 20.7 45.0 35.3 53.7 45.8 28.3 45.9 37.5 44.1 10.1 42.9 26.6 94.7 49.8 49.7 9.8 27.7 109.6 46.7 13.8 57.9 36.8 44.3 51.2 67.1 39.2 46.8 49.9 9.6 70.5 32.0 30.3 72.8 48.1 112.8 43.8 79.6 64.0 21.3 59.2 15.6 40.6 88.0 69.7 102.3 52.9 56.7 54.7 58.6 55.4 51.9 50.5 57.5 39.8 40.9 92.4 59.5 55.3 94.0 71.8 51.4 94.0 91.1 89.0 133.1 93.1 87.8 93.4 92.7 89.4 89.9 98.9 92.7 56.3 32.1 45.1 7.8 32.9 103.1 54.1 170.2 51.2 67.7 76.7 74.8 51.6 70.1 66.4 53.3 18.8 162.5 32.4 214.4 137.0 101.2 43.5 71.5 64.8 56.8 104.1 69.2 10.4 109.9 197.8 75.3 53.0 45.4 24.1 58.2 62.4 51.0 73.8 47.1 7.5 141.8 89.5 24.1 72.6 93.3 74.3 32.9 110.3 2.8 52.4 95.9 36.0 4.0 8.9 120.7 210.0 85.4 33.2 62.1 138.1 152.8 83.2 52.0 59.2 36.2 72.6 69.5 25.0 57.7 119.1 255.0 36.0 57.8 117.1 63.4 BCAP31 "6C6-Ag, BAP31, CDM, DXS1357E" ENSG00000185825 "B cell receptor associated protein 31" P51572 X 153700492-153724565 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Deafness, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003906, CAB015350, CAB015424" Supported Approved Enhanced "Endoplasmic reticulum" NA NA 170000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 47: Cytotrophoblasts - Unknown function" "Endoplasmic reticulum" "CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270" "unprognostic (1.02e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.36e-2)" "prognostic unfavorable (9.87e-4)" "unprognostic (3.25e-3)" "unprognostic (4.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.75e-2)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.28e-2)" "unprognostic (8.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" 294.1 213.9 171.5 100.9 175.5 151.3 210.9 171.8 213.9 139.5 202.5 157.7 133.3 127.4 228.9 214.0 151.0 118.0 123.5 183.0 192.1 160.7 185.5 144.5 111.8 190.8 187.5 130.9 266.4 193.7 123.5 143.3 195.3 154.6 166.5 63.9 179.7 177.7 81.9 187.3 143.8 155.0 183.4 138.5 129.3 117.3 186.9 99.7 161.4 75.5 134.6 177.9 145.8 185.0 505.5 482.4 128.0 650.6 593.8 179.1 295.3 269.9 287.5 291.6 371.6 386.8 361.9 315.9 1068.1 412.2 373.9 506.8 337.3 518.6 221.0 152.8 436.9 198.4 350.4 323.3 276.4 335.1 373.2 233.8 454.2 282.3 330.1 298.4 372.6 172.0 268.0 528.3 332.7 535.3 187.3 402.5 145.8 704.6 431.7 207.5 152.8 693.2 459.3 546.8 173.3 241.8 111.8 520.6 350.0 200.3 196.2 320.2 380.0 248.9 234.7 338.9 495.1 518.0 1120.1 397.3 460.9 402.6 223.7 630.5 484.2 489.1 507.5 535.7 454.7 436.1 504.5 507.4 420.7 463.6 439.1 474.7 624.5 449.8 632.3 666.9 457.1 1110.8 171.5 175.5 171.8 213.9 183.0 192.1 190.8 187.5 195.3 183.4 186.9 185.0 184.9 112.2 114.1 14.7 97.5 141.9 232.2 374.0 172.4 53.0 127.3 165.7 60.3 134.4 222.8 128.8 45.9 467.5 113.5 194.1 37.2 252.4 7.8 99.7 70.1 165.5 103.2 59.3 16.9 210.0 444.8 103.6 78.5 103.9 95.6 68.5 199.6 216.0 356.2 32.0 12.8 155.1 244.1 148.4 125.6 20.6 105.3 166.2 160.1 17.8 137.5 138.2 111.2 11.6 12.9 247.1 187.4 98.9 120.8 191.8 242.8 170.9 172.6 51.8 157.8 42.9 106.5 310.3 231.3 174.0 130.4 538.1 114.6 120.4 187.0 260.4 BECN1 "ATG6, VPS30" ENSG00000126581 "Beclin 1" Q14457 17 42810134-42833350 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Autophagy, Cell cycle, Cell division, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003949, CAB010143, HPA028949" Supported Supported "Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" Cytosol "Nuclear bodies" "CAB010143: AB_626746, HPA003949: , HPA028949: AB_2672839" "unprognostic (1.97e-1)" "unprognostic (2.66e-2)" "unprognostic (9.97e-2)" "unprognostic (3.80e-3)" "unprognostic (1.46e-1)" "unprognostic (2.01e-2)" "unprognostic (5.16e-3)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.59e-2)" "unprognostic (4.33e-2)" "unprognostic (1.81e-1)" "unprognostic (2.34e-1)" "unprognostic (1.02e-1)" "unprognostic (4.63e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" 45.3 41.4 26.9 41.8 27.7 50.7 43.9 27.4 37.8 35.7 30.9 70.3 56.6 31.5 47.7 49.5 36.1 34.4 58.9 28.5 29.1 47.9 43.7 39.6 47.9 27.4 27.9 26.7 39.5 41.7 20.5 26.2 27.8 42.3 64.8 26.5 36.0 41.3 95.8 36.4 50.1 44.4 28.4 39.8 53.0 24.2 28.3 41.4 36.7 77.6 56.2 49.2 29.7 28.5 47.4 79.0 27.9 48.7 95.7 56.8 54.9 95.1 104.2 69.5 73.8 61.4 61.9 68.9 69.3 118.9 70.0 52.7 48.9 85.3 123.4 105.0 59.4 58.0 74.9 105.5 71.4 111.0 114.3 76.8 99.1 69.4 66.0 61.8 90.2 75.4 50.5 67.1 86.4 40.1 66.1 61.1 29.0 88.5 40.6 56.3 100.6 69.3 74.1 88.6 33.5 34.9 52.0 43.5 100.7 61.4 72.0 92.9 121.6 82.8 38.8 57.0 99.7 103.8 84.8 57.4 84.3 54.0 106.7 154.1 133.2 122.1 103.1 152.1 105.1 112.6 114.4 111.6 120.2 123.7 96.4 100.2 191.0 107.8 144.2 75.7 180.1 171.8 26.9 27.7 27.4 37.8 28.5 29.1 27.4 27.9 27.8 28.4 28.3 28.5 43.7 38.5 46.1 11.8 38.7 29.7 26.7 40.1 39.3 12.3 38.3 22.7 6.0 30.0 39.1 12.9 10.4 23.5 37.8 59.5 58.7 46.2 18.2 35.0 28.3 33.9 28.3 36.2 12.1 69.6 32.3 23.1 42.3 31.5 43.1 20.5 31.4 46.2 38.8 21.9 11.7 60.2 30.5 65.4 36.8 11.9 21.5 43.1 42.7 3.7 67.2 26.9 50.4 5.5 9.8 53.6 45.4 26.7 51.2 37.8 49.1 40.3 51.7 13.4 26.3 25.6 36.0 31.6 14.9 44.9 37.6 38.0 39.8 33.8 51.1 46.7 BIK NBK ENSG00000100290 "BCL2 interacting killer" Q13323 22 43110750-43129712 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 17.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 329.3;Club cells: 215.6;Ionocytes: 443.5;Paneth cells: 140.5;Respiratory ciliated cells: 204.1;Urothelial cells: 175.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 72.9;plasmacytoid DC: 58.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 89.9;CAPAN-2: 44.3;Daudi: 44.2;U-698: 172.1" "Not detected" "Not detected" HPA051360 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA051360: AB_2681453" "unprognostic (1.18e-3)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.09e-1)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.86e-3)" "unprognostic (3.27e-1)" "unprognostic (2.71e-2)" "unprognostic (4.36e-3)" "unprognostic (2.36e-1)" "prognostic favorable (7.45e-5)" "unprognostic (1.38e-2)" "unprognostic (2.56e-1)" "unprognostic (4.08e-2)" "unprognostic (3.04e-1)" 0.2 2.3 0.2 4.1 0.4 4.1 4.9 0.7 0.3 2.8 0.0 8.5 3.6 0.2 1.2 11.3 3.0 3.1 0.3 0.5 0.0 3.8 0.5 1.4 11.6 0.0 0.0 0.3 2.5 1.6 1.0 0.1 0.1 11.4 5.2 0.2 17.5 0.5 0.0 3.5 5.3 0.2 0.0 2.9 13.4 2.0 0.1 1.4 1.8 0.1 11.2 2.6 6.5 0.0 89.9 0.7 0.2 0.1 0.0 0.0 1.1 0.0 0.2 0.0 0.0 28.8 44.3 44.2 4.2 0.0 0.9 19.5 4.8 1.9 0.0 0.7 6.7 0.1 0.6 4.9 0.7 21.2 4.1 0.0 8.8 0.0 0.0 0.3 0.2 9.5 0.3 2.0 0.0 22.9 16.9 28.9 6.7 24.2 7.3 0.2 0.1 20.6 0.9 2.6 1.7 0.0 3.1 8.2 6.5 3.1 1.6 28.9 0.8 0.1 2.4 0.2 1.0 10.4 17.1 172.1 0.0 2.2 0.2 1.8 2.9 72.9 2.7 0.7 4.3 17.1 9.5 4.2 10.4 11.7 6.4 3.5 11.3 0.9 0.8 58.6 7.1 6.3 0.2 0.4 0.7 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 4.2 0.0 9.3 12.6 32.7 329.3 3.4 0.0 39.7 24.1 0.7 17.2 215.6 7.3 0.0 1.4 7.9 43.0 7.9 62.2 0.3 17.7 0.8 2.3 50.6 5.7 0.3 16.2 1.2 0.9 90.7 9.1 0.0 0.1 5.3 0.7 0.9 0.0 0.2 52.9 443.5 1.4 4.8 0.4 0.0 4.0 35.6 0.0 6.4 0.0 1.0 0.0 0.1 105.2 140.5 0.7 79.7 53.1 10.2 15.7 204.1 0.0 0.0 0.0 14.9 0.2 11.0 16.1 11.8 1.0 12.9 0.3 53.9 175.3 BLOC1S1 "BLOS1, BORCS1, GCN5L1" ENSG00000135441 "Biogenesis of lysosomal organelles complex 1 subunit 1" P78537 12 55716037-55720087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 1180.5;Proximal tubular cells: 719.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA021381 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA021381: AB_2228026" "unprognostic (1.27e-1)" "prognostic favorable (2.77e-4)" "unprognostic (1.65e-1)" "unprognostic (4.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (1.59e-1)" "unprognostic (6.77e-2)" "unprognostic (2.22e-1)" "prognostic favorable (2.19e-4)" "unprognostic (6.51e-3)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (1.83e-2)" 125.6 168.5 248.4 81.5 256.8 223.7 112.5 261.4 294.0 94.0 248.6 184.6 145.3 118.9 151.1 177.1 133.4 77.0 169.7 249.4 260.6 196.1 219.3 113.0 107.5 259.1 254.9 93.6 110.1 175.6 109.6 71.6 258.7 113.1 167.5 81.7 107.3 77.1 309.8 114.8 155.4 99.7 258.9 174.9 164.8 55.0 250.9 146.8 118.8 201.1 111.7 125.2 106.2 271.6 134.9 258.3 133.7 113.3 170.6 217.1 75.7 93.7 154.4 112.9 111.8 148.5 267.3 148.6 166.5 194.6 95.2 91.7 70.8 132.4 110.9 142.5 160.5 84.6 220.5 224.9 163.6 104.5 177.7 139.8 137.3 108.2 83.1 145.8 152.4 172.0 77.5 221.0 183.3 294.0 164.3 123.8 84.6 219.1 134.2 110.9 129.9 163.3 182.9 164.2 85.1 141.6 85.1 86.0 150.5 93.2 177.5 169.2 114.2 87.2 142.7 96.5 74.0 99.4 126.2 134.6 158.8 97.2 121.8 612.0 471.8 746.5 238.6 543.1 162.2 345.1 224.4 239.8 486.6 326.5 160.9 201.1 631.4 221.7 586.1 409.0 318.2 637.9 248.4 256.8 261.4 294.0 249.4 260.6 259.1 254.9 258.7 258.9 250.9 271.6 155.2 16.0 20.7 0.0 110.4 83.1 120.0 143.2 61.5 51.6 123.8 158.5 37.6 160.2 92.0 160.0 25.0 98.1 159.5 439.5 369.8 207.3 53.7 123.9 60.6 92.1 99.5 191.3 0.0 320.7 182.3 105.1 103.0 88.6 20.2 77.9 122.4 378.7 430.7 30.3 0.0 266.8 179.0 403.1 213.2 213.9 134.2 238.6 176.1 0.0 347.9 192.0 230.7 0.0 0.0 291.0 409.3 98.9 66.9 122.6 1180.5 719.6 114.2 92.9 78.9 133.9 208.5 46.9 55.0 86.6 88.9 73.2 111.5 77.4 256.7 180.7 BRK1 "C3orf10, HSPC300, MDS027" ENSG00000254999 "BRICK1 subunit of SCAR/WAVE actin nucleating complex" Q8WUW1 3 10115675-10127190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 2544.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060391 Approved "Nuclear speckles,Cell Junctions" NA NA 170000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Nuclear speckles" "Cell Junctions" "HPA060391: AB_2684272" "unprognostic (4.99e-2)" "unprognostic (3.48e-2)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (2.91e-1)" "unprognostic (9.60e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.49e-2)" "unprognostic (2.89e-1)" "unprognostic (1.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.37e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-1)" "unprognostic (9.40e-2)" "unprognostic (4.35e-2)" "unprognostic (7.75e-3)" 165.2 120.7 167.4 109.9 169.3 163.5 161.3 163.9 201.1 157.7 166.2 186.4 101.2 150.9 171.6 175.7 152.6 118.1 154.3 173.0 174.0 176.6 154.4 135.2 157.3 165.7 165.3 152.5 116.7 154.5 111.5 109.3 165.5 138.0 133.2 62.1 137.8 130.3 185.7 153.8 123.4 155.3 168.9 131.2 150.9 142.1 172.4 151.7 134.0 167.3 180.3 174.1 147.6 169.0 179.1 210.4 218.0 114.1 358.2 389.0 516.5 259.0 258.1 238.9 235.6 145.5 203.9 205.1 120.5 301.0 208.2 91.0 159.7 263.9 260.5 227.3 220.8 282.7 233.5 219.9 203.4 272.1 204.2 256.8 250.4 267.9 193.0 312.2 339.2 168.9 187.3 231.9 366.4 393.0 177.1 216.7 252.1 251.9 263.6 168.8 224.5 224.2 315.9 292.5 84.6 146.8 208.6 179.3 217.2 216.0 291.8 233.8 307.9 237.9 182.2 281.4 234.8 131.9 385.1 460.6 343.9 368.5 200.4 303.2 334.5 357.1 238.7 337.0 213.8 304.7 228.6 226.9 380.0 307.9 205.9 223.5 337.5 228.7 345.8 404.8 287.9 469.9 167.4 169.3 163.9 201.1 173.0 174.0 165.7 165.3 165.5 168.9 172.4 169.0 224.7 64.1 79.3 16.6 198.4 263.8 307.2 560.2 137.7 41.6 332.8 352.2 125.5 233.1 291.4 204.1 20.9 254.2 220.3 149.0 493.1 375.7 1034.0 145.6 152.2 273.7 298.7 191.2 33.5 361.6 282.9 223.2 119.3 127.3 173.3 152.3 272.4 255.0 442.7 47.1 20.7 211.3 307.2 373.9 380.3 2544.4 247.3 295.5 354.0 28.1 556.8 208.4 375.9 13.6 21.7 479.4 202.9 253.9 130.2 338.3 274.7 887.5 204.6 38.7 236.7 158.7 254.6 212.0 160.1 264.4 315.4 213.2 185.9 267.4 235.4 418.7 BTF3L4 MGC23908 ENSG00000134717 "Basic transcription factor 3 like 4" Q96K17 1 52056199-52090716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067026 Approved Approved Nucleoplasm,Cytosol NA NA 59000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA067026: AB_2685765" "unprognostic (6.12e-2)" "unprognostic (6.33e-2)" "unprognostic (5.09e-2)" "unprognostic (8.83e-3)" "unprognostic (1.42e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (6.73e-8)" "unprognostic (8.85e-2)" "unprognostic (5.59e-2)" "unprognostic (1.71e-3)" "unprognostic (2.61e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.43e-6)" "unprognostic (1.62e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (8.56e-2)" 44.6 51.9 28.4 30.3 29.3 61.0 43.6 28.8 36.1 31.4 28.3 25.1 14.5 36.4 30.7 36.0 36.5 23.9 40.1 28.8 33.0 35.0 40.9 26.3 36.6 31.0 31.2 52.9 38.3 42.1 31.0 37.4 31.6 29.2 23.6 31.4 29.9 24.5 70.1 35.9 18.6 34.8 30.3 28.1 27.6 34.0 31.8 49.2 43.1 59.0 40.8 42.3 29.9 39.7 99.8 23.7 113.5 59.6 60.4 76.4 117.3 96.1 96.3 108.0 115.2 43.8 50.8 92.3 93.9 68.3 127.1 56.6 111.1 75.0 137.0 64.4 77.7 105.8 41.0 65.5 163.8 118.2 70.0 79.2 101.0 100.2 140.1 89.1 86.9 75.1 81.5 57.0 98.0 42.1 82.6 69.9 202.7 76.7 51.2 53.6 132.1 109.8 105.3 78.6 89.1 100.6 112.5 102.8 141.7 124.8 92.8 124.8 64.0 60.5 65.4 78.4 114.8 98.9 176.3 89.4 52.2 90.0 77.9 70.3 74.2 70.9 29.7 78.9 40.2 49.9 42.8 31.0 72.9 49.7 49.1 38.2 31.6 49.7 70.9 34.3 62.6 64.3 28.4 29.3 28.8 36.1 28.8 33.0 31.0 31.2 31.6 30.3 31.8 39.7 60.4 35.3 22.3 17.0 76.0 107.7 91.7 153.6 65.4 43.6 81.2 75.6 44.7 52.9 82.2 69.9 33.3 111.1 45.9 18.7 168.3 106.0 115.3 82.9 83.6 55.1 52.2 114.9 30.8 80.1 137.6 77.2 44.4 73.3 22.8 128.2 56.0 81.0 129.3 38.7 32.9 33.8 120.1 127.8 92.9 25.4 72.4 87.4 78.2 27.2 86.5 62.0 49.4 29.7 39.5 72.7 26.3 55.7 58.7 135.9 23.4 162.9 75.7 33.2 59.2 73.7 106.3 97.1 31.1 108.5 160.3 145.8 56.0 114.9 34.8 106.7 BTN2A1 "BT2.1, BTF1, BTN2.1" ENSG00000112763 "Butyrophilin subfamily 2 member A1" Q7KYR7 6 26457904-26476621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA019208 Approved Approved "Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane" "HPA019208: AB_1845492" "unprognostic (1.86e-1)" "unprognostic (3.48e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "unprognostic (2.29e-1)" "unprognostic (6.17e-2)" "unprognostic (5.74e-3)" "unprognostic (1.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.26e-2)" "unprognostic (6.90e-3)" "unprognostic (5.14e-2)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.97e-1)" "unprognostic (4.89e-2)" "unprognostic (7.92e-2)" "prognostic favorable (4.52e-5)" 16.1 17.3 10.8 11.4 10.7 16.8 13.3 19.9 13.1 15.5 11.4 17.7 9.8 16.7 8.3 8.9 16.1 10.2 16.0 11.1 15.2 13.6 9.1 18.4 13.9 12.1 13.2 15.2 8.9 4.8 11.9 19.0 13.7 13.3 11.0 4.5 9.5 14.4 11.7 8.2 15.0 16.9 12.0 25.7 12.2 11.7 13.5 10.6 10.5 10.1 11.4 17.3 13.3 12.2 16.4 14.5 28.9 18.3 12.7 10.2 1.4 36.1 30.1 42.3 38.7 13.5 11.0 13.3 47.3 24.5 54.9 7.0 22.1 8.9 40.2 18.4 21.6 7.9 15.3 16.0 19.9 11.8 21.2 13.9 8.2 47.1 15.2 25.1 15.3 25.4 13.5 20.6 35.7 6.7 19.9 18.2 9.7 4.8 11.9 17.0 27.3 13.6 16.5 7.3 28.9 16.4 11.2 14.8 26.4 17.8 4.3 9.9 21.3 32.1 16.6 28.1 40.8 16.1 40.4 11.1 12.8 22.0 52.1 43.6 9.0 30.2 11.1 5.2 9.8 8.6 9.3 12.4 8.4 6.2 8.6 11.0 51.7 9.9 8.8 8.9 16.0 7.2 10.8 10.7 19.9 13.1 11.1 15.2 12.1 13.2 13.7 12.0 13.5 12.2 21.2 16.0 14.7 7.5 20.0 8.0 8.0 8.5 9.1 8.0 11.8 10.9 17.6 7.2 11.7 9.2 6.2 6.1 35.4 16.0 3.9 10.9 3.2 18.1 17.7 22.1 9.0 4.6 8.9 12.8 11.2 14.7 18.8 20.8 24.6 13.3 21.8 6.2 11.6 3.3 10.2 14.8 12.2 17.9 16.7 6.2 12.8 18.4 10.6 10.3 21.9 6.0 25.7 10.6 7.8 16.4 10.2 12.8 18.9 13.1 11.4 4.7 26.9 2.3 39.5 12.4 24.4 8.7 12.9 7.3 8.1 11.8 25.0 14.9 12.9 17.9 BUD31 "Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W" ENSG00000106245 "BUD31 homolog" P41223 7 99408641-99419616 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028943 Approved Approved Nucleoplasm,Microtubules,Centrosome NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Microtubules, Centrosome" "HPA028943: AB_10602396" "unprognostic (1.68e-1)" "unprognostic (2.73e-2)" "unprognostic (2.89e-2)" "unprognostic (2.63e-2)" "unprognostic (5.29e-2)" "unprognostic (2.38e-2)" "unprognostic (2.02e-3)" "unprognostic (2.16e-2)" "unprognostic (4.02e-2)" "unprognostic (1.46e-2)" "unprognostic (8.71e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (1.42e-1)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (1.71e-1)" 48.2 47.1 51.3 32.6 51.0 91.7 45.9 54.5 59.7 37.8 52.3 46.4 32.0 38.1 35.4 49.6 39.9 32.2 39.6 51.9 51.8 65.5 42.9 43.4 45.5 51.4 51.3 39.0 33.9 41.1 54.0 33.9 51.6 42.3 25.7 14.8 37.9 30.8 31.6 40.8 35.2 29.2 51.5 40.9 44.0 68.4 55.0 41.1 41.2 25.1 35.8 40.3 40.7 53.2 111.2 123.9 67.5 153.9 67.3 75.0 67.0 103.7 96.7 113.4 124.1 148.5 104.5 83.7 122.7 98.3 123.8 65.5 76.0 92.9 93.8 102.3 106.9 61.1 83.1 98.2 139.4 106.0 78.2 73.8 112.1 104.1 195.1 66.4 89.8 87.6 151.7 182.3 106.2 283.9 143.3 281.2 152.2 114.6 156.8 73.2 69.5 145.7 100.7 85.6 120.3 145.8 101.8 114.9 216.8 43.8 72.2 129.0 74.8 108.1 138.5 216.8 163.6 115.0 207.2 220.9 94.9 153.6 199.4 390.7 206.8 516.9 175.8 232.0 164.7 226.1 165.5 171.2 175.9 223.9 140.0 145.7 451.2 203.7 252.6 171.2 215.7 360.5 51.3 51.0 54.5 59.7 51.9 51.8 51.4 51.3 51.6 51.5 55.0 53.2 103.2 83.3 81.2 3.6 88.1 192.7 142.3 192.7 103.6 32.8 94.8 134.1 12.8 68.6 110.5 92.0 10.4 169.9 118.5 157.7 238.7 169.9 173.1 137.3 91.7 98.1 146.8 85.2 5.7 187.1 163.0 97.9 65.2 111.9 91.2 79.6 86.0 84.3 151.5 16.8 5.6 187.2 111.9 89.2 125.1 121.3 82.0 90.8 136.9 5.6 148.5 103.5 116.4 5.0 6.8 248.1 153.8 74.1 68.4 153.9 155.4 242.3 171.2 40.1 59.2 77.4 144.3 298.2 135.7 99.1 183.8 182.4 112.0 86.9 132.3 174.8 BZW1 "BZAP45, KIAA0005" ENSG00000082153 "Basic leucine zipper and W2 domains 1" Q7L1Q6 2 200810594-200827338 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 3845.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047288, HPA053272" Uncertain Approved Vesicles NA NA 34000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" Vesicles "HPA047288: , HPA053272: " "unprognostic (2.45e-2)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.08e-3)" "unprognostic (1.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.31e-3)" "unprognostic (3.98e-3)" "prognostic unfavorable (5.10e-4)" "unprognostic (4.49e-3)" "unprognostic (7.93e-3)" "unprognostic (1.08e-3)" "unprognostic (8.97e-3)" "unprognostic (4.38e-2)" "unprognostic (3.04e-1)" "unprognostic (7.61e-2)" "unprognostic (8.03e-2)" "unprognostic (1.24e-1)" 130.6 129.1 30.3 97.5 33.0 219.6 88.7 37.7 40.9 65.5 49.2 98.4 64.6 66.6 58.4 120.8 53.4 93.1 56.4 33.9 36.9 88.5 227.0 73.5 97.9 36.5 36.7 62.3 62.6 72.4 30.7 105.2 35.3 99.6 90.6 45.8 61.2 61.7 101.7 47.9 71.4 80.1 39.1 62.8 69.0 170.9 42.1 123.0 74.4 75.2 109.4 164.6 61.4 45.4 296.6 230.1 309.4 187.1 305.2 353.3 221.6 425.2 501.8 281.2 244.5 360.7 195.3 142.5 144.7 339.7 186.1 159.8 284.9 512.6 521.8 154.6 151.3 370.8 453.9 280.1 244.5 420.9 199.6 205.3 233.5 373.2 398.9 244.6 495.4 132.3 328.5 234.0 379.3 236.6 387.9 201.3 392.4 120.1 575.4 293.1 333.4 148.6 256.1 435.2 188.9 218.7 325.5 120.9 226.1 255.5 126.6 216.7 555.0 416.8 242.9 255.2 276.6 286.1 428.6 377.8 341.2 209.3 312.1 236.7 140.7 168.5 177.9 173.4 207.2 102.0 126.0 167.5 162.6 87.1 112.4 156.7 117.0 218.5 195.1 75.5 171.5 294.6 30.3 33.0 37.7 40.9 33.9 36.9 36.5 36.7 35.3 39.1 42.1 45.4 207.3 86.6 108.1 31.3 148.5 198.5 318.5 310.7 125.7 37.1 159.0 89.8 18.1 82.9 290.3 90.1 18.8 115.4 263.2 127.5 138.9 250.2 927.0 108.3 145.3 149.0 96.7 72.8 28.7 233.1 164.3 181.2 72.4 150.0 196.9 72.7 99.2 262.4 114.1 58.9 32.1 113.3 183.1 88.6 194.0 3845.6 102.2 169.1 124.5 15.0 308.1 119.6 170.0 24.6 36.6 464.4 106.5 95.9 132.7 242.3 68.2 163.3 121.7 33.4 98.6 159.4 179.8 175.2 169.2 133.2 196.1 195.2 200.3 103.3 106.1 370.9 C18orf21 "HsT3108, PNAS-124, PNAS-131" ENSG00000141428 "Chromosome 18 open reading frame 21" Q32NC0 18 35972625-35979286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 145.2;Late spermatids: 76.3;Spermatocytes: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065505, HPA067322" Uncertain Approved "Nucleoli,Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Plasma membrane" "HPA065505: AB_2685498, HPA067322: AB_2685822" "unprognostic (7.31e-2)" "unprognostic (2.14e-3)" "unprognostic (9.88e-2)" "unprognostic (8.66e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.38e-6)" "unprognostic (2.53e-3)" "unprognostic (1.83e-2)" "prognostic favorable (1.81e-6)" "unprognostic (2.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (5.15e-3)" "unprognostic (2.35e-3)" "unprognostic (5.97e-2)" 16.4 18.2 15.2 12.8 15.7 71.9 20.5 18.6 19.7 13.6 14.2 15.1 16.2 15.3 18.4 14.7 14.9 12.3 18.3 15.4 15.2 15.1 16.9 12.2 21.8 15.0 15.0 17.0 23.2 17.9 12.9 14.6 15.0 14.4 13.1 19.2 19.3 12.9 34.1 16.3 15.2 13.0 15.6 18.1 19.8 35.8 15.4 21.9 14.0 26.4 18.8 16.3 12.3 16.5 24.9 17.2 35.3 27.0 25.4 36.2 25.9 34.3 34.9 42.3 44.7 15.8 17.8 22.4 33.7 27.4 26.9 26.2 28.2 28.8 45.7 33.4 30.4 22.5 21.2 35.5 35.3 65.4 26.3 37.9 46.7 38.2 39.3 36.8 37.0 30.6 39.7 34.0 29.4 29.5 42.4 48.0 30.4 11.6 18.9 28.0 30.7 43.0 29.2 29.5 25.5 36.0 25.4 18.8 58.3 32.7 28.2 31.2 24.3 43.3 19.1 15.8 31.0 43.2 41.4 46.0 21.4 37.3 22.1 97.5 28.8 34.2 24.5 30.7 24.2 34.7 25.9 23.2 27.1 30.9 19.8 25.9 28.0 28.8 30.0 26.6 41.5 19.8 15.2 15.7 18.6 19.7 15.4 15.2 15.0 15.0 15.0 15.6 15.4 16.5 9.6 19.2 6.1 3.9 13.7 11.9 8.9 17.4 18.2 9.6 13.1 16.5 12.7 10.0 12.1 1.8 6.2 19.0 23.0 10.4 11.7 20.2 145.2 13.7 14.7 10.8 7.2 12.4 5.5 28.8 32.0 12.4 8.6 14.4 14.0 12.9 10.0 9.6 21.3 8.4 6.0 12.9 16.2 20.1 10.3 76.3 22.4 14.4 12.4 5.6 24.4 13.1 20.6 4.5 5.1 20.0 14.0 17.0 13.5 11.7 17.8 20.1 5.1 12.1 0.0 14.1 11.3 124.0 35.9 12.8 12.4 13.1 13.6 17.3 15.9 9.3 C19orf25 FLJ36666 ENSG00000119559 "Chromosome 19 open reading frame 25" Q9UFG5 19 1461143-1479219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050270, HPA067491" Approved Approved "Intermediate filaments" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Intermediate filaments" "HPA050270: AB_2681069, HPA067491: AB_2685849" "unprognostic (5.82e-2)" "unprognostic (3.87e-2)" "unprognostic (6.51e-2)" "prognostic favorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (2.14e-3)" "prognostic unfavorable (3.81e-4)" "unprognostic (1.10e-2)" "unprognostic (1.36e-1)" "unprognostic (2.49e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.35e-2)" "prognostic favorable (9.20e-8)" "unprognostic (3.50e-3)" "unprognostic (8.01e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-3)" 14.4 23.5 33.3 8.8 33.2 7.8 15.9 31.1 43.8 17.7 29.3 18.0 15.6 15.8 5.3 20.4 15.7 8.1 21.2 31.6 30.0 31.0 29.5 14.8 15.0 35.3 33.1 15.9 19.9 15.6 27.1 8.6 32.0 22.1 5.2 6.9 17.6 8.1 16.2 17.3 17.7 6.1 32.7 23.4 17.8 22.0 34.0 9.7 23.8 7.4 7.0 17.5 15.6 36.7 25.0 19.2 11.6 18.3 11.0 10.0 23.4 24.4 16.8 25.5 23.5 27.4 12.1 14.2 18.7 13.0 12.1 30.1 17.9 15.0 6.0 44.7 27.1 17.3 12.2 32.3 23.6 27.5 33.5 9.2 33.2 10.7 17.2 18.3 13.2 29.3 46.1 32.7 16.6 13.9 25.6 21.8 36.2 15.2 29.5 41.4 16.0 36.5 17.8 16.7 19.8 26.5 18.0 23.0 28.5 6.0 33.4 31.8 16.3 19.8 22.4 40.6 23.4 46.3 26.7 24.2 20.4 27.4 35.1 50.1 32.1 59.1 41.3 33.0 33.5 36.6 37.9 35.7 23.4 45.6 38.2 30.9 52.0 30.5 27.7 47.6 52.6 38.6 33.3 33.2 31.1 43.8 31.6 30.0 35.3 33.1 32.0 32.7 34.0 36.7 24.2 16.0 8.7 10.4 44.3 19.2 30.5 27.3 18.8 62.7 28.9 29.7 10.3 21.5 19.9 51.5 64.6 41.5 45.2 68.1 49.0 40.1 6.2 14.7 21.0 23.0 50.6 17.2 14.5 46.1 33.3 21.7 31.1 19.3 11.4 30.4 29.3 18.2 35.9 97.6 11.5 33.7 34.6 27.9 24.9 7.3 26.4 26.4 24.9 8.4 56.7 49.2 82.4 14.1 20.6 52.6 52.0 21.8 26.7 33.5 83.2 35.5 15.3 87.8 46.0 20.0 24.1 33.8 33.0 14.8 19.7 52.9 47.3 36.1 38.2 33.6 C1orf50 MGC955 ENSG00000164008 "Chromosome 1 open reading frame 50" Q9BV19 1 42767249-42779491 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 67.8;Late spermatids: 201.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030236 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA030236: AB_10602110" "unprognostic (1.86e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-1)" "unprognostic (6.35e-3)" "unprognostic (2.86e-1)" "unprognostic (1.29e-1)" "unprognostic (1.76e-3)" "unprognostic (9.15e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (5.63e-2)" "unprognostic (6.53e-3)" "unprognostic (1.72e-2)" "unprognostic (7.90e-3)" "unprognostic (3.64e-1)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.53e-1)" 9.2 11.5 2.6 1.4 2.7 3.9 9.0 2.4 2.6 9.3 1.3 9.7 1.7 6.9 1.7 8.9 7.2 1.0 14.0 2.5 3.1 13.0 16.9 6.4 1.7 2.5 2.5 9.9 8.8 2.4 12.3 1.5 2.3 9.6 1.6 3.1 7.0 1.4 15.5 8.7 8.5 1.5 2.7 9.2 8.9 14.9 3.1 1.7 7.6 3.3 1.6 9.1 8.7 2.8 1.4 0.6 3.7 3.1 2.3 3.0 2.2 2.2 2.0 2.0 2.0 1.1 1.5 3.5 2.2 3.0 1.0 1.9 2.8 1.6 1.9 4.0 1.7 3.3 2.1 1.6 2.1 3.8 2.7 2.3 2.6 2.2 3.5 2.1 2.0 4.0 3.7 1.8 1.8 1.1 3.7 1.9 3.0 1.6 1.6 3.7 3.5 2.7 1.8 2.4 4.1 2.8 2.9 1.9 2.6 3.2 1.6 3.9 2.0 1.5 1.6 2.7 1.9 2.8 2.8 2.5 1.5 2.7 1.5 1.6 1.1 1.7 1.0 1.1 0.8 1.5 1.0 1.1 1.0 1.1 1.1 1.1 1.1 1.1 2.3 1.8 1.3 1.0 2.6 2.7 2.4 2.6 2.5 3.1 2.5 2.5 2.3 2.7 3.1 2.8 4.9 0.0 3.7 3.9 17.0 9.2 10.1 28.5 10.8 3.4 5.5 9.8 22.5 8.6 16.0 11.0 2.1 27.9 8.9 13.5 23.5 10.0 67.8 4.1 5.5 9.3 19.2 12.4 9.2 4.0 30.3 10.9 9.2 3.3 10.2 5.7 20.3 29.2 27.4 0.0 8.4 14.3 22.4 20.0 14.7 201.1 13.7 8.7 14.2 5.6 18.0 11.8 17.5 6.0 10.7 7.7 17.5 6.8 16.2 14.1 40.0 21.0 11.0 8.2 6.6 10.8 11.3 43.6 35.5 14.3 7.7 33.8 14.6 7.0 13.1 11.2 C22orf39 MGC74441 ENSG00000242259 "Chromosome 22 open reading frame 39" Q6P5X5 22 19351368-19447711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 118.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073701 Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" "Endoplasmic reticulum" "HPA073701: AB_2686627" "unprognostic (4.97e-2)" "unprognostic (2.67e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.16e-4)" "unprognostic (1.27e-2)" "unprognostic (6.53e-2)" "unprognostic (5.07e-2)" "unprognostic (1.95e-3)" "unprognostic (8.93e-2)" "unprognostic (1.51e-2)" "unprognostic (1.45e-3)" "unprognostic (5.34e-3)" "prognostic favorable (1.44e-4)" "unprognostic (6.51e-2)" "unprognostic (2.92e-1)" "unprognostic (1.32e-2)" "unprognostic (5.32e-2)" 25.2 22.9 35.2 8.9 34.3 13.7 22.0 34.7 49.6 22.0 33.8 38.1 10.5 22.2 11.2 15.4 22.3 7.7 47.2 34.2 33.2 26.5 18.0 17.8 12.8 35.6 34.8 19.8 26.3 22.6 24.3 10.4 36.3 26.2 11.8 23.9 16.4 13.6 118.6 19.3 19.7 11.3 35.0 21.0 23.5 16.7 35.9 16.2 27.9 44.8 12.4 26.9 17.8 34.4 20.7 7.1 16.3 11.5 17.5 15.4 12.1 5.9 5.7 13.7 15.8 11.3 4.8 15.8 6.8 6.4 8.2 17.3 16.3 10.9 14.7 17.3 66.7 20.1 19.2 26.5 17.1 30.8 19.5 12.9 17.6 7.3 19.9 14.7 14.0 33.6 60.6 21.5 9.0 10.1 24.0 27.3 7.2 42.4 18.2 25.8 23.9 11.5 18.4 12.1 24.8 12.4 11.8 8.3 23.9 14.9 11.4 18.4 13.4 9.9 18.6 7.0 9.1 29.4 12.6 22.8 11.6 14.7 9.4 36.4 29.6 72.0 23.0 33.8 21.9 27.8 25.7 19.7 26.1 27.9 25.9 21.4 43.0 31.1 30.3 38.8 35.3 26.7 35.2 34.3 34.7 49.6 34.2 33.2 35.6 34.8 36.3 35.0 35.9 34.4 41.6 22.4 40.4 10.1 39.5 24.3 28.4 58.8 23.3 28.7 42.8 44.3 94.1 27.1 50.8 36.8 16.7 54.6 50.8 44.3 107.6 40.4 21.5 36.0 20.8 29.7 45.1 41.2 13.9 77.9 47.9 31.2 35.7 26.4 26.6 25.9 36.0 35.3 65.4 18.5 17.3 44.4 52.9 38.0 33.5 12.7 35.1 32.8 39.2 5.6 59.6 52.3 60.8 10.1 14.5 58.7 42.0 33.8 37.6 34.6 69.0 67.2 46.1 20.4 46.0 31.9 36.9 54.8 57.6 37.8 32.5 50.3 34.9 33.1 55.9 31.2 C4orf3 "ALN, HCVFTP1" ENSG00000164096 "Chromosome 4 open reading frame 3" Q8WVX3 4 119296419-119304445 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 1070.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026907 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum" "HPA026907: AB_10600760" "unprognostic (2.97e-1)" "unprognostic (4.68e-2)" "unprognostic (3.32e-1)" "unprognostic (6.85e-3)" "unprognostic (9.30e-2)" "unprognostic (7.15e-3)" "unprognostic (2.04e-1)" "unprognostic (8.85e-2)" "unprognostic (4.90e-2)" "unprognostic (7.11e-2)" "unprognostic (9.94e-3)" "unprognostic (1.84e-1)" "prognostic favorable (3.46e-4)" "unprognostic (8.32e-2)" "unprognostic (2.65e-1)" "unprognostic (3.90e-1)" "unprognostic (1.59e-1)" 80.0 67.8 96.4 54.1 107.1 34.1 69.4 103.1 148.1 123.2 83.3 80.2 60.5 79.7 77.9 268.2 68.9 65.1 107.8 90.1 99.6 97.9 110.8 70.3 61.3 107.9 104.9 85.5 51.5 55.5 56.6 60.3 106.4 71.8 43.6 74.7 89.6 69.8 79.6 89.3 67.3 70.6 109.6 63.1 49.6 39.8 109.2 64.8 71.4 59.7 56.8 75.9 150.2 112.8 116.8 13.7 58.4 49.8 107.1 97.0 34.1 59.3 31.6 35.3 62.6 15.6 44.5 95.9 36.6 87.3 31.0 24.8 29.6 54.1 61.8 57.1 21.3 40.9 33.5 67.9 35.9 64.7 42.8 96.4 64.5 30.0 14.4 120.6 52.8 29.1 33.8 50.4 137.6 41.8 50.9 64.0 24.2 60.7 20.9 32.9 62.6 27.3 53.5 32.2 38.4 54.8 46.4 58.5 43.2 56.9 32.6 37.5 55.7 80.3 34.6 52.5 21.4 51.3 59.8 37.2 156.7 36.7 40.9 257.8 110.0 145.4 85.1 132.6 92.9 126.7 109.6 101.5 95.1 104.8 120.4 114.4 239.4 109.6 128.0 131.6 112.9 157.1 96.4 107.1 103.1 148.1 90.1 99.6 107.9 104.9 106.4 109.6 109.2 112.8 213.2 157.0 150.5 11.4 211.3 315.5 292.0 809.1 132.1 79.1 198.4 191.9 544.4 158.7 456.3 222.5 25.0 321.5 228.9 117.0 383.5 288.5 38.1 272.5 148.7 245.6 68.4 78.6 22.2 179.1 403.9 215.0 46.4 134.3 186.1 108.0 234.9 446.4 317.4 153.1 21.6 170.2 408.9 303.5 298.4 31.0 167.4 244.9 199.3 16.9 423.9 233.4 253.3 6.6 16.3 207.6 196.8 215.5 239.0 392.5 500.1 1070.2 542.7 78.9 197.2 145.8 246.0 182.7 67.0 245.9 346.6 445.7 203.2 150.3 135.8 428.1 C4orf48 ENSG00000243449 "Chromosome 4 open reading frame 48" Q5BLP8 4 2041993-2043970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.9;choroid plexus: 62.6;pituitary gland: 74.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 412.4;Paneth cells: 484.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 158.3;NB-4: 117.3;PC-3: 343.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052447 Uncertain Approved Cytosol "Secreted to blood" NA NA 190000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA052447: AB_2681837" "unprognostic (7.96e-2)" "unprognostic (2.57e-3)" "unprognostic (2.08e-1)" "unprognostic (3.20e-2)" "unprognostic (4.01e-2)" "unprognostic (8.26e-2)" "unprognostic (4.85e-3)" "unprognostic (2.51e-3)" "unprognostic (2.28e-3)" "unprognostic (1.80e-1)" "unprognostic (1.95e-2)" "unprognostic (5.55e-2)" "unprognostic (3.42e-2)" "unprognostic (5.38e-3)" "unprognostic (2.68e-1)" "unprognostic (5.55e-2)" "unprognostic (3.17e-3)" 13.5 18.3 50.0 4.6 68.4 2.7 9.6 71.0 66.6 5.2 62.6 20.4 2.7 5.5 0.2 4.3 7.8 0.4 8.2 49.4 60.8 20.2 4.0 7.9 1.3 81.5 63.2 6.6 18.9 2.4 74.5 2.1 58.6 7.1 0.9 0.2 9.2 1.4 1.2 3.1 16.3 0.6 67.8 18.5 11.9 56.1 60.3 0.3 9.3 0.0 0.6 6.8 2.9 97.9 33.4 27.1 5.3 24.9 2.4 3.9 35.3 31.2 6.0 5.6 5.3 18.6 19.6 4.4 29.2 1.2 10.4 9.2 0.6 3.5 1.7 20.1 158.3 10.5 15.8 10.7 5.2 21.7 70.3 3.0 5.9 1.2 0.0 1.8 5.9 17.9 35.1 0.1 3.9 20.6 24.6 117.3 15.8 1.8 343.1 56.1 8.3 11.2 5.0 12.3 42.7 60.0 15.3 0.7 47.7 0.5 8.3 10.3 26.5 14.7 31.9 11.0 35.3 23.8 22.4 0.4 14.6 13.2 20.8 88.5 451.6 431.5 123.6 325.6 127.5 187.7 157.2 138.3 270.0 167.9 89.1 92.9 349.2 29.6 290.7 301.1 199.8 192.8 50.0 68.4 71.0 66.6 49.4 60.8 81.5 63.2 58.6 67.8 60.3 97.9 13.3 0.0 1.9 8.8 58.1 21.9 6.6 13.2 7.4 12.0 147.0 139.8 10.6 20.0 14.2 200.5 0.0 8.0 52.8 412.4 70.5 320.8 97.1 326.7 92.6 42.1 235.1 30.7 5.6 222.7 116.5 47.7 35.7 107.3 107.5 209.0 123.1 11.9 235.5 18.5 8.2 154.2 44.7 272.1 113.3 350.5 19.3 158.9 327.3 7.5 205.2 78.8 20.6 6.0 41.1 198.2 484.2 28.2 84.1 10.9 223.7 7.9 28.8 15.0 13.1 1.7 53.2 99.7 193.2 5.7 10.1 13.1 73.9 50.9 117.1 11.1 CAMTA1 KIAA0833 ENSG00000171735 "Calmodulin binding transcription activator 1" Q9Y6Y1 1 6785454-7769706 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036342, HPA036343" Approved Supported Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA036342: AB_2675072, HPA036343: AB_10671839" "unprognostic (1.11e-1)" "unprognostic (6.31e-2)" "unprognostic (5.80e-2)" "unprognostic (4.14e-3)" "unprognostic (3.10e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "prognostic favorable (4.10e-4)" "unprognostic (3.90e-3)" "unprognostic (8.84e-2)" "unprognostic (1.35e-3)" "unprognostic (2.17e-2)" "unprognostic (9.19e-3)" "unprognostic (1.42e-1)" "unprognostic (9.03e-3)" 37.1 43.7 56.2 23.6 55.3 26.5 38.7 63.4 75.8 33.0 29.4 71.8 52.8 40.1 81.7 37.5 36.0 30.4 114.0 55.0 68.6 68.4 70.5 36.7 27.3 69.4 66.0 35.4 26.4 43.3 35.5 26.4 68.7 47.0 48.5 68.2 50.5 50.5 101.6 26.0 41.1 42.4 61.5 30.7 45.2 44.5 66.4 31.9 52.0 104.7 33.5 56.5 35.2 60.8 67.6 37.2 101.2 51.7 51.2 77.6 28.4 71.0 54.7 75.3 63.1 45.1 83.2 55.5 54.6 75.2 50.3 40.8 53.6 73.7 106.5 41.8 57.8 62.7 85.1 89.6 83.0 48.2 43.6 52.5 50.2 54.5 83.0 64.6 85.1 77.7 44.8 73.2 87.9 65.0 64.6 130.9 70.2 85.2 43.2 42.5 90.2 123.7 103.4 38.7 104.2 83.7 50.4 74.1 113.9 72.3 40.2 59.4 50.1 53.1 44.9 55.3 45.2 55.2 74.3 153.2 79.6 107.4 30.7 80.1 74.7 70.5 25.8 48.5 28.3 48.1 39.8 32.0 73.4 41.8 32.2 28.1 15.4 26.7 37.9 77.5 45.6 46.3 56.2 55.3 63.4 75.8 55.0 68.6 69.4 66.0 68.7 61.5 66.4 60.8 142.1 54.5 48.8 314.7 74.3 309.7 340.6 306.6 169.0 106.7 231.7 283.2 565.2 101.5 135.3 191.3 252.3 69.8 44.3 198.3 418.7 180.1 166.1 84.1 80.3 155.8 130.8 81.8 346.1 206.3 144.9 134.4 63.2 99.8 55.2 205.4 106.1 239.0 106.3 158.2 479.3 185.8 223.8 95.5 254.0 137.9 76.4 122.0 238.3 117.1 172.9 112.3 38.1 330.3 227.5 184.2 234.5 128.6 87.9 486.4 251.7 750.7 117.1 156.2 138.1 91.1 233.2 151.0 211.0 158.9 282.7 88.1 68.2 137.8 186.5 413.7 CAPG "AFCP, MCP" ENSG00000042493 "Capping actin protein, gelsolin like" P40121 2 85394753-85418432 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018843, HPA019080, HPA019092" Enhanced Enhanced Nucleoplasm Yes No 5400000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980" "unprognostic (2.82e-2)" "unprognostic (1.37e-1)" "unprognostic (8.80e-2)" "unprognostic (1.28e-2)" "unprognostic (4.37e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-5)" "unprognostic (8.83e-2)" "unprognostic (3.22e-2)" "unprognostic (1.54e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-1)" "prognostic favorable (2.96e-4)" "unprognostic (1.45e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-3)" "unprognostic (7.89e-3)" 92.4 26.3 42.8 82.4 44.2 159.3 94.9 46.3 79.6 119.1 37.5 56.9 30.3 50.0 46.2 289.5 48.7 44.4 19.2 41.7 51.1 201.1 8.9 175.7 117.9 60.2 46.3 19.7 44.9 151.7 27.2 26.1 57.2 76.5 42.9 4.2 111.8 38.0 16.5 219.9 54.2 24.5 57.5 46.2 94.4 26.0 66.1 58.0 162.3 5.8 109.5 97.1 174.8 79.4 165.5 75.9 0.7 6.9 50.2 102.8 83.7 59.6 6.1 51.2 49.8 9.4 563.6 28.1 96.6 116.0 64.0 181.1 0.2 113.7 23.0 142.0 4.4 74.3 128.0 29.3 40.6 44.8 972.7 93.8 80.5 53.8 70.3 3.6 37.5 143.8 8.2 60.1 38.1 150.1 101.3 414.8 23.2 166.5 112.8 87.3 13.3 11.8 220.6 77.7 0.8 1.4 86.9 128.4 722.2 44.2 40.0 513.5 148.7 111.6 26.8 4.6 2.4 1.4 6.2 10.3 259.5 569.5 1.5 1136.5 1139.3 712.7 12.2 431.6 39.2 575.6 107.8 41.1 1363.2 516.8 30.5 13.9 162.9 605.5 131.3 959.7 122.1 977.9 42.8 44.2 46.3 79.6 41.7 51.1 60.2 46.3 57.2 57.5 66.1 79.4 6.6 19.2 24.5 3.3 84.7 121.2 167.5 265.0 60.9 0.8 86.8 70.4 1.3 51.5 119.6 316.3 0.0 34.3 91.5 211.0 211.3 113.8 4.1 33.0 10.3 16.2 28.8 16.0 0.2 91.5 324.0 34.7 124.9 63.9 548.8 1.2 3.6 1.1 1107.4 1.7 0.2 55.9 50.8 141.6 337.2 15.2 46.9 432.1 147.7 1.0 432.4 43.6 11.3 0.5 0.1 405.8 205.4 22.6 17.2 106.0 74.1 168.5 48.8 1.7 13.1 2.0 54.0 9.6 33.1 167.4 169.5 35.7 101.9 0.9 83.9 253.1 CBLL1 "FLJ23109, HAKAI, RNF188" ENSG00000105879 "Cbl proto-oncogene like 1" Q75N03 7 107743949-107761667 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021773, HPA026699" Enhanced Supported "Nuclear speckles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nuclear speckles" "HPA021773: AB_1846103, HPA026699: AB_1846104" "unprognostic (1.90e-2)" "unprognostic (2.25e-1)" "unprognostic (8.57e-2)" "unprognostic (3.79e-2)" "unprognostic (8.16e-2)" "unprognostic (7.20e-2)" "unprognostic (1.37e-2)" "unprognostic (3.96e-3)" "unprognostic (4.28e-2)" "unprognostic (2.16e-3)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (2.12e-3)" "unprognostic (9.12e-2)" "unprognostic (2.07e-1)" "unprognostic (1.09e-1)" "unprognostic (8.71e-2)" 11.2 8.1 3.1 12.5 5.3 40.0 15.1 7.8 9.5 12.0 3.0 11.3 9.5 13.5 8.4 11.3 11.2 8.7 10.4 4.2 5.8 10.0 11.2 10.3 16.1 4.1 3.7 14.3 11.7 14.1 5.1 12.0 4.1 16.5 11.1 14.4 8.9 12.7 29.0 10.7 10.3 13.4 3.0 14.2 9.2 19.7 3.7 20.2 13.8 21.0 17.8 11.9 7.2 6.6 27.8 31.1 23.7 30.7 21.7 18.6 16.2 20.5 21.6 22.8 22.5 21.4 27.9 40.6 28.5 23.5 37.6 19.3 33.4 25.0 31.0 28.4 21.1 32.5 23.0 18.2 24.9 49.1 30.9 19.6 22.7 30.7 33.0 17.6 23.8 27.8 53.0 33.3 22.4 48.0 66.5 34.4 34.4 23.3 21.3 30.6 25.4 42.0 17.4 25.5 25.4 39.6 30.7 44.9 23.4 27.7 15.1 24.7 23.4 35.0 25.0 33.4 32.0 53.0 62.3 64.1 21.3 29.8 30.3 88.8 31.1 53.3 39.5 32.0 58.2 39.0 61.9 45.8 36.9 39.8 41.8 40.0 48.9 55.1 38.0 20.1 92.6 48.4 3.1 5.3 7.8 9.5 4.2 5.8 4.1 3.7 4.1 3.0 3.7 6.6 18.2 19.2 11.0 6.5 29.6 23.6 16.7 10.5 27.3 12.2 15.9 13.7 16.4 17.2 10.7 3.7 4.2 10.3 27.6 9.9 7.9 9.7 12.4 15.6 19.8 13.5 16.8 39.1 13.9 10.8 9.5 12.6 10.7 13.7 13.3 16.6 12.5 11.0 10.7 10.1 13.1 8.0 8.2 23.3 12.4 5.4 9.3 15.1 19.6 15.9 15.0 7.6 25.7 10.1 20.5 10.1 15.0 11.7 17.3 16.2 8.5 11.2 8.9 14.4 19.7 13.2 14.5 27.2 14.3 19.5 19.9 10.3 27.3 9.5 10.0 18.4 CBWD2 ENSG00000136682 "COBW domain containing 2" Q8IUF1 2 113437691-113496204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 110.3;Suprabasal keratinocytes: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 28: Keratinocytes - Keratinization" "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (4.14e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (7.69e-2)" "unprognostic (2.17e-1)" "unprognostic (2.16e-3)" "unprognostic (1.31e-3)" "unprognostic (3.69e-2)" "unprognostic (1.72e-2)" "unprognostic (5.85e-2)" "unprognostic (1.39e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (7.57e-3)" 4.7 8.3 5.8 5.3 6.3 1.5 7.0 7.0 7.2 8.2 7.1 8.4 2.2 7.0 7.1 9.4 4.5 4.5 15.9 6.3 6.7 13.8 10.5 4.0 3.2 6.0 6.2 5.4 5.6 16.2 8.8 5.9 6.1 6.4 5.9 6.3 8.1 7.4 26.0 4.3 4.6 8.1 5.5 4.9 6.5 2.0 6.0 6.8 9.6 23.9 4.6 8.7 5.4 6.4 16.1 9.7 9.8 11.2 25.7 11.8 19.2 11.9 7.4 9.1 12.0 16.0 9.6 20.7 36.2 12.8 42.1 13.2 10.8 13.2 12.0 7.5 28.9 17.4 16.8 29.8 8.6 8.1 7.8 11.1 8.1 13.4 8.1 17.7 17.1 11.1 10.1 22.2 13.4 17.1 23.3 24.2 11.9 30.2 20.7 10.9 26.6 54.6 24.6 25.1 28.0 8.0 31.4 4.6 5.1 33.7 14.5 21.6 20.8 7.7 10.7 4.8 11.9 8.5 38.2 10.5 12.8 44.5 19.3 15.6 67.7 35.6 12.1 68.4 13.2 17.9 18.2 14.3 65.3 22.7 15.3 14.1 18.5 20.2 56.2 16.2 27.0 52.9 5.8 6.3 7.0 7.2 6.3 6.7 6.0 6.2 6.1 5.5 6.0 6.4 5.6 9.6 20.5 11.8 32.5 110.3 12.8 24.5 62.6 10.5 15.9 14.9 49.6 18.6 20.0 14.7 16.7 17.6 7.1 7.2 39.2 29.6 18.6 10.3 7.1 11.9 2.4 23.7 27.3 14.3 13.2 16.4 23.0 11.1 15.8 9.5 6.1 11.4 9.0 13.5 25.8 11.4 16.2 9.4 62.5 18.4 10.8 20.0 26.6 21.5 53.8 10.9 2.1 15.6 24.9 12.7 14.1 17.3 78.7 14.9 13.7 33.9 26.4 14.0 0.0 9.6 17.1 21.7 13.6 61.0 120.0 25.9 18.4 11.6 17.3 12.2 CCDC159 ENSG00000183401 "Coiled-coil domain containing 159" P0C7I6 19 11344684-11354944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 275.7;Late spermatids: 277.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047126, HPA054655" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" Cytosol "HPA047126: AB_10961722, HPA054655: AB_2682558" "unprognostic (1.46e-1)" "unprognostic (3.05e-3)" "unprognostic (2.35e-3)" "prognostic favorable (1.87e-7)" "unprognostic (5.02e-2)" "unprognostic (1.06e-3)" "unprognostic (9.23e-3)" "unprognostic (2.40e-2)" "unprognostic (6.68e-2)" "prognostic favorable (9.46e-4)" "prognostic favorable (1.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.97e-2)" "unprognostic (5.09e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-2)" "prognostic favorable (8.62e-4)" 15.7 43.4 29.3 17.3 33.8 32.6 18.2 28.9 41.0 30.0 29.2 25.8 22.9 22.5 24.9 18.2 24.0 20.6 21.8 32.3 31.3 25.9 36.0 22.8 20.9 34.4 31.3 31.3 23.3 39.5 33.5 9.3 33.4 45.1 11.8 12.4 21.6 18.5 6.1 19.0 24.0 13.8 27.4 41.8 26.2 43.2 34.2 12.4 30.4 6.7 14.5 24.2 21.7 38.1 3.7 3.2 2.6 8.0 10.3 14.8 2.7 5.8 6.0 6.7 8.9 1.0 3.8 3.0 14.7 11.0 2.0 3.0 1.5 9.2 4.1 15.0 2.2 7.2 2.5 3.9 17.9 2.8 10.4 17.8 24.0 4.9 6.5 7.1 19.2 5.3 6.5 33.6 3.4 4.5 4.5 6.0 1.4 5.0 11.5 4.8 0.0 19.6 6.1 5.3 1.1 4.3 5.9 6.6 11.0 4.6 9.8 11.9 12.8 5.3 1.6 9.3 5.5 30.8 8.0 6.2 7.2 14.7 7.9 51.5 52.8 38.5 21.5 46.3 21.1 16.0 14.6 20.2 31.6 20.4 13.2 10.4 25.3 30.2 33.8 8.4 31.5 23.5 29.3 33.8 28.9 41.0 32.3 31.3 34.4 31.3 33.4 27.4 34.2 38.1 10.7 16.0 13.6 7.5 14.5 7.5 15.4 14.9 10.8 11.3 12.5 8.9 9.8 12.8 16.7 18.4 41.7 5.1 12.4 13.0 25.4 8.2 275.7 9.0 8.8 10.3 10.8 4.6 4.5 9.5 5.5 8.1 30.5 10.0 34.2 11.5 12.8 10.9 23.3 6.7 3.0 12.5 10.2 26.7 14.8 277.4 11.5 20.3 12.4 2.8 28.9 16.6 39.1 2.0 10.2 8.7 24.0 13.5 15.0 16.6 29.2 38.6 16.9 27.9 0.0 5.2 8.4 4.7 3.9 11.0 8.1 6.0 17.9 20.1 9.5 19.7 CCDC47 GK001 ENSG00000108588 "Coiled-coil domain containing 47" Q96A33 17 63745255-63776351 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029674, HPA072573, HPA075958" Approved Enhanced "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Endoplasmic reticulum" "HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: " "unprognostic (6.33e-2)" "unprognostic (3.26e-2)" "prognostic favorable (2.17e-4)" "unprognostic (1.38e-1)" "unprognostic (3.54e-1)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (9.08e-2)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.73e-1)" "unprognostic (1.26e-1)" "unprognostic (8.35e-2)" "unprognostic (1.88e-1)" "unprognostic (6.43e-2)" "unprognostic (7.46e-2)" "unprognostic (1.16e-1)" 57.9 67.3 24.3 42.5 33.6 29.0 57.1 28.8 39.2 47.7 46.9 83.4 87.1 39.1 53.7 52.6 43.9 48.2 65.5 29.3 27.9 72.0 102.2 52.7 33.5 28.8 27.4 35.3 59.8 84.6 21.9 54.8 29.9 60.2 80.6 46.9 62.4 52.0 115.3 52.2 78.2 42.1 30.1 35.6 78.5 32.1 26.0 29.9 62.0 83.7 40.5 58.5 29.3 34.3 143.3 133.8 81.4 71.9 112.4 74.0 158.0 141.9 92.6 96.1 112.4 118.7 127.0 112.9 74.3 100.9 110.8 114.3 99.3 88.1 168.9 39.4 101.2 160.9 106.4 117.3 107.6 129.9 81.3 78.5 121.3 132.4 113.2 67.9 81.3 55.3 183.5 95.5 79.4 116.1 100.5 48.1 70.8 179.4 134.0 92.2 157.9 154.6 115.3 161.1 74.2 101.5 95.2 242.8 120.3 103.0 159.8 70.4 104.0 177.6 112.9 130.6 166.0 93.9 119.9 112.8 103.9 81.4 147.3 53.2 59.7 75.6 40.7 61.5 47.9 38.4 39.8 37.9 82.5 31.7 41.1 36.2 47.6 43.4 65.9 54.7 49.0 52.0 24.3 33.6 28.8 39.2 29.3 27.9 28.8 27.4 29.9 30.1 26.0 34.3 96.9 144.2 122.2 16.3 46.6 100.8 108.5 95.9 98.4 40.9 65.9 53.6 129.0 72.9 128.3 60.7 14.6 111.1 59.0 99.8 9.8 115.3 17.9 80.3 73.9 83.9 52.2 76.6 26.2 105.1 98.3 85.3 65.7 126.0 45.5 31.2 68.2 96.3 57.5 57.2 25.9 95.1 83.4 56.9 58.3 11.5 47.8 60.7 39.2 13.1 52.9 55.3 25.7 22.6 25.5 92.0 62.6 56.1 56.0 89.6 87.5 32.6 83.0 27.9 72.3 117.2 92.1 82.0 44.7 90.1 90.8 144.1 42.7 53.0 110.5 83.3 CCS ENSG00000173992 "Copper chaperone for superoxide dismutase" O14618 11 66593153-66606019 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 204.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008672, HPA040026, HPA044090" Approved NA NA 190000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" "CAB008672: AB_1623300, HPA040026: AB_2676806, HPA044090: AB_2678805" "unprognostic (1.19e-1)" "unprognostic (8.46e-3)" "unprognostic (3.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.57e-2)" "unprognostic (3.22e-2)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.01e-1)" "unprognostic (3.00e-1)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (3.25e-3)" 21.1 26.6 29.6 18.5 30.5 34.4 14.1 33.4 40.5 18.5 30.7 21.9 27.9 19.8 18.3 16.5 17.7 21.1 21.4 30.7 31.1 21.3 56.2 15.6 23.8 32.4 30.9 23.6 31.1 22.6 17.3 17.9 30.4 22.6 14.7 24.9 36.8 20.0 19.1 21.9 30.1 17.2 30.3 21.8 23.3 16.9 31.3 15.9 17.3 14.2 17.3 17.7 14.7 35.0 24.6 34.1 24.4 26.9 22.0 21.4 29.9 22.4 18.7 15.9 10.7 38.8 26.5 14.4 31.3 19.9 23.8 24.6 7.2 25.8 5.3 26.8 10.9 23.3 30.5 51.1 42.3 6.0 18.3 35.8 18.9 16.9 11.1 33.6 26.0 16.5 12.3 19.2 16.5 55.0 9.5 30.1 22.7 40.2 23.9 17.4 23.3 29.8 25.0 25.6 19.9 12.9 37.2 25.4 49.7 14.4 38.9 17.4 23.6 10.8 17.7 24.4 10.8 32.1 19.2 7.6 29.7 9.2 26.5 23.6 26.4 60.0 19.7 21.0 17.0 32.5 16.9 16.0 31.1 25.3 17.7 17.9 17.8 19.1 13.0 83.7 18.4 17.3 29.6 30.5 33.4 40.5 30.7 31.1 32.4 30.9 30.4 30.3 31.3 35.0 37.8 19.2 33.7 58.8 56.1 24.2 52.9 44.7 31.3 42.4 33.6 37.5 29.9 45.8 30.4 36.8 25.0 55.2 59.3 49.7 82.2 34.1 25.4 16.5 38.0 28.7 73.0 204.4 20.2 59.8 43.8 60.4 44.4 27.2 21.5 63.9 39.3 163.5 64.9 11.8 19.1 41.1 26.4 35.8 32.3 12.6 71.4 43.8 44.4 23.4 38.5 65.4 44.3 15.1 20.6 40.5 44.9 57.2 50.6 31.2 90.4 132.9 19.7 104.2 19.7 31.8 67.1 46.7 31.4 30.1 20.3 51.6 41.0 191.3 46.7 37.2 CCZ1 "C7orf28A, CCZ1A, CGI-43" ENSG00000122674 "CCZ1 homolog, vacuolar protein trafficking and biogenesis associated" P86791 7 5898725-5926550 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045114, HPA050006" Uncertain Enhanced Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Vesicles "HPA045114: AB_2679219, HPA050006: AB_2680989" "unprognostic (1.91e-1)" "unprognostic (2.97e-3)" "unprognostic (3.15e-2)" "unprognostic (1.25e-2)" "unprognostic (1.82e-1)" "unprognostic (5.35e-2)" "unprognostic (3.74e-3)" "unprognostic (4.10e-1)" "unprognostic (9.25e-3)" "unprognostic (7.66e-2)" "unprognostic (6.64e-2)" "unprognostic (2.67e-2)" "unprognostic (5.27e-3)" "unprognostic (3.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-1)" "unprognostic (4.41e-1)" 32.5 55.8 10.7 12.8 10.9 26.9 30.2 12.2 13.7 28.7 12.9 31.1 13.0 29.7 9.4 40.8 25.2 10.3 31.3 11.4 10.5 27.3 27.3 26.0 15.4 10.7 10.4 23.0 27.3 29.9 24.9 12.2 10.6 24.6 16.0 12.6 32.1 11.9 43.2 30.3 26.9 13.9 10.5 31.5 29.0 22.1 11.0 20.5 25.5 13.0 16.2 31.7 28.9 11.6 52.2 29.8 30.3 27.1 41.8 35.4 15.3 15.6 30.1 23.1 25.0 9.1 27.2 42.8 4.8 40.8 61.9 27.8 16.6 26.7 26.5 16.2 37.3 18.1 30.2 16.8 38.0 13.1 7.1 40.5 42.4 15.6 19.5 42.5 57.2 25.4 52.4 29.7 38.8 26.9 16.8 56.9 39.5 26.4 28.3 36.0 13.8 28.9 21.1 38.3 23.9 31.9 15.3 36.6 13.6 57.9 26.1 21.0 27.7 28.8 57.4 18.7 25.7 13.6 24.6 58.0 9.6 30.8 41.6 3.1 1.9 2.7 1.8 2.3 1.4 1.3 2.2 2.2 1.8 1.3 1.5 1.6 3.4 3.0 2.4 1.8 4.6 0.7 10.7 10.9 12.2 13.7 11.4 10.5 10.7 10.4 10.6 10.5 11.0 11.6 30.7 3.2 23.5 15.7 26.3 45.2 30.6 21.2 9.6 59.2 29.5 20.2 11.0 24.3 24.0 31.3 62.6 45.0 47.2 38.0 31.3 61.0 6.5 18.7 18.1 35.0 29.9 26.7 20.2 71.4 35.9 26.7 11.2 21.3 15.8 21.1 76.4 17.6 35.7 23.5 20.5 30.8 50.8 39.0 61.6 4.9 37.9 27.5 46.2 8.4 80.8 41.5 72.1 15.6 28.7 74.0 30.1 36.1 14.3 26.2 40.2 21.9 32.9 69.2 78.9 19.4 32.0 40.6 34.5 11.0 54.1 34.9 32.8 38.2 34.4 33.7 CD2BP2 "LIN1, PPP1R59, Snu40, U5-52K" ENSG00000169217 "CD2 cytoplasmic tail binding protein 2" O95400 16 30350773-30355308 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041508, HPA061309" Enhanced Enhanced "Nuclear speckles,Cytosol" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" "Nuclear speckles" Cytosol "HPA041508: AB_2677523, HPA061309: AB_2684476" "unprognostic (5.66e-2)" "unprognostic (7.50e-3)" "unprognostic (1.47e-1)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.71e-2)" "unprognostic (1.16e-1)" "unprognostic (9.76e-2)" "unprognostic (2.30e-2)" "unprognostic (7.47e-2)" "unprognostic (2.09e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" 31.1 49.3 38.9 34.0 39.7 23.9 32.9 38.0 41.5 39.6 34.0 39.3 29.9 45.0 24.9 35.3 41.0 22.0 35.2 39.9 41.2 42.8 27.3 32.8 38.8 41.4 39.8 36.9 40.7 42.5 42.7 24.4 39.1 38.3 23.7 16.2 30.0 35.5 46.9 33.6 35.2 31.6 39.0 46.4 36.9 24.0 41.6 35.7 42.5 26.6 43.7 37.0 30.1 42.0 55.4 65.7 54.4 49.4 44.3 41.9 46.0 60.0 71.5 66.8 71.3 50.6 64.9 84.6 72.3 65.5 61.4 59.4 57.0 70.3 53.6 50.6 66.6 35.9 67.7 60.3 63.6 51.3 63.4 45.2 58.7 74.2 47.3 45.6 70.3 62.1 41.4 63.2 67.7 132.1 71.6 43.6 73.8 42.9 38.5 104.2 45.3 64.3 54.2 54.7 44.7 85.1 40.2 69.9 42.0 44.7 66.4 41.1 50.6 76.3 53.3 38.9 53.1 105.0 82.3 78.5 52.5 47.2 64.0 107.4 61.7 116.6 71.3 76.3 56.8 87.5 57.3 66.7 55.8 97.3 47.6 58.9 121.9 74.5 102.7 67.1 94.4 79.6 38.9 39.7 38.0 41.5 39.9 41.2 41.4 39.8 39.1 39.0 41.6 42.0 38.1 32.1 29.0 7.2 39.5 28.8 49.6 58.4 31.9 29.8 33.2 29.6 26.5 45.8 41.2 36.8 20.9 61.0 57.0 50.5 60.7 83.6 19.9 41.7 30.7 42.8 33.0 22.3 6.7 97.5 58.1 36.4 28.1 45.2 47.6 33.4 28.2 13.9 69.7 11.8 7.1 32.7 36.7 38.3 23.6 14.2 35.4 34.0 39.2 8.4 84.1 47.6 97.9 3.5 10.7 87.8 64.9 35.7 52.7 40.7 60.3 81.5 46.3 29.0 39.5 30.5 44.6 38.5 40.1 27.4 30.4 88.7 41.9 38.9 31.6 50.7 CD300A "CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60" ENSG00000167851 "CD300a molecule" Q9UGN4 17 74466399-74484794 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 95.2" "Cell type enhanced" "Detected in some" "dendritic cells: 103.5;granulocytes: 59.5;Hofbauer cells: 114.0;Kupffer cells: 97.6;Macrophages: 90.9;NK-cells: 225.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 104.4;NB-4: 45.9;RPMI-8226: 88.7" "HPA010971, HPA011645" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Vesicles, Cytosol" "HPA010971: , HPA011645: AB_1846988" "unprognostic (1.99e-1)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.01e-1)" "unprognostic (1.04e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.17e-2)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (5.97e-2)" "unprognostic (5.45e-3)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" 10.6 7.5 6.7 31.1 7.1 24.4 4.6 7.1 31.1 2.8 7.5 9.2 11.3 3.5 1.8 3.5 3.1 14.2 4.7 6.9 7.8 3.5 14.6 18.1 27.0 11.4 8.6 1.5 3.2 1.4 3.6 13.9 13.2 4.0 8.6 1.0 4.0 2.5 1.6 4.5 13.5 11.7 9.2 95.2 4.9 1.2 12.1 14.1 2.3 2.7 11.7 9.5 2.6 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 5.5 104.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 1.5 45.9 0.0 0.0 0.0 0.2 0.0 88.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 17.1 0.0 845.6 170.3 481.9 226.4 374.2 48.3 18.9 45.5 67.5 159.2 6.4 16.7 52.5 560.5 456.5 387.6 149.7 3.1 197.0 6.7 7.1 7.1 31.1 6.9 7.8 11.4 8.6 13.2 9.2 12.1 12.5 1.0 0.0 7.4 0.3 7.8 0.9 0.1 0.2 0.0 0.0 0.6 1.8 0.6 1.5 0.7 0.0 0.0 0.7 103.5 0.1 0.0 0.1 0.0 0.6 0.2 2.5 0.0 5.7 0.1 0.0 1.2 0.8 0.5 0.7 59.5 0.0 2.2 1.3 114.0 0.0 0.3 0.2 0.0 97.6 24.0 0.4 0.0 90.9 3.6 5.6 36.6 0.0 225.6 1.0 0.0 0.0 0.1 0.0 14.5 0.1 0.0 0.4 0.6 0.1 6.6 0.6 0.5 0.0 0.4 0.2 0.6 1.5 33.2 0.0 0.2 0.2 CD58 LFA3 ENSG00000116815 "CD58 molecule" P19256 1 116514534-116571039 "CD markers, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 144.1;Langerhans cells: 195.9;monocytes: 156.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 135.9" "Low region specificity" "Detected in all" NA NA 6500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (4.48e-3)" "unprognostic (3.20e-1)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "unprognostic (8.45e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.32e-6)" "unprognostic (9.84e-2)" "unprognostic (7.17e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.68e-2)" "unprognostic (2.17e-2)" "unprognostic (9.66e-2)" 22.7 10.1 7.5 24.8 8.2 57.9 18.0 8.0 10.5 13.6 10.2 22.3 28.8 12.8 16.1 25.4 12.5 21.5 34.3 7.4 8.8 20.0 12.7 29.1 19.0 9.2 8.4 5.4 7.0 11.9 6.7 16.9 9.4 9.3 29.0 2.0 20.7 10.3 8.7 20.0 29.6 16.9 8.6 24.7 19.0 6.8 9.0 9.7 13.2 10.8 20.3 29.7 19.7 10.2 36.4 20.5 14.7 14.2 24.4 40.7 9.3 18.2 31.3 31.0 30.2 9.2 68.4 6.5 33.2 31.8 36.2 45.9 11.0 31.4 32.7 35.8 12.8 32.8 36.9 12.9 15.5 45.8 43.5 11.2 41.4 25.9 23.0 66.4 17.9 8.5 29.4 135.9 19.2 64.7 19.8 34.6 7.3 53.7 22.3 38.4 49.9 8.6 63.0 29.4 4.9 10.3 36.6 26.9 108.3 15.1 14.0 16.8 33.8 22.3 17.1 30.3 47.2 20.6 39.4 4.6 51.3 22.4 113.2 133.7 50.6 89.8 37.3 51.0 26.1 20.7 32.7 31.7 43.9 9.5 4.2 18.2 165.7 18.5 64.4 5.0 64.3 37.4 7.5 8.2 8.0 10.5 7.4 8.8 9.2 8.4 9.4 8.6 9.0 10.2 52.3 9.6 31.5 10.1 23.8 18.2 20.0 144.1 15.4 0.2 9.9 7.1 28.9 30.0 63.2 14.7 0.0 4.4 40.2 48.1 3.9 39.4 3.2 16.0 5.1 38.1 10.8 46.7 3.2 27.6 1.6 31.9 13.3 19.0 53.0 3.4 28.2 7.7 58.7 1.7 1.5 18.7 34.6 33.0 195.9 3.6 10.5 72.2 12.4 45.0 156.1 3.3 34.0 4.5 1.4 46.7 41.7 11.7 24.3 16.9 46.3 26.5 41.3 0.7 32.9 27.9 23.6 11.3 2.4 28.2 27.8 1.9 44.7 9.6 18.6 42.6 CDK5RAP3 "C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114" ENSG00000108465 "CDK5 regulatory subunit associated protein 3" Q96JB5 17 47967810-47981781 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022141, HPA022882, HPA027883" Supported Supported Nucleoli,Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Nucleoli, Vesicles" "HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797" "unprognostic (4.27e-2)" "unprognostic (1.01e-3)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "unprognostic (5.98e-2)" "unprognostic (7.19e-3)" "unprognostic (3.84e-1)" "unprognostic (4.44e-2)" "unprognostic (7.55e-2)" "unprognostic (2.06e-1)" "unprognostic (2.59e-3)" "unprognostic (1.92e-2)" "prognostic unfavorable (3.61e-5)" "unprognostic (8.35e-3)" "unprognostic (2.30e-1)" "unprognostic (9.58e-2)" "prognostic favorable (7.31e-5)" 45.8 48.2 83.8 42.0 85.7 52.3 48.7 83.7 111.3 58.1 100.4 53.0 54.5 42.4 91.9 52.8 54.2 46.1 39.2 85.5 85.5 60.2 80.6 44.6 51.7 86.4 84.7 69.5 133.6 53.6 93.0 34.3 85.7 62.6 53.8 34.1 77.0 48.5 29.6 43.5 68.5 33.8 83.1 81.4 81.8 83.5 86.6 44.2 73.2 28.1 54.8 48.1 48.3 86.7 72.7 116.5 60.8 114.6 52.6 53.3 112.7 51.4 63.9 52.3 51.0 92.5 72.3 88.7 107.8 55.5 35.2 72.8 41.6 61.4 59.3 127.0 58.1 43.4 157.9 123.8 58.7 50.0 47.5 60.7 51.5 45.9 91.8 64.2 52.8 169.1 49.6 80.8 52.9 140.3 128.3 79.2 38.5 87.4 55.0 74.6 101.4 101.7 52.8 91.3 43.0 104.1 38.3 37.1 51.7 65.3 84.5 65.4 38.9 43.6 38.2 53.1 66.8 106.8 102.9 54.2 54.3 69.1 53.5 20.8 62.6 54.8 33.8 63.8 36.8 40.9 31.4 30.6 50.1 44.7 28.0 31.4 30.5 45.3 67.4 46.0 32.9 41.3 83.8 85.7 83.7 111.3 85.5 85.5 86.4 84.7 85.7 83.1 86.6 86.7 31.3 25.6 62.6 60.7 61.8 33.6 63.3 89.3 50.7 52.0 52.8 40.4 28.4 44.3 84.1 40.5 31.3 68.8 44.9 56.5 50.9 56.8 53.0 35.7 32.9 32.1 61.6 22.9 31.1 67.7 57.4 44.7 147.8 42.5 69.6 68.3 27.5 55.6 61.7 57.2 27.9 70.8 71.2 33.6 40.7 36.3 40.7 44.1 46.2 25.3 47.6 45.1 33.0 25.6 50.6 37.1 60.9 29.7 87.2 49.0 77.2 45.1 85.2 52.6 32.9 34.3 33.2 132.8 45.7 31.0 25.9 61.6 53.0 38.6 56.8 56.6 CFDP1 "BCNT, CENP-29, CP27, p97, SWC5, Yeti" ENSG00000153774 "Craniofacial development protein 1" Q9UEE9 16 75293698-75433503 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 493.3;Paneth cells: 745.2;Proximal enterocytes: 612.2;Proximal tubular cells: 637.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041316, HPA048242" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Vesicles "HPA041316: AB_10794371, HPA048242: AB_2680327" "unprognostic (1.45e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-1)" "unprognostic (4.88e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (9.63e-5)" "unprognostic (5.81e-3)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.61e-2)" "unprognostic (1.42e-1)" "unprognostic (7.37e-2)" "unprognostic (2.85e-2)" "unprognostic (6.54e-2)" "unprognostic (1.36e-1)" "unprognostic (4.92e-3)" "unprognostic (1.25e-1)" 45.0 51.0 57.4 24.0 58.0 35.0 45.2 60.8 75.3 69.1 57.9 47.5 30.4 58.6 62.3 41.2 55.6 29.7 36.8 57.1 61.7 64.5 43.1 37.3 27.1 58.8 59.3 83.1 41.2 30.8 57.1 63.1 58.8 39.9 40.2 49.6 39.4 38.1 35.7 42.4 36.4 51.0 56.7 30.2 34.7 59.5 59.6 57.0 45.0 34.9 35.8 44.8 50.7 60.8 65.0 47.6 158.9 59.2 141.2 156.3 47.2 63.2 74.1 83.0 119.1 82.5 86.6 61.3 91.1 79.3 92.7 71.5 123.3 101.9 164.9 26.4 58.6 63.0 46.6 177.2 97.3 69.2 51.6 98.4 85.5 100.2 121.4 144.6 91.5 114.0 91.3 28.3 93.9 149.0 102.2 152.6 77.1 110.0 24.8 182.7 64.3 108.5 93.1 35.5 94.5 79.4 105.7 22.3 92.5 136.4 91.8 121.6 53.8 59.2 63.1 63.2 40.8 54.4 89.2 228.6 59.3 89.9 53.3 61.3 45.5 60.8 31.2 47.8 44.5 33.6 42.7 34.7 48.8 35.4 38.7 36.5 38.1 28.5 46.2 48.7 68.5 25.8 57.4 58.0 60.8 75.3 57.1 61.7 58.8 59.3 58.8 56.7 59.6 60.8 87.4 38.5 57.5 37.5 45.5 57.9 116.3 135.9 47.3 87.2 89.5 103.4 34.7 91.5 111.2 115.8 116.7 119.0 50.5 493.3 197.6 79.1 133.7 197.7 118.5 97.6 82.2 78.9 49.5 94.9 114.0 82.9 61.2 121.3 28.5 194.5 62.8 153.9 77.1 62.2 50.5 219.2 59.0 53.1 44.5 69.7 125.2 51.1 33.8 45.9 64.8 60.8 84.5 49.8 75.6 92.4 745.2 112.5 42.3 116.9 612.2 637.6 205.3 112.5 98.6 55.3 88.2 311.2 178.0 49.5 65.6 154.9 51.6 103.5 120.0 130.4 CGAS "C6orf150, MB21D1" ENSG00000164430 "Cyclic GMP-AMP synthase" Q8N884 6 73413515-73452297 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.0" "Cell type enhanced" "Detected in some" "Adipocytes: 10.2;dendritic cells: 12.0;Glandular and luminal cells: 12.5;Hofbauer cells: 12.4;Macrophages: 10.0;monocytes: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 37.1;RH-30: 43.8;RPMI-8226: 45.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031700, HPA031702" Enhanced Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031700: AB_10601693, HPA031702: AB_2673999" "unprognostic (2.49e-1)" "unprognostic (2.36e-1)" "unprognostic (4.61e-2)" "unprognostic (4.95e-2)" "unprognostic (2.49e-2)" "unprognostic (1.81e-1)" "unprognostic (4.84e-3)" "unprognostic (1.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.25e-2)" "unprognostic (2.20e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.27e-7)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-1)" 2.9 1.1 1.7 6.4 2.1 14.0 1.7 2.2 3.0 2.4 1.7 1.9 2.7 1.9 0.6 2.3 1.8 2.6 1.5 1.9 2.0 1.1 0.8 3.5 7.4 2.6 2.2 1.2 1.2 0.6 0.6 3.1 2.6 1.9 1.8 0.2 1.8 1.8 0.5 1.1 2.5 2.0 2.4 5.2 2.3 1.0 3.0 2.3 1.6 0.9 4.7 4.3 2.1 3.4 19.9 5.8 0.1 0.2 1.2 2.7 0.1 10.1 3.7 11.3 12.6 20.7 14.2 0.2 20.9 4.3 6.3 10.1 9.8 0.2 12.0 31.9 0.0 16.9 8.2 0.1 4.0 12.3 11.5 1.6 3.2 11.8 0.1 0.0 3.5 0.1 0.0 37.1 8.7 8.0 0.0 27.1 6.2 2.4 11.2 23.4 43.8 45.2 0.0 7.3 0.3 0.1 17.3 0.4 10.2 0.2 0.0 33.9 5.0 0.0 9.1 8.5 0.2 8.1 19.8 0.2 0.1 17.5 11.4 26.3 12.7 19.0 6.0 17.5 4.7 8.4 7.9 5.9 7.5 6.7 1.8 3.4 8.5 4.2 11.6 17.6 8.0 6.0 1.7 2.1 2.2 3.0 1.9 2.0 2.6 2.2 2.6 2.4 3.0 3.4 10.2 3.2 4.8 0.0 4.7 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 0.6 0.0 0.0 0.2 12.0 0.0 0.0 2.0 0.0 8.4 8.5 6.0 0.0 0.0 0.0 3.9 0.7 2.3 0.0 12.5 5.1 1.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 3.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.3 8.0 0.7 0.0 0.0 CHMP5 "C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60" ENSG00000086065 "Charged multivesicular body protein 5" Q9NZZ3 9 33264879-33282070 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033874, HPA042883, HPA056437" Enhanced Supported Microtubules,Midbody,Cytosol Yes No 22000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Microtubules, Cytosol" Midbody "CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (9.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.32e-1)" "unprognostic (4.56e-2)" "unprognostic (3.87e-2)" "unprognostic (2.18e-2)" "unprognostic (4.71e-2)" "unprognostic (2.14e-3)" "unprognostic (7.94e-2)" "unprognostic (2.66e-1)" "prognostic favorable (2.87e-7)" "unprognostic (2.22e-1)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (7.31e-2)" 54.6 54.6 48.3 36.7 49.2 30.5 49.6 50.4 63.8 56.4 50.0 55.7 55.2 41.3 48.1 64.6 43.8 42.1 50.8 49.0 50.3 77.8 56.3 53.5 41.6 50.4 49.7 42.9 32.7 63.9 49.7 63.8 50.7 54.8 55.9 53.8 43.7 39.4 48.2 47.0 59.2 33.9 52.7 43.5 54.6 36.2 49.4 44.9 55.8 44.3 38.1 49.7 56.5 56.9 92.2 66.5 67.0 43.5 99.0 89.0 61.9 90.1 99.7 138.3 152.6 50.9 56.9 49.0 96.3 84.3 95.9 39.2 70.5 72.8 111.1 102.5 49.3 41.5 129.7 55.8 85.9 53.4 78.8 95.6 131.3 93.6 86.4 114.5 73.3 68.3 44.9 63.6 110.5 41.3 56.1 164.1 61.8 70.1 80.6 34.0 59.2 32.9 115.2 48.7 32.7 83.6 91.0 53.4 87.2 77.8 54.2 82.7 74.4 69.5 73.0 60.2 80.8 42.3 87.6 57.0 100.5 36.0 45.6 98.6 50.3 106.3 25.3 56.5 27.6 31.0 33.7 33.8 46.5 26.4 30.6 29.4 129.4 47.4 67.3 71.2 43.4 51.3 48.3 49.2 50.4 63.8 49.0 50.3 50.4 49.7 50.7 52.7 49.4 56.9 182.7 89.8 59.0 14.0 52.9 188.1 156.2 372.5 71.7 63.7 85.2 75.1 64.7 94.4 228.6 110.3 27.1 172.0 77.4 241.0 285.7 141.7 245.2 228.0 90.6 133.8 80.2 90.1 19.6 86.1 186.1 104.4 56.1 167.0 58.4 66.5 97.5 70.5 154.9 26.9 19.0 137.9 246.2 100.9 103.2 35.9 93.2 95.3 117.4 15.0 166.3 156.2 38.1 14.6 26.8 151.9 247.9 104.6 45.2 182.4 226.3 355.2 328.9 68.2 85.5 97.0 130.0 99.5 68.7 70.1 236.3 259.0 68.5 71.4 78.5 246.0 CINP MGC849 ENSG00000100865 "Cyclin dependent kinase 2 interacting protein" Q9BW66 14 102341102-102362916 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (3.47e-1)" "unprognostic (2.84e-1)" "unprognostic (1.50e-2)" "unprognostic (8.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.17e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.61e-2)" "unprognostic (3.41e-2)" "unprognostic (2.55e-1)" "unprognostic (1.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.46e-1)" "unprognostic (2.40e-1)" "unprognostic (2.71e-1)" 20.9 23.9 27.4 13.3 30.5 28.8 19.8 31.1 32.2 14.3 23.1 18.0 13.6 11.5 21.9 25.2 14.3 15.0 27.8 25.7 28.4 22.6 33.5 15.7 20.3 30.0 28.7 13.7 44.1 19.3 12.6 15.0 30.0 15.9 15.9 4.5 29.8 13.7 31.9 16.9 15.1 17.1 30.3 17.1 23.6 29.2 28.7 19.5 18.3 27.0 17.8 18.2 14.4 33.3 32.1 75.1 29.1 33.3 54.5 71.6 33.4 47.0 61.1 63.3 52.3 50.8 49.6 36.3 45.8 59.4 31.6 52.7 52.0 64.7 57.6 41.6 40.2 26.2 48.0 60.4 46.7 67.2 25.7 54.7 47.5 46.1 52.6 41.9 67.7 34.2 38.5 44.0 57.9 161.2 39.8 36.4 31.2 90.2 74.5 26.2 41.3 47.8 61.5 73.2 30.9 30.2 36.6 60.0 33.6 25.7 71.3 31.5 47.3 36.1 22.0 108.7 42.1 84.9 70.9 63.3 60.4 42.5 41.9 46.1 58.3 55.0 37.5 58.4 34.4 44.1 33.4 35.1 54.3 37.6 31.9 31.5 49.8 38.0 50.8 50.7 41.6 46.4 27.4 30.5 31.1 32.2 25.7 28.4 30.0 28.7 30.0 30.3 28.7 33.3 27.5 28.9 16.2 3.3 19.1 14.0 26.0 37.5 14.2 18.2 25.2 28.1 39.7 15.7 29.0 20.2 12.5 48.5 18.4 19.1 56.7 39.6 59.4 15.4 24.9 28.8 19.7 29.5 4.1 45.2 53.7 27.8 16.3 16.7 19.6 25.8 28.5 43.9 59.8 15.2 3.6 27.1 18.3 25.5 22.2 111.2 29.8 28.1 17.8 0.0 65.8 25.2 35.0 4.0 10.0 42.6 21.9 20.3 36.5 25.9 43.9 82.2 19.8 20.1 32.9 18.0 21.4 90.1 16.1 33.6 15.8 37.1 20.5 33.9 32.9 25.4 CLK1 ENSG00000013441 "CDC like kinase 1" P49759 2 200853009-200864744 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033141, HPA062405" Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Nuclear membrane" "CAB033141: AB_1121713, HPA062405: AB_2684753" "unprognostic (9.79e-2)" "unprognostic (2.05e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (9.19e-2)" "unprognostic (4.50e-3)" "unprognostic (1.52e-1)" "unprognostic (2.77e-3)" "unprognostic (1.78e-2)" "unprognostic (2.09e-2)" "unprognostic (1.09e-2)" "unprognostic (5.63e-3)" "unprognostic (2.03e-3)" "unprognostic (9.66e-2)" "unprognostic (2.30e-1)" "unprognostic (1.18e-1)" "prognostic favorable (2.28e-4)" 89.6 82.7 132.9 25.4 137.1 178.0 72.2 140.9 201.6 118.5 136.2 78.3 20.8 65.8 51.1 58.5 85.5 56.5 83.9 133.9 137.7 83.3 84.4 90.3 55.9 138.1 133.4 140.3 63.6 29.0 82.3 64.8 138.6 109.7 24.2 133.8 68.9 49.6 80.4 62.5 51.6 30.9 135.2 113.0 53.2 28.1 134.1 76.0 92.5 71.4 42.0 77.8 112.8 176.0 17.9 13.5 22.6 6.5 24.4 26.1 17.1 19.2 26.8 19.3 25.5 24.6 11.8 5.5 13.1 11.4 11.1 19.7 27.9 8.8 38.2 27.3 24.0 18.1 35.9 30.7 14.7 19.5 31.1 12.3 39.9 23.4 41.8 20.6 11.4 9.5 23.3 77.1 27.0 12.3 23.0 58.4 13.9 11.4 29.8 24.8 25.7 31.8 13.0 11.2 22.0 17.8 16.4 6.1 32.7 12.9 5.3 13.2 19.5 21.4 14.8 21.5 22.0 46.8 20.9 13.7 14.2 15.4 14.9 40.0 7.2 18.6 14.5 5.0 17.3 17.4 15.7 15.8 4.8 11.7 15.6 12.9 16.9 9.5 6.0 11.1 17.2 10.4 132.9 137.1 140.9 201.6 133.9 137.7 138.1 133.4 138.6 135.2 134.1 176.0 122.1 44.8 85.4 112.0 164.2 168.8 263.0 73.6 114.4 59.0 112.9 97.0 96.6 41.5 87.1 27.6 100.1 46.7 213.5 110.9 19.6 31.4 2.3 111.2 108.8 113.6 134.3 87.5 51.7 26.9 56.6 142.5 81.1 173.6 136.9 77.9 82.1 43.3 58.5 52.2 53.6 124.2 50.8 100.5 285.8 9.4 92.9 192.3 154.7 62.8 56.2 54.6 76.2 58.3 169.0 32.0 117.7 75.6 169.0 133.3 88.2 14.9 70.1 99.6 111.7 97.8 128.4 33.1 27.7 117.0 151.7 90.3 261.2 43.0 88.6 184.2 CLN3 "BTN1, BTS, JNCL" ENSG00000188603 "CLN3 lysosomal/endosomal transmembrane protein, battenin" Q13286 16 28474111-28495575 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 315.9;Extravillous trophoblasts: 106.9;Syncytiotrophoblasts: 451.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 178.0;SK-BR-3: 186.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063280 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA063280: AB_2684975" "unprognostic (2.38e-3)" "unprognostic (2.41e-2)" "unprognostic (7.06e-2)" "unprognostic (8.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (2.36e-2)" "unprognostic (1.69e-2)" "unprognostic (6.38e-3)" "unprognostic (8.16e-2)" "unprognostic (6.27e-2)" "unprognostic (5.26e-1)" "unprognostic (9.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.05e-2)" 18.1 30.5 13.1 19.6 14.2 13.4 21.4 14.2 16.0 16.9 16.5 38.3 21.9 15.9 9.9 22.2 16.0 15.2 11.7 13.2 13.6 21.2 31.9 23.6 13.8 14.6 13.6 16.8 27.7 30.0 8.2 36.9 15.1 17.3 29.2 3.1 34.5 21.0 14.5 24.1 25.7 13.3 13.5 20.4 26.1 7.9 15.6 14.0 24.7 13.8 12.1 19.3 15.6 17.1 23.1 39.2 15.4 38.4 41.1 19.9 178.0 14.8 40.7 28.3 34.9 19.7 52.9 16.0 45.8 24.8 52.0 23.5 25.8 24.7 12.9 38.0 38.5 15.6 24.1 60.6 60.5 23.3 64.7 28.0 66.8 21.9 14.7 26.3 32.9 24.9 30.9 55.0 28.8 61.9 20.7 45.1 21.8 35.3 26.0 37.2 13.4 54.5 30.2 53.0 20.8 19.6 5.7 186.5 18.3 14.0 62.2 32.4 20.2 19.2 10.1 24.9 22.5 58.3 64.2 15.9 28.4 47.3 11.9 63.4 59.8 98.4 57.6 47.6 42.7 24.3 43.6 53.6 63.8 29.3 38.3 40.6 23.8 41.2 38.7 68.1 53.5 46.6 13.1 14.2 14.2 16.0 13.2 13.6 14.6 13.6 15.1 13.5 15.6 17.1 1.2 22.4 15.9 11.1 10.8 0.1 17.2 0.0 23.9 10.9 1.7 0.6 0.0 38.6 6.2 1.8 12.5 315.9 25.8 46.4 0.0 2.2 1.1 1.8 1.3 11.2 17.0 17.5 7.5 0.5 106.9 9.3 20.9 2.6 2.5 7.6 21.0 39.0 70.1 13.5 8.1 39.3 0.0 36.7 0.4 2.5 19.0 17.7 0.0 2.8 17.5 25.0 40.2 7.1 11.4 1.5 43.7 12.4 13.1 10.6 53.1 0.8 1.5 12.1 13.1 9.9 3.5 3.2 8.4 17.1 0.1 451.4 15.9 3.6 50.2 13.3 CLTA Lca ENSG00000122705 "Clathrin light chain A" P09496 9 36190856-36304781 "Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1299.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002665, HPA050918, HPA054667" Enhanced Enhanced Vesicles,Endosomes,Lysosomes NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 10: Non-specific - Unknown function" "Vesicles, Endosomes, Lysosomes" "CAB002665: , HPA050918: AB_2681273, HPA054667: AB_2682565" "prognostic favorable (5.64e-4)" "unprognostic (7.62e-2)" "unprognostic (9.22e-2)" "unprognostic (8.45e-3)" "unprognostic (1.71e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (9.46e-5)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.92e-3)" "unprognostic (7.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-2)" "unprognostic (1.56e-1)" "prognostic favorable (1.01e-4)" "unprognostic (4.98e-2)" 172.8 174.2 131.6 80.8 139.1 67.2 165.6 144.7 165.1 170.9 137.5 163.3 107.9 165.6 100.7 207.1 158.9 64.4 98.1 133.3 143.8 236.0 146.8 146.2 84.1 145.1 138.5 205.6 164.3 104.3 139.3 124.4 151.4 145.0 108.6 84.8 162.8 71.2 87.7 163.2 136.0 84.9 141.6 153.0 161.4 108.5 141.7 85.2 160.1 51.5 93.4 150.9 158.4 151.5 326.3 257.2 188.4 146.3 270.0 269.8 302.6 328.5 248.2 258.1 301.5 194.2 143.9 243.8 177.0 220.9 460.7 136.2 238.8 228.2 238.4 166.0 193.1 187.5 255.0 199.8 359.4 201.0 166.5 297.3 250.5 297.4 234.3 241.0 329.6 129.3 166.0 126.4 399.0 113.3 182.2 254.8 301.8 218.8 360.3 173.3 124.8 142.1 353.7 229.1 146.1 245.3 137.3 160.0 289.4 220.2 146.9 244.2 418.4 209.4 234.0 240.3 347.9 83.0 208.9 259.5 256.9 278.0 188.9 142.2 221.7 115.4 97.1 239.6 101.9 121.0 104.9 100.2 222.6 119.6 92.9 82.0 86.7 96.2 191.8 192.2 162.9 209.4 131.6 139.1 144.7 165.1 133.3 143.8 145.1 138.5 151.4 141.6 141.7 151.5 291.5 128.2 143.9 14.4 105.9 197.3 274.3 374.3 169.0 139.4 274.0 315.0 51.5 217.3 247.4 180.3 60.5 958.0 140.1 349.3 463.7 480.5 51.9 241.5 174.3 244.0 183.8 154.8 28.5 335.6 469.1 187.5 142.2 182.7 73.5 198.4 312.7 170.6 903.7 92.5 30.4 350.5 248.2 391.7 172.0 97.6 262.9 249.3 195.7 20.6 343.5 282.8 117.4 16.1 49.0 465.2 426.4 215.5 97.7 320.5 411.5 651.7 304.7 127.3 177.5 170.0 310.4 288.0 216.8 210.9 193.2 1299.5 103.7 281.6 380.0 360.4 CNBP "CNBP1, DM2, RNF163, ZCCHC22, ZNF9" ENSG00000169714 "CCHC-type zinc finger nucleic acid binding protein" P62633 3 129167827-129183922 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063097 Approved Nucleoplasm,Cytosol NA NA 160000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA063097: AB_2684939" "unprognostic (1.74e-1)" "unprognostic (3.11e-2)" "unprognostic (4.84e-1)" "unprognostic (3.35e-2)" "unprognostic (6.28e-2)" "unprognostic (7.38e-2)" "unprognostic (7.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (6.39e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.72e-3)" "unprognostic (4.62e-3)" "unprognostic (1.89e-1)" "unprognostic (2.03e-1)" "unprognostic (2.51e-1)" "unprognostic (1.58e-1)" 292.7 308.2 175.2 181.1 184.0 254.1 274.6 198.6 211.3 295.9 175.7 314.1 198.5 285.8 197.6 264.6 275.7 195.1 487.2 170.6 184.3 231.6 433.7 258.3 251.0 182.7 175.1 385.8 307.4 277.9 169.5 214.3 187.1 256.6 219.0 231.8 250.8 282.4 1207.6 288.0 199.2 234.9 195.6 200.7 262.1 131.2 181.9 254.2 261.8 797.9 250.7 317.5 269.2 211.7 452.7 266.4 369.9 294.6 355.2 303.9 294.9 344.2 535.7 362.2 412.4 389.2 305.7 589.8 292.2 318.1 269.6 328.3 484.3 396.4 484.6 404.5 357.9 569.2 251.7 420.2 355.7 622.4 314.5 295.5 449.2 254.8 897.8 247.6 324.1 328.1 437.6 391.9 384.0 538.9 578.6 454.1 452.7 399.7 439.1 502.4 343.4 707.7 379.1 425.4 501.2 402.8 271.5 263.0 766.3 214.4 305.6 421.3 347.9 268.4 266.2 374.1 353.7 367.3 365.4 932.3 277.3 419.2 362.4 1077.7 810.5 930.9 551.8 596.8 699.0 691.0 658.8 595.3 552.8 603.8 700.3 610.5 1102.3 601.1 485.5 320.4 704.3 2029.8 175.2 184.0 198.6 211.3 170.6 184.3 182.7 175.1 187.1 195.6 181.9 211.7 253.7 259.6 263.9 27.1 292.8 524.7 417.0 262.9 259.6 153.7 177.5 272.5 608.0 141.5 235.1 79.1 33.3 252.3 188.1 143.9 373.7 226.9 36.0 141.4 195.1 267.5 171.3 246.5 28.2 290.7 396.6 309.4 142.8 172.8 314.5 173.0 167.0 138.5 246.5 92.5 33.7 178.6 140.4 194.4 463.0 42.9 316.0 232.4 318.4 35.6 392.7 350.3 236.9 32.6 42.8 230.1 158.0 319.7 311.7 405.1 196.5 237.4 164.8 153.8 263.0 343.6 571.0 305.2 271.5 286.5 586.7 291.7 304.2 277.7 213.6 376.2 COA5 "C2orf64, FLJ27524, MGC52110, Pet191" ENSG00000183513 "Cytochrome c oxidase assembly factor 5" Q86WW8 2 98599314-98608515 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 180.0;Proximal tubular cells: 175.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057768 Uncertain Supported Mitochondria No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA057768: AB_2683521" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (1.67e-3)" "unprognostic (2.61e-2)" "unprognostic (7.11e-2)" "unprognostic (4.69e-2)" "prognostic favorable (2.65e-4)" "unprognostic (1.32e-3)" "unprognostic (3.71e-3)" "unprognostic (8.00e-3)" "unprognostic (3.08e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-1)" "unprognostic (4.93e-2)" "unprognostic (2.50e-1)" "prognostic favorable (1.00e-5)" 14.9 20.9 39.7 10.4 40.9 9.7 18.5 46.0 46.0 19.0 35.6 21.4 14.7 18.5 29.8 11.7 19.2 11.0 21.2 40.1 40.4 26.6 22.8 12.9 16.3 40.7 40.8 21.2 15.6 22.0 23.5 13.4 40.6 19.8 14.4 38.4 15.1 17.6 28.5 16.8 17.7 12.4 40.3 19.4 17.8 12.9 42.6 17.3 22.5 22.0 15.5 18.1 14.1 44.1 18.5 7.9 24.4 17.5 28.1 22.6 20.4 10.6 8.5 11.4 11.8 16.3 15.1 9.6 18.4 8.7 21.7 13.1 21.2 11.5 13.8 24.5 18.5 13.3 15.2 26.0 20.4 13.1 11.6 22.7 23.6 8.1 10.5 19.7 12.0 26.6 18.6 10.8 12.4 14.6 17.2 22.9 16.9 19.8 16.7 10.4 17.2 21.1 24.8 9.9 18.4 23.1 9.1 11.3 27.6 27.4 13.9 26.4 11.1 17.2 15.3 10.4 9.0 17.6 25.0 12.0 21.0 28.0 14.5 20.2 24.9 29.4 23.9 23.5 20.3 23.6 21.0 22.5 24.0 25.3 25.5 25.5 28.0 20.1 25.8 31.2 31.1 22.9 39.7 40.9 46.0 46.0 40.1 40.4 40.7 40.8 40.6 40.3 42.6 44.1 39.5 16.0 28.7 10.4 27.3 10.5 26.3 46.5 28.5 25.5 45.5 62.6 66.6 37.1 32.6 47.8 6.2 36.9 34.8 26.3 180.0 43.4 28.0 52.8 30.4 30.6 27.0 29.4 12.0 24.5 38.8 29.8 21.9 35.6 26.6 33.3 31.8 63.6 52.8 21.9 12.4 37.2 59.0 38.1 12.5 14.9 32.6 30.5 28.4 4.7 41.3 51.4 54.6 8.5 19.1 30.8 29.6 35.0 24.0 34.4 46.1 175.0 49.2 32.0 13.1 23.5 29.7 118.4 33.8 32.5 11.6 32.7 23.5 46.1 33.2 33.6 COMMD5 "FLJ13008, HCaRG, HT002" ENSG00000170619 "COMM domain containing 5" Q9GZQ3 8 144841042-144853736 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046905 Supported Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Cytosol" "HPA046905: AB_2732535" "unprognostic (2.95e-2)" "unprognostic (7.62e-2)" "unprognostic (2.63e-1)" "unprognostic (1.16e-1)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (5.05e-3)" "unprognostic (6.82e-2)" "unprognostic (3.24e-1)" "unprognostic (9.35e-2)" "unprognostic (2.25e-1)" "unprognostic (7.97e-3)" "unprognostic (1.25e-2)" "unprognostic (8.58e-2)" "unprognostic (3.43e-1)" "unprognostic (2.02e-1)" "unprognostic (7.73e-3)" 17.0 22.9 16.6 11.9 17.0 21.2 15.7 18.1 19.7 14.9 15.6 15.6 12.1 16.1 9.7 20.1 14.2 11.3 18.9 16.2 16.3 18.7 23.2 15.1 16.2 18.1 16.9 12.8 16.7 14.5 17.7 11.0 17.5 16.4 6.8 3.8 15.5 10.7 18.2 16.8 14.9 8.8 17.3 21.9 16.4 11.2 17.2 11.3 16.4 11.4 10.6 15.9 14.3 18.7 32.8 38.3 17.9 24.2 21.8 17.4 16.0 18.5 19.7 30.9 24.2 23.0 25.1 22.3 40.4 22.6 17.9 21.7 22.5 30.6 13.2 29.6 31.7 47.1 35.3 38.8 28.8 16.0 39.6 23.1 27.6 21.2 15.7 15.0 24.2 7.9 34.2 39.8 25.2 59.4 14.6 16.8 27.1 45.6 75.3 18.8 20.4 34.8 30.2 28.3 41.6 36.6 30.9 18.5 27.4 11.9 36.3 29.7 22.4 23.1 45.9 33.3 36.8 16.6 19.2 21.3 32.5 29.7 30.5 66.1 84.3 76.6 55.8 72.4 49.8 60.7 42.4 54.9 74.2 54.1 41.6 46.7 52.3 69.2 47.0 26.8 71.2 70.1 16.6 17.0 18.1 19.7 16.2 16.3 18.1 16.9 17.5 17.3 17.2 18.7 27.8 12.8 15.0 8.5 27.5 27.8 20.4 46.4 11.4 12.3 22.8 23.9 10.9 21.5 25.0 16.5 12.5 35.8 39.0 26.4 39.2 46.4 3.5 19.6 16.4 27.6 19.9 14.1 6.2 40.1 23.8 22.7 13.7 18.6 24.8 15.6 25.7 19.0 70.0 11.8 7.7 16.8 34.6 31.4 27.6 2.5 18.6 34.2 26.6 5.6 37.2 22.3 38.1 6.6 9.5 50.0 18.4 23.3 20.3 42.7 29.8 44.6 28.2 15.2 13.1 16.0 24.6 12.1 17.2 18.4 30.0 33.1 27.0 28.7 18.9 28.5 COMMD7 "C20orf92, dJ1085F17.3" ENSG00000149600 "COMM domain containing 7" Q86VX2 20 32702699-32743467 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 225.9;Syncytiotrophoblasts: 264.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 331.1" "Low region specificity" "Detected in all" HPA054119 Approved Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "HPA054119: AB_2682388" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (9.90e-2)" "unprognostic (1.64e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.31e-2)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.57e-2)" "unprognostic (2.98e-1)" "unprognostic (2.90e-3)" "unprognostic (5.04e-2)" "unprognostic (8.28e-2)" "unprognostic (8.52e-2)" "prognostic favorable (3.53e-4)" 34.6 38.7 60.2 23.0 62.5 40.5 36.6 59.3 87.1 27.9 58.6 41.4 18.1 29.1 49.1 27.2 27.3 25.7 61.7 62.2 59.7 52.7 44.5 29.4 29.9 59.4 62.5 24.1 36.7 40.7 17.7 38.5 59.1 35.6 30.3 24.7 31.7 31.2 66.4 37.1 26.4 33.2 58.9 36.8 36.0 11.5 61.9 25.8 49.7 54.4 34.0 38.3 28.3 58.8 69.9 45.2 43.6 30.9 32.4 58.7 80.3 59.8 96.8 96.4 66.0 88.0 44.0 55.3 51.1 71.4 80.3 30.6 38.0 49.7 72.0 22.3 25.2 154.8 25.3 65.6 83.6 63.5 84.2 45.6 61.1 73.9 43.3 76.1 95.9 30.1 55.8 26.7 62.4 51.4 55.4 133.2 37.4 68.6 43.9 51.4 4.2 19.0 103.2 46.6 26.8 41.3 59.1 81.6 101.3 47.5 48.3 101.6 65.3 97.3 54.0 61.8 61.3 29.8 25.6 18.6 119.0 331.1 39.6 116.9 105.8 162.7 76.5 144.0 67.7 63.5 61.4 70.9 122.7 61.2 67.7 64.6 10.4 99.9 165.2 82.2 75.1 166.2 60.2 62.5 59.3 87.1 62.2 59.7 59.4 62.5 59.1 58.9 61.9 58.8 71.3 22.4 17.9 10.1 43.2 16.6 31.4 44.4 23.9 56.8 58.7 50.2 48.3 47.1 32.1 36.8 68.8 225.9 70.5 33.6 88.0 102.8 3.1 27.7 25.8 54.8 33.0 36.6 19.6 118.5 116.5 36.8 31.1 31.1 53.3 49.2 44.3 39.8 124.3 67.3 25.4 44.4 59.0 46.4 30.9 4.6 37.6 69.6 56.9 16.9 92.7 81.8 123.6 4.5 10.3 118.7 47.0 47.8 35.3 32.8 27.6 124.3 23.3 74.3 46.0 27.0 49.3 13.1 19.1 36.8 28.8 264.5 75.6 36.9 45.8 37.9 COPE epsilon-COP ENSG00000105669 "COPI coat complex subunit epsilon" O14579 19 18899514-18919387 "Metabolic proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034345, HPA041605, HPA043576" Supported Enhanced "Golgi apparatus" NA NA 66000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563" "unprognostic (1.48e-1)" "prognostic favorable (2.41e-4)" "unprognostic (1.15e-1)" "unprognostic (5.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.40e-2)" "unprognostic (3.39e-2)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (1.97e-2)" "unprognostic (8.75e-2)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.26e-1)" "unprognostic (3.16e-2)" "unprognostic (6.75e-2)" 102.3 163.7 127.2 85.5 133.4 159.6 100.3 139.4 176.0 101.3 131.3 113.8 90.5 104.1 45.0 160.3 89.8 44.1 135.2 122.4 131.0 141.9 194.3 108.3 91.7 140.6 132.0 80.8 152.0 80.8 160.1 59.3 130.0 127.4 37.7 23.5 144.2 65.4 128.0 120.9 107.8 42.9 137.1 150.0 126.8 171.9 135.9 82.4 123.7 50.0 56.9 99.2 107.1 151.2 186.7 177.4 99.3 177.3 89.0 104.7 287.2 159.2 150.8 174.8 198.7 215.1 148.2 150.8 210.5 134.9 112.9 123.2 82.5 161.0 33.9 94.2 369.9 89.6 150.9 331.1 236.1 180.0 221.1 128.3 149.2 106.2 115.6 92.5 138.9 170.5 140.2 373.6 90.0 443.0 196.9 341.0 188.4 243.0 420.2 222.4 89.6 448.2 115.8 185.4 138.8 222.4 100.0 159.1 181.1 44.9 134.8 291.3 140.9 110.5 81.5 283.3 170.9 357.7 337.5 187.7 189.1 309.9 187.3 656.0 598.5 639.1 337.1 533.1 298.1 391.2 321.9 298.6 528.4 381.9 236.4 270.9 594.9 344.4 468.5 659.3 449.3 930.0 127.2 133.4 139.4 176.0 122.4 131.0 140.6 132.0 130.0 137.1 135.9 151.2 110.5 3.2 16.2 22.2 204.7 159.8 197.9 390.9 54.1 53.2 140.5 111.6 10.4 111.5 205.8 115.8 29.2 386.5 242.8 408.9 463.7 323.7 179.7 134.4 131.8 127.1 168.5 130.5 8.6 368.7 439.1 140.7 166.2 187.8 102.9 176.7 113.6 153.4 447.2 57.2 11.3 445.5 303.2 189.4 286.8 381.0 144.8 217.8 245.5 4.7 373.5 251.9 187.4 8.5 20.8 336.7 421.4 133.2 417.5 255.7 425.6 493.1 152.6 72.1 124.9 92.8 200.5 178.4 202.1 108.6 196.6 542.2 174.9 235.3 297.4 267.2 COPS7A CSN7A ENSG00000111652 "COP9 signalosome subunit 7A" Q9UBW8 12 6724014-6731875 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026915 Supported Supported Nucleoplasm,Cytosol NA NA 54000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "HPA026915: AB_1847156" "unprognostic (3.50e-1)" "unprognostic (1.33e-2)" "unprognostic (3.95e-3)" "unprognostic (3.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.96e-3)" "unprognostic (3.91e-2)" "unprognostic (4.26e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" 45.0 52.8 69.2 32.9 69.1 19.7 36.1 69.7 71.7 34.1 66.0 44.5 29.9 39.2 46.7 55.2 44.7 32.7 79.1 71.9 70.9 48.3 53.3 34.7 29.9 72.0 72.0 34.8 40.3 71.9 51.1 42.7 71.4 42.8 30.1 46.8 44.5 40.2 103.6 39.2 29.0 43.1 67.3 33.3 41.2 24.0 77.1 22.8 45.8 98.1 30.4 45.8 38.5 67.4 73.3 78.8 34.0 33.3 96.3 114.0 84.9 93.2 107.8 87.6 86.7 54.3 95.0 47.1 37.1 111.2 49.9 55.9 45.7 86.6 75.5 70.3 57.8 47.0 50.1 63.9 84.6 47.1 28.3 106.7 80.6 97.5 183.4 100.1 61.8 29.2 33.3 18.1 116.0 58.7 29.5 30.3 92.9 91.4 64.1 18.8 71.9 47.2 69.0 69.0 19.4 47.2 58.4 67.5 97.2 79.5 29.9 68.0 70.1 90.8 48.4 82.3 85.6 21.0 24.7 38.4 150.6 60.0 104.7 85.9 56.4 86.1 36.3 73.2 35.8 26.2 30.7 32.2 65.3 36.0 30.2 29.8 43.7 31.0 58.9 41.3 30.9 49.9 69.2 69.1 69.7 71.7 71.9 70.9 72.0 72.0 71.4 67.3 77.1 67.4 23.7 16.0 17.5 17.0 14.7 13.9 31.4 39.8 25.0 37.0 29.1 27.6 36.7 22.8 28.0 23.9 6.2 72.6 11.7 15.7 66.5 47.8 4.3 21.4 28.0 23.4 12.6 17.0 13.0 49.7 58.2 34.8 13.7 22.9 16.5 13.0 22.9 26.3 63.2 30.3 15.3 18.6 69.2 24.2 14.4 6.5 23.0 26.1 12.4 5.6 50.0 51.4 13.4 11.1 11.9 49.8 18.6 25.6 16.2 34.3 22.3 47.3 23.8 23.8 39.5 21.7 33.2 16.9 40.6 39.2 13.9 59.1 12.6 40.6 17.1 30.7 COX17 ENSG00000138495 "Cytochrome c oxidase copper chaperone COX17" Q14061 3 119654513-119677454 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042226, HPA048158" Supported Supported Mitochondria NA NA 220000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Mitochondria "HPA042226: AB_2677911, HPA048158: AB_2680292" "unprognostic (1.98e-2)" "unprognostic (3.49e-2)" "unprognostic (1.96e-2)" "unprognostic (8.29e-2)" "unprognostic (2.88e-2)" "unprognostic (6.63e-3)" "unprognostic (3.49e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-1)" "unprognostic (7.11e-3)" "unprognostic (2.12e-1)" "unprognostic (4.45e-2)" "unprognostic (1.33e-2)" "unprognostic (2.15e-2)" "unprognostic (1.65e-1)" "unprognostic (9.19e-2)" "unprognostic (2.64e-2)" 81.6 178.5 106.5 77.1 111.2 113.3 68.8 117.5 122.4 50.3 149.2 90.2 90.2 41.2 114.1 55.9 47.3 59.4 279.9 105.5 123.6 94.7 172.7 62.3 110.4 115.8 115.3 31.5 102.0 412.1 119.2 63.9 115.7 78.6 78.7 120.6 80.8 90.7 401.4 43.3 88.5 62.9 112.5 64.9 107.5 44.4 113.0 106.6 94.4 363.9 89.8 75.9 35.7 118.6 219.6 257.0 122.7 33.3 53.4 53.1 45.7 130.5 84.2 127.3 133.4 226.4 157.7 164.6 158.0 72.1 174.8 84.0 138.5 154.9 74.9 205.5 155.9 145.0 195.3 180.1 63.1 205.0 246.7 56.6 142.7 77.9 106.0 82.2 87.9 200.8 122.4 370.7 155.4 410.2 212.8 283.5 133.8 212.2 413.3 88.3 82.3 273.7 203.2 141.0 210.5 86.4 153.1 137.1 189.7 76.9 180.5 313.0 66.6 91.3 144.9 59.8 168.4 257.5 348.9 361.1 129.0 157.8 164.2 591.4 241.1 630.6 218.1 357.5 208.1 378.3 241.7 230.3 252.8 320.4 189.1 187.0 174.4 213.6 487.3 538.7 352.6 260.1 106.5 111.2 117.5 122.4 105.5 123.6 115.8 115.3 115.7 112.5 113.0 118.6 194.5 157.0 167.1 5.2 161.5 94.1 132.8 267.9 46.7 108.9 153.8 147.2 622.8 238.8 202.4 498.4 43.8 137.4 116.7 385.3 716.1 264.0 115.0 282.4 64.3 164.7 214.2 162.9 3.8 413.7 193.9 99.3 150.3 178.8 309.3 70.2 116.0 779.8 216.1 75.7 5.6 327.8 427.2 181.8 281.2 39.9 91.0 190.8 277.5 11.2 345.7 178.8 137.0 8.5 8.8 459.7 512.8 136.9 176.5 198.2 434.6 786.2 280.2 174.4 184.1 112.9 171.6 286.0 159.2 85.4 125.4 211.0 129.0 49.6 151.1 199.0 COX5B ENSG00000135940 "Cytochrome c oxidase subunit 5B" P10606 2 97646062-97648383 "Metabolic proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1151.3;skeletal muscle: 1332.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 3614.3;Distal tubular cells: 3621.5;Proximal enterocytes: 2795.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034517 Supported Enhanced Mitochondria NA NA 230000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA034517: AB_10603561" "unprognostic (4.61e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.73e-4)" 209.1 252.9 323.0 42.8 339.7 113.3 178.7 373.1 436.0 138.1 349.2 322.6 164.2 124.6 72.3 284.6 136.9 32.6 1151.3 319.2 357.2 478.6 372.8 120.4 40.3 341.7 339.9 138.4 165.6 234.0 169.0 47.1 339.9 158.2 113.4 74.5 196.7 90.1 1332.7 213.2 211.9 51.1 332.9 153.2 290.6 101.2 353.1 64.4 185.0 705.9 54.3 179.8 179.1 355.3 144.9 165.5 106.8 169.7 115.9 105.8 428.3 180.0 100.8 118.3 130.5 459.9 148.7 240.8 377.3 116.5 188.4 217.9 117.5 181.8 56.4 188.7 493.2 324.2 166.6 559.8 220.3 310.6 231.2 193.8 161.6 113.4 91.2 125.4 104.4 187.8 243.6 115.5 94.0 360.0 203.5 450.0 196.6 257.2 854.3 194.9 170.6 368.8 167.5 227.9 202.2 210.3 175.0 225.0 374.8 146.0 115.7 345.5 186.9 107.5 181.4 174.4 118.7 265.8 274.7 183.1 194.9 264.5 113.5 1086.6 1062.7 933.1 458.0 1057.0 445.1 801.5 547.4 481.8 990.1 666.0 528.0 468.8 1016.6 469.6 926.3 677.6 783.4 1543.0 323.0 339.7 373.1 436.0 319.2 357.2 341.7 339.9 339.9 332.9 353.1 355.3 461.0 221.2 256.0 33.3 292.7 386.6 629.5 1166.0 377.9 239.1 433.2 536.2 3614.3 567.6 618.5 800.0 227.2 736.0 257.4 1960.0 3621.5 599.5 207.5 399.4 300.8 380.0 740.3 308.8 27.3 604.1 897.1 391.6 616.7 439.7 330.6 392.2 361.3 1234.9 875.0 141.3 33.7 1430.5 1043.6 485.2 651.9 360.8 351.6 456.6 912.4 30.0 711.7 461.5 314.1 15.6 39.4 505.4 1836.0 304.6 353.3 468.2 2795.9 2663.5 485.4 386.3 447.0 340.2 569.9 265.2 310.7 944.2 479.9 613.2 291.9 455.7 1576.9 915.9 COX6B1 "COX6B, COXG" ENSG00000126267 "Cytochrome c oxidase subunit 6B1" P14854 19 35648323-35658782 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 2453.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 2710.8;Distal tubular cells: 2985.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004192 Supported Supported Mitochondria NA NA 150000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA004192: AB_1847180" "unprognostic (5.12e-2)" "unprognostic (1.86e-2)" "unprognostic (3.81e-2)" "unprognostic (1.22e-1)" "unprognostic (1.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.18e-1)" "unprognostic (6.16e-2)" "unprognostic (3.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" "prognostic favorable (5.42e-4)" "unprognostic (2.10e-2)" "unprognostic (6.98e-2)" "unprognostic (5.74e-2)" "unprognostic (5.48e-3)" 322.3 211.6 733.9 206.6 741.0 465.2 371.1 780.8 935.9 291.0 758.1 598.9 427.0 197.2 633.9 410.0 329.7 245.8 1284.7 749.3 761.3 519.5 582.3 201.7 316.0 768.3 740.1 241.1 292.4 850.2 169.9 222.3 757.0 249.2 690.0 276.5 356.6 328.6 1467.0 264.7 351.3 342.8 735.4 193.3 336.8 107.0 759.7 426.3 270.5 2453.4 510.5 402.2 205.1 747.2 480.3 1219.5 479.2 649.4 665.5 701.3 455.3 383.4 641.0 684.8 686.4 1018.3 478.0 555.8 663.1 656.6 413.4 341.7 836.5 700.6 683.5 632.0 570.1 929.4 626.6 1014.1 521.1 835.0 454.9 800.2 906.5 619.5 361.1 606.3 690.4 577.8 616.9 783.0 714.9 1019.4 589.2 626.8 357.0 2445.6 811.5 502.1 525.9 930.4 1567.1 1035.9 434.4 484.5 615.9 1049.3 393.4 568.5 419.6 892.9 365.9 363.8 398.0 382.3 605.6 450.5 683.3 776.7 470.9 695.0 472.7 1138.1 1099.7 998.5 628.9 1228.5 607.0 1150.2 854.9 732.8 1140.2 956.3 839.9 744.3 1115.9 672.8 1178.4 1176.1 1138.3 2058.8 733.9 741.0 780.8 935.9 749.3 761.3 768.3 740.1 757.0 735.4 759.7 747.2 324.6 243.6 227.3 27.4 409.4 427.1 436.6 1071.1 373.3 143.5 498.4 615.2 2710.8 664.8 529.6 698.9 64.6 623.0 361.5 1496.0 2985.6 711.7 328.0 427.4 293.2 312.6 625.7 436.5 21.2 808.9 735.5 360.9 484.2 397.2 280.8 277.9 338.8 1270.7 1041.1 89.2 27.9 1277.1 736.5 800.2 705.9 942.4 327.7 582.7 748.8 18.7 807.7 351.1 435.6 16.1 31.6 863.0 1445.3 273.1 523.2 548.7 2291.0 2228.5 445.5 193.3 263.0 293.8 454.2 175.7 186.6 784.8 565.6 670.7 373.1 229.1 1277.5 717.0 COX8A "COX, COX8, COX8-2, COX8L, VIII, VIII-L" ENSG00000176340 "Cytochrome c oxidase subunit 8A" P10176 11 63974620-63976543 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2341.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055942 Supported NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA055942: AB_2682979" "unprognostic (6.93e-2)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "unprognostic (7.70e-3)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (3.46e-1)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.51e-6)" "unprognostic (2.70e-2)" "unprognostic (5.41e-2)" "unprognostic (1.13e-1)" "unprognostic (8.44e-2)" 322.0 443.8 421.6 134.1 435.5 292.0 286.8 470.0 544.7 259.3 524.0 516.1 337.8 236.1 121.2 612.5 246.8 78.4 1287.8 415.9 469.2 771.1 449.9 265.4 119.9 421.5 420.4 248.0 275.7 366.3 373.9 105.7 414.7 316.0 250.2 149.5 362.1 223.8 1523.9 362.0 381.5 132.3 427.7 277.0 467.3 96.7 480.4 206.6 342.9 1005.3 175.8 307.1 331.2 427.9 613.9 803.9 505.6 505.2 213.8 260.8 365.3 317.0 355.2 621.2 480.1 543.1 489.1 290.1 680.8 447.1 581.6 597.7 395.7 550.9 212.5 427.6 687.8 423.2 621.8 650.3 341.4 431.0 527.7 336.7 412.4 497.3 398.6 274.1 391.9 676.2 503.9 613.3 397.7 1600.5 613.8 1461.1 460.7 726.4 1401.4 473.9 406.3 1234.3 512.9 512.7 457.8 645.0 377.1 541.2 816.1 215.0 796.1 459.8 240.7 356.1 481.0 769.2 374.2 760.8 662.4 461.7 462.0 420.9 436.9 764.9 743.9 692.9 407.0 848.8 301.5 398.5 441.6 403.5 867.0 347.3 337.1 369.6 530.6 418.3 794.1 851.2 589.5 723.9 421.6 435.5 470.0 544.7 415.9 469.2 421.5 420.4 414.7 427.7 480.4 427.9 236.7 224.4 259.8 13.7 255.3 294.6 392.2 640.4 385.3 196.8 394.3 458.2 1263.1 424.7 396.1 437.7 73.0 451.2 305.9 1382.7 2341.9 453.1 9.6 271.6 217.2 215.7 721.6 272.9 12.5 483.1 559.6 246.1 395.0 305.1 224.5 209.3 227.4 811.5 927.5 107.7 16.8 1011.7 592.0 535.2 427.0 25.6 239.6 455.4 627.9 11.2 508.9 429.3 416.1 7.5 15.2 562.9 1103.8 221.2 393.2 419.8 1417.0 1658.2 345.2 187.5 157.8 256.0 339.9 74.0 55.5 844.0 370.9 366.9 290.4 203.7 1088.7 593.4 CSNK2B "Ckb1, Ckb2" ENSG00000204435 "Casein kinase 2 beta" P67870 6 31665227-31670343 "Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004349, HPA005944, CAB013087, CAB016059" Approved NA NA 83000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "CAB004349: AB_626791, CAB013087: AB_2533571, CAB016059: AB_626792, HPA005944: AB_1847290" "unprognostic (1.61e-1)" "unprognostic (3.21e-2)" "unprognostic (8.88e-2)" "unprognostic (1.55e-3)" "unprognostic (9.51e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-3)" "unprognostic (1.60e-1)" "unprognostic (7.52e-2)" "unprognostic (1.62e-3)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (5.88e-2)" "unprognostic (1.72e-1)" "unprognostic (9.67e-2)" "unprognostic (3.72e-2)" 155.8 157.4 15.8 31.9 24.6 62.2 150.2 17.6 54.1 147.9 16.8 142.2 27.8 126.7 183.7 166.6 130.1 33.1 178.9 15.9 16.4 172.1 163.7 133.0 72.5 16.3 17.5 161.2 142.3 69.3 130.0 68.2 17.8 120.3 50.4 41.4 131.9 57.6 232.0 294.2 126.5 66.3 15.4 146.0 146.7 257.9 17.1 56.5 132.4 94.8 30.1 126.2 139.8 17.4 0.9 95.5 2.5 164.9 97.4 158.0 120.8 200.9 350.2 407.6 377.9 0.2 129.3 302.5 127.9 196.8 146.0 0.1 1.0 374.5 409.4 153.1 322.6 4.3 0.6 1.1 260.0 341.5 0.9 257.8 1.5 0.8 0.2 0.2 4.7 208.3 1.7 1.7 0.8 2.9 237.1 2.2 102.0 240.0 0.0 221.1 2.3 247.7 222.3 136.5 1.2 243.0 1.8 0.9 175.8 101.0 7.4 1.3 118.8 210.3 203.9 198.0 1.3 167.3 285.9 267.6 122.3 1.6 196.1 87.3 114.8 121.8 80.1 125.9 80.5 113.7 81.7 85.1 111.0 99.1 71.4 61.9 95.2 90.8 83.2 131.7 113.4 95.0 15.8 24.6 17.6 54.1 15.9 16.4 16.3 17.5 17.8 15.4 17.1 17.4 114.3 51.3 67.0 11.1 124.4 186.1 125.1 196.1 138.9 56.8 135.5 196.3 91.3 105.8 116.5 101.2 12.5 211.8 106.4 185.6 270.1 184.7 452.7 75.1 71.7 122.7 125.7 103.5 14.1 175.2 252.7 118.3 93.3 68.2 129.5 102.3 125.7 126.6 296.2 48.8 14.3 175.4 138.4 204.4 218.5 270.7 153.7 146.2 152.9 8.4 181.1 168.3 121.5 14.6 19.1 182.9 248.1 125.3 152.1 154.3 283.1 397.5 91.3 47.8 138.1 107.9 152.2 485.6 186.5 142.7 186.3 282.1 111.5 116.8 184.3 150.6 CTBP2 ribeye ENSG00000175029 "C-terminal binding protein 2" P56545 10 124984317-125161170 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Transcription, Transcription regulation" "Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023559, HPA023564, CAB031916, HPA044971, CAB079018" Approved Approved Approved Nucleoplasm NA NA 10000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: AB_2679161" "unprognostic (8.69e-2)" "unprognostic (1.27e-2)" "unprognostic (4.14e-2)" "unprognostic (1.41e-2)" "unprognostic (6.84e-3)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (5.60e-3)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (3.24e-2)" "unprognostic (3.99e-3)" "prognostic favorable (1.70e-4)" "unprognostic (4.34e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.62e-1)" 27.1 25.4 21.4 17.1 23.7 17.2 30.6 32.9 20.1 47.9 47.8 36.7 33.3 46.8 21.0 30.4 37.3 22.1 19.9 22.8 25.5 31.7 5.7 33.1 9.4 24.3 24.1 41.8 40.7 21.9 23.6 24.7 22.0 38.6 29.2 55.4 36.7 24.0 22.8 16.7 33.4 30.0 22.1 21.6 36.9 19.7 28.8 9.0 53.9 19.8 9.1 29.9 30.9 23.7 87.3 96.5 83.6 70.2 43.9 43.0 46.1 66.4 77.0 61.2 69.3 60.4 99.7 0.1 33.6 66.9 38.6 67.2 83.8 106.5 45.8 0.3 63.8 63.8 61.6 1.3 91.7 27.2 48.9 37.1 82.7 63.5 125.5 80.9 79.1 4.9 2.6 0.5 38.7 96.5 3.0 27.8 63.0 90.3 61.3 77.4 35.0 0.8 72.5 38.8 25.5 73.1 64.7 56.0 86.5 64.7 39.7 43.9 64.4 36.8 46.2 53.0 57.9 1.4 5.3 0.3 46.1 0.3 37.1 30.8 8.5 16.4 8.5 9.0 1.1 0.5 0.4 2.3 11.2 0.3 0.5 3.6 14.3 34.6 22.4 9.4 0.3 4.7 21.4 23.7 32.9 20.1 22.8 25.5 24.3 24.1 22.0 22.1 28.8 23.7 64.7 32.1 27.2 72.1 4.0 47.2 83.4 41.5 33.6 182.5 75.8 59.8 32.7 55.8 53.2 38.6 158.4 22.3 50.7 81.7 68.4 69.3 29.9 125.0 65.1 63.0 55.0 42.3 41.8 60.8 70.5 42.3 40.2 163.0 17.7 43.1 61.4 1.2 29.6 107.7 35.0 93.9 50.8 49.3 46.9 38.1 60.3 47.0 58.7 127.4 60.6 63.2 124.6 44.2 87.1 83.8 61.6 77.8 6.9 89.3 45.1 31.6 94.1 107.5 59.2 59.6 67.0 12.7 45.5 42.1 39.8 19.3 15.3 81.3 106.1 102.7 CTDNEP1 "DULLARD, HSA011916, NET56" ENSG00000175826 "CTD nuclear envelope phosphatase 1" O95476 17 7243591-7252491 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 410.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037439, HPA066466" Uncertain Approved "Lipid droplets" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Lipid droplets" "HPA037439: AB_10601264, HPA066466: AB_2732745" "unprognostic (7.11e-2)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "prognostic favorable (6.45e-4)" "unprognostic (3.12e-1)" "unprognostic (2.13e-1)" "unprognostic (4.61e-2)" "unprognostic (1.50e-2)" "unprognostic (2.98e-1)" "unprognostic (9.90e-2)" "prognostic favorable (1.81e-4)" "unprognostic (3.37e-1)" "unprognostic (2.77e-3)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (9.97e-2)" "unprognostic (2.02e-2)" 99.7 94.2 53.0 41.4 52.5 48.8 91.4 49.2 55.1 102.4 51.2 89.8 36.4 97.6 37.1 105.2 88.2 32.1 119.0 49.9 49.0 85.5 69.1 91.6 45.9 55.9 52.7 103.4 98.5 44.4 83.8 41.1 51.2 81.8 46.7 29.7 82.6 33.6 410.0 114.7 93.8 45.0 50.5 115.9 95.4 66.5 55.8 56.2 81.2 179.2 61.8 88.2 87.0 52.8 86.2 123.9 68.4 73.7 105.0 128.0 52.5 62.4 102.8 97.4 83.1 59.6 57.7 80.6 65.6 111.5 68.6 70.5 90.8 95.4 108.6 118.5 74.6 55.2 79.7 104.1 96.5 63.3 100.3 103.4 113.8 111.9 118.3 99.9 105.2 76.2 50.9 56.3 93.3 53.4 77.3 67.0 48.3 75.7 50.9 85.3 61.3 62.6 77.9 44.1 26.3 75.5 49.8 48.9 69.8 67.6 46.3 51.5 61.6 70.9 61.3 57.5 119.4 49.2 46.0 40.6 91.5 85.8 75.1 4.2 6.3 11.0 5.5 6.7 4.4 7.8 5.2 5.9 4.6 7.4 4.0 5.9 8.4 4.1 4.5 9.7 5.7 2.3 53.0 52.5 49.2 55.1 49.9 49.0 55.9 52.7 51.2 50.5 55.8 52.8 48.0 25.6 23.2 12.7 47.1 47.2 42.4 36.1 19.9 44.8 73.9 70.1 13.1 37.1 33.5 40.5 22.9 66.1 68.3 84.5 11.7 63.7 4.8 50.0 59.9 47.2 73.7 18.5 14.7 85.2 129.9 43.5 22.4 68.5 20.3 71.3 44.6 35.6 90.6 30.3 17.0 79.6 22.4 104.4 62.2 7.9 57.8 69.8 28.4 14.0 69.2 47.9 59.8 11.6 21.9 84.5 52.1 47.0 41.3 58.3 62.8 34.8 25.8 35.4 26.3 42.5 51.4 23.7 35.5 32.5 67.1 83.2 41.3 68.3 69.6 61.8 CYB561D2 "101F6, TSP10" ENSG00000114395 "Cytochrome b561 family member D2" O14569 3 50350845-50358460 "Enzymes, Predicted membrane proteins" "Electron transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071862 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA071862: " "unprognostic (4.89e-2)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (5.15e-2)" "unprognostic (2.72e-2)" "unprognostic (2.28e-3)" "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (5.41e-2)" "prognostic favorable (1.86e-4)" "unprognostic (3.26e-1)" "prognostic favorable (6.16e-5)" "unprognostic (4.33e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-1)" "unprognostic (7.57e-2)" 13.3 20.7 8.1 16.7 9.8 22.0 13.9 9.7 9.2 10.6 10.5 19.7 22.0 7.6 25.8 14.6 9.7 14.6 10.1 8.3 8.6 19.8 34.3 14.1 22.2 9.8 9.6 7.0 19.5 18.2 13.8 11.1 9.8 16.3 18.0 3.1 20.3 11.5 10.0 9.8 22.7 7.1 9.6 24.7 21.7 10.5 9.2 13.2 20.3 3.5 15.3 12.3 9.3 11.3 16.2 33.5 8.4 15.8 17.2 14.7 19.2 27.4 20.4 24.5 28.0 24.1 25.3 25.3 29.3 33.8 29.8 16.5 12.8 25.2 10.7 38.5 31.9 23.7 40.7 22.5 24.2 26.3 52.3 23.0 11.3 29.3 13.5 12.4 21.1 19.1 10.5 32.3 19.7 30.3 17.0 22.9 13.4 24.6 52.1 11.6 5.8 50.2 26.3 27.0 8.4 23.7 13.7 56.1 17.5 8.4 19.8 30.9 23.1 22.5 18.9 37.6 35.8 24.6 26.2 16.8 30.2 32.1 24.4 145.8 113.9 176.1 144.3 140.1 95.6 88.4 96.1 115.7 86.3 79.3 67.1 99.6 110.8 109.3 136.2 89.0 114.7 112.4 8.1 9.8 9.7 9.2 8.3 8.6 9.8 9.6 9.8 9.6 9.2 11.3 13.3 6.4 21.7 5.5 24.4 5.0 12.0 37.4 8.6 6.8 26.5 12.3 0.0 0.0 30.9 25.8 6.2 35.0 40.2 47.1 11.7 44.9 19.9 19.7 14.7 9.1 31.8 6.7 6.7 68.1 46.0 13.0 31.1 18.4 21.5 8.4 0.0 0.0 57.3 8.4 5.8 47.0 46.8 0.0 12.3 9.1 8.7 29.1 19.6 6.5 36.2 22.2 45.3 6.0 13.3 43.3 49.4 7.9 36.7 17.9 55.6 22.3 38.4 8.2 13.1 8.0 15.6 6.1 14.1 14.0 7.4 55.1 32.9 15.9 28.1 18.4 DBI "ACBD1, ACBP" ENSG00000155368 "Diazepam binding inhibitor, acyl-CoA binding protein" P07108 2 119366921-119372560 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 2215.1;Proximal tubular cells: 2834.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 2479.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051428 Approved NA NA 9100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" "HPA051428: AB_2681482" "unprognostic (1.24e-1)" "prognostic favorable (5.77e-5)" "unprognostic (4.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.71e-2)" "unprognostic (1.92e-2)" "unprognostic (7.28e-3)" "unprognostic (1.70e-3)" "unprognostic (1.71e-1)" "unprognostic (2.85e-2)" "unprognostic (1.45e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (1.03e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (1.45e-1)" 358.3 153.9 486.0 158.7 470.8 121.9 717.3 495.6 726.7 218.6 452.3 322.8 312.8 73.5 653.7 667.7 85.8 129.7 515.4 493.0 498.5 536.2 971.1 236.0 182.9 499.4 495.1 86.0 143.8 866.9 76.9 116.3 510.0 451.5 297.3 116.3 369.9 215.1 273.0 451.0 229.6 97.2 512.7 115.5 185.1 201.3 487.6 173.3 133.7 460.5 324.5 136.5 327.7 516.4 543.0 276.9 557.1 257.2 1339.7 1131.9 350.7 281.3 708.7 387.0 746.1 580.6 427.8 747.3 312.1 440.6 938.5 277.9 397.0 588.3 345.9 498.2 262.1 641.4 279.9 775.8 335.6 206.1 2479.2 648.2 376.5 596.2 222.1 255.4 464.3 358.8 77.0 679.2 558.8 559.1 436.5 585.9 370.2 349.7 429.7 157.4 541.4 658.5 948.1 816.5 263.2 210.1 235.3 548.5 634.9 388.8 338.0 952.8 332.5 259.3 329.8 288.8 346.3 220.9 170.5 610.0 365.7 364.8 315.3 1180.7 439.9 1077.9 472.9 489.1 347.3 461.4 367.8 465.2 748.8 505.3 279.1 419.2 285.8 450.7 402.5 791.0 615.7 792.2 486.0 470.8 495.6 726.7 493.0 498.5 499.4 495.1 510.0 512.7 487.6 516.4 505.2 150.6 613.0 46.0 256.7 289.2 249.4 724.2 190.1 37.9 806.5 1025.9 1079.6 663.4 390.0 310.8 14.6 796.5 395.6 737.5 1197.4 466.9 844.4 154.8 194.7 206.2 371.3 108.8 5.2 670.3 643.2 258.2 243.1 185.6 433.4 219.4 167.8 2215.1 1069.4 30.3 3.9 495.0 524.9 305.0 785.7 325.7 152.2 476.1 1058.3 15.0 871.5 928.6 552.0 33.2 25.0 372.7 612.0 127.5 192.0 355.0 753.6 2834.8 340.5 59.1 151.2 267.2 289.9 462.0 30.1 972.6 684.9 516.3 260.8 456.0 673.2 361.0 DBNL "ABP1, HIP-55, SH3P7" ENSG00000136279 "Drebrin like" Q9UJU6 7 44044640-44069456 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Endocytosis, Immunity, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 338.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020265, HPA027735" Enhanced Supported "Vesicles,Plasma membrane" NA NA 3500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 3: Monocytes - Immune response regulation" "Vesicles, Plasma membrane" "HPA020265: AB_1850723, HPA027735: AB_10603790" "unprognostic (9.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.12e-5)" "unprognostic (2.25e-1)" "unprognostic (6.18e-3)" "unprognostic (1.83e-1)" "unprognostic (5.88e-2)" "unprognostic (8.92e-2)" "unprognostic (5.76e-3)" "unprognostic (5.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-1)" "unprognostic (1.46e-1)" "unprognostic (9.51e-2)" 58.1 51.6 44.2 62.8 45.1 76.6 51.3 41.7 50.4 72.4 39.9 54.6 34.7 56.0 20.2 189.0 47.8 47.2 49.2 45.8 45.2 50.7 51.1 57.8 99.6 46.2 44.8 38.0 44.3 38.4 47.8 34.9 48.4 57.0 30.6 9.4 57.5 38.0 34.3 59.9 64.7 44.8 44.3 119.5 54.7 20.8 44.6 64.8 47.6 16.4 89.1 60.3 92.0 43.4 57.6 89.1 60.5 56.6 77.0 49.7 46.0 95.9 93.6 111.5 91.5 90.0 82.5 132.3 70.0 126.1 133.6 101.9 35.6 130.6 40.7 70.6 38.9 51.9 73.8 52.4 78.5 75.8 70.3 46.6 53.3 107.1 35.2 71.5 74.1 83.9 63.8 49.3 105.5 91.5 136.5 85.3 43.1 72.9 73.0 69.4 48.1 64.5 69.8 90.5 65.6 89.8 69.6 121.5 24.4 43.8 94.0 99.4 121.1 82.7 75.5 49.5 113.6 102.7 49.4 81.2 78.3 83.2 183.8 263.3 377.1 295.0 190.3 422.7 148.3 253.9 138.0 155.0 362.5 261.7 136.5 145.1 357.4 192.4 437.9 376.6 183.1 558.8 44.2 45.1 41.7 50.4 45.8 45.2 46.2 44.8 48.4 44.3 44.6 43.4 49.9 44.8 36.2 10.7 105.4 17.6 34.1 62.9 19.4 33.0 26.7 24.0 30.6 25.8 42.2 31.3 35.5 78.9 101.6 58.5 45.0 87.0 10.3 30.7 39.3 44.8 37.8 45.8 7.4 73.2 146.4 39.3 54.6 50.7 65.9 42.3 32.5 22.5 176.0 40.4 6.7 50.0 38.7 129.6 48.6 10.6 37.0 113.4 55.2 7.5 338.3 42.5 112.3 5.5 11.4 105.9 74.0 33.8 50.2 31.5 49.0 33.6 21.6 38.6 6.6 29.0 54.6 24.4 12.8 64.4 26.7 87.3 69.5 51.9 44.0 51.1 DCAF11 "GL014, PRO2389, WDR23" ENSG00000100897 "DDB1 and CUL4 associated factor 11" Q8TEB1 14 24114195-24125242 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 201.2;Hepatocytes: 156.0;Proximal enterocytes: 147.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003583, HPA031157" Approved Enhanced Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "HPA003583: AB_2667001, HPA031157: AB_10603002" "unprognostic (1.50e-1)" "unprognostic (4.72e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (1.01e-1)" "unprognostic (9.58e-2)" "unprognostic (1.91e-3)" "unprognostic (1.48e-3)" "unprognostic (3.23e-2)" "unprognostic (4.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.01e-1)" "prognostic favorable (3.50e-13)" "unprognostic (2.58e-1)" "unprognostic (3.48e-1)" "unprognostic (6.80e-2)" "unprognostic (1.68e-1)" 15.4 41.6 21.5 13.4 21.7 39.5 17.1 19.7 23.0 15.4 19.9 24.5 29.3 17.1 23.2 29.8 15.6 13.6 38.1 22.3 19.9 35.8 107.2 17.5 15.6 21.0 20.3 23.1 59.7 28.2 25.6 9.2 19.8 23.6 16.6 17.6 25.9 17.5 62.3 20.1 37.5 11.7 19.2 28.9 34.3 16.5 22.0 19.0 26.4 50.0 16.1 20.3 16.2 21.1 12.5 18.3 12.3 10.9 10.7 8.8 16.6 9.1 10.7 16.0 19.5 12.0 21.3 19.4 10.3 12.2 13.3 16.1 15.8 9.6 7.4 23.1 9.5 15.6 19.7 67.3 14.3 27.7 31.0 5.3 23.1 6.7 16.7 13.1 12.3 31.6 15.0 23.0 9.7 39.2 23.7 28.5 7.2 35.0 17.0 25.1 16.0 28.2 12.2 28.1 22.1 17.0 5.3 29.9 13.4 12.7 15.4 19.6 5.1 12.5 10.0 13.6 13.2 38.6 36.2 25.3 6.0 17.7 10.9 14.0 13.8 20.5 13.8 15.8 11.7 12.1 12.5 13.5 17.1 11.5 12.2 11.4 11.7 23.0 13.9 8.6 16.7 15.2 21.5 21.7 19.7 23.0 22.3 19.9 21.0 20.3 19.8 19.2 22.0 21.1 18.2 28.9 45.4 10.4 30.5 8.8 22.2 18.7 31.3 34.1 34.8 20.7 41.2 44.3 23.9 38.6 47.9 34.6 34.2 76.1 46.9 41.6 19.3 22.0 10.8 15.2 28.9 201.2 9.2 46.2 31.5 14.1 29.0 22.5 12.6 26.5 22.1 156.0 37.4 16.8 6.9 40.7 20.3 27.0 12.8 26.6 9.0 24.1 17.8 9.4 39.2 38.8 55.6 7.1 9.7 31.9 34.6 14.7 26.6 25.0 147.9 56.0 22.3 29.4 26.3 15.9 14.5 23.7 12.4 32.6 11.4 50.5 31.2 60.7 49.0 22.7 DCAF12 "CT102, DKFZP434O125, KIAA1892, MGC1058, TCC52, WDR40A" ENSG00000198876 "DDB1 and CUL4 associated factor 12" Q5T6F0 9 34086387-34127399 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.9;Erythroid cells: 315.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062279 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 43: THP-1 - Innate immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA062279: AB_2684734" "unprognostic (9.56e-2)" "unprognostic (3.47e-2)" "unprognostic (3.92e-3)" "unprognostic (2.22e-2)" "unprognostic (6.61e-2)" "unprognostic (2.40e-1)" "unprognostic (6.34e-3)" "unprognostic (6.57e-2)" "unprognostic (2.86e-3)" "prognostic favorable (2.81e-5)" "unprognostic (1.77e-1)" "unprognostic (4.37e-1)" "unprognostic (2.21e-3)" "unprognostic (3.09e-2)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (1.03e-1)" 16.2 32.3 10.4 20.0 10.2 33.7 21.7 9.9 10.8 20.3 13.6 22.2 17.1 17.3 16.8 29.4 18.4 16.9 12.7 9.6 10.1 17.4 23.2 17.3 37.0 11.8 10.7 16.0 15.8 22.7 10.0 28.6 11.2 16.2 25.9 17.4 16.8 14.4 18.2 16.6 17.3 17.5 10.9 17.5 17.3 62.4 10.5 30.0 19.5 23.3 42.2 24.1 16.8 11.4 45.1 29.2 58.1 26.1 24.9 21.6 33.0 24.5 31.4 43.8 37.6 25.6 21.4 88.6 20.7 27.7 15.2 19.6 64.4 28.7 37.6 40.3 34.6 70.1 58.6 36.1 36.4 86.5 41.7 21.6 54.8 28.0 53.1 33.7 35.3 48.9 70.2 30.0 28.6 18.5 55.3 85.8 29.9 29.5 28.3 51.8 31.6 39.3 46.0 32.5 57.0 48.9 49.6 42.0 20.2 30.6 23.5 134.4 25.4 20.8 25.3 17.8 33.5 19.6 38.8 68.7 19.8 65.2 51.2 36.4 28.6 28.3 12.3 24.0 18.5 1.2 12.2 14.1 25.3 0.4 9.8 11.4 27.6 16.0 20.4 20.4 22.9 20.2 10.4 10.2 9.9 10.8 9.6 10.1 11.8 10.7 11.2 10.9 10.5 11.4 13.8 6.4 20.0 7.5 5.9 38.5 18.8 13.3 21.1 6.9 20.3 14.7 6.7 8.6 13.4 5.5 6.2 21.5 27.6 22.0 25.4 16.0 165.9 27.3 13.7 18.2 25.2 315.8 10.0 18.2 25.2 14.5 16.3 19.3 17.7 20.6 15.0 21.9 31.4 10.1 10.4 22.3 10.2 63.9 16.2 63.0 20.2 32.1 17.8 12.2 22.4 7.5 11.3 11.6 8.8 18.0 15.7 21.1 29.6 28.6 13.1 21.5 23.4 7.0 13.1 13.8 17.5 40.1 43.2 33.1 38.6 22.4 16.7 30.0 19.6 38.4 DCTN3 DCTN-22 ENSG00000137100 "Dynactin subunit 3" O75935 9 34613545-34620523 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044905 Approved Approved Nucleoli,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Cytosol Nucleoli "HPA044905: AB_10960996" "unprognostic (3.38e-1)" "unprognostic (4.13e-2)" "unprognostic (3.47e-1)" "unprognostic (6.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.92e-3)" "unprognostic (9.88e-2)" "unprognostic (4.41e-2)" "prognostic favorable (2.10e-5)" "unprognostic (1.26e-3)" "unprognostic (4.24e-3)" "prognostic favorable (5.76e-11)" "unprognostic (3.06e-1)" "unprognostic (2.25e-1)" "unprognostic (3.22e-1)" "unprognostic (4.43e-2)" 72.9 87.9 98.3 33.7 104.6 107.3 72.2 97.0 123.5 80.6 92.9 81.1 42.0 72.9 46.8 98.5 66.4 38.7 127.1 106.0 103.3 88.6 67.0 60.8 48.0 97.1 97.2 78.7 76.5 94.4 108.4 40.7 102.4 68.2 39.0 57.0 69.2 51.4 152.5 111.1 51.1 53.6 94.1 58.7 75.6 36.3 100.3 81.3 71.5 114.4 59.0 69.5 79.2 95.6 147.1 120.7 110.1 115.6 95.1 132.3 45.1 122.7 112.8 166.4 130.2 77.7 53.8 67.0 74.6 161.8 58.4 57.4 101.0 128.3 105.6 211.9 126.5 44.9 202.9 68.5 102.6 118.8 131.3 117.5 109.4 115.6 75.0 81.4 111.1 123.6 54.2 135.3 147.4 120.9 151.4 320.0 33.4 61.0 192.7 75.2 59.7 93.4 81.5 51.2 36.5 93.3 90.9 82.7 48.0 32.2 110.6 134.5 102.7 104.6 84.1 120.1 121.0 90.6 126.0 45.5 164.1 68.6 217.4 235.2 131.1 187.4 99.9 139.4 92.1 88.4 106.0 106.8 133.8 94.7 83.6 98.9 114.4 102.2 150.3 136.1 179.1 152.5 98.3 104.6 97.0 123.5 106.0 103.3 97.1 97.2 102.4 94.1 100.3 95.6 103.7 32.1 38.3 13.1 61.3 101.6 111.8 180.7 82.0 83.2 97.3 146.9 86.1 77.2 91.8 80.9 25.0 128.8 105.6 74.1 207.4 127.5 14.3 78.6 98.8 79.2 74.7 115.7 16.8 154.6 111.9 97.9 56.6 67.1 87.5 82.4 88.5 84.9 133.8 74.0 16.2 64.9 91.6 88.8 99.0 21.1 103.5 76.8 149.4 5.6 94.9 212.9 125.7 7.5 16.8 126.7 84.5 122.6 89.1 54.7 89.0 240.2 95.0 96.7 59.2 82.0 150.5 82.2 72.9 109.9 142.6 99.7 95.7 143.2 61.6 96.6 DDAH2 G6A ENSG00000213722 "Dimethylarginine dimethylaminohydrolase 2" O95865 6 31727038-31730617 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 386.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 63.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012389, HPA012509" Uncertain Supported Mitochondria NA NA 1500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA012389: , HPA012509: AB_1847533" "unprognostic (2.29e-2)" "unprognostic (1.38e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-1)" "unprognostic (7.67e-2)" "unprognostic (1.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.62e-1)" "unprognostic (8.78e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (1.02e-1)" "unprognostic (9.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.24e-2)" "unprognostic (2.72e-2)" 96.5 17.2 26.6 12.0 24.7 10.8 81.2 24.2 44.7 131.5 26.1 72.2 4.4 94.4 8.7 39.0 80.5 44.0 63.2 23.9 33.5 67.1 32.1 62.3 20.6 31.8 28.2 67.7 16.5 17.5 26.0 18.3 28.1 65.2 7.7 5.8 58.2 27.0 13.4 67.7 38.9 11.9 32.0 49.4 35.4 13.4 27.4 9.6 65.1 4.5 7.8 61.0 91.0 30.9 2.0 20.1 0.7 28.5 17.0 26.6 3.8 0.0 10.6 10.9 7.3 40.4 6.7 0.4 24.4 26.5 0.9 2.4 0.5 9.7 1.9 0.0 14.2 1.9 7.8 22.4 18.2 0.3 1.5 18.8 1.2 12.2 0.9 3.7 33.3 14.1 0.4 11.1 4.8 63.0 1.5 27.5 4.1 4.3 12.2 0.2 0.9 10.5 21.6 0.5 1.5 5.7 0.0 4.7 27.4 2.9 37.7 7.8 0.1 16.9 24.7 11.2 0.0 4.1 12.8 3.3 11.3 5.9 4.3 141.3 15.4 135.0 14.8 37.4 5.8 49.7 4.0 5.3 26.8 39.6 2.7 3.4 27.8 29.2 44.9 93.9 4.1 11.4 26.6 24.7 24.2 44.7 23.9 33.5 31.8 28.2 28.1 32.0 27.4 30.9 102.3 28.9 14.7 10.4 76.8 66.9 88.7 49.6 56.3 4.5 132.8 96.0 39.5 62.9 36.9 82.8 29.2 15.5 84.4 386.3 178.1 148.2 83.1 62.6 94.2 101.2 150.0 20.4 0.3 32.3 37.3 154.1 33.1 75.0 113.3 121.7 94.9 31.9 223.2 0.0 0.3 71.5 109.9 139.7 301.2 23.6 180.5 95.7 103.2 14.0 64.2 120.9 40.2 4.5 2.7 85.1 299.5 153.1 24.5 95.2 61.5 165.8 50.5 25.7 105.2 122.7 153.0 4.1 12.5 35.8 59.2 18.1 41.1 21.3 104.6 67.0 DDOST "GATD6, KIAA0115, OST, OST48, WBP1" ENSG00000244038 "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit" P39656 1 20651767-20661544 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 350.7;Syncytiotrophoblasts: 349.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009746, HPA046841, HPA052867" Supported Supported "Endoplasmic reticulum" NA NA 120000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977" "unprognostic (8.57e-3)" "unprognostic (1.35e-2)" "unprognostic (1.57e-2)" "prognostic favorable (5.99e-4)" "unprognostic (1.62e-1)" "prognostic unfavorable (4.88e-4)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (2.70e-2)" "unprognostic (3.59e-2)" "unprognostic (3.72e-1)" "prognostic unfavorable (9.05e-7)" "unprognostic (1.07e-1)" "unprognostic (2.98e-1)" "unprognostic (1.69e-2)" "unprognostic (1.07e-1)" 98.1 132.7 44.6 108.5 46.4 191.4 111.9 44.9 46.3 130.7 64.1 161.4 119.4 115.8 224.5 113.2 137.4 98.2 123.4 47.2 53.7 100.6 137.2 104.4 104.6 48.1 45.3 139.5 259.8 112.7 119.1 183.3 46.9 99.8 165.7 42.1 151.7 130.4 80.0 87.3 108.4 122.8 46.1 113.1 139.0 83.4 52.4 84.0 185.6 66.4 121.6 119.3 92.8 51.4 366.0 206.7 178.8 533.9 347.4 359.8 376.6 286.1 545.9 435.5 445.3 278.9 678.8 275.8 501.8 447.0 238.7 292.7 250.4 334.3 321.3 257.0 256.3 235.7 138.5 375.0 513.2 377.5 618.8 371.6 370.2 365.2 439.5 522.8 504.1 180.5 116.3 445.0 266.5 251.1 179.6 308.2 196.5 529.8 214.2 164.5 238.6 492.2 358.7 150.4 133.0 238.3 294.0 299.1 413.5 257.1 237.8 566.8 260.2 249.7 279.6 435.1 274.6 586.1 677.5 195.6 409.4 489.4 342.0 272.0 268.3 257.3 255.6 284.2 270.3 230.4 218.1 239.9 389.7 207.8 203.1 209.6 63.8 266.1 251.4 320.1 256.0 490.6 44.6 46.4 44.9 46.3 47.2 53.7 48.1 45.3 46.9 46.1 52.4 51.4 62.0 35.3 72.3 7.5 93.6 50.2 95.8 200.6 47.3 18.3 70.0 62.5 22.1 77.2 120.0 35.0 29.2 350.7 92.9 52.5 39.2 162.5 29.9 44.7 71.9 65.2 71.8 49.6 10.9 148.3 270.0 102.8 74.5 71.6 79.1 113.2 55.3 74.4 140.8 16.8 9.4 152.6 79.3 66.8 78.8 13.9 74.6 74.5 85.4 6.5 96.4 54.1 87.6 15.6 10.7 93.5 89.7 60.9 320.5 68.9 69.1 54.3 78.9 24.6 46.0 42.5 103.3 136.0 171.3 55.1 53.6 349.7 78.5 122.9 133.7 84.3 DGUOK dGK ENSG00000114956 "Deoxyguanosine kinase" Q16854 2 73926826-73958961 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034766, HPA057246" Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA034766: AB_10669850, HPA057246: AB_2683381" "unprognostic (3.40e-1)" "unprognostic (2.43e-1)" "unprognostic (1.45e-2)" "unprognostic (2.94e-2)" "unprognostic (1.20e-1)" "unprognostic (4.17e-2)" "unprognostic (2.14e-2)" "unprognostic (1.37e-2)" "unprognostic (4.10e-3)" "unprognostic (5.07e-2)" "unprognostic (1.41e-1)" "unprognostic (9.84e-2)" "prognostic unfavorable (8.69e-7)" "unprognostic (3.86e-1)" "unprognostic (2.21e-2)" "unprognostic (5.98e-2)" "prognostic favorable (7.47e-4)" 20.8 30.0 37.1 20.3 39.2 27.1 28.1 36.5 48.4 23.0 36.8 25.0 17.7 23.1 34.4 21.8 31.3 19.4 23.0 38.5 42.8 24.6 30.5 17.7 36.8 37.9 37.7 30.0 16.3 11.0 41.3 21.5 39.1 24.5 29.1 34.5 19.8 22.5 17.1 26.5 20.2 21.9 37.9 25.9 21.0 32.8 38.8 36.3 22.6 17.7 40.9 22.2 20.9 38.8 45.1 72.5 74.4 67.9 47.8 53.8 37.1 29.3 56.0 66.7 61.1 91.2 51.5 83.0 27.4 42.1 74.1 34.7 85.4 57.1 79.3 47.1 53.6 65.8 25.4 107.5 70.5 62.1 66.0 49.7 51.3 50.4 58.9 48.6 48.3 91.4 67.2 37.0 78.8 54.4 59.6 101.2 76.7 60.5 53.9 73.8 73.1 59.7 55.8 49.6 85.0 82.6 27.9 28.2 77.1 35.5 34.0 34.8 45.3 43.3 68.8 37.8 52.6 32.3 31.4 86.1 62.2 65.9 95.1 129.8 70.9 138.7 62.3 87.3 72.4 108.5 77.0 69.6 81.6 114.5 98.6 79.6 56.4 79.4 84.7 91.3 79.9 91.3 37.1 39.2 36.5 48.4 38.5 42.8 37.9 37.7 39.1 37.9 38.8 38.8 72.5 32.1 42.8 14.7 103.4 74.2 138.7 249.6 88.2 52.3 85.0 128.1 19.1 78.6 108.6 60.7 6.2 159.4 89.7 58.9 84.1 102.6 12.3 82.3 69.1 74.1 113.1 67.1 17.5 149.1 165.4 88.3 40.2 82.6 57.6 87.4 76.1 69.9 90.9 52.2 21.1 100.1 158.7 88.3 112.3 15.1 93.5 80.2 110.3 15.9 151.9 89.5 118.4 12.5 27.2 173.0 88.1 86.9 70.2 146.2 88.2 119.7 87.2 40.4 92.1 55.3 89.3 105.3 129.4 88.3 83.3 124.5 101.4 124.5 104.9 142.9 DNAJB6 "LGMD1D, MRJ" ENSG00000105993 "DnaJ heat shock protein family (Hsp40) member B6" O75190 7 157335381-157417439 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 960.5;Urothelial cells: 876.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004670, HPA024258, HPA058593" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Cytosol "CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767" "unprognostic (4.37e-1)" "unprognostic (1.62e-2)" "unprognostic (3.22e-2)" "unprognostic (9.26e-3)" "unprognostic (6.66e-3)" "unprognostic (4.68e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.01e-2)" "unprognostic (8.41e-2)" "unprognostic (3.19e-1)" "unprognostic (6.33e-2)" "unprognostic (2.24e-1)" "unprognostic (1.54e-1)" "unprognostic (6.45e-2)" "unprognostic (1.52e-1)" 82.7 66.0 112.4 55.9 119.0 183.2 87.0 124.0 219.8 76.0 125.6 103.7 43.5 81.5 109.4 117.0 73.8 50.5 121.0 119.5 122.2 73.3 49.8 69.9 54.8 122.8 122.8 76.6 43.6 57.6 65.2 73.7 123.7 58.1 49.2 87.4 74.8 70.5 328.3 132.7 56.9 73.3 120.3 59.3 62.1 118.2 118.5 81.1 52.6 177.5 68.0 92.7 90.8 139.5 179.8 106.7 127.0 130.9 126.3 113.1 117.6 196.2 159.8 179.1 194.4 146.4 176.0 68.7 359.2 146.9 162.4 111.9 87.3 137.8 275.3 138.3 119.6 123.1 61.7 104.6 116.1 92.4 99.4 100.2 130.7 136.1 64.2 178.9 135.6 72.2 203.8 66.9 232.5 121.7 232.4 181.0 255.7 126.1 141.2 122.7 91.1 96.0 148.9 108.1 76.5 201.2 153.5 119.3 151.2 259.6 87.2 129.8 170.0 113.0 85.4 270.6 172.0 126.1 193.1 80.9 160.1 208.7 146.4 345.1 160.8 201.9 133.8 168.2 135.2 134.8 120.8 138.4 120.2 124.0 152.0 141.7 287.8 148.0 206.3 109.9 159.6 247.0 112.4 119.0 124.0 219.8 119.5 122.2 122.8 122.8 123.7 120.3 118.5 139.5 225.2 48.1 62.7 41.1 150.9 756.7 640.9 632.6 182.7 100.4 281.8 175.9 115.0 62.9 206.8 97.5 81.3 276.9 287.0 143.0 193.7 134.9 105.8 225.6 125.2 178.8 193.5 131.1 49.4 69.4 241.8 159.8 66.8 296.3 212.7 70.5 101.4 46.7 164.7 94.2 56.4 149.8 223.8 133.7 803.5 126.4 151.0 339.2 282.8 60.9 313.6 122.7 173.0 37.2 73.5 138.5 132.4 202.3 132.9 413.2 82.4 196.1 253.8 104.0 98.6 146.0 198.8 319.4 504.8 204.1 960.5 508.1 288.0 111.4 155.1 876.8 DNTTIP2 "ERBP, HSU15552, TdIF2" ENSG00000067334 "Deoxynucleotidyltransferase terminal interacting protein 2" Q5QJE6 1 93866284-93879918 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044502, HPA053707" Supported Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044502: AB_10960277, HPA053707: AB_2682236" "unprognostic (2.95e-3)" "unprognostic (3.84e-2)" "unprognostic (6.21e-3)" "unprognostic (1.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.92e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (7.94e-2)" "unprognostic (5.57e-3)" "unprognostic (2.69e-2)" "unprognostic (2.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (2.59e-1)" "unprognostic (8.41e-2)" "unprognostic (2.25e-1)" "unprognostic (1.06e-2)" 5.0 3.7 4.9 3.5 5.2 15.3 5.0 10.3 6.7 3.5 5.6 3.4 2.7 4.0 6.3 4.4 3.5 4.5 4.5 5.5 5.4 4.2 5.0 3.7 5.5 4.8 4.9 4.3 3.4 3.8 2.1 4.6 5.1 3.7 3.6 4.2 2.9 3.0 8.9 5.5 2.7 3.7 3.8 4.5 3.6 4.5 5.3 4.3 4.7 5.0 5.2 6.5 2.8 6.8 14.3 6.6 7.2 7.8 6.9 6.2 11.1 9.4 6.6 11.0 9.4 7.3 6.1 18.8 12.2 9.9 13.8 7.7 11.9 11.2 15.6 11.4 6.6 15.4 11.3 11.0 7.2 17.4 5.3 6.8 11.9 11.9 9.8 5.5 7.9 6.0 18.6 6.0 15.1 6.3 12.2 11.3 14.2 6.3 10.6 7.0 15.6 7.2 11.3 10.8 8.7 7.7 9.8 14.4 10.5 9.2 6.2 12.6 7.7 8.8 9.2 10.2 15.9 6.4 9.3 15.3 5.1 13.6 5.9 9.7 5.7 11.6 6.4 8.3 7.7 8.2 5.8 5.8 5.1 8.4 5.3 6.9 8.0 9.6 8.5 3.5 6.4 6.8 4.9 5.2 10.3 6.7 5.5 5.4 4.8 4.9 5.1 3.8 5.3 6.8 98.9 57.7 78.2 3.6 66.7 54.4 163.0 57.9 43.3 33.9 27.5 38.9 73.0 11.5 91.2 12.9 58.4 52.0 110.2 17.3 21.5 74.3 53.8 85.1 72.0 74.2 8.4 20.6 6.8 60.3 44.4 54.3 38.2 122.4 119.4 36.6 25.7 19.4 38.1 20.2 7.7 14.5 46.8 29.5 72.1 11.0 25.7 75.8 23.2 8.4 52.1 29.2 48.4 3.5 7.2 88.6 20.1 25.9 50.1 96.7 17.2 19.6 85.1 34.4 19.7 90.7 79.0 62.8 65.9 40.0 50.6 55.8 87.7 44.4 23.1 112.0 DOCK11 "ACG, FLJ32122, FLJ43653, ZIZ2" ENSG00000147251 "Dedicator of cytokinesis 11" Q5JSL3 X 118495815-118686163 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 54.3" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 100.4;Kupffer cells: 47.5;Macrophages: 45.7;Microglial cells: 67.5;NK-cells: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 63.3;HMC-1: 92.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059695 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA059695: AB_2684104" "unprognostic (4.09e-1)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.56e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.50e-1)" "unprognostic (5.56e-2)" "unprognostic (1.76e-1)" "unprognostic (6.37e-3)" "unprognostic (3.06e-1)" "unprognostic (2.66e-1)" "unprognostic (3.49e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (8.11e-2)" "unprognostic (8.16e-3)" 54.3 8.2 5.7 15.4 11.2 33.6 34.9 4.1 6.8 17.1 4.7 26.0 3.1 12.6 9.7 6.1 13.7 8.5 6.9 5.6 9.9 10.8 3.5 25.8 23.7 6.3 6.8 4.2 2.3 4.4 28.3 12.8 7.1 6.7 5.7 1.2 7.0 3.1 3.8 8.2 19.9 8.9 5.8 34.1 12.3 2.6 5.6 21.0 18.3 4.8 17.8 16.6 14.3 7.7 0.1 5.9 4.8 4.5 63.3 26.8 12.7 6.7 14.5 5.5 14.2 0.7 0.1 18.2 0.6 24.3 6.5 0.2 8.5 0.0 4.8 22.7 7.4 39.8 6.2 0.2 20.4 24.3 92.3 18.9 0.4 5.8 6.4 3.8 0.2 15.6 12.3 32.0 3.5 4.1 14.6 32.2 5.0 5.3 9.2 9.7 12.3 0.6 0.1 1.3 1.7 11.3 20.3 18.7 6.6 3.7 2.2 20.3 0.3 4.4 1.4 25.5 3.0 9.8 15.7 16.6 9.5 38.1 2.3 5.7 3.3 6.2 6.4 4.9 4.1 3.7 5.4 5.2 3.6 3.8 4.8 6.1 10.1 5.9 6.2 2.8 9.1 1.8 5.7 11.2 4.1 6.8 5.6 9.9 6.3 6.8 7.1 5.8 5.6 7.7 10.9 28.9 3.7 6.8 38.3 2.9 0.1 0.4 0.6 0.5 0.7 0.9 2.7 0.0 7.7 7.3 0.0 3.0 34.5 0.3 0.0 0.2 0.5 0.4 5.4 7.4 4.2 14.7 4.4 0.0 3.2 18.7 5.1 0.3 44.4 0.2 2.9 1.1 20.6 0.0 100.4 3.2 2.0 47.5 24.9 0.6 12.2 45.7 8.8 67.5 38.6 0.3 52.5 20.6 14.8 0.7 1.5 4.9 22.7 0.4 3.0 6.3 1.2 0.4 26.3 4.3 14.0 3.8 3.3 0.6 1.8 6.8 36.6 0.2 1.3 0.4 DPF2 "BAF45d, REQ, ubi-d4" ENSG00000133884 "Double PHD fingers 2" Q92785 11 65333852-65354262 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020880, HPA056786" Approved Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA020880: AB_1847845, HPA056786: AB_2683235" "unprognostic (2.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.45e-2)" "unprognostic (2.90e-3)" "unprognostic (1.40e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.04e-1)" "unprognostic (3.29e-2)" "unprognostic (3.07e-1)" "unprognostic (2.43e-1)" "unprognostic (1.33e-1)" "unprognostic (6.93e-2)" "unprognostic (3.04e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" 21.2 21.0 41.3 14.2 45.1 24.7 21.6 43.6 43.3 35.0 35.2 36.1 13.1 37.6 22.8 23.1 31.3 14.7 34.2 39.5 42.2 20.8 16.8 19.5 22.3 43.1 43.7 40.9 20.5 19.7 20.1 17.6 42.8 28.6 13.8 17.6 21.1 25.8 38.6 19.3 24.3 27.8 43.7 29.7 24.2 37.7 43.0 37.6 22.5 29.2 24.5 34.2 24.1 48.7 29.9 36.4 45.9 40.5 39.7 39.8 25.5 25.0 35.1 53.5 38.6 36.0 34.8 39.5 40.8 34.0 46.6 31.2 52.2 31.9 37.7 47.6 23.1 50.4 24.6 37.7 61.1 47.0 36.5 35.0 30.4 48.4 86.6 40.1 43.3 47.0 48.7 51.0 35.2 47.3 60.0 49.3 51.6 31.9 37.4 65.1 29.9 46.8 34.0 24.1 29.9 27.3 32.1 45.7 47.0 29.7 59.0 26.2 25.8 35.2 31.3 38.9 25.9 62.7 78.8 51.1 21.6 30.6 40.4 186.4 75.4 141.1 79.7 70.8 87.0 102.0 76.9 78.4 76.2 109.1 78.6 71.9 161.5 125.8 83.0 70.6 107.3 108.4 41.3 45.1 43.6 43.3 39.5 42.2 43.1 43.7 42.8 43.7 43.0 48.7 19.2 6.4 10.1 14.0 35.7 22.7 21.8 41.7 23.9 42.2 20.1 24.9 12.7 27.1 24.2 33.1 47.9 27.2 42.0 11.5 19.6 21.2 5.2 18.3 29.5 24.2 17.4 32.8 18.5 17.4 22.9 27.2 15.3 18.5 16.5 31.8 24.3 13.3 19.5 30.3 19.9 16.8 32.6 17.5 33.8 12.3 58.7 16.9 19.6 15.0 30.0 22.8 35.0 24.1 32.3 19.3 8.6 53.4 21.6 22.6 23.7 22.0 19.3 50.5 32.9 28.8 32.2 60.2 63.5 15.4 23.2 26.5 30.6 28.7 17.9 19.7 DPH3 "DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2" ENSG00000154813 "Diphthamide biosynthesis 3" Q96FX2 3 16257061-16264969 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035287 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Cytosol "HPA035287: AB_10604113" "unprognostic (2.49e-2)" "unprognostic (8.80e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (2.83e-1)" "unprognostic (5.06e-2)" "unprognostic (5.83e-2)" "unprognostic (4.13e-1)" "unprognostic (5.90e-3)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (1.19e-2)" "unprognostic (6.44e-2)" 14.2 11.9 12.7 9.6 13.5 8.4 10.3 14.3 14.3 10.2 13.6 11.5 10.7 10.0 11.0 9.4 8.9 10.2 13.9 12.2 15.6 13.1 15.3 11.1 8.9 15.4 14.4 6.1 7.8 9.0 8.5 13.2 15.0 9.3 8.7 13.4 5.7 11.1 29.4 4.9 13.3 15.2 14.7 9.1 9.4 8.5 13.6 11.5 12.4 20.1 8.1 12.4 5.8 15.5 10.5 14.6 31.9 18.9 58.9 39.7 24.8 29.9 24.4 28.0 31.3 18.1 5.8 10.0 9.3 37.5 24.0 6.2 29.4 17.7 32.6 50.5 20.4 16.6 11.5 21.0 36.7 24.5 15.6 28.6 23.6 36.0 15.2 17.6 25.5 17.4 26.9 16.4 39.9 14.1 19.0 16.5 25.6 15.9 14.7 12.9 20.7 15.4 24.9 8.0 7.2 20.2 13.8 6.7 35.4 25.6 12.5 23.9 29.9 22.9 15.0 41.7 24.0 12.6 44.5 12.8 33.6 27.2 20.7 27.1 16.7 25.7 11.3 22.8 14.0 10.1 11.9 13.8 15.9 9.9 9.9 11.9 35.5 10.7 21.6 6.2 11.9 12.7 12.7 13.5 14.3 14.3 12.2 15.6 15.4 14.4 15.0 14.7 13.6 15.5 32.3 19.2 22.4 10.1 31.0 51.6 42.9 41.0 29.0 11.6 32.9 34.7 34.9 25.8 32.4 16.5 12.5 47.9 28.1 43.0 41.1 49.5 109.1 27.5 35.3 32.5 17.9 32.0 12.0 57.2 80.6 34.4 30.1 33.3 52.0 11.2 26.7 41.6 101.6 6.7 10.3 22.6 26.4 45.5 61.7 63.3 20.5 46.4 28.4 3.7 71.5 24.8 29.9 6.6 9.2 66.6 32.4 15.8 42.2 42.6 79.1 45.4 33.9 15.1 13.1 33.4 36.7 80.4 40.1 31.3 52.4 80.9 34.5 18.7 19.0 47.1 DPY30 "Cps25, HDPY-30, Saf19" ENSG00000162961 "Dpy-30 histone methyltransferase complex regulatory subunit" Q9C005 2 31867809-32039805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 388.8;Respiratory ciliated cells: 396.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043761 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA 29000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA043761: AB_10960501" "unprognostic (2.76e-2)" "unprognostic (1.48e-1)" "unprognostic (2.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.64e-1)" "unprognostic (4.57e-3)" "unprognostic (4.14e-3)" "unprognostic (1.91e-1)" "unprognostic (7.87e-2)" "unprognostic (1.01e-3)" "unprognostic (1.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.79e-2)" "unprognostic (1.49e-1)" 40.2 75.2 66.9 34.3 68.6 31.4 61.3 72.1 84.4 53.2 73.6 50.9 43.4 38.3 78.3 60.2 90.5 42.4 46.7 68.4 73.6 79.1 84.8 44.1 51.8 71.6 71.5 42.7 48.1 58.3 50.9 43.9 73.6 57.3 46.4 33.3 64.6 47.0 48.8 49.7 44.4 37.4 73.2 36.1 46.8 22.6 69.1 52.3 81.6 45.4 49.3 51.8 50.0 77.5 201.8 136.8 100.8 78.1 86.7 128.8 134.9 102.1 90.8 81.2 79.5 197.2 158.3 123.2 102.2 90.8 148.3 79.9 93.1 118.6 88.1 146.4 149.5 110.8 89.7 225.5 76.5 114.3 66.8 87.4 135.6 87.4 76.9 109.1 130.4 55.1 132.5 85.3 125.6 219.4 128.8 228.9 139.2 184.3 140.5 104.0 118.9 155.7 144.2 137.1 162.5 115.9 101.2 141.1 143.6 118.2 98.3 82.1 100.5 73.9 119.1 69.2 125.4 99.9 161.3 166.2 77.6 123.2 91.7 177.6 101.0 150.8 95.5 99.9 116.5 165.9 133.5 119.4 100.5 135.6 118.1 112.0 117.3 105.8 112.8 91.5 200.3 130.6 66.9 68.6 72.1 84.4 68.4 73.6 71.6 71.5 73.6 73.2 69.1 77.5 65.7 51.3 61.5 10.1 61.7 98.0 107.7 233.5 53.5 17.9 110.5 135.1 71.3 80.1 140.8 103.0 0.0 190.2 41.0 84.2 283.7 114.3 64.5 388.8 59.7 62.9 92.1 55.5 16.0 117.2 252.4 63.1 44.4 107.3 46.9 65.1 63.1 102.7 123.5 21.9 17.7 107.6 175.0 65.4 67.2 18.5 72.4 58.7 65.8 13.1 106.8 50.8 55.6 13.6 26.7 125.7 117.8 88.0 40.6 130.5 138.4 296.7 396.4 26.8 85.5 52.4 108.4 65.7 57.4 72.0 122.6 138.7 67.3 67.7 109.0 127.5 DUSP11 PIR1 ENSG00000144048 "Dual specificity phosphatase 11" O75319 2 73762184-73780157 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021052 Supported "Nucleoplasm,Nucleoli fibrillar center,Cytokinetic bridge" Yes Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Nucleoli fibrillar center" "Cytokinetic bridge" "HPA021052: AB_2670577" "unprognostic (2.45e-3)" "unprognostic (1.06e-1)" "unprognostic (2.19e-2)" "unprognostic (7.87e-3)" "unprognostic (9.14e-2)" "unprognostic (5.28e-3)" "prognostic unfavorable (2.10e-7)" "unprognostic (7.20e-2)" "unprognostic (5.43e-2)" "unprognostic (5.85e-2)" "unprognostic (8.67e-3)" "unprognostic (3.84e-2)" "unprognostic (7.56e-3)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" "unprognostic (1.46e-1)" 16.0 13.3 7.9 17.1 7.7 35.2 20.4 13.4 11.2 22.4 7.6 16.0 17.3 21.2 19.3 30.5 39.0 15.9 14.2 8.1 6.9 20.2 17.9 14.3 25.3 6.1 5.7 23.5 11.0 14.7 14.0 20.5 6.1 16.5 17.4 8.3 16.0 14.4 14.3 27.6 15.3 19.6 4.8 19.0 16.3 16.8 6.5 24.8 16.5 17.8 26.1 25.2 22.4 8.3 39.4 16.7 17.6 18.6 31.2 38.7 31.2 28.2 36.7 35.8 36.4 24.2 29.1 50.6 17.7 30.6 32.1 26.7 22.0 56.8 34.3 35.2 22.9 31.2 12.0 37.3 32.7 35.5 28.0 31.6 67.3 32.1 44.1 31.1 40.4 24.2 33.6 28.6 40.2 21.3 34.3 37.6 28.4 36.7 22.7 13.6 47.3 46.0 29.3 32.1 25.9 14.1 26.1 30.6 35.7 21.0 16.4 18.6 23.1 25.4 31.4 29.5 33.7 30.7 26.2 68.1 23.5 35.5 25.3 72.5 42.2 99.5 56.3 39.3 73.5 68.3 65.8 67.4 47.3 65.9 69.4 65.5 65.2 69.8 40.6 35.7 88.6 71.7 7.9 7.7 13.4 11.2 8.1 6.9 6.1 5.7 6.1 4.8 6.5 8.3 26.5 9.6 12.0 7.5 39.5 83.2 55.1 93.0 39.3 11.0 12.9 15.1 8.6 27.1 45.7 12.9 4.2 32.8 34.8 15.5 50.9 29.6 9.1 18.0 15.7 34.6 12.0 21.0 14.9 27.3 42.0 26.5 16.3 13.6 40.7 20.5 52.1 15.3 30.7 5.0 12.7 18.0 36.7 20.2 27.1 7.0 28.9 17.0 23.2 10.3 34.8 9.8 41.2 13.0 13.8 28.2 17.8 25.6 31.8 30.0 22.8 50.4 38.2 16.6 6.6 18.2 23.1 23.8 34.6 42.8 83.0 38.6 39.8 20.7 18.8 60.9 DUSP18 DUSP20 ENSG00000167065 "Dual specificity phosphatase 18" Q8NEJ0 22 30652051-30667887 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 123.4;Late spermatids: 344.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034070, HPA051349" Uncertain Supported Nucleoplasm Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "CAB034070: AB_2094867, HPA051349: AB_2681450" "unprognostic (1.11e-1)" "unprognostic (2.34e-2)" "unprognostic (3.49e-3)" "unprognostic (4.88e-3)" "unprognostic (1.88e-1)" "unprognostic (9.12e-2)" "unprognostic (3.77e-4)" "unprognostic (1.83e-1)" "unprognostic (1.61e-1)" "unprognostic (3.53e-2)" "unprognostic (9.62e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-3)" "unprognostic (6.55e-2)" "unprognostic (1.97e-1)" "unprognostic (4.56e-2)" "unprognostic (1.02e-1)" 3.3 1.9 3.4 4.5 3.6 3.3 2.8 2.9 5.3 2.4 9.1 5.4 5.0 2.9 4.9 4.1 10.9 4.2 2.0 3.7 4.0 2.2 1.0 5.5 4.7 5.4 7.6 2.4 2.9 3.3 4.2 2.1 4.9 2.1 6.8 5.2 2.5 2.4 1.3 4.8 4.6 3.8 4.8 4.3 4.8 13.9 4.5 4.0 3.3 1.6 3.9 3.3 2.6 6.0 5.4 5.4 2.5 5.8 6.2 11.9 2.3 4.9 5.3 4.7 5.1 3.1 5.3 3.6 3.3 6.0 6.2 3.8 1.3 3.8 5.3 9.8 6.1 1.5 2.2 2.2 2.6 7.4 5.3 3.1 5.4 7.8 3.0 5.3 15.0 4.1 1.7 2.8 5.2 4.8 4.2 1.8 0.8 6.4 3.3 2.8 1.7 1.2 5.6 3.7 6.2 3.7 4.8 1.7 3.5 3.2 4.5 2.2 11.1 9.9 5.4 2.7 2.8 2.1 2.6 1.7 11.4 1.3 5.0 31.4 15.3 29.9 8.6 19.3 6.6 9.7 9.6 7.7 17.2 8.7 6.6 7.5 31.8 7.4 21.4 9.7 13.2 8.4 3.4 3.6 2.9 5.3 3.7 4.0 5.4 7.6 4.9 4.8 4.5 6.0 7.2 19.2 5.4 11.4 7.1 21.4 13.3 6.5 2.2 2.9 4.9 3.4 2.0 10.0 9.6 5.5 45.9 1.2 12.0 10.0 3.9 10.1 123.4 34.5 5.0 10.1 35.5 2.1 8.0 9.4 3.9 6.8 8.6 5.0 7.0 4.4 13.9 1.1 8.1 1.7 4.4 15.4 6.1 15.6 28.5 344.2 8.4 13.2 8.8 13.1 13.9 10.1 9.2 1.5 14.3 9.3 15.4 6.8 3.9 8.8 24.2 4.1 64.6 16.8 6.6 8.6 6.6 63.0 17.2 5.7 21.3 1.0 9.7 3.5 19.0 8.7 DUSP23 "DUSP25, FLJ20442" ENSG00000158716 "Dual specificity phosphatase 23" Q9BVJ7 1 159780932-159782543 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 458.5;Proximal tubular cells: 800.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 142.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028211, HPA045792" Approved Supported Nucleoplasm NA NA 22000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 43: THP-1 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA028211: AB_2672522, HPA045792: AB_10961133" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-2)" "unprognostic (4.36e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (3.16e-1)" "unprognostic (4.62e-1)" "unprognostic (3.33e-3)" "unprognostic (4.72e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (8.58e-2)" "unprognostic (2.84e-2)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" 75.0 122.4 29.1 15.4 31.5 20.5 99.9 32.0 38.5 57.6 30.0 46.3 26.7 55.0 15.5 82.0 52.3 13.4 36.1 31.8 31.4 199.1 189.3 55.3 10.4 32.0 30.1 35.6 76.8 34.6 20.8 5.9 32.1 55.3 13.9 8.1 152.4 15.3 65.4 61.1 42.9 12.0 32.8 39.2 39.7 18.2 31.3 15.2 58.8 16.6 9.1 45.1 53.6 31.0 39.5 42.2 0.3 0.2 39.5 33.5 0.4 15.8 13.0 18.4 14.3 17.3 44.7 0.1 90.9 17.6 4.2 1.5 10.8 14.5 10.0 9.9 4.6 54.4 14.7 0.0 58.6 33.3 40.4 142.8 38.3 12.1 43.0 13.2 71.0 0.1 25.2 19.4 26.3 72.5 3.5 1.4 71.3 71.6 58.7 0.1 0.0 18.8 22.7 6.9 17.8 39.4 28.6 63.0 78.5 7.3 40.6 51.7 51.7 15.3 0.8 1.9 0.2 13.5 34.8 0.5 25.8 26.5 11.7 111.8 181.7 229.1 97.9 153.4 54.6 60.5 72.7 92.8 261.3 43.7 44.0 65.1 185.6 100.5 105.6 59.2 70.8 112.2 29.1 31.5 32.0 38.5 31.8 31.4 32.0 30.1 32.1 32.8 31.3 31.0 100.4 41.7 58.7 3.3 23.8 74.6 129.2 151.8 100.7 8.5 110.6 112.1 29.5 95.8 122.2 51.5 6.2 16.1 28.4 97.7 262.2 210.7 48.3 47.5 30.8 155.8 35.4 37.5 1.4 458.5 29.2 31.2 32.1 130.9 54.5 66.1 75.0 249.4 170.3 1.7 0.5 124.9 91.6 94.3 72.9 8.4 26.4 92.2 42.7 4.7 58.9 74.8 69.0 1.0 4.4 208.4 112.2 15.8 14.6 121.5 140.4 800.7 54.8 10.0 13.1 16.0 34.9 5.4 19.9 123.2 74.4 5.7 43.6 72.3 109.5 116.1 DYNLRB1 "DNCL2A, DNLC2A, ROBLD1" ENSG00000125971 "Dynein light chain roadblock-type 1" Q9NP97 20 34516414-34540958 "Plasma proteins, Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 781.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009845 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "CAB009845: AB_2093671" "unprognostic (2.23e-1)" "unprognostic (7.60e-3)" "unprognostic (5.33e-2)" "unprognostic (2.57e-1)" "unprognostic (3.52e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (6.44e-4)" "unprognostic (9.10e-2)" "unprognostic (3.41e-2)" "unprognostic (7.79e-2)" "unprognostic (1.71e-1)" "unprognostic (2.11e-1)" "unprognostic (7.55e-2)" "unprognostic (1.32e-1)" "unprognostic (3.37e-2)" "unprognostic (2.00e-2)" "unprognostic (2.00e-1)" 168.7 208.4 430.4 96.9 440.2 113.7 163.7 416.5 552.8 163.7 400.8 228.4 113.8 193.0 204.9 155.4 198.5 117.1 275.7 448.5 454.1 265.8 122.0 169.4 123.9 444.7 443.3 153.9 115.0 222.9 204.3 154.6 436.7 180.9 128.2 171.7 142.1 170.7 222.8 222.1 156.4 158.7 416.1 143.0 166.7 66.6 422.8 154.3 174.4 224.5 135.1 191.4 158.8 458.8 244.4 317.6 259.4 207.3 307.5 294.9 175.4 264.1 393.5 399.2 340.7 853.3 231.1 135.6 327.4 402.0 385.5 215.3 282.2 391.6 265.9 164.5 198.8 463.2 286.8 679.1 345.7 217.5 249.6 251.4 250.4 320.2 245.7 306.2 282.2 255.8 195.1 249.0 415.5 313.4 314.7 427.4 148.6 284.7 345.2 158.6 359.6 220.2 618.7 160.8 264.2 273.9 382.9 631.9 359.4 249.2 362.5 240.7 251.9 500.8 122.4 351.2 295.8 208.8 310.3 157.3 430.1 186.7 225.0 225.4 112.5 221.2 88.0 123.1 88.8 144.2 145.6 117.2 128.8 127.3 101.4 102.1 111.4 132.4 144.3 161.2 238.7 135.0 430.4 440.2 416.5 552.8 448.5 454.1 444.7 443.3 436.7 416.1 422.8 458.8 188.4 169.9 106.5 26.1 107.9 146.8 176.8 215.9 100.2 105.4 136.0 200.3 125.5 170.1 157.4 292.4 58.4 297.8 112.9 283.9 481.3 264.4 34.0 266.4 139.5 170.9 226.7 98.2 34.7 223.4 211.4 149.1 85.1 208.5 159.0 149.8 162.4 104.1 287.9 80.8 30.0 284.6 256.3 127.8 131.5 51.0 234.9 139.1 193.9 19.7 236.2 435.8 148.3 20.1 61.4 317.5 379.3 240.3 117.0 240.4 388.9 781.8 253.1 127.6 203.8 101.8 210.8 65.6 77.2 106.3 150.0 342.3 124.9 90.9 160.5 184.3 EAPP "BM036, C14orf11, FLJ20578" ENSG00000129518 "E2F associated phosphoprotein" Q56P03 14 34515938-34539711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002916 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA002916: AB_1078715" "unprognostic (8.76e-3)" "unprognostic (1.27e-3)" "unprognostic (2.08e-3)" "unprognostic (1.94e-1)" "unprognostic (4.59e-2)" "unprognostic (1.64e-1)" "unprognostic (2.80e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.81e-1)" "unprognostic (6.38e-2)" "unprognostic (2.05e-1)" "unprognostic (7.80e-2)" "prognostic favorable (2.23e-6)" "unprognostic (2.64e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.96e-4)" "unprognostic (3.24e-2)" 37.3 35.8 26.3 24.6 27.0 89.2 51.0 29.7 35.5 33.3 27.1 50.8 35.7 35.0 44.7 29.0 39.4 28.1 29.0 27.1 28.6 42.4 50.2 29.5 37.2 25.9 26.5 49.7 26.7 54.7 21.6 35.2 26.3 33.7 51.7 37.1 36.4 31.2 37.0 46.9 45.6 29.2 28.1 31.3 29.3 23.5 27.1 49.1 45.5 29.3 37.1 31.1 30.0 30.0 37.7 45.1 41.3 24.4 47.8 48.7 64.1 33.8 51.6 41.5 43.1 21.6 48.6 39.1 46.6 41.5 24.7 34.5 30.8 45.1 48.3 49.1 27.1 28.7 31.6 91.7 65.1 51.5 30.4 56.3 56.7 23.8 60.9 54.6 41.7 54.1 28.9 42.0 39.1 88.0 71.4 41.5 24.3 69.4 50.0 44.8 49.5 39.5 50.2 50.3 33.1 36.5 47.8 45.6 76.4 39.4 79.7 32.3 45.2 21.4 18.1 28.1 22.0 52.8 63.1 41.5 20.1 28.0 27.6 139.9 61.9 134.3 65.3 57.8 79.1 107.7 81.9 75.0 54.9 101.0 82.7 75.8 140.2 100.6 80.9 47.8 124.4 80.0 26.3 27.0 29.7 35.5 27.1 28.6 25.9 26.5 26.3 28.1 27.1 30.0 59.8 22.4 53.3 17.0 78.6 46.4 67.2 145.0 74.6 75.6 60.0 70.1 35.4 60.1 78.8 82.8 31.3 125.3 76.3 91.8 174.1 86.6 20.9 82.0 59.6 57.8 66.0 66.7 20.5 84.5 76.5 67.6 26.5 54.8 73.5 98.7 57.5 109.0 58.8 25.2 21.3 112.8 87.5 50.6 33.9 14.9 89.5 47.5 90.7 16.9 71.3 122.0 87.6 17.6 23.1 59.8 102.5 94.4 46.8 61.4 131.5 164.8 102.0 75.7 72.3 69.9 78.7 103.3 38.3 63.8 66.5 189.4 74.2 101.2 98.0 58.2 EDEM2 "bA4204.1, C20orf31, C20orf49, FLJ10783" ENSG00000088298 "ER degradation enhancing alpha-mannosidase like protein 2" Q9BV94 20 35115364-35147336 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 137.9;Plasma cells: 89.0;Syncytiotrophoblasts: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037238, HPA048353" Approved "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB037238: AB_1840826, HPA048353: AB_2680369" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.05e-2)" "unprognostic (2.19e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-2)" "unprognostic (9.87e-2)" "unprognostic (1.46e-1)" "unprognostic (5.09e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (4.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.50e-3)" "unprognostic (2.29e-2)" 21.1 26.9 10.3 16.2 11.4 27.7 17.9 16.0 12.8 18.5 13.6 19.5 20.0 11.6 44.9 14.5 16.2 14.7 15.0 9.8 10.7 19.1 38.9 26.7 20.1 13.4 11.4 10.4 32.4 13.2 24.5 28.1 12.9 16.0 21.8 10.7 19.1 15.5 7.5 13.9 19.4 15.4 11.0 32.5 16.4 6.6 14.8 16.8 15.3 5.9 21.7 16.4 12.2 12.5 18.6 54.4 8.6 34.0 98.0 33.9 49.2 20.8 70.5 24.4 34.4 61.3 47.7 16.0 61.3 40.9 77.0 37.6 31.5 43.3 19.6 12.3 8.8 31.6 11.8 58.7 54.1 23.2 117.6 41.3 59.4 23.5 58.2 60.2 91.9 30.3 14.9 66.5 33.9 20.6 18.6 28.9 9.7 52.8 35.0 15.5 29.5 33.6 54.6 16.0 7.1 11.1 21.8 55.8 53.9 36.3 26.2 38.5 41.0 36.9 22.0 21.9 25.6 34.5 23.2 9.7 64.7 29.2 31.4 35.9 96.9 75.3 39.9 72.4 78.4 42.3 36.4 39.6 101.4 42.0 26.0 32.9 67.2 42.9 72.9 59.1 47.7 79.9 10.3 11.4 16.0 12.8 9.8 10.7 13.4 11.4 12.9 11.0 14.8 12.5 16.7 16.0 17.4 6.8 27.5 4.0 14.6 34.7 6.2 3.7 12.0 9.3 4.6 24.3 18.9 12.9 2.1 72.9 27.4 14.7 11.7 35.5 2.5 11.4 13.8 16.4 4.8 13.3 5.2 29.1 137.9 14.1 7.7 16.6 55.1 13.6 13.9 23.3 72.2 0.0 6.5 13.8 32.6 21.3 7.9 1.2 7.8 28.3 12.4 9.4 26.8 7.9 14.4 1.5 6.9 28.9 16.1 5.3 89.0 12.8 43.6 18.9 15.3 6.5 13.1 7.9 19.0 8.7 11.2 8.9 4.7 94.7 18.7 15.7 17.3 12.7 EGFL7 ZNEU1 ENSG00000172889 "EGF like domain multiple 7" Q9UHF1 9 136658856-136672678 "Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 806.1;Endothelial cells: 436.5;Hepatic stellate cells: 511.5;Hofbauer cells: 290.3;Spermatogonia: 179.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.1;eosinophil: 3.5;intermediate monocyte: 6.2;non-classical monocyte: 5.5;plasmacytoid DC: 5.9" "Group enriched" "Detected in many" 20 "dendritic cells: 5.9;granulocytes: 3.5;monocytes: 6.2" "Cell line enhanced" "Detected in many" "EFO-21: 183.9;HUVEC TERT2: 329.0;RPMI-8226: 136.8;TIME: 312.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050716 Approved "Secreted to extracellular matrix" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA050716: AB_2732562" "unprognostic (1.72e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (4.22e-6)" "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (9.76e-3)" "unprognostic (5.03e-1)" "unprognostic (1.03e-1)" "unprognostic (4.31e-3)" "unprognostic (4.39e-2)" "unprognostic (1.14e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (5.69e-2)" "unprognostic (1.74e-1)" "unprognostic (4.09e-2)" "unprognostic (4.49e-2)" 195.6 50.2 108.8 13.4 90.4 14.4 192.3 85.0 144.3 112.9 74.4 49.1 13.4 104.3 9.8 39.8 98.5 27.4 243.3 89.8 86.5 144.3 56.1 204.2 20.8 102.0 96.9 37.8 28.2 18.5 51.3 181.6 100.9 74.9 3.5 1.0 39.4 13.2 60.5 47.8 51.4 13.4 89.9 191.7 40.7 43.3 111.7 5.6 105.5 25.2 2.9 87.5 86.3 85.2 0.1 45.7 14.6 52.7 1.2 1.0 33.4 12.9 2.3 7.3 2.3 16.2 42.4 0.3 183.9 4.3 11.9 6.5 3.7 8.3 0.3 77.2 14.1 28.8 3.4 1.3 11.4 0.0 40.1 1.5 3.2 3.7 0.0 2.5 329.0 2.1 104.9 0.1 2.5 83.5 0.5 0.7 21.1 64.3 2.6 91.4 5.9 136.8 4.6 1.1 9.3 31.0 6.3 5.9 12.2 4.2 15.5 43.6 312.6 1.8 37.2 4.4 2.5 0.4 0.1 0.5 0.2 0.1 38.4 0.0 2.1 3.5 0.0 6.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.8 0.2 5.5 5.9 0.0 2.4 108.8 90.4 85.0 144.3 89.8 86.5 102.0 96.9 100.9 89.9 111.7 85.2 806.1 0.0 26.5 2.3 6.2 11.9 5.6 5.5 9.6 2.0 5.9 6.7 23.7 5.7 4.2 3.7 0.0 3.1 5.9 1.4 7.9 19.4 2.7 1.4 3.4 436.5 1.2 58.9 15.0 2.0 17.8 18.5 0.5 1.9 20.3 2.0 511.5 20.5 290.3 3.3 10.1 4.6 2.0 24.5 14.2 9.2 8.7 18.7 19.6 102.1 1.2 1.9 0.0 3.5 1.8 5.8 3.7 6.0 4.0 19.1 22.5 25.2 0.2 2.3 13.1 13.0 18.4 18.9 179.8 2.7 9.5 6.0 2.9 4.8 0.5 3.5 EIF4E3 MGC39820 ENSG00000163412 "Eukaryotic translation initiation factor 4E family member 3" Q8N5X7 3 71675414-71754773 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 14.7" "Group enriched" "Detected in many" 7 "granulocytes: 14.7;monocytes: 4.2;T-cells: 5.7" "Cell line enhanced" "Detected in many" "HDLM-2: 28.0;Karpas-707: 36.3;U-937: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058649, HPA076465" Approved Approved "Nucleoli fibrillar center" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 2: Karpas-707 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoli fibrillar center" "HPA058649: AB_2683785, HPA076465: " "unprognostic (3.16e-3)" "unprognostic (7.60e-3)" "unprognostic (4.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.31e-2)" "prognostic favorable (6.63e-4)" "unprognostic (3.10e-2)" "prognostic favorable (4.64e-5)" "unprognostic (3.16e-2)" "unprognostic (4.58e-2)" "prognostic favorable (6.99e-5)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.64e-2)" "unprognostic (1.83e-2)" 27.5 12.0 13.5 12.7 17.5 26.6 13.9 10.7 18.3 11.5 1.7 18.0 14.2 14.5 9.8 19.6 15.7 10.6 29.9 17.5 12.3 13.9 11.7 16.1 12.7 8.7 10.0 22.7 15.9 24.5 9.8 6.3 8.1 16.0 17.0 8.2 14.3 18.2 61.8 9.7 18.6 17.3 10.6 17.7 12.7 5.6 15.7 15.8 17.4 54.5 10.9 15.1 9.9 15.5 0.6 2.5 2.4 7.8 2.3 5.9 3.0 2.1 2.3 2.1 1.2 1.3 1.2 0.0 5.1 2.0 13.4 2.8 8.6 12.1 1.7 28.0 2.7 0.0 0.2 0.2 8.2 4.3 4.6 5.3 7.5 0.6 6.4 1.1 6.7 4.9 0.9 36.3 0.4 9.4 3.9 1.0 18.9 0.9 4.3 2.1 9.4 1.2 25.9 13.3 4.8 12.9 14.4 3.1 0.3 7.4 13.6 0.2 1.8 1.2 5.9 16.6 2.0 25.2 25.0 0.0 0.9 50.3 4.8 2.0 4.2 6.1 2.1 1.8 3.2 0.2 2.9 3.5 0.9 0.1 2.1 2.5 14.7 1.1 2.6 0.0 5.7 1.7 13.5 17.5 10.7 18.3 17.5 12.3 8.7 10.0 8.1 10.6 15.7 15.5 16.6 28.9 14.5 5.5 1.9 10.1 10.3 2.0 5.2 9.4 14.5 10.3 39.3 11.5 7.4 11.0 0.0 3.7 20.3 41.0 3.9 5.2 1.0 8.6 19.0 11.0 9.1 1.7 37.0 5.8 3.0 12.5 7.1 35.2 7.0 6.4 17.5 7.3 3.9 1.7 32.0 10.8 2.0 19.5 6.2 1.7 12.8 15.8 3.6 11.2 31.2 13.0 17.5 11.6 11.9 8.6 17.1 9.4 10.9 12.2 40.0 14.9 8.1 0.5 0.0 11.5 14.1 0.6 1.3 8.3 13.5 1.5 20.8 2.6 10.1 9.5 EIF4EBP1 "4E-BP1, PHAS-I" ENSG00000187840 "Eukaryotic translation initiation factor 4E binding protein 1" Q13541 8 38030534-38060365 "Cancer-related genes, Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 188.9;salivary gland: 164.2" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 730.0;Pancreatic endocrine cells: 277.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005032, CAB005039, HPA023501" Supported Supported Nucleoplasm,Cytosol NA NA 44000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095" "unprognostic (1.55e-2)" "unprognostic (2.45e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (6.94e-2)" "unprognostic (2.69e-1)" "unprognostic (1.94e-2)" "unprognostic (3.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.16e-2)" "unprognostic (3.18e-3)" "unprognostic (7.21e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (4.57e-2)" "unprognostic (5.72e-3)" 60.9 12.6 7.7 16.9 8.0 35.0 53.6 8.0 10.9 24.9 12.7 25.3 18.5 19.7 2.2 86.0 21.7 8.9 32.7 8.0 9.8 19.5 63.5 25.0 10.3 9.8 8.5 22.2 188.9 7.8 9.2 28.6 9.8 19.2 15.4 1.5 164.2 17.0 98.1 20.8 23.1 14.4 8.5 23.9 43.8 5.5 10.1 9.6 9.6 27.2 10.4 33.6 26.5 10.8 146.9 113.2 32.4 193.2 41.3 32.3 77.0 130.5 111.9 128.4 203.5 74.8 56.3 46.3 101.5 121.3 77.1 85.1 109.1 197.5 74.8 36.0 190.9 269.6 52.0 104.9 423.6 98.8 60.4 100.0 314.9 142.0 264.1 40.1 208.2 57.7 152.7 221.8 54.8 141.7 95.9 297.8 186.0 112.9 243.7 80.3 80.4 197.4 49.3 22.3 281.6 200.8 26.1 78.8 534.8 20.3 105.8 192.2 105.2 76.1 167.1 179.9 137.8 185.1 121.6 72.1 173.4 213.4 169.1 51.1 416.3 258.3 27.9 336.6 27.3 130.7 32.8 30.9 335.0 103.3 26.2 26.0 39.4 35.0 268.3 242.6 66.0 258.3 7.7 8.0 8.0 10.9 8.0 9.8 9.8 8.5 9.8 8.5 10.1 10.8 23.6 9.6 8.3 1.6 25.2 74.4 42.4 114.8 51.8 3.6 84.8 72.8 41.7 57.2 97.3 20.2 2.1 41.3 27.3 70.1 29.4 226.1 17.0 11.6 39.0 54.6 40.2 79.9 0.8 730.0 224.2 68.6 35.7 12.5 18.4 76.0 65.3 103.4 223.4 0.0 1.3 138.2 79.3 108.6 82.2 106.2 43.5 83.9 72.9 1.9 101.9 19.2 21.6 4.0 0.4 277.9 64.5 19.2 38.7 100.2 19.5 103.1 33.5 2.2 13.1 17.6 85.2 1.9 25.5 209.3 85.4 38.6 19.8 69.3 83.8 58.9 EIF4H "KIAA0038, WBSCR1, WSCR1" ENSG00000106682 "Eukaryotic translation initiation factor 4H" Q15056 7 74174231-74197122 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 990.0;Late spermatids: 2765.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030542 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 750000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Nucleoplasm, Nuclear bodies" "HPA030542: AB_10601368" "unprognostic (2.83e-1)" "unprognostic (9.50e-2)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (3.89e-4)" "prognostic unfavorable (2.15e-4)" "unprognostic (1.61e-2)" "unprognostic (2.72e-3)" "unprognostic (1.79e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-2)" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.68e-2)" "unprognostic (1.27e-2)" 186.9 174.9 151.0 117.8 159.3 283.3 168.3 163.8 157.3 179.8 129.6 208.4 130.2 186.4 76.6 249.3 163.6 100.0 171.0 149.9 151.9 156.6 197.0 158.4 130.3 161.9 156.9 181.2 226.4 160.7 119.9 162.8 162.2 150.3 100.2 149.8 170.1 125.1 399.8 230.9 148.9 119.2 165.2 137.4 192.9 79.9 164.6 150.2 141.2 173.4 137.2 175.3 179.7 187.1 526.3 341.4 251.3 303.1 220.8 231.8 283.4 359.8 276.3 300.3 289.5 423.3 388.6 444.3 96.6 338.8 424.2 266.6 280.5 481.5 286.3 298.0 329.2 247.5 305.2 345.9 253.1 429.0 236.9 273.2 300.8 326.2 460.7 341.5 326.8 260.1 445.8 186.4 305.2 448.2 342.0 516.8 337.6 430.3 328.9 386.9 342.7 401.5 250.9 324.7 252.7 325.4 340.9 420.3 296.0 331.3 476.8 272.4 340.2 411.6 284.6 345.1 474.4 218.8 299.8 771.4 326.3 435.1 441.4 213.7 229.7 245.6 156.9 255.6 164.5 146.4 161.4 158.3 224.2 132.9 183.9 151.7 150.1 193.5 270.2 95.1 194.7 388.0 151.0 159.3 163.8 157.3 149.9 151.9 161.9 156.9 162.2 165.2 164.6 187.1 105.8 83.3 81.2 15.7 97.1 119.2 153.8 101.5 78.0 93.1 103.0 95.5 43.3 68.6 68.7 44.1 25.0 198.8 91.9 98.7 107.6 148.1 990.0 104.8 98.3 103.0 90.4 79.5 25.3 157.7 381.4 101.6 61.2 112.5 122.4 112.1 79.6 95.7 124.2 97.6 24.6 87.2 91.6 101.2 102.7 2765.8 103.8 86.8 72.9 15.9 157.4 134.7 119.4 16.6 44.2 147.0 82.8 110.6 82.7 140.7 84.6 69.0 57.8 72.3 85.5 107.3 117.7 61.2 64.6 90.1 116.1 395.3 92.4 116.9 109.5 140.4 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 266.1;Extravillous trophoblasts: 326.2;Hofbauer cells: 313.7;Pancreatic endocrine cells: 317.3;Proximal tubular cells: 341.3;Syncytiotrophoblasts: 332.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" NA NA 140000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cell Junctions" "HPA078113: AB_2686877" "prognostic unfavorable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 78.3 83.9 86.5 45.0 89.6 93.1 59.9 88.6 116.1 47.9 79.8 61.3 30.2 48.1 67.0 75.3 46.2 39.3 141.0 92.5 85.3 97.2 76.0 62.0 52.5 83.6 83.9 46.1 41.1 58.5 57.2 56.0 83.9 45.2 44.8 69.4 46.7 43.7 190.3 48.4 40.7 54.8 84.2 48.2 57.3 111.2 85.1 64.4 43.3 125.6 65.7 69.3 52.0 89.5 211.2 169.2 151.1 110.2 113.0 146.7 108.1 203.6 165.3 194.8 199.0 151.1 178.2 106.3 160.7 181.9 263.4 147.2 168.7 203.6 256.8 123.2 141.5 185.7 174.2 243.0 147.3 120.4 133.6 149.4 159.9 177.0 226.8 144.2 184.8 180.2 166.2 137.8 260.2 155.9 311.7 214.9 137.5 341.9 271.8 111.9 95.1 100.8 216.2 181.9 142.1 134.3 85.2 458.9 202.4 155.1 169.2 127.9 142.2 140.1 160.6 156.1 208.1 155.6 204.5 198.9 169.6 130.2 175.0 138.6 66.4 85.6 62.0 78.6 68.3 83.1 74.2 70.8 73.6 73.9 66.5 67.5 79.8 73.4 77.3 118.4 99.1 60.0 86.5 89.6 88.6 116.1 92.5 85.3 83.6 83.9 83.9 84.2 85.1 89.5 236.0 67.3 98.9 0.0 24.8 0.0 0.0 0.0 0.0 0.0 147.6 185.4 0.0 0.0 49.5 119.5 0.0 220.1 74.5 0.0 266.1 216.7 0.0 147.9 98.9 77.1 0.0 0.0 0.0 227.2 326.2 66.0 0.0 168.8 69.4 65.9 0.0 0.0 313.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.9 0.0 0.0 112.7 0.0 0.0 0.0 0.0 317.3 0.0 0.0 12.1 0.0 0.0 341.3 63.4 0.0 0.0 0.0 78.2 0.0 0.0 0.0 0.0 332.5 40.7 98.8 0.0 0.0 ELOVL1 Ssc1 ENSG00000066322 "ELOVL fatty acid elongase 1" Q9BW60 1 43363398-43368074 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033426, HPA056557" Enhanced Supported "Endoplasmic reticulum" NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "Endoplasmic reticulum" "CAB033426: AB_2099896, HPA056557: AB_2683173" "unprognostic (5.23e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (8.00e-2)" "unprognostic (8.45e-2)" "unprognostic (7.60e-2)" "unprognostic (7.40e-2)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.74e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (9.00e-2)" 78.5 54.7 77.2 39.8 115.6 52.9 66.6 121.1 116.9 57.1 61.4 63.9 51.6 46.5 30.6 176.6 38.9 42.4 47.2 76.8 93.2 59.7 45.8 59.6 40.1 152.0 110.1 28.9 55.4 46.2 27.2 51.0 140.7 58.7 48.6 8.4 72.7 48.8 24.1 201.9 55.4 50.8 114.8 57.1 70.6 18.6 107.7 22.2 66.8 28.0 55.7 68.5 86.8 165.7 108.0 119.5 22.6 44.8 148.4 138.2 70.2 125.2 154.5 153.5 122.4 105.9 182.5 73.9 94.3 193.6 130.3 119.4 79.7 152.2 93.2 94.6 53.9 96.6 77.3 77.1 128.2 84.2 98.0 106.2 168.2 180.9 198.4 114.8 155.0 27.7 68.1 54.8 178.5 79.5 19.9 69.5 33.5 136.9 120.2 43.6 59.9 89.7 195.5 128.7 27.4 28.8 73.7 258.4 105.8 66.8 121.2 82.4 132.2 129.7 82.5 161.2 161.3 26.6 31.2 35.4 127.8 85.2 120.1 134.9 189.6 172.7 105.1 180.0 93.4 109.0 98.4 103.2 212.8 94.2 63.5 88.0 133.0 114.7 179.6 148.8 113.8 203.1 77.2 115.6 121.1 116.9 76.8 93.2 152.0 110.1 140.7 114.8 107.7 165.7 44.0 19.2 12.5 7.5 28.1 15.6 25.9 61.1 29.6 5.7 60.3 37.5 4.7 34.3 40.2 40.5 10.4 93.4 36.0 114.0 7.9 91.5 3.4 22.9 26.3 43.6 19.2 67.8 3.8 100.1 127.4 26.1 48.4 45.2 21.0 52.6 24.7 16.7 74.9 3.3 3.4 33.8 46.8 46.3 37.5 4.6 20.2 41.5 12.4 7.5 92.5 13.7 32.0 3.0 66.1 133.3 63.9 25.6 19.0 44.7 66.0 23.3 14.5 9.5 19.7 10.0 39.7 8.4 11.2 70.1 31.0 95.9 31.5 50.8 47.2 49.2 EMC3 TMEM111 ENSG00000125037 "ER membrane protein complex subunit 3" Q9P0I2 3 9962537-10011116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 360.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042372 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 51: Myeloid cells - Hemostasis" "HPA042372: AB_10795609" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.59e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-3)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.81e-6)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.71e-2)" "unprognostic (5.58e-2)" 71.1 41.1 26.5 28.9 27.6 65.7 33.3 28.5 29.9 26.1 29.7 40.6 37.4 23.2 26.9 46.1 28.9 27.9 34.3 29.2 29.4 40.3 65.7 36.1 22.7 31.0 29.5 22.5 43.6 70.5 17.2 20.3 30.4 25.8 36.0 24.2 42.8 32.0 78.5 33.6 37.3 32.0 28.3 23.1 35.3 48.5 28.8 27.2 39.9 46.7 28.5 40.7 25.1 30.4 48.9 100.7 37.4 22.5 232.6 90.3 125.1 98.1 84.6 60.1 64.8 69.5 75.6 38.7 69.8 111.9 115.2 66.7 64.2 58.3 61.7 105.2 64.3 63.6 69.9 46.5 100.4 71.8 68.2 107.4 102.5 104.9 60.1 76.5 75.6 41.8 82.0 109.2 90.2 119.5 38.3 35.6 41.5 103.2 68.7 49.0 52.4 115.7 72.8 86.7 26.4 53.1 69.9 103.3 63.4 39.1 87.5 58.0 87.6 59.8 49.6 65.0 100.8 58.3 165.6 79.0 126.2 52.0 76.4 119.7 115.1 108.5 64.5 93.6 66.8 65.6 63.7 74.5 88.3 71.2 45.8 61.5 103.5 77.3 95.3 79.1 107.3 156.1 26.5 27.6 28.5 29.9 29.2 29.4 31.0 29.5 30.4 28.3 28.8 30.4 59.1 54.5 72.9 19.9 45.3 50.6 59.9 178.0 24.5 40.6 43.0 39.9 108.1 57.2 121.4 46.0 39.6 49.5 52.7 58.6 46.9 100.6 360.7 61.6 50.2 59.2 21.1 240.2 25.4 119.9 51.8 51.1 38.7 64.0 34.1 36.5 46.1 105.0 97.8 23.5 21.1 40.2 109.9 51.0 66.6 109.3 50.4 101.7 58.7 9.4 97.5 65.2 57.7 21.1 17.8 107.4 71.3 37.6 55.6 58.7 92.6 76.9 99.1 63.5 59.2 44.7 60.7 199.7 63.0 49.6 60.7 85.8 52.7 60.6 52.0 80.2 EMC7 "C11orf3, C15orf24" ENSG00000134153 "ER membrane protein complex subunit 7" Q9NPA0 15 34084017-34101862 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010029 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" "HPA010029: AB_1078335" "unprognostic (2.16e-1)" "unprognostic (8.16e-3)" "unprognostic (5.28e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.75e-2)" "prognostic unfavorable (9.25e-5)" "unprognostic (1.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-3)" "unprognostic (4.67e-2)" "unprognostic (3.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.31e-1)" "unprognostic (2.58e-1)" "unprognostic (2.49e-2)" "unprognostic (2.47e-3)" 65.4 86.5 74.2 48.3 78.2 75.2 58.5 82.6 92.9 47.2 91.4 61.3 52.1 49.6 104.4 47.6 45.9 50.4 70.4 74.1 85.7 90.7 103.8 54.4 43.8 78.5 79.2 43.1 79.1 93.2 54.7 77.3 79.7 62.2 64.8 67.2 59.9 57.0 91.0 56.0 46.8 58.8 82.1 42.5 57.7 76.9 79.6 40.1 71.0 70.9 46.2 63.0 44.0 87.0 68.1 185.7 62.2 84.2 249.3 143.3 69.3 190.4 199.3 174.8 181.0 170.6 79.7 40.4 187.4 189.5 181.3 128.9 94.7 96.3 128.5 99.7 96.5 99.4 273.6 147.3 229.1 101.2 135.0 155.1 181.5 125.0 178.7 117.3 110.3 75.9 99.5 259.9 170.7 79.8 54.5 115.2 58.1 157.2 122.3 69.5 76.2 140.3 187.3 119.1 107.2 78.2 114.0 151.8 97.7 75.5 110.0 161.2 94.9 185.8 71.6 123.7 144.4 172.4 219.7 86.2 187.8 153.3 154.8 316.0 161.1 178.1 139.7 184.2 136.9 137.0 138.6 144.0 150.6 102.9 100.4 124.1 143.8 122.7 206.2 242.6 195.8 196.4 74.2 78.2 82.6 92.9 74.1 85.7 78.5 79.2 79.7 82.1 79.6 87.0 65.5 28.9 36.1 20.2 51.7 86.9 56.8 194.6 40.9 58.6 44.0 50.3 92.9 54.3 117.9 103.0 45.9 127.5 92.1 56.5 39.2 124.4 117.3 52.4 66.2 67.3 45.6 48.0 15.5 172.4 153.4 90.1 32.6 52.6 45.1 40.2 60.3 78.6 112.6 30.3 17.8 57.6 146.5 65.2 60.1 81.6 90.1 61.2 103.2 12.2 70.9 112.4 40.2 17.6 27.7 137.9 63.0 104.2 97.1 61.3 72.5 90.8 94.5 62.9 118.3 65.4 136.5 257.9 57.4 43.1 86.4 160.1 65.8 100.4 61.3 55.2 ENO3 ENSG00000108515 "Enolase 3" P13929 17 4948092-4957131 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 26 "skeletal muscle: 14758.3;tongue: 10771.0" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 582.2;Skeletal myocytes: 248.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 263.8;HeLa: 120.0;HMC-1: 115.1;RH-30: 170.2;RPMI-8226: 96.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000793, HPA068284, HPA068721" Enhanced Supported "Plasma membrane,Cytosol" Yes No 86000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane, Cytosol" "HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119" "unprognostic (7.35e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (2.08e-2)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.04e-3)" "unprognostic (2.21e-2)" "unprognostic (4.63e-2)" "unprognostic (5.34e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "unprognostic (4.50e-2)" 7.8 5.5 3.8 15.6 3.9 20.4 8.0 7.1 4.3 6.6 5.0 8.0 20.1 7.2 7.1 173.8 7.4 2.6 499.8 3.5 3.7 10.3 108.0 8.6 13.0 4.3 5.0 6.0 5.5 4.0 7.9 6.3 4.6 47.3 3.0 5.0 116.8 3.1 14758.3 8.3 15.6 2.8 4.1 16.9 10.1 9.3 4.3 5.8 10.3 10771.0 4.9 5.6 5.0 4.9 12.0 25.5 11.3 10.7 9.1 2.2 27.6 21.0 2.7 1.5 1.3 12.8 8.1 21.9 25.8 1.9 3.5 15.4 3.8 1.9 1.0 263.8 24.3 21.9 120.0 18.9 3.7 6.8 115.1 14.4 3.8 2.1 4.1 9.8 1.4 24.8 10.2 39.0 4.9 6.6 7.9 26.5 14.8 3.3 10.6 34.6 170.2 96.9 3.1 7.9 7.1 27.1 13.6 11.4 14.7 7.6 10.2 7.0 6.5 12.1 21.3 5.4 16.0 27.6 16.8 18.2 6.7 20.8 12.2 31.4 28.5 50.4 36.8 41.5 24.8 24.5 30.8 34.4 37.6 20.1 20.0 32.2 34.4 34.9 47.6 29.9 43.2 83.6 3.8 3.9 7.1 4.3 3.5 3.7 4.3 5.0 4.6 4.1 4.3 4.9 1.2 0.0 1.8 2.3 2.7 2.0 1.2 2.1 4.0 6.6 3.0 3.0 582.2 0.0 2.2 5.5 4.2 5.4 3.2 2.9 0.0 1.5 1.8 0.9 1.6 7.3 0.0 3.8 0.2 0.8 3.8 17.3 4.6 2.2 8.2 2.4 2.2 56.2 4.5 3.3 0.2 2.2 2.0 3.5 6.7 3.7 0.3 4.3 1.8 0.0 78.3 1.9 4.1 1.0 0.5 1.8 1.9 0.4 2.3 1.2 6.6 9.5 0.3 2.5 6.6 248.4 55.8 7.9 7.5 2.1 1.8 3.3 4.5 1.1 2.6 0.8 ENSA "ARPP-19e, MGC4319, MGC78563, MGC8394" ENSG00000143420 "Endosulfine alpha" O43768 1 150600851-150629612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 11 "U-698: 8664.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051294 Uncertain Approved Nucleoplasm,Nucleoli,Microtubules,Cytosol NA NA 700000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Nucleoli" "Microtubules, Cytosol" "HPA051294: AB_2681425" "unprognostic (6.27e-2)" "prognostic favorable (8.24e-4)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (2.58e-1)" "unprognostic (8.24e-2)" "unprognostic (1.94e-3)" "unprognostic (1.82e-1)" "unprognostic (2.02e-1)" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (5.40e-2)" "unprognostic (2.21e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-1)" "unprognostic (7.64e-2)" "unprognostic (8.07e-3)" 140.5 106.6 151.2 115.1 156.7 219.8 154.9 133.6 188.2 145.2 132.6 135.9 133.6 117.8 183.3 288.0 100.5 94.9 120.2 161.6 144.1 118.8 148.8 124.0 128.4 137.2 135.6 102.4 108.5 173.0 92.0 103.7 134.2 97.7 123.9 121.8 122.9 94.6 301.0 241.3 132.7 105.8 136.9 99.7 124.1 45.2 147.4 157.8 134.4 212.3 146.7 147.0 165.6 157.0 287.1 170.8 236.9 206.9 149.7 126.8 220.7 141.0 148.4 199.9 171.7 207.3 216.6 288.9 196.8 122.1 125.1 238.3 198.5 325.4 160.1 415.1 277.4 434.3 239.6 158.2 108.3 372.1 462.6 100.5 202.0 214.1 293.6 118.8 206.2 224.8 321.7 551.8 140.9 775.5 302.3 272.6 431.2 386.2 211.1 298.6 199.9 328.0 299.2 306.0 303.8 193.3 201.6 385.6 222.1 200.8 533.9 442.9 208.2 143.9 261.9 171.8 340.3 309.4 441.4 8664.2 197.1 357.6 191.8 67.3 54.4 94.3 55.6 62.9 52.2 64.3 46.3 57.5 70.7 55.3 37.7 56.0 53.0 68.8 64.3 58.3 58.2 75.1 151.2 156.7 133.6 188.2 161.6 144.1 137.2 135.6 134.2 136.9 147.4 157.0 103.1 41.7 166.1 20.9 132.9 190.3 225.1 303.9 124.7 59.7 152.7 117.1 102.6 98.7 172.9 82.8 45.9 286.5 148.9 170.7 254.3 160.3 9.7 109.1 68.5 114.2 130.8 178.2 44.7 152.4 184.2 85.9 71.9 93.7 224.3 51.1 80.3 86.9 203.3 67.3 29.3 169.1 211.6 101.1 171.4 17.7 86.0 123.3 103.2 19.7 409.7 83.6 184.4 21.6 19.3 91.5 146.8 104.2 135.6 128.0 187.2 186.0 128.8 50.0 72.3 85.5 94.4 27.6 25.0 269.7 286.8 382.8 140.4 87.9 163.9 253.7 ENY2 "DC6, FLJ20480, Sus1" ENSG00000120533 "ENY2 transcription and export complex 2 subunit" Q9NPA8 8 109334324-109345954 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024648 Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Mitochondria" "HPA024648: AB_2100208" "unprognostic (2.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.18e-1)" "unprognostic (7.85e-2)" "unprognostic (7.70e-2)" "unprognostic (7.45e-3)" "unprognostic (1.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "prognostic unfavorable (7.17e-6)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (2.66e-1)" 54.4 55.5 28.1 44.7 29.1 87.6 57.0 29.3 45.3 44.2 32.9 59.5 54.5 37.9 53.8 48.2 36.1 29.9 64.2 29.1 32.2 74.4 101.3 40.4 49.6 31.5 30.5 29.5 44.9 47.2 34.4 41.3 30.1 39.0 55.1 24.5 43.7 36.0 71.7 34.7 47.9 44.1 29.8 47.7 47.9 34.8 29.7 60.3 38.0 68.5 53.8 48.4 38.9 30.9 180.3 145.9 213.6 97.1 79.5 101.0 61.4 140.0 89.9 141.2 177.2 109.0 109.1 115.3 127.9 110.9 63.6 89.7 96.8 99.5 171.7 184.1 113.9 223.5 106.7 227.4 85.4 78.3 133.5 77.5 66.7 92.5 87.3 102.2 215.1 111.5 216.5 63.7 162.7 289.9 235.9 175.5 156.1 207.1 140.3 148.4 93.2 144.5 192.5 134.7 128.9 137.5 87.7 109.3 127.2 117.0 138.6 132.3 146.9 94.1 158.9 97.8 144.7 107.9 125.6 222.2 95.2 128.3 112.7 65.6 102.5 93.5 28.9 112.8 36.7 41.4 39.0 35.6 93.8 27.3 31.9 35.8 56.8 42.4 121.8 80.3 42.3 74.5 28.1 29.1 29.3 45.3 29.1 32.2 31.5 30.5 30.1 29.8 29.7 30.9 231.3 70.5 93.8 16.3 135.0 185.6 196.3 305.7 159.9 63.8 149.2 192.7 170.6 138.7 184.6 145.3 123.0 263.3 157.0 171.5 381.5 214.3 173.3 146.4 134.7 226.3 154.2 160.1 22.7 200.0 284.5 161.0 88.7 144.8 91.8 99.3 142.5 371.1 276.8 45.4 23.9 245.1 225.9 230.3 265.7 111.0 148.2 205.0 158.3 17.8 260.9 112.4 126.7 19.6 27.6 251.2 237.1 112.5 147.2 230.3 264.5 546.1 125.0 139.9 78.9 163.9 262.9 208.7 130.4 151.0 174.6 167.3 132.4 143.9 209.1 208.0 ERP44 "KIAA0573, PDIA10, TXNDC4" ENSG00000023318 "Endoplasmic reticulum protein 44" Q9BS26 9 99979185-100099000 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001318 Supported "Intracellular and membrane" NA NA 5300000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "HPA001318: AB_1080427" "unprognostic (8.28e-2)" "unprognostic (1.32e-1)" "unprognostic (5.56e-2)" "unprognostic (5.97e-3)" "unprognostic (1.55e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (1.29e-1)" "unprognostic (3.88e-2)" "unprognostic (2.58e-1)" "unprognostic (2.00e-2)" "unprognostic (5.38e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.66e-1)" "unprognostic (3.90e-1)" "unprognostic (2.31e-1)" 18.4 17.3 8.1 17.7 8.5 21.3 16.2 12.9 10.5 19.5 10.1 22.0 22.4 15.2 39.3 17.8 13.7 16.7 15.9 8.2 9.1 18.0 34.2 18.6 17.9 8.0 8.7 12.4 27.4 18.7 13.3 32.6 8.5 18.9 23.6 15.8 20.8 18.3 11.6 12.9 23.8 16.8 8.4 18.4 24.1 10.6 8.6 14.6 27.1 11.6 18.6 19.3 14.1 9.0 18.5 14.7 20.7 23.6 73.5 34.9 37.6 39.9 54.2 27.6 36.3 31.2 52.4 47.3 25.7 45.5 41.1 65.9 25.7 28.1 24.9 24.5 14.4 17.8 14.3 22.8 64.3 32.2 27.0 39.4 41.5 24.2 34.7 26.2 34.2 15.7 34.7 35.7 22.7 28.8 22.1 22.6 21.5 72.0 18.9 19.2 34.7 32.9 35.9 20.9 16.2 18.9 32.8 40.2 28.9 30.5 15.0 32.8 23.8 20.5 19.2 27.4 17.7 20.5 19.3 15.8 31.3 21.0 28.3 32.8 45.7 42.7 20.2 49.2 19.5 28.1 19.9 22.1 37.4 26.5 15.1 17.6 41.5 27.4 62.3 23.4 23.5 37.7 8.1 8.5 12.9 10.5 8.2 9.1 8.0 8.7 8.5 8.4 8.6 9.0 72.3 54.5 41.8 38.8 77.5 43.3 80.3 146.6 29.0 34.3 33.9 25.3 34.7 54.3 84.6 33.1 18.8 141.4 72.5 90.0 17.6 104.4 8.4 42.2 61.4 62.5 53.1 38.3 69.4 111.8 150.5 72.0 57.1 62.3 71.0 54.2 64.6 73.3 165.7 30.3 70.0 118.1 73.2 79.5 101.9 7.7 61.2 102.2 64.0 85.3 128.5 32.7 61.8 45.8 68.9 92.8 90.0 67.7 97.9 75.9 111.2 51.4 60.2 30.6 72.3 48.9 95.9 83.3 41.4 40.0 49.6 229.3 60.3 87.5 88.9 84.2 ETV7 "TEL-2, TEL2" ENSG00000010030 "ETS variant transcription factor 7" Q9Y603 6 36354091-36387800 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 16.0;skin 1: 15.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Cytotrophoblasts: 28.8;Exocrine glandular cells: 23.8;Proximal enterocytes: 21.5;Spermatogonia: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 18.9;T-reg: 16.3" "Group enriched" "Detected in many" 4 "granulocytes: 18.9;monocytes: 5.7;T-cells: 16.3" "Cell line enhanced" "Detected in some" "BEWO: 27.1;BJ hTERT+ SV40 Large T+: 14.7;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HDLM-2: 59.7" "Low region specificity" "Detected in all" HPA029033 Uncertain Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 31: Skin - Epidermis development" "Cluster 44: HDLM-2 - Immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "HPA029033: AB_10601375" "unprognostic (1.67e-2)" "prognostic favorable (5.16e-4)" "unprognostic (9.48e-2)" "unprognostic (1.57e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-3)" "unprognostic (9.08e-2)" "unprognostic (4.11e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.32e-4)" "unprognostic (6.81e-3)" "unprognostic (1.11e-1)" "unprognostic (1.69e-3)" "unprognostic (5.54e-2)" "unprognostic (4.93e-1)" "unprognostic (1.27e-2)" "prognostic favorable (2.95e-6)" 1.9 2.1 1.5 6.9 1.5 0.9 2.1 1.0 1.7 2.1 1.4 3.3 16.0 1.0 1.3 3.6 2.2 3.4 0.4 1.5 1.4 2.3 2.9 4.9 5.3 2.2 1.2 1.5 1.6 2.2 3.8 3.6 2.1 2.9 2.6 0.4 8.6 1.5 0.2 15.4 12.7 1.0 2.1 3.1 6.2 1.1 1.4 4.0 1.2 0.3 3.9 5.5 2.5 1.4 3.2 0.0 0.2 0.1 0.0 0.2 27.1 0.0 9.2 14.7 27.8 0.5 6.2 0.1 0.7 0.2 2.3 3.3 0.4 1.7 0.7 59.7 0.5 0.5 0.0 0.0 1.8 0.0 0.3 1.2 2.4 0.7 0.2 0.0 0.4 0.0 0.1 0.2 0.3 0.1 0.2 0.3 0.2 0.3 0.1 6.1 0.1 0.2 0.2 1.1 0.8 0.0 0.6 2.1 0.5 0.0 3.1 0.6 0.2 0.3 0.7 0.3 0.1 0.1 0.1 0.2 0.0 2.7 0.4 0.0 3.7 0.3 1.6 5.7 3.9 3.3 5.4 2.2 0.9 2.4 1.0 1.4 18.9 0.6 1.9 0.0 16.3 2.5 1.5 1.5 1.0 1.7 1.5 1.4 2.2 1.2 2.1 2.1 1.4 1.4 1.4 19.2 14.8 0.3 1.2 2.0 2.2 8.0 6.2 0.2 2.5 2.7 0.5 7.2 7.1 0.0 0.0 28.8 0.7 6.6 0.0 12.4 0.4 0.4 1.4 1.1 3.6 0.0 0.5 23.8 6.6 2.7 8.2 0.7 2.5 1.7 0.0 0.4 2.9 0.0 0.3 6.5 6.1 1.3 1.6 0.5 1.5 1.0 3.6 0.0 6.5 3.1 1.0 0.0 0.3 13.4 7.8 1.2 5.6 4.8 21.5 1.3 3.0 0.6 0.0 1.0 5.5 0.9 26.8 6.4 3.7 8.5 3.6 0.7 7.6 4.8 FAS "APO-1, APT1, CD95, FAS1, TNFRSF6" ENSG00000026103 "Fas cell surface death receptor" P25445 10 88990531-89017059 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis "Calmodulin-binding, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 114.7" "Group enriched" "Detected in all" 5 "granulocytes: 114.7;T-cells: 96.2" "Cell line enhanced" "Detected in many" "HDLM-2: 83.4;Karpas-707: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027444 Uncertain Supported "Nuclear bodies,Plasma membrane,Cytosol" "Secreted to blood" NA NA 11900000 420000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Nuclear bodies, Cytosol" "HPA027444: AB_10601378" "unprognostic (6.84e-2)" "unprognostic (2.88e-3)" "unprognostic (8.38e-3)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (9.56e-2)" "unprognostic (7.00e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (7.70e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.52e-3)" "unprognostic (2.10e-1)" "unprognostic (2.32e-2)" "unprognostic (4.95e-3)" "unprognostic (1.65e-1)" 14.1 26.3 3.6 17.0 3.6 20.8 10.9 2.9 4.7 12.7 2.8 16.4 7.0 12.8 10.3 10.8 14.8 15.7 7.5 3.6 3.7 7.2 23.3 21.7 18.9 4.6 3.1 20.1 3.7 2.7 3.7 10.4 4.0 8.9 23.3 3.3 6.5 9.3 2.3 9.4 9.2 15.0 3.5 11.2 4.4 2.6 3.9 14.4 7.3 2.6 15.6 12.9 10.2 4.3 22.7 8.2 5.4 13.9 37.0 51.3 0.0 51.8 50.2 1.7 9.1 0.1 23.4 4.7 19.0 52.1 9.6 4.0 1.0 44.8 3.2 83.4 8.7 0.4 5.2 14.7 31.6 3.4 1.6 69.2 38.7 31.4 66.0 24.5 4.7 17.8 0.0 109.0 44.0 1.4 6.4 3.4 0.6 0.2 1.8 1.4 0.5 5.0 60.7 7.3 0.4 0.2 7.7 0.0 0.8 7.0 13.9 1.0 9.5 15.8 9.0 15.2 12.3 45.3 5.3 0.4 11.8 10.2 4.5 43.1 9.4 30.9 9.9 12.3 13.8 7.5 27.6 19.6 11.5 4.0 3.1 10.0 114.7 3.1 22.1 0.2 96.2 12.8 3.6 3.6 2.9 4.7 3.6 3.7 4.6 3.1 4.0 3.5 3.9 4.3 10.3 57.7 13.8 40.1 12.8 45.9 109.7 53.1 39.9 0.0 5.5 9.5 3.5 12.8 27.5 9.2 0.0 0.4 16.3 24.9 0.0 6.3 11.3 9.2 22.3 8.9 8.4 9.5 8.8 4.3 0.2 35.4 8.6 15.5 3.8 4.9 2.2 19.3 5.5 1.7 2.8 14.4 8.2 7.0 31.7 4.9 19.0 17.7 12.4 17.8 20.9 14.5 10.3 8.0 0.7 6.5 8.7 13.9 32.2 46.0 15.6 14.4 26.3 0.7 6.6 26.8 29.1 11.3 1.1 28.5 43.9 0.4 48.4 11.8 24.4 30.0 FERMT3 "KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2" ENSG00000149781 "Fermitin family member 3" Q86UX7 11 64206678-64223891 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 180.6;lymphoid tissue: 130.1" "Cell type enhanced" "Detected in many" "dendritic cells: 118.3;granulocytes: 96.4;Hofbauer cells: 193.1;Kupffer cells: 95.8;Langerhans cells: 88.0;Macrophages: 232.9;monocytes: 142.9;NK-cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 306.9;HL-60: 135.9;HMC-1: 314.2;Karpas-707: 127.6;MOLT-4: 121.8;NB-4: 174.1;U-937: 138.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA065231 Approved Vesicles NA NA 160000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "HPA065231: AB_2685439" "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.38e-3)" "prognostic favorable (9.89e-4)" "unprognostic (8.77e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.46e-1)" "unprognostic (4.20e-1)" "unprognostic (3.98e-1)" "unprognostic (2.70e-1)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.12e-5)" "unprognostic (3.08e-3)" "unprognostic (5.25e-2)" "unprognostic (4.97e-2)" "unprognostic (1.75e-1)" 25.1 14.5 9.4 63.3 11.6 180.6 13.0 11.2 18.1 8.5 12.2 17.3 22.0 8.4 0.7 6.4 13.6 15.6 12.0 9.8 11.6 11.1 12.5 46.2 89.2 17.9 12.2 5.1 7.0 1.3 5.9 15.0 13.2 8.2 8.1 0.6 10.7 4.4 6.0 7.1 34.1 9.4 13.3 130.1 29.6 4.5 17.1 48.7 10.0 4.6 41.8 19.8 7.3 15.3 1.2 1.6 0.5 0.9 0.3 0.8 2.0 1.4 0.2 0.4 0.3 2.6 2.3 32.6 3.2 6.3 0.7 2.4 1.0 0.5 0.5 83.9 0.6 306.9 1.6 0.1 10.8 135.9 314.2 1.2 1.1 5.2 0.0 0.5 81.2 77.0 7.3 127.6 8.6 3.5 121.8 174.1 1.2 1.0 2.3 72.4 8.8 0.7 0.3 0.7 1.9 0.5 0.7 4.5 1.7 0.7 2.0 92.6 7.8 1.1 2.5 1.9 0.9 1.5 3.3 59.4 19.5 138.9 86.6 204.1 207.0 236.5 120.0 192.6 114.9 54.5 94.1 112.0 162.0 53.1 60.9 80.6 184.6 102.4 151.2 195.7 120.9 292.6 9.4 11.6 11.2 18.1 9.8 11.6 17.9 12.2 13.2 13.3 17.1 15.3 3.8 9.6 14.7 0.7 52.1 4.7 0.9 0.3 3.4 0.5 3.3 5.2 2.4 4.3 3.9 0.0 0.0 1.2 118.3 6.1 0.0 0.8 0.4 4.3 5.6 7.9 0.0 62.5 1.2 2.4 1.4 5.4 19.9 7.3 96.4 0.4 19.6 1.4 193.1 0.0 1.5 32.1 0.0 95.8 88.0 0.9 0.9 232.9 17.8 5.6 142.9 0.3 93.7 1.0 1.5 4.3 10.9 2.6 35.2 0.9 8.2 0.4 1.0 0.3 6.6 13.7 6.6 1.2 0.8 1.9 4.5 2.6 78.5 1.4 15.0 0.7 FGFR1OP2 DKFZp564O1863 ENSG00000111790 "FGFR1 oncogene partner 2" Q9NVK5 12 26938470-26966650 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 249.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038308, HPA038696" Supported Approved Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria "HPA038308: AB_10672524, HPA038696: AB_10675948" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (1.95e-1)" "unprognostic (2.34e-1)" "unprognostic (4.01e-2)" "unprognostic (1.19e-1)" "unprognostic (4.37e-3)" "unprognostic (1.72e-1)" "unprognostic (8.17e-2)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (1.55e-2)" "unprognostic (6.82e-2)" "unprognostic (1.40e-1)" "unprognostic (5.33e-2)" "unprognostic (1.36e-2)" 29.4 41.6 29.0 30.6 32.6 61.6 26.3 28.6 48.3 24.9 21.0 23.1 23.1 31.6 29.0 23.1 23.7 28.7 28.5 34.2 28.1 30.9 27.8 25.7 42.4 29.2 28.6 59.5 15.1 19.3 17.8 27.1 29.3 19.9 20.0 30.7 18.2 18.6 23.3 23.5 22.9 26.6 29.8 33.2 20.5 23.0 27.5 36.2 24.1 32.8 30.9 25.2 21.1 44.3 30.3 36.9 30.5 41.1 51.9 37.4 44.2 51.6 60.1 39.1 42.5 57.3 34.4 44.3 24.8 45.9 37.4 31.4 21.3 38.8 55.5 33.6 31.1 75.0 39.4 38.4 61.3 43.5 54.9 27.3 24.8 47.7 61.6 53.3 56.8 39.6 45.3 33.0 46.2 36.3 58.0 103.3 50.4 39.1 59.9 34.6 84.2 37.1 34.8 36.5 9.3 18.5 58.9 21.5 52.1 69.9 38.5 65.3 61.7 51.6 52.0 95.9 48.5 23.1 25.2 93.4 43.2 50.2 42.7 81.1 31.5 40.6 31.6 31.4 28.3 22.3 33.0 30.7 25.2 19.7 29.8 33.3 32.0 25.9 31.3 20.6 61.3 23.7 29.0 32.6 28.6 48.3 34.2 28.1 29.2 28.6 29.3 29.8 27.5 44.3 70.8 38.5 37.2 39.2 97.1 140.3 62.3 30.6 86.0 52.7 45.4 39.6 45.4 24.3 41.2 27.6 77.2 41.5 114.1 19.9 72.4 28.9 17.9 28.9 47.8 70.1 26.9 249.0 79.4 23.1 37.8 86.5 23.0 30.8 59.5 77.9 70.6 30.7 60.6 58.9 30.6 22.0 26.4 64.7 96.2 18.8 105.3 74.6 88.9 47.8 49.6 64.3 83.4 63.8 128.5 29.7 29.0 170.8 138.2 56.7 27.2 70.0 20.8 48.0 46.0 69.6 81.4 32.9 70.1 57.4 119.8 59.5 141.2 42.9 20.0 63.5 FNTB FPTB ENSG00000257365 "Farnesyltransferase, CAAX box, beta" P49356 14 64986895-65062652 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Prenyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 70.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA062743 Uncertain Approved Centrosome NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 17: WM-115 - Nervous system development" "Cluster 51: Myeloid cells - Hemostasis" Centrosome "HPA062743: AB_2684861" "unprognostic (2.79e-1)" "unprognostic (1.50e-2)" "unprognostic (1.54e-1)" "unprognostic (8.57e-3)" "unprognostic (1.88e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (6.21e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-2)" "unprognostic (1.70e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-3)" "unprognostic (2.36e-2)" "unprognostic (3.60e-1)" "unprognostic (5.56e-2)" "unprognostic (1.11e-3)" 8.7 8.7 15.9 5.1 30.2 2.9 7.8 40.7 20.1 7.7 13.5 6.5 5.9 6.6 8.4 13.3 9.5 5.9 12.9 14.5 20.7 8.2 5.8 6.7 5.7 55.0 34.2 7.3 5.6 13.0 7.0 8.7 46.5 9.1 7.7 6.1 9.2 9.3 18.1 11.8 5.2 11.6 36.7 4.7 5.5 9.5 30.7 6.5 5.8 19.7 8.3 7.6 8.9 70.0 37.1 31.9 20.4 12.5 13.9 11.9 14.6 20.2 14.7 22.4 23.0 15.9 14.6 6.0 12.0 21.1 13.2 24.1 47.5 15.1 18.3 9.0 15.9 23.2 8.0 28.1 9.0 8.3 32.2 9.7 14.3 9.4 5.7 22.4 19.1 10.9 13.7 8.4 13.1 30.9 13.3 22.6 8.4 23.1 29.9 12.2 17.6 7.6 16.2 15.7 12.0 13.5 11.9 24.4 30.2 15.9 22.7 14.0 15.2 16.2 34.7 8.4 14.2 5.7 5.6 6.6 18.3 10.3 39.4 21.9 12.8 11.5 3.8 9.9 9.6 2.5 6.2 5.1 7.4 1.7 4.7 3.7 3.4 4.0 5.1 5.8 6.2 7.4 15.9 30.2 40.7 20.1 14.5 20.7 55.0 34.2 46.5 36.7 30.7 70.0 3.9 12.8 2.2 0.0 1.6 2.4 3.5 4.3 2.8 4.6 6.2 6.6 8.3 2.8 5.6 3.7 2.1 15.9 2.4 4.3 0.0 6.6 9.2 3.9 3.0 4.5 7.7 7.8 0.0 4.8 15.3 4.9 4.1 4.8 0.0 12.7 5.0 8.0 8.1 5.0 0.0 5.9 6.1 8.1 2.5 6.0 5.6 15.7 5.4 0.0 7.5 7.6 2.1 0.0 0.0 4.2 1.9 8.6 2.1 4.7 4.0 6.0 4.0 4.1 19.7 5.1 5.5 2.7 4.7 6.7 3.7 8.2 2.5 7.3 5.3 3.3 FRG1 "FRG1A, FSG1" ENSG00000109536 "FSHD region gene 1" Q14331 4 189940870-189963202 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Myogenesis, Ribosome biogenesis, rRNA processing" "Actin-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA075683 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" "HPA075683: " "unprognostic (1.67e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (1.52e-1)" "unprognostic (5.56e-2)" "unprognostic (7.14e-2)" "unprognostic (5.62e-2)" "unprognostic (9.60e-2)" "unprognostic (6.45e-3)" "unprognostic (2.83e-3)" "unprognostic (2.55e-1)" "unprognostic (2.42e-1)" "unprognostic (3.84e-3)" "prognostic favorable (9.65e-4)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.01e-1)" 36.8 25.7 6.0 6.4 6.0 16.6 33.9 6.1 13.0 29.5 6.1 35.0 6.6 32.9 9.6 30.7 27.6 5.9 31.9 6.0 6.1 29.2 24.8 23.5 7.9 6.0 6.0 32.0 30.6 13.1 18.5 5.9 6.0 21.7 7.7 3.6 24.9 7.5 31.1 28.6 26.7 8.6 6.0 29.0 30.0 19.8 6.0 13.0 23.4 9.4 8.4 28.8 28.3 6.1 12.2 8.5 21.5 19.0 11.0 16.4 14.6 18.0 13.4 23.3 15.6 6.1 20.1 21.9 8.5 13.5 8.8 7.3 20.3 13.8 24.6 13.3 9.6 39.4 9.3 4.3 18.8 28.9 14.9 12.1 15.5 12.9 4.2 15.8 15.5 19.1 25.4 42.4 19.0 6.9 38.6 42.7 4.4 5.4 12.8 27.2 4.9 14.4 16.3 6.9 15.8 15.7 11.4 13.0 21.1 11.8 6.7 20.3 15.4 8.8 11.6 6.5 13.4 15.4 12.8 17.6 15.7 18.7 13.1 30.7 13.4 19.7 13.6 18.0 13.8 16.9 16.0 15.1 12.1 15.4 13.6 14.8 13.3 16.9 19.1 13.4 20.1 13.6 6.0 6.0 6.1 13.0 6.0 6.1 6.0 6.0 6.0 6.0 6.0 6.1 69.3 80.1 52.9 6.5 61.9 33.4 42.5 62.9 18.2 43.1 47.6 56.9 70.6 64.3 52.9 33.1 16.7 77.0 82.2 45.6 131.0 106.0 50.4 42.4 51.4 61.1 44.9 94.1 12.5 121.9 65.2 50.9 18.8 40.9 84.2 34.8 83.6 133.8 68.1 32.0 11.6 53.9 50.8 92.6 46.7 20.4 76.1 57.4 21.4 4.7 107.6 61.1 124.6 12.5 17.0 88.4 48.9 72.6 41.9 20.7 60.8 126.2 51.7 52.0 52.6 50.7 84.6 75.9 70.6 27.5 28.1 53.5 64.6 42.8 52.9 32.4 GALNT4 GalNAc-T4 ENSG00000257594 "Polypeptide N-acetylgalactosaminyltransferase 4" Q8N4A0 12 89519412-89524796 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 31.6" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 11.2;Glandular and luminal cells: 3.4;Paneth cells: 3.4;Respiratory ciliated cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 22.2" HPA076116 Approved "Golgi apparatus" NA NA 520000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus" "HPA076116: AB_2686778" "unprognostic (2.96e-2)" "unprognostic (7.65e-3)" "unprognostic (8.76e-2)" "unprognostic (3.94e-5)" "unprognostic (3.50e-1)" "unprognostic (4.87e-2)" "unprognostic (2.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-2)" "unprognostic (1.28e-2)" "unprognostic (2.24e-1)" "unprognostic (5.81e-6)" "unprognostic (2.34e-1)" "unprognostic (1.91e-1)" "unprognostic (9.65e-2)" "unprognostic (2.52e-1)" 3.1 2.2 1.2 6.1 1.7 7.7 4.0 1.3 1.7 16.1 1.1 18.6 17.3 13.5 2.6 3.3 11.9 11.8 1.9 1.3 1.7 5.6 4.8 3.7 3.4 1.9 1.4 2.8 5.0 1.9 1.2 3.0 1.8 3.8 17.3 3.9 16.1 2.2 0.3 1.9 18.4 3.1 1.7 5.9 31.6 0.8 1.5 1.2 3.2 1.7 3.5 4.9 1.5 1.7 3.2 9.4 3.3 18.2 6.3 9.1 2.3 7.6 3.6 3.1 3.3 3.5 5.8 0.0 1.9 5.7 1.3 4.8 0.9 4.9 5.2 8.4 2.1 3.9 1.6 3.2 3.3 3.8 8.3 4.1 2.2 6.3 2.7 7.1 9.9 0.7 2.5 1.7 4.8 2.6 0.3 7.2 2.2 7.1 22.2 1.0 0.6 1.6 9.2 9.6 0.2 1.7 1.0 5.0 7.0 3.1 10.0 3.7 9.1 6.2 2.2 3.9 2.7 1.7 2.9 1.6 3.2 2.0 3.8 3.9 3.3 1.6 2.0 4.9 3.5 1.3 1.1 1.5 2.2 1.9 1.5 1.3 3.2 4.9 5.3 0.8 1.3 2.0 1.2 1.7 1.3 1.7 1.3 1.7 1.9 1.4 1.8 1.7 1.5 1.7 0.1 0.0 0.6 0.0 0.6 0.0 0.0 0.0 1.2 0.3 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 1.0 0.6 0.1 0.0 1.3 0.0 0.2 0.0 0.7 11.2 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.4 0.0 2.9 0.9 0.0 0.1 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.1 0.1 0.1 GBP2 ENSG00000162645 "Guanylate binding protein 2" P32456 1 89106132-89150456 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 19.1;EFO-21: 20.3;HDLM-2: 25.9;HUVEC TERT2: 18.1;RT4: 21.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042682, CAB045975" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" "CAB045975: AB_10584474, HPA042682: AB_2678113" "prognostic favorable (7.57e-4)" "unprognostic (2.92e-2)" "unprognostic (3.65e-2)" "unprognostic (3.02e-2)" "unprognostic (1.34e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.75e-3)" "prognostic unfavorable (5.73e-5)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.14e-10)" "unprognostic (7.75e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-2)" "prognostic favorable (1.10e-5)" 66.6 89.2 3.1 31.8 3.2 8.0 64.6 2.8 4.7 80.4 2.5 100.4 15.0 63.4 11.7 41.2 64.4 22.7 21.4 2.5 4.6 27.3 27.7 89.7 26.2 8.8 5.1 60.5 7.5 27.9 13.8 8.1 5.7 54.6 18.4 0.5 34.6 20.6 53.8 55.4 62.0 31.8 3.7 51.1 46.0 9.0 6.4 9.3 21.1 16.5 15.9 83.8 65.4 4.0 5.4 0.1 0.0 0.0 19.1 12.5 1.9 2.1 17.0 2.1 6.8 0.0 5.0 0.0 20.3 14.0 14.8 0.7 0.0 0.1 1.3 25.9 0.0 0.1 3.1 1.3 2.6 0.5 0.9 14.1 0.0 5.1 0.0 9.3 18.1 0.0 0.3 0.4 7.4 0.0 0.0 4.3 0.0 4.6 0.1 0.0 7.5 0.0 3.7 21.6 0.0 0.2 7.4 1.5 0.1 0.5 0.1 1.0 13.9 2.7 0.1 3.1 1.5 14.0 0.0 0.0 6.9 0.1 0.1 19.1 31.4 10.9 34.4 42.8 43.3 4.7 32.4 32.9 11.6 3.4 24.3 25.4 139.4 26.7 77.8 0.6 79.1 32.5 3.1 3.2 2.8 4.7 2.5 4.6 8.8 5.1 5.7 3.7 6.4 4.0 35.4 25.6 34.3 0.7 21.5 46.5 123.5 24.9 18.2 0.2 56.1 30.4 4.1 27.1 27.1 18.4 0.0 40.2 47.7 41.9 0.0 113.9 35.7 59.6 39.7 60.5 10.2 8.2 0.6 73.2 51.2 41.2 18.3 152.4 47.4 2.5 28.2 30.5 33.2 0.0 1.1 15.7 8.2 84.5 29.4 33.3 4.7 81.1 8.8 14.0 60.6 0.5 110.2 1.5 0.1 73.2 25.9 8.6 17.3 80.3 128.3 12.2 27.5 0.2 19.7 81.9 45.2 1.8 4.6 24.9 61.8 57.7 81.8 33.3 15.3 87.0 GBP6 DKFZp686G0786 ENSG00000183347 "Guanylate binding protein family member 6" Q6ZN66 1 89364059-89388160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 327.3" "Cell type enriched" "Detected in some" 25 "Squamous epithelial cells: 325.0" "Group enriched" "Detected in many" 7 "cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "A-431: 5.4;HaCaT: 11.3" "Low region specificity" "Detected in all" HPA027744 Enhanced NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA027744: AB_10602809" "unprognostic (7.60e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-2)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (7.05e-3)" "unprognostic (5.85e-2)" "unprognostic (5.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "unprognostic (7.99e-4)" "unprognostic (1.63e-1)" "unprognostic (2.04e-6)" "unprognostic (1.43e-1)" "unprognostic (1.03e-1)" "unprognostic (3.41e-1)" "unprognostic (3.91e-3)" 0.0 0.0 0.3 0.2 0.3 0.2 0.2 0.3 0.4 25.9 0.1 0.0 0.0 0.1 0.1 327.3 0.3 0.2 0.1 0.3 0.2 0.0 0.1 0.3 0.1 0.5 0.2 0.4 0.1 0.0 0.8 0.0 0.5 0.1 0.0 0.1 62.8 0.1 0.2 0.9 0.0 0.0 0.3 0.2 0.3 0.0 0.3 1.1 0.2 0.2 55.0 0.1 32.0 0.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 11.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.3 0.3 0.7 0.2 0.1 0.1 0.6 0.1 0.3 0.3 0.3 0.4 0.3 0.2 0.5 0.2 0.5 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.2 12.5 0.1 0.0 0.0 0.2 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.5 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.4 0.0 0.0 12.8 0.0 0.0 0.0 1.2 0.0 0.1 325.0 0.0 0.0 0.2 1.2 0.0 1.2 GHITM "DERP2, HSPC282, My021, PTD010, TMBIM5" ENSG00000165678 "Growth hormone inducible transmembrane protein" Q9H3K2 10 84139509-84153568 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1114.2;Late spermatids: 2559.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016464, HPA061664" Approved Supported Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA016464: AB_1849656, HPA061664: AB_2684579" "unprognostic (6.26e-3)" "unprognostic (1.85e-1)" "unprognostic (2.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (5.71e-2)" "unprognostic (4.56e-2)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (8.14e-2)" "unprognostic (5.71e-2)" "prognostic favorable (2.32e-10)" "unprognostic (2.46e-2)" "unprognostic (2.09e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" 113.9 179.5 124.3 87.0 133.3 110.6 93.8 138.6 147.7 73.1 150.6 171.2 163.5 76.8 86.1 114.4 71.4 68.9 365.3 136.1 146.1 300.7 271.1 74.1 87.3 136.6 128.1 72.7 77.7 197.3 88.8 70.3 138.5 80.6 166.4 144.3 94.4 84.2 369.3 79.7 137.1 85.7 125.4 73.8 123.1 115.7 137.5 86.5 105.9 456.6 103.3 92.3 76.5 123.1 228.2 230.8 97.1 223.5 162.6 143.3 171.6 153.3 267.4 193.7 180.2 283.1 183.8 178.9 167.7 203.2 170.9 199.9 208.4 200.0 185.9 179.8 157.4 127.7 227.3 281.0 306.5 402.0 200.0 162.7 384.1 200.4 577.8 201.8 169.9 150.5 299.9 324.3 180.4 197.4 143.6 318.9 98.3 184.8 203.2 128.3 89.4 270.5 271.4 179.2 79.4 92.4 154.7 134.1 325.1 111.2 273.7 254.2 145.3 94.0 126.5 138.5 251.1 227.9 265.7 199.9 246.8 364.4 67.1 293.7 284.9 276.5 173.9 304.7 194.2 211.0 178.9 186.0 279.9 177.9 166.6 178.8 223.7 206.7 281.3 145.3 235.3 578.0 124.3 133.3 138.6 147.7 136.1 146.1 136.6 128.1 138.5 125.4 137.5 123.1 94.1 96.1 87.6 23.2 138.0 170.3 185.1 440.9 87.0 135.9 102.2 71.8 689.3 140.2 235.8 158.2 70.9 260.4 134.0 376.0 579.2 295.3 1114.2 58.7 68.6 120.7 125.6 242.9 33.6 232.3 234.9 119.6 107.6 67.1 102.0 79.3 88.5 326.1 267.7 101.0 34.5 206.0 443.5 156.2 169.2 2559.1 110.3 153.0 163.7 16.9 228.3 269.0 114.4 14.6 24.3 223.3 276.3 136.9 167.3 180.1 343.7 802.9 173.4 159.9 144.7 114.5 219.8 263.1 153.2 150.4 170.3 386.0 141.6 158.4 281.4 212.9 GLE1 "GLE1L, hGLE1, LCCS1" ENSG00000119392 "GLE1 RNA export mediator" Q53GS7 9 128504719-128542288 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041689, HPA043538, HPA061560" Supported Supported "Nuclear membrane,Nucleoli" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear membrane" Nucleoli "HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560" "unprognostic (8.74e-3)" "unprognostic (2.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.49e-4)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (7.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.95e-2)" "unprognostic (4.00e-2)" "prognostic favorable (7.04e-4)" "unprognostic (2.62e-1)" "unprognostic (1.99e-3)" "unprognostic (5.64e-2)" 11.6 14.0 9.2 15.7 9.2 15.1 15.7 12.4 11.3 13.0 13.4 17.4 16.2 11.6 10.8 16.4 14.1 7.8 14.9 8.9 8.8 14.1 16.3 12.3 20.4 8.7 9.2 16.2 9.5 17.6 14.1 9.2 8.6 11.8 18.3 16.5 11.1 12.4 22.5 19.1 15.8 12.9 8.4 15.2 12.9 32.0 9.3 25.9 13.3 12.4 22.2 12.8 12.3 8.9 29.6 54.5 26.2 44.9 25.3 25.5 34.6 29.2 24.9 40.2 28.4 36.8 20.1 59.6 23.0 33.0 38.6 101.4 45.9 41.7 34.5 56.9 29.8 30.6 57.8 34.6 28.5 49.9 38.8 18.1 39.7 45.6 48.5 22.3 22.9 54.7 44.7 51.0 46.7 68.6 49.5 35.2 22.2 79.1 46.7 49.8 64.2 79.0 27.3 26.1 30.9 23.1 71.3 42.7 25.9 21.1 78.9 34.9 17.0 42.5 28.1 50.2 41.2 50.9 131.9 45.9 39.9 37.5 46.8 40.0 21.1 24.4 22.1 26.0 18.1 13.4 17.2 20.0 22.1 20.5 15.2 17.7 18.0 27.4 27.5 13.0 22.3 19.8 9.2 9.2 12.4 11.3 8.9 8.8 8.7 9.2 8.6 8.4 9.3 8.9 4.0 9.6 9.0 11.1 11.4 6.5 5.3 10.4 8.6 7.6 8.8 7.6 13.0 5.7 7.2 7.3 8.4 16.1 6.9 13.2 5.9 11.7 77.0 12.2 7.4 3.6 5.4 12.0 14.0 6.2 11.7 7.6 10.2 9.4 9.5 10.9 4.6 14.2 15.7 10.1 15.5 12.7 8.2 15.1 5.7 58.1 10.2 13.5 3.6 10.3 20.0 8.9 15.5 18.1 15.5 8.3 8.0 6.4 13.4 6.1 16.3 13.7 12.6 8.6 13.1 7.7 7.3 51.3 25.5 14.4 6.8 13.3 12.1 7.1 14.1 5.4 GMPPA ENSG00000144591 "GDP-mannose pyrophosphorylase A" Q96IJ6 2 219498884-219506989 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035512, HPA035513" Approved Approved Nucleoplasm NA NA 51000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "HPA035512: AB_2674660, HPA035513: AB_10671934" "unprognostic (3.43e-1)" "unprognostic (3.95e-2)" "unprognostic (7.75e-3)" "unprognostic (1.40e-3)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.57e-1)" "unprognostic (2.39e-1)" "unprognostic (2.25e-1)" "unprognostic (1.17e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.90e-10)" "prognostic favorable (5.24e-4)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (2.28e-1)" 22.6 25.8 19.3 23.9 20.1 19.0 21.6 20.1 22.6 32.1 22.4 29.7 28.8 26.4 68.7 25.5 24.6 19.7 27.1 20.1 20.5 25.7 68.5 20.9 20.7 20.5 19.8 20.1 60.3 24.7 48.5 21.2 20.0 37.3 32.3 8.0 40.1 23.4 22.8 17.8 30.0 26.2 19.6 35.2 32.5 9.6 21.3 13.2 28.6 12.6 23.8 25.2 23.1 19.8 43.4 36.0 21.2 37.8 79.5 70.6 56.4 73.8 98.6 85.2 105.2 66.8 40.5 23.4 51.1 107.7 54.3 40.1 39.7 63.9 73.3 45.3 35.0 45.5 35.7 119.3 72.0 24.1 51.7 54.3 50.7 79.9 89.9 43.9 52.8 29.7 82.3 66.3 66.8 55.5 23.8 45.3 21.7 52.8 38.5 18.6 22.9 42.4 48.6 30.1 27.4 24.0 31.0 46.3 52.1 44.4 31.5 38.8 30.9 49.2 33.6 89.4 40.9 45.4 19.4 28.9 100.4 26.7 55.8 76.0 52.6 37.3 30.1 56.0 35.0 32.1 23.4 31.9 43.5 24.1 17.3 15.7 11.8 36.4 59.3 43.9 34.8 35.2 19.3 20.1 20.1 22.6 20.1 20.5 20.5 19.8 20.0 19.6 21.3 19.8 12.5 16.0 14.4 5.5 18.8 5.6 12.8 25.2 6.2 6.1 20.9 13.5 13.2 10.0 20.1 16.5 6.2 37.6 16.6 37.7 35.2 24.3 1.3 8.5 15.8 9.5 10.8 19.1 3.1 30.0 79.8 19.2 38.7 14.4 19.0 13.3 11.0 36.3 33.7 1.7 3.6 61.6 10.2 17.6 10.0 3.4 18.3 16.5 12.4 1.9 15.9 11.1 12.3 1.0 4.9 19.0 37.6 13.5 50.3 15.1 45.9 36.8 11.6 4.7 13.1 7.9 27.1 4.4 6.5 9.9 8.5 47.2 13.5 10.7 29.1 15.1 GNB1 ENSG00000078369 "G protein subunit beta 1" P62873 1 1785285-1891117 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "retina: 2629.0" "Cell type enriched" "Detected in all" 5 "Rod photoreceptor cells: 1373.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040736 Supported Approved "Golgi apparatus,Plasma membrane" NA NA 1900000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 79: Retina - Phototransduction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (9.49e-2)" "unprognostic (4.91e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (9.07e-3)" "prognostic unfavorable (3.61e-6)" "unprognostic (1.99e-2)" "unprognostic (3.60e-1)" "unprognostic (7.27e-2)" "unprognostic (8.47e-3)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (1.08e-1)" "unprognostic (4.62e-2)" "unprognostic (1.14e-1)" "unprognostic (7.90e-2)" 178.1 123.8 167.9 179.9 212.3 147.6 119.7 147.8 234.4 124.3 87.1 165.7 173.7 127.1 90.8 126.7 114.4 110.9 119.6 228.3 172.0 125.1 103.3 146.7 160.0 159.5 153.2 130.2 105.9 148.2 106.8 141.1 169.5 118.3 123.1 2629.0 120.6 118.9 66.8 111.8 208.2 156.1 131.6 142.6 129.7 99.0 168.9 167.3 113.6 97.1 145.6 152.6 102.7 203.9 373.2 344.2 400.2 280.4 222.4 242.4 154.4 515.4 339.9 456.2 355.2 282.8 361.8 385.5 369.3 522.5 258.6 192.0 405.5 373.5 411.4 595.9 199.2 375.0 308.2 325.6 279.1 227.7 394.4 216.4 256.6 437.2 402.9 306.1 376.8 298.8 236.8 337.8 440.0 230.3 501.9 177.4 230.8 190.0 275.0 482.9 308.7 306.4 310.8 227.5 489.9 556.5 477.1 306.6 420.5 272.8 214.8 305.9 579.4 399.3 267.5 314.8 379.1 227.1 432.8 888.7 341.4 470.1 230.5 11.4 13.3 21.9 9.9 16.4 9.1 9.0 9.9 11.2 13.3 9.6 6.7 7.2 22.1 12.8 17.5 22.7 12.5 8.2 167.9 212.3 147.8 234.4 228.3 172.0 159.5 153.2 169.5 131.6 168.9 203.9 172.0 70.5 42.6 57.5 67.9 86.3 51.6 47.4 33.0 149.8 65.3 57.8 60.6 52.9 42.4 75.4 175.2 44.2 124.4 140.9 46.9 88.0 29.1 93.3 112.9 131.6 122.9 40.3 102.4 100.5 99.4 77.8 52.0 121.6 53.8 101.9 95.3 60.3 100.8 180.0 101.9 95.5 40.7 152.7 114.6 33.8 76.1 128.0 53.4 115.2 119.5 250.3 73.2 70.9 110.1 175.4 91.0 88.0 75.3 100.5 167.6 67.4 41.1 1373.7 78.9 71.0 105.9 68.8 67.1 51.6 101.7 36.4 74.5 83.7 83.0 94.1 GNPTG "C16orf27, c316G12.3, CAB56184, GNPTAG" ENSG00000090581 "N-acetylglucosamine-1-phosphate transferase subunit gamma" Q9UJJ9 16 1351931-1364113 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Mucolipidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 135.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004055 Approved Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 560000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" "Endoplasmic reticulum" Cytosol "HPA004055: AB_1079006" "unprognostic (4.37e-2)" "unprognostic (2.20e-2)" "unprognostic (1.84e-1)" "unprognostic (9.57e-3)" "unprognostic (2.70e-3)" "unprognostic (2.09e-1)" "unprognostic (3.03e-2)" "unprognostic (3.66e-1)" "unprognostic (1.69e-1)" "unprognostic (3.29e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.14e-2)" "unprognostic (2.20e-1)" "unprognostic (2.31e-1)" "unprognostic (4.85e-2)" "unprognostic (2.07e-2)" 34.8 94.0 33.5 19.3 41.3 25.0 34.5 37.8 43.3 31.4 43.2 27.9 17.7 29.7 28.9 23.6 28.5 23.7 28.7 32.6 34.8 37.1 40.9 28.4 27.9 38.8 35.5 35.7 39.6 40.2 32.9 20.9 39.3 29.9 16.2 15.6 42.9 20.7 34.6 37.2 30.9 14.9 35.1 38.3 34.8 21.4 35.7 13.3 33.9 16.9 14.4 28.8 26.5 44.5 13.3 21.2 15.3 26.9 135.2 50.3 20.1 38.3 49.6 14.9 28.4 19.1 37.0 8.4 43.0 51.8 22.5 24.0 9.2 22.4 7.6 27.0 20.2 11.3 73.9 33.0 57.6 18.2 43.2 67.3 38.4 14.2 20.3 41.6 27.5 15.2 13.7 48.4 24.6 30.7 8.7 18.7 14.4 33.9 11.8 30.5 12.9 38.6 37.3 17.1 12.0 15.5 38.5 39.2 28.7 8.5 36.9 27.3 27.0 29.8 25.5 24.6 19.1 50.6 40.4 17.7 24.4 15.6 20.3 70.5 77.0 49.5 43.3 74.4 39.6 32.1 36.7 40.8 61.5 31.1 33.4 30.8 32.0 32.6 73.9 52.2 46.9 49.7 33.5 41.3 37.8 43.3 32.6 34.8 38.8 35.5 39.3 35.1 35.7 44.5 39.7 41.7 41.7 17.3 31.9 20.9 26.5 25.4 46.7 15.1 34.0 42.9 9.4 37.1 43.2 20.2 25.0 25.0 34.9 25.8 9.8 27.4 2.6 17.7 29.8 25.6 9.1 9.9 22.7 14.5 20.3 49.7 47.4 23.7 24.6 21.1 30.7 35.2 50.2 8.4 20.5 18.0 14.2 43.4 41.7 4.6 30.1 47.8 33.8 9.4 25.7 31.0 30.9 15.1 32.4 14.8 32.9 17.7 76.1 22.1 32.1 41.7 28.5 24.5 19.7 24.4 22.9 25.4 24.2 48.1 20.3 31.1 30.6 20.5 21.7 24.5 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 83.4;stomach 1: 52.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 125.1;Excitatory neurons: 99.4;Inhibitory neurons: 131.1;Melanocytes: 152.9;Oligodendrocyte precursor cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 14.6;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: AB_2683424" "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.3 9.7 8.7 5.9 16.3 2.3 2.4 6.5 12.1 2.4 83.4 10.2 3.8 1.9 12.3 5.9 1.6 5.7 7.0 12.2 5.3 20.1 7.3 3.0 6.3 5.5 5.3 2.5 18.2 8.9 2.3 4.4 5.2 7.5 3.7 10.0 3.6 8.4 4.7 13.2 4.0 6.1 3.5 5.4 52.6 2.2 7.1 3.0 8.3 4.4 3.6 4.1 2.7 6.1 0.7 0.3 0.8 2.0 4.9 2.7 0.5 3.8 1.3 0.6 2.1 0.3 0.2 2.2 1.2 2.8 1.3 0.2 1.3 1.1 2.1 0.8 1.5 2.3 1.1 0.2 0.9 0.7 1.1 3.9 3.1 1.9 0.6 4.0 1.0 3.0 0.3 5.5 4.2 0.6 1.6 0.8 0.4 2.3 1.5 1.9 5.6 1.0 2.0 1.3 5.9 5.0 1.2 0.8 2.0 2.5 0.3 0.3 2.6 2.7 1.0 3.9 0.5 14.6 2.2 0.3 3.0 0.6 9.9 1.3 2.2 0.1 1.8 4.0 1.6 1.1 3.1 2.9 0.6 1.0 2.5 3.9 7.3 3.6 5.7 0.3 5.5 1.4 8.7 16.3 6.5 12.1 12.2 5.3 5.5 5.3 5.2 3.5 7.1 6.1 18.5 12.8 3.6 31.3 9.8 42.7 4.0 4.0 29.0 34.9 5.8 6.1 26.0 2.8 6.8 11.0 125.1 1.5 12.2 0.6 1.9 1.9 0.7 1.4 24.1 9.8 12.7 15.2 99.4 6.0 1.2 9.7 9.7 0.6 1.3 4.0 16.1 16.1 6.1 50.5 131.1 0.8 2.0 50.4 23.0 1.8 14.9 27.0 152.9 8.4 34.3 16.7 11.3 130.2 21.2 3.5 0.1 32.0 14.3 3.1 0.4 41.7 0.5 25.8 0.0 16.9 9.5 3.3 3.2 7.5 28.6 0.8 25.7 52.4 1.0 1.8 GPS2 ENSG00000132522 "G protein pathway suppressor 2" Q13227 17 7311324-7315564 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 279.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067540 Approved Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA067540: AB_2685860" "unprognostic (1.53e-2)" "unprognostic (3.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.71e-3)" "unprognostic (1.55e-1)" "unprognostic (1.53e-4)" "unprognostic (1.37e-2)" "unprognostic (1.33e-1)" "unprognostic (3.18e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.50e-5)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.42e-5)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (6.87e-2)" "unprognostic (1.28e-3)" 45.4 47.7 30.3 15.5 30.9 26.8 39.7 30.7 37.8 42.1 28.4 47.5 14.6 39.5 14.2 38.0 36.8 13.2 65.8 30.3 30.9 49.8 33.3 34.0 17.2 31.8 30.7 39.5 39.0 24.4 33.8 13.9 31.1 35.3 17.1 12.0 39.4 16.9 154.9 52.0 34.5 15.6 29.5 34.6 40.0 102.7 31.2 21.6 34.6 52.9 20.1 43.9 37.2 31.7 28.1 60.6 24.9 26.4 36.5 20.2 21.2 20.1 26.7 45.2 39.0 39.2 16.1 32.0 15.5 31.1 32.3 42.1 25.4 42.4 31.5 37.9 34.8 30.1 62.2 53.0 26.4 19.1 37.1 19.3 31.2 59.0 17.1 19.5 26.0 29.7 18.8 8.6 43.2 25.8 38.2 21.2 24.6 29.3 22.8 29.5 30.8 34.1 36.4 32.1 23.5 39.5 35.6 23.6 28.9 21.4 23.6 18.6 15.9 23.0 20.5 28.2 48.9 25.0 37.0 21.0 30.3 23.2 38.1 78.3 47.2 82.7 53.5 59.8 49.5 81.6 56.6 58.5 39.5 63.8 51.9 47.8 79.1 41.5 67.7 66.0 81.2 58.1 30.3 30.9 30.7 37.8 30.3 30.9 31.8 30.7 31.1 29.5 31.2 31.7 29.1 12.8 10.8 19.9 36.9 15.8 11.5 11.4 29.0 29.9 19.2 17.8 1.2 17.2 16.6 20.2 66.7 13.5 55.7 52.4 25.4 21.7 100.3 15.0 22.6 18.9 16.8 29.9 15.0 26.8 11.1 14.9 25.5 17.5 19.0 23.4 11.4 10.6 10.3 38.7 12.5 23.2 6.1 14.1 25.0 279.3 21.1 21.1 19.6 13.1 21.6 15.5 41.2 10.6 17.1 19.5 35.9 15.4 42.2 8.4 42.2 25.7 14.6 44.8 19.7 17.4 18.8 37.4 42.9 18.1 16.9 19.6 39.0 17.1 21.8 9.1 GPX4 "MCSP, PHGPx" ENSG00000167468 "Glutathione peroxidase 4" P36969 19 1103926-1106791 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Oxidoreductase, Peroxidase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 18580.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008630, HPA047224, HPA058546" Enhanced Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA 150000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Mitochondria" "CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749" "unprognostic (8.42e-3)" "prognostic favorable (7.18e-4)" "unprognostic (8.14e-3)" "prognostic favorable (1.84e-5)" "unprognostic (1.00e-1)" "unprognostic (8.72e-2)" "unprognostic (2.53e-3)" "unprognostic (8.49e-2)" "unprognostic (2.69e-2)" "unprognostic (1.47e-1)" "prognostic favorable (7.72e-4)" "unprognostic (1.29e-1)" "prognostic favorable (8.61e-4)" "unprognostic (1.61e-2)" "unprognostic (2.20e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 927.8 535.3 415.1 127.4 428.7 178.0 733.3 440.7 519.1 280.8 478.7 249.0 259.0 188.4 318.9 220.4 199.2 196.6 426.0 419.2 450.3 536.5 687.8 307.9 216.4 430.9 448.3 260.3 157.9 285.5 398.4 147.2 454.1 322.1 110.9 167.5 304.9 193.8 672.3 290.4 236.2 87.9 418.2 213.2 219.0 1403.5 444.0 158.7 291.5 399.7 182.5 319.0 245.2 429.1 258.1 286.8 405.8 863.0 1202.1 706.0 449.3 199.3 713.5 371.1 375.9 590.5 339.8 92.8 211.8 405.8 313.5 283.1 239.7 289.3 180.5 522.3 436.5 175.0 246.9 849.2 697.4 207.6 269.4 707.3 432.1 188.3 314.7 665.9 527.1 317.5 249.4 225.7 311.1 660.4 353.8 354.9 386.2 569.7 458.9 482.8 55.3 271.3 408.9 629.9 348.3 220.6 390.5 366.1 422.1 246.7 358.1 498.0 450.9 392.3 257.4 680.6 254.6 786.5 582.0 224.3 369.4 412.2 230.9 578.9 539.6 564.4 219.8 405.4 256.9 352.7 319.7 230.7 404.0 309.9 339.4 245.0 265.1 196.6 462.2 278.8 310.3 841.7 415.1 428.7 440.7 519.1 419.2 450.3 430.9 448.3 454.1 418.2 444.0 429.1 415.9 179.5 189.7 21.2 281.7 510.0 525.8 1188.1 512.2 332.2 845.1 868.2 264.6 316.0 600.6 472.6 98.0 562.5 231.3 479.1 1592.6 515.8 4209.7 546.8 326.3 268.7 397.1 215.0 24.5 368.7 1327.3 536.1 99.9 442.3 346.1 242.6 322.0 826.2 1184.1 208.6 33.1 328.7 671.4 583.1 1304.8 18580.2 384.9 735.2 677.7 21.5 1786.8 502.6 192.6 13.6 35.4 484.0 507.9 312.9 189.2 694.7 1861.9 3024.7 800.9 246.0 243.3 244.6 587.1 1310.8 202.4 357.7 467.0 978.1 281.0 186.7 336.4 662.6 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 166.1;Early spermatids: 384.9;Late spermatids: 321.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus, Vesicles" Nucleoli "HPA043054: AB_2678293, HPA046782: AB_2679803" "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 11.4 13.1 13.6 17.5 16.7 16.2 13.2 14.7 16.7 10.4 10.9 60.4 48.3 10.6 11.3 41.0 10.9 14.2 11.0 15.7 14.8 16.4 23.3 9.7 19.6 12.9 12.0 6.7 9.9 9.5 8.1 13.8 13.3 13.9 54.6 67.8 12.1 9.9 12.7 14.5 56.6 15.9 13.9 11.8 23.3 48.7 13.7 11.1 10.3 10.6 22.4 21.1 16.2 14.9 21.9 30.5 33.6 23.1 25.2 29.1 56.6 39.7 30.7 26.2 28.8 22.7 36.6 20.9 23.6 30.4 15.9 23.8 22.1 24.2 37.9 49.9 21.1 8.8 16.1 17.5 23.4 23.1 14.5 23.2 37.7 33.1 32.7 20.1 34.6 23.5 19.2 18.7 33.6 53.5 17.0 18.6 37.3 33.9 38.3 16.7 31.4 19.3 61.5 79.9 11.8 38.4 44.8 41.6 34.9 33.7 31.9 14.3 37.8 12.0 15.1 25.6 12.8 21.7 67.0 17.8 30.6 16.4 19.6 64.4 20.9 47.0 27.7 24.3 42.8 38.3 37.6 32.4 21.2 33.1 37.0 34.5 40.9 37.5 33.6 17.9 66.6 28.6 13.6 16.7 14.7 16.7 15.7 14.8 12.9 12.0 13.3 13.9 13.7 14.9 12.6 12.8 7.4 5.9 24.8 45.2 24.2 27.6 19.9 26.8 18.4 14.5 18.9 14.3 21.7 20.2 41.7 42.7 17.9 166.1 72.4 34.1 384.9 32.3 11.1 17.4 28.1 24.0 14.3 39.4 43.3 12.1 41.8 32.2 19.7 6.6 17.9 17.3 23.6 23.5 10.8 73.0 52.9 19.8 19.6 321.7 8.1 16.8 19.6 5.6 25.2 22.3 16.5 10.6 17.9 39.9 102.9 7.9 22.6 37.4 81.8 47.4 28.6 104.0 19.7 6.5 16.5 40.0 34.1 35.7 65.9 119.6 24.4 7.9 69.1 43.7 GTF2A2 "HsT18745, TFIIA" ENSG00000140307 "General transcription factor IIA subunit 2" P52657 15 59638062-59657541 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 1134.9;Late spermatids: 732.8;Spermatocytes: 1264.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056239 Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA056239: AB_2683074" "unprognostic (2.18e-2)" "unprognostic (3.21e-1)" "unprognostic (9.37e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (3.06e-2)" "unprognostic (1.31e-2)" "unprognostic (7.35e-2)" "unprognostic (6.29e-2)" "unprognostic (3.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.58e-1)" "unprognostic (2.79e-1)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" 54.4 56.9 37.6 54.5 39.5 72.0 49.6 42.7 44.0 52.5 38.8 62.8 40.3 48.7 54.6 60.9 46.2 43.6 64.0 38.1 42.7 69.8 49.8 39.7 52.6 41.5 40.1 52.0 43.1 65.4 58.3 43.3 41.0 46.0 51.1 41.9 58.2 34.3 75.1 39.5 42.0 45.4 42.2 43.3 46.3 211.9 38.6 60.0 41.1 55.1 51.8 61.4 65.5 44.1 149.1 206.4 136.8 130.9 83.8 70.5 157.7 164.0 79.8 134.6 133.3 224.4 58.9 136.5 149.5 107.9 197.6 124.3 138.7 100.6 95.4 242.2 112.9 157.4 146.5 143.4 107.5 171.5 134.1 66.0 95.1 112.3 94.9 95.3 87.6 105.6 226.7 136.1 113.6 103.8 112.9 130.8 181.7 49.6 120.0 104.4 142.9 166.5 133.7 172.2 148.0 157.1 152.1 171.5 160.1 180.5 120.7 179.2 121.5 126.4 224.7 142.5 297.7 134.1 426.3 303.8 143.2 284.0 157.2 174.0 129.8 170.3 88.1 140.7 92.4 126.9 103.1 98.9 174.2 100.2 87.4 96.7 70.0 117.5 135.1 201.0 132.7 134.9 37.6 39.5 42.7 44.0 38.1 42.7 41.5 40.1 41.0 42.2 38.6 44.1 109.4 41.7 58.5 17.0 89.8 98.7 184.6 213.0 83.1 51.1 107.3 155.8 120.4 62.9 132.2 64.4 47.9 217.8 99.9 122.4 211.3 148.8 1134.9 129.9 85.8 96.6 82.1 121.4 22.4 148.8 199.7 103.7 51.5 92.4 82.2 87.9 74.6 78.4 148.3 50.5 27.5 100.8 195.3 100.1 107.7 732.8 125.9 101.9 80.0 16.9 158.9 173.8 107.1 24.1 35.4 181.6 104.6 137.3 109.6 210.7 83.5 149.2 129.7 62.2 65.7 102.9 133.7 1264.3 166.3 89.8 106.8 151.9 87.3 120.8 120.5 236.2 GTF2F2 "BTF4, RAP30, TFIIF" ENSG00000188342 "General transcription factor IIF subunit 2" P13984 13 45120510-45284893 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006912 Supported Supported Nucleoplasm,Microtubules NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Microtubules "HPA006912: AB_1080256" "unprognostic (3.39e-1)" "unprognostic (2.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (3.67e-2)" "unprognostic (3.17e-1)" "unprognostic (3.36e-2)" "unprognostic (2.53e-3)" "unprognostic (2.31e-2)" "unprognostic (4.76e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.53e-3)" "unprognostic (3.94e-2)" "unprognostic (6.44e-3)" 10.9 16.6 12.4 11.0 13.2 18.3 12.9 12.4 14.9 13.5 18.1 18.3 10.4 11.6 15.4 16.5 10.0 8.4 20.0 13.1 13.2 15.0 11.3 9.6 13.4 12.3 13.0 12.1 10.7 14.1 12.9 11.0 12.4 10.7 14.2 9.9 12.2 13.0 25.0 24.9 10.0 12.9 13.5 10.2 11.3 13.3 13.0 14.8 11.4 15.8 14.4 15.5 14.8 15.6 43.2 15.9 29.3 21.8 17.6 25.8 24.3 46.2 30.2 46.1 44.9 26.8 65.7 42.9 25.4 33.9 44.8 46.9 44.3 37.1 66.7 32.6 38.4 50.8 20.7 35.2 28.1 57.0 27.9 21.8 55.9 34.4 57.8 52.0 29.9 32.9 36.6 15.8 125.6 24.2 42.0 65.2 34.8 68.6 38.3 39.0 22.2 24.8 101.4 15.0 15.6 26.0 23.5 22.9 39.8 27.5 18.6 45.9 23.7 38.6 33.1 30.8 79.9 10.0 14.6 42.7 44.9 36.1 41.2 16.2 15.9 29.9 10.3 16.7 12.4 17.3 12.1 12.4 18.8 17.8 13.5 13.5 22.5 18.9 18.9 14.7 14.7 10.1 12.4 13.2 12.4 14.9 13.1 13.2 12.3 13.0 12.4 13.5 13.0 15.6 21.6 41.7 32.1 41.1 36.0 75.1 82.8 80.2 35.9 19.2 27.3 30.2 79.4 10.0 41.6 11.0 4.2 33.0 25.7 29.0 49.0 49.7 93.0 34.9 37.5 27.6 28.2 32.6 23.7 33.6 49.4 28.9 13.7 56.8 39.3 25.6 18.2 21.4 49.1 8.4 35.1 26.4 50.8 27.1 38.2 82.3 24.2 32.0 76.5 36.5 38.2 36.8 27.8 57.8 48.9 48.5 30.3 31.6 30.4 88.3 22.6 42.7 29.4 21.5 6.6 35.6 32.3 68.6 83.9 34.5 72.7 33.8 28.8 33.5 40.7 75.1 GUK1 ENSG00000143774 "Guanylate kinase 1" Q16774 1 228139962-228148984 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028118, HPA048587, HPA068324" Approved Uncertain Nucleoplasm,Cytosol NA NA 240000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Cytosol "HPA028118: AB_2756308, HPA048587: AB_2680453, HPA068324: " "unprognostic (9.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.60e-3)" "unprognostic (7.91e-2)" "unprognostic (8.54e-3)" "unprognostic (1.24e-1)" "unprognostic (3.55e-3)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (7.32e-2)" "unprognostic (3.38e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (2.91e-1)" "unprognostic (5.41e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-2)" 226.7 198.9 291.7 93.9 277.9 251.9 213.3 255.3 465.2 187.1 274.1 196.5 113.8 169.2 48.6 333.8 161.8 116.3 240.0 302.8 257.9 230.6 318.1 222.8 124.5 263.1 263.0 146.9 208.9 72.0 165.7 78.9 261.8 161.3 31.5 110.8 191.0 71.6 149.0 285.7 155.0 53.6 266.3 179.4 202.0 107.3 281.3 97.1 151.3 61.8 39.2 188.6 202.4 289.4 356.1 122.4 53.0 164.5 155.6 186.6 264.3 230.8 116.5 130.8 102.8 70.6 239.1 133.4 266.5 151.4 110.0 230.3 45.7 252.0 14.0 203.7 357.1 79.3 292.9 156.3 282.8 90.5 133.0 260.0 150.6 91.9 73.3 94.2 179.2 279.9 219.5 205.1 109.5 295.2 411.4 194.3 166.8 172.6 522.9 155.3 99.9 354.9 125.2 164.1 173.7 311.3 148.7 250.2 309.7 13.5 185.2 191.7 318.5 237.7 157.4 353.4 387.5 186.8 221.9 151.6 300.3 146.2 246.0 379.0 323.8 663.9 420.6 363.0 406.5 265.0 346.8 454.1 279.7 230.8 256.5 323.4 420.1 339.5 390.9 567.3 394.6 571.4 291.7 277.9 255.3 465.2 302.8 257.9 263.1 263.0 261.8 266.3 281.3 289.4 503.7 60.9 87.2 35.3 199.9 660.0 271.5 643.5 215.7 195.5 425.9 448.7 130.8 195.9 312.2 237.3 717.2 241.6 351.2 655.8 694.6 510.9 134.0 212.5 272.0 451.4 269.6 866.9 50.2 685.5 417.9 276.9 189.1 304.2 182.6 162.5 365.5 353.4 407.5 109.4 33.5 426.5 384.5 291.7 557.0 609.3 233.6 265.6 519.4 22.5 355.5 411.0 398.6 16.1 58.6 975.0 718.8 243.8 365.6 571.5 857.7 801.1 231.6 570.9 249.8 158.2 378.6 89.8 100.3 448.6 719.7 262.4 326.7 226.3 331.5 612.2 HAAO ENSG00000162882 "3-hydroxyanthranilate 3,4-dioxygenase" P46952 2 42767089-42792593 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 295.8" "Group enriched" "Detected in many" 5 "Hepatocytes: 209.8;Proximal enterocytes: 236.8;Proximal tubular cells: 162.7" "Group enriched" "Detected in all" 5 "liver cancer: 46.5;renal cancer: 13.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 23.2" "Group enriched" "Detected in many" 5 "dendritic cells: 23.2;granulocytes: 19.2;monocytes: 17.4" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;Hep G2: 49.4;REH: 9.9;THP-1: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036394, HPA042024" Enhanced NA NA 580000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA036394: AB_10673131, HPA042024: AB_2677803" "unprognostic (6.97e-3)" "unprognostic (1.86e-2)" "unprognostic (1.63e-2)" "unprognostic (4.44e-2)" "unprognostic (1.78e-1)" "unprognostic (7.23e-3)" "prognostic favorable (5.77e-4)" "unprognostic (6.20e-2)" "unprognostic (7.58e-2)" "unprognostic (5.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (1.37e-1)" "unprognostic (2.56e-1)" "unprognostic (2.03e-1)" 8.7 5.4 1.8 5.9 2.1 4.1 12.9 2.1 2.5 16.0 3.3 13.2 23.1 10.5 14.5 6.0 10.6 6.1 7.0 1.8 2.3 41.8 295.8 5.7 6.1 2.0 2.5 14.0 26.3 2.9 4.5 8.5 2.3 10.1 11.6 0.3 3.8 11.3 2.4 5.0 40.8 4.7 2.1 5.4 9.6 1.8 2.1 4.0 5.8 3.2 4.5 15.8 9.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 4.6 14.0 0.1 0.0 0.1 0.6 0.0 0.0 4.7 0.0 0.8 0.0 1.4 5.6 0.0 49.4 0.4 1.9 0.1 2.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 2.6 0.2 0.0 9.9 1.1 0.3 0.0 0.0 0.1 0.0 0.6 1.0 0.0 1.3 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 7.9 17.4 19.2 0.0 10.5 0.0 3.5 0.0 0.0 23.2 3.9 0.0 0.1 5.5 0.7 2.9 7.7 0.0 5.6 1.8 2.1 2.1 2.5 1.8 2.3 2.0 2.5 2.3 2.1 2.1 2.3 2.5 0.0 1.1 3.6 3.5 4.0 6.3 2.3 14.8 0.1 2.9 7.6 0.6 14.3 1.6 1.8 0.0 1.1 2.9 18.3 17.6 7.4 0.0 0.6 8.1 1.9 6.7 12.0 3.4 13.3 0.5 18.0 1.5 0.3 30.4 1.2 4.6 209.8 21.3 0.0 2.2 14.9 0.0 13.5 4.9 0.2 12.5 8.7 5.4 8.4 8.4 3.6 1.0 5.5 1.0 4.8 28.7 10.5 0.5 2.1 236.8 162.7 0.5 0.3 13.1 37.7 13.8 0.4 0.7 6.0 4.8 1.2 1.2 2.2 25.5 2.7 HAT1 KAT1 ENSG00000128708 "Histone acetyltransferase 1" O14929 2 171922448-171983686 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036788, CAB037191" Supported Supported Nucleoplasm NA NA 27000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "CAB037191: AB_477070, HPA036788: AB_10672267" "unprognostic (1.76e-1)" "unprognostic (1.01e-2)" "unprognostic (7.39e-3)" "unprognostic (8.24e-3)" "unprognostic (2.76e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (5.72e-5)" "unprognostic (2.71e-2)" "unprognostic (9.08e-3)" "unprognostic (3.69e-2)" "unprognostic (1.56e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (6.89e-2)" "unprognostic (1.80e-1)" "unprognostic (3.97e-2)" "unprognostic (6.69e-2)" 27.7 27.0 14.3 33.5 15.5 59.8 41.4 15.9 19.2 26.8 15.3 27.7 19.9 24.6 16.7 26.6 24.4 24.6 31.4 13.1 16.2 32.2 30.2 25.7 48.7 15.0 14.6 23.2 30.0 37.9 16.9 30.6 15.5 29.0 30.7 28.8 32.8 24.0 67.7 23.8 21.7 29.3 16.1 27.7 23.6 20.1 15.5 50.7 32.8 50.8 47.5 39.0 19.6 17.3 132.4 61.5 106.6 98.8 55.2 56.8 75.2 133.9 88.9 144.4 149.9 144.3 88.2 147.0 85.0 81.5 122.7 101.3 116.7 109.5 220.5 83.5 115.8 131.1 91.5 131.0 26.7 165.5 77.9 34.2 62.2 191.0 63.6 45.5 92.6 100.4 136.5 93.1 166.5 91.8 131.1 148.3 89.0 158.9 63.9 102.8 134.4 99.4 85.3 130.2 67.8 55.4 112.4 62.4 118.1 81.5 86.4 164.5 47.5 129.8 99.2 109.5 137.1 40.9 100.5 173.8 87.6 117.8 113.8 47.6 35.3 53.7 32.8 42.0 40.6 35.5 34.9 34.0 27.4 30.7 33.9 37.6 40.3 44.6 59.2 14.3 49.2 34.0 14.3 15.5 15.9 19.2 13.1 16.2 15.0 14.6 15.5 16.1 15.5 17.3 55.6 35.3 28.9 13.7 49.7 74.2 117.7 129.7 46.1 24.2 36.4 42.3 49.5 25.8 66.2 27.6 33.3 77.5 43.5 19.0 82.2 45.2 70.3 33.1 32.3 43.2 14.3 103.1 28.6 46.5 83.1 43.7 15.8 28.9 40.6 30.7 28.9 20.1 51.8 28.6 45.3 20.9 111.9 29.5 36.3 14.7 30.7 34.5 32.0 16.9 28.8 53.4 43.3 21.6 28.0 27.8 21.0 36.9 50.8 52.0 18.2 46.0 65.4 42.0 39.5 43.8 51.3 65.7 67.5 28.8 52.7 58.3 49.0 43.9 29.4 64.1 HCCS "CCHL, MLS" ENSG00000004961 "Holocytochrome c synthase" P53701 X 11111301-11123086 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002946 Approved Enhanced Mitochondria "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" Mitochondria "HPA002946: AB_1079041" "prognostic unfavorable (8.69e-5)" "unprognostic (6.89e-3)" "unprognostic (8.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.34e-1)" "unprognostic (5.44e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (9.18e-2)" "unprognostic (2.73e-1)" "unprognostic (2.52e-2)" "unprognostic (2.10e-2)" "unprognostic (1.60e-1)" "prognostic favorable (6.17e-8)" "unprognostic (2.66e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.93e-2)" 13.9 16.1 6.2 13.7 6.7 20.5 12.6 7.0 8.4 8.4 8.4 21.6 23.1 9.6 7.6 19.3 8.5 10.8 39.0 7.4 6.8 17.6 22.9 11.5 15.6 6.7 6.2 8.3 9.9 25.1 8.3 13.1 6.4 9.5 21.6 13.5 15.2 10.0 64.4 17.6 20.2 12.5 6.2 14.5 15.3 10.2 6.7 13.0 10.8 57.0 17.1 22.3 11.6 6.1 54.3 60.5 31.8 28.5 25.6 25.2 29.2 52.0 43.0 67.8 57.5 70.7 38.5 34.3 26.3 46.1 80.8 49.8 63.2 51.8 70.5 30.8 48.0 34.1 80.8 38.6 47.3 40.9 39.4 24.2 37.4 67.9 46.5 37.9 49.1 26.1 63.1 41.1 46.3 72.5 28.0 31.4 51.5 36.6 70.1 27.3 59.9 65.4 44.0 44.8 20.9 24.2 54.8 58.7 38.2 66.7 45.6 27.1 48.7 42.4 23.6 110.4 47.0 26.9 29.0 47.8 35.5 28.8 42.7 25.6 47.8 30.1 20.2 66.4 19.0 39.0 19.6 18.2 62.2 34.7 17.1 22.1 13.1 19.1 57.4 56.2 23.5 19.0 6.2 6.7 7.0 8.4 7.4 6.8 6.7 6.2 6.4 6.2 6.7 6.1 15.5 6.4 4.8 2.3 20.8 54.8 53.2 57.0 22.8 5.3 16.1 13.7 49.3 17.2 33.3 16.5 0.0 32.9 12.4 44.6 50.9 34.9 13.7 19.0 10.4 21.0 10.8 32.8 3.8 29.3 37.9 17.1 12.8 16.7 13.3 10.4 15.7 18.5 41.8 8.4 4.5 19.2 67.1 21.0 44.1 2.3 13.4 23.5 24.9 1.9 27.9 13.0 7.2 2.0 2.7 68.4 31.9 10.5 18.4 63.5 46.4 36.0 28.9 7.1 6.6 12.5 20.1 24.4 28.4 21.8 46.0 40.9 12.0 15.6 30.2 88.6 HDGF HMG1L2 ENSG00000143321 "Heparin binding growth factor" P51858 1 156742109-156766925 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "DNA-binding, Growth factor, Heparin-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026035, HPA048728, HPA053422" Enhanced Enhanced Nucleoplasm "Secreted to blood" NA NA 790000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 43: THP-1 - Innate immune response" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146" "unprognostic (2.80e-1)" "unprognostic (9.63e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (9.06e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.43e-8)" "unprognostic (9.80e-3)" "unprognostic (2.34e-2)" "prognostic favorable (9.84e-4)" "unprognostic (2.45e-3)" "unprognostic (3.67e-2)" "unprognostic (1.40e-3)" "unprognostic (8.66e-3)" "unprognostic (2.14e-1)" "unprognostic (2.06e-1)" "unprognostic (3.86e-2)" 96.3 89.7 95.9 72.8 98.8 305.3 90.6 98.4 113.4 91.4 98.0 109.2 130.2 77.6 70.0 186.3 112.8 62.5 119.0 92.8 95.1 135.4 222.3 113.5 64.6 106.3 99.7 86.8 93.2 92.8 67.8 71.8 98.8 81.7 118.1 68.9 96.6 56.8 234.9 155.3 128.4 70.5 100.8 77.2 99.1 42.6 99.6 157.2 90.7 132.5 114.9 106.7 102.7 105.7 491.5 249.1 258.2 125.6 150.0 203.0 296.8 158.4 406.3 366.8 234.4 279.4 500.9 335.5 310.6 325.0 158.6 338.8 408.9 365.0 356.0 276.1 299.9 278.1 339.4 241.2 202.0 411.9 227.4 152.4 335.7 292.8 560.4 278.6 272.4 249.6 387.0 260.4 293.7 369.3 345.5 459.2 472.1 755.4 347.7 384.8 156.9 435.1 401.0 162.6 396.9 432.0 380.4 480.3 199.3 319.8 387.6 621.9 242.4 181.1 286.5 230.3 408.9 364.0 486.0 555.6 238.9 318.4 235.2 6.2 9.9 9.2 6.6 8.8 4.9 5.6 5.6 5.9 11.6 6.6 5.0 4.7 5.6 5.2 10.0 11.9 8.2 6.8 95.9 98.8 98.4 113.4 92.8 95.1 106.3 99.7 98.8 100.8 99.6 105.7 51.9 70.5 99.2 12.1 35.3 147.3 185.1 90.5 76.2 66.7 89.9 66.0 91.0 98.7 75.3 71.7 27.1 44.1 72.4 121.4 80.3 112.2 48.4 144.0 79.2 66.1 124.6 217.8 12.0 132.0 107.3 66.7 62.7 91.8 30.4 67.4 35.0 164.5 52.7 53.8 12.4 104.3 48.8 45.6 89.1 47.0 40.7 71.0 39.2 14.0 57.3 71.4 25.7 5.5 16.1 165.7 59.5 45.9 59.0 281.3 138.2 118.1 126.8 34.9 19.7 70.9 57.8 27.7 28.3 108.6 159.4 54.9 50.5 83.2 114.9 228.6 HERC5 CEB1 ENSG00000138646 "HECT and RLD domain containing E3 ubiquitin protein ligase 5" Q9UII4 4 88457119-88506163 "Predicted membrane proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.9" "Cell type enhanced" "Detected in many" "Early spermatids: 90.5;Spermatocytes: 272.1;Spermatogonia: 431.3" "Cancer enriched" "Detected in all" 5 "testis cancer: 31.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 89.9;BJ hTERT+ SV40 Large T+ RasG12V: 123.5;SK-MEL-30: 58.1" "Low region specificity" "Detected in all" HPA043929 Supported NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA043929: AB_10962492" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (4.46e-5)" "unprognostic (3.00e-1)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (2.58e-1)" "unprognostic (9.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.35e-1)" "unprognostic (2.54e-2)" "unprognostic (2.56e-1)" "unprognostic (2.23e-2)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (1.61e-1)" 5.5 6.0 3.1 6.0 3.8 18.8 4.9 2.7 5.1 7.8 4.8 3.9 4.0 15.4 3.3 2.6 5.9 5.8 4.0 2.8 3.0 6.4 9.7 6.5 7.2 4.5 4.0 14.0 7.7 9.6 4.1 10.2 4.1 5.5 2.6 3.7 11.9 5.8 1.5 2.5 4.6 13.4 5.6 12.1 4.8 57.9 3.1 13.9 5.3 3.4 4.3 4.5 4.4 4.6 7.5 3.5 2.0 0.4 0.4 0.8 27.9 0.6 10.7 89.9 123.5 1.1 19.9 0.3 4.9 0.0 40.8 1.4 13.7 2.1 7.6 46.4 8.4 12.1 13.2 0.3 0.8 14.8 5.5 0.8 0.6 22.7 0.0 4.9 0.6 24.4 0.5 28.2 1.7 0.8 45.9 18.2 7.5 0.4 2.4 45.3 35.9 1.9 1.6 1.7 0.5 11.7 15.0 0.3 58.1 23.3 1.2 8.2 0.3 1.1 0.2 0.5 5.9 38.7 36.3 0.3 8.6 10.9 1.1 14.8 7.2 11.6 7.6 8.4 8.6 7.1 8.7 6.3 2.7 4.4 5.4 4.7 25.1 8.0 7.9 8.0 27.7 5.0 3.1 3.8 2.7 5.1 2.8 3.0 4.5 4.0 4.1 5.6 3.1 4.6 26.9 0.0 0.5 5.5 14.8 4.0 5.9 0.8 8.0 7.9 6.4 7.1 2.3 2.8 1.0 1.8 18.8 25.8 19.9 1.1 23.5 2.6 90.5 5.4 2.0 20.6 0.0 3.8 0.4 5.1 12.1 10.9 3.6 3.9 2.5 57.1 14.3 7.8 15.0 0.0 1.1 0.7 0.0 8.1 2.5 19.4 9.9 16.6 7.2 7.5 8.3 9.6 16.5 18.1 1.8 2.8 2.3 9.1 34.5 7.3 2.6 9.8 1.7 2.8 19.7 10.8 7.9 272.1 431.3 2.5 1.8 11.9 19.2 20.2 0.4 1.7 HMG20B "BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL" ENSG00000064961 "High mobility group 20B" Q9P0W2 19 3572777-3579088 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 265.7;Melanocytes: 229.5;Syncytiotrophoblasts: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 411.1;WM-115: 405.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050220, HPA053157, HPA069832" Approved Enhanced Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA050220: AB_2681056, HPA053157: AB_2682061, HPA069832: AB_2686210" "unprognostic (2.97e-1)" "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.72e-7)" "unprognostic (2.18e-2)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (2.97e-1)" "unprognostic (1.66e-1)" "unprognostic (4.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.91e-3)" "unprognostic (2.78e-2)" "unprognostic (1.84e-1)" "prognostic favorable (2.89e-5)" 50.4 41.4 27.3 18.2 29.3 30.1 49.9 29.1 33.7 50.9 29.4 59.0 28.1 54.5 15.6 48.1 44.7 16.8 36.8 26.0 27.5 56.0 54.4 38.3 20.1 32.6 28.4 38.0 38.1 30.3 18.1 22.7 31.8 68.9 17.2 8.8 49.9 25.6 25.9 58.3 47.6 19.9 29.6 39.2 54.2 36.0 30.3 48.2 39.3 12.0 15.9 49.0 43.8 34.1 93.1 39.0 34.6 83.0 42.2 38.1 64.1 58.7 42.4 52.6 40.0 14.1 33.5 50.5 53.7 42.6 47.5 44.4 20.3 40.0 31.3 45.1 46.6 24.8 132.2 37.7 27.2 33.9 117.5 32.5 47.0 30.2 20.0 53.4 53.4 44.8 42.0 81.9 35.0 126.3 64.7 62.0 39.7 78.5 78.4 42.3 60.4 69.5 39.0 58.4 21.7 66.0 81.7 141.3 411.1 32.4 106.8 90.5 77.4 27.7 62.1 99.3 50.8 76.4 43.0 36.2 72.0 85.6 405.1 44.9 68.1 66.2 40.1 70.1 35.8 35.2 34.1 43.6 66.1 30.2 36.3 35.3 37.9 59.5 77.0 59.5 41.4 51.8 27.3 29.3 29.1 33.7 26.0 27.5 32.6 28.4 31.8 29.6 30.3 34.1 50.1 28.9 19.3 9.8 27.9 70.5 52.1 67.4 47.8 3.4 75.0 70.9 8.7 28.6 40.0 18.4 10.4 122.9 34.1 50.0 92.0 65.0 26.7 39.7 41.4 42.5 66.8 24.4 0.7 45.5 265.7 35.4 32.6 44.4 37.5 58.1 38.6 20.9 81.9 8.4 0.7 170.8 57.0 29.6 93.4 49.6 37.3 47.1 229.5 3.7 86.2 41.2 42.2 0.5 11.7 58.6 68.5 44.8 34.9 62.8 74.7 76.2 29.5 18.7 32.9 22.4 53.4 39.9 17.4 53.0 79.8 303.7 30.8 49.6 68.7 62.9 HMGB1 "DKFZp686A04236, HMG1, HMG3, SBP-1" ENSG00000189403 "High mobility group box 1" P09429 13 30456704-30617597 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003506, CAB005873, HPA073663" Supported Supported Nucleoplasm "Secreted to blood" NA NA 2800000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 14: REH - Unknown function" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB005873: AB_444360, HPA003506: AB_1079070, HPA073663: " "unprognostic (9.56e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-2)" "unprognostic (1.07e-1)" "unprognostic (4.44e-2)" "unprognostic (4.29e-2)" "unprognostic (3.16e-2)" "unprognostic (4.33e-2)" "unprognostic (5.73e-2)" "unprognostic (1.73e-1)" "unprognostic (2.64e-2)" "unprognostic (2.30e-2)" "unprognostic (4.28e-3)" "unprognostic (5.22e-3)" "unprognostic (4.67e-1)" "unprognostic (9.13e-3)" "unprognostic (1.97e-2)" 312.0 224.3 266.2 355.1 282.2 1021.3 318.2 267.6 362.4 319.0 227.0 327.8 281.9 363.6 270.1 297.0 265.5 227.0 242.2 250.1 282.9 243.7 360.8 242.2 664.8 281.5 273.3 254.9 189.3 226.1 163.3 252.1 286.2 265.9 381.2 174.8 224.5 280.1 388.5 244.2 309.2 319.5 277.7 284.9 269.0 153.9 269.9 900.3 267.4 364.7 738.9 282.7 274.1 308.2 816.7 617.4 1402.5 1054.0 384.5 380.1 551.4 1012.6 547.9 957.3 643.5 983.6 1328.6 1639.3 515.5 924.0 880.6 886.5 1484.7 817.4 1639.6 869.6 622.4 1727.4 455.4 913.5 210.3 2513.6 1009.8 253.4 426.0 713.3 656.6 497.8 1302.2 1350.8 1167.9 571.7 855.6 1508.3 3224.3 2682.1 1184.3 1424.3 683.7 2673.3 1927.8 965.8 908.1 792.8 1264.0 1139.8 928.6 682.0 541.0 672.3 668.5 1857.9 814.7 637.2 921.8 689.7 1197.1 513.9 714.8 3508.3 261.1 1634.0 1369.3 1036.6 503.7 926.1 467.3 410.9 522.1 582.6 532.3 530.7 520.1 590.7 477.4 459.7 631.7 615.4 411.0 512.5 702.6 1072.0 266.2 282.2 267.6 362.4 250.1 282.9 281.5 273.3 286.2 277.7 269.9 308.2 948.9 458.3 496.6 188.4 920.7 791.1 986.7 942.7 752.4 414.3 471.9 630.0 172.5 561.9 561.3 603.2 131.3 998.9 759.9 408.1 766.9 941.3 113.4 611.2 1040.2 766.0 423.0 1808.9 58.5 967.2 1441.4 676.5 486.3 728.3 546.8 772.2 589.0 749.5 728.8 196.9 47.2 675.6 710.1 549.9 884.4 107.2 720.1 694.2 674.1 81.5 578.7 609.9 879.5 99.5 149.3 1212.3 554.8 666.9 1252.9 811.2 506.7 827.5 418.7 252.8 650.8 588.9 1005.9 549.1 1211.0 1045.8 691.9 465.7 797.9 515.7 839.1 867.9 HMGCL HL ENSG00000117305 "3-hydroxy-3-methylglutaryl-CoA lyase" P35914 1 23801885-23838620 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 322.5" "Cell type enhanced" "Detected in all" "Hepatocytes: 172.4;Proximal tubular cells: 216.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004727 Enhanced "Intracellular and membrane" NA NA 34000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA004727: AB_1079074" "unprognostic (8.24e-2)" "unprognostic (3.21e-2)" "prognostic favorable (7.67e-4)" "unprognostic (1.23e-3)" "unprognostic (5.47e-3)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (3.05e-1)" "unprognostic (8.24e-2)" "prognostic favorable (5.07e-8)" "unprognostic (1.72e-1)" "unprognostic (2.46e-2)" "unprognostic (8.60e-2)" "unprognostic (3.39e-3)" 27.5 63.0 26.3 16.8 27.5 7.5 25.8 27.5 28.3 27.5 33.0 53.3 45.7 20.2 47.2 32.8 35.6 26.3 42.5 24.6 26.9 115.5 322.5 23.6 21.7 28.0 26.2 21.6 33.4 60.2 26.3 19.9 27.7 31.7 52.9 16.1 30.3 27.9 63.7 25.5 40.0 23.3 27.4 26.8 40.9 17.9 30.1 23.4 40.5 70.2 25.1 28.6 24.2 29.6 28.5 16.0 17.7 13.4 70.6 53.5 6.8 22.0 38.3 23.3 28.2 10.2 53.7 14.8 44.3 34.6 19.0 22.4 21.3 35.7 25.2 30.4 16.1 19.8 13.8 23.5 90.9 7.8 12.7 62.4 52.0 30.8 58.5 62.5 32.2 27.4 20.6 20.3 43.3 29.3 12.2 15.3 4.6 77.4 22.1 17.2 14.5 27.9 55.4 14.5 14.8 13.2 28.6 10.8 49.3 23.3 33.9 19.3 24.3 19.3 11.6 35.5 9.7 28.7 15.2 13.3 47.7 28.7 23.0 103.5 67.0 66.0 36.3 66.0 39.8 45.9 39.1 42.1 58.0 51.2 39.6 37.7 25.5 54.4 77.5 43.9 45.5 61.7 26.3 27.5 27.5 28.3 24.6 26.9 28.0 26.2 27.7 27.4 30.1 29.6 19.9 12.8 25.7 14.0 16.3 5.9 29.9 54.3 9.6 24.6 19.9 17.1 33.7 41.5 30.6 49.7 18.8 43.0 10.0 48.1 119.3 57.7 2.3 25.0 17.5 22.5 9.0 18.7 4.3 24.0 27.3 20.8 30.5 23.1 17.7 29.7 30.4 172.4 61.6 35.3 5.3 49.5 28.5 23.5 7.7 3.6 21.8 23.5 21.4 8.4 41.4 37.1 24.7 6.0 12.5 31.2 53.8 24.5 8.3 29.4 70.9 216.8 31.5 25.5 6.6 17.1 21.6 6.6 5.4 13.8 6.5 41.3 15.2 65.6 48.9 24.3 HMGN2 HMG17 ENSG00000198830 "High mobility group nucleosomal binding domain 2" P05204 1 26472440-26476642 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018371, HPA077364" Supported Supported Nucleoplasm,Nucleoli NA NA 640000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB018371: , HPA077364: AB_2686835" "unprognostic (3.10e-2)" "unprognostic (6.88e-2)" "unprognostic (3.10e-3)" "unprognostic (4.13e-2)" "unprognostic (4.06e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.36e-1)" "unprognostic (2.44e-3)" "unprognostic (2.86e-2)" "unprognostic (1.05e-3)" "unprognostic (5.23e-3)" "prognostic unfavorable (3.92e-4)" "unprognostic (3.00e-2)" "unprognostic (2.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.15e-1)" 216.3 225.6 180.2 254.5 187.3 1137.3 234.8 179.6 251.3 328.1 162.5 280.3 176.3 283.8 359.3 291.1 293.4 142.9 192.5 170.6 183.1 259.7 212.9 259.2 436.5 185.1 178.8 394.6 252.5 160.4 328.7 214.9 188.4 281.6 301.1 285.0 217.1 162.8 251.8 242.8 270.0 235.8 188.7 324.3 224.7 160.4 175.8 916.1 306.1 133.5 534.0 245.1 250.7 211.6 1074.5 304.8 1192.5 496.5 112.0 251.6 390.8 517.2 331.2 1089.4 835.7 305.8 1073.1 1107.2 443.1 482.3 338.4 627.8 1564.6 565.6 1001.7 684.2 906.7 1222.2 401.5 360.2 197.7 2793.6 738.7 254.9 303.4 602.1 369.1 245.1 541.7 866.8 964.3 643.0 623.0 690.8 1906.1 1363.3 922.7 1463.0 619.6 1384.3 1598.6 776.5 380.3 278.6 1064.5 641.1 1384.3 498.7 651.4 304.9 759.0 1508.9 322.3 536.9 920.4 977.1 943.6 641.2 899.2 1266.9 338.9 2989.0 1056.9 331.8 530.8 1430.5 279.2 622.3 267.3 532.2 379.7 343.3 531.5 505.6 412.4 337.7 462.4 355.5 690.4 704.7 746.7 1084.6 180.2 187.3 179.6 251.3 170.6 183.1 185.1 178.8 188.4 188.7 175.8 211.6 128.7 342.9 394.4 28.1 459.3 288.6 323.8 383.2 211.1 180.2 353.0 241.3 93.4 221.6 314.8 261.1 141.8 898.7 325.2 227.2 371.7 218.4 204.3 328.9 291.1 190.3 576.9 980.4 14.4 268.7 606.4 435.4 263.5 278.1 383.0 375.0 185.6 147.5 763.0 94.2 22.2 564.5 193.3 434.3 467.9 53.5 185.8 477.5 227.7 15.0 655.6 376.0 399.6 15.1 36.9 93.7 304.4 151.9 669.5 250.4 238.0 320.4 495.6 370.2 124.9 249.0 325.7 306.4 412.0 585.8 213.4 923.4 369.5 351.9 613.2 314.0 HNRNPK "CSBP, HNRPK, TUNP" ENSG00000165119 "Heterogeneous nuclear ribonucleoprotein K" P61978 9 83968083-83980616 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004435, HPA007644, CAB016225, HPA044105" Supported Enhanced Nucleoplasm NA NA 7100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812" "unprognostic (4.84e-2)" "unprognostic (4.69e-1)" "unprognostic (1.15e-2)" "unprognostic (8.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.83e-3)" "prognostic unfavorable (6.68e-5)" "unprognostic (3.46e-3)" "unprognostic (8.11e-2)" "unprognostic (1.47e-1)" "unprognostic (8.85e-3)" "unprognostic (2.81e-2)" "unprognostic (2.76e-3)" "unprognostic (2.23e-3)" "unprognostic (6.50e-2)" "unprognostic (4.59e-1)" "unprognostic (2.82e-1)" 283.6 308.1 186.1 326.2 197.1 637.3 265.3 202.4 236.6 264.5 227.4 270.2 287.0 297.0 227.3 276.8 269.7 243.8 275.8 188.8 220.3 279.2 346.8 240.4 401.9 203.1 187.8 317.5 247.4 350.8 198.2 325.8 203.0 251.3 277.5 342.2 242.2 251.4 315.3 256.1 282.9 287.6 205.7 298.3 250.1 183.4 194.4 548.5 297.2 312.9 423.7 351.2 230.7 241.0 926.1 624.2 1048.4 625.7 492.2 540.7 840.0 634.1 785.0 778.2 726.4 527.0 641.2 1087.2 425.8 671.1 673.8 689.5 1061.5 772.9 941.8 753.7 624.2 765.1 511.9 754.6 648.7 958.6 726.5 554.6 577.4 665.6 876.1 583.7 806.1 605.5 792.8 541.4 776.4 809.0 1198.4 652.1 934.7 929.3 599.3 1030.2 835.0 727.6 760.3 747.6 677.1 802.6 669.6 703.8 645.5 721.8 698.6 801.6 665.8 537.9 631.7 552.7 844.2 564.7 795.5 784.6 514.3 762.6 779.5 582.0 438.9 559.2 302.2 419.8 378.9 347.8 346.6 348.7 457.5 324.4 354.8 327.2 546.1 477.9 429.1 270.8 457.4 1012.5 186.1 197.1 202.4 236.6 188.8 220.3 203.1 187.8 203.0 205.7 194.4 241.0 354.7 205.1 270.0 58.4 398.4 506.0 540.7 421.5 313.0 180.9 281.6 203.3 195.0 230.2 322.4 263.0 89.6 585.3 379.9 288.1 395.2 448.2 43.4 326.2 329.0 331.7 387.0 447.9 45.9 368.3 738.5 323.4 233.9 384.2 336.8 300.0 260.9 356.6 388.4 156.5 51.2 379.2 307.2 352.9 412.9 45.4 334.6 333.4 327.3 58.1 448.9 362.5 338.8 71.9 116.2 397.0 282.7 321.2 281.0 353.3 260.0 416.7 308.1 182.6 276.1 340.9 479.7 345.9 241.7 309.5 448.7 728.5 368.6 334.9 406.9 453.2 HSPA5 "BiP, GRP78" ENSG00000044574 "Heat shock protein family A (Hsp70) member 5" P11021 9 125234853-125241382 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1327.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005221, HPA038845, HPA038846" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 790000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478" "unprognostic (3.98e-2)" "unprognostic (2.50e-3)" "unprognostic (6.64e-2)" "unprognostic (9.60e-3)" "unprognostic (1.54e-3)" "unprognostic (6.02e-3)" "unprognostic (9.08e-3)" "unprognostic (9.11e-3)" "unprognostic (4.50e-2)" "unprognostic (7.45e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (7.28e-2)" "unprognostic (3.66e-2)" 211.2 170.2 83.7 276.1 91.7 856.2 147.2 101.8 107.3 202.9 112.0 181.6 166.5 183.6 379.1 150.7 177.9 130.6 284.0 90.2 126.8 168.7 327.8 182.8 145.4 105.8 107.0 142.1 260.7 223.3 182.7 311.3 120.2 192.8 183.7 105.1 211.0 167.5 87.6 143.2 175.8 205.2 111.4 129.8 177.9 173.5 101.7 116.2 692.8 85.2 180.0 197.7 105.1 163.9 593.4 380.3 480.2 631.3 505.6 592.0 1152.8 1047.6 728.2 675.9 778.5 558.4 1093.4 649.5 644.7 682.4 1564.0 732.5 403.3 839.4 684.7 403.7 213.8 396.7 392.9 945.1 2692.4 547.4 730.2 363.6 1515.2 551.3 2309.4 728.1 1065.6 129.0 291.9 870.3 482.2 382.6 249.7 297.8 559.1 1327.5 362.2 233.2 492.4 1061.2 608.4 352.7 248.5 448.0 648.1 653.4 1079.3 715.5 694.3 378.0 791.8 439.5 433.0 462.7 484.2 939.0 994.7 551.2 1070.4 435.9 689.0 455.5 366.3 305.3 384.7 361.8 390.0 209.0 276.7 360.1 322.0 173.9 224.6 277.2 280.9 362.9 252.5 349.5 213.6 758.2 83.7 91.7 101.8 107.3 90.2 126.8 105.8 107.0 120.2 111.4 101.7 163.9 227.1 185.9 273.5 38.5 254.0 292.9 1225.2 573.2 192.9 97.3 193.7 166.2 803.4 97.2 416.9 112.2 352.3 505.9 408.7 426.5 45.0 415.0 86.2 372.1 402.2 247.9 508.8 82.3 19.7 258.4 955.2 455.5 258.4 467.4 334.2 304.6 147.4 379.4 449.4 63.9 34.6 508.2 195.3 133.4 271.0 50.3 175.2 261.6 181.5 30.0 135.0 134.6 80.3 29.7 41.1 313.7 408.3 174.5 1041.5 360.8 196.9 121.2 267.6 176.6 118.3 245.9 673.8 435.7 204.3 167.4 236.4 1327.5 323.8 243.0 376.4 795.4 IDH3G ENSG00000067829 "Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 284.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria Yes No 19000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favorable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 52.0 67.1 45.5 38.5 50.0 60.3 49.9 47.8 61.3 44.1 46.5 57.2 52.3 50.7 23.5 50.2 44.8 35.0 91.9 54.9 48.8 68.5 49.2 42.0 40.3 50.5 45.7 49.3 48.3 45.5 47.9 28.3 52.3 43.8 34.6 24.4 51.7 39.9 100.5 51.7 54.7 34.5 43.9 51.8 52.2 32.1 49.1 35.2 48.0 82.9 34.9 44.3 43.2 47.2 94.9 90.0 47.3 65.9 74.4 59.4 62.0 47.3 64.1 80.5 84.3 76.0 66.5 121.4 80.2 74.7 68.2 67.2 72.6 69.2 30.0 38.9 101.7 43.0 118.9 59.0 85.5 61.6 87.5 76.1 48.0 64.4 69.4 50.4 65.3 50.3 24.7 60.4 64.7 138.5 72.0 76.0 21.6 84.2 118.0 62.7 43.3 105.8 94.4 61.1 59.5 42.8 30.2 96.3 48.0 20.8 39.6 51.9 56.0 49.9 34.1 76.8 112.5 89.0 22.6 152.1 81.8 75.8 57.6 178.1 159.3 165.8 71.8 163.9 68.0 68.5 73.2 71.2 163.1 78.9 57.9 63.7 57.8 86.5 169.6 101.3 107.5 140.1 45.5 50.0 47.8 61.3 54.9 48.8 50.5 45.7 52.3 43.9 49.1 47.2 44.4 35.3 33.8 5.5 49.2 80.9 67.5 103.9 37.5 34.9 48.4 57.9 55.1 50.1 55.0 51.5 29.2 99.8 48.2 145.0 207.4 93.4 132.0 42.2 39.4 44.6 62.3 41.4 5.6 90.5 98.7 48.2 47.9 39.8 93.8 43.6 43.2 35.4 131.0 18.5 6.4 107.0 79.3 98.0 77.0 284.2 53.4 75.6 67.6 3.7 116.4 50.8 64.9 3.0 5.0 73.5 133.8 58.6 49.7 35.6 222.4 253.1 50.7 49.3 52.6 47.4 68.2 15.9 18.3 50.3 77.4 110.8 55.2 103.0 112.7 64.2 IFT20 ENSG00000109083 "Intraflagellar transport 20" Q8IY31 17 28328325-28335489 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021376 Approved Approved Microtubules NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 10: Non-specific - Unknown function" Microtubules "HPA021376: AB_1851460" "unprognostic (1.29e-1)" "unprognostic (2.35e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (8.65e-4)" "unprognostic (1.13e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (8.02e-2)" "unprognostic (4.86e-3)" "unprognostic (2.42e-1)" "unprognostic (2.48e-2)" "unprognostic (6.19e-3)" "prognostic unfavorable (5.09e-7)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (2.59e-2)" "unprognostic (4.71e-3)" 24.9 32.9 26.6 14.7 26.9 77.0 26.8 27.0 46.1 23.4 29.1 37.0 28.8 20.9 39.2 18.8 22.6 22.2 19.7 26.9 28.3 33.5 41.4 22.3 20.7 27.7 27.6 21.6 116.1 25.5 45.2 24.1 27.0 29.9 20.0 26.7 41.2 20.5 9.5 17.6 28.0 20.0 27.5 24.9 42.4 50.1 27.0 22.8 29.2 7.5 19.9 27.9 19.6 27.9 27.3 39.0 25.2 20.7 74.2 75.2 24.2 47.2 58.0 28.9 45.5 59.6 12.7 13.4 24.8 59.8 17.5 29.1 16.9 35.1 41.8 55.0 72.5 8.0 39.7 26.7 72.7 34.1 16.0 57.6 46.4 24.8 39.9 48.2 46.1 26.6 24.2 32.8 23.0 38.2 30.7 26.8 16.9 82.4 21.8 14.4 32.6 35.4 46.2 26.7 31.7 46.2 31.3 64.3 74.8 43.6 41.0 38.2 51.3 16.9 25.8 25.3 25.9 49.6 44.8 17.1 61.6 24.6 25.1 53.7 67.7 52.6 38.6 50.6 44.8 43.2 39.2 38.6 78.1 51.6 39.8 34.7 71.1 36.8 49.0 56.1 45.8 53.7 26.6 26.9 27.0 46.1 26.9 28.3 27.7 27.6 27.0 27.5 27.0 27.9 42.1 38.5 55.8 17.9 36.7 37.0 38.0 63.0 34.7 63.3 74.6 68.3 6.1 47.1 51.5 51.5 60.5 73.0 47.4 30.7 140.8 60.8 245.4 79.8 40.3 47.3 62.6 25.7 31.3 113.2 82.6 47.4 32.1 39.5 23.5 34.2 38.2 48.6 54.2 57.2 36.5 69.5 40.7 47.8 69.4 53.4 60.3 49.6 32.0 7.5 72.8 37.4 42.2 24.6 30.7 68.0 29.9 57.6 57.8 45.9 127.8 98.0 102.6 78.3 78.9 33.5 67.0 164.8 53.0 25.7 42.8 81.4 35.9 59.6 43.1 49.5 IK "RED, RER" ENSG00000113141 "IK cytokine" Q13123 5 140647058-140662480 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 438.7;Endometrial ciliated cells: 510.8;Respiratory ciliated cells: 732.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048798 Supported Enhanced "Nuclear speckles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 16: U-266 - Nucleosome" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear speckles" "HPA048798: AB_2680525" "unprognostic (9.90e-2)" "prognostic favorable (1.29e-4)" "unprognostic (6.99e-2)" "unprognostic (1.49e-2)" "unprognostic (3.23e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (2.32e-7)" "unprognostic (1.19e-1)" "unprognostic (4.87e-2)" "unprognostic (4.37e-2)" "unprognostic (8.45e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-3)" "unprognostic (3.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.26e-2)" "unprognostic (2.83e-1)" 73.9 64.0 53.4 68.7 56.6 135.4 66.9 64.4 70.8 70.0 62.3 76.1 55.4 73.9 74.4 77.0 143.5 53.4 74.2 54.2 68.6 67.0 68.6 69.5 89.9 60.6 60.6 78.8 48.3 74.3 55.8 64.9 59.9 60.3 70.3 90.4 65.2 66.2 136.5 73.4 67.9 64.6 57.0 71.6 60.5 107.7 57.6 114.0 72.6 83.0 96.0 69.6 68.1 62.3 119.1 132.5 114.4 163.2 125.7 106.4 133.4 139.0 146.7 151.6 153.2 184.1 133.4 138.9 167.4 145.4 172.3 120.9 168.2 190.1 175.4 198.1 136.6 130.4 213.2 117.8 129.6 214.6 136.9 117.2 124.4 151.5 136.8 112.0 132.7 114.9 144.3 121.1 137.3 110.0 184.1 216.8 74.5 100.3 134.2 145.5 160.7 141.4 117.7 109.2 103.6 112.3 171.5 155.6 172.9 97.9 181.3 171.8 141.2 126.2 87.9 106.2 167.8 181.8 294.1 188.4 141.8 162.4 94.5 353.1 136.5 240.3 188.3 157.1 168.9 197.4 202.7 194.3 139.0 191.5 212.7 199.1 229.4 198.8 193.0 131.2 284.4 247.0 53.4 56.6 64.4 70.8 54.2 68.6 60.6 60.6 59.9 57.0 57.6 62.3 110.7 163.5 134.9 10.1 102.8 46.1 86.4 127.5 61.5 75.3 40.0 57.7 126.7 80.1 177.1 86.5 29.2 115.2 139.9 69.2 121.3 106.4 438.7 510.8 124.9 91.4 34.1 137.6 7.6 99.6 99.6 82.6 50.0 107.2 132.2 68.0 54.3 74.7 70.6 53.8 8.2 66.4 97.6 56.8 58.8 55.0 98.2 80.2 56.9 8.4 107.4 116.1 151.4 8.5 7.4 110.1 67.3 83.8 76.9 50.5 80.4 120.8 732.0 97.3 72.3 96.0 115.7 311.3 145.0 65.3 45.5 132.8 128.5 93.0 65.5 66.9 ILK ENSG00000166333 "Integrin linked kinase" Q13418 11 6603708-6610874 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004041, HPA048437" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 30000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 51: Myeloid cells - Hemostasis" "Plasma membrane, Focal adhesion sites" Nucleoplasm "CAB004041: AB_2127050, HPA048437: AB_2680391" "unprognostic (1.78e-1)" "unprognostic (2.26e-2)" "unprognostic (5.26e-2)" "unprognostic (2.12e-2)" "unprognostic (7.57e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-3)" "unprognostic (5.25e-3)" "unprognostic (1.49e-2)" "unprognostic (9.65e-2)" "unprognostic (2.64e-1)" "unprognostic (8.12e-2)" "prognostic favorable (2.44e-4)" "unprognostic (4.01e-3)" "unprognostic (9.27e-2)" "unprognostic (2.42e-1)" "unprognostic (6.36e-3)" 108.0 77.2 49.8 85.1 52.4 43.7 91.8 51.7 50.6 151.6 55.0 398.2 66.4 359.1 81.8 115.5 164.2 88.0 175.9 47.4 50.7 78.8 65.9 107.9 72.4 51.8 50.6 101.0 89.3 73.2 47.1 98.8 50.9 182.7 116.8 28.3 69.5 412.2 90.8 61.5 117.4 364.7 51.1 95.5 149.7 26.5 53.7 45.8 72.0 92.0 70.5 226.7 118.8 51.9 127.8 94.4 148.9 51.8 224.8 159.4 67.2 182.2 360.0 211.9 256.0 102.7 145.7 47.0 47.0 304.1 206.9 99.5 84.4 155.6 213.0 83.5 74.3 69.1 84.9 82.8 150.8 55.9 74.7 153.2 72.8 143.8 108.9 217.7 206.9 40.5 63.7 55.0 282.8 97.1 49.4 97.4 94.3 107.5 110.8 51.0 77.8 50.5 160.3 100.8 25.6 57.4 86.0 118.4 103.6 144.0 82.2 62.2 238.8 263.9 118.0 111.1 90.7 38.9 25.9 67.1 195.6 82.8 125.3 314.9 260.0 417.6 127.3 258.1 124.9 96.9 114.4 122.3 242.7 92.9 70.2 88.5 165.5 257.8 254.8 98.5 142.8 402.8 49.8 52.4 51.7 50.6 47.4 50.7 51.8 50.6 50.9 51.1 53.7 51.9 79.5 44.8 17.9 24.2 33.6 50.5 73.7 100.6 24.5 21.5 43.1 68.2 0.5 70.1 49.7 57.0 8.4 119.8 46.0 71.9 58.7 136.1 64.6 33.2 78.1 69.4 37.9 53.7 14.6 125.0 177.7 83.2 50.4 52.5 30.4 41.6 76.4 31.4 127.4 8.4 17.1 50.1 69.2 51.5 97.7 143.7 71.4 115.9 85.4 30.9 143.0 54.3 77.2 15.6 15.3 117.1 60.0 147.4 35.1 42.0 74.5 98.6 31.0 32.9 157.8 53.3 165.8 31.7 17.1 32.3 43.2 110.0 49.3 65.0 50.1 43.9 ING3 "Eaf4, FLJ20089, MEAF4, p47ING3" ENSG00000071243 "Inhibitor of growth family member 3" Q9NXR8 7 120950763-120977216 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 80.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004762, HPA067388, HPA067575" Uncertain Enhanced Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863" "unprognostic (1.35e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.78e-1)" "unprognostic (3.03e-1)" "unprognostic (1.39e-2)" "unprognostic (4.26e-2)" "unprognostic (7.09e-3)" "unprognostic (4.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.04e-3)" "unprognostic (2.86e-1)" "unprognostic (6.90e-2)" "unprognostic (3.96e-2)" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (5.64e-2)" 9.3 7.7 3.8 9.9 4.5 80.5 10.1 11.3 5.5 8.3 3.3 9.1 8.2 10.8 10.5 7.4 9.7 8.5 8.5 3.5 4.5 9.7 9.2 10.9 14.9 4.2 4.7 8.9 8.5 7.7 6.0 15.1 4.7 8.0 11.8 7.6 8.6 7.7 4.7 4.6 7.6 13.0 4.8 15.5 9.7 8.1 4.2 18.6 11.5 8.4 13.5 8.5 5.0 5.7 19.3 5.6 24.8 14.0 9.2 7.3 8.3 12.9 10.1 18.1 21.1 7.3 21.6 31.3 5.7 11.3 19.0 9.2 24.1 9.9 20.7 22.1 42.2 22.5 21.2 4.3 12.6 43.8 25.5 5.4 5.0 16.0 11.3 8.7 28.7 19.1 51.0 48.4 17.5 6.7 36.0 26.0 29.9 10.9 10.4 17.6 17.7 25.7 18.4 19.4 22.4 24.1 13.3 26.9 14.0 15.3 6.1 17.0 10.4 18.5 6.8 40.0 23.7 22.2 15.1 46.0 9.3 28.9 15.6 44.0 28.0 26.4 20.1 30.8 19.9 21.7 20.3 18.7 23.4 24.3 20.4 18.6 50.7 30.6 32.3 17.7 27.1 14.8 3.8 4.5 11.3 5.5 3.5 4.5 4.2 4.7 4.7 4.8 4.2 5.7 27.1 19.2 18.4 24.5 37.7 7.6 20.4 17.6 9.1 23.3 16.3 14.4 14.2 11.5 14.0 7.3 4.2 38.8 31.7 19.6 21.5 12.6 7.2 21.5 20.1 24.7 12.0 27.0 14.5 18.0 22.0 19.5 16.8 28.3 33.7 21.8 21.4 14.3 17.9 26.9 21.5 18.7 22.4 35.8 16.6 4.3 13.7 23.4 16.0 18.7 24.3 17.6 27.8 22.6 24.3 15.5 17.7 9.8 26.8 14.0 17.7 12.8 13.5 19.8 19.7 26.9 25.9 16.6 15.3 12.0 11.2 45.7 28.6 25.7 15.4 18.7 INIP "C9orf80, HSPC043, hSSBIP1, MISE, SOSS-C" ENSG00000148153 "INTS3 and NABP interacting protein" Q9NRY2 9 112683926-112718149 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020382 Approved Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA020382: AB_1845840" "prognostic unfavorable (7.08e-4)" "unprognostic (1.67e-1)" "unprognostic (9.64e-2)" "unprognostic (2.35e-1)" "unprognostic (8.05e-2)" "unprognostic (8.56e-2)" "unprognostic (1.01e-2)" "unprognostic (6.29e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (4.47e-3)" "prognostic favorable (2.00e-8)" "prognostic favorable (2.53e-4)" "unprognostic (2.28e-1)" "unprognostic (3.50e-2)" "unprognostic (1.26e-1)" 7.4 8.7 8.0 8.4 10.9 10.4 11.4 9.7 11.9 8.0 5.4 10.1 10.3 7.2 8.6 9.8 8.4 8.6 7.5 8.1 9.6 10.8 11.0 8.4 14.5 9.2 8.8 8.2 5.0 10.7 6.5 6.1 9.6 6.9 11.5 10.3 8.1 6.5 6.5 9.2 10.9 7.6 8.4 9.7 7.4 5.4 9.6 14.5 10.6 10.0 14.1 9.3 6.2 15.5 16.5 15.6 21.4 31.0 18.2 19.2 21.9 22.7 12.4 19.4 19.3 19.7 13.2 43.8 13.9 15.7 14.6 22.9 21.0 10.9 25.8 53.0 12.3 18.2 17.6 18.0 11.8 37.1 13.3 10.4 14.7 20.6 16.6 9.5 18.2 22.1 31.7 27.5 21.4 27.8 33.3 19.0 11.1 29.8 28.8 36.5 45.1 18.9 22.2 21.9 27.9 20.9 28.7 18.1 15.7 14.2 27.1 23.1 15.4 16.1 24.7 30.9 22.4 13.7 62.4 37.3 20.4 21.3 27.7 30.4 24.8 32.5 15.7 29.3 20.7 15.5 20.1 23.4 27.1 20.0 21.8 18.9 19.8 18.4 27.0 9.7 20.8 20.3 8.0 10.9 9.7 11.9 8.1 9.6 9.2 8.8 9.6 8.4 9.6 15.5 15.6 22.4 15.6 9.1 19.1 36.7 18.1 31.4 13.1 17.1 19.2 16.5 15.5 15.7 22.4 14.7 16.7 21.4 20.6 19.4 56.7 23.4 3.9 21.0 18.8 18.1 22.3 19.4 18.3 16.1 32.0 14.9 12.8 18.7 26.6 11.2 15.7 17.7 26.1 43.7 15.4 17.1 32.6 24.5 33.5 3.2 14.0 26.2 19.6 3.7 42.3 24.7 34.0 16.6 25.2 24.2 12.3 12.0 11.8 17.9 21.7 31.7 13.0 16.9 0.0 17.3 13.1 17.4 15.8 19.4 41.8 14.8 23.0 12.4 19.8 25.2 INO80C "C18orf37, FLJ38183, hIes6, IES6" ENSG00000153391 "INO80 complex subunit C" Q6PI98 18 35452230-35497979 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 184.7;Pancreatic endocrine cells: 165.1;Spermatocytes: 209.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049060 Approved Approved "Nucleoli fibrillar center" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli fibrillar center" "HPA049060: AB_2680617" "unprognostic (3.40e-1)" "prognostic favorable (3.58e-4)" "unprognostic (2.29e-1)" "prognostic unfavorable (2.62e-5)" "unprognostic (5.56e-2)" "unprognostic (9.68e-2)" "unprognostic (1.72e-3)" "unprognostic (2.03e-1)" "unprognostic (3.32e-3)" "unprognostic (2.08e-3)" "unprognostic (2.61e-1)" "unprognostic (6.94e-3)" "unprognostic (1.18e-1)" "unprognostic (5.82e-2)" "unprognostic (1.44e-2)" "unprognostic (5.14e-3)" "unprognostic (5.38e-2)" 18.0 17.4 23.2 14.5 24.4 46.2 16.0 24.9 23.7 18.4 30.9 21.1 18.4 12.0 13.6 45.7 13.7 13.0 25.6 23.2 31.1 21.8 19.2 17.5 26.2 22.2 23.1 9.8 13.3 8.0 29.2 20.7 24.2 13.9 21.8 33.6 20.7 9.2 42.4 40.5 18.6 11.0 21.0 31.2 30.4 92.2 31.5 21.9 15.2 30.7 29.2 21.4 20.8 23.6 46.5 30.1 27.1 14.9 9.5 23.6 29.7 17.5 13.2 27.3 36.5 37.5 38.7 77.4 36.6 11.9 41.6 31.3 52.4 112.7 24.8 22.9 28.3 97.8 36.0 40.7 21.0 57.4 60.1 10.7 31.9 70.7 37.9 33.7 80.0 32.3 30.4 27.8 44.7 49.3 36.4 48.5 34.6 32.2 18.0 28.5 19.2 26.5 58.4 58.9 37.3 25.8 27.9 31.6 23.4 41.8 31.5 46.1 51.5 30.9 13.5 24.0 32.3 24.1 28.4 137.8 25.2 52.7 19.2 21.3 14.8 35.6 12.3 20.6 12.2 24.9 17.0 16.3 22.2 17.8 17.2 14.2 23.0 12.4 18.3 33.5 21.7 11.8 23.2 24.4 24.9 23.7 23.2 31.1 22.2 23.1 24.2 21.0 31.5 23.6 40.2 6.4 10.1 5.9 19.5 24.0 22.1 72.3 18.8 4.4 16.3 15.2 17.8 18.6 31.6 12.9 4.2 59.8 14.0 81.4 31.3 43.9 184.7 16.7 6.6 30.5 15.0 29.0 15.6 40.0 105.1 14.1 41.8 14.4 20.3 9.0 22.1 16.6 52.2 5.0 11.3 20.4 36.7 17.9 15.0 49.6 6.2 16.4 23.2 6.5 14.1 22.8 14.4 9.0 10.9 165.1 76.0 7.2 26.4 20.7 48.8 80.9 31.5 14.1 0.0 18.5 15.6 209.0 40.3 35.3 39.9 73.2 16.4 11.9 35.9 34.7 INPP5K SKIP ENSG00000132376 "Inositol polyphosphate-5-phosphatase K" Q9BT40 17 1494577-1516742 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cataract, Congenital muscular dystrophy, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 96.1;Late spermatids: 345.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (7.47e-2)" "prognostic favorable (3.91e-4)" "unprognostic (8.91e-2)" "prognostic favorable (2.33e-5)" "unprognostic (3.25e-1)" "unprognostic (9.22e-2)" "unprognostic (1.50e-1)" "unprognostic (7.50e-2)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.47e-6)" "unprognostic (4.71e-2)" "unprognostic (9.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.20e-2)" "unprognostic (4.28e-3)" "unprognostic (1.04e-1)" 34.7 15.2 25.8 12.9 26.0 34.5 29.2 25.3 30.2 19.5 61.5 19.6 10.2 17.0 13.1 17.9 15.3 10.7 28.9 29.8 25.7 16.7 15.0 27.3 18.6 26.9 26.9 17.8 21.9 13.7 14.8 18.6 26.9 19.6 12.7 15.9 18.1 12.9 40.5 30.1 19.4 12.0 25.4 22.8 19.1 20.4 26.9 25.8 30.4 25.2 19.7 18.2 17.9 27.0 14.9 24.0 9.2 18.4 22.5 13.2 12.1 12.0 23.6 15.8 19.6 15.7 9.1 14.6 23.2 22.2 12.5 19.4 22.1 9.6 14.3 35.3 33.0 8.6 18.1 5.9 31.3 7.9 17.0 16.2 24.0 15.8 16.1 10.0 25.3 25.3 9.4 25.9 10.6 12.5 24.5 7.1 3.9 23.9 14.6 19.0 6.7 14.6 12.8 10.3 7.1 18.0 10.2 21.6 24.3 13.0 17.9 7.3 16.2 13.6 13.3 19.8 16.8 12.9 23.4 7.4 14.7 9.1 17.3 104.3 42.2 74.3 48.7 41.9 39.7 27.5 44.5 50.2 36.2 24.4 37.5 41.1 74.7 42.3 66.6 27.0 75.1 62.5 25.8 26.0 25.3 30.2 29.8 25.7 26.9 26.9 26.9 25.4 26.9 27.0 26.1 32.1 14.1 8.5 20.6 30.0 15.7 10.8 18.8 7.8 15.6 12.2 35.8 8.6 11.0 23.9 2.1 13.9 27.5 26.0 13.7 19.4 96.1 10.3 6.9 27.0 17.4 25.2 5.4 24.3 16.4 15.5 13.3 17.4 19.7 7.7 28.5 10.2 11.9 20.2 5.9 17.3 14.2 18.4 19.0 345.7 11.5 13.8 32.0 2.8 37.1 23.1 27.8 2.5 7.0 27.1 23.4 7.5 18.0 13.3 33.2 11.2 6.4 7.9 19.7 12.6 15.3 35.5 20.4 18.1 30.3 31.1 27.2 5.8 13.5 17.4 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294414 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.5" "Cell line enhanced" "Detected in many" "Karpas-707: 54.9;U-266/70: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" NA Yes 190000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles "Plasma membrane" "HPA036302: AB_2675048, HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 13.0 22.6 12.5 2.8 16.8 5.6 13.0 17.3 12.8 14.6 18.8 15.0 10.0 18.4 6.3 4.1 16.9 8.2 26.3 10.0 12.2 21.8 33.0 7.2 2.3 18.3 16.3 39.9 64.2 13.0 16.3 7.4 18.7 15.2 10.4 6.5 16.9 9.9 23.5 11.5 12.2 11.5 14.1 48.2 12.5 5.4 16.6 2.7 14.5 13.3 3.5 12.3 9.2 22.5 6.2 3.2 3.6 5.7 18.8 6.1 11.1 3.5 2.9 1.6 1.6 8.4 7.0 9.0 8.2 6.8 4.0 1.6 8.9 1.4 1.2 0.0 6.4 0.0 2.3 22.6 8.2 4.3 6.7 10.0 4.5 0.2 4.9 4.2 3.8 4.8 9.5 54.9 1.8 3.2 3.1 7.8 3.3 3.8 5.2 29.0 2.1 7.6 0.1 27.8 6.6 5.2 6.5 3.8 3.3 6.4 1.4 21.6 3.6 3.4 2.1 8.2 5.1 40.4 23.9 20.2 4.3 7.3 0.0 2.7 8.6 5.9 0.2 8.8 0.3 0.8 0.3 0.1 9.8 1.1 0.7 0.1 1.9 1.0 12.5 8.2 0.0 1.6 12.5 16.8 17.3 12.8 10.0 12.2 18.3 16.3 18.7 14.1 16.6 22.5 75.6 48.1 34.7 64.9 10.6 64.9 63.6 34.7 8.0 40.4 134.0 76.2 92.1 137.2 83.3 62.5 79.2 17.8 6.7 124.1 15.6 55.1 4.7 26.8 106.8 123.9 163.6 25.0 68.3 78.7 53.7 43.7 20.4 42.1 3.8 168.4 255.2 246.0 9.2 38.7 100.8 97.3 32.6 49.0 31.1 9.0 96.3 35.0 51.6 62.8 24.2 31.6 0.0 62.8 183.5 50.7 68.8 245.3 21.8 107.9 122.9 114.1 65.3 23.6 59.2 37.6 44.2 5.2 3.6 3.2 68.8 38.3 4.7 81.4 65.2 130.0 INTS12 "INT12, PHF22, SBBI22" ENSG00000138785 "Integrator complex subunit 12" Q96CB8 4 105682627-105895986 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035772, HPA041814" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies, Plasma membrane" "HPA035772: AB_10671109, HPA041814: AB_2677687" "unprognostic (5.30e-2)" "unprognostic (4.54e-2)" "unprognostic (1.84e-3)" "unprognostic (1.78e-1)" "unprognostic (3.68e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.95e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-3)" "unprognostic (3.00e-2)" "unprognostic (3.48e-2)" "unprognostic (5.93e-3)" "unprognostic (3.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-1)" 15.2 11.1 12.8 10.9 13.3 30.4 20.2 14.9 18.0 14.1 12.0 14.7 18.1 14.6 17.8 13.5 13.2 12.7 18.9 12.4 14.9 18.7 22.6 16.4 14.0 12.3 14.0 11.6 12.6 17.2 10.3 11.9 12.5 18.1 15.6 17.2 14.4 13.4 26.5 14.0 15.5 17.1 12.7 12.6 15.0 13.9 14.3 19.9 19.9 26.0 17.0 15.6 11.2 13.7 24.4 12.8 28.5 29.8 27.5 32.6 20.8 28.2 29.1 34.7 35.9 18.1 26.9 34.9 15.4 31.9 26.9 13.8 31.7 40.7 42.8 36.9 19.0 26.3 19.6 25.7 44.3 46.7 23.0 31.0 51.7 34.5 51.4 22.5 32.3 29.1 39.8 26.7 37.8 25.6 55.3 28.9 12.4 35.3 19.5 28.0 31.0 26.8 32.5 16.3 30.7 24.6 19.8 32.6 31.0 22.4 26.4 27.2 21.3 22.7 23.3 24.8 30.5 40.8 40.9 52.2 25.3 31.5 46.0 64.0 23.7 38.5 25.7 26.6 28.9 33.0 29.4 29.4 27.7 32.1 30.6 28.3 17.9 42.9 28.3 42.6 34.8 21.9 12.8 13.3 14.9 18.0 12.4 14.9 12.3 14.0 12.5 12.7 14.3 13.7 19.0 12.8 11.8 14.0 15.1 11.0 11.8 25.8 15.4 10.5 12.1 11.7 18.7 11.5 12.9 3.7 10.4 16.1 13.6 8.3 43.0 25.2 35.8 8.1 11.2 16.8 6.0 15.6 13.8 20.3 18.6 10.8 8.6 8.7 24.7 9.9 11.7 9.3 17.8 10.1 15.7 5.2 30.5 9.0 9.5 28.4 12.2 9.8 7.2 9.4 15.5 14.0 21.6 27.2 19.1 20.5 6.8 8.2 18.9 14.2 16.5 17.1 6.2 9.3 0.0 12.9 20.1 13.4 16.2 14.1 10.4 18.3 13.0 14.9 10.2 11.0 IP6K2 IHPK2 ENSG00000068745 "Inositol hexakisphosphate kinase 2" Q9UHH9 3 48688003-48740353 "Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007532, HPA070811" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 20: HeLa - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA007532: AB_1851542, HPA070811: AB_2732165" "prognostic favorable (1.25e-4)" "unprognostic (2.55e-2)" "unprognostic (8.86e-2)" "unprognostic (6.69e-3)" "unprognostic (1.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (6.57e-3)" "unprognostic (1.56e-1)" "unprognostic (1.92e-3)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.64e-1)" "unprognostic (3.50e-2)" "prognostic favorable (1.83e-4)" 57.6 96.3 53.1 39.5 57.2 130.1 80.1 84.6 57.8 117.2 52.8 106.0 79.8 101.8 108.4 95.4 78.3 47.9 62.3 53.7 58.4 106.9 83.5 55.4 53.7 56.2 53.3 99.1 91.2 48.0 121.8 44.8 55.1 111.6 88.0 63.7 88.7 42.2 45.8 145.4 89.1 43.1 49.7 78.9 79.5 55.5 55.2 72.2 108.8 31.5 43.5 66.7 113.4 64.2 25.9 49.5 100.6 71.2 55.5 69.3 72.6 48.0 54.0 54.0 62.2 41.1 67.0 45.5 38.7 45.5 67.8 65.3 50.6 72.1 50.0 54.1 44.9 52.2 172.7 89.5 45.0 50.3 48.9 65.7 103.0 73.3 59.7 71.8 76.2 143.8 39.5 55.4 63.9 57.3 107.4 68.3 77.4 50.0 90.4 44.4 33.3 50.0 73.7 121.7 62.4 94.6 103.9 69.5 53.0 79.6 67.7 83.3 54.8 58.3 57.4 37.0 48.7 50.6 65.4 64.2 53.3 57.7 52.4 158.1 50.5 92.7 63.4 50.8 57.6 60.8 55.1 60.4 50.1 60.2 51.1 52.7 80.3 67.5 65.3 52.0 84.2 46.8 53.1 57.2 84.6 57.8 53.7 58.4 56.2 53.3 55.1 49.7 55.2 64.2 63.3 70.5 52.9 38.5 41.3 83.1 87.2 182.5 174.2 66.5 69.9 77.5 12.9 38.6 109.1 99.3 39.6 114.3 39.4 157.4 76.3 58.7 43.8 50.8 64.8 46.1 110.2 40.1 31.1 47.4 73.9 73.7 64.2 56.9 54.5 60.3 32.5 25.1 41.4 20.2 40.6 108.6 150.5 16.6 33.5 16.4 81.1 24.5 26.6 22.5 30.3 32.4 44.3 50.8 52.6 60.5 105.7 68.4 34.0 59.0 84.7 65.5 68.4 56.0 52.6 31.5 50.6 71.6 57.9 90.3 83.0 124.0 43.3 87.9 89.8 89.3 IPO11 RanBP11 ENSG00000086200 "Importin 11" Q9UI26 5 62403972-62628582 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 68.4;Hepatic stellate cells: 65.0;Inhibitory neurons: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "NK-cell: 22.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065346, HPA067097" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Cytosol "HPA065346: , HPA067097: AB_2685776" "unprognostic (9.29e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.35e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (4.28e-5)" "unprognostic (4.26e-2)" "unprognostic (6.45e-2)" "unprognostic (1.26e-3)" "unprognostic (9.63e-2)" "unprognostic (5.09e-2)" "unprognostic (8.38e-3)" "unprognostic (1.62e-1)" "unprognostic (1.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.24e-2)" 16.0 9.1 13.4 9.7 13.7 6.6 14.4 13.6 14.6 10.6 16.3 9.2 6.9 9.4 8.5 12.0 10.2 10.7 14.7 14.7 13.7 11.9 11.4 7.7 10.4 14.1 13.7 9.4 8.6 13.4 6.0 16.5 13.6 9.0 8.6 6.3 8.5 8.4 12.6 8.8 7.9 11.0 14.4 13.4 8.5 21.4 13.9 10.0 14.0 14.4 10.1 13.4 9.9 15.7 27.1 25.4 22.3 34.6 17.0 23.4 30.9 28.4 20.5 29.1 31.9 27.5 20.2 45.3 22.2 28.9 35.5 21.4 47.3 32.0 45.6 17.5 24.6 21.6 24.5 24.4 12.8 23.7 11.6 16.7 17.7 34.3 35.7 13.7 113.8 22.4 41.5 14.5 27.9 26.0 26.1 32.2 28.0 15.4 14.5 31.6 33.7 41.6 17.7 26.4 24.1 13.9 24.8 19.3 21.0 21.9 24.9 17.0 51.8 17.4 19.3 19.8 26.4 11.3 20.0 31.3 21.2 33.4 21.3 16.5 2.4 2.2 3.8 3.8 4.5 3.3 3.9 3.9 4.0 4.8 5.5 4.0 2.5 22.7 7.0 2.4 2.8 3.6 13.4 13.7 13.6 14.6 14.7 13.7 14.1 13.7 13.6 14.4 13.9 15.7 39.6 9.6 3.7 35.9 11.8 8.5 4.2 3.3 13.6 4.2 6.2 4.8 13.2 5.7 4.5 7.3 2.1 7.6 7.9 2.7 3.9 4.2 42.2 8.4 7.0 40.0 3.0 21.7 68.4 5.5 6.7 7.6 6.1 5.6 13.3 9.6 65.0 6.2 5.2 5.0 55.0 4.4 2.0 6.5 6.4 25.3 5.6 7.4 3.6 20.6 2.6 3.9 10.3 28.1 48.3 3.3 1.7 4.1 10.7 5.2 2.6 3.6 25.6 4.9 6.6 9.7 8.7 14.6 16.2 10.9 8.8 5.1 8.8 4.6 5.7 4.8 IST1 "CHMP8, KIAA0174" ENSG00000182149 "IST1 factor associated with ESCRT-III" P53990 16 71845996-71931199 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041802, HPA054532" Approved Supported Vesicles NA NA 270000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA041802: AB_10794491, HPA054532: AB_2682517" "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-3)" "unprognostic (2.04e-2)" "unprognostic (3.13e-3)" "unprognostic (2.11e-2)" "unprognostic (4.49e-2)" "unprognostic (3.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" "unprognostic (1.02e-1)" "prognostic favorable (4.55e-4)" "unprognostic (1.64e-2)" "unprognostic (7.88e-3)" "unprognostic (8.43e-3)" "prognostic favorable (8.88e-4)" 47.7 44.1 43.2 38.8 49.7 81.0 50.5 46.2 50.6 49.0 43.9 68.3 52.4 55.9 42.4 50.5 61.4 46.8 50.4 42.9 45.3 68.7 37.9 50.0 64.3 47.2 47.6 60.0 46.9 90.4 57.2 60.1 47.1 45.7 62.9 32.4 52.0 45.8 64.1 52.5 52.0 60.8 45.5 50.6 52.5 47.4 46.1 62.2 59.4 80.8 81.6 53.0 44.3 53.8 57.0 81.9 113.3 73.2 110.7 77.9 95.7 70.0 87.1 95.2 98.9 90.1 77.1 80.5 84.2 81.2 67.7 83.8 112.0 74.2 120.4 53.7 54.1 68.1 46.8 146.9 83.8 66.9 91.9 92.7 100.8 85.5 81.6 94.8 120.6 74.8 94.5 28.7 99.5 94.9 87.4 55.6 129.7 92.7 50.6 135.7 62.0 99.1 78.5 81.8 85.0 63.3 77.2 40.3 63.9 138.2 73.7 82.2 60.7 71.8 70.9 44.5 55.9 75.0 145.5 226.7 60.7 59.2 88.6 234.9 195.1 243.5 158.7 185.4 172.6 179.1 150.6 166.9 180.1 178.5 159.6 150.1 300.0 193.7 185.1 124.9 244.9 293.9 43.2 49.7 46.2 50.6 42.9 45.3 47.2 47.6 47.1 45.5 46.1 53.8 59.7 48.1 51.8 39.8 57.1 70.1 41.2 49.8 39.9 29.2 69.1 50.0 43.9 60.1 48.1 46.0 25.0 56.7 68.4 130.6 35.2 47.1 18.4 50.0 52.8 55.4 75.4 30.7 35.5 41.7 44.3 48.1 42.3 70.1 61.4 55.1 61.1 40.8 53.4 21.9 41.6 76.3 46.8 81.1 73.8 22.5 41.0 57.2 42.7 38.4 75.9 22.2 51.5 34.2 59.7 58.1 88.4 47.8 45.2 51.5 82.2 52.4 56.2 30.3 59.2 45.3 44.4 52.4 57.3 34.4 70.0 65.7 51.8 31.3 57.6 66.4 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: AB_2686429" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 25.9 34.9 23.6 17.7 26.5 22.9 32.5 29.5 30.3 23.0 34.2 29.6 17.3 30.5 26.4 17.8 31.2 30.8 25.9 22.9 30.2 44.5 34.0 30.7 25.2 30.1 29.8 25.8 20.7 56.6 28.6 33.8 31.3 29.9 29.5 34.7 25.4 27.0 17.1 17.9 24.0 27.7 28.7 23.0 24.4 30.4 26.1 22.1 34.6 21.1 20.7 26.4 16.2 32.0 54.8 68.0 57.3 46.8 40.9 59.0 42.8 85.9 76.6 52.6 62.9 21.8 108.1 27.7 75.6 85.5 55.3 40.0 41.2 52.8 72.1 82.8 24.0 30.3 38.5 42.3 56.0 45.6 53.6 60.9 56.6 45.9 32.6 82.1 55.7 35.8 25.4 54.9 100.7 54.1 25.6 37.8 31.2 45.9 60.4 31.4 73.6 27.9 92.1 59.3 23.7 40.9 82.8 68.4 45.1 40.0 66.4 32.3 72.4 54.9 65.6 53.0 58.0 21.7 45.5 32.7 80.7 33.2 68.0 86.3 59.3 82.3 34.4 74.8 34.3 36.1 37.0 37.0 51.9 34.1 38.9 36.5 89.4 50.2 83.0 70.5 47.0 57.8 23.6 26.5 29.5 30.3 22.9 30.2 30.1 29.8 31.3 28.7 26.1 32.0 25.5 22.4 31.2 29.7 23.6 30.0 32.8 132.9 54.1 30.3 31.6 27.1 10.2 41.5 66.3 46.0 18.8 64.2 42.0 27.4 7.9 45.4 174.5 43.3 31.7 26.9 31.2 40.8 30.3 54.8 64.8 37.4 27.5 20.9 34.9 28.0 26.4 41.9 57.8 28.6 26.8 26.7 89.5 60.3 31.4 61.2 35.4 40.4 48.0 19.7 34.2 40.1 29.9 28.1 34.5 51.4 21.3 31.6 50.2 26.3 22.4 53.0 110.6 30.3 13.1 27.5 58.8 85.1 41.1 30.7 29.1 29.8 27.6 30.3 24.6 20.9 JOSD2 SBBI54 ENSG00000161677 "Josephin domain containing 2" Q8TAC2 19 50505998-50511220 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (8.77e-2)" "unprognostic (3.09e-2)" "unprognostic (2.59e-1)" "unprognostic (1.57e-2)" "unprognostic (7.25e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (3.63e-2)" "unprognostic (2.41e-1)" "unprognostic (5.68e-2)" "unprognostic (1.75e-2)" "unprognostic (6.49e-2)" "unprognostic (2.42e-3)" "unprognostic (8.05e-2)" "unprognostic (2.04e-1)" "unprognostic (6.05e-2)" "unprognostic (9.34e-2)" 39.7 33.4 30.1 10.6 37.4 13.2 34.1 37.7 48.1 38.3 20.5 40.5 16.7 37.9 2.5 49.1 31.8 5.8 44.3 27.3 32.0 37.6 48.1 29.0 6.7 41.0 34.8 29.6 26.8 11.3 28.2 8.0 38.2 32.5 2.8 1.5 26.5 8.2 50.2 37.0 29.5 5.8 35.0 32.8 37.4 18.6 35.0 5.5 40.5 7.9 4.0 37.9 38.9 44.8 38.5 65.7 0.3 18.2 20.4 23.6 12.5 46.8 15.9 12.1 12.9 11.4 26.8 12.2 26.7 16.6 14.6 24.8 1.9 20.2 3.2 54.0 31.3 11.7 12.2 5.8 25.5 3.2 39.1 26.1 17.7 7.8 6.2 15.5 11.4 12.8 15.7 27.2 12.6 27.9 13.3 15.6 4.6 23.9 67.4 3.7 31.1 21.6 11.8 36.8 11.0 29.4 14.0 32.8 40.8 1.5 27.1 19.7 27.5 21.0 25.9 27.6 27.0 30.2 26.1 4.2 59.5 15.7 41.4 55.4 95.3 95.0 45.0 93.8 38.6 24.1 41.9 46.1 70.1 25.1 29.9 33.3 16.2 31.9 70.0 50.6 51.6 48.9 30.1 37.4 37.7 48.1 27.3 32.0 41.0 34.8 38.2 35.0 35.0 44.8 42.8 6.4 1.7 6.2 18.4 31.0 45.4 83.2 38.1 11.1 45.3 48.0 3.1 47.1 30.1 33.1 0.0 39.5 30.0 153.4 66.5 88.3 12.3 25.4 61.4 30.7 16.8 21.0 3.1 86.3 92.8 47.3 57.6 36.2 5.7 52.5 47.5 56.3 93.5 16.8 2.8 67.8 50.8 70.6 48.8 34.6 89.2 59.4 78.2 3.7 94.1 32.9 30.9 3.0 21.7 120.8 103.2 97.8 21.4 26.3 157.8 106.6 63.0 10.0 52.6 26.2 52.7 32.0 18.4 58.5 45.9 41.3 33.6 48.9 51.8 57.0 KIF5B "KNS, KNS1" ENSG00000170759 "Kinesin family member 5B" P33176 10 32009015-32056425 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009846, HPA037589, HPA037590" Approved Enhanced "Centriolar satellite,Cytosol" NA Yes 97000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 10: Non-specific - Unknown function" "Centriolar satellite, Cytosol" "CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (4.00e-2)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.70e-1)" "unprognostic (6.37e-3)" "unprognostic (2.03e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-1)" "unprognostic (2.43e-2)" "unprognostic (2.39e-1)" "unprognostic (8.06e-2)" "unprognostic (1.76e-1)" 59.7 41.8 110.0 46.7 128.2 84.9 45.3 107.7 149.7 47.3 75.6 66.4 52.0 54.1 30.3 52.7 39.2 59.8 87.4 85.8 100.2 44.7 31.9 52.5 39.9 121.9 123.8 27.6 41.8 91.6 22.9 54.4 120.6 65.9 63.6 45.1 39.1 52.0 65.0 38.9 54.7 81.3 128.1 48.1 51.4 64.4 116.8 44.0 50.5 67.3 36.6 60.8 29.8 143.4 115.8 96.4 127.3 89.9 89.2 97.7 54.4 155.6 73.3 117.6 99.6 106.6 124.0 78.7 65.8 185.8 66.9 93.3 117.6 99.4 156.4 68.4 64.1 100.2 87.9 104.5 102.5 70.5 105.6 79.9 138.0 135.8 94.0 93.4 152.8 68.2 122.9 80.5 164.7 69.7 74.0 39.7 20.7 110.1 43.4 95.7 237.2 32.6 90.6 79.5 123.3 89.9 120.4 47.5 117.3 88.0 57.5 99.4 128.4 118.7 111.0 139.3 117.2 24.2 29.8 90.9 113.2 142.2 114.1 41.8 25.9 44.0 19.1 33.0 18.7 23.7 24.0 20.6 24.7 24.3 21.1 20.8 51.1 24.3 35.7 47.9 29.4 18.4 110.0 128.2 107.7 149.7 85.8 100.2 121.9 123.8 120.6 128.1 116.8 143.4 160.3 182.7 206.8 49.3 86.3 213.1 177.7 200.6 66.0 181.9 119.0 103.8 396.0 115.8 198.4 104.8 100.1 121.0 125.5 145.0 45.0 209.4 185.5 167.8 171.4 181.0 132.3 69.2 44.6 176.0 134.9 141.2 85.6 158.9 91.2 159.7 88.5 46.2 132.7 151.4 56.0 227.3 213.6 111.8 129.1 51.8 59.0 137.2 101.4 84.3 169.3 160.5 82.4 61.9 83.3 202.2 164.9 130.9 84.2 254.1 120.2 59.5 206.1 123.8 85.5 176.0 244.8 566.0 195.6 87.6 236.7 331.9 116.0 137.4 208.1 246.8 KLHL13 "BKLHD2, FLJ10262, KIAA1309" ENSG00000003096 "Kelch like family member 13" Q9P2N7 X 117897813-118117340 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Inhibitory neurons: 29.3;Microglial cells: 30.9;Oligodendrocyte precursor cells: 102.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 7.3;plasmacytoid DC: 4.1" "Group enriched" "Detected in many" 5 "dendritic cells: 4.1;granulocytes: 7.3" "Cell line enhanced" "Detected in many" "HAP1: 33.8;HeLa: 57.3;RH-30: 37.2;RPTEC TERT1: 106.0;SH-SY5Y: 94.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046039, HPA059901" Approved Approved Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol "HPA046039: AB_2679514, HPA059901: AB_2684155" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.09e-2)" "unprognostic (1.07e-2)" "unprognostic (9.54e-2)" "unprognostic (7.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (6.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.09e-3)" "unprognostic (1.24e-2)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (2.31e-1)" 2.7 7.3 4.6 2.6 11.1 0.4 24.6 2.7 4.8 20.5 5.5 5.4 3.1 31.4 7.3 5.9 10.7 5.6 7.8 3.2 5.9 16.0 4.7 1.4 0.6 5.9 10.3 7.4 4.6 3.4 2.2 0.8 6.4 6.2 3.9 4.2 2.2 12.3 3.6 1.1 4.8 29.3 4.0 1.6 3.2 3.6 5.9 5.0 0.8 5.6 1.2 7.5 5.0 3.8 1.1 0.4 6.9 14.5 0.1 0.0 0.2 0.5 0.0 0.4 0.0 9.1 0.1 0.0 16.5 0.0 0.7 16.9 33.8 5.6 0.0 0.0 12.9 0.4 57.3 0.1 0.8 1.1 2.2 1.8 2.3 0.2 0.7 6.9 25.8 0.0 0.0 0.0 0.0 1.4 5.9 1.6 13.4 0.0 9.6 0.0 37.2 0.1 106.0 4.0 0.0 94.3 0.5 1.2 0.9 2.7 20.9 0.2 0.7 2.4 2.9 2.0 8.6 0.4 0.0 0.2 10.2 0.0 4.1 2.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.6 0.6 0.0 1.1 0.0 4.1 0.2 0.3 4.6 11.1 2.7 4.8 3.2 5.9 5.9 10.3 6.4 4.0 5.9 3.8 0.7 0.0 0.0 13.7 0.0 0.8 6.8 5.4 12.0 6.2 2.4 19.9 10.5 0.0 4.8 1.8 0.0 0.2 0.1 1.2 29.4 1.1 0.3 8.0 22.7 1.9 1.2 1.3 8.0 3.4 0.1 8.7 0.0 1.3 0.0 10.0 8.6 1.3 0.6 0.0 29.3 2.1 0.0 0.0 1.2 0.9 6.2 1.0 1.8 30.9 0.2 7.2 0.0 102.5 12.3 0.7 3.4 1.9 0.1 2.7 2.9 12.7 22.3 1.2 6.6 18.1 5.3 1.8 10.6 4.8 0.4 0.0 0.6 6.4 4.1 3.6 LAMTOR2 "ENDAP, MAPBPIP, MAPKSP1AP, p14, Ragulator2, ROBLD3" ENSG00000116586 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2" Q9Y2Q5 1 156054782-156058506 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 627.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004126 Approved Approved Nucleoplasm,Vesicles No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Vesicles" "HPA004126: AB_1849916" "unprognostic (2.09e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-2)" "unprognostic (4.52e-2)" "unprognostic (8.64e-2)" "unprognostic (3.90e-2)" "unprognostic (3.79e-1)" "unprognostic (1.66e-2)" "unprognostic (2.06e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (1.10e-6)" "unprognostic (2.47e-1)" "unprognostic (1.34e-1)" "unprognostic (8.65e-2)" "unprognostic (1.35e-1)" 64.3 84.4 81.9 41.6 81.4 57.1 57.7 83.9 98.9 44.8 83.0 62.0 51.5 42.3 76.7 75.2 52.1 43.8 96.1 81.6 84.7 91.0 164.3 53.8 56.3 81.6 82.5 26.7 87.8 74.4 44.6 37.5 82.0 50.9 56.5 18.0 59.3 44.0 88.6 57.8 53.7 48.9 82.2 65.7 78.1 26.6 85.8 56.1 44.7 70.2 52.0 53.6 46.7 85.8 63.9 142.3 65.4 90.9 131.9 106.7 72.3 55.7 94.4 68.8 78.1 65.9 106.1 94.0 94.4 108.7 60.0 91.5 67.7 151.1 38.7 78.4 103.0 54.9 96.2 88.6 104.4 78.0 86.5 126.1 93.4 73.1 93.3 94.4 142.6 137.3 50.8 68.1 100.9 128.7 80.6 111.4 69.4 250.9 212.1 67.5 48.7 138.7 152.5 93.2 25.3 145.3 70.4 195.1 116.3 104.1 136.5 227.9 96.6 57.5 52.4 83.4 53.0 101.6 166.5 56.2 102.2 87.3 62.9 281.8 465.8 376.2 172.2 446.9 169.8 290.6 188.2 188.7 537.2 249.4 142.6 152.8 231.8 207.0 363.2 284.1 298.3 389.7 81.9 81.4 83.9 98.9 81.6 84.7 81.6 82.5 82.0 82.2 85.8 85.8 102.5 57.7 46.5 3.6 64.5 48.4 59.5 190.3 43.3 29.4 129.9 123.2 113.5 114.4 120.2 108.5 6.2 146.3 73.9 247.5 387.4 193.0 44.5 113.2 78.7 92.6 126.1 48.0 4.5 179.3 203.1 67.5 68.3 105.0 107.3 56.7 86.7 322.1 416.1 6.7 5.4 164.7 197.4 188.9 150.1 89.0 47.2 165.0 158.3 5.6 297.4 92.8 94.7 4.5 5.8 183.2 267.4 50.8 76.8 80.2 317.8 627.2 144.1 30.5 32.9 38.9 124.6 25.5 33.9 99.4 80.0 77.2 64.2 83.3 166.9 97.7 LAMTOR3 "MAP2K1IP1, MAPBP, MAPKSP1, MP1, Ragulator3" ENSG00000109270 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 3" Q9UHA4 4 99878336-99894428 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026858 Supported NA NA 120000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA026858: AB_1853523" "unprognostic (7.77e-2)" "unprognostic (4.13e-2)" "unprognostic (3.07e-1)" "unprognostic (5.36e-3)" "unprognostic (3.96e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.61e-2)" "unprognostic (3.20e-3)" "unprognostic (1.58e-1)" "unprognostic (5.57e-2)" "unprognostic (1.66e-1)" "prognostic favorable (1.75e-9)" "unprognostic (5.17e-2)" "unprognostic (1.66e-2)" "unprognostic (2.98e-1)" "unprognostic (1.40e-2)" 16.9 25.7 14.6 16.4 15.4 32.5 24.9 17.3 26.7 20.8 14.5 24.9 23.5 23.3 39.5 30.1 19.2 19.4 24.3 15.4 15.8 38.1 21.7 17.5 20.4 15.2 16.4 24.3 17.3 36.4 18.9 22.5 15.5 28.3 26.2 23.3 24.6 17.1 21.0 23.8 23.8 19.1 13.6 16.6 21.3 15.6 15.7 20.1 33.9 20.2 21.0 23.8 21.6 14.8 19.9 6.4 26.1 17.5 36.2 35.1 20.2 18.9 18.6 18.3 15.0 15.0 39.0 17.3 18.6 19.5 17.8 9.3 26.1 23.9 25.4 20.5 14.0 12.0 13.1 28.3 35.0 36.1 34.1 23.1 48.9 13.8 15.4 26.9 20.7 12.9 30.4 21.1 35.2 20.4 30.5 35.4 16.1 42.8 10.7 20.2 14.9 19.5 55.2 22.9 20.2 25.2 12.2 40.6 41.0 26.3 20.9 29.3 20.5 14.2 16.7 24.0 14.8 26.5 30.6 33.8 30.0 20.6 20.5 43.5 17.6 38.5 9.8 26.8 12.9 11.4 12.1 11.1 19.0 9.3 14.0 14.1 58.6 18.8 28.4 13.3 13.5 13.8 14.6 15.4 17.3 26.7 15.4 15.8 15.2 16.4 15.5 13.6 15.7 14.8 38.8 57.7 33.7 8.8 35.6 49.6 60.7 77.8 68.3 28.0 53.9 46.1 35.9 24.3 44.2 35.0 12.5 48.8 30.3 95.7 135.0 50.9 12.0 38.3 29.8 27.6 36.1 46.7 15.2 32.6 55.8 37.4 43.8 61.3 41.8 23.9 22.9 25.2 77.8 18.5 13.7 48.9 52.9 41.5 89.8 9.4 40.0 56.9 37.4 3.7 60.7 50.7 38.1 8.5 12.7 43.9 102.5 42.5 30.7 63.9 53.9 130.2 30.3 26.3 19.7 30.9 30.9 72.6 40.2 86.6 64.6 78.4 32.6 22.8 43.3 78.8 LAMTOR5 "HBXIP, MGC71071, XIP" ENSG00000134248 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5" O43504 1 110401249-110407942 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1113.2;Proximal tubular cells: 2532.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006812 Approved Supported Cytosol NA NA 150000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA006812: AB_1079040" "unprognostic (1.18e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (3.54e-3)" "unprognostic (2.75e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (9.97e-2)" "unprognostic (7.58e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.80e-1)" "unprognostic (2.93e-1)" "unprognostic (1.65e-2)" "unprognostic (3.77e-2)" "unprognostic (3.80e-3)" "prognostic favorable (5.52e-4)" "unprognostic (6.66e-2)" 143.6 134.9 152.2 79.5 156.3 250.3 127.7 167.7 179.0 107.7 168.0 108.3 85.7 86.2 162.6 121.0 93.2 101.9 269.7 150.9 163.6 433.9 150.2 115.2 114.1 159.6 155.4 121.0 95.3 192.3 141.2 120.7 157.9 109.4 110.9 140.0 100.1 77.6 260.3 98.7 102.2 81.5 165.1 126.0 127.8 88.6 161.4 102.2 107.8 277.3 122.6 124.2 109.4 168.1 272.1 223.2 197.3 118.5 325.3 245.3 196.1 224.4 176.5 186.8 176.6 196.0 130.0 214.5 233.0 220.9 228.4 107.5 203.4 189.2 229.8 231.4 227.9 157.7 257.1 402.1 247.1 227.7 188.0 216.3 287.3 193.9 122.6 236.2 227.7 156.9 189.3 196.0 275.8 443.0 208.7 274.7 140.1 151.8 366.9 141.9 355.1 164.2 439.0 302.0 145.4 189.6 198.8 287.7 516.4 169.5 111.0 317.3 217.8 140.5 182.9 355.7 214.4 204.5 250.7 277.2 459.1 225.6 329.6 295.4 223.1 485.8 125.9 229.5 112.1 345.3 146.6 137.6 187.9 322.3 127.1 134.4 347.7 149.2 225.0 321.5 181.1 250.6 152.2 156.3 167.7 179.0 150.9 163.6 159.6 155.4 157.9 165.1 161.4 168.1 131.2 160.3 174.4 16.3 208.2 307.8 284.1 661.5 101.3 111.0 186.0 197.9 597.6 211.6 371.9 445.1 25.0 424.5 141.5 225.1 1113.2 389.2 67.5 215.8 141.8 193.1 222.3 158.9 15.4 331.0 370.7 194.0 99.9 191.1 146.4 97.0 133.9 311.9 424.8 89.2 17.6 302.6 449.6 154.4 189.2 112.8 264.7 175.3 350.4 18.7 320.9 297.9 137.0 9.5 23.3 403.9 296.4 239.2 100.6 360.9 315.4 2532.5 340.9 150.5 170.9 168.2 185.2 297.9 361.3 121.3 322.5 500.5 125.7 163.2 252.0 441.8 LARP7 "DKFZP564K112, HDCMA18P, PIP7S" ENSG00000174720 "La ribonucleoprotein 7, transcriptional regulator" Q4G0J3 4 112637107-112657592 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation" RNA-binding "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026842, HPA027930" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "HPA026842: AB_10611116, HPA027930: AB_10601233" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (5.72e-2)" "unprognostic (2.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-2)" "unprognostic (1.68e-1)" "unprognostic (1.82e-2)" "unprognostic (1.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 37.2 31.6 26.3 32.8 28.3 44.6 35.7 28.6 34.6 28.0 28.0 36.2 33.8 33.3 29.8 31.7 25.8 30.5 59.6 24.9 33.5 40.2 44.1 28.1 44.9 30.2 30.2 34.2 18.3 29.9 20.1 34.1 31.0 32.1 36.7 31.5 23.2 27.2 46.6 30.6 33.2 29.5 28.3 36.9 31.5 24.6 29.1 42.2 38.7 45.3 40.3 33.0 21.8 30.8 42.9 34.9 77.7 44.3 50.7 61.6 44.0 55.3 40.6 45.3 42.0 27.9 62.0 95.4 43.7 46.9 42.2 29.6 75.1 45.2 60.2 86.8 52.1 56.4 35.2 41.9 41.0 131.6 84.6 49.3 50.7 40.4 25.1 62.6 40.4 47.6 71.4 51.1 55.3 35.2 107.4 56.7 182.2 67.5 28.2 62.9 66.2 44.3 68.8 44.8 46.5 64.4 32.0 83.4 55.4 131.4 35.1 61.0 43.7 42.4 49.5 47.7 57.6 34.7 62.5 97.6 57.7 52.4 49.2 70.1 28.1 49.9 32.8 43.1 30.3 48.1 33.9 34.2 25.3 47.4 32.3 31.3 33.2 38.7 60.7 64.0 37.9 20.8 26.3 28.3 28.6 34.6 24.9 33.5 30.2 30.2 31.0 28.3 29.1 30.8 66.1 96.1 79.2 45.1 68.8 24.9 66.5 102.6 34.1 61.3 48.3 50.4 113.2 95.8 91.6 47.8 29.2 79.0 88.7 83.2 111.6 69.3 17.6 78.7 70.5 63.2 38.9 43.6 18.0 64.4 70.2 60.6 32.1 58.8 104.4 51.5 81.4 160.9 70.4 58.9 19.9 79.7 61.1 93.7 27.1 14.9 94.4 67.2 24.9 32.8 96.0 107.1 107.1 20.6 43.1 62.0 85.6 100.1 39.1 38.8 73.1 117.0 109.8 54.1 118.3 74.5 68.3 83.5 87.8 33.3 20.9 100.4 65.9 74.2 75.6 47.9 LMAN2 "C5orf8, GP36B, VIP36" ENSG00000169223 "Lectin, mannose binding 2" Q12907 5 177331567-177351668 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 530.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003927 Approved NA NA 88000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" "HPA003927: AB_1079257" "unprognostic (5.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.87e-2)" "unprognostic (1.85e-3)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (2.88e-3)" "unprognostic (2.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.51e-3)" "unprognostic (4.56e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (4.43e-2)" "unprognostic (6.13e-2)" "unprognostic (1.45e-2)" "unprognostic (2.32e-1)" 72.0 79.5 40.1 63.2 43.5 77.6 65.3 42.4 49.3 76.7 62.6 77.0 91.4 74.0 136.1 147.1 70.3 57.0 74.7 44.5 43.0 85.5 207.8 78.8 66.2 45.2 41.5 69.6 155.9 49.9 60.8 72.6 43.1 64.7 40.1 14.7 117.9 48.7 50.6 64.6 81.2 36.2 41.7 86.9 82.4 93.5 46.4 54.8 97.2 29.2 42.7 67.0 73.1 43.6 108.6 196.4 57.3 317.9 201.5 76.2 298.0 122.1 120.8 105.6 132.9 326.2 254.0 115.9 286.2 162.7 196.3 163.9 69.6 242.9 39.6 556.7 166.6 73.9 136.7 196.5 196.2 155.4 210.7 140.5 94.2 106.0 94.8 118.3 142.3 100.3 90.8 452.0 79.3 318.5 115.8 268.3 82.7 159.7 174.8 132.4 97.6 404.9 99.5 122.6 94.9 105.4 113.3 191.9 205.0 51.9 150.4 349.5 145.5 168.2 108.0 89.2 182.7 252.0 200.8 114.8 234.5 217.8 186.6 569.9 411.8 476.9 408.9 379.2 349.7 252.1 295.6 342.9 358.8 256.6 241.0 280.7 552.6 364.8 346.1 500.9 350.2 828.4 40.1 43.5 42.4 49.3 44.5 43.0 45.2 41.5 43.1 41.7 46.4 43.6 82.7 57.7 74.5 12.1 114.8 57.0 147.9 384.3 47.8 33.2 100.9 74.4 44.6 124.4 229.9 108.5 16.7 312.7 147.4 168.3 52.8 233.2 103.8 87.2 99.5 99.5 58.9 71.8 7.0 237.3 444.4 120.4 70.8 131.2 77.4 97.2 81.8 223.4 240.4 55.5 8.3 190.0 266.5 105.0 85.3 28.2 88.0 107.4 120.9 13.1 116.4 89.0 162.7 13.0 9.7 226.1 130.9 63.9 388.4 146.1 186.1 111.9 151.9 46.5 65.7 70.8 108.9 275.8 192.0 134.1 69.9 530.3 112.5 111.8 160.6 165.6 LRRC57 FLJ36812 ENSG00000180979 "Leucine rich repeat containing 57" Q8N9N7 15 42537820-42548802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 60.5;Rod photoreceptor cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040894 Approved Approved Mitochondria,Cytosol NA NA 26000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Mitochondria, Cytosol" "HPA040894: AB_10794996" "unprognostic (8.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.84e-2)" "unprognostic (4.77e-2)" "unprognostic (4.16e-2)" "unprognostic (4.78e-2)" "unprognostic (2.57e-1)" "unprognostic (1.32e-1)" "unprognostic (3.31e-2)" "unprognostic (3.73e-2)" "prognostic favorable (2.15e-4)" "unprognostic (7.45e-2)" "unprognostic (7.23e-2)" "unprognostic (2.35e-1)" "unprognostic (1.05e-2)" 7.7 7.3 4.8 5.5 4.6 22.0 7.5 4.8 8.5 7.3 3.3 9.3 6.5 7.7 5.5 9.6 8.3 5.3 6.9 6.1 3.1 8.0 6.1 8.6 6.6 3.6 3.4 8.6 7.3 14.0 6.0 7.9 4.1 6.6 10.7 14.9 8.0 5.8 6.0 9.6 8.1 7.3 3.2 6.7 7.8 5.7 3.7 9.6 7.0 6.9 7.4 6.8 8.6 5.4 14.7 11.0 19.5 13.8 16.5 12.7 9.7 20.5 11.2 14.7 15.4 23.3 11.0 6.8 13.8 16.9 16.5 22.7 13.2 16.7 14.7 12.8 12.2 27.7 23.6 10.7 14.7 17.8 15.0 14.0 22.8 13.2 17.1 10.1 23.7 17.3 21.9 14.5 13.6 6.6 9.8 7.5 4.6 26.6 8.5 15.1 19.6 10.5 9.8 24.4 9.8 11.9 24.8 16.3 11.8 12.7 16.1 19.6 24.3 16.5 11.4 17.5 15.5 11.9 36.4 29.0 8.9 16.4 21.0 36.9 9.7 32.0 7.4 14.6 9.3 5.8 7.2 7.2 10.2 7.1 5.8 7.3 12.2 16.9 19.3 5.9 8.5 6.9 4.8 4.6 4.8 8.5 6.1 3.1 3.6 3.4 4.1 3.2 3.7 5.4 16.3 9.6 10.8 6.8 10.4 5.7 13.6 6.5 6.8 13.6 9.6 8.1 11.1 15.7 7.3 9.2 60.5 11.6 18.8 16.4 13.7 10.9 18.7 13.5 13.8 17.3 12.5 15.8 17.1 9.8 19.3 12.7 9.2 13.2 14.5 10.2 19.2 7.5 14.1 20.2 8.8 13.1 6.1 14.2 4.8 20.0 9.6 13.1 7.2 7.5 21.9 21.1 20.6 11.6 8.3 15.2 15.9 16.1 8.4 12.4 15.2 8.4 14.8 87.4 6.6 16.9 10.1 7.8 6.4 11.4 5.5 15.9 11.3 18.4 12.2 12.8 LRRFIP2 HUFI-2 ENSG00000093167 "LRR binding FLII interacting protein 2" Q9Y608 3 37052626-37183689 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 516.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035956, HPA042023" Uncertain Approved "Plasma membrane,Actin filaments" NA NA 150000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Actin filaments" "HPA035956: AB_10671238, HPA042023: AB_2677802" "unprognostic (2.03e-3)" "prognostic favorable (6.31e-4)" "unprognostic (1.16e-2)" "unprognostic (7.90e-2)" "unprognostic (2.48e-1)" "unprognostic (2.97e-1)" "unprognostic (5.41e-2)" "unprognostic (1.82e-1)" "unprognostic (3.09e-2)" "unprognostic (2.56e-2)" "unprognostic (4.99e-3)" "unprognostic (1.98e-1)" "unprognostic (4.13e-3)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (4.84e-3)" "unprognostic (3.76e-2)" 23.4 24.0 43.7 20.1 46.9 44.3 22.3 43.6 49.0 46.0 33.6 38.3 35.4 31.8 19.7 52.6 25.8 22.0 75.8 38.8 44.4 24.0 48.5 27.0 18.1 43.4 42.0 27.4 19.2 33.3 18.6 20.8 44.8 41.0 34.2 36.0 28.5 24.3 97.9 37.0 36.2 31.5 41.0 45.0 26.5 71.8 46.4 18.8 27.5 45.3 23.2 24.2 40.9 60.9 56.6 30.8 34.9 27.7 45.5 69.3 30.5 149.9 148.2 82.6 94.3 29.0 25.3 22.2 24.0 145.4 40.8 28.8 25.8 74.2 134.3 49.7 20.2 39.8 44.0 28.6 64.8 31.9 23.3 31.1 52.1 107.8 110.4 45.8 58.2 34.0 32.3 37.8 69.5 14.4 27.2 17.0 23.0 23.0 39.2 13.0 99.2 22.6 58.4 21.7 12.6 19.9 57.9 53.0 49.4 28.0 30.6 32.6 56.5 63.1 42.6 93.4 71.5 29.1 57.1 33.9 37.1 28.1 91.4 20.5 21.4 33.8 8.8 14.9 11.3 9.7 9.3 9.5 14.1 8.5 6.8 8.3 19.2 16.9 26.9 7.9 13.0 11.7 43.7 46.9 43.6 49.0 38.8 44.4 43.4 42.0 44.8 41.0 46.4 60.9 47.8 28.9 36.5 98.6 29.1 136.1 143.0 41.3 113.8 36.3 64.7 53.2 123.1 38.6 53.7 23.9 29.2 29.2 28.7 117.2 64.6 89.8 516.2 78.9 44.0 59.9 54.0 60.0 169.8 94.3 46.1 57.4 37.8 127.3 52.6 29.4 56.7 58.8 24.9 122.8 197.7 45.6 28.5 35.6 128.3 330.7 42.3 48.2 74.7 62.8 67.7 51.9 30.9 130.7 309.0 109.9 90.1 57.6 45.8 325.6 125.8 46.1 36.2 51.9 39.5 32.4 72.8 159.9 73.4 139.3 170.5 39.3 34.1 90.0 66.0 303.2 LSM1 "CASM, YJL124C" ENSG00000175324 "LSM1 homolog, mRNA degradation associated" O15116 8 38163335-38176730 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024601 Approved "Cytosol,Cytoplasmic bodies" NA NA 22000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 51: Myeloid cells - Hemostasis" "Cytoplasmic bodies" Cytosol "HPA024601: AB_1853379" "unprognostic (1.19e-2)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" "unprognostic (9.59e-2)" "unprognostic (7.26e-2)" "unprognostic (1.69e-1)" "unprognostic (2.08e-3)" "unprognostic (2.18e-2)" "unprognostic (1.95e-2)" "unprognostic (2.48e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (3.47e-2)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (8.75e-2)" "unprognostic (2.97e-1)" 30.0 31.9 42.1 27.6 43.0 34.4 28.0 44.1 49.2 25.1 43.4 31.0 25.3 27.5 39.6 27.5 22.9 26.7 61.1 41.5 44.0 36.1 36.7 20.4 33.9 42.8 43.2 20.0 28.3 29.5 22.1 34.6 43.0 27.3 29.4 21.4 32.4 34.1 34.8 24.7 25.4 31.7 43.0 22.4 27.0 20.9 44.1 34.8 28.7 35.0 31.8 37.8 22.5 43.2 66.8 72.1 47.6 54.2 78.1 71.8 41.2 78.6 81.9 74.9 78.3 51.3 45.7 32.2 69.4 96.9 75.3 33.1 61.2 67.0 83.7 49.0 71.8 102.9 52.2 65.4 68.1 36.4 65.3 70.1 60.9 62.0 51.2 57.1 66.1 65.0 83.2 78.7 94.7 66.7 110.7 70.4 68.7 100.9 73.9 53.2 49.2 38.1 102.9 78.8 80.3 67.1 34.3 51.0 98.7 48.3 43.3 76.2 65.1 63.9 77.1 96.0 65.0 82.2 123.2 66.2 74.8 73.7 67.3 161.5 65.7 105.0 58.6 75.0 61.1 59.8 64.6 64.9 66.0 52.4 58.4 67.2 50.5 62.9 78.8 111.1 82.1 78.8 42.1 43.0 44.1 49.2 41.5 44.0 42.8 43.2 43.0 43.0 44.1 43.2 40.8 12.8 24.6 5.2 49.5 66.3 45.6 101.7 26.2 26.6 58.5 42.4 5.9 48.6 61.7 68.0 10.4 109.3 78.4 40.7 180.0 90.6 9.0 65.0 47.1 42.9 46.7 36.2 9.3 119.2 138.9 40.7 25.5 53.0 24.1 29.5 42.5 58.5 84.9 13.5 11.6 48.8 75.3 51.5 46.9 8.4 61.5 58.6 48.0 12.2 104.8 55.0 125.7 7.5 12.4 120.0 54.5 56.8 57.1 92.1 59.8 121.4 51.1 24.1 52.6 39.0 58.0 64.7 129.3 40.8 70.3 102.2 57.8 67.3 49.9 87.3 LSM10 MGC15749 ENSG00000181817 "LSM10, U7 small nuclear RNA associated" Q969L4 1 36391238-36397908 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048469 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 57: B-cells - Immune response" Nucleoplasm "Nuclear bodies" "HPA048469: AB_2756307" "unprognostic (2.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (6.21e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (1.90e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.84e-1)" "unprognostic (2.80e-1)" "unprognostic (3.59e-2)" "unprognostic (8.54e-2)" 39.2 32.7 53.1 32.0 54.2 23.9 32.8 54.5 67.5 31.9 55.0 62.3 20.1 36.3 30.4 26.8 31.6 22.7 72.9 53.4 58.7 42.3 51.7 30.6 52.3 54.4 55.2 31.7 30.5 36.9 41.8 18.0 55.3 40.8 17.7 9.7 29.1 30.5 165.0 30.1 36.7 27.9 55.2 55.3 38.7 28.9 57.8 27.2 31.0 110.3 47.6 42.8 28.2 54.3 54.6 81.2 29.9 80.7 68.9 67.2 31.0 47.9 69.4 75.1 57.1 36.4 50.6 127.4 64.5 65.0 55.6 29.3 51.2 62.1 49.5 87.1 61.2 64.1 47.1 87.1 83.8 49.0 90.3 56.8 54.4 67.6 47.6 40.7 77.8 71.7 60.2 60.5 53.4 96.3 54.8 55.5 77.5 67.0 83.3 40.9 28.8 86.3 73.6 32.6 38.1 28.7 38.7 49.4 120.6 47.9 25.5 41.3 52.2 34.0 47.3 90.0 76.0 79.5 115.7 102.4 68.4 73.9 78.7 240.2 264.1 340.1 125.3 266.4 139.0 386.4 125.1 132.0 189.4 388.0 112.1 120.7 346.4 111.6 256.4 243.9 172.3 301.8 53.1 54.2 54.5 67.5 53.4 58.7 54.4 55.2 55.3 55.2 57.8 54.3 27.8 12.8 14.4 3.9 82.2 32.2 37.2 53.3 13.1 17.4 40.9 44.4 55.9 21.5 30.4 46.0 6.2 56.1 58.5 23.4 140.8 40.7 9.7 18.6 32.7 31.7 28.2 40.2 8.6 47.1 58.8 36.8 19.4 23.3 41.2 25.7 32.2 66.8 105.7 18.5 9.1 23.4 63.1 77.0 89.3 32.9 38.8 67.6 51.6 7.5 72.0 41.0 66.9 3.5 6.7 47.4 35.3 47.0 67.0 40.3 47.7 106.4 12.4 14.3 13.1 28.4 38.8 7.8 23.4 27.7 40.1 40.0 51.0 43.3 28.5 27.3 LSM3 "SMX4, USS2, YLR438C" ENSG00000170860 "LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated" P62310 3 14178817-14201122 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 752.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044966 Approved Approved Nucleoplasm,Nucleoli NA NA 30000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoli Nucleoplasm "HPA044966: AB_2679159" "unprognostic (3.84e-3)" "unprognostic (7.00e-3)" "unprognostic (3.61e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-1)" "unprognostic (2.94e-3)" "unprognostic (5.01e-2)" "unprognostic (2.70e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-2)" "unprognostic (8.07e-3)" "unprognostic (4.93e-3)" "unprognostic (5.57e-2)" "unprognostic (2.88e-1)" "unprognostic (1.46e-1)" "unprognostic (1.89e-3)" 12.6 10.8 12.1 11.0 12.6 18.9 12.6 13.2 16.6 8.7 12.1 12.1 12.4 9.1 10.4 12.1 8.2 6.5 17.4 12.6 12.7 23.3 18.4 8.2 12.9 12.3 12.0 9.4 9.5 11.0 9.0 10.3 12.5 9.8 11.2 10.7 9.2 8.3 30.1 10.1 12.9 8.1 12.4 9.7 10.5 12.3 12.6 16.8 10.7 22.4 11.8 10.3 8.7 13.2 36.0 28.6 30.1 31.3 13.8 16.0 76.3 29.0 19.3 36.6 34.8 32.6 27.6 39.5 23.5 20.3 25.7 16.4 34.5 28.4 36.0 37.5 42.3 41.8 38.1 31.5 7.1 47.3 29.0 12.0 20.2 36.8 15.6 16.4 19.1 34.0 45.9 30.7 27.4 41.5 50.4 64.2 52.1 40.2 38.5 27.4 37.3 43.5 34.6 36.7 16.8 27.2 33.2 46.1 28.6 34.3 53.2 59.7 17.3 23.3 37.2 28.3 50.6 21.4 67.3 73.6 29.5 45.9 33.8 44.1 18.9 30.0 14.8 23.7 17.7 27.3 17.1 17.5 18.3 21.7 18.4 19.7 17.8 21.9 20.3 28.7 22.9 25.7 12.1 12.6 13.2 16.6 12.6 12.7 12.3 12.0 12.5 12.4 12.6 13.2 114.2 67.3 94.3 11.4 118.2 97.8 135.4 328.8 115.5 52.5 124.2 171.4 263.4 155.8 164.6 126.9 18.8 391.8 114.2 158.2 485.2 220.4 337.8 111.2 97.8 104.5 104.7 111.9 8.3 265.5 409.6 120.0 67.8 115.2 138.2 142.4 128.8 234.8 235.5 55.5 8.3 195.4 175.0 132.9 115.0 153.1 140.1 119.6 97.8 5.6 202.4 180.7 170.0 7.1 13.3 219.2 196.7 139.9 154.2 110.2 203.9 752.2 122.3 68.2 105.2 111.5 117.9 288.5 295.5 150.8 101.2 318.4 93.6 144.6 205.7 177.2 LYPLA1 "APT-1, LPL1" ENSG00000120992 "Lysophospholipase 1" O75608 8 54046367-54102017 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 787.7;Late spermatids: 796.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050941, HPA063151" Enhanced Approved Nucleoplasm,Cytosol NA NA 330000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 3: HMC-1 - Innate immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Cytosol" "HPA050941: AB_2681284, HPA063151: " "unprognostic (2.62e-2)" "unprognostic (1.28e-2)" "unprognostic (3.25e-3)" "unprognostic (9.42e-2)" "unprognostic (9.48e-2)" "unprognostic (3.56e-1)" "unprognostic (9.58e-2)" "unprognostic (2.05e-2)" "unprognostic (6.52e-3)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.58e-1)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (2.56e-3)" 25.8 30.3 8.8 31.8 7.6 43.6 45.0 10.5 12.7 23.3 14.7 42.6 44.4 19.7 16.1 55.0 22.9 25.9 40.9 7.9 10.8 63.4 83.5 25.9 49.0 9.9 9.5 11.7 23.8 40.8 8.8 50.4 9.1 35.0 42.1 45.9 35.5 15.0 54.5 41.4 42.8 24.3 9.7 30.2 35.4 65.1 10.3 28.8 28.4 70.7 52.0 63.1 27.5 10.0 124.0 69.3 85.9 78.7 31.0 49.4 109.8 71.7 41.6 65.0 61.1 53.2 116.7 214.8 83.6 47.2 70.5 80.7 122.8 119.9 89.8 78.9 70.0 148.8 37.9 80.0 50.8 91.4 196.1 44.6 103.8 50.8 114.0 55.6 171.6 91.6 154.5 63.4 91.3 32.7 141.1 69.9 129.3 206.3 31.5 85.3 45.2 99.3 100.2 163.6 45.2 77.6 50.1 93.6 113.4 81.0 137.0 81.7 83.4 39.0 56.9 68.7 67.8 89.3 143.8 194.0 52.9 97.1 78.7 93.7 80.7 111.1 44.8 79.6 44.6 73.0 42.2 43.5 92.3 64.4 42.1 41.1 49.3 69.6 108.2 59.7 75.5 98.3 8.8 7.6 10.5 12.7 7.9 10.8 9.9 9.5 9.1 9.7 10.3 10.0 60.4 28.9 53.3 19.9 83.8 61.7 94.8 96.6 82.6 34.9 103.8 64.0 70.8 57.2 71.8 62.5 52.1 199.7 74.5 70.4 303.3 82.8 787.7 86.6 34.7 69.3 57.5 50.0 30.0 89.0 318.3 36.4 74.9 96.3 49.5 31.5 81.4 120.1 121.0 18.5 43.7 77.3 99.7 108.4 83.3 796.2 28.3 82.6 74.7 25.3 102.1 36.9 69.0 20.6 9.8 127.4 63.7 23.0 104.5 171.0 91.6 194.3 62.9 70.3 46.0 24.5 43.1 92.1 239.1 118.2 81.1 334.2 57.0 94.0 90.2 229.7 LZIC MGC15436 ENSG00000162441 "Leucine zipper and CTNNBIP1 domain containing" Q8WZA0 1 9922113-9943407 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 304.7;Spermatocytes: 191.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028184, HPA058614" Approved Approved Nucleoplasm,Cytosol NA NA 160000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA028184: AB_10602706, HPA058614: AB_2683779" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (1.76e-2)" "unprognostic (1.62e-1)" "unprognostic (6.26e-2)" "unprognostic (8.37e-2)" "prognostic unfavorable (2.47e-5)" "unprognostic (2.89e-1)" "unprognostic (3.79e-3)" "unprognostic (7.84e-2)" "unprognostic (1.70e-3)" "unprognostic (1.23e-1)" "prognostic favorable (3.56e-5)" "unprognostic (1.19e-1)" "unprognostic (3.76e-3)" "unprognostic (1.50e-2)" "unprognostic (1.95e-2)" 20.6 18.1 20.2 18.8 24.4 19.4 25.5 24.8 23.4 24.3 16.2 28.5 29.0 25.9 16.2 22.9 23.7 18.1 29.6 19.8 21.2 28.9 30.4 17.0 21.9 24.0 24.1 35.0 13.4 29.2 12.3 22.3 24.2 21.9 27.6 25.9 20.9 19.8 27.3 20.1 27.1 24.8 24.2 15.8 16.7 66.9 21.6 30.0 24.6 27.5 23.8 18.1 15.3 28.4 43.0 27.8 52.5 37.2 32.0 51.9 23.3 38.1 32.1 52.8 50.9 34.6 73.4 51.6 42.3 48.1 33.3 31.9 49.7 55.1 78.7 48.5 33.5 75.7 34.9 57.9 30.7 69.7 37.5 34.3 77.0 74.1 69.2 37.6 41.8 67.4 95.6 28.7 49.1 30.5 57.3 33.8 26.6 53.7 44.5 60.7 69.4 41.9 28.5 19.2 26.1 41.2 46.6 20.2 91.2 49.9 33.5 35.1 38.6 36.5 49.6 52.4 40.8 23.2 57.5 87.4 37.3 101.7 49.6 34.9 25.1 40.3 20.5 29.5 17.8 18.4 20.6 20.1 24.8 20.4 20.1 21.2 25.6 23.2 33.2 38.0 29.3 17.5 20.2 24.4 24.8 23.4 19.8 21.2 24.0 24.1 24.2 24.2 21.6 28.4 34.3 6.4 17.3 6.8 20.7 12.7 21.9 24.1 17.6 12.0 22.6 27.3 57.4 10.0 15.9 7.3 6.2 26.9 26.9 25.9 49.0 27.0 304.7 34.7 36.4 19.9 9.1 24.0 11.1 21.2 45.7 27.8 13.3 27.0 30.4 27.2 14.3 23.9 42.7 42.1 14.8 18.1 10.2 22.6 15.7 91.6 26.4 34.9 14.2 14.0 36.8 45.6 20.6 13.6 23.8 22.6 27.8 27.4 22.4 27.6 41.7 53.0 27.4 18.0 19.7 26.6 31.1 191.3 86.2 29.2 16.8 34.5 26.8 21.4 22.5 21.6 MAP10 "KIAA1383, MTR120" ENSG00000212916 "Microtubule associated protein 10" Q9P2G4 1 232804892-232808407 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 12.3;Cone photoreceptor cells: 22.9;Spermatocytes: 11.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 6.8;NB-4: 6.7;REH: 5.5;THP-1: 10.1;U-937: 6.9" "Low region specificity" "Detected in all" HPA052496 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 43: THP-1 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA052496: AB_2681852" "unprognostic (2.70e-1)" "unprognostic (6.18e-2)" "unprognostic (4.41e-2)" "unprognostic (6.05e-2)" "unprognostic (4.41e-1)" "unprognostic (3.06e-2)" "unprognostic (1.87e-2)" "unprognostic (4.60e-1)" "unprognostic (6.84e-2)" "unprognostic (1.04e-1)" "unprognostic (6.26e-3)" "unprognostic (2.03e-2)" "unprognostic (1.73e-3)" "unprognostic (3.97e-2)" "unprognostic (3.42e-1)" "unprognostic (1.37e-1)" "unprognostic (7.98e-2)" 1.0 1.0 0.5 1.2 0.7 0.7 1.8 0.2 0.8 1.6 0.0 0.9 1.4 1.1 2.6 0.5 1.3 1.3 2.6 0.6 0.6 1.1 2.5 1.2 2.7 0.7 0.2 2.2 1.7 0.7 0.8 1.1 0.6 1.0 0.8 3.6 1.5 0.9 2.6 0.4 1.7 1.3 0.2 1.5 1.5 3.1 0.2 3.7 2.2 1.5 2.0 0.9 0.5 0.5 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.8 0.6 0.2 0.3 0.0 4.0 0.0 2.0 1.6 0.0 0.0 0.0 0.9 0.6 1.5 0.0 0.2 0.2 0.0 1.7 2.6 0.0 2.4 0.2 0.2 0.0 0.3 3.1 0.0 1.0 0.0 1.4 1.9 6.8 6.7 0.0 1.7 0.0 5.5 0.0 1.9 1.4 1.6 3.3 2.7 0.0 0.3 0.0 0.9 0.6 10.1 0.7 0.0 1.7 0.2 1.2 1.9 0.0 0.0 1.5 6.9 0.1 5.1 1.9 1.7 0.5 1.4 0.6 0.6 0.8 0.2 2.5 1.3 1.2 0.9 0.0 1.2 3.2 2.9 1.4 0.7 0.5 0.7 0.2 0.8 0.6 0.6 0.7 0.2 0.6 0.2 0.2 0.5 4.4 0.0 1.1 0.7 1.6 0.4 0.3 1.0 1.2 12.3 1.0 1.0 4.9 5.7 2.1 0.0 22.9 0.7 1.9 0.7 0.0 2.9 3.1 1.0 2.2 2.6 0.0 0.4 4.2 3.0 0.5 1.8 1.5 0.5 1.3 3.4 0.4 1.3 1.5 0.0 3.5 2.3 6.1 1.2 0.8 2.2 0.6 1.1 0.0 1.0 5.6 3.2 2.1 2.5 3.2 1.7 0.3 0.7 0.7 0.2 1.9 0.2 1.5 8.5 0.0 2.4 1.2 11.2 6.1 0.8 0.3 0.3 1.3 4.4 2.0 0.4 MAP3K7 "MEKK7, TAK1" ENSG00000135341 "Mitogen-activated protein kinase kinase kinase 7" O43318 6 90513573-90587072 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 137.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007633, HPA075335" Approved Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 21: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "Nuclear speckles, Plasma membrane" "HPA007633: AB_1079359, HPA075335: " "unprognostic (1.48e-1)" "unprognostic (3.45e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (1.44e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (9.77e-2)" "unprognostic (6.51e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-1)" "unprognostic (2.56e-3)" "unprognostic (4.76e-2)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (1.17e-1)" 11.8 12.5 13.1 12.5 15.1 8.7 14.3 15.6 17.3 14.3 11.7 11.6 9.2 16.6 16.5 10.6 11.0 12.7 16.9 14.7 14.9 11.4 11.6 10.4 16.4 15.3 13.7 15.8 9.7 16.3 13.0 17.4 15.8 14.9 10.9 23.5 12.1 13.3 16.9 13.9 9.8 14.0 15.3 17.6 10.8 9.9 13.8 20.8 14.7 18.4 16.8 14.3 12.2 22.4 16.7 14.4 41.3 35.6 29.5 39.1 29.0 32.7 37.7 28.8 36.1 18.6 15.5 36.9 20.4 35.6 25.6 17.3 26.3 25.5 48.7 19.0 27.7 32.9 19.9 24.9 30.8 36.9 24.4 32.5 30.5 28.2 34.2 33.1 27.4 31.8 67.0 29.3 41.8 20.3 17.2 31.2 34.0 25.7 18.0 29.3 73.9 18.0 24.2 18.4 20.8 29.5 22.9 15.6 24.8 32.2 15.5 64.7 26.5 23.3 14.7 21.6 30.9 25.9 24.7 15.8 35.7 39.7 35.0 18.2 11.5 18.4 12.8 15.9 14.5 13.0 12.3 12.5 14.6 9.9 13.7 13.4 11.5 17.9 17.6 8.9 20.8 13.4 13.1 15.1 15.6 17.3 14.7 14.9 15.3 13.7 15.8 15.3 13.8 22.4 16.1 16.0 26.9 47.0 24.3 36.3 20.8 19.5 21.6 23.3 17.9 12.3 31.0 14.3 16.9 16.5 27.1 31.8 17.8 12.4 7.9 17.6 3.6 10.9 19.8 21.2 12.1 14.1 85.7 20.9 34.6 23.2 16.3 14.8 13.9 25.9 25.7 20.7 24.3 28.6 63.8 13.7 20.3 27.3 24.6 3.2 26.8 21.7 21.4 36.5 35.2 19.6 16.5 50.8 137.2 20.1 9.1 41.0 18.8 30.1 11.1 16.6 21.4 21.5 19.7 28.0 18.5 25.9 24.9 21.3 37.2 48.4 22.7 18.1 15.1 24.8 MAPRE1 EB1 ENSG00000101367 "Microtubule associated protein RP/EB family member 1" Q15691 20 32819954-32850405 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003600, CAB009337, CAB019391" Supported Enhanced "Centriolar satellite,Cytosol" NA NA 11000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Centriolar satellite, Cytosol" "CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309" "unprognostic (3.74e-1)" "unprognostic (1.89e-1)" "unprognostic (2.68e-1)" "unprognostic (4.48e-3)" "unprognostic (2.98e-3)" "unprognostic (1.10e-2)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.25e-2)" "unprognostic (1.17e-1)" "unprognostic (7.24e-2)" "unprognostic (5.99e-2)" "unprognostic (6.05e-2)" "unprognostic (3.76e-2)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (5.42e-2)" "unprognostic (4.59e-3)" 66.7 44.5 41.2 69.7 46.7 192.7 48.3 45.3 45.5 45.9 41.9 69.0 39.7 61.0 52.9 62.7 44.8 57.4 58.2 37.0 50.0 54.1 30.4 50.6 75.8 48.0 52.5 37.8 40.4 38.3 24.3 66.8 47.9 56.0 58.0 16.1 32.7 70.6 34.1 34.7 41.2 91.3 47.7 57.7 43.9 54.4 47.5 88.0 74.1 39.7 69.3 83.1 37.8 47.0 179.7 161.4 176.6 102.0 93.5 84.3 250.7 171.3 106.3 261.0 191.0 470.0 161.9 271.2 167.4 154.8 265.6 159.9 213.1 191.6 283.7 92.4 83.1 523.3 105.0 253.2 98.7 190.6 222.8 91.6 94.1 213.8 141.7 89.3 165.0 151.4 240.0 150.6 232.4 111.0 263.0 166.2 127.6 182.7 147.5 174.4 312.8 145.9 143.0 121.8 109.7 115.3 307.2 134.3 179.4 160.6 194.3 140.0 147.5 291.9 157.7 147.3 224.7 131.5 194.5 289.6 154.9 428.3 166.0 256.8 125.8 262.1 100.1 150.8 104.0 75.1 94.1 92.9 97.4 81.8 94.6 104.3 139.7 111.1 170.6 89.5 107.1 185.6 41.2 46.7 45.3 45.5 37.0 50.0 48.0 52.5 47.9 47.7 47.5 47.0 71.6 19.2 30.2 8.1 67.0 132.8 194.4 48.1 62.0 11.1 54.7 42.3 36.5 25.8 44.5 55.2 8.4 108.0 82.0 67.6 84.1 68.8 90.2 43.5 44.7 64.8 71.5 52.8 7.8 78.3 130.0 61.4 40.8 60.9 115.4 45.7 39.3 14.9 107.0 10.1 8.5 43.6 36.7 94.6 121.2 76.6 35.8 99.5 71.2 12.2 120.5 36.5 92.7 7.5 12.6 75.0 40.5 64.3 71.1 115.3 32.6 74.3 39.4 11.5 65.7 61.5 102.8 72.1 62.1 65.2 110.8 169.2 89.8 76.6 44.4 123.1 MAT2B "MATIIbeta, SDR23E1" ENSG00000038274 "Methionine adenosyltransferase 2B" Q9NZL9 5 163503114-163519354 "Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037721, HPA037722" Uncertain Approved "Plasma membrane" NA NA 1100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 59: Non-specific - Transcription" "Plasma membrane" "HPA037721: AB_10672389, HPA037722: AB_10671718" "unprognostic (1.22e-2)" "unprognostic (2.80e-2)" "unprognostic (1.80e-3)" "unprognostic (1.64e-1)" "unprognostic (5.06e-1)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (9.72e-2)" "unprognostic (1.68e-1)" "unprognostic (5.19e-3)" "unprognostic (3.57e-2)" "prognostic favorable (4.51e-7)" "unprognostic (1.06e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-3)" 36.6 54.6 31.1 64.7 32.4 31.1 50.5 35.3 39.8 46.9 37.5 61.5 86.9 45.4 59.4 40.9 66.7 42.1 75.3 32.8 33.7 104.8 82.7 56.1 102.6 32.2 35.3 73.3 23.9 69.2 22.0 48.9 33.3 46.1 66.5 47.8 64.3 53.2 57.8 34.6 84.4 44.4 34.6 84.5 57.2 31.7 33.3 89.6 81.4 63.7 92.7 60.9 33.2 34.0 72.4 60.0 100.6 55.1 73.4 72.9 62.2 61.8 68.5 67.7 99.4 41.5 128.5 74.8 127.6 66.0 99.5 56.6 84.8 125.4 89.1 254.5 69.6 67.3 63.3 62.1 95.9 71.0 44.7 60.4 101.1 86.1 66.4 81.8 149.5 76.6 54.8 90.8 84.0 40.7 99.2 85.9 38.6 43.9 40.0 112.4 49.2 123.4 111.7 76.6 40.4 57.9 82.8 58.2 93.8 44.1 76.5 95.1 121.2 73.6 48.5 51.8 107.7 78.4 82.3 68.3 54.1 129.1 51.3 619.4 227.5 477.4 321.5 274.3 355.8 359.1 351.2 349.3 204.6 345.3 352.7 341.4 357.8 401.5 302.4 167.2 528.3 689.9 31.1 32.4 35.3 39.8 32.8 33.7 32.2 35.3 33.3 34.6 33.3 34.0 24.9 48.1 43.3 8.8 90.1 42.7 35.1 75.6 129.1 23.2 26.0 20.7 57.7 41.5 48.1 44.1 8.4 61.3 62.8 49.2 62.6 38.8 39.0 63.5 36.2 38.9 15.0 79.3 15.0 26.2 29.7 34.6 36.2 44.2 28.4 28.1 35.7 58.3 45.3 18.5 12.8 40.8 61.1 83.3 55.3 13.3 34.5 48.5 42.7 18.7 70.6 41.7 80.3 9.0 16.2 28.9 38.1 31.2 65.7 46.8 53.4 103.7 72.6 17.6 46.0 21.7 35.6 23.6 30.5 69.8 36.2 37.6 84.2 23.3 51.3 45.7 MED4 "DRIP36, HSPC126, TRAP36, VDRIP" ENSG00000136146 "Mediator complex subunit 4" Q9NPJ6 13 48053323-48095131 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006232 Approved Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA006232: AB_1079351" "unprognostic (1.10e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-1)" "unprognostic (2.80e-1)" "unprognostic (5.79e-1)" "unprognostic (2.56e-2)" "unprognostic (4.09e-1)" "unprognostic (7.97e-2)" "unprognostic (7.34e-3)" "unprognostic (3.21e-1)" "unprognostic (2.35e-1)" "unprognostic (2.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.86e-3)" "unprognostic (6.54e-3)" "unprognostic (1.94e-2)" "unprognostic (1.84e-1)" 44.2 34.1 26.5 34.0 26.0 78.6 46.7 33.6 35.1 37.2 25.2 41.3 40.6 40.3 43.5 41.1 31.2 32.9 49.4 26.5 26.7 38.4 51.4 36.9 46.7 25.7 25.5 31.9 27.4 43.2 31.4 45.6 27.0 36.7 46.4 41.4 33.6 38.5 57.7 39.9 41.1 43.2 25.7 35.9 33.9 55.9 26.2 63.7 41.1 58.4 55.5 43.4 35.8 28.4 40.2 25.8 86.1 47.8 55.8 71.4 59.5 57.1 70.9 66.8 47.1 49.3 66.9 65.2 16.0 60.5 41.3 59.6 63.1 54.2 86.7 85.0 51.9 85.6 49.5 77.6 51.7 128.1 76.4 49.6 75.2 39.7 58.2 65.2 63.1 64.8 61.9 40.7 75.5 40.6 121.3 121.4 85.4 128.2 33.5 87.4 58.3 52.9 87.0 61.7 38.0 61.2 46.5 57.8 63.4 55.5 49.3 94.6 51.1 37.5 43.4 47.0 52.7 39.2 61.7 100.2 32.2 65.9 72.6 105.0 65.5 106.3 74.6 70.0 82.6 65.4 84.2 76.6 64.5 58.0 80.4 77.0 69.8 86.6 74.3 58.5 101.6 91.2 26.5 26.0 33.6 35.1 26.5 26.7 25.7 25.5 27.0 25.7 26.2 28.4 71.3 96.1 53.4 12.7 71.1 91.3 72.8 164.9 34.7 51.5 48.1 42.9 100.8 60.1 116.5 57.0 16.7 116.4 96.0 51.7 152.6 79.4 87.9 46.4 69.8 73.8 26.9 106.9 24.7 63.4 104.4 74.1 31.6 60.5 98.1 43.9 59.3 66.8 70.3 37.0 20.1 51.2 124.1 51.9 65.4 185.6 76.7 51.2 78.2 14.0 136.6 65.2 102.0 20.1 20.4 66.8 67.4 77.5 46.5 69.7 66.1 100.1 62.8 50.2 52.6 58.7 78.7 141.4 162.8 48.6 97.3 134.9 79.4 61.1 56.9 71.5 MIEN1 "C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4" ENSG00000141741 "Migration and invasion enhancer 1" Q9BRT3 17 39728496-39730532 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 14 "OE19: 1667.9;SK-BR-3: 502.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056650, HPA061344" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane, Cytosol" Nucleoplasm "HPA056650: , HPA061344: AB_2684484" "unprognostic (2.48e-1)" "unprognostic (3.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.13e-2)" "unprognostic (3.04e-1)" "unprognostic (1.17e-1)" "unprognostic (4.47e-2)" "unprognostic (8.37e-2)" "unprognostic (6.72e-2)" "unprognostic (2.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.17e-1)" "unprognostic (2.99e-2)" "unprognostic (3.70e-1)" "unprognostic (2.00e-1)" "unprognostic (3.88e-3)" "unprognostic (2.22e-3)" 29.1 35.9 33.4 17.5 35.4 27.0 31.5 36.2 44.8 31.1 34.2 42.4 26.3 29.0 14.6 47.3 27.2 12.1 49.5 32.5 35.3 57.2 53.7 29.6 20.2 34.5 34.8 18.5 40.7 21.6 39.6 13.5 34.5 46.3 12.8 4.8 46.2 13.8 47.2 35.0 37.5 9.5 32.9 36.2 48.5 41.3 35.4 13.9 37.0 5.3 13.7 31.0 32.0 37.2 38.8 59.7 13.4 34.5 16.3 12.0 16.2 40.7 21.4 24.2 23.6 12.9 27.2 28.1 55.5 15.1 39.0 47.1 15.6 13.8 8.2 58.2 65.8 26.5 29.8 36.5 28.2 33.9 39.2 10.8 23.3 11.7 12.0 18.8 15.6 52.9 38.2 48.9 14.7 22.5 70.1 38.2 12.5 1667.9 26.4 32.2 23.6 56.8 12.2 21.8 43.6 41.7 40.8 502.3 70.7 12.0 66.1 48.1 41.5 16.4 41.8 78.9 47.1 62.3 62.8 55.1 64.5 41.1 32.4 138.5 76.2 107.3 80.1 100.9 43.4 109.2 56.2 72.3 54.5 88.3 43.9 63.1 132.9 58.7 104.2 79.4 94.6 119.9 33.4 35.4 36.2 44.8 32.5 35.3 34.5 34.8 34.5 32.9 35.4 37.2 59.8 44.8 64.2 7.8 60.9 60.2 138.1 185.1 95.6 25.7 127.0 114.2 59.6 82.9 129.3 99.3 4.2 150.2 69.1 226.6 303.3 137.0 136.2 81.6 48.7 58.9 188.8 72.0 11.0 176.1 74.4 50.9 76.5 77.3 81.8 43.8 54.7 118.9 148.0 35.3 9.6 178.3 254.3 101.3 42.8 76.7 42.3 81.3 138.7 12.2 80.1 90.7 130.7 4.5 20.8 216.8 283.7 49.7 54.0 194.8 188.5 224.9 122.1 17.3 46.0 31.5 61.1 108.5 68.0 131.7 70.3 266.1 65.4 51.7 128.1 204.0 MMADHC "C2orf25, cblD, CL25022" ENSG00000168288 "Metabolism of cobalamin associated D" Q9H3L0 2 149569637-149587778 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037531, HPA037532" Supported NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA037531: AB_10671628, HPA037532: AB_2675526" "unprognostic (5.67e-2)" "unprognostic (8.86e-2)" "unprognostic (1.98e-2)" "unprognostic (1.80e-3)" "unprognostic (1.15e-1)" "unprognostic (2.07e-3)" "unprognostic (8.17e-2)" "unprognostic (4.18e-3)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (3.14e-2)" "unprognostic (5.64e-2)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (3.54e-1)" "unprognostic (1.16e-1)" 64.9 62.5 32.0 53.0 33.3 144.3 96.7 36.1 40.7 71.0 38.9 78.0 66.4 68.3 55.5 88.7 64.6 58.0 113.9 32.9 34.7 97.1 195.1 53.7 75.3 33.8 33.0 67.6 86.9 91.7 38.6 76.5 34.5 76.7 90.1 37.8 86.0 69.5 201.2 85.5 62.1 79.0 35.5 56.2 68.7 70.4 34.3 88.8 65.8 187.8 93.3 85.7 57.6 36.9 124.8 90.8 113.9 282.4 134.4 222.9 173.9 198.7 262.0 204.8 175.1 174.8 135.3 199.0 109.5 214.0 121.1 156.7 160.8 203.2 257.5 134.9 130.4 159.0 111.0 193.4 218.0 241.0 145.6 180.2 204.4 265.7 273.1 190.3 233.8 130.5 216.2 205.3 245.0 134.7 106.3 151.8 163.6 168.5 182.9 129.2 130.5 170.9 219.4 209.6 144.0 80.4 148.4 135.4 196.7 122.7 139.6 133.4 160.1 162.5 153.4 120.8 155.2 130.1 177.2 213.9 159.5 143.9 220.6 183.5 77.1 129.6 75.0 87.4 88.3 103.2 94.0 83.4 113.8 85.2 98.4 81.5 150.0 119.7 106.0 96.3 124.0 119.8 32.0 33.3 36.1 40.7 32.9 34.7 33.8 33.0 34.5 35.5 34.3 36.9 50.3 48.1 57.4 12.1 78.3 131.7 183.9 262.2 106.4 24.7 64.2 70.0 162.8 80.1 147.3 49.7 12.5 150.4 63.2 76.7 201.5 148.8 179.9 68.6 48.0 77.5 97.4 156.5 14.7 186.0 178.7 86.5 82.6 53.5 66.0 47.5 79.9 135.6 129.5 20.2 21.1 128.2 166.8 101.9 69.3 46.4 66.5 67.2 78.2 11.2 93.8 55.9 87.6 18.1 19.1 154.5 80.1 78.2 125.8 177.3 95.9 215.0 143.2 19.2 98.6 74.3 89.7 223.0 53.6 114.2 141.5 245.0 68.1 90.3 87.1 237.0 MPC2 "BRP44, DKFZP564B167, SLC54A2" ENSG00000143158 "Mitochondrial pyruvate carrier 2" O95563 1 167916675-167937072 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 2288.1;Late spermatids: 5134.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056091 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" "HPA056091: AB_2683035" "unprognostic (3.25e-1)" "unprognostic (6.82e-2)" "unprognostic (8.79e-3)" "unprognostic (4.15e-2)" "unprognostic (3.47e-1)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (1.53e-1)" "unprognostic (7.93e-2)" "unprognostic (3.36e-3)" "unprognostic (1.44e-3)" "unprognostic (1.08e-2)" "unprognostic (9.13e-2)" "unprognostic (2.39e-1)" "unprognostic (6.95e-2)" "unprognostic (5.43e-2)" "unprognostic (1.67e-1)" 53.6 89.9 32.3 15.8 37.1 63.3 50.7 34.2 39.0 34.3 35.0 80.3 47.8 30.6 15.8 38.8 34.5 19.6 174.0 36.8 35.6 148.1 266.6 35.1 14.0 31.8 33.4 35.3 52.4 35.6 73.5 13.8 31.6 89.3 33.7 28.4 55.3 16.0 162.1 42.5 65.8 14.8 31.5 28.9 140.4 240.4 34.9 20.1 32.3 66.3 15.0 43.0 35.4 34.4 40.7 43.2 14.6 32.3 31.5 26.2 4.1 70.2 26.9 23.7 27.2 92.3 19.6 75.0 49.4 29.1 21.4 31.4 17.0 28.1 20.3 98.3 34.5 33.2 34.1 60.7 22.4 38.1 21.9 19.6 23.6 41.8 21.8 20.0 20.3 52.5 39.6 34.9 38.7 18.1 52.4 31.4 26.2 73.7 45.2 27.8 31.3 54.7 155.0 30.5 25.8 28.4 41.6 39.1 34.3 29.2 73.9 38.9 30.4 27.8 24.8 45.3 29.9 61.2 65.9 74.5 73.5 28.6 14.6 95.0 33.1 92.5 44.1 30.5 45.7 50.2 51.6 45.8 58.7 41.3 48.6 46.7 61.4 55.6 38.5 40.2 81.3 84.2 32.3 37.1 34.2 39.0 36.8 35.6 31.8 33.4 31.6 31.5 34.9 34.4 81.6 35.3 43.7 14.4 75.0 126.1 157.7 213.8 52.9 54.5 167.2 166.9 428.0 513.3 119.2 130.6 22.9 468.6 78.2 267.5 1025.2 206.1 2288.1 153.3 38.5 75.0 331.5 388.3 23.5 145.5 55.3 119.3 112.1 98.3 88.2 332.1 55.3 679.5 159.6 45.4 19.9 326.4 146.5 77.1 113.3 5134.8 106.2 93.9 120.9 15.9 272.9 123.8 76.2 13.0 16.8 100.5 237.2 112.8 84.7 245.6 516.2 974.3 175.3 69.7 65.7 90.3 147.1 788.0 170.5 75.3 114.4 343.1 94.9 705.0 415.5 173.9 MPLKIP "C7orf11, ORF20, TTDN1" ENSG00000168303 "M-phase specific PLK1 interacting protein" Q8TAP9 7 40126027-40134622 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058457, HPA065463" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Golgi apparatus, Vesicles" "HPA058457: AB_2683724, HPA065463: AB_2685493" "unprognostic (5.59e-2)" "unprognostic (1.74e-1)" "unprognostic (9.40e-2)" "unprognostic (2.39e-2)" "unprognostic (5.55e-2)" "unprognostic (1.34e-3)" "unprognostic (2.73e-1)" "unprognostic (3.40e-2)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (3.16e-3)" "unprognostic (8.89e-2)" "unprognostic (1.61e-2)" "unprognostic (8.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-2)" "unprognostic (6.08e-2)" 2.9 3.8 2.6 2.0 2.6 2.4 2.8 4.7 3.0 2.8 3.0 2.8 2.2 2.6 2.0 3.1 2.5 1.2 2.1 2.6 2.3 4.2 8.0 2.1 2.6 2.4 2.3 2.8 2.9 2.5 3.0 1.8 2.6 2.5 1.8 3.1 2.7 1.5 2.4 3.0 2.6 1.1 2.0 3.1 2.4 2.3 2.5 3.3 3.0 1.4 2.0 2.5 2.7 4.0 8.2 2.5 4.8 6.6 4.3 4.9 4.9 3.1 3.3 4.4 4.3 3.1 4.0 6.8 4.2 3.0 8.7 10.3 3.0 5.3 5.6 5.2 9.2 5.4 3.7 6.9 4.9 6.7 5.2 4.8 6.7 3.4 4.1 4.5 5.1 7.5 13.1 5.5 4.4 4.1 6.8 20.4 6.7 6.7 7.4 9.6 3.3 8.9 5.0 2.1 7.1 8.4 5.0 4.8 7.7 6.2 6.1 9.3 5.5 2.8 7.5 3.6 4.7 8.6 9.6 10.9 4.4 10.5 7.6 20.6 11.2 16.8 8.0 10.8 9.0 16.9 10.1 9.4 11.8 15.3 11.3 9.9 9.2 10.6 10.4 13.1 14.2 13.1 2.6 2.6 4.7 3.0 2.6 2.3 2.4 2.3 2.6 2.0 2.5 4.0 49.8 51.3 34.5 6.5 53.3 110.1 96.2 151.8 58.6 43.5 53.8 66.2 18.0 67.2 79.6 58.8 25.0 110.8 41.3 60.3 117.4 66.6 118.4 73.6 62.3 58.0 48.6 52.2 7.4 54.6 79.7 51.1 35.7 56.6 51.3 63.6 47.2 133.4 69.0 53.8 8.1 63.4 85.5 59.3 62.6 38.6 75.8 50.4 58.7 7.5 74.6 52.9 66.9 12.1 12.5 59.9 97.2 55.3 36.3 76.2 61.6 190.5 91.1 50.1 52.6 57.1 58.4 66.6 53.9 67.1 134.1 95.6 46.8 125.7 82.3 105.7 MR1 HLALS ENSG00000153029 "Major histocompatibility complex, class I-related" Q95460 1 181033425-181061938 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA048304 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane" "HPA048304: AB_2680347" "unprognostic (6.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.31e-2)" "unprognostic (1.96e-1)" "unprognostic (8.66e-3)" "unprognostic (4.37e-2)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.18e-1)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.05e-2)" "unprognostic (7.40e-3)" "unprognostic (4.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.07e-2)" 8.6 9.6 3.2 14.2 3.3 11.1 9.7 2.2 3.5 10.2 5.8 6.7 7.4 9.5 9.6 9.6 10.4 12.7 6.2 3.1 3.8 9.9 10.6 18.0 14.6 4.7 3.3 13.6 3.7 14.0 8.9 13.5 3.7 10.9 8.1 1.5 5.9 10.5 2.1 8.7 6.9 12.5 3.8 12.3 8.7 2.6 4.4 20.2 16.7 3.8 15.2 16.3 7.4 4.8 7.9 5.4 0.1 4.6 32.2 38.8 13.9 15.5 42.2 12.7 21.5 2.2 31.9 9.7 31.6 28.1 9.9 20.5 0.7 18.3 11.1 29.6 5.2 14.2 5.6 9.8 10.8 11.5 40.6 25.2 49.6 18.9 20.3 23.7 1.3 17.8 26.7 25.6 24.9 8.8 12.1 8.3 0.1 0.1 0.8 13.7 0.3 27.3 13.9 23.1 0.2 0.3 8.2 14.8 10.9 6.0 15.4 24.6 8.1 12.5 1.7 21.8 7.7 42.2 15.3 17.9 11.7 14.7 1.2 32.6 21.8 22.9 16.3 27.4 14.6 14.3 14.6 14.6 18.8 18.3 10.8 16.2 14.7 19.0 23.6 10.2 17.0 15.2 3.2 3.3 2.2 3.5 3.1 3.8 4.7 3.3 3.7 3.8 4.4 4.8 4.4 19.2 32.4 8.8 14.7 5.0 8.3 32.6 12.0 0.8 7.7 6.1 4.1 8.6 20.9 14.7 0.0 17.5 15.9 1.6 5.9 10.8 0.3 5.9 12.1 4.9 2.4 11.4 3.1 6.4 9.5 12.8 2.6 7.3 17.1 13.5 3.6 8.9 25.8 0.0 1.7 2.7 32.6 25.2 9.1 0.4 10.8 25.3 7.2 11.2 30.8 4.1 26.8 0.0 0.5 7.5 4.5 12.0 9.1 7.4 2.2 2.4 15.3 0.6 0.0 8.6 9.2 0.4 1.6 10.9 5.4 24.5 15.7 22.4 3.5 13.4 MRFAP1 "PAM14, PGR1" ENSG00000179010 "Morf4 family associated protein 1" Q9Y605 4 6640091-6642745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB042447, HPA056367" Approved Supported Nucleoplasm No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "CAB042447: AB_2145271, HPA056367: AB_2683107" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (3.82e-2)" "unprognostic (1.31e-2)" "unprognostic (7.03e-2)" "unprognostic (9.55e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-3)" "unprognostic (1.30e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-3)" "unprognostic (1.02e-1)" "prognostic favorable (2.90e-7)" "unprognostic (1.24e-1)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" 227.9 291.8 348.2 126.4 355.0 108.2 209.1 360.6 382.1 222.2 330.6 254.2 147.1 254.8 207.9 189.0 221.4 134.3 260.4 335.9 359.7 266.1 245.3 203.4 114.8 409.8 362.8 243.2 156.1 260.7 262.1 194.2 367.5 193.0 132.7 165.7 164.8 207.0 372.3 179.8 163.4 215.1 358.3 181.3 196.1 154.7 359.7 131.0 177.7 308.2 132.8 220.3 194.6 389.3 344.4 371.8 311.7 360.9 373.9 336.6 245.7 444.2 407.3 401.1 398.9 368.7 362.7 214.4 333.0 411.9 455.0 192.2 425.4 462.3 482.5 85.4 306.6 319.6 430.5 405.8 349.7 241.6 151.2 351.0 416.2 369.2 371.6 380.2 452.2 185.9 427.9 136.4 401.2 432.5 182.2 565.1 387.7 297.6 472.6 233.6 564.5 182.3 490.3 255.6 488.0 381.6 287.7 204.2 429.7 270.4 569.8 291.2 408.6 350.3 235.2 262.6 592.2 196.8 266.4 351.5 362.5 507.6 347.7 202.0 186.2 163.2 126.9 154.0 127.9 89.4 125.3 127.0 177.8 94.8 127.8 126.3 198.6 137.1 153.1 143.8 147.1 196.4 348.2 355.0 360.6 382.1 335.9 359.7 409.8 362.8 367.5 358.3 359.7 389.3 141.8 160.3 158.9 14.4 84.7 188.5 262.6 155.6 130.9 113.9 148.6 155.2 227.0 163.0 124.4 88.3 16.7 547.5 103.7 83.8 219.2 241.8 43.1 161.8 184.2 196.4 178.1 123.1 18.7 204.2 312.7 197.2 69.8 166.8 150.4 141.4 171.4 179.7 200.4 111.0 20.9 129.7 130.2 144.4 114.1 65.1 314.0 106.8 126.3 12.2 158.5 270.7 113.3 12.5 33.7 189.0 121.3 304.6 61.1 257.3 168.0 252.6 126.0 111.5 216.9 230.7 197.7 349.3 211.8 126.3 173.8 322.2 121.4 337.1 138.3 236.7 MRPL28 "MAAT1, p15" ENSG00000086504 "Mitochondrial ribosomal protein L28" Q13084 16 366969-371289 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030594, CAB033542, HPA055589" Supported Supported Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Mitochondria "CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855" "unprognostic (2.39e-1)" "unprognostic (7.39e-3)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.15e-2)" "unprognostic (9.92e-2)" "unprognostic (2.92e-1)" "unprognostic (3.45e-3)" "unprognostic (6.76e-2)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (4.36e-1)" "unprognostic (2.60e-1)" "unprognostic (6.56e-2)" 43.3 63.2 43.2 25.8 46.6 43.7 43.6 41.6 55.9 40.8 39.9 48.9 31.4 47.0 20.6 58.0 39.4 23.3 101.0 46.9 42.7 74.9 79.9 38.7 30.4 41.2 41.7 36.4 32.2 46.6 44.0 21.1 42.5 45.3 18.1 20.4 37.9 23.8 87.6 45.9 43.0 25.8 41.2 52.2 43.8 85.2 42.2 36.8 44.2 59.3 27.1 43.1 42.3 43.9 72.8 135.8 68.3 82.9 37.9 48.6 90.1 82.6 107.3 147.2 143.2 175.4 95.9 105.5 88.6 85.0 75.3 87.6 107.8 172.6 78.2 95.4 211.8 78.7 110.0 149.2 123.9 98.1 96.1 73.8 84.6 136.3 110.5 69.0 109.5 99.5 143.8 75.6 93.0 249.0 152.9 98.2 109.1 72.3 82.5 181.7 85.2 149.1 121.4 41.3 115.2 102.4 102.5 100.3 84.6 66.4 131.1 92.4 85.5 86.0 118.6 70.8 92.4 111.1 100.3 143.0 60.0 68.4 140.8 95.4 105.7 122.1 71.0 107.2 59.1 93.3 62.0 68.9 96.6 105.0 43.0 54.7 120.5 79.3 115.1 119.0 125.8 97.9 43.2 46.6 41.6 55.9 46.9 42.7 41.2 41.7 42.5 41.2 42.2 43.9 44.2 38.5 34.1 8.5 43.6 34.7 50.4 134.5 25.6 34.8 35.6 36.4 55.4 40.0 69.0 69.9 8.4 87.0 46.8 70.2 193.7 112.5 97.7 35.3 30.0 44.9 64.1 51.3 5.8 111.9 108.0 41.2 37.2 31.2 26.6 57.2 47.2 66.6 99.7 28.6 5.0 54.6 77.3 66.5 36.1 232.6 38.2 47.8 71.2 2.8 136.1 56.1 45.3 3.0 5.4 107.0 76.5 38.4 47.2 46.7 106.3 180.0 55.4 42.5 39.5 31.0 61.9 122.2 50.5 38.9 32.4 45.8 37.1 86.6 65.8 52.9 MRPS36 "DC47, MRP-S36" ENSG00000134056 "Mitochondrial ribosomal protein S36" P82909 5 69217760-69230158 "Predicted intracellular proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 546.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035802, HPA056795" Supported Enhanced Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA035802: AB_10600933, HPA056795: AB_2683237" "unprognostic (1.19e-1)" "unprognostic (6.78e-3)" "unprognostic (4.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (2.96e-3)" "unprognostic (1.99e-1)" "unprognostic (7.49e-2)" "unprognostic (1.49e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-1)" "unprognostic (3.90e-1)" "prognostic favorable (5.02e-6)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.37e-2)" "unprognostic (4.84e-3)" 20.3 18.4 20.1 12.7 20.3 21.0 16.5 21.3 26.3 12.7 20.2 23.6 24.1 12.8 15.4 20.3 12.7 10.4 67.3 20.1 21.5 49.2 38.0 14.7 15.1 20.3 20.6 12.4 14.7 31.3 9.8 13.0 20.6 14.4 24.3 18.9 13.7 12.1 47.0 12.6 24.0 12.4 20.3 11.6 21.8 8.6 20.8 15.7 17.2 67.7 16.7 16.6 14.0 20.5 29.2 27.6 19.1 26.4 32.8 33.1 50.3 25.6 24.5 32.1 39.4 38.6 31.8 31.2 51.9 21.8 71.8 29.3 32.1 38.8 31.7 36.8 33.6 21.3 31.4 43.4 38.7 22.9 27.9 34.6 27.3 30.7 14.5 33.4 24.0 31.9 25.7 22.9 28.7 31.8 35.3 34.9 14.2 26.8 31.9 20.6 33.2 47.9 56.4 32.5 26.6 25.9 26.2 37.9 46.3 30.9 29.0 32.9 17.6 14.3 24.5 32.0 44.5 23.9 41.9 41.6 25.0 42.1 19.1 36.3 22.1 29.3 22.7 32.0 25.4 31.1 25.7 25.8 27.9 25.0 22.8 24.7 25.1 26.5 30.2 27.4 40.3 17.7 20.1 20.3 21.3 26.3 20.1 21.5 20.3 20.6 20.6 20.3 20.8 20.5 64.5 115.4 83.6 16.3 76.5 81.4 101.1 204.0 83.1 26.3 72.4 109.3 333.1 97.2 104.3 88.3 14.6 126.8 67.5 220.5 401.1 118.4 127.7 123.3 79.5 57.2 92.8 97.2 20.4 139.5 192.4 68.6 67.2 113.0 56.4 41.4 52.1 216.1 127.1 28.6 21.4 162.8 120.1 102.4 67.5 45.2 64.7 72.9 106.7 10.3 142.0 61.8 56.7 10.6 17.1 137.1 190.1 69.2 60.5 100.5 256.6 546.3 86.4 45.9 72.3 78.7 92.3 66.1 37.9 86.9 76.9 123.3 64.2 76.9 168.1 114.6 MTIF3 "IF-3mt, IF3(mt)" ENSG00000122033 "Mitochondrial translational initiation factor 3" Q9H2K0 13 27435643-27450591 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 610.0;Proximal tubular cells: 475.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039791 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoplasm "HPA039791: AB_10795296" "unprognostic (1.82e-1)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (3.26e-3)" "unprognostic (1.49e-2)" "unprognostic (8.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (1.64e-2)" "unprognostic (1.62e-1)" "unprognostic (2.40e-1)" "unprognostic (3.24e-2)" "unprognostic (1.13e-1)" "unprognostic (9.27e-2)" "prognostic favorable (8.41e-4)" 61.8 55.0 59.5 29.2 59.8 17.1 51.0 61.0 93.4 36.7 60.4 46.7 42.8 28.4 67.1 39.9 30.4 37.0 133.4 59.0 61.7 63.1 65.5 29.2 44.5 60.9 60.2 37.1 54.4 43.4 50.8 30.9 60.9 45.3 44.6 74.7 82.9 43.9 90.8 39.9 41.8 30.5 58.8 49.6 48.1 61.8 60.6 47.3 36.9 109.8 46.1 36.7 34.0 62.0 29.9 21.9 48.5 23.5 53.2 78.8 22.6 44.0 51.1 33.8 33.8 28.3 37.5 33.3 28.4 50.8 22.8 25.1 27.2 37.1 46.3 34.3 31.2 42.6 19.1 36.7 52.2 43.8 38.8 44.6 65.5 27.7 35.1 75.6 60.0 33.8 24.0 13.6 51.2 54.0 39.7 54.2 24.4 100.1 24.0 22.8 24.3 37.5 69.8 31.3 32.9 20.6 28.4 39.1 50.7 51.8 31.3 62.5 38.1 21.4 12.5 56.1 29.5 10.0 14.9 19.1 21.5 44.3 31.1 85.8 53.0 75.4 30.8 51.2 32.9 49.1 38.9 31.1 55.2 42.8 34.0 35.2 36.5 37.2 48.3 88.2 47.4 41.3 59.5 59.8 61.0 93.4 59.0 61.7 60.9 60.2 60.9 58.8 60.6 62.0 88.5 28.9 47.4 29.0 74.0 34.0 34.0 103.9 43.9 0.0 91.6 95.4 179.1 87.2 76.3 115.8 0.0 102.6 60.4 102.2 326.8 89.6 610.0 93.7 63.4 70.3 64.1 59.7 22.8 104.1 67.0 62.7 47.4 74.5 71.7 50.6 79.9 223.0 102.3 0.0 26.4 112.8 103.7 114.8 50.2 283.4 139.8 67.7 106.7 24.4 106.4 0.0 80.3 30.7 43.7 98.3 108.8 124.8 71.1 43.7 142.8 475.5 83.2 0.0 124.9 48.8 69.2 243.6 87.6 62.8 42.5 56.8 58.5 69.6 96.8 44.8 MVB12A "FAM125A, FLJ32495" ENSG00000141971 "Multivesicular body subunit 12A" Q96EY5 19 17405722-17433724 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041885, HPA042231" Approved Supported Vesicles NA No "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA041885: AB_10964218, HPA042231: AB_10961043" "unprognostic (1.34e-2)" "prognostic favorable (3.26e-4)" "unprognostic (1.48e-1)" "unprognostic (2.35e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" "unprognostic (5.96e-3)" "unprognostic (8.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.77e-1)" "unprognostic (9.93e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.75e-1)" "unprognostic (1.33e-2)" 21.3 28.4 10.5 17.3 11.5 18.2 21.4 11.4 12.3 18.6 11.8 16.7 29.1 17.3 7.4 29.5 22.0 18.7 13.1 10.0 10.3 20.2 19.9 15.5 21.7 14.0 11.0 34.0 20.0 22.2 7.4 19.2 11.6 13.7 11.6 1.2 24.2 17.5 14.4 24.7 22.0 11.6 12.3 22.3 20.9 5.2 11.4 24.0 21.2 12.4 19.3 17.0 18.0 13.5 51.2 23.4 12.1 33.9 15.7 28.8 71.1 18.3 28.4 33.8 40.8 20.1 60.5 32.7 52.7 28.2 28.8 25.5 19.5 35.5 9.0 37.6 60.7 9.5 41.8 44.0 50.3 13.0 29.1 28.2 28.5 29.1 18.0 25.5 40.7 29.9 26.8 65.2 15.6 32.2 24.6 26.2 17.0 40.8 63.9 34.7 14.8 53.1 32.4 21.2 25.3 40.7 19.6 30.2 77.6 10.9 40.1 30.9 21.7 31.5 18.4 35.1 20.5 59.3 72.9 35.0 34.1 49.3 38.9 57.4 61.7 42.9 33.0 66.9 31.0 23.3 34.0 32.0 60.5 29.8 28.0 27.5 36.0 38.2 53.4 53.3 57.2 36.2 10.5 11.5 11.4 12.3 10.0 10.3 14.0 11.0 11.6 12.3 11.4 13.5 67.5 9.6 8.2 5.9 16.4 39.0 41.4 65.1 42.1 5.3 53.6 61.8 5.6 48.6 33.5 46.0 6.2 60.7 18.1 85.0 54.8 78.7 13.5 30.1 26.8 47.7 26.5 8.4 2.2 48.4 99.0 38.6 43.3 30.2 21.6 45.7 62.4 28.0 72.3 3.3 3.2 48.5 50.8 44.9 30.8 16.3 43.5 31.2 32.0 11.2 46.7 32.7 19.6 4.0 7.3 63.4 84.1 47.0 23.5 19.0 104.4 61.3 36.4 13.8 6.6 22.8 40.9 11.8 12.3 58.3 43.9 40.6 21.2 44.3 57.1 45.0 MYCBP AMY-1 ENSG00000214114 "MYC binding protein" Q99417 1 38862493-38873368 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 106.0;Respiratory ciliated cells: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041188, HPA078331" Supported Approved Nucleoplasm,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: AB_2686882" "unprognostic (2.42e-2)" "unprognostic (6.60e-2)" "unprognostic (3.85e-3)" "unprognostic (9.46e-3)" "unprognostic (8.77e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.03e-6)" "unprognostic (7.59e-2)" "unprognostic (3.00e-3)" "unprognostic (5.03e-3)" "unprognostic (4.41e-3)" "unprognostic (2.34e-3)" "unprognostic (5.81e-3)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (2.41e-2)" 11.5 11.0 2.6 16.9 3.4 16.1 18.7 3.4 4.3 12.5 3.7 22.6 16.3 9.6 17.4 23.1 27.1 11.3 8.4 2.4 2.9 18.0 11.5 12.4 16.3 5.6 7.4 6.7 16.1 18.6 8.7 19.3 4.5 14.9 22.5 8.6 16.8 16.1 12.1 13.2 21.6 11.7 2.7 11.2 16.1 15.5 3.2 12.6 18.5 5.6 17.9 16.8 11.7 5.6 51.3 22.5 18.0 13.0 10.7 18.4 74.4 38.9 12.9 38.6 29.7 27.8 56.5 42.1 43.3 18.3 6.5 35.8 29.1 51.9 46.0 52.3 49.7 44.1 29.5 26.7 2.8 107.7 38.9 16.4 38.9 32.3 20.3 14.7 28.3 45.6 64.1 35.8 41.4 31.3 35.1 54.9 47.3 75.3 53.4 33.4 54.4 58.0 50.3 40.6 34.9 23.5 37.0 47.5 25.7 42.4 33.5 52.6 23.2 20.4 33.5 31.2 45.6 25.3 48.7 45.1 20.5 63.9 26.0 51.6 32.8 85.2 18.8 39.7 21.6 22.0 22.1 22.5 40.9 17.7 18.8 21.4 64.4 27.2 38.0 54.3 33.8 22.6 2.6 3.4 3.4 4.3 2.4 2.9 5.6 7.4 4.5 2.7 3.2 5.6 9.2 9.6 13.1 0.0 18.7 10.6 15.7 31.8 22.2 0.7 25.9 14.1 7.9 20.0 37.5 27.6 0.0 106.0 26.7 35.1 64.6 27.0 68.3 84.1 11.4 11.8 9.6 38.7 0.0 27.2 86.2 9.5 21.9 17.9 26.1 9.3 8.9 15.3 21.0 10.1 0.0 25.2 26.4 15.0 14.8 25.2 7.2 20.5 19.6 0.0 31.0 5.5 18.6 0.0 0.0 29.7 40.2 9.1 69.6 18.2 31.2 50.3 142.2 5.0 6.6 6.7 14.8 29.9 64.5 53.4 17.8 88.1 19.3 14.0 31.5 22.4 MYL6 "ESMLC, MLC1SM, MLC3NM" ENSG00000092841 "Myosin light chain 6" P60660 12 56158346-56163496 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046859, HPA063034" Approved NA NA 60000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (1.10e-1)" "unprognostic (4.99e-2)" "unprognostic (1.89e-1)" "unprognostic (3.86e-2)" "unprognostic (1.43e-1)" "unprognostic (1.89e-1)" "unprognostic (3.73e-2)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" "unprognostic (3.51e-3)" "unprognostic (4.11e-2)" "unprognostic (2.04e-1)" "unprognostic (2.86e-2)" "unprognostic (8.33e-3)" "unprognostic (1.71e-1)" "unprognostic (7.90e-2)" "unprognostic (2.01e-1)" 2247.0 1427.5 830.7 1207.0 830.7 1756.5 1977.9 864.2 962.6 1767.3 901.0 5900.2 1027.9 2971.8 1635.0 1777.8 2197.9 905.8 1153.9 809.9 863.8 1915.8 1172.0 1946.7 882.9 900.5 874.9 1155.2 1032.8 1466.7 747.7 1441.7 869.2 2037.5 2360.3 927.1 1167.6 2912.2 411.1 1090.1 1867.5 4209.9 858.5 1547.8 2128.0 494.6 899.3 1151.3 1316.7 578.7 1404.7 3041.7 1685.0 869.9 1924.9 1739.1 3199.3 958.8 2063.5 2065.5 1755.8 4056.4 4162.8 5469.7 3191.3 2738.5 1720.0 735.0 2274.3 5778.4 1417.7 1222.8 1995.9 2846.0 3556.8 1423.1 666.5 1311.5 2481.7 1536.9 1512.2 913.8 2304.1 2389.9 2013.5 3242.3 1263.1 4706.8 4854.4 867.2 708.1 2121.5 4585.6 2052.1 1291.6 1402.8 1629.5 1071.6 1746.1 1027.3 1265.3 932.9 5125.1 2361.7 1169.2 862.9 4456.0 1380.0 760.4 2312.4 2148.7 2383.0 5212.3 1486.3 1011.6 2077.3 2746.8 635.3 1150.3 867.7 1953.3 1168.9 1578.1 11449.4 4509.8 13302.4 3191.2 5016.0 2404.9 2844.7 2828.6 2994.0 4747.3 2558.5 2020.7 2528.3 8440.7 2233.9 6531.2 5167.0 4209.8 14776.8 830.7 830.7 864.2 962.6 809.9 863.8 900.5 874.9 869.2 858.5 899.3 869.9 2044.5 1733.9 1161.8 16.0 704.4 2114.0 2470.4 2988.3 746.1 278.4 896.3 1394.8 672.8 946.5 2016.5 1475.0 316.9 1704.4 1144.5 2568.2 2406.5 4126.7 292.4 1134.2 1714.2 1628.1 1017.3 857.4 15.6 4820.4 2604.5 1264.0 871.6 1676.6 994.3 1307.8 1328.6 887.8 3370.3 80.8 19.8 1572.3 1845.3 1148.3 2472.8 910.7 1064.0 1872.2 1469.2 39.4 4426.3 820.8 1195.7 17.6 31.3 6222.1 2715.8 2775.1 892.8 1762.1 3007.9 2956.9 1870.9 763.7 1735.5 685.8 3305.2 76.2 115.0 1139.6 2066.1 1929.9 1191.9 1039.1 1406.1 2558.6 NAA38 "LSMD1, MGC14151, PFAAP2" ENSG00000183011 "N-alpha-acetyltransferase 38, NatC auxiliary subunit" Q9BRA0 17 7856685-7885238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1601.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059189 Supported Nucleoplasm "Intracellular and membrane" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA059189: " "unprognostic (6.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.30e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (3.35e-1)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-1)" "unprognostic (7.28e-3)" "unprognostic (1.48e-3)" "unprognostic (3.31e-1)" "unprognostic (5.83e-3)" "unprognostic (1.58e-1)" "unprognostic (6.02e-2)" "unprognostic (2.66e-1)" "unprognostic (9.75e-2)" 72.1 102.2 137.4 33.3 142.4 76.0 67.3 143.6 188.0 58.3 135.3 77.4 30.8 54.9 30.9 65.8 57.4 29.1 99.7 139.4 139.3 87.6 67.8 50.7 45.7 137.7 137.3 45.3 60.1 76.6 73.0 22.6 137.9 71.5 27.0 29.4 56.2 31.8 130.4 59.5 49.2 24.5 138.1 72.6 65.9 97.8 142.5 45.2 60.1 93.4 31.4 60.0 55.5 142.0 131.4 234.9 129.4 132.9 70.8 78.3 44.8 59.7 68.4 108.3 89.9 89.0 54.6 89.6 98.5 63.6 69.2 105.4 69.8 110.3 26.8 134.1 318.2 137.3 279.7 131.0 68.4 38.6 101.9 114.3 60.4 71.0 46.3 74.5 105.9 201.9 29.1 95.3 63.6 157.3 140.0 91.6 29.2 98.9 271.5 142.0 59.6 59.4 101.0 72.6 57.6 110.5 46.6 111.1 87.3 18.7 68.8 100.0 57.6 72.2 52.0 59.0 170.8 39.1 43.8 34.8 121.5 159.1 72.2 313.1 275.2 196.9 176.1 244.0 163.4 273.8 186.3 181.9 332.4 234.2 167.1 173.6 201.1 152.9 239.8 304.0 215.3 299.0 137.4 142.4 143.6 188.0 139.4 139.3 137.7 137.3 137.9 138.1 142.5 142.0 263.1 76.9 140.5 16.3 117.8 94.1 85.8 171.8 144.5 98.5 218.1 305.4 344.3 128.7 107.7 253.8 50.1 160.2 107.4 227.2 518.5 100.6 646.3 189.4 104.9 183.6 226.6 201.2 18.3 158.4 128.0 102.6 80.5 133.1 100.1 131.1 213.5 381.3 210.5 40.4 21.7 211.2 146.5 222.8 96.8 1601.4 116.8 149.9 76.5 14.0 195.2 221.6 182.3 34.7 13.3 134.0 161.6 113.2 161.7 86.8 184.1 468.0 107.1 126.5 111.7 70.2 109.8 120.5 132.4 182.1 99.4 91.9 103.5 175.3 289.5 129.3 NABP1 "DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2" ENSG00000173559 "Nucleic acid binding protein 1" Q96AH0 2 191678068-191741097 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.7" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 452.0;Langerhans cells: 301.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054978, HPA067802" Enhanced Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm Cytosol "HPA054978: AB_2682660, HPA067802: AB_2685899" "unprognostic (5.43e-2)" "unprognostic (5.33e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.48e-1)" "unprognostic (6.89e-2)" "unprognostic (8.07e-4)" "unprognostic (1.33e-1)" "unprognostic (2.89e-2)" "unprognostic (2.99e-1)" "unprognostic (2.82e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (8.20e-7)" "unprognostic (5.64e-2)" "unprognostic (7.50e-2)" "unprognostic (1.48e-1)" "unprognostic (6.02e-2)" 22.0 5.3 2.3 23.2 1.8 5.5 9.8 1.5 2.4 4.7 4.9 5.2 10.0 4.6 0.6 13.2 5.4 7.4 3.9 2.5 2.5 10.5 9.8 21.1 12.4 2.7 2.7 4.5 3.8 0.8 4.3 7.6 2.5 4.4 3.8 1.0 5.2 3.2 2.8 4.4 18.8 3.7 2.2 36.7 4.7 9.2 5.1 6.3 3.2 3.3 11.6 18.4 7.6 3.6 36.2 5.5 1.5 1.6 15.7 16.4 10.2 53.4 31.3 28.6 15.1 30.9 18.7 2.6 43.1 26.3 23.9 11.5 5.7 22.1 29.0 21.2 5.5 18.4 10.8 5.6 14.3 9.8 16.5 22.5 20.3 47.9 23.4 13.8 8.3 4.8 28.7 76.3 31.8 3.3 3.5 10.8 3.6 6.8 31.4 7.1 6.1 16.8 30.2 22.2 2.0 1.3 21.3 7.7 14.1 18.7 2.7 4.7 31.4 28.2 24.6 15.4 33.6 25.2 12.7 9.1 25.1 9.7 6.4 20.0 10.4 8.8 13.2 17.1 19.1 10.8 17.3 13.7 7.3 3.5 8.0 10.7 38.8 6.6 21.5 6.9 28.5 8.5 2.3 1.8 1.5 2.4 2.5 2.5 2.7 2.7 2.5 2.2 5.1 3.6 42.2 214.7 452.0 2.0 66.5 53.0 141.0 15.7 32.5 3.3 33.1 34.3 9.3 8.6 106.2 11.0 2.1 23.6 46.9 79.0 3.9 16.7 212.8 64.9 28.1 34.0 4.2 9.1 3.5 5.7 43.5 62.2 32.1 179.6 139.6 2.2 10.8 8.6 54.9 3.3 3.6 20.2 8.2 113.8 301.8 69.9 10.2 151.3 40.9 18.7 108.8 1.9 18.6 1.5 1.7 30.7 85.7 3.8 43.9 44.8 109.2 22.4 57.6 3.6 6.6 101.5 46.3 25.7 18.4 35.6 45.3 146.3 111.6 12.2 31.7 112.8 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871832-119876662 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 3202.9;Distal tubular cells: 2191.3;Proximal tubular cells: 1764.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Approved Mitochondria,Cytosol No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Mitochondria "HPA029768: AB_2673192, HPA054359: AB_2682461" "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 260.4 276.7 541.8 179.3 547.2 316.3 275.0 560.4 746.6 226.5 637.9 467.4 387.4 132.4 323.9 145.0 193.2 133.0 983.7 539.2 555.3 495.1 449.6 153.8 186.7 549.0 541.6 149.3 228.5 773.9 121.4 171.4 551.2 185.8 371.3 398.6 280.0 240.2 1381.0 90.8 334.6 180.7 545.6 169.4 297.4 65.8 551.2 273.2 173.3 1367.9 219.4 228.5 90.5 549.6 436.8 561.9 342.0 365.6 466.3 317.8 423.6 346.6 395.9 297.8 368.1 326.5 377.8 385.1 509.4 431.0 514.7 416.5 555.7 392.8 354.6 492.2 751.7 380.6 1110.1 750.5 357.0 575.9 387.2 485.4 577.0 296.5 232.5 413.2 389.1 372.4 230.9 553.4 435.6 965.3 412.5 563.2 489.1 1214.3 988.4 405.3 315.2 1169.8 887.0 765.2 255.9 319.8 714.9 871.1 479.6 476.5 224.2 653.8 395.1 209.4 198.2 422.7 672.5 469.4 798.3 524.9 377.5 719.5 262.1 1064.7 680.6 822.0 486.1 726.1 468.4 560.6 540.8 516.7 745.6 447.7 435.9 523.1 851.5 468.5 815.5 809.1 675.4 780.5 541.8 547.2 560.4 746.6 539.2 555.3 549.0 541.6 551.2 545.6 551.2 549.6 251.9 160.3 188.6 10.7 261.6 213.7 251.4 991.0 194.1 156.2 268.0 322.7 3202.9 511.9 445.8 562.8 79.2 396.5 273.9 1264.2 2191.3 503.6 34.2 332.0 237.9 228.9 459.0 272.3 12.3 512.5 416.1 266.9 322.1 348.9 210.3 177.5 260.3 1022.5 661.7 82.4 14.8 907.2 581.8 413.5 350.6 43.8 294.5 329.3 570.9 14.0 492.3 364.2 277.1 8.0 16.5 506.4 1024.5 285.1 389.2 228.8 1546.3 1764.0 443.2 231.2 216.9 208.4 289.9 50.8 105.2 394.3 249.3 380.6 255.7 126.7 887.7 339.3 NDUFA2 B8 ENSG00000131495 "NADH:ubiquinone oxidoreductase subunit A2" O43678 5 140638740-140647771 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 1052.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035933 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "HPA035933: AB_10669661" "unprognostic (4.48e-1)" "prognostic favorable (6.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.96e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-3)" "unprognostic (4.01e-1)" "unprognostic (2.75e-2)" "unprognostic (1.60e-1)" "unprognostic (4.39e-3)" "unprognostic (1.84e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.78e-2)" "unprognostic (9.96e-2)" "unprognostic (4.22e-1)" "unprognostic (1.30e-3)" 76.1 127.9 131.0 52.3 131.3 96.0 67.3 139.0 156.1 49.2 139.8 81.0 90.2 43.8 79.0 73.5 50.3 45.8 197.3 129.8 137.1 144.9 145.1 53.3 66.1 133.3 131.0 54.9 81.5 99.8 79.1 47.3 133.3 68.7 60.9 51.8 102.2 46.8 283.8 52.4 86.1 31.6 135.8 72.6 90.8 79.7 134.9 78.1 64.2 233.0 48.2 55.5 51.3 142.3 131.1 202.5 91.3 195.9 113.6 84.5 117.8 76.6 69.0 99.4 120.4 328.1 149.5 125.4 191.2 65.9 122.9 103.7 88.4 153.9 57.1 120.6 226.6 80.1 170.6 248.3 67.7 138.7 102.6 100.6 116.6 65.4 47.5 84.3 101.2 111.8 86.9 194.4 93.1 204.9 168.4 285.9 97.5 152.8 203.6 144.7 110.4 212.7 167.5 146.4 119.6 99.4 104.7 292.2 221.8 81.9 269.7 216.3 70.1 113.9 84.8 96.3 125.9 214.2 339.4 190.1 132.3 152.8 65.0 195.0 304.6 311.5 133.1 270.1 137.4 222.0 141.1 143.0 258.1 178.0 127.0 135.6 255.8 156.8 219.9 273.3 205.6 322.8 131.0 131.3 139.0 156.1 129.8 137.1 133.3 131.0 133.3 135.8 134.9 142.3 138.4 109.0 125.4 10.4 127.5 97.8 116.4 311.1 105.3 87.4 182.2 203.5 314.4 200.1 199.7 244.6 37.5 294.1 168.0 499.6 815.9 187.8 526.6 194.5 114.1 115.8 193.2 222.2 6.5 220.4 231.0 115.9 122.9 171.9 92.5 121.2 169.6 516.1 291.9 53.8 7.7 337.9 258.4 251.3 144.6 435.1 165.0 168.0 190.3 5.6 265.1 227.3 211.2 5.5 12.9 194.7 474.4 153.4 151.8 153.8 682.9 1052.3 207.9 113.0 118.3 104.8 139.0 182.7 237.0 165.8 117.1 222.5 124.3 196.1 367.5 164.4 NDUFB3 B12 ENSG00000119013 "NADH:ubiquinone oxidoreductase subunit B3" O43676 2 201071433-201085750 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 704.3;tongue: 727.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1711.2;Distal tubular cells: 1064.4;Proximal tubular cells: 780.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034596 Enhanced NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "HPA034596: AB_10602712" "unprognostic (5.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (7.24e-4)" "unprognostic (1.41e-3)" "unprognostic (6.29e-2)" "unprognostic (8.81e-3)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-2)" "unprognostic (9.40e-3)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.27e-2)" 119.4 114.4 151.2 88.9 152.7 79.7 105.5 165.7 227.5 69.9 161.9 185.7 136.7 46.4 132.2 98.4 66.1 66.3 389.3 151.5 165.1 247.1 195.3 63.5 103.7 158.2 155.4 46.2 54.7 219.3 57.8 78.0 158.1 77.1 174.6 140.8 100.8 75.8 704.3 52.0 127.9 73.8 157.2 61.6 115.5 83.1 158.2 143.4 96.0 727.7 128.8 95.4 53.7 160.6 180.1 148.9 227.5 122.0 226.3 207.0 183.1 224.8 160.1 171.9 200.3 347.2 211.3 144.4 249.8 211.4 261.9 154.5 209.6 287.7 269.4 294.5 460.6 349.0 363.8 394.8 141.2 500.9 170.5 180.1 223.6 203.3 119.2 211.3 250.3 259.2 311.1 240.3 313.1 234.4 313.8 459.8 129.9 392.4 536.7 215.6 200.4 388.0 380.6 278.7 209.5 150.1 176.0 153.2 258.2 353.2 150.7 373.0 227.3 144.8 179.7 150.9 222.8 174.5 435.3 452.6 246.0 284.4 172.6 205.2 135.4 159.4 116.1 205.3 129.2 148.8 132.7 135.7 177.3 117.3 115.2 140.9 267.3 141.6 213.3 211.8 183.1 109.6 151.2 152.7 165.7 227.5 151.5 165.1 158.2 155.4 158.1 157.2 158.2 160.6 95.3 80.1 57.7 18.9 100.9 78.1 100.0 433.7 66.6 52.9 101.7 128.1 1711.2 141.5 205.1 187.6 12.5 254.6 83.5 473.9 1064.4 247.0 218.1 191.6 93.9 101.9 146.4 113.8 13.2 201.7 208.9 103.4 118.7 135.2 78.0 61.0 86.7 260.5 288.2 32.0 14.7 299.0 248.2 121.6 107.1 59.9 95.4 126.8 168.9 10.3 292.9 184.6 116.4 7.5 19.9 177.3 411.0 101.5 135.2 72.5 496.3 780.3 229.2 92.0 92.1 82.3 125.4 270.0 89.7 169.2 91.9 157.6 89.7 113.9 322.1 132.9 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068297-78079862 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 39: CACO-2 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favorable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 202.3 278.0 118.8 84.5 126.1 126.1 143.0 128.7 150.7 103.0 125.6 143.6 218.4 125.3 68.4 142.6 120.2 108.6 240.7 129.0 145.8 151.1 286.8 100.0 109.1 121.6 117.1 96.2 168.8 186.1 133.5 74.8 124.2 88.7 66.1 59.8 275.1 83.2 487.6 121.9 194.3 63.6 136.8 96.2 130.0 103.0 126.1 73.5 207.0 254.0 62.8 97.1 100.1 136.3 287.6 342.2 183.3 118.8 168.3 105.6 227.2 335.7 190.9 252.4 179.9 910.4 311.8 166.3 583.3 155.8 210.2 293.1 136.1 190.9 99.5 318.8 386.7 183.8 337.4 727.9 270.9 409.7 164.2 147.9 177.8 195.6 75.2 156.0 172.9 158.8 365.3 278.4 137.9 478.7 254.5 722.4 212.4 670.4 415.6 224.5 352.5 570.5 196.4 420.7 261.2 229.0 235.0 499.5 182.3 158.8 391.4 328.2 241.0 256.4 314.9 611.8 297.9 251.5 541.9 400.4 146.4 236.6 251.0 374.5 337.6 354.0 150.1 293.0 138.3 230.8 172.4 163.4 363.5 212.1 144.5 159.8 102.2 225.4 243.0 290.4 202.7 410.9 118.8 126.1 128.7 150.7 129.0 145.8 121.6 117.1 124.2 136.8 126.1 136.3 256.6 166.7 194.7 0.0 106.4 95.5 166.1 443.7 40.5 145.8 346.2 414.0 240.9 243.1 288.2 391.8 66.7 408.8 166.4 206.3 305.2 395.6 311.8 413.8 129.3 183.7 167.9 106.5 0.0 431.5 392.8 165.7 43.3 241.7 153.2 158.1 184.9 856.9 346.2 90.9 0.0 317.9 429.3 174.5 110.7 84.7 215.6 129.4 245.5 0.0 246.7 310.0 175.1 0.0 0.0 456.5 329.1 201.6 102.5 239.0 461.8 454.6 300.0 131.6 236.7 154.5 222.7 384.4 162.1 67.5 114.4 387.1 109.9 226.3 373.2 215.6 NEDD8 Nedd-8 ENSG00000129559 "NEDD8 ubiquitin like modifier" Q15843 14 24216857-24232367 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004082, HPA027583, HPA060254" Uncertain Enhanced Nucleoplasm,Cytosol NA NA 990000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Cytosol "CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644" "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.34e-3)" "unprognostic (1.83e-3)" "unprognostic (9.19e-2)" "unprognostic (4.66e-1)" "unprognostic (1.35e-2)" "unprognostic (2.66e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-3)" "unprognostic (2.76e-2)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (5.25e-3)" 169.0 224.3 156.9 71.5 162.3 91.0 156.7 158.6 219.1 152.4 152.5 172.9 55.9 147.6 132.6 202.1 131.3 51.0 299.8 163.1 168.6 195.8 175.7 147.7 81.2 163.7 158.7 138.1 110.9 289.1 143.9 84.3 162.4 133.7 88.7 74.6 139.3 85.5 294.3 182.2 128.8 97.7 157.5 164.6 146.8 77.9 162.1 125.7 132.8 197.1 113.1 152.0 157.5 162.0 166.9 292.7 223.8 159.9 255.2 223.2 165.6 218.7 237.4 259.5 237.5 204.6 196.1 142.1 126.9 317.1 212.3 169.2 230.8 349.5 365.6 201.9 139.7 150.2 272.9 710.7 220.8 251.8 151.6 237.0 231.8 217.2 172.0 239.1 317.3 162.3 139.3 161.5 409.4 380.3 203.4 241.1 166.1 303.7 335.8 141.3 176.9 146.1 302.7 322.1 96.7 221.7 188.3 192.6 168.4 229.5 117.6 199.2 230.3 145.4 144.9 184.9 198.5 187.9 322.7 210.6 102.6 146.2 139.6 461.6 277.3 459.9 214.7 302.8 235.5 311.9 246.0 241.0 276.3 273.4 229.8 233.1 299.8 233.7 310.5 369.7 327.3 526.6 156.9 162.3 158.6 219.1 163.1 168.6 163.7 158.7 162.4 157.5 162.1 162.0 276.4 144.2 156.8 0.0 182.1 277.9 227.5 644.7 166.8 101.0 263.4 301.5 464.7 215.9 301.5 310.8 47.9 525.7 237.0 267.8 594.8 344.9 72.6 201.8 189.4 259.5 212.4 220.7 0.0 406.9 625.0 246.0 108.1 195.4 218.6 228.7 222.0 431.5 576.3 106.0 0.0 286.4 362.2 288.7 345.5 77.3 272.1 255.4 268.6 0.0 394.0 275.0 346.1 0.0 0.0 449.8 311.5 275.7 161.3 254.4 340.2 845.8 279.7 95.9 210.4 178.7 318.4 150.0 196.9 252.1 386.6 419.5 216.0 289.8 291.8 275.5 NKIRAS2 "DKFZP434N1526, kappaB-Ras2, KBRAS2" ENSG00000168256 "NFKB inhibitor interacting Ras like 2" Q9NYR9 17 42011382-42025644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062861 Approved Nucleoplasm,Nucleoli NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA062861: AB_2684884" "unprognostic (2.53e-1)" "unprognostic (1.09e-3)" "unprognostic (2.31e-2)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.56e-4)" "unprognostic (9.37e-3)" "unprognostic (2.89e-2)" "unprognostic (2.56e-1)" "unprognostic (6.96e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (3.25e-2)" "unprognostic (5.42e-3)" 21.7 15.7 14.1 20.8 17.1 25.6 18.4 15.3 15.4 18.8 15.6 20.8 15.2 19.0 11.0 32.7 14.4 17.8 45.8 14.3 12.0 16.9 19.3 16.7 17.8 14.8 13.3 16.0 13.3 19.4 10.8 33.9 13.1 16.1 16.3 13.7 16.2 18.0 50.0 26.6 16.2 26.4 12.1 15.1 16.9 20.8 15.5 22.1 13.5 36.8 19.0 20.8 20.1 15.0 22.4 42.5 57.4 31.1 39.8 26.8 33.7 36.4 28.1 56.6 41.6 43.6 31.3 37.4 57.3 38.6 38.4 47.1 47.3 28.6 29.6 30.6 54.2 32.9 37.1 33.0 62.8 45.8 25.9 41.0 50.8 38.1 29.8 38.6 71.3 47.8 47.1 36.9 33.8 23.7 87.3 30.4 34.4 30.0 30.0 67.9 63.7 35.8 40.3 23.2 68.5 90.0 26.6 84.0 38.6 55.6 51.5 55.5 50.3 36.2 38.8 40.5 41.5 47.4 82.7 30.0 24.6 27.5 52.2 54.5 54.2 46.1 14.2 45.1 14.1 15.4 14.2 14.4 43.5 17.1 14.4 14.0 30.7 27.0 50.0 48.4 13.4 25.2 14.1 17.1 15.3 15.4 14.3 12.0 14.8 13.3 13.1 12.1 15.5 15.0 26.6 16.0 10.3 3.9 19.0 17.0 18.7 27.2 12.5 21.0 19.9 17.1 26.3 10.0 23.8 16.5 20.9 52.3 13.8 19.1 21.5 30.0 27.8 11.9 18.5 27.1 19.2 21.2 5.4 28.1 39.7 20.1 11.2 16.3 14.0 28.1 19.2 15.6 37.9 23.5 4.8 17.5 42.7 31.1 29.1 6.6 19.6 27.8 10.6 5.6 37.2 24.7 14.4 1.5 4.5 30.4 14.7 18.4 13.3 20.8 20.9 19.0 10.9 26.6 6.6 15.3 24.5 34.7 41.3 21.0 25.7 62.3 12.8 23.3 15.2 21.6 NT5C3A "cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1" ENSG00000122643 "5'-nucleotidase, cytosolic IIIA" Q9H0P0 7 33014114-33062797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.4" "Cell type enhanced" "Detected in all" "Distal enterocytes: 191.0;Paneth cells: 186.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010520, HPA010630, HPA029058" Uncertain Supported "Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 10000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 51: Myeloid cells - Hemostasis" "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380" "unprognostic (7.50e-2)" "unprognostic (3.10e-1)" "unprognostic (1.14e-1)" "unprognostic (2.69e-2)" "unprognostic (1.22e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (3.25e-2)" "unprognostic (3.12e-2)" "unprognostic (2.82e-3)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (9.37e-2)" "unprognostic (2.05e-1)" "unprognostic (2.12e-3)" "unprognostic (3.43e-3)" 12.4 14.3 11.4 26.1 11.4 32.6 21.3 15.2 15.6 12.6 10.8 51.9 40.0 16.9 14.3 18.6 15.9 23.4 16.6 11.5 11.5 22.4 11.8 17.6 30.8 11.1 11.8 13.4 21.4 9.7 7.5 16.3 11.5 12.3 51.0 20.4 9.7 10.0 87.4 28.7 37.3 13.2 12.7 22.9 27.0 9.5 12.0 22.5 17.1 51.0 45.8 23.8 14.4 13.1 42.2 27.6 25.2 29.6 21.2 16.1 20.3 44.8 30.5 29.2 38.9 19.9 115.1 100.4 27.7 29.6 48.3 63.8 28.3 30.8 40.4 16.2 36.2 54.7 36.5 28.7 23.3 55.6 36.9 21.7 23.8 35.9 63.0 16.4 22.2 33.2 43.3 24.8 37.3 29.9 25.0 87.8 27.8 47.1 31.2 25.9 22.9 60.0 87.8 39.8 28.1 37.0 31.1 52.4 66.6 24.5 35.2 33.5 19.8 25.1 20.9 42.6 55.7 50.6 69.0 54.8 20.6 34.9 42.5 112.5 25.9 82.5 26.6 32.7 30.6 64.0 34.2 30.8 22.1 63.6 34.5 29.1 103.8 28.2 39.2 20.6 56.2 37.9 11.4 11.4 15.2 15.6 11.5 11.5 11.1 11.8 11.5 12.7 12.0 13.1 39.1 22.4 13.7 30.7 85.1 46.8 40.9 85.3 47.8 23.9 22.6 18.9 16.9 32.9 40.4 16.5 41.7 36.9 42.5 191.0 29.4 34.4 5.7 40.9 21.0 40.8 119.6 127.1 45.3 79.0 31.6 35.2 42.8 21.4 17.7 38.3 30.0 18.9 25.0 1.7 49.4 98.9 40.7 31.2 23.5 5.0 33.8 111.4 26.6 29.0 37.0 23.4 55.6 48.2 52.4 48.3 186.6 22.2 43.8 45.7 91.8 84.8 53.7 27.1 13.1 30.7 24.9 46.4 24.0 35.5 38.9 28.3 53.7 23.3 71.0 65.9 NUDT17 FLJ34433 ENSG00000186364 "Nudix hydrolase 17" P0C025 1 145845630-145848954 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 15.1;Muller glia cells: 9.1;Spermatogonia: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 8.3;eosinophil: 17.5;plasmacytoid DC: 26.6" "Group enriched" "Detected in many" 9 "dendritic cells: 26.6;granulocytes: 17.5" "Cell line enhanced" "Detected in many" "T-47d: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030145 Approved Approved Centrosome,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 65: Plasmacytoid DCs - Unknown function" "Centrosome, Cytosol" "HPA030145: AB_10603883" "unprognostic (8.93e-3)" "unprognostic (2.28e-1)" "unprognostic (2.63e-3)" "unprognostic (8.72e-3)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.07e-3)" "unprognostic (6.55e-2)" "unprognostic (6.03e-2)" "unprognostic (1.24e-2)" "unprognostic (5.40e-2)" "prognostic unfavorable (1.81e-7)" "unprognostic (5.59e-2)" "unprognostic (1.63e-1)" "unprognostic (6.16e-2)" "unprognostic (1.96e-1)" 1.7 2.3 5.8 1.7 6.0 3.3 2.0 6.3 7.1 2.8 5.1 2.6 0.5 2.0 1.2 2.1 2.8 1.8 3.4 5.8 6.2 4.0 2.0 1.8 4.2 5.9 5.7 2.6 2.8 2.3 3.1 0.8 5.5 2.7 1.1 2.6 1.9 2.2 3.1 2.1 2.4 1.2 5.6 4.1 2.1 4.0 6.6 2.0 2.5 2.2 3.3 2.8 2.3 5.6 3.7 2.6 2.4 1.3 1.2 2.0 2.4 1.7 2.8 1.8 2.4 1.6 2.6 5.3 1.8 2.9 0.4 0.7 1.8 1.0 1.2 0.6 3.0 2.1 2.5 2.5 3.8 1.6 6.7 2.0 1.6 1.2 2.0 2.2 3.6 8.6 4.6 4.8 3.3 5.8 1.8 3.1 2.0 2.2 0.3 4.8 0.9 1.7 3.0 0.9 1.1 2.7 1.1 2.2 3.0 2.5 12.2 7.5 2.1 2.1 1.3 1.0 0.7 4.2 2.1 1.4 1.9 2.3 1.6 8.3 0.9 17.5 0.8 2.5 0.5 1.4 0.7 0.5 0.9 0.8 1.5 1.1 0.1 0.3 1.7 26.6 0.8 1.1 5.8 6.0 6.3 7.1 5.8 6.2 5.9 5.7 5.5 5.6 6.6 5.6 3.1 3.2 5.5 0.7 1.8 1.8 0.8 1.4 2.2 1.9 2.6 4.6 0.8 2.8 3.4 0.0 0.0 0.6 15.1 0.8 1.9 1.0 3.3 3.5 1.7 1.8 1.2 0.4 0.6 0.7 0.7 2.3 2.6 4.1 2.5 1.7 1.8 0.5 3.0 0.0 0.7 0.5 2.0 0.6 1.6 2.1 1.5 2.3 1.8 1.9 0.5 9.1 3.1 2.0 0.9 1.4 1.4 0.4 3.8 1.0 0.7 0.6 1.7 3.8 0.0 3.7 1.2 6.8 14.8 1.6 1.3 0.5 2.2 1.8 1.2 0.8 OCEL1 FLJ22709 ENSG00000099330 "Occludin/ELL domain containing 1" Q9H607 19 17226213-17229219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 75.5" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 137.0;Proximal tubular cells: 150.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042070, HPA043223" Uncertain Approved "Golgi apparatus" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA042070: AB_2677830, HPA043223: " "unprognostic (6.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.13e-1)" "unprognostic (3.00e-3)" "unprognostic (6.40e-2)" "unprognostic (2.06e-2)" "unprognostic (4.33e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (4.64e-1)" "unprognostic (1.34e-1)" "unprognostic (2.52e-1)" "unprognostic (2.88e-1)" "unprognostic (9.19e-2)" "unprognostic (1.18e-3)" 18.3 21.6 14.9 4.7 15.8 5.6 16.4 15.9 24.9 14.8 15.5 20.9 19.0 13.5 18.9 9.4 18.1 5.8 17.4 14.6 15.6 37.4 75.5 14.6 7.3 17.4 16.0 11.2 22.7 7.2 9.2 6.7 17.0 21.1 12.3 8.9 14.9 9.0 14.0 8.8 20.0 7.2 16.4 17.3 22.1 6.7 16.5 6.7 20.5 13.5 9.5 13.9 12.3 15.8 8.2 6.4 3.3 2.9 34.9 13.8 8.5 5.3 14.5 4.1 7.2 4.6 9.8 7.2 19.5 7.8 3.6 3.9 4.5 5.4 3.8 6.0 5.3 6.7 6.8 22.6 11.7 1.4 10.5 11.1 5.6 4.8 8.1 14.2 5.9 8.9 5.8 6.8 7.5 6.7 3.7 4.0 5.6 12.3 11.3 2.7 2.8 18.2 17.7 11.2 1.1 5.6 3.3 10.8 9.4 6.9 16.4 6.8 3.9 2.6 3.0 5.1 2.6 18.5 15.3 5.8 7.7 6.3 1.2 27.7 30.8 15.2 9.9 20.9 9.5 15.7 15.1 11.4 23.3 17.0 16.5 10.8 9.7 16.0 17.1 10.0 19.1 13.4 14.9 15.8 15.9 24.9 14.6 15.6 17.4 16.0 17.0 16.4 16.5 15.8 14.6 12.8 8.2 3.9 16.4 6.4 26.7 18.8 17.1 11.4 21.4 23.7 7.3 27.1 21.9 20.2 2.1 38.6 23.9 66.8 60.7 21.4 6.3 59.3 12.5 15.6 17.4 9.7 4.7 27.1 46.0 17.2 25.5 20.4 15.9 8.0 25.0 93.5 25.8 25.2 5.2 40.5 10.2 26.1 7.5 14.6 28.3 22.3 16.0 3.7 19.2 29.6 24.7 1.0 4.6 21.0 67.4 23.3 23.2 20.7 137.0 150.5 71.8 9.7 32.9 12.5 25.8 7.8 13.8 8.8 6.7 103.2 16.4 19.9 28.1 21.9 ORAI3 "MGC13024, TMEM142C" ENSG00000175938 "ORAI calcium release-activated calcium modulator 3" Q9BRQ5 16 30949068-30956461 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 77.3;Hofbauer cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 94.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015022 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Cytosol" "HPA015022: AB_1854807" "unprognostic (1.17e-1)" "unprognostic (3.88e-2)" "unprognostic (2.94e-3)" "unprognostic (1.15e-2)" "unprognostic (8.29e-2)" "unprognostic (1.46e-1)" "unprognostic (8.60e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.87e-5)" "unprognostic (2.30e-2)" "unprognostic (4.46e-2)" "unprognostic (6.43e-3)" "unprognostic (9.17e-3)" 17.3 34.1 18.0 8.2 16.5 17.6 15.2 16.9 17.1 24.4 26.0 22.7 9.2 18.3 16.3 15.4 19.2 9.9 16.7 15.3 16.3 19.3 70.2 14.2 11.9 18.6 18.5 18.9 17.7 18.9 18.0 14.9 17.1 26.3 8.6 4.0 14.6 17.0 7.9 14.3 16.1 9.8 17.4 22.5 17.1 15.6 20.5 11.2 16.4 8.1 10.6 27.2 20.2 17.7 2.8 15.8 8.1 10.7 68.1 60.7 0.6 9.3 62.3 6.8 17.2 1.5 26.1 3.9 20.7 17.9 27.5 12.7 1.4 17.6 4.6 12.3 5.2 10.2 4.9 16.1 94.9 11.2 30.5 65.5 45.9 13.1 25.5 63.8 11.7 2.2 11.7 20.6 22.1 10.8 0.7 42.6 6.6 9.1 4.3 8.6 6.3 30.8 26.2 6.8 2.0 13.5 8.4 2.6 14.9 19.5 19.7 45.5 8.5 5.1 3.5 11.4 2.2 50.4 4.0 3.1 25.3 26.4 7.9 23.2 8.7 26.6 3.4 9.2 3.6 7.1 1.8 2.7 8.5 6.7 2.2 2.9 15.3 11.7 12.6 9.5 2.7 3.3 18.0 16.5 16.9 17.1 15.3 16.3 18.6 18.5 17.1 17.4 20.5 17.7 12.1 6.4 10.8 0.0 23.9 7.9 24.5 25.6 32.5 1.5 11.1 19.6 6.9 5.7 11.6 16.5 2.1 28.1 25.9 11.1 13.7 21.4 61.1 16.5 21.8 16.5 15.0 16.2 0.0 11.4 2.7 25.9 4.1 10.5 7.0 17.9 23.6 77.3 93.8 35.3 0.0 11.3 10.2 43.7 11.5 36.7 53.1 31.4 21.4 0.0 39.1 24.4 17.5 0.0 0.0 9.5 18.4 43.2 18.1 14.0 9.5 48.2 14.7 3.6 26.3 11.0 14.0 26.5 2.5 17.0 4.5 4.4 9.7 61.0 5.8 20.4 OST4 ENSG00000228474 "Oligosaccharyltransferase complex subunit 4, non-catalytic" P0C6T2 2 27070472-27071654 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 32: Non-specific - Translation" "unprognostic (5.15e-2)" "unprognostic (4.42e-2)" "unprognostic (2.24e-1)" "unprognostic (3.63e-1)" "unprognostic (5.95e-2)" "unprognostic (1.95e-3)" "prognostic unfavorable (5.11e-4)" "unprognostic (2.66e-1)" "unprognostic (1.18e-1)" "unprognostic (2.88e-2)" "unprognostic (7.89e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (7.35e-5)" "unprognostic (1.33e-1)" "unprognostic (8.52e-2)" "unprognostic (1.38e-1)" "unprognostic (9.88e-2)" 302.0 323.9 359.4 276.6 368.6 446.0 288.7 370.1 440.9 365.2 371.6 366.6 255.3 214.6 458.9 268.4 258.6 297.8 541.4 357.5 387.2 313.6 392.9 220.8 370.4 373.4 375.4 329.2 295.3 377.2 169.0 232.2 375.8 268.4 327.6 146.3 411.8 320.7 396.9 211.7 298.1 325.7 375.9 260.8 269.2 137.9 371.6 443.2 277.0 534.2 352.1 480.9 231.8 387.8 526.7 444.8 492.1 336.3 1362.9 1154.9 327.7 635.8 749.7 386.9 559.9 450.5 435.2 248.4 427.1 1044.1 572.4 244.1 321.3 701.9 305.9 486.4 491.5 527.4 300.4 1082.4 769.3 386.5 465.7 1235.3 591.0 509.8 468.3 952.9 916.5 490.1 337.2 509.8 882.5 641.8 472.7 710.4 293.7 1029.8 695.8 274.1 543.6 617.9 906.6 577.2 289.7 660.5 337.8 541.2 469.8 622.6 294.5 449.5 683.7 541.5 461.0 409.5 449.6 835.8 720.7 893.5 551.9 427.2 466.0 3182.5 1405.3 2129.1 1337.7 1230.8 1558.0 1748.5 1752.0 1469.2 1341.1 1473.3 1607.2 1551.1 1133.7 1049.8 1221.4 2614.4 1818.9 4735.8 359.4 368.6 370.1 440.9 357.5 387.2 373.4 375.4 375.8 375.9 371.6 387.8 370.4 176.3 301.9 13.7 522.3 411.2 417.7 1106.0 233.9 58.1 754.0 1020.4 369.3 377.4 595.2 663.9 20.9 527.6 555.4 597.3 1195.4 611.5 211.3 296.4 453.3 395.7 435.1 465.9 4.7 661.7 841.8 394.3 215.6 561.8 460.2 316.1 616.8 808.5 843.3 33.7 6.1 993.1 573.7 569.5 600.1 142.5 504.2 577.1 597.7 6.5 1041.6 309.1 632.4 9.5 13.5 668.3 725.3 429.1 749.7 509.8 1012.6 1348.1 310.0 81.8 295.9 230.7 492.5 242.3 392.6 424.9 589.0 577.1 532.4 299.2 669.3 620.6 OTUB1 "FLJ20113, FLJ40710" ENSG00000167770 "OTU deubiquitinase, ubiquitin aldehyde binding 1" Q96FW1 11 63985853-64001811 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039176, CAB072836" Approved Supported Approved Nucleoplasm,Cytosol NA NA 500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "CAB072836: , HPA039176: AB_10674980" "unprognostic (2.50e-1)" "unprognostic (5.70e-3)" "unprognostic (3.93e-2)" "unprognostic (1.63e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.45e-1)" "unprognostic (1.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (6.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.84e-2)" "unprognostic (1.82e-1)" 44.8 57.0 69.9 43.0 78.0 63.5 47.3 53.0 93.4 54.1 39.7 51.9 42.0 49.0 37.4 85.4 55.8 35.9 62.4 79.3 62.5 61.3 47.0 47.1 59.8 65.0 58.0 44.5 43.9 47.1 48.6 49.3 66.1 53.5 39.3 25.6 54.3 42.6 70.2 78.1 51.9 38.0 51.2 58.6 54.0 57.1 65.0 56.0 51.9 48.4 57.1 52.5 56.7 67.7 113.4 198.9 107.2 95.7 70.7 77.8 83.0 66.0 97.1 143.6 105.1 138.1 104.5 59.3 122.0 106.6 124.4 138.1 140.4 165.4 88.1 69.9 111.7 99.3 114.1 172.9 98.8 99.2 104.3 83.4 106.4 110.2 69.8 74.4 137.2 54.6 71.2 65.3 97.9 237.2 109.2 133.0 126.5 95.4 94.1 88.3 41.8 102.5 151.1 162.1 81.5 117.5 74.6 114.1 123.3 72.9 178.2 86.3 100.1 75.8 74.2 103.3 88.4 76.2 51.7 86.4 98.4 64.0 74.5 228.8 186.8 189.9 165.5 244.2 131.2 149.6 152.1 153.6 203.1 139.3 117.1 130.4 184.6 161.8 218.9 140.7 224.7 313.4 69.9 78.0 53.0 93.4 79.3 62.5 65.0 58.0 66.1 51.2 65.0 67.7 37.0 19.2 56.5 15.0 67.2 48.3 70.9 137.8 83.6 44.4 42.5 48.8 31.9 37.1 82.5 46.0 39.6 146.2 56.5 104.7 74.3 80.7 72.6 55.4 36.2 43.4 87.8 35.5 17.8 85.5 109.2 50.0 71.9 44.3 48.7 54.6 35.7 33.2 90.4 30.3 16.9 70.8 101.7 57.4 65.9 87.1 34.2 61.0 51.6 8.4 98.0 43.2 78.2 12.5 18.8 90.1 92.0 25.6 80.8 51.8 90.8 85.2 89.2 55.7 26.3 28.1 62.0 48.0 71.4 77.7 52.6 194.8 73.7 51.7 62.7 71.6 P3H1 "GROS1, LEPRE1, LEPRECAN, MGC117314" ENSG00000117385 "Prolyl 3-hydroxylase 1" Q32P28 1 42746335-42767084 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 47.9;Extravillous trophoblasts: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 193.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012113, HPA016980" Approved Approved Nucleoli,Vesicles "Intracellular and membrane" NA NA 18000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 28: Placenta - Pregnancy" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" Vesicles Nucleoli "HPA012113: AB_2668626, HPA016980: AB_2669498" "unprognostic (3.24e-1)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (4.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.95e-7)" "unprognostic (5.41e-2)" "unprognostic (2.70e-3)" "unprognostic (9.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" "unprognostic (2.67e-2)" "unprognostic (1.60e-3)" 12.4 11.1 3.6 8.7 3.5 6.1 10.2 3.6 4.4 13.4 7.3 8.3 2.4 13.8 6.1 4.4 9.8 12.0 9.1 3.8 3.8 7.2 13.3 11.6 5.1 5.2 3.5 12.8 6.8 5.9 15.5 37.4 3.8 7.5 5.4 1.3 6.7 5.9 3.0 7.6 7.4 20.3 3.4 11.5 6.7 15.2 3.8 7.6 7.6 3.9 5.1 12.3 8.5 3.6 8.7 22.3 48.7 115.0 112.8 85.4 20.1 101.8 131.9 71.9 121.7 11.3 18.8 13.0 79.7 193.0 29.2 7.8 20.9 25.9 49.2 19.5 26.3 30.5 32.2 32.6 65.2 30.9 34.0 73.8 17.4 72.6 30.9 102.4 102.9 18.3 17.5 16.1 49.0 4.7 20.6 17.8 53.1 4.7 16.0 19.9 71.9 17.7 38.2 4.9 10.2 17.3 62.5 1.7 45.8 85.2 3.7 127.0 85.1 53.8 47.2 43.4 41.2 14.5 17.5 11.9 61.5 41.5 77.0 5.0 18.9 16.8 8.3 20.4 8.8 4.1 6.3 7.0 23.6 3.3 5.1 5.3 1.8 17.8 26.3 10.9 12.4 9.3 3.6 3.5 3.6 4.4 3.8 3.8 5.2 3.5 3.8 3.4 3.8 3.6 13.7 3.2 2.3 5.9 10.5 0.0 6.4 0.0 6.2 10.2 4.5 6.5 5.0 7.2 0.6 11.0 25.0 47.9 11.1 0.4 0.0 11.5 17.1 3.2 30.1 16.4 6.1 11.3 12.9 7.6 56.6 34.4 3.6 4.4 1.3 28.8 16.8 11.3 17.6 15.2 10.8 2.5 0.0 8.7 0.0 10.8 19.3 11.7 0.0 9.4 10.5 3.5 6.2 9.5 6.9 7.4 2.0 16.1 11.2 3.4 1.7 1.9 0.7 22.1 0.0 17.2 22.3 30.6 18.8 3.5 0.0 17.5 9.6 27.0 1.9 4.5 PARL "PRO2207, PSARL, PSARL1, RHBDS1" ENSG00000175193 "Presenilin associated rhomboid like" Q9H300 3 183829271-183884933 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA019545 Approved Approved Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA019545: AB_1855796" "unprognostic (2.10e-1)" "unprognostic (1.53e-3)" "unprognostic (5.88e-2)" "unprognostic (1.17e-2)" "unprognostic (5.76e-2)" "unprognostic (9.55e-2)" "unprognostic (3.17e-3)" "unprognostic (8.97e-2)" "unprognostic (1.81e-1)" "unprognostic (3.62e-3)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (4.28e-2)" "unprognostic (5.49e-2)" "unprognostic (2.58e-1)" "unprognostic (1.73e-1)" "prognostic favorable (9.11e-5)" 38.4 35.8 46.5 26.6 48.2 33.8 40.3 47.4 66.2 33.8 50.7 47.7 29.2 31.9 57.7 36.7 30.2 19.7 54.1 46.6 48.2 39.6 45.0 28.4 32.0 47.7 48.7 31.7 49.9 39.7 32.0 25.5 47.4 37.1 41.9 32.7 40.5 30.3 54.9 37.1 34.7 29.7 47.2 36.2 42.6 26.7 47.6 34.5 31.4 51.6 33.8 38.9 31.5 48.4 115.1 55.6 39.7 33.0 38.8 42.1 80.2 39.2 59.4 80.5 65.0 172.0 59.0 47.8 90.0 56.7 73.5 49.2 64.1 68.0 90.0 71.6 76.1 73.9 35.5 96.9 57.3 73.9 61.6 60.0 85.4 58.0 70.7 38.5 59.0 82.4 42.6 45.0 69.2 131.0 148.3 194.3 105.5 100.6 53.3 64.7 72.8 92.0 79.0 97.6 37.9 52.0 47.6 162.9 107.8 48.1 159.2 143.5 31.8 29.3 63.0 60.9 108.2 89.2 65.7 116.0 56.6 75.1 35.5 97.5 143.1 133.4 51.3 107.8 60.9 62.4 57.3 59.9 132.4 59.1 68.7 54.2 41.3 67.1 83.3 79.7 73.7 116.1 46.5 48.2 47.4 66.2 46.6 48.2 47.7 48.7 47.4 47.2 47.6 48.4 30.3 22.4 19.7 17.9 37.6 30.3 54.9 93.5 26.7 35.9 31.8 31.5 41.2 35.8 44.5 31.3 31.3 58.9 38.4 24.4 117.4 63.9 24.0 15.2 18.3 30.2 33.7 23.3 23.4 84.7 49.0 35.1 28.1 13.7 69.8 33.1 33.2 30.4 77.7 33.7 24.1 42.0 77.3 56.2 55.7 9.7 28.9 57.5 42.7 33.7 79.3 55.9 50.4 17.1 28.0 60.3 35.1 27.1 42.3 55.4 47.3 86.0 30.5 51.1 6.6 44.8 96.6 47.8 47.4 40.2 30.0 42.1 40.9 49.0 49.2 58.8 PCBD2 "DCOH2, DCOHM" ENSG00000132570 "Pterin-4 alpha-carbinolamine dehydratase 2" Q9H0N5 5 134905120-135007959 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 49.4;tongue: 42.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036428 Uncertain Approved "Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 6: T47d - Mammary gland" "Cluster 39: Non-specific - Basic cellular processes" "Plasma membrane" "HPA036428: AB_10670103" "unprognostic (3.70e-2)" "unprognostic (3.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (4.22e-1)" "unprognostic (6.43e-2)" "unprognostic (4.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.22e-1)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.57e-2)" "unprognostic (6.34e-2)" "unprognostic (9.32e-3)" "unprognostic (1.50e-1)" 5.3 7.7 7.3 4.8 8.5 7.6 6.0 7.8 7.6 4.3 11.0 6.1 9.5 4.2 4.1 8.3 5.7 4.6 17.1 6.4 7.5 10.2 11.9 4.9 5.9 8.7 7.7 5.1 8.0 13.0 3.8 3.5 8.0 5.4 7.0 9.9 9.6 3.8 49.4 9.2 8.1 3.6 6.8 5.8 8.2 3.2 8.1 5.5 9.6 42.7 6.1 4.5 4.9 10.8 7.5 7.2 9.4 6.9 5.7 5.2 5.2 6.0 5.2 3.8 3.8 12.0 17.5 8.7 8.8 4.4 6.1 6.5 5.6 5.9 3.4 12.3 3.1 6.0 9.5 7.1 5.4 7.1 3.6 3.4 7.1 3.6 7.6 5.1 4.3 7.7 7.7 12.2 6.9 13.0 7.5 12.3 5.1 11.5 6.9 10.9 8.4 9.7 8.1 7.4 7.2 9.2 10.4 6.0 9.1 7.1 13.0 9.4 5.9 6.4 4.3 7.1 8.1 10.6 15.7 5.5 7.8 8.8 4.8 5.7 5.1 5.4 3.6 4.5 2.9 4.5 4.0 3.4 4.4 4.2 3.8 4.3 2.8 4.0 4.6 7.7 3.9 2.7 7.3 8.5 7.8 7.6 6.4 7.5 8.7 7.7 8.0 6.8 8.1 10.8 4.2 9.6 10.3 28.7 8.8 3.6 6.4 15.8 7.4 13.5 11.7 8.4 32.5 20.0 12.5 16.5 12.5 13.6 10.1 13.6 21.5 17.1 8.4 7.9 6.1 6.9 4.2 31.5 10.6 18.2 24.4 5.8 13.3 8.7 6.3 22.4 7.1 23.1 24.6 23.5 12.9 9.5 20.3 10.0 9.6 3.5 7.2 10.2 5.4 17.8 26.9 14.8 7.2 13.0 20.6 17.8 6.2 2.2 13.1 7.1 26.5 26.3 11.9 45.9 0.0 9.0 7.4 5.2 11.5 13.8 6.0 10.1 7.8 9.5 15.9 8.7 PCMT1 ENSG00000120265 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase" P22061 6 149749443-149811420 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1022.2;Late spermatids: 428.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003239 Approved Supported Cytosol No No 4100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 47: Non-specific - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "HPA003239: AB_1079580" "prognostic unfavorable (4.02e-7)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.35e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.88e-4)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.91e-2)" "unprognostic (1.58e-2)" "unprognostic (9.02e-2)" "unprognostic (6.45e-2)" "unprognostic (6.77e-2)" "unprognostic (6.14e-2)" "unprognostic (4.38e-1)" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "prognostic unfavorable (6.38e-4)" 48.7 43.2 77.5 32.8 85.1 75.9 46.2 70.2 107.1 46.4 56.4 45.5 36.6 38.8 48.5 45.3 39.2 28.4 121.7 87.5 84.8 51.1 73.8 37.9 41.4 80.3 73.0 39.3 38.1 46.3 43.3 42.9 86.2 52.1 43.1 55.8 39.8 50.1 211.9 44.6 34.6 48.9 71.1 34.5 37.8 76.7 72.3 57.4 49.0 163.3 46.7 40.7 38.0 79.2 87.3 68.4 70.4 88.6 152.1 125.9 77.6 140.7 82.9 114.7 143.4 200.1 65.4 117.9 113.0 127.5 126.5 106.6 123.9 143.6 159.9 79.2 180.0 175.5 122.2 192.1 99.2 203.7 197.7 62.8 105.2 128.5 138.5 80.7 107.6 89.8 256.5 107.7 142.3 258.9 98.5 150.4 56.5 84.7 78.6 83.4 89.7 82.6 108.9 62.4 137.5 52.4 111.2 173.9 97.7 82.5 107.8 146.1 83.3 67.2 80.7 124.7 151.2 64.1 109.9 115.4 103.6 135.8 137.7 162.9 193.2 178.0 93.0 182.4 94.7 105.0 93.7 102.8 176.0 81.5 86.5 98.0 101.6 108.5 185.7 79.9 129.2 204.1 77.5 85.1 70.2 107.1 87.5 84.8 80.3 73.0 86.2 71.1 72.3 79.2 57.0 54.5 41.4 21.2 62.6 175.1 74.4 204.4 56.3 72.6 48.0 40.6 154.1 60.1 96.4 79.1 37.5 169.3 66.8 56.6 78.2 113.5 1022.2 51.9 58.4 69.8 55.2 170.1 77.0 110.7 214.0 79.2 26.0 48.8 107.7 38.8 53.9 115.6 119.1 65.6 52.8 72.9 187.2 78.7 127.5 428.1 71.7 78.2 138.7 31.9 143.7 121.2 74.2 30.7 72.2 106.6 57.9 73.7 71.8 67.8 65.1 89.3 106.2 66.3 111.7 64.0 110.4 224.9 96.3 60.7 157.6 148.3 83.0 55.0 58.7 59.1 PDCD10 "CCM3, TFAR15" ENSG00000114209 "Programmed cell death 10" Q9BUL8 3 167683298-167734939 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Angiogenesis, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027095 Approved NA NA 190000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "HPA027095: AB_1855101" "unprognostic (3.39e-2)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "prognostic unfavorable (9.34e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.89e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (4.98e-3)" "unprognostic (2.41e-2)" "unprognostic (9.95e-3)" "prognostic unfavorable (5.22e-5)" "unprognostic (3.08e-2)" "prognostic favorable (5.88e-4)" "unprognostic (1.98e-1)" "unprognostic (2.45e-1)" "unprognostic (3.14e-1)" "unprognostic (5.58e-2)" 34.4 30.4 24.0 39.2 27.1 61.7 41.3 28.4 34.3 24.9 22.6 50.9 48.7 27.3 29.1 50.4 24.4 29.5 35.9 25.6 28.0 43.5 36.4 31.4 53.0 26.9 25.6 25.6 25.7 41.5 21.9 44.4 27.3 31.0 48.7 20.3 31.4 24.7 21.8 27.6 43.4 30.3 27.9 33.1 41.3 44.1 25.9 50.9 37.9 29.6 52.6 50.2 32.3 32.2 133.1 49.3 61.6 39.6 56.7 62.1 67.7 78.5 82.7 89.8 89.9 92.3 153.3 107.5 150.0 73.2 156.5 86.0 73.1 91.1 108.0 172.2 52.9 164.8 59.3 61.1 80.3 109.8 93.0 47.9 92.7 56.9 92.6 64.3 73.3 89.1 129.6 105.2 82.1 117.2 88.4 67.7 79.3 119.3 67.9 51.3 46.9 157.9 112.7 53.5 58.9 52.1 75.2 80.8 148.5 76.8 149.0 92.4 70.5 63.5 41.2 68.9 113.5 113.4 170.9 187.6 75.3 114.6 53.2 224.8 81.7 196.5 82.4 107.0 100.1 136.2 111.2 100.2 79.4 136.4 92.0 95.3 175.0 107.1 138.9 73.2 181.9 133.8 24.0 27.1 28.4 34.3 25.6 28.0 26.9 25.6 27.3 27.9 25.9 32.2 103.3 44.8 42.6 18.6 74.8 108.1 91.0 227.1 69.4 20.2 49.1 57.4 71.1 32.9 120.9 33.1 6.2 106.2 76.9 100.1 105.7 101.4 76.0 58.8 48.3 69.8 34.6 123.3 48.0 122.0 112.3 52.9 62.7 61.4 62.7 34.8 45.3 41.5 91.2 20.2 33.8 75.4 120.1 53.8 73.6 33.5 49.7 89.0 49.8 27.2 100.5 52.9 88.6 19.1 49.7 121.7 103.0 39.5 51.2 97.2 72.0 123.5 92.8 24.1 32.9 37.9 128.4 119.5 103.7 66.6 129.0 103.0 77.9 38.9 55.9 122.7 PDE6D JBTS22 ENSG00000156973 "Phosphodiesterase 6D" O43924 2 231732433-231786272 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 211.9;Late spermatids: 147.9;Spermatocytes: 236.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037433, HPA037434" Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA037433: AB_2675475, HPA037434: AB_10672490" "unprognostic (1.95e-1)" "unprognostic (2.33e-2)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (7.07e-2)" "unprognostic (5.41e-2)" "unprognostic (1.15e-1)" "unprognostic (9.48e-2)" "unprognostic (3.91e-1)" "unprognostic (1.41e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-2)" "prognostic unfavorable (4.02e-5)" "unprognostic (1.11e-2)" "unprognostic (1.80e-2)" "unprognostic (1.46e-1)" "prognostic favorable (4.97e-4)" 16.8 28.1 43.4 16.2 47.3 14.6 16.3 47.4 50.7 19.2 38.0 19.6 13.4 17.6 14.9 16.3 15.5 14.2 19.3 44.4 45.7 19.5 15.4 15.2 23.3 45.6 46.0 13.4 13.2 23.5 25.0 23.0 45.7 13.7 17.6 69.6 14.2 17.6 13.7 16.4 15.7 22.0 46.5 18.8 16.2 27.8 45.8 32.4 14.0 16.7 24.0 17.9 16.4 49.6 26.3 20.3 37.0 28.2 43.7 36.1 15.7 27.0 44.6 40.8 56.9 8.1 24.5 21.4 22.7 23.2 74.9 20.4 22.3 30.2 52.6 63.5 26.4 31.2 12.4 13.0 20.2 20.6 17.2 25.5 26.4 39.8 30.4 27.5 44.1 68.3 9.1 23.5 27.5 52.0 67.7 64.4 28.6 39.6 28.1 45.7 17.0 32.9 42.8 19.5 36.4 32.6 23.0 19.4 46.3 36.1 17.5 43.0 19.5 26.5 7.3 57.9 21.4 57.9 26.3 52.6 27.4 38.6 42.5 84.4 48.2 68.4 46.3 48.7 36.3 50.4 46.0 47.3 49.3 55.5 31.7 44.3 42.0 34.4 64.9 55.8 84.4 43.1 43.4 47.3 47.4 50.7 44.4 45.7 45.6 46.0 45.7 46.5 45.8 49.6 20.8 0.0 8.7 18.3 19.5 13.8 12.4 23.6 21.1 14.7 13.3 17.7 13.1 12.8 15.8 12.9 16.7 16.4 18.2 10.2 25.4 23.1 211.9 6.8 9.2 19.6 17.4 15.8 13.4 23.9 21.9 14.7 13.3 6.5 14.5 7.3 19.2 5.0 18.9 11.8 18.1 10.0 14.2 14.4 15.1 147.9 13.1 17.5 23.2 16.9 24.6 22.0 17.5 48.7 34.0 26.0 14.9 12.4 17.0 10.5 11.2 18.4 11.8 29.0 19.7 10.7 24.9 236.8 65.1 20.3 14.2 13.5 18.5 11.5 10.5 11.0 PET100 C19orf79 ENSG00000229833 "PET100 cytochrome c oxidase chaperone" P0DJ07 19 7629793-7631956 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067288 Approved Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" Mitochondria "HPA067288: AB_2732762" "unprognostic (7.02e-2)" "prognostic favorable (6.81e-4)" "unprognostic (1.57e-1)" "unprognostic (9.87e-3)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (1.70e-1)" "prognostic favorable (7.97e-4)" "unprognostic (4.89e-1)" "unprognostic (2.88e-3)" "unprognostic (2.49e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (2.66e-2)" "prognostic favorable (2.44e-4)" 35.0 45.6 77.8 38.3 76.8 85.2 38.8 77.3 125.7 28.0 81.7 39.5 38.1 25.1 46.1 40.3 23.4 6.6 70.0 77.0 77.2 49.7 65.5 28.4 26.6 76.8 78.1 23.0 33.1 75.9 41.5 23.0 77.3 29.9 28.1 64.8 43.3 22.8 79.3 31.3 33.0 17.0 75.5 36.5 45.8 31.1 76.7 75.9 34.7 65.1 31.9 27.3 29.5 79.0 72.2 63.5 112.2 67.9 54.9 39.3 40.7 60.0 34.6 40.9 39.7 60.6 47.3 48.3 102.8 46.3 49.8 61.9 52.3 55.4 34.1 110.5 108.0 69.1 136.8 96.5 27.4 118.8 62.2 44.4 35.4 27.6 28.6 64.5 59.2 113.5 50.5 179.4 43.2 80.7 128.1 182.0 73.0 83.2 141.0 77.0 64.4 113.6 85.8 86.8 63.3 74.3 79.4 71.5 68.3 69.6 51.9 153.2 63.6 31.8 39.1 64.4 90.1 157.5 134.0 86.0 58.1 89.3 38.7 806.4 481.1 576.6 241.3 408.1 227.5 338.5 276.8 256.6 309.2 332.5 256.1 268.1 468.2 227.4 370.5 538.5 390.0 501.2 77.8 76.8 77.3 125.7 77.0 77.2 76.8 78.1 77.3 75.5 76.7 79.0 109.5 150.6 189.0 6.2 137.2 50.2 39.8 194.1 87.6 52.7 136.8 109.6 54.1 197.3 150.6 259.3 22.9 126.7 159.3 275.4 215.2 215.7 51.1 156.7 101.9 93.3 191.5 238.4 4.5 318.3 128.9 82.6 144.3 160.7 106.9 69.0 171.0 542.3 171.7 18.5 4.5 255.4 158.7 236.4 103.8 47.3 101.5 161.2 113.8 10.3 228.8 123.0 130.7 4.5 8.4 351.4 302.4 83.1 198.9 57.0 341.9 295.9 160.2 96.5 85.5 52.0 80.4 126.5 84.0 127.0 59.1 178.8 131.0 30.1 213.1 53.0 PFN1 ENSG00000108518 "Profilin 1" P07737 17 4945652-4949061 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 5241.0;monocytes: 4824.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037134, CAB037140" Enhanced Approved Cytosol NA NA 660000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 3: Monocytes - Immune response regulation" Cytosol "CAB037134: AB_1079599, CAB037140: AB_1079598" "unprognostic (1.07e-1)" "unprognostic (3.57e-1)" "unprognostic (1.60e-1)" "unprognostic (5.45e-3)" "unprognostic (1.65e-1)" "unprognostic (7.54e-2)" "unprognostic (4.01e-3)" "unprognostic (7.83e-3)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" "unprognostic (2.17e-1)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.62e-1)" "unprognostic (8.17e-2)" "unprognostic (1.02e-2)" "unprognostic (1.28e-1)" 573.1 365.8 278.0 1133.4 302.0 1613.0 397.0 323.2 333.0 393.7 289.2 970.2 764.0 734.4 346.4 582.7 500.9 372.7 343.8 281.8 301.5 460.9 661.6 559.2 1357.9 347.3 325.4 247.7 246.4 311.3 198.9 581.1 348.6 419.4 808.4 71.8 346.9 601.4 337.9 449.8 772.9 1034.7 315.2 910.8 675.1 116.2 366.2 1197.6 269.2 238.7 1440.0 842.6 425.0 355.2 3019.5 4276.8 1461.5 1205.2 778.8 977.1 1972.7 2416.8 1970.4 2568.6 1923.7 1684.1 1181.1 2476.9 1892.0 2542.0 1453.6 1825.4 1383.6 3040.5 2049.6 3560.1 2355.1 2516.6 2034.3 2225.8 2144.0 1630.4 5006.0 1152.4 1331.9 1957.6 1939.8 1477.6 2361.3 1646.4 1488.6 1736.7 3150.5 1815.0 2469.9 3448.0 2095.2 1474.7 2297.3 2451.9 2035.1 1494.6 2491.7 1909.8 564.0 1586.2 1910.5 1180.9 1679.7 1226.8 1121.0 1359.7 2731.7 2136.6 1675.1 1512.3 3969.3 931.3 1070.7 1799.3 1834.4 1949.7 3316.4 8100.1 8206.3 13914.4 9850.0 10858.8 6780.3 5722.0 8185.7 9586.6 9920.0 4970.0 5238.0 7604.7 9387.0 9112.1 13547.4 7809.7 11245.6 23570.1 278.0 302.0 323.2 333.0 281.8 301.5 347.3 325.4 348.6 315.2 366.2 355.2 561.8 112.2 176.1 12.1 1070.6 1806.0 873.2 3658.3 1003.3 25.0 767.4 914.1 147.6 457.5 1020.0 741.2 0.0 1911.0 1725.6 1733.8 992.0 1866.6 19.7 313.4 546.1 806.6 603.7 713.5 7.1 1625.2 5241.0 599.9 733.4 422.7 486.5 291.2 637.5 754.3 4094.2 38.7 6.4 1399.7 1452.6 1434.3 2934.8 31.0 263.8 1854.7 873.4 21.5 4824.7 99.8 3216.3 9.0 37.2 2933.5 1585.7 375.0 927.8 1238.2 1472.2 1671.2 559.4 17.8 506.2 282.3 1838.4 97.4 355.4 1170.1 1513.5 1682.8 1804.7 410.7 1355.5 1177.9 PGLS 6PGL ENSG00000130313 6-phosphogluconolactonase O95336 19 17511636-17521288 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 244.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040744, HPA042032" Approved Supported Nucleoplasm,Cytosol NA NA 7200000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm Cytosol "HPA040744: AB_2677111, HPA042032: AB_2677809" "unprognostic (3.68e-2)" "unprognostic (8.98e-3)" "unprognostic (1.25e-1)" "unprognostic (9.64e-3)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (3.55e-3)" "unprognostic (2.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.30e-1)" "unprognostic (4.75e-3)" "unprognostic (2.39e-1)" "unprognostic (1.99e-1)" "unprognostic (5.05e-2)" "unprognostic (9.26e-3)" 65.0 85.9 31.6 20.0 33.8 40.6 60.9 33.8 41.8 53.2 33.9 53.9 26.2 42.6 13.2 107.4 44.6 16.9 32.1 30.1 33.3 64.7 75.6 46.5 27.2 36.5 32.4 59.7 88.2 28.5 43.0 17.1 35.2 57.3 16.1 3.7 66.1 19.0 18.0 83.6 49.0 15.9 34.5 73.6 54.7 23.2 34.6 26.2 58.3 11.6 20.6 50.1 62.6 38.5 68.7 62.2 38.7 26.3 57.6 94.8 70.6 45.4 76.5 46.4 59.5 29.7 104.0 74.4 50.0 74.9 33.1 46.6 21.9 73.6 14.5 37.3 80.9 35.3 28.0 54.1 97.8 38.7 38.6 111.8 100.5 27.9 83.9 48.3 63.3 29.4 40.7 18.7 58.5 77.2 84.6 108.6 50.6 72.9 244.0 57.3 23.3 49.9 64.3 56.3 47.3 56.0 28.3 33.2 70.3 21.1 47.9 69.7 57.2 47.9 12.9 96.0 26.6 31.4 23.9 32.2 68.2 97.5 48.0 73.0 163.5 194.6 55.3 185.4 44.9 61.5 49.5 50.1 185.0 71.4 45.4 46.1 158.8 72.5 180.2 137.2 57.3 102.7 31.6 33.8 33.8 41.8 30.1 33.3 36.5 32.4 35.2 34.5 34.6 38.5 93.7 28.9 38.3 7.2 84.8 64.5 94.5 132.5 100.2 22.2 128.9 177.8 8.9 110.1 89.4 47.8 16.7 122.4 98.8 194.0 111.6 177.5 35.5 89.4 99.7 72.0 133.0 48.4 3.5 208.8 169.6 94.2 82.0 90.9 25.4 163.7 99.2 94.0 263.4 26.9 4.9 147.0 75.3 306.5 142.4 70.8 90.7 208.2 74.7 8.4 325.3 79.4 139.0 8.0 11.8 175.7 211.6 69.2 40.4 107.6 263.1 211.1 66.7 28.1 52.6 51.4 103.9 28.7 25.8 210.7 96.2 105.2 85.2 178.3 173.4 143.5 PGM1 ENSG00000079739 "Phosphoglucomutase 1" P36871 1 63593411-63660245 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Congenital disorder of glycosylation, Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 1559.1;tongue: 788.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 238.4;Extravillous trophoblasts: 185.9;Hepatocytes: 214.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004666, HPA024190, HPA024637, HPA046329" Enhanced Supported Cytosol NA NA 21000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol "CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625" "unprognostic (2.50e-1)" "unprognostic (2.26e-3)" "unprognostic (1.74e-2)" "unprognostic (5.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.28e-2)" "unprognostic (1.86e-3)" "unprognostic (2.42e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.74e-5)" "unprognostic (7.07e-2)" "unprognostic (1.55e-2)" "unprognostic (6.58e-3)" "unprognostic (1.37e-1)" "unprognostic (2.46e-1)" "unprognostic (9.74e-3)" 113.7 70.8 31.6 20.7 34.7 21.5 57.4 34.3 38.4 33.9 53.1 58.9 60.8 22.9 19.2 49.3 17.0 30.3 178.9 31.4 34.0 52.2 279.8 42.6 14.7 44.7 34.1 51.0 112.2 65.3 31.8 26.9 32.7 46.6 49.9 22.6 41.8 49.7 1559.1 30.6 55.1 41.4 31.9 14.7 30.6 11.1 36.5 14.3 27.5 788.0 19.4 38.4 22.1 30.2 113.4 47.0 17.3 57.0 111.0 81.4 138.6 45.7 61.8 48.9 79.0 38.8 51.3 35.8 93.2 71.2 107.4 26.5 24.0 96.3 55.9 44.0 32.1 75.3 72.6 40.3 91.6 66.8 4.3 103.4 60.7 57.1 88.5 129.8 29.6 36.3 0.1 46.3 78.8 6.9 19.6 36.7 78.3 3.4 73.9 26.8 80.0 11.8 70.0 35.3 10.4 66.7 100.0 103.0 157.4 78.6 32.4 25.2 3.1 71.6 36.0 64.0 39.4 29.1 45.5 57.8 117.0 58.0 31.5 46.0 33.2 49.2 40.5 22.4 32.7 22.4 23.5 31.0 48.4 11.8 21.0 24.7 38.7 43.9 21.2 13.9 20.4 35.4 31.6 34.7 34.3 38.4 31.4 34.0 44.7 34.1 32.7 31.9 36.5 30.2 8.4 93.0 29.4 48.3 16.9 17.8 29.0 58.8 47.8 9.2 33.8 21.8 139.2 48.6 24.2 16.5 10.4 76.6 14.2 81.8 88.0 55.9 32.0 8.2 12.1 12.7 13.1 5.7 17.9 238.4 185.9 37.0 27.0 13.5 5.1 134.3 15.0 214.4 24.6 0.0 26.3 47.5 20.3 17.0 10.8 8.5 22.1 13.5 26.6 4.7 32.8 75.8 29.9 32.2 9.8 70.5 31.6 38.0 40.4 29.2 90.2 74.8 17.0 11.4 13.1 53.4 25.5 5.6 10.1 57.3 18.2 58.8 19.0 20.2 81.5 19.0 PHKG2 ENSG00000156873 "Phosphorylase kinase catalytic subunit gamma 2" P15735 16 30748293-30761176 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 130.1" "Group enriched" "Detected in many" 5 "Early spermatids: 397.0;Late spermatids: 1576.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065618, HPA068751" Supported Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA065618: AB_2685520, HPA068751: AB_2686025" "unprognostic (7.63e-3)" "prognostic favorable (7.90e-4)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "prognostic favorable (1.90e-4)" "unprognostic (6.45e-2)" "unprognostic (1.25e-2)" "prognostic favorable (8.02e-4)" "unprognostic (6.15e-2)" "unprognostic (5.27e-2)" "unprognostic (1.36e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" 9.0 15.8 17.5 11.5 16.9 30.0 9.9 17.1 18.7 10.0 15.9 12.9 11.0 10.1 9.5 10.2 11.7 8.2 12.1 18.9 16.4 14.7 19.1 10.0 12.5 17.7 17.2 8.3 9.7 18.9 15.9 7.8 18.8 14.7 12.0 8.9 11.5 12.0 13.2 14.6 12.0 9.9 16.0 12.9 13.8 130.1 17.5 11.6 13.6 8.8 12.7 10.1 9.2 16.2 24.7 16.3 13.1 16.2 11.8 9.4 29.8 17.2 24.6 22.1 25.1 13.5 12.6 21.0 19.3 17.1 11.5 24.0 13.5 21.5 17.6 11.4 38.2 11.9 28.8 38.7 18.1 18.1 16.9 12.9 11.2 21.4 9.9 10.7 22.8 15.3 16.1 11.7 16.3 55.5 22.3 27.1 18.0 17.6 18.0 29.4 20.0 28.2 25.7 27.2 17.5 11.9 13.5 38.1 16.6 11.8 30.1 15.5 13.6 14.4 15.1 17.2 16.0 24.1 14.4 14.8 27.3 35.2 11.4 44.0 55.8 114.9 37.8 56.5 30.9 21.1 27.1 38.8 52.0 21.5 24.2 27.7 44.7 63.8 42.3 46.1 43.3 49.0 17.5 16.9 17.1 18.7 18.9 16.4 17.7 17.2 18.8 16.0 17.5 16.2 10.4 12.8 21.7 13.7 18.5 21.0 15.2 28.7 22.8 8.8 21.8 17.1 15.9 10.0 32.0 18.4 10.4 29.6 32.2 32.1 27.4 11.9 397.0 35.8 13.0 10.0 16.3 20.2 14.7 24.4 41.5 11.8 44.4 38.8 13.3 16.1 10.4 24.1 28.2 20.2 14.5 21.4 26.4 19.1 27.2 1576.6 17.4 26.4 12.4 11.2 40.3 13.7 39.1 9.0 8.1 19.6 18.5 23.3 20.5 31.5 27.8 47.3 33.0 9.9 0.0 8.9 14.8 180.5 22.9 20.5 23.0 75.5 25.9 20.8 27.0 16.9 PIGBOS1 ENSG00000225973 "PIGB opposite strand 1" A0A0B4J2F0 15 55317184-55319161 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" "prognostic favorable (4.19e-4)" "unprognostic (1.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (2.31e-1)" "unprognostic (3.27e-2)" "unprognostic (2.58e-3)" "unprognostic (4.62e-3)" "unprognostic (7.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (4.96e-1)" 14.5 13.0 6.1 11.6 6.6 17.4 14.9 6.4 7.4 12.5 7.5 12.7 10.2 13.6 9.1 9.1 13.5 8.2 11.9 6.2 7.1 15.3 15.0 11.4 13.9 7.7 6.8 12.5 12.4 8.2 13.4 11.7 7.7 11.4 8.1 6.6 12.8 6.4 13.8 8.9 13.5 7.7 6.5 16.4 15.4 11.3 6.9 10.1 16.3 6.8 8.8 12.9 10.8 8.9 15.7 15.3 12.7 9.2 16.3 18.0 16.2 14.8 15.2 12.3 8.3 8.4 9.7 19.8 18.3 10.6 19.6 13.8 4.6 8.3 7.8 25.2 7.4 33.6 14.6 15.8 14.1 23.4 26.6 16.3 14.8 8.1 9.2 16.6 14.1 17.7 39.5 17.6 11.1 12.9 12.0 44.9 7.7 16.3 7.7 16.6 12.3 36.8 10.1 10.2 9.5 15.9 9.5 15.6 48.6 15.9 15.8 52.1 14.1 19.1 22.4 11.0 23.9 17.8 48.9 16.2 17.8 49.3 19.7 49.7 41.9 58.0 24.7 33.2 23.5 31.0 29.8 27.1 33.6 30.6 40.3 29.4 44.3 33.3 46.3 42.7 41.0 26.4 6.1 6.6 6.4 7.4 6.2 7.1 7.7 6.8 7.7 6.5 6.9 8.9 20.0 28.9 21.6 0.0 24.8 0.0 12.3 0.0 14.8 14.1 15.9 22.2 8.9 14.3 9.9 18.4 6.2 33.4 34.0 15.6 39.2 24.6 19.4 21.0 23.7 22.5 30.1 23.8 0.0 39.5 35.3 21.7 13.3 15.4 7.0 21.7 25.0 34.5 38.7 18.5 0.0 18.5 0.0 27.4 0.0 5.1 29.8 21.9 0.0 0.0 45.1 21.4 50.4 0.0 0.0 31.2 22.5 19.5 19.6 21.3 34.6 48.1 19.0 19.2 32.9 16.6 16.3 23.4 15.8 14.2 0.0 23.8 19.7 22.3 15.3 12.1 PIGS ENSG00000087111 "Phosphatidylinositol glycan anchor biosynthesis class S" Q96S52 17 28553383-28571794 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018149 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA018149: AB_1855373" "unprognostic (2.29e-2)" "unprognostic (1.37e-2)" "unprognostic (3.89e-1)" "unprognostic (2.52e-1)" "unprognostic (6.61e-2)" "unprognostic (3.82e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.65e-1)" "unprognostic (9.09e-2)" "unprognostic (2.25e-3)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (2.90e-2)" "unprognostic (1.23e-1)" "unprognostic (8.06e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (5.31e-4)" 25.0 15.5 8.3 15.5 8.5 25.3 11.4 8.2 8.6 12.9 18.6 25.5 30.9 12.0 3.3 23.5 20.1 15.6 25.4 10.5 9.1 16.6 4.9 20.2 18.9 8.8 9.4 13.3 16.8 28.5 3.3 17.4 8.8 17.7 15.7 3.4 14.8 16.2 31.4 18.5 32.2 16.1 7.8 18.2 26.9 13.4 8.7 17.5 24.3 19.7 13.7 17.7 5.3 8.0 34.7 57.4 26.5 67.9 51.1 38.2 40.1 42.3 34.5 44.4 58.1 60.4 33.8 22.3 62.9 57.8 43.1 64.5 32.4 48.2 16.6 65.8 92.5 30.1 45.3 26.2 47.8 58.5 73.8 46.7 33.6 27.8 37.8 44.5 60.3 37.8 89.3 34.1 38.5 42.6 36.9 40.2 13.2 77.9 17.6 31.2 87.8 73.6 30.6 36.9 54.3 37.7 60.3 115.4 32.8 26.4 105.4 69.5 52.2 31.5 32.5 27.1 35.0 56.5 84.0 17.0 56.6 56.8 45.1 86.2 60.4 78.9 34.3 55.0 31.0 23.5 27.5 32.5 64.9 22.3 28.8 24.0 29.4 43.0 39.6 49.8 45.2 46.3 8.3 8.5 8.2 8.6 10.5 9.1 8.8 9.4 8.8 7.8 8.7 8.0 15.7 44.8 21.4 10.7 15.9 8.3 11.3 21.1 13.6 20.5 20.5 17.1 40.7 20.0 18.8 46.0 64.6 35.0 31.6 48.5 11.7 43.5 9.5 15.3 15.7 18.7 40.7 17.9 10.9 26.3 53.4 14.9 18.3 21.5 3.8 17.1 26.4 7.9 31.1 52.2 12.6 28.3 24.4 28.1 8.0 13.1 23.9 22.9 7.2 1.9 66.1 17.5 93.7 9.0 11.7 22.5 21.6 22.6 16.8 15.0 49.0 19.1 14.4 56.1 6.6 12.3 15.9 74.2 62.0 19.3 12.5 36.4 21.8 25.0 27.6 12.4 PIGT ENSG00000124155 "Phosphatidylinositol glycan anchor biosynthesis class T" Q969N2 20 45416084-45456934 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (6.06e-2)" "unprognostic (4.60e-3)" "unprognostic (7.63e-2)" "unprognostic (6.00e-2)" "unprognostic (6.18e-3)" "unprognostic (6.68e-2)" "unprognostic (7.34e-3)" "unprognostic (1.17e-1)" "unprognostic (2.70e-2)" "unprognostic (3.32e-1)" "prognostic favorable (2.51e-4)" "unprognostic (5.48e-2)" "unprognostic (7.60e-2)" "unprognostic (9.21e-2)" "unprognostic (5.66e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-2)" 57.4 51.9 30.7 39.4 38.9 70.8 52.7 41.2 37.5 65.5 44.6 75.8 49.9 69.6 89.5 37.7 61.2 48.3 113.5 29.9 37.2 47.1 48.9 45.3 26.6 41.0 38.1 46.1 65.0 105.4 48.9 48.5 38.9 39.5 77.2 13.0 48.2 55.6 61.2 46.0 54.3 69.7 37.6 36.5 62.1 38.1 38.8 25.8 57.0 51.8 27.4 57.0 42.8 47.6 79.0 95.3 35.8 138.7 218.0 152.9 68.5 90.4 172.8 126.8 99.7 179.9 123.6 47.1 122.0 142.9 108.4 152.4 43.6 124.8 67.8 25.2 53.5 49.0 80.8 100.9 99.9 93.5 203.1 117.3 117.0 99.9 108.6 179.4 109.3 39.2 65.0 163.8 107.4 165.3 44.8 74.7 29.4 227.5 162.1 38.0 107.6 168.0 102.5 51.1 60.2 77.0 177.7 173.2 88.7 61.4 150.6 169.8 96.5 301.4 138.1 57.1 128.8 93.9 144.0 30.0 190.7 74.7 140.9 58.9 77.9 66.3 57.4 83.2 43.6 27.2 41.0 53.8 92.2 28.1 35.7 41.8 30.7 57.6 79.2 71.4 61.6 83.1 30.7 38.9 41.2 37.5 29.9 37.2 41.0 38.1 38.9 37.6 38.8 47.6 41.9 41.7 29.5 9.1 43.9 30.0 46.4 86.8 13.6 21.0 43.7 31.4 169.2 41.5 63.7 44.1 14.6 62.1 58.9 106.1 13.7 107.5 31.8 45.2 32.3 46.0 65.5 24.2 7.6 114.5 73.9 94.2 44.9 59.2 33.6 58.5 39.7 41.5 76.8 38.7 9.8 145.3 85.5 49.6 42.6 81.4 60.6 44.3 88.9 4.7 39.8 25.8 37.0 6.0 27.1 79.5 61.8 56.1 69.2 40.7 103.8 26.1 46.2 15.6 65.7 39.4 47.2 88.4 96.9 23.5 27.8 52.1 43.4 47.9 111.6 57.7 PIK3C3 Vps34 ENSG00000078142 "Phosphatidylinositol 3-kinase catalytic subunit type 3" Q8NEB9 18 41955234-42087830 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 114.9;Inhibitory neurons: 104.1;Oligodendrocytes: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040718 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA040718: AB_10793862" "unprognostic (1.26e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" "unprognostic (3.55e-3)" "unprognostic (6.15e-2)" "unprognostic (3.61e-2)" "unprognostic (6.00e-3)" "unprognostic (1.91e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-2)" "unprognostic (3.86e-2)" "unprognostic (6.41e-2)" "prognostic favorable (4.97e-4)" "unprognostic (1.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-3)" 10.9 16.1 6.8 12.0 10.0 15.9 16.4 18.2 11.5 13.2 12.7 11.7 8.9 15.0 16.6 11.8 12.2 12.1 11.5 7.3 7.8 16.2 14.3 11.7 14.1 8.3 7.0 17.0 9.0 18.6 8.0 17.2 9.9 12.8 13.7 16.7 10.9 12.5 12.2 11.4 10.6 13.9 8.7 13.3 11.5 18.0 7.6 18.5 15.3 16.2 15.8 15.1 9.9 12.9 16.2 11.3 27.8 21.3 31.6 33.8 17.1 31.4 39.8 24.7 33.2 5.4 8.0 10.0 17.6 31.8 19.4 26.0 22.1 17.5 34.2 16.3 15.5 20.8 15.4 21.7 26.3 30.9 22.1 37.3 25.8 23.2 29.9 37.9 25.6 19.9 20.9 12.2 34.3 5.3 13.6 19.8 20.4 6.0 8.1 81.9 21.0 26.1 28.3 17.1 24.2 28.1 10.2 7.3 22.2 30.8 10.8 24.8 33.7 33.3 9.7 7.4 14.6 33.3 42.2 11.3 27.5 41.4 18.0 20.5 9.9 21.2 9.2 11.0 10.3 11.4 9.3 11.5 10.2 10.1 11.8 8.9 19.2 12.1 12.5 5.8 17.0 8.2 6.8 10.0 18.2 11.5 7.3 7.8 8.3 7.0 9.9 8.7 7.6 12.9 22.4 22.4 36.9 70.2 21.1 11.5 10.8 15.3 15.4 28.2 11.5 11.0 23.5 4.3 27.3 14.7 20.9 20.6 26.8 13.8 7.9 14.4 28.6 16.9 22.4 19.9 4.9 19.1 114.9 10.3 13.3 22.4 13.7 18.3 17.1 25.4 17.2 13.4 15.6 55.5 104.1 11.5 16.2 17.9 10.1 13.2 14.6 20.9 7.2 58.1 21.5 26.2 13.4 83.4 115.6 14.3 10.0 24.0 18.2 14.5 12.9 12.3 22.4 22.5 19.7 25.4 18.9 20.0 18.6 14.3 11.4 27.4 23.8 24.7 10.6 15.9 PIN1 dod ENSG00000127445 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 1" Q13526 19 9835257-9849689 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 782.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004528, CAB009326, HPA068650, HPA070887" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 120000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: " "unprognostic (2.54e-1)" "unprognostic (6.14e-3)" "unprognostic (6.50e-2)" "unprognostic (4.36e-2)" "unprognostic (1.71e-2)" "unprognostic (6.50e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (2.67e-1)" "unprognostic (7.23e-3)" "prognostic favorable (3.25e-4)" "unprognostic (9.43e-2)" "prognostic favorable (7.80e-5)" "unprognostic (2.20e-2)" "unprognostic (2.56e-1)" "unprognostic (3.13e-2)" "unprognostic (1.21e-2)" 55.3 90.1 130.7 31.2 140.6 48.1 52.3 132.5 201.4 59.4 99.9 83.2 36.4 61.7 7.2 59.5 63.7 13.0 105.5 149.6 141.4 70.1 63.2 49.0 26.4 152.6 134.4 54.6 43.5 28.2 69.2 20.5 156.7 74.7 9.3 20.6 39.6 22.0 90.4 54.3 49.0 16.7 113.9 53.8 61.1 98.4 133.8 42.3 44.8 33.4 12.4 67.4 52.4 132.7 116.8 104.5 75.4 70.8 25.8 22.9 45.1 85.3 35.7 60.9 58.3 97.5 36.1 72.0 132.0 31.7 63.8 58.4 52.2 49.6 19.3 153.9 223.5 187.0 137.2 85.5 41.9 88.0 105.0 31.5 33.5 39.5 18.7 45.7 49.9 124.1 86.1 105.4 37.3 81.0 133.7 338.6 72.8 47.8 156.8 120.6 79.4 121.2 44.5 56.4 95.1 112.4 82.0 40.5 96.6 30.8 51.9 104.3 87.3 85.6 68.3 133.6 139.1 135.0 137.0 97.1 90.9 111.3 107.2 280.9 181.0 397.6 170.1 202.0 159.8 165.5 165.5 171.8 171.4 176.5 130.5 146.0 114.0 192.2 195.8 316.9 245.5 214.7 130.7 140.6 132.5 201.4 149.6 141.4 152.6 134.4 156.7 113.9 133.8 132.7 73.8 28.9 20.5 11.1 48.8 48.3 65.7 153.9 23.3 77.3 56.1 62.0 79.6 44.3 67.4 62.5 12.5 119.4 81.3 82.3 164.4 101.5 270.5 75.9 57.6 65.6 99.9 78.9 41.3 108.6 98.1 66.5 38.7 40.6 63.5 83.6 56.4 45.8 140.7 60.6 39.2 70.6 160.7 54.7 75.2 782.4 90.1 60.6 124.5 20.6 131.6 87.9 138.0 11.6 24.3 113.7 81.2 129.8 74.3 68.9 97.0 143.8 104.5 76.0 65.7 52.3 98.6 186.7 94.7 54.0 65.9 55.0 77.8 81.8 69.2 58.5 PLPBP PROSC ENSG00000147471 "Pyridoxal phosphate binding protein" O94903 8 37762595-37779768 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 101.8;Exocrine glandular cells: 49.8;Hofbauer cells: 47.3;Proximal tubular cells: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017033, HPA023646, HPA023733" Approved Enhanced Cytosol NA NA 34000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742" "unprognostic (1.55e-2)" "unprognostic (2.17e-2)" "unprognostic (2.14e-2)" "unprognostic (2.95e-2)" "unprognostic (1.34e-1)" "unprognostic (2.35e-2)" "unprognostic (2.36e-1)" "unprognostic (7.78e-3)" "unprognostic (1.80e-1)" "unprognostic (4.28e-2)" "unprognostic (2.83e-2)" "unprognostic (2.59e-2)" "unprognostic (9.41e-3)" "unprognostic (3.16e-2)" "unprognostic (3.99e-2)" "unprognostic (2.90e-1)" "unprognostic (7.85e-2)" 34.2 23.1 22.2 21.2 24.3 14.6 23.3 25.3 27.1 22.1 26.8 47.2 34.5 19.2 23.3 20.2 27.5 19.1 39.2 24.0 25.0 58.5 78.2 25.7 25.0 22.8 24.9 24.7 40.3 37.4 16.2 20.1 23.7 20.2 37.9 10.9 28.3 27.8 46.4 17.0 37.3 25.9 23.7 25.0 33.5 8.4 24.5 27.4 31.8 42.1 29.0 22.9 16.1 28.6 50.3 45.4 35.1 32.0 25.9 31.1 31.6 55.2 45.8 34.7 38.9 51.6 24.3 58.4 61.9 39.9 55.5 41.4 65.4 52.5 56.6 49.9 34.3 79.4 16.4 51.7 51.6 36.8 52.5 22.9 49.8 33.0 52.0 37.6 52.3 78.3 42.8 42.1 28.7 34.8 116.4 32.4 43.0 92.8 41.9 73.6 46.6 34.8 56.5 60.0 21.5 25.1 45.4 20.0 56.8 25.4 44.2 48.6 52.1 19.1 60.7 69.8 38.1 43.3 90.9 43.0 27.4 51.8 35.0 164.3 109.6 136.1 85.6 130.0 90.0 77.8 87.8 83.6 115.2 61.9 77.0 74.3 46.9 75.9 147.4 66.5 116.7 110.2 22.2 24.3 25.3 27.1 24.0 25.0 22.8 24.9 23.7 23.7 24.5 28.6 35.9 9.6 26.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 27.8 23.0 0.0 0.0 8.1 31.3 0.0 21.2 20.0 0.0 101.8 38.2 0.0 12.8 20.7 13.5 0.0 0.0 0.0 49.8 31.6 13.9 0.0 19.6 12.6 14.8 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 11.9 0.0 0.0 0.0 0.0 33.2 0.0 0.0 1.8 0.0 0.0 82.2 13.8 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 12.9 9.8 17.1 0.0 0.0 POLR2E "hRPB25, hsRPB5, RPABC1, RPB5, XAP4" ENSG00000099817 "RNA polymerase II, I and III subunit E" P19388 19 1086574-1095380 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Host-virus interaction, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063030, HPA068992" Supported Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 3: Monocytes - Immune response regulation" Nucleoplasm "HPA063030: AB_2684926, HPA068992: AB_2686065" "unprognostic (2.52e-1)" "unprognostic (3.73e-2)" "unprognostic (2.49e-1)" "unprognostic (1.51e-2)" "unprognostic (2.14e-1)" "unprognostic (6.42e-2)" "unprognostic (2.59e-3)" "unprognostic (1.60e-1)" "unprognostic (2.08e-1)" "unprognostic (2.05e-1)" "unprognostic (2.03e-3)" "unprognostic (3.03e-2)" "prognostic favorable (3.21e-6)" "unprognostic (3.22e-1)" "unprognostic (1.47e-1)" "unprognostic (1.72e-3)" "unprognostic (4.77e-2)" 30.8 16.7 25.5 16.3 22.9 15.4 18.1 23.0 28.9 13.0 16.0 18.7 13.7 12.8 14.4 22.8 17.3 7.9 14.6 25.9 23.5 23.6 41.1 17.0 18.6 28.1 24.7 14.0 13.2 20.3 12.2 10.3 28.6 12.5 19.5 17.5 14.8 12.1 16.4 16.2 17.0 16.7 23.4 19.3 15.9 13.0 26.6 13.8 17.0 22.6 26.6 14.0 11.2 24.1 33.6 30.8 41.6 33.4 55.6 34.5 19.5 24.2 34.1 39.5 23.1 36.1 11.9 27.5 10.7 72.1 6.1 26.5 79.1 26.9 73.1 29.2 23.9 36.3 36.2 33.9 22.3 54.3 26.4 25.5 17.5 27.7 51.0 40.6 36.7 14.7 42.3 31.0 44.3 27.6 30.0 17.1 33.6 23.9 23.1 31.9 40.7 27.0 39.5 38.3 21.0 23.9 40.2 27.8 17.5 37.2 29.5 24.7 49.9 19.6 21.7 36.0 28.4 47.6 70.9 50.9 32.3 34.6 23.2 24.2 50.2 29.5 25.5 33.7 26.5 18.2 23.2 26.0 44.3 19.6 18.5 18.4 25.2 28.7 38.7 31.2 24.5 38.4 25.5 22.9 23.0 28.9 25.9 23.5 28.1 24.7 28.6 23.4 26.6 24.1 67.7 32.1 63.0 8.1 80.1 104.3 83.9 152.1 59.7 55.7 80.9 82.9 78.2 60.1 79.9 55.2 41.7 234.3 67.4 103.1 174.1 156.7 21.0 64.0 64.4 77.8 70.6 77.4 13.0 141.1 264.1 95.1 66.3 57.2 71.0 74.9 68.9 96.6 259.7 55.5 13.9 91.8 107.8 93.6 221.7 37.8 69.3 103.7 99.6 6.5 361.7 78.1 103.0 4.5 10.6 162.5 84.6 62.1 93.8 111.7 163.1 188.4 72.3 48.9 26.3 50.5 96.9 125.4 82.5 104.1 109.7 234.6 73.4 110.6 130.5 106.9 POLR2F "HRBP14.4, RPB6" ENSG00000100142 "RNA polymerase II, I and III subunit F" P61218 22 37952607-38041915 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in single" 4 "melanoma: 1.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000827, CAB009882" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli fibrillar center" "CAB009882: AB_2299942, HPA000827: AB_1079834" "unprognostic (8.27e-2)" "unprognostic (7.50e-2)" "unprognostic (1.51e-3)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (2.73e-3)" "unprognostic (2.85e-1)" "unprognostic (5.87e-2)" "unprognostic (4.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.11e-4)" "unprognostic (9.08e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-1)" "unprognostic (7.86e-2)" 52.5 61.1 73.4 34.6 92.3 38.9 50.8 77.5 90.2 59.5 56.9 64.9 37.7 53.2 24.8 58.7 50.2 19.5 91.8 74.2 91.2 58.2 118.6 41.6 31.0 87.9 83.9 60.9 47.5 76.5 62.7 30.2 82.6 47.7 28.7 16.8 56.1 39.6 111.0 45.8 42.3 28.8 75.3 36.4 57.6 48.8 86.8 36.7 54.7 68.4 26.3 53.1 52.7 123.7 150.7 176.2 120.6 128.7 141.1 81.7 109.4 138.0 81.0 141.4 130.5 210.0 51.8 117.4 99.1 120.3 138.3 106.4 166.9 135.7 67.1 143.0 303.7 107.3 181.3 289.1 125.9 213.6 67.0 112.4 99.8 186.3 72.1 71.2 118.7 130.4 208.9 93.7 101.9 220.2 168.4 258.2 174.3 175.4 134.7 162.3 110.4 134.5 77.4 94.8 180.6 67.2 129.5 88.9 215.3 69.6 62.9 144.3 110.5 119.8 173.9 150.4 158.1 106.0 178.0 247.9 122.4 107.9 138.4 118.9 92.9 140.8 83.8 90.4 78.5 95.8 71.9 81.8 86.3 71.3 63.1 63.7 122.8 113.7 78.5 123.3 103.4 85.3 73.4 92.3 77.5 90.2 74.2 91.2 87.9 83.9 82.6 75.3 86.8 123.7 82.6 38.5 85.9 9.4 73.2 204.3 113.9 205.4 63.7 26.7 133.8 168.7 0.3 101.5 122.5 121.4 25.0 243.5 70.5 148.7 193.7 160.0 117.0 96.0 117.2 94.8 117.2 109.6 9.9 159.5 303.4 97.4 58.1 82.4 90.0 90.0 98.6 304.4 178.5 28.6 10.7 143.1 116.0 94.2 102.9 42.0 159.7 65.9 225.9 2.8 102.3 99.4 111.2 9.5 99.0 182.4 152.9 151.2 65.7 137.3 196.6 306.5 114.3 33.3 157.8 90.1 197.1 237.0 241.0 106.0 224.3 211.9 82.4 82.7 145.7 121.2 POLR2J "hRPB14, POLR2J1, RPB11, RPB11A, RPB11m" ENSG00000005075 "RNA polymerase II subunit J" P52435 7 102473118-102478907 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046970 Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA046970: AB_2679882" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (1.62e-1)" "unprognostic (1.90e-2)" "unprognostic (4.80e-2)" "unprognostic (6.47e-2)" "unprognostic (4.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.53e-3)" "unprognostic (4.46e-2)" "unprognostic (7.32e-2)" "unprognostic (7.13e-2)" "unprognostic (2.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" 54.8 87.0 85.3 36.5 87.4 90.0 51.7 88.2 108.0 48.3 83.2 59.1 46.4 48.1 54.7 60.0 46.5 32.7 125.8 85.3 89.6 71.2 99.4 43.3 46.1 89.2 87.2 59.3 58.6 62.9 66.4 32.5 87.4 59.7 33.9 17.8 58.6 38.2 195.7 56.5 51.1 28.3 88.3 59.1 63.6 43.6 90.2 53.2 56.0 127.7 40.1 51.1 48.1 88.4 143.4 143.0 96.2 127.5 89.2 68.5 70.4 77.4 82.3 111.2 94.2 131.1 108.4 65.7 145.9 108.7 160.2 74.8 89.8 95.6 67.8 123.3 160.4 65.9 101.2 129.1 108.9 128.5 94.6 89.6 117.4 100.1 55.8 72.5 100.8 138.3 156.8 190.0 92.5 439.6 212.9 228.5 89.5 141.4 182.2 100.1 94.4 194.0 91.2 93.6 81.4 135.6 93.5 176.1 113.9 97.3 79.1 155.3 82.3 125.0 160.0 198.4 154.5 116.5 183.6 171.0 111.3 157.8 149.1 180.3 116.5 199.5 90.5 122.5 86.2 137.6 96.0 101.0 93.8 122.9 81.4 81.8 174.6 84.7 115.5 127.5 140.8 128.9 85.3 87.4 88.2 108.0 85.3 89.6 89.2 87.2 87.4 88.3 90.2 88.4 87.9 35.3 46.7 17.9 91.1 95.0 113.5 190.7 79.1 37.0 149.6 195.2 193.2 81.5 107.4 125.0 12.5 197.7 93.0 241.7 273.9 139.0 53.1 84.1 64.4 86.8 103.0 128.2 5.6 199.6 195.5 94.4 78.0 73.2 43.7 90.7 86.0 203.5 202.5 35.3 6.2 164.0 146.5 111.0 107.6 43.2 127.1 99.5 142.3 4.7 154.0 171.3 127.7 8.5 10.8 191.8 281.6 110.6 111.4 128.9 236.3 242.0 107.0 46.7 52.6 76.9 113.2 117.1 229.3 114.3 116.1 182.1 91.4 114.5 131.2 153.9 POLR2J3 ENSG00000285437 "RNA polymerase II subunit J3" 7 102562133-102572583 "Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 243.5;Cone photoreceptor cells: 354.5;Rod photoreceptor cells: 343.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046970 Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA046970: AB_2679882" 9.7 16.7 21.2 16.0 18.9 37.8 11.5 28.4 74.7 2.1 15.3 26.2 15.8 18.2 22.0 14.0 3.5 8.0 3.4 21.3 24.8 18.4 19.8 8.0 15.9 26.0 21.1 11.5 7.2 17.7 8.6 18.5 8.6 14.7 44.3 5.2 8.1 84.7 15.6 14.3 4.0 11.2 16.6 12.8 12.2 22.3 34.6 8.1 40.6 11.9 12.9 25.6 49.6 6.2 67.8 60.6 3.3 13.7 26.1 68.1 2.6 14.4 4.2 22.9 37.9 22.2 32.4 11.9 35.0 31.0 8.9 16.7 44.1 2.9 10.5 52.2 90.5 69.1 9.4 89.4 49.4 15.1 19.6 7.7 5.7 38.7 19.8 40.9 46.4 128.3 6.2 25.0 126.1 38.9 20.6 62.5 1.9 58.7 60.9 64.4 19.4 62.0 32.5 48.6 53.6 53.1 53.2 76.1 20.7 50.0 21.3 89.9 40.8 79.2 56.0 57.5 93.7 143.0 49.7 60.0 55.4 41.9 24.9 36.9 20.6 22.4 18.8 29.4 27.0 23.8 22.2 25.3 23.1 22.5 24.9 20.9 33.1 33.7 27.9 22.6 21.2 18.9 28.4 74.7 21.3 24.8 26.0 21.1 18.5 11.2 22.3 25.6 2.6 6.4 2.6 49.0 58.0 12.2 97.8 32.5 21.6 243.5 4.0 1.3 15.9 105.8 19.9 7.3 354.5 0.0 63.3 55.3 1.9 0.4 8.3 2.2 2.4 43.1 58.4 65.0 43.4 0.4 0.0 23.6 46.9 1.9 13.4 0.3 137.0 43.9 0.0 178.4 40.4 44.1 26.4 85.9 19.0 11.2 90.7 24.6 24.9 30.0 58.9 53.0 178.2 29.1 35.6 0.9 46.5 51.6 25.7 69.3 79.3 3.5 16.6 343.4 26.3 97.3 33.9 84.4 111.1 22.3 14.8 0.0 59.1 0.4 42.5 105.0 PPCDC "FLJ14585, MDS018" ENSG00000138621 "Phosphopantothenoylcysteine decarboxylase" Q96CD2 15 75023586-75117462 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 71.4;granulocytes: 153.5;monocytes: 71.6" "Cell line enhanced" "Detected in all" "Karpas-707: 133.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045667 Approved Approved Cytosol NA NA 25000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA045667: AB_2679412" "unprognostic (8.66e-2)" "unprognostic (1.07e-3)" "unprognostic (6.03e-2)" "unprognostic (2.57e-2)" "unprognostic (2.95e-2)" "unprognostic (6.53e-2)" "unprognostic (1.76e-2)" "unprognostic (8.40e-2)" "unprognostic (1.72e-1)" "unprognostic (1.53e-1)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (1.60e-2)" "unprognostic (7.67e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-1)" "unprognostic (2.13e-3)" 11.1 19.1 7.4 10.8 8.8 19.7 10.9 8.3 8.4 9.7 8.7 11.5 9.7 8.3 9.8 19.0 10.8 8.4 8.5 6.9 8.0 17.2 13.1 10.8 16.4 9.2 8.8 9.0 16.5 21.3 9.3 9.2 8.5 13.0 9.4 7.6 13.9 7.6 11.9 9.0 9.9 5.4 8.0 18.8 11.3 9.7 8.6 12.1 11.2 5.9 12.3 11.2 10.0 10.3 15.6 28.8 11.8 9.2 7.0 6.4 10.1 15.5 7.0 20.3 15.9 16.9 41.2 17.7 26.8 7.8 12.5 15.9 19.2 25.6 10.4 62.6 23.4 31.1 18.8 18.3 19.9 18.3 38.7 8.6 16.7 21.0 32.3 8.2 16.6 25.8 21.3 133.2 14.8 30.0 10.9 28.1 18.9 32.9 13.4 18.2 23.0 38.3 15.3 22.2 28.3 8.3 22.9 31.3 34.6 13.4 38.7 23.4 9.4 20.6 14.4 10.5 27.6 40.5 29.3 30.1 12.7 45.9 23.7 47.2 23.1 153.5 11.6 65.6 19.4 15.7 10.6 13.0 17.6 8.6 11.7 14.5 139.7 18.5 71.6 71.4 12.7 15.8 7.4 8.8 8.3 8.4 6.9 8.0 9.2 8.8 8.5 8.0 8.6 10.3 10.2 16.0 5.2 2.9 10.5 3.8 6.1 8.5 8.6 2.8 9.6 8.8 4.2 4.3 9.7 9.2 0.0 17.5 16.0 19.7 25.4 17.3 1.0 8.2 4.3 10.7 4.2 11.6 1.4 15.3 13.6 7.4 14.8 8.3 12.0 9.9 10.4 5.3 20.0 8.4 1.7 10.9 12.2 15.7 6.7 2.5 4.4 15.5 14.2 2.8 20.0 4.7 8.2 2.5 4.6 18.0 38.1 5.3 33.9 6.5 10.5 19.0 12.2 10.7 6.6 6.3 8.7 6.9 15.7 10.8 4.0 10.9 9.7 11.3 11.7 13.6 PPP1CA "PP-1A, PP1A, PP1alpha, PPP1A" ENSG00000172531 "Protein phosphatase 1 catalytic subunit alpha" P62136 11 67398181-67421183 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004545, HPA046833" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Plasma membrane, Cytosol" "CAB004545: AB_628177, HPA046833: AB_2679829" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.51e-2)" "unprognostic (3.15e-3)" "unprognostic (3.93e-2)" "unprognostic (2.07e-1)" "unprognostic (3.89e-2)" "unprognostic (5.05e-3)" "unprognostic (8.00e-2)" "unprognostic (1.66e-1)" "unprognostic (9.96e-2)" "unprognostic (7.69e-2)" "prognostic favorable (1.17e-4)" "unprognostic (7.60e-2)" 70.0 102.4 61.2 102.6 70.8 127.8 63.5 64.0 70.7 62.1 61.2 110.8 95.9 50.5 66.8 184.0 61.1 51.2 122.0 63.5 63.6 121.8 128.2 78.9 147.8 68.3 62.4 33.1 105.1 64.2 59.8 83.5 63.8 81.1 89.6 21.6 100.4 51.0 123.2 105.8 107.1 56.1 63.9 148.7 102.7 34.6 65.8 113.7 88.7 81.3 155.6 74.9 80.6 68.2 283.1 305.6 181.1 270.3 88.4 108.9 185.6 136.1 158.4 267.4 202.3 445.8 328.5 237.2 227.3 208.1 198.4 238.7 213.9 280.2 169.6 256.3 139.9 227.5 129.3 232.7 195.2 295.2 281.1 123.3 181.1 225.7 130.7 125.4 272.2 226.0 217.4 191.1 220.5 619.4 378.2 562.2 303.5 526.7 241.1 262.7 254.0 209.8 262.2 220.7 142.5 236.7 159.2 283.0 439.8 135.3 338.5 201.2 196.4 208.5 208.9 245.3 179.0 190.1 193.2 271.8 244.6 199.9 224.3 921.6 735.9 1234.1 779.2 962.9 604.3 733.4 679.9 792.5 705.3 779.6 412.6 584.2 853.8 688.8 1186.1 500.4 1098.7 2042.5 61.2 70.8 64.0 70.7 63.5 63.6 68.3 62.4 63.8 63.9 65.8 68.2 49.2 76.9 92.2 8.8 165.8 99.9 143.5 305.9 64.3 35.5 81.7 79.1 8.4 102.9 157.8 86.5 10.4 360.4 151.2 377.5 213.2 265.6 2.5 63.1 67.2 101.6 96.9 108.8 8.8 311.1 507.0 68.8 132.0 107.1 109.6 87.1 89.3 113.9 377.1 43.7 7.7 241.3 181.0 219.8 138.5 7.7 49.0 186.5 136.9 9.4 353.0 53.8 408.8 6.0 13.1 318.4 308.4 28.6 206.5 139.0 341.3 297.4 70.5 30.5 98.6 67.1 100.7 13.6 94.6 142.0 121.6 427.3 176.3 100.1 231.7 205.4 PPP1R35 "C7orf47, MGC22793" ENSG00000160813 "Protein phosphatase 1 regulatory subunit 35" Q8TAP8 7 100435282-100436497 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.7" "Cell type enhanced" "Detected in all" "Spermatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021604, HPA051607" Approved Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA021604: AB_2670774, HPA051607: AB_2681548" "unprognostic (2.17e-3)" "unprognostic (2.17e-1)" "unprognostic (7.40e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.15e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (6.99e-2)" "unprognostic (1.20e-1)" "unprognostic (6.77e-2)" "unprognostic (5.17e-2)" "unprognostic (1.85e-3)" "unprognostic (1.40e-1)" "unprognostic (9.51e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.97e-4)" 8.8 16.7 7.8 11.9 7.7 8.7 9.7 9.6 13.8 12.3 8.7 10.6 11.5 10.9 2.2 11.1 11.0 3.1 9.4 7.7 8.0 12.4 12.9 9.4 14.5 8.2 7.7 13.5 10.5 7.8 11.9 6.8 7.8 11.2 2.4 2.4 9.9 5.4 6.3 7.8 12.0 2.8 8.0 22.1 10.9 48.7 8.2 15.3 12.0 3.5 5.5 10.3 10.3 7.7 41.0 14.7 11.1 19.4 3.3 4.9 14.5 11.6 10.5 8.2 9.4 6.8 36.2 14.0 22.2 6.4 39.3 17.4 5.9 9.4 1.8 30.9 18.3 11.6 11.8 14.1 14.5 12.2 16.4 6.8 17.0 7.3 12.0 14.1 17.2 38.8 21.1 24.1 9.9 34.1 36.2 64.6 23.0 17.1 20.1 14.6 4.7 37.9 11.4 9.5 11.8 35.0 8.9 62.5 35.0 6.9 18.0 28.8 13.9 12.2 18.4 16.4 28.9 37.9 23.1 20.2 13.3 19.6 25.0 17.1 2.3 5.7 5.8 1.0 6.2 4.3 5.9 6.6 1.7 5.4 3.3 3.2 10.5 3.8 0.7 7.6 7.6 2.7 7.8 7.7 9.6 13.8 7.7 8.0 8.2 7.7 7.8 8.0 8.2 7.7 47.7 16.0 9.6 13.1 30.8 21.0 39.9 13.9 28.5 35.7 51.3 60.6 2.0 27.1 7.8 47.8 8.4 66.5 47.8 23.6 52.8 9.1 17.3 34.6 22.7 22.1 18.6 17.2 10.2 10.0 40.2 16.5 20.4 24.9 8.2 28.3 15.4 16.1 16.8 48.8 11.8 32.0 18.3 12.0 15.4 8.7 18.0 17.4 17.8 12.2 11.6 26.8 27.8 12.1 12.5 10.7 30.2 9.4 24.2 55.2 26.2 39.5 16.5 37.7 13.1 12.4 17.8 106.1 29.8 36.7 33.4 33.9 37.6 35.2 28.1 43.9 PPP1R7 sds22 ENSG00000115685 "Protein phosphatase 1 regulatory subunit 7" Q15435 2 241149576-241183652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 968.8;Late spermatids: 1709.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA034500, HPA034501" Supported Approved Nucleoli NA NA 960000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 34: Spermatids - Unknown function" Nucleoli "HPA034500: AB_2674192, HPA034501: AB_10670965" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (4.38e-1)" "unprognostic (8.07e-3)" "unprognostic (5.01e-2)" "unprognostic (2.49e-1)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.15e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (4.51e-3)" "unprognostic (1.23e-1)" 59.0 55.9 71.3 54.4 94.7 68.1 50.2 65.5 82.4 46.4 68.3 66.0 58.8 48.5 61.4 80.3 81.3 40.2 100.5 77.5 69.4 64.6 76.0 53.9 78.7 67.2 67.2 37.5 60.0 55.8 42.6 44.5 65.7 94.5 64.2 58.0 63.1 54.0 100.4 64.3 61.0 55.0 66.5 48.7 58.9 158.2 67.2 66.8 65.1 64.4 80.8 58.9 52.9 75.1 117.6 69.5 77.4 98.3 149.7 149.0 106.4 126.3 114.7 85.2 119.8 38.1 145.6 60.0 37.1 108.9 128.0 112.1 127.9 119.6 130.2 156.4 126.1 105.1 112.4 151.4 96.3 147.0 105.9 116.0 92.7 101.1 74.2 115.7 128.5 121.0 108.0 86.2 202.0 155.8 132.0 112.6 106.3 185.7 64.5 90.4 200.9 121.9 159.6 116.7 104.6 82.8 67.6 157.4 120.3 86.4 93.8 156.7 127.7 76.8 72.5 146.1 103.4 90.8 59.6 162.8 215.2 154.1 103.7 107.9 84.9 108.9 64.6 87.6 68.3 71.6 76.5 77.1 81.3 66.5 58.5 67.6 66.5 75.8 96.2 48.4 121.5 89.9 71.3 94.7 65.5 82.4 77.5 69.4 67.2 67.2 65.7 66.5 67.2 75.1 50.5 57.7 54.5 17.6 47.9 27.8 48.6 126.2 25.6 41.5 44.6 36.8 98.4 45.8 105.5 44.1 16.7 89.6 46.9 53.4 121.3 90.6 968.8 83.6 39.3 45.9 25.7 48.0 33.8 145.9 92.4 47.5 34.7 53.4 59.5 48.9 32.9 49.9 100.5 32.0 19.4 68.7 109.9 40.7 46.3 1709.4 51.0 49.4 87.2 13.1 63.7 78.6 80.3 18.1 21.9 94.5 71.3 67.4 54.5 52.1 81.7 120.8 112.2 58.9 72.3 35.1 65.6 315.5 122.5 45.9 38.1 71.6 57.9 117.2 55.3 56.0 PPP2R3C "C14orf10, FLJ20644, G4-1, G5PR" ENSG00000092020 "Protein phosphatase 2 regulatory subunit B''gamma" Q969Q6 14 35085467-35122517 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 489.7;Late spermatids: 233.5;Spermatocytes: 239.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040835, HPA058834" Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus, Cytosol" "HPA040835: AB_10794152, HPA058834: AB_2683831" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (7.32e-3)" "unprognostic (5.33e-2)" "unprognostic (9.73e-2)" "unprognostic (1.10e-3)" "unprognostic (3.05e-1)" "unprognostic (7.85e-2)" "unprognostic (9.48e-3)" "unprognostic (1.17e-2)" "unprognostic (1.91e-1)" "unprognostic (2.18e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-3)" "unprognostic (8.55e-2)" "unprognostic (8.29e-2)" 19.9 15.5 23.5 23.9 25.0 42.8 17.1 24.4 41.6 18.1 23.3 18.6 21.0 16.2 16.4 12.5 14.0 18.6 22.9 23.8 25.6 14.4 16.1 17.7 31.0 25.3 24.4 15.9 10.2 17.0 17.6 18.8 25.6 17.1 20.3 15.4 13.5 14.1 24.9 7.1 22.5 21.0 24.9 24.4 16.2 71.6 24.4 26.4 12.4 25.7 25.9 22.3 10.4 27.5 41.2 21.8 41.7 33.9 32.4 54.5 29.6 33.0 32.0 41.0 48.0 18.1 32.2 47.2 13.4 33.9 15.5 17.6 20.0 13.8 60.5 47.8 19.3 26.2 11.9 65.2 43.3 51.2 51.7 41.9 14.4 29.0 19.7 24.0 55.7 26.2 25.7 46.3 57.4 28.4 46.4 43.1 37.1 27.4 24.3 50.2 27.1 32.8 15.8 24.1 39.9 37.5 41.7 27.6 57.8 19.9 17.9 57.0 47.9 41.3 17.3 36.0 34.9 44.8 52.4 92.8 22.8 47.9 48.1 66.5 41.6 86.9 23.4 52.5 27.0 31.0 24.8 29.5 36.1 33.1 22.0 26.9 76.9 33.1 42.7 16.3 40.8 34.0 23.5 25.0 24.4 41.6 23.8 25.6 25.3 24.4 25.6 24.9 24.4 27.5 35.5 16.0 24.7 32.7 40.2 11.5 23.3 31.7 9.6 15.9 18.8 14.7 26.3 17.2 25.8 20.2 4.2 19.4 48.1 29.1 33.2 31.2 489.7 23.1 28.1 33.8 31.2 69.7 28.3 36.1 26.2 26.5 19.9 21.7 33.7 31.3 34.6 22.8 61.3 8.4 30.4 26.8 32.6 49.7 36.3 233.5 28.3 42.6 28.4 24.4 71.5 28.7 46.4 36.2 58.8 49.2 22.3 30.5 37.4 24.8 37.8 43.2 25.1 21.5 32.9 24.0 43.1 239.2 58.6 19.6 13.5 34.8 45.2 36.2 24.6 30.5 PRDX5 "ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10" ENSG00000126432 "Peroxiredoxin 5" P30044 11 64318121-64321811 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 2430.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008661, HPA037915, HPA037916" Enhanced Supported Mitochondria NA NA 6900000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria "CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736" "unprognostic (2.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (9.43e-2)" "unprognostic (6.71e-3)" "unprognostic (1.08e-3)" "unprognostic (3.11e-1)" "unprognostic (9.30e-2)" "unprognostic (1.07e-3)" "unprognostic (1.57e-2)" "unprognostic (2.20e-1)" "prognostic favorable (1.24e-5)" "unprognostic (8.19e-2)" "unprognostic (2.30e-1)" "unprognostic (9.63e-2)" "unprognostic (5.03e-2)" 181.8 400.3 346.0 112.7 342.6 285.7 170.1 375.9 429.4 227.2 480.2 346.6 213.3 153.7 176.6 448.5 400.3 120.7 467.4 340.4 384.6 377.1 280.3 217.2 110.1 382.8 373.3 246.0 224.9 254.5 313.3 164.1 387.0 165.5 299.6 109.0 286.2 164.4 504.0 181.1 226.1 97.1 365.2 162.9 313.9 150.1 377.8 167.7 354.5 439.6 137.8 192.5 244.8 346.4 225.3 453.4 267.9 444.5 284.3 424.4 308.5 274.9 442.3 199.8 247.4 332.9 451.8 329.2 467.0 447.4 712.6 503.5 253.3 589.4 125.8 456.6 200.8 333.3 728.8 386.3 581.0 127.8 271.3 432.4 757.2 334.9 337.8 387.6 308.4 380.6 191.5 755.6 285.5 572.0 220.9 547.8 402.6 356.5 573.9 210.9 274.5 1178.8 760.1 442.9 224.7 424.9 230.8 506.8 818.8 254.3 370.5 283.3 298.3 281.8 258.6 326.7 123.1 383.1 490.8 392.4 340.7 253.7 223.6 703.9 465.4 630.7 251.0 432.9 218.3 393.5 229.0 205.1 369.8 409.0 224.5 225.9 802.3 368.5 399.0 487.9 297.1 639.6 346.0 342.6 375.9 429.4 340.4 384.6 382.8 373.3 387.0 365.2 377.8 346.4 213.7 266.0 463.4 17.6 182.1 326.5 760.2 1591.9 405.2 159.0 266.2 435.9 617.6 371.8 931.2 450.6 70.9 1122.2 185.8 846.1 1612.1 788.4 79.6 865.2 221.3 204.7 801.9 200.6 12.4 1039.2 1144.0 296.1 365.4 285.9 104.7 299.8 205.6 405.2 476.9 92.5 14.0 1041.6 1072.1 206.5 261.0 294.9 279.0 210.8 435.8 8.4 339.7 309.6 278.1 14.1 15.3 1487.3 641.3 226.8 288.9 401.3 922.4 1468.5 2430.7 150.3 197.2 176.2 433.1 150.2 333.9 482.8 257.7 978.9 165.2 713.3 1231.7 1077.1 PREX1 "KIAA1415, P-REX1" ENSG00000124126 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1" Q8TCU6 20 48624252-48827999 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 52.5;brain: 78.1" "Cell type enhanced" "Detected in many" "Astrocytes: 87.1;dendritic cells: 84.0;Kupffer cells: 104.7;Macrophages: 76.5;Microglial cells: 95.5;NK-cells: 90.6;Oligodendrocytes: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 157.9;SK-BR-3: 162.2;T-47d: 145.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001927 Supported Supported Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" "Vesicles, Cytosol" "HPA001927: AB_1079674" "unprognostic (8.07e-2)" "unprognostic (3.16e-2)" "unprognostic (2.15e-2)" "unprognostic (2.55e-1)" "unprognostic (7.47e-2)" "prognostic favorable (8.56e-4)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (5.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.70e-2)" "unprognostic (5.86e-3)" "unprognostic (6.84e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" 14.8 10.6 32.8 37.4 56.4 52.5 15.0 43.2 47.2 12.3 1.2 7.0 6.3 4.0 1.4 6.4 4.7 13.0 6.7 32.1 42.0 4.8 5.2 26.8 36.6 52.1 52.0 2.5 5.3 6.9 7.6 11.7 53.8 4.8 6.0 3.9 5.3 3.4 6.6 3.5 12.7 7.7 43.5 42.9 8.8 6.0 45.3 9.8 9.4 8.6 21.8 12.3 3.2 78.1 2.3 6.1 78.4 0.0 1.3 5.7 27.2 2.7 3.5 11.2 2.8 0.4 0.3 16.4 49.5 7.2 21.4 1.0 4.1 0.2 7.5 3.7 2.0 2.4 8.8 0.0 4.6 9.0 51.1 6.3 0.0 25.7 0.0 7.6 68.4 7.2 0.2 0.6 14.8 157.9 0.2 24.7 3.1 8.1 6.4 24.1 22.8 9.8 0.5 0.0 16.5 2.4 14.7 162.2 17.8 4.4 145.0 67.4 77.2 4.5 15.6 0.2 4.6 0.9 3.5 20.1 72.4 17.8 24.3 4.5 1.9 2.2 3.7 2.2 2.2 1.5 2.0 3.2 1.6 1.4 0.3 1.1 9.2 1.8 2.0 1.3 7.3 2.0 32.8 56.4 43.2 47.2 32.1 42.0 52.1 52.0 53.8 43.5 45.3 78.1 43.2 3.2 6.6 87.1 35.4 2.5 0.3 0.4 1.2 0.3 40.0 21.5 3.7 2.8 2.6 1.8 8.4 0.7 84.0 0.9 0.0 0.2 3.5 3.5 4.7 24.5 1.2 14.1 13.3 1.2 4.4 10.3 4.1 6.2 1.3 0.7 20.7 1.9 32.1 0.0 4.6 1.8 0.0 104.7 28.2 2.9 0.9 76.5 8.8 95.5 47.1 19.4 90.6 49.3 190.2 0.1 1.0 0.4 23.3 0.7 0.3 0.2 4.5 0.7 0.0 18.1 3.3 2.2 11.6 0.4 2.4 9.3 63.9 41.2 4.5 0.7 PRKAA1 AMPKa1 ENSG00000132356 "Protein kinase AMP-activated catalytic subunit alpha 1" Q13131 5 40759379-40798374 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 292.5;Late spermatids: 478.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005050, HPA035409, HPA064946" Supported Supported "Nuclear speckles,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear speckles" Cytosol "CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390" "unprognostic (2.07e-1)" "unprognostic (1.41e-2)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (3.97e-1)" "unprognostic (1.05e-1)" "unprognostic (3.51e-2)" "unprognostic (7.53e-2)" "unprognostic (1.66e-2)" "unprognostic (2.88e-1)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (2.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.10e-2)" 33.3 21.0 7.9 27.2 9.6 52.6 30.2 10.3 11.0 26.7 12.3 30.0 35.4 26.3 18.6 20.6 21.0 33.5 20.2 6.9 11.3 32.0 49.9 27.4 29.2 11.8 9.9 19.1 23.1 32.0 9.2 21.2 12.2 31.9 34.7 19.0 27.4 24.7 16.9 23.1 30.9 26.4 10.2 27.8 33.7 41.1 10.0 21.8 32.3 19.9 23.9 28.8 17.8 10.3 28.4 28.9 22.8 30.2 55.0 57.0 21.6 47.3 48.1 34.7 30.8 27.6 35.9 16.6 21.4 48.8 45.3 22.4 21.3 43.1 64.9 49.2 19.2 33.1 66.1 22.1 45.3 31.9 33.5 52.8 20.6 46.5 47.5 38.4 52.1 21.0 15.9 46.7 52.4 13.6 29.7 24.9 9.9 28.9 34.6 24.5 48.7 24.6 53.3 47.5 19.6 19.7 83.0 54.3 28.8 12.3 28.4 26.0 56.0 62.1 33.5 36.2 39.2 18.5 15.4 19.6 38.9 67.9 33.9 17.0 6.5 12.8 8.9 7.9 11.5 8.2 8.4 8.6 6.4 7.9 10.1 9.0 15.4 10.9 9.3 1.9 11.6 6.5 7.9 9.6 10.3 11.0 6.9 11.3 11.8 9.9 12.2 10.2 10.0 10.3 47.3 41.7 26.5 19.2 34.1 24.1 24.7 40.5 15.4 20.3 36.1 17.9 18.3 42.9 43.4 47.8 35.5 13.8 45.8 44.1 7.9 27.9 292.5 19.7 35.8 42.4 21.1 25.4 24.5 44.9 13.7 36.2 36.7 20.7 18.3 17.8 37.1 83.4 20.0 15.2 30.3 28.8 42.7 25.3 28.5 478.5 30.4 24.1 35.6 24.4 40.9 15.4 44.3 30.7 43.8 36.0 32.8 25.9 23.4 33.4 33.7 35.4 42.9 27.9 0.0 22.7 43.1 82.8 17.6 19.9 32.7 18.6 44.0 19.2 36.9 35.0 PRKAG1 ENSG00000181929 "Protein kinase AMP-activated non-catalytic subunit gamma 1" P54619 12 49002274-49018807 "FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 339.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077805 Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Nucleoplasm "HPA077805: AB_2686855" "unprognostic (3.24e-2)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (2.84e-7)" "unprognostic (1.45e-1)" "unprognostic (4.68e-2)" "unprognostic (1.93e-2)" "unprognostic (5.35e-2)" "unprognostic (8.49e-2)" "prognostic favorable (1.83e-4)" "unprognostic (3.40e-1)" "unprognostic (2.57e-1)" "unprognostic (1.97e-2)" "unprognostic (5.57e-2)" 42.8 54.5 36.4 29.8 40.5 47.4 50.5 39.9 46.3 37.6 41.9 40.7 32.6 32.9 59.1 44.2 33.4 31.3 80.9 38.2 38.6 50.5 49.4 30.8 38.7 34.5 35.5 25.6 37.4 59.1 33.9 35.1 36.5 37.7 47.8 42.3 36.1 39.9 122.7 43.0 29.9 44.8 33.5 28.6 33.5 33.5 34.9 41.8 37.7 112.4 50.8 40.1 30.8 41.5 79.8 45.8 50.5 76.3 157.8 141.6 33.2 85.5 117.4 84.4 55.7 50.9 66.1 50.4 72.9 98.9 53.9 65.4 42.5 115.6 80.4 69.6 57.1 70.4 66.5 34.2 120.2 97.7 54.6 110.0 94.6 65.9 141.4 123.6 90.3 67.6 60.1 70.0 108.6 52.8 45.8 31.5 29.1 339.6 96.8 24.1 53.3 59.7 114.0 67.6 42.1 57.7 61.0 99.1 142.5 39.7 134.1 49.5 72.5 44.4 52.3 87.7 63.5 109.1 113.3 36.0 89.3 69.9 34.5 87.3 59.8 59.9 53.0 58.7 50.0 51.9 46.1 47.6 68.7 51.3 41.3 43.0 70.9 71.8 56.0 45.2 66.8 73.0 36.4 40.5 39.9 46.3 38.2 38.6 34.5 35.5 36.5 33.5 34.9 41.5 20.2 9.6 22.7 16.6 31.2 20.0 30.3 64.5 11.4 29.2 24.3 20.8 49.8 18.6 29.9 36.8 37.5 65.6 30.5 24.5 76.3 48.3 11.3 11.4 21.3 21.9 21.0 30.3 18.1 46.4 57.7 26.7 15.8 12.9 21.5 31.4 30.4 23.2 52.2 15.2 24.1 31.6 63.1 36.2 26.5 15.7 36.7 26.7 37.4 9.4 55.5 41.6 55.6 23.1 21.1 47.8 16.5 27.1 25.0 24.2 38.6 69.3 19.2 30.1 19.7 18.5 27.5 49.3 43.9 19.1 26.0 67.0 26.3 33.6 32.2 23.6 PSEN1 "AD3, FAD, PS1, S182" ENSG00000080815 "Presenilin 1" P49768 14 73136418-73223691 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell adhesion, Notch signaling pathway" "Hydrolase, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Oligodendrocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006844, HPA030760, HPA067496" Approved Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "Nucleoplasm, Cell Junctions" "CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853" "unprognostic (1.67e-1)" "unprognostic (4.79e-2)" "unprognostic (7.39e-2)" "unprognostic (8.68e-3)" "unprognostic (3.84e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.99e-5)" "unprognostic (1.65e-1)" "unprognostic (8.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "prognostic favorable (1.52e-8)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (7.12e-3)" "unprognostic (1.85e-1)" 25.1 22.6 44.3 26.5 80.7 39.6 28.2 62.4 56.0 28.1 48.9 49.5 50.2 25.3 26.9 35.2 22.9 31.7 18.0 47.4 51.6 35.5 31.9 32.1 22.4 73.0 63.8 22.0 22.9 35.1 11.6 43.1 71.5 24.3 46.3 23.4 22.9 23.4 18.4 38.2 49.0 27.1 55.7 22.6 31.0 32.5 60.8 26.2 36.9 23.3 30.7 35.0 19.2 119.1 37.1 55.9 50.6 20.0 68.9 49.9 46.7 52.5 60.1 52.6 66.7 69.9 88.9 23.7 34.1 50.5 43.0 94.9 43.2 40.1 57.3 54.6 26.7 27.1 35.1 34.4 63.8 27.7 50.7 50.4 71.9 44.3 54.4 48.5 43.2 26.2 31.0 46.6 50.0 72.8 21.0 35.7 22.0 64.5 40.4 26.4 42.7 30.2 73.7 76.5 28.1 38.3 57.4 53.0 47.1 45.4 66.3 60.7 45.7 53.1 43.5 44.1 25.3 30.3 47.9 23.7 44.9 32.8 33.3 126.8 94.5 96.3 23.1 106.0 22.6 23.1 22.3 19.0 83.4 31.8 20.7 20.1 129.3 42.8 125.0 43.6 37.0 70.3 44.3 80.7 62.4 56.0 47.4 51.6 73.0 63.8 71.5 55.7 60.8 119.1 22.2 28.9 30.5 35.9 25.8 28.6 24.6 24.7 12.0 17.1 25.0 17.7 12.5 15.7 30.2 23.9 39.6 27.1 30.7 79.1 5.9 27.1 22.9 26.3 26.4 22.3 16.2 12.0 38.9 26.7 29.2 23.7 32.1 47.4 18.3 29.6 15.7 24.6 30.5 13.5 40.2 39.5 24.4 50.5 40.8 12.9 16.4 52.3 16.0 39.4 51.8 13.8 14.4 48.7 395.8 38.2 58.8 15.4 23.6 38.8 76.2 13.0 29.0 28.0 26.3 20.0 19.0 40.2 14.4 20.4 33.0 49.9 21.6 18.6 41.3 51.5 PSMA2 "HC3, MU, PMSA2" ENSG00000106588 "Proteasome 20S subunit alpha 2" P25787 7 42916828-42932185 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 439.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008188 Uncertain NA NA 61000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 3: Monocytes - Immune response regulation" "HPA008188: AB_1855819" "unprognostic (9.40e-3)" "unprognostic (2.08e-2)" "unprognostic (8.21e-2)" "unprognostic (2.23e-2)" "unprognostic (4.13e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.01e-2)" "unprognostic (9.25e-2)" "prognostic favorable (6.73e-5)" "unprognostic (1.77e-1)" "unprognostic (3.42e-1)" "unprognostic (1.62e-3)" "unprognostic (1.79e-1)" "unprognostic (1.06e-1)" "unprognostic (6.38e-2)" "unprognostic (4.24e-2)" 100.7 113.4 53.7 89.0 54.1 120.2 100.1 55.7 82.8 71.2 56.4 90.9 104.3 75.6 83.1 110.0 70.5 49.4 119.2 52.5 56.6 117.0 319.5 85.9 101.4 55.6 54.5 66.4 91.0 71.0 63.8 78.9 55.5 91.1 86.8 42.2 76.0 58.2 227.5 86.9 96.7 67.3 58.6 94.1 104.8 56.1 55.4 137.5 67.4 120.1 108.8 92.4 77.0 62.8 202.8 212.5 243.4 296.4 128.1 142.1 181.1 174.7 202.8 274.9 292.3 316.5 322.2 371.5 301.7 155.5 431.6 273.3 254.3 242.4 314.2 270.3 202.3 189.8 279.1 337.1 137.3 325.8 197.7 131.7 172.7 211.7 125.7 196.1 265.1 226.0 389.8 219.4 223.5 235.9 295.0 634.9 482.4 331.3 259.9 282.1 235.5 364.3 268.2 271.6 196.8 199.1 189.5 429.9 200.9 328.3 312.4 375.6 189.9 161.0 295.3 174.5 348.6 282.6 470.3 611.1 276.0 406.0 468.9 278.5 185.4 351.9 133.9 193.4 156.9 195.4 163.3 157.9 199.8 175.2 146.0 155.2 93.1 160.7 210.0 225.0 240.8 363.3 53.7 54.1 55.7 82.8 52.5 56.6 55.6 54.5 55.5 58.6 55.4 62.8 92.2 89.8 100.5 11.1 100.6 0.1 89.3 0.2 41.5 32.4 125.2 121.4 0.0 123.0 66.8 95.6 22.9 293.3 141.3 130.3 170.2 348.6 23.9 42.3 41.5 93.2 154.9 126.9 15.3 380.0 300.1 67.2 23.9 37.6 166.0 27.5 122.8 204.8 193.5 28.6 16.0 199.8 0.0 173.5 0.3 19.1 79.2 94.1 0.0 12.2 439.1 85.3 153.5 17.1 27.9 314.5 166.9 84.7 72.6 97.8 332.7 301.5 58.3 46.6 131.5 55.3 74.4 125.8 115.6 44.3 0.0 279.1 81.8 39.1 252.8 98.2 PSMA7 "C6, HSPC, RC6-1, XAPC7" ENSG00000101182 "Proteasome 20S subunit alpha 7" O14818 20 62136733-62143440 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 753.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046007, CAB046008, HPA047266" Approved NA NA 22000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 39: CACO-2 - Unknown function" "Cluster 10: Non-specific - Unknown function" "CAB046007: AB_11128404, CAB046008: AB_2171861, HPA047266: AB_2680006" "unprognostic (1.49e-2)" "unprognostic (4.44e-2)" "unprognostic (1.78e-2)" "unprognostic (2.79e-2)" "unprognostic (6.36e-1)" "unprognostic (6.57e-3)" "prognostic unfavorable (2.54e-5)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (5.06e-3)" "unprognostic (1.16e-1)" "unprognostic (7.30e-2)" "unprognostic (7.04e-2)" "unprognostic (2.31e-1)" "unprognostic (2.21e-2)" "unprognostic (6.31e-2)" "unprognostic (1.98e-2)" 223.2 200.1 127.6 148.5 132.0 260.4 198.0 136.9 146.2 134.6 127.1 180.3 132.2 163.4 102.9 191.0 140.5 91.3 266.2 131.9 137.0 168.9 214.0 170.3 164.9 134.0 131.7 134.4 140.2 114.1 104.1 115.0 136.7 117.8 108.0 54.5 129.2 104.2 753.9 136.6 151.3 117.1 134.7 163.3 152.9 61.3 136.4 188.0 121.9 375.3 155.4 168.2 141.3 143.7 532.8 674.6 390.9 419.4 357.2 277.8 345.0 398.3 343.6 1024.7 428.8 1785.8 504.0 438.2 926.2 421.0 644.1 627.2 371.9 752.5 497.0 261.0 261.1 1009.7 641.9 913.2 454.0 434.3 570.4 297.9 602.0 525.1 454.5 248.8 509.2 436.1 439.2 419.2 441.8 568.6 696.1 673.6 332.5 595.0 859.8 476.9 753.5 482.6 385.3 515.4 526.2 321.6 625.9 777.1 701.9 252.7 468.3 643.3 416.1 898.9 725.4 473.3 631.1 286.9 483.9 531.2 626.7 327.7 536.1 754.4 682.6 801.5 536.5 692.6 458.2 579.3 533.3 531.4 632.2 522.7 415.1 427.3 582.2 421.7 720.3 676.3 723.4 1131.2 127.6 132.0 136.9 146.2 131.9 137.0 134.0 131.7 136.7 134.7 136.4 143.7 402.9 211.5 180.8 20.9 252.3 374.5 350.6 616.4 167.4 127.5 223.0 296.4 304.9 327.5 369.2 257.5 73.0 666.2 309.5 375.2 498.9 581.9 355.5 290.2 345.4 397.3 232.0 439.4 19.2 727.7 775.7 321.9 132.0 276.5 251.4 304.7 335.5 787.5 807.0 82.4 18.4 325.6 453.7 435.7 453.1 211.0 334.6 414.8 368.2 18.7 598.4 219.3 377.9 15.1 28.9 663.3 386.4 293.8 234.5 639.7 455.1 759.6 288.8 122.5 230.1 237.0 659.7 81.4 126.3 291.9 309.3 852.6 310.4 410.0 386.9 438.7 PSMB9 "beta1i, LMP2, PSMB6i, RING12" ENSG00000240065 "Proteasome 20S subunit beta 9" P28065 6 32844136-32859851 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 160.9" "Cell type enhanced" "Detected in many" "monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015180, HPA042818, HPA053280" Enhanced Supported Cytosol NA NA 340000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098" "unprognostic (1.09e-2)" "unprognostic (1.68e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-3)" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (5.68e-2)" "unprognostic (6.67e-2)" "unprognostic (1.56e-2)" "unprognostic (6.50e-3)" "unprognostic (1.87e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.96e-3)" "unprognostic (5.99e-2)" 47.0 31.1 4.8 18.4 4.9 6.9 41.4 4.3 5.5 28.8 2.6 38.4 10.2 26.8 2.3 25.7 25.9 4.7 31.6 4.8 5.6 36.3 37.4 60.2 26.2 7.6 4.9 18.1 12.1 1.5 14.0 3.4 5.9 26.5 8.7 1.3 20.3 5.0 11.9 27.7 78.1 5.7 5.7 160.9 26.5 4.9 5.1 15.0 28.7 3.8 22.2 23.6 30.8 5.8 5.5 0.3 0.0 0.2 3.4 8.5 3.0 0.7 11.5 17.3 27.7 0.0 3.1 40.8 1.3 2.9 14.3 10.0 0.2 5.8 2.6 9.3 0.1 17.6 0.7 0.8 17.3 1.8 2.2 2.1 0.3 7.0 1.0 3.3 2.7 10.1 1.4 12.8 1.9 1.0 16.1 8.0 0.0 0.0 0.8 19.0 1.2 7.4 2.1 2.5 0.0 0.0 1.0 2.1 10.7 0.0 4.4 10.3 0.0 2.5 1.6 14.7 1.2 11.3 23.9 9.3 7.5 6.8 4.0 92.7 30.3 75.6 56.1 55.8 45.9 59.7 45.1 55.9 26.6 45.3 41.0 49.6 96.3 61.5 60.9 20.5 61.0 46.2 4.8 4.9 4.3 5.5 4.8 5.6 7.6 4.9 5.9 5.7 5.1 5.8 258.6 41.7 51.1 1.3 197.2 72.5 37.4 155.6 30.1 2.4 25.3 47.0 7.3 50.1 64.8 25.8 0.0 1.5 216.2 88.0 19.6 116.6 1.3 28.9 47.5 146.5 33.5 29.9 0.0 115.6 6.6 45.1 34.1 42.6 77.3 20.0 119.6 26.6 117.2 0.0 0.1 148.0 99.7 126.8 155.7 2.1 29.2 145.2 35.6 8.4 323.0 22.7 495.4 0.5 8.3 67.8 150.3 15.8 136.1 40.4 318.5 40.5 133.7 1.7 32.9 23.1 50.8 1.5 7.4 21.0 58.7 1.4 241.8 45.3 110.6 39.1 PSMC1 "p56, S4" ENSG00000100764 "Proteasome 26S subunit, ATPase 1" P62191 14 90256527-90275429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 308.0" "Cell type enhanced" "Detected in all" "Early spermatids: 593.2;Late spermatids: 549.5;Syncytiotrophoblasts: 469.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000872, HPA016885" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 110000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA000872: AB_1079705, HPA016885: " "unprognostic (4.10e-1)" "unprognostic (9.70e-2)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (1.23e-2)" "unprognostic (1.00e-2)" "unprognostic (1.58e-1)" "unprognostic (1.03e-3)" "unprognostic (1.12e-2)" "unprognostic (1.10e-2)" "unprognostic (1.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.85e-1)" "unprognostic (1.11e-2)" 76.7 61.3 47.6 48.0 50.3 86.3 64.9 50.8 63.3 51.7 47.6 72.4 35.7 67.3 71.6 71.5 53.4 37.5 114.9 49.5 53.6 62.2 83.3 55.0 49.5 50.5 51.3 45.6 52.7 69.3 37.0 69.6 53.0 49.7 60.4 40.1 55.3 57.5 308.0 74.1 54.5 61.5 49.4 57.5 61.1 82.2 50.3 62.5 48.1 142.5 72.2 64.7 54.1 50.8 141.6 131.1 147.5 154.8 126.6 115.4 154.9 133.5 185.7 287.9 215.4 122.3 154.7 119.4 198.4 162.3 132.2 142.8 182.2 155.8 334.2 143.9 80.0 93.8 84.6 105.9 109.1 143.7 120.4 104.3 120.7 187.9 137.1 120.2 176.2 130.3 134.8 69.9 200.6 267.9 108.0 186.7 130.6 180.7 160.4 127.5 190.8 97.6 163.0 144.6 154.6 103.2 109.0 279.6 118.0 121.8 175.9 125.2 134.9 110.1 98.8 119.6 196.3 120.0 204.3 178.3 159.8 129.1 172.1 95.1 101.4 160.1 67.1 93.7 66.4 57.7 68.5 69.0 101.1 56.8 62.5 60.7 109.9 82.0 110.7 70.8 101.2 116.5 47.6 50.3 50.8 63.3 49.5 53.6 50.5 51.3 53.0 49.4 50.3 50.8 63.1 102.5 80.4 11.4 51.4 65.0 90.3 175.3 30.1 51.3 48.6 45.7 39.2 88.6 136.0 55.2 52.1 304.2 48.2 91.2 119.3 180.8 593.2 68.9 56.1 90.1 57.0 80.6 21.0 197.7 178.9 71.4 30.1 70.1 98.2 82.4 75.7 196.6 150.2 79.1 21.2 68.7 111.9 91.8 82.2 549.5 76.4 74.7 67.6 14.0 146.0 88.1 72.1 10.6 22.3 210.3 71.5 82.0 50.7 75.5 104.2 160.4 123.9 65.8 85.5 67.5 139.5 198.1 48.7 44.1 50.2 469.4 55.4 82.5 74.4 92.7 PSMD13 "p40.5, Rpn9" ENSG00000185627 "Proteasome 26S subunit, non-ATPase 13" Q9UNM6 11 236966-252984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038691, HPA038692" Approved Approved "Nuclear speckles,Cytosol" NA NA 81000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear speckles" Cytosol "HPA038691: AB_2676153, HPA038692: AB_10671749" "unprognostic (1.32e-2)" "unprognostic (7.98e-2)" "unprognostic (9.19e-2)" "prognostic favorable (5.74e-4)" "unprognostic (2.24e-2)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.76e-5)" "unprognostic (7.54e-3)" "unprognostic (2.94e-1)" "unprognostic (1.90e-1)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (1.52e-13)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" 56.6 41.3 48.2 65.2 49.1 69.4 74.9 50.0 51.5 57.8 49.5 64.1 57.0 50.7 62.6 63.6 51.8 42.9 76.1 50.3 52.6 53.6 71.8 56.2 79.5 50.3 50.2 40.0 48.9 45.6 18.0 64.9 54.0 67.1 66.7 30.8 46.3 52.0 122.4 62.4 55.7 68.1 51.1 54.3 45.9 44.2 49.5 91.6 48.3 124.3 86.9 65.5 20.1 52.3 240.7 163.7 155.2 163.7 135.3 114.0 102.3 151.8 186.1 277.7 210.6 156.1 352.4 193.0 178.2 172.7 145.5 179.4 154.6 200.2 251.0 202.7 148.7 109.9 52.4 131.7 160.9 203.8 207.7 116.3 149.7 138.4 121.2 114.0 241.7 186.3 249.1 158.1 189.9 126.3 197.4 185.0 243.1 195.0 184.0 168.6 145.3 156.3 190.2 59.2 141.7 111.5 106.5 166.7 111.0 103.6 97.7 123.7 192.6 115.2 96.8 60.3 160.6 161.2 192.4 271.8 185.2 193.0 176.3 198.6 171.3 133.6 145.8 173.0 143.0 125.0 133.1 141.1 176.1 128.6 121.3 130.3 127.8 168.7 194.7 122.1 169.2 286.0 48.2 49.1 50.0 51.5 50.3 52.6 50.3 50.2 54.0 51.1 49.5 52.3 80.8 48.1 41.4 17.0 64.7 35.8 54.1 124.8 26.2 43.2 43.8 41.7 45.7 52.9 68.8 31.3 31.3 162.3 79.9 76.5 82.2 114.8 39.2 41.6 47.1 75.1 48.0 35.7 16.8 130.8 138.6 55.9 34.1 45.2 67.2 59.9 54.7 59.0 100.5 37.0 15.5 75.2 71.2 47.5 43.5 57.8 68.6 64.4 46.2 11.2 91.9 65.0 71.1 8.5 17.2 123.4 65.5 59.8 73.9 58.7 80.8 76.2 61.3 44.2 85.5 40.8 66.9 94.0 86.4 34.4 38.8 205.8 71.6 73.8 74.2 51.4 PSMD4 "AF, AF-1, Rpn10, S5A" ENSG00000159352 "Proteasome 26S subunit, non-ATPase 4" P55036 1 151254709-151267479 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038807, HPA039252, CAB047300" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 69000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418" "unprognostic (3.83e-2)" "unprognostic (7.89e-2)" "unprognostic (6.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-2)" "unprognostic (1.79e-3)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.61e-2)" "unprognostic (7.57e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (6.66e-10)" "unprognostic (9.80e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (3.91e-1)" 108.8 118.0 198.8 77.8 203.8 89.4 97.9 203.0 288.1 88.7 195.2 136.9 68.9 99.5 114.3 115.5 91.0 58.2 191.2 202.8 205.8 110.2 170.5 81.7 95.7 208.5 215.3 85.8 114.0 91.6 79.4 91.1 209.3 91.3 82.1 64.5 83.9 86.4 404.1 103.3 91.3 91.0 204.2 109.6 115.4 152.0 203.7 114.3 76.7 188.0 114.0 118.6 88.2 203.4 251.4 294.8 213.4 175.2 227.4 167.0 231.9 166.0 202.1 258.6 205.1 388.3 278.2 202.2 396.2 235.4 178.7 255.4 277.1 250.6 219.6 331.9 236.6 197.8 256.2 396.6 250.8 234.7 220.5 182.5 204.2 296.3 271.4 193.3 229.5 222.4 313.6 247.9 220.2 723.5 217.4 276.7 406.0 384.3 293.4 181.6 207.7 364.7 252.7 210.6 166.7 283.8 184.5 266.3 222.7 313.0 278.9 452.3 203.4 128.1 201.2 159.2 288.2 295.1 397.7 430.3 212.6 218.1 238.7 439.4 439.0 713.9 247.3 478.1 281.2 399.0 287.4 274.4 398.4 426.1 261.0 258.1 580.2 351.2 502.3 240.3 476.6 651.0 198.8 203.8 203.0 288.1 202.8 205.8 208.5 215.3 209.3 204.2 203.7 203.4 90.1 57.7 62.9 15.7 78.5 88.6 111.9 249.0 58.1 50.9 60.9 69.3 245.2 82.9 125.0 60.7 27.1 328.6 74.0 104.1 168.3 177.3 279.1 91.5 63.0 95.8 84.2 107.3 25.3 186.9 234.1 88.5 46.9 59.1 83.6 88.8 83.2 116.0 184.5 33.7 24.2 94.1 156.6 104.0 98.0 243.2 105.3 90.3 104.9 11.2 256.6 91.9 115.4 16.1 23.2 172.2 129.1 98.6 67.0 121.4 168.6 206.6 148.3 54.6 118.3 79.0 221.1 234.8 83.5 66.7 86.5 414.6 77.7 105.6 114.5 107.2 PSMD9 "p27, Rpn4" ENSG00000110801 "Proteasome 26S subunit, non-ATPase 9" O00233 12 121888732-121918297 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040512, HPA044220" Enhanced Supported "Plasma membrane,Cytosol" NA NA 500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Cytosol "Plasma membrane" "HPA040512: AB_2677014, HPA044220: AB_2678860" "unprognostic (2.24e-1)" "unprognostic (2.48e-3)" "unprognostic (2.12e-1)" "unprognostic (3.36e-1)" "unprognostic (1.20e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (9.64e-3)" "unprognostic (3.17e-2)" "unprognostic (5.73e-2)" "unprognostic (6.19e-2)" "unprognostic (8.63e-2)" 16.5 4.6 7.5 2.3 8.1 19.2 4.8 8.0 10.0 5.8 11.8 13.8 11.5 7.1 2.2 6.2 6.4 3.8 5.5 7.9 8.1 10.8 4.6 6.0 5.7 9.0 8.9 5.9 10.6 4.8 3.5 3.9 8.3 4.6 2.2 3.6 8.8 6.7 18.5 5.9 6.2 3.3 8.3 8.9 14.9 5.1 8.7 6.6 5.1 6.0 3.2 4.1 5.5 9.4 54.8 81.8 6.7 12.2 11.2 11.6 13.9 54.5 17.8 27.3 15.5 60.0 6.3 40.5 45.0 28.6 9.2 22.1 20.0 29.1 16.3 78.5 41.6 33.3 40.9 30.5 27.5 23.3 22.7 20.4 14.0 30.4 11.7 9.9 16.6 24.7 30.1 5.3 17.6 63.2 47.1 17.8 14.0 7.1 63.4 35.6 18.3 24.9 13.4 53.9 14.1 19.3 54.4 7.7 29.3 5.8 23.3 11.3 43.3 25.4 29.0 50.1 38.4 30.4 73.0 62.1 45.5 30.1 23.8 41.8 43.6 53.0 33.9 46.2 27.3 47.6 32.6 31.0 38.5 38.5 25.0 21.2 41.3 29.3 41.7 63.7 48.1 51.6 7.5 8.1 8.0 10.0 7.9 8.1 9.0 8.9 8.3 8.3 8.7 9.4 22.8 48.1 33.7 10.1 32.6 60.5 11.4 64.1 67.2 7.3 40.9 34.8 8.0 34.3 40.0 35.0 18.8 30.3 45.8 66.6 52.8 116.9 34.9 32.6 28.7 29.7 46.6 121.4 12.9 121.4 30.7 30.5 42.8 27.4 44.4 11.0 33.9 26.8 39.8 15.2 10.7 66.5 54.9 37.9 55.3 11.4 37.9 43.6 55.2 7.5 93.9 17.2 35.0 7.1 18.7 138.2 64.2 38.7 73.2 9.5 146.8 100.7 36.6 14.8 39.5 19.5 46.8 33.9 37.5 69.4 71.6 37.8 44.9 12.9 67.7 12.8 PSME3IP1 "C16orf94, FAM192A, NIP30, PIP30" ENSG00000172775 "Proteasome activator subunit 3 interacting protein 1" Q9GZU8 16 57152466-57186116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 82.3;Cytotrophoblasts: 56.7;Extravillous trophoblasts: 59.5;Hofbauer cells: 64.6;Syncytiotrophoblasts: 53.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054382, HPA059652" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "HPA054382: AB_2682469, HPA059652: AB_2684095" "unprognostic (1.69e-2)" "unprognostic (5.20e-2)" "unprognostic (1.36e-1)" "unprognostic (9.20e-3)" "unprognostic (4.69e-3)" "unprognostic (2.45e-2)" "unprognostic (1.01e-2)" "unprognostic (2.22e-1)" "unprognostic (6.09e-2)" "unprognostic (1.52e-2)" "unprognostic (1.41e-1)" "unprognostic (4.19e-1)" "unprognostic (3.00e-1)" "unprognostic (3.87e-3)" "unprognostic (4.14e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-3)" 48.8 50.2 80.5 72.9 93.9 151.0 66.7 85.8 99.0 52.4 83.8 75.4 67.6 54.1 64.7 63.5 54.1 47.3 59.2 78.4 89.7 66.3 62.6 57.6 94.8 91.7 87.3 54.6 55.3 76.7 65.3 56.0 87.3 64.7 87.5 75.2 55.2 50.3 79.0 90.3 76.1 52.3 87.9 93.3 62.6 96.8 85.8 85.0 71.5 66.0 96.5 53.3 56.1 103.7 119.3 148.6 163.6 109.8 70.3 86.2 153.4 138.3 102.3 166.3 107.1 141.3 122.5 179.2 150.6 105.8 84.2 155.9 114.4 137.9 167.1 80.3 92.1 125.0 141.6 148.3 101.0 154.8 170.8 86.6 134.8 158.2 127.4 101.8 121.0 134.4 170.1 56.5 110.8 88.2 169.4 143.2 105.1 88.0 111.3 205.6 236.9 174.5 113.1 96.4 116.3 133.9 250.2 105.2 92.7 113.0 87.1 105.9 120.2 122.0 102.3 90.2 103.7 133.2 113.1 228.6 125.0 109.7 119.6 170.3 78.3 124.1 47.6 93.0 46.8 83.1 45.8 44.7 90.0 77.8 47.0 49.1 107.6 57.1 123.4 62.4 69.2 68.1 80.5 93.9 85.8 99.0 78.4 89.7 91.7 87.3 87.3 87.9 85.8 103.7 16.9 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.3 0.0 0.0 0.0 0.0 56.7 10.2 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 59.5 16.8 0.0 0.0 0.0 0.0 0.0 0.0 64.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 53.1 1.5 0.0 0.0 0.0 RAB8A "MEL, RAB8" ENSG00000167461 "RAB8A, member RAS oncogene family" P61006 19 16111889-16134234 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041945 Approved "Nucleoplasm,Plasma membrane" No No 4800000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 9: Intestine - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Plasma membrane" "HPA041945: " "unprognostic (1.10e-1)" "unprognostic (3.95e-3)" "unprognostic (1.98e-2)" "unprognostic (2.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (2.57e-1)" "unprognostic (1.14e-2)" "unprognostic (2.52e-3)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (6.60e-2)" "unprognostic (7.25e-2)" "prognostic favorable (1.71e-4)" "unprognostic (9.99e-2)" 21.3 24.5 17.4 40.4 17.5 61.3 18.7 19.5 17.6 24.6 20.7 37.4 58.5 18.5 18.9 25.9 27.8 22.0 11.5 17.2 19.1 20.8 51.5 28.6 44.3 21.1 19.5 21.5 23.4 17.7 15.3 25.0 21.6 21.7 32.8 8.7 30.7 21.2 7.0 27.5 58.7 22.8 20.3 40.4 32.4 15.4 19.0 34.3 16.3 8.1 45.1 25.9 21.2 23.3 94.2 62.6 50.5 43.0 42.7 36.7 77.9 56.0 48.8 74.2 76.8 76.1 105.7 66.1 61.9 58.6 63.5 60.6 71.2 69.1 50.9 132.6 39.9 135.9 57.1 75.6 46.7 119.4 129.3 36.6 37.6 69.5 32.1 38.9 63.5 65.0 64.4 97.0 63.4 111.6 100.1 113.7 63.3 114.3 100.5 111.6 56.2 115.6 58.2 71.9 46.9 45.3 56.6 68.0 35.9 34.2 53.8 44.2 61.7 61.4 39.2 119.2 96.6 51.4 113.4 97.3 58.7 121.5 67.0 244.5 278.6 315.0 164.3 387.5 145.7 190.5 143.3 147.5 247.5 190.0 112.5 131.7 292.2 225.9 485.1 177.8 150.9 514.1 17.4 17.5 19.5 17.6 17.2 19.1 21.1 19.5 21.6 20.3 19.0 23.3 47.2 25.6 29.1 2.3 70.2 47.7 47.4 53.5 31.3 15.2 37.0 34.7 3.0 17.2 35.7 31.3 14.6 95.7 97.9 115.9 82.2 70.7 31.0 33.7 29.7 37.3 30.4 47.5 4.2 51.5 98.6 36.3 29.6 45.0 48.7 36.2 26.0 50.3 88.9 6.7 3.5 55.3 48.8 50.6 81.5 19.0 27.7 100.9 33.8 2.8 124.8 34.9 131.8 3.0 8.8 76.8 90.0 24.8 96.5 30.7 130.7 62.6 35.4 13.9 32.9 22.0 38.1 33.3 23.4 30.4 52.6 79.6 64.8 43.4 52.0 38.4 RABAC1 "PRA1, PRAF1, YIP3" ENSG00000105404 "Rab acceptor 1" Q9UI14 19 41956681-41959321 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019320, HPA029171" Supported NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "CAB019320: , HPA029171: AB_10602121" "unprognostic (7.70e-2)" "unprognostic (5.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (2.61e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.93e-1)" "unprognostic (3.41e-2)" "unprognostic (1.19e-2)" "unprognostic (3.32e-3)" "unprognostic (9.69e-2)" "unprognostic (1.76e-1)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.97e-2)" "unprognostic (7.45e-2)" 180.4 163.6 128.4 61.1 129.5 53.2 170.4 136.7 177.5 213.4 137.5 192.0 75.3 234.5 28.2 115.9 174.2 37.9 166.5 122.3 149.5 181.7 198.9 180.7 51.9 151.7 135.4 184.3 177.9 68.7 242.4 55.4 149.1 160.4 28.4 14.6 197.2 57.9 125.9 146.7 148.9 49.0 136.7 166.0 189.9 155.4 144.5 34.0 171.4 38.0 31.3 168.6 171.4 147.7 95.7 261.0 35.5 94.6 234.8 136.7 47.7 278.8 144.9 67.3 93.8 46.8 60.6 277.0 140.4 161.9 39.1 70.0 21.9 89.0 25.5 102.1 151.6 40.4 73.0 82.1 130.8 35.5 106.7 137.5 86.5 45.5 31.0 84.4 94.2 76.0 17.9 346.6 61.0 149.2 62.6 32.0 44.4 136.8 167.6 83.3 77.4 54.4 65.0 71.8 67.0 97.4 73.5 157.3 71.3 26.2 59.1 29.4 187.2 119.3 77.4 116.2 40.4 303.8 111.0 96.1 172.3 66.3 131.3 720.0 389.3 551.7 372.2 217.3 313.6 398.7 331.0 325.0 232.5 339.4 222.3 298.8 774.6 253.4 220.1 410.2 403.4 511.2 128.4 129.5 136.7 177.5 122.3 149.5 151.7 135.4 149.1 136.7 144.5 147.7 333.1 128.2 109.8 19.2 203.4 124.7 160.1 242.1 119.5 62.6 173.6 232.3 59.9 163.0 162.3 182.1 16.7 187.5 173.6 411.2 137.0 339.7 203.1 91.9 247.0 234.4 195.0 35.1 14.8 301.4 467.1 309.7 138.6 143.8 142.7 163.5 241.3 237.7 174.0 57.2 18.8 507.5 246.2 119.8 187.0 658.2 307.0 133.1 405.6 21.5 230.8 168.4 161.7 21.1 43.1 427.9 371.7 251.3 625.9 222.3 358.3 326.7 154.8 69.2 230.1 129.4 337.8 234.3 136.1 89.7 136.4 271.7 188.7 176.1 247.4 223.3 RABIF "mss4, RASGRF3" ENSG00000183155 "RAB interacting factor" P47224 1 202878282-202889149 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 3764.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027715 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" "HPA027715: AB_10602151" "unprognostic (4.87e-2)" "unprognostic (3.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.37e-1)" "unprognostic (3.51e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.70e-1)" "unprognostic (5.62e-3)" "prognostic favorable (5.64e-5)" "unprognostic (4.40e-2)" "unprognostic (2.94e-1)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.23e-1)" "unprognostic (5.21e-2)" "unprognostic (8.54e-2)" "unprognostic (2.47e-1)" 4.0 3.9 6.3 5.7 6.6 8.4 3.9 5.8 8.4 4.1 4.2 5.5 5.6 3.4 3.9 8.9 3.0 4.1 4.5 7.0 6.5 5.6 5.3 4.7 6.7 6.2 6.3 2.0 3.3 3.2 3.9 4.9 6.3 4.2 6.0 6.8 4.8 3.2 4.8 5.5 5.3 4.7 5.9 6.2 3.8 18.0 6.3 5.7 3.1 4.3 8.6 5.1 4.8 6.6 11.7 12.2 8.8 10.6 13.4 9.9 9.5 12.9 7.1 12.8 11.8 8.9 9.9 9.6 6.0 10.0 8.8 10.9 6.9 8.0 9.7 11.8 12.7 7.9 9.8 9.1 10.8 11.1 13.4 8.5 11.2 16.0 4.1 6.3 16.9 12.4 12.7 10.3 12.5 19.5 12.5 12.0 7.2 9.1 15.1 8.7 12.3 13.2 13.2 12.2 12.3 11.0 11.0 19.1 10.4 10.6 12.6 8.1 13.3 8.9 8.2 4.3 11.2 5.4 13.0 10.1 8.8 10.3 8.5 32.4 21.1 31.6 18.4 23.2 13.5 17.8 17.3 17.4 19.0 17.8 15.6 16.5 33.3 17.9 22.0 18.1 21.1 18.3 6.3 6.6 5.8 8.4 7.0 6.5 6.2 6.3 6.3 5.9 6.3 6.6 11.8 0.0 15.9 4.6 26.2 54.3 37.8 53.3 17.6 5.4 18.9 12.3 11.2 17.2 33.8 12.9 2.1 52.5 39.1 42.4 15.6 37.3 696.1 17.9 8.5 20.6 23.4 21.2 9.0 53.4 50.5 16.6 13.7 14.5 12.7 8.0 20.3 34.9 42.1 1.7 7.0 14.7 40.7 37.4 36.0 3764.0 28.3 29.1 53.4 5.6 48.4 18.2 62.8 5.5 7.3 77.5 40.9 30.1 27.1 28.2 34.3 59.1 32.0 6.0 13.1 9.5 21.7 98.0 62.7 23.4 51.9 78.9 35.0 10.8 14.6 49.2 RAMAC "C15orf18, FAM103A1, HsT19360, MGC2560, RAM, RAMMET" ENSG00000169612 "RNA guanine-7 methyltransferase activating subunit" Q9BTL3 15 82986210-82991057 "Predicted intracellular proteins" "mRNA capping, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 108.2;Extravillous trophoblasts: 82.2;Hofbauer cells: 69.4;Syncytiotrophoblasts: 92.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041923, HPA041948" Supported Supported Nucleoplasm No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041923: AB_10796467, HPA041948: AB_10797270" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" "unprognostic (5.30e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (3.63e-3)" "unprognostic (2.09e-2)" "unprognostic (4.72e-2)" "unprognostic (7.46e-3)" "unprognostic (9.57e-2)" "unprognostic (2.72e-2)" "unprognostic (9.47e-2)" "unprognostic (2.45e-1)" 12.9 14.8 10.9 16.4 11.4 30.1 26.1 12.9 14.8 16.6 11.6 18.4 14.5 18.2 30.1 24.1 19.5 13.4 14.8 11.6 12.2 16.8 24.2 13.0 23.0 11.6 11.3 20.6 16.4 18.8 12.9 25.9 11.3 18.0 19.3 19.9 18.2 15.2 29.1 21.5 13.4 16.8 11.6 14.1 19.0 15.6 11.1 23.3 18.2 20.2 28.9 20.8 15.6 11.6 34.1 44.7 44.3 27.1 23.5 15.9 32.7 33.7 33.5 37.6 30.4 49.4 42.9 16.8 45.8 29.2 45.4 37.9 77.1 32.4 40.6 42.0 49.7 52.7 22.7 58.7 33.3 38.0 44.9 34.9 61.4 30.6 38.5 28.7 23.6 28.5 62.8 33.9 39.8 35.7 29.5 48.3 52.0 45.0 21.1 33.4 38.2 26.0 49.0 64.6 41.1 42.0 34.6 36.7 87.0 71.5 58.6 47.9 16.8 27.5 34.9 26.1 48.8 53.1 104.0 41.8 25.2 50.7 34.5 138.6 59.2 98.2 47.9 57.0 51.8 64.8 54.1 52.3 56.1 61.1 53.9 53.4 117.4 70.4 62.8 51.6 69.9 65.9 10.9 11.4 12.9 14.8 11.6 12.2 11.6 11.3 11.3 11.6 11.1 11.6 18.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.2 19.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 82.2 10.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 92.9 2.7 0.0 0.0 0.0 RBM4 "LARK, RBM4A, ZCCHC21, ZCRB3A" ENSG00000173933 "RNA binding motif protein 4" Q9BWF3 11 66638667-66668374 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042174, HPA047849" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA042174: AB_2677885, HPA047849: AB_2680180" "unprognostic (8.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.17e-1)" "unprognostic (1.53e-2)" "unprognostic (9.46e-3)" "unprognostic (1.13e-1)" "unprognostic (5.41e-3)" "unprognostic (6.42e-2)" "unprognostic (4.34e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (4.42e-2)" "unprognostic (2.53e-1)" "unprognostic (2.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.76e-2)" "unprognostic (3.07e-3)" 82.6 111.5 60.8 71.0 63.3 131.5 75.8 81.1 66.7 90.8 69.4 96.1 67.8 87.1 90.3 100.3 79.4 59.0 75.6 61.5 67.1 119.8 82.3 77.4 97.5 59.0 58.5 103.6 115.5 77.2 86.1 72.8 58.9 95.9 62.6 74.4 89.1 60.0 96.6 80.9 83.6 69.1 61.1 104.8 98.4 74.3 69.5 109.8 85.7 72.4 99.1 84.2 84.1 65.4 127.2 163.6 246.5 136.4 90.1 95.6 153.9 128.6 106.1 134.1 97.3 281.5 160.9 161.1 174.4 132.3 120.5 136.4 263.5 159.1 142.9 162.1 138.4 220.7 163.5 170.3 173.1 152.8 91.9 138.8 134.3 158.6 213.9 136.4 184.3 155.0 180.1 115.0 147.3 263.3 252.9 157.9 309.7 246.8 176.0 234.2 224.6 181.7 180.7 199.5 204.5 149.5 227.1 168.6 379.9 163.8 315.3 154.4 180.9 140.4 124.0 86.5 107.3 143.9 162.5 258.8 109.9 118.3 205.8 210.0 119.4 131.3 135.5 123.2 122.3 119.3 139.8 149.9 116.2 130.4 147.5 149.8 137.5 155.4 144.0 103.6 194.3 159.1 60.8 63.3 81.1 66.7 61.5 67.1 59.0 58.5 58.9 61.1 69.5 65.4 19.7 28.9 42.2 8.1 64.0 17.8 61.4 36.3 112.7 58.2 24.2 12.7 4.6 15.7 36.5 20.2 93.8 36.2 48.7 16.6 15.6 25.1 39.8 26.6 28.0 28.5 34.7 42.5 23.9 23.1 30.1 33.6 53.0 30.7 36.8 38.1 25.7 11.1 14.5 62.2 21.4 15.5 32.6 18.8 29.2 9.3 27.4 27.5 19.6 7.5 28.8 15.9 69.0 15.1 18.8 19.6 23.6 20.3 60.2 62.6 32.9 10.6 41.1 90.0 19.7 29.7 28.3 41.1 40.1 68.6 22.3 43.8 66.3 42.4 24.8 65.5 RBM8A "BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP" ENSG00000265241 "RNA binding motif protein 8A" Q9Y5S9 1 145917714-145927678 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 735.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018403 Supported Supported "Nuclear speckles" NA NA 100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles" "HPA018403: AB_1858908" "unprognostic (3.81e-1)" "unprognostic (3.99e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-2)" "unprognostic (1.12e-1)" "unprognostic (3.16e-1)" "unprognostic (4.62e-3)" "unprognostic (1.91e-1)" "unprognostic (1.38e-1)" "unprognostic (8.79e-3)" "unprognostic (7.27e-3)" "prognostic unfavorable (1.55e-4)" "unprognostic (3.30e-3)" "unprognostic (2.18e-1)" "unprognostic (3.77e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-3)" 86.1 74.9 37.2 105.4 39.1 214.7 82.3 38.7 43.0 69.6 35.6 70.5 70.1 67.7 49.3 163.6 62.2 58.0 73.0 36.8 41.7 81.6 77.5 72.8 126.4 39.7 39.8 72.0 59.9 78.4 65.8 85.3 40.8 66.4 56.4 45.0 79.2 48.2 214.9 92.0 69.2 57.7 42.1 81.6 67.5 71.3 40.0 120.7 68.8 100.1 123.7 112.8 80.4 43.9 377.0 300.7 268.8 215.7 94.6 92.2 330.0 224.3 150.7 315.0 230.1 400.0 277.4 342.0 344.9 155.3 166.5 252.5 289.3 245.3 257.0 305.6 275.7 264.2 229.2 299.8 133.6 446.6 222.6 102.2 180.8 283.0 300.3 137.4 238.1 291.9 405.2 314.7 246.2 1033.8 452.3 352.2 463.7 323.9 518.4 394.4 234.6 341.2 203.2 355.6 274.6 335.7 334.5 169.7 316.5 231.0 318.0 534.3 247.3 252.3 324.0 250.9 626.0 352.2 603.4 502.6 226.4 264.9 223.2 464.6 316.5 513.6 337.2 363.9 322.1 444.3 317.6 346.4 318.0 389.6 296.1 328.3 363.7 389.8 361.3 498.4 386.3 582.7 37.2 39.1 38.7 43.0 36.8 41.7 39.7 39.8 40.8 42.1 40.0 43.9 289.1 70.5 132.4 8.1 251.0 332.9 396.7 475.4 244.2 66.3 168.5 184.7 78.0 98.7 262.8 88.3 54.2 376.2 276.0 125.3 187.9 224.1 243.7 148.0 134.3 206.0 158.9 149.2 10.8 223.2 506.3 174.1 80.5 152.8 244.0 136.8 120.3 124.4 204.3 35.3 9.1 127.6 313.3 100.3 265.2 54.4 102.2 170.7 208.1 9.4 197.7 120.3 165.8 6.0 16.1 245.4 159.8 85.4 174.9 259.6 119.5 204.1 195.1 86.3 98.6 213.7 208.1 212.0 168.9 208.1 318.0 735.5 282.1 139.7 141.7 393.0 REEP5 "C5orf18, D5S346, DP1, POB16, TB2, Yip2e" ENSG00000129625 "Receptor accessory protein 5" Q00765 5 112876385-112922289 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003895, HPA069960" Approved Supported "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 6: T47d - Mammary gland" "Cluster 10: Non-specific - Unknown function" "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA069960: AB_2686221" "unprognostic (3.26e-3)" "unprognostic (2.60e-1)" "unprognostic (2.71e-1)" "prognostic favorable (5.23e-6)" "unprognostic (8.29e-2)" "unprognostic (1.44e-2)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.85e-1)" "unprognostic (3.75e-2)" "unprognostic (7.75e-2)" "unprognostic (5.90e-2)" "prognostic favorable (2.05e-5)" "unprognostic (2.88e-2)" "unprognostic (4.14e-2)" "unprognostic (1.83e-1)" "unprognostic (3.24e-2)" 76.9 105.4 97.1 50.5 100.2 27.3 130.6 92.7 120.7 87.1 76.8 66.6 56.8 58.4 120.0 52.1 64.7 60.8 133.2 107.3 110.5 148.0 124.3 80.4 48.2 112.2 104.8 72.2 123.0 140.7 41.5 66.6 115.2 98.9 58.1 81.5 147.7 84.2 114.3 59.1 58.1 55.0 96.4 54.3 70.2 28.3 120.0 32.1 239.4 99.6 56.7 73.2 49.1 98.3 101.7 90.9 29.7 72.5 136.0 115.9 104.7 102.2 92.6 96.4 103.4 74.9 138.1 42.5 179.6 105.1 112.5 107.5 66.8 138.9 88.5 190.6 116.4 42.8 56.3 63.5 126.8 36.9 77.4 81.3 136.0 82.2 78.0 94.5 113.7 38.7 26.0 84.5 121.3 100.0 15.7 60.7 43.4 73.5 75.3 22.4 84.3 116.6 229.1 108.4 56.9 43.1 148.5 244.6 99.8 75.5 287.3 58.9 142.4 83.4 32.0 126.5 126.4 97.6 126.2 33.8 142.6 65.4 47.8 224.4 222.9 234.3 140.1 249.5 149.4 175.7 112.7 133.9 189.0 149.2 52.5 94.6 253.0 112.7 316.2 133.6 177.9 236.4 97.1 100.2 92.7 120.7 107.3 110.5 112.2 104.8 115.2 96.4 120.0 98.3 141.2 166.7 102.3 30.0 131.1 93.0 177.7 291.6 89.4 83.5 225.3 188.1 217.3 145.8 213.7 195.0 89.6 296.0 138.4 77.0 82.2 275.1 231.5 111.8 97.0 130.5 118.0 34.9 78.6 414.1 352.8 182.3 65.7 141.6 108.9 76.0 118.2 197.0 267.1 87.5 95.0 127.5 256.3 135.0 159.9 42.0 116.2 168.8 206.3 36.5 188.6 97.2 101.0 44.7 71.5 316.5 141.1 133.9 271.6 225.3 134.1 146.1 170.6 80.0 111.7 92.6 253.0 162.8 63.9 118.1 101.6 489.8 123.7 100.3 104.5 214.8 RER1 ENSG00000157916 "Retention in endoplasmic reticulum sorting receptor 1" O15258 1 2391775-2405442 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037240, HPA051400" Supported Supported "Golgi apparatus" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" "CAB037240: AB_2179604, HPA051400: AB_2681469" "unprognostic (2.90e-2)" "unprognostic (3.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.23e-8)" "unprognostic (1.01e-1)" "unprognostic (5.41e-2)" "unprognostic (1.06e-1)" "unprognostic (3.27e-2)" 100.4 154.2 60.0 89.3 67.6 81.6 97.1 67.0 62.8 93.6 78.3 137.4 114.8 74.4 122.7 176.4 86.1 86.9 75.7 61.1 64.1 106.3 224.8 79.6 94.6 67.0 65.1 92.9 122.3 100.9 82.9 99.0 66.9 94.3 151.4 73.8 101.1 104.2 105.2 101.7 120.0 104.6 65.6 102.2 118.6 107.1 68.5 94.5 85.9 85.1 143.5 101.0 106.5 76.1 203.1 111.0 131.1 146.8 233.7 275.7 100.9 297.1 261.1 254.3 253.2 157.6 299.3 143.9 242.7 297.7 205.1 213.3 152.2 176.7 322.2 180.8 156.1 163.9 247.2 153.0 252.5 181.3 188.6 225.0 176.1 264.3 233.1 175.4 235.8 160.3 197.8 232.6 299.8 141.5 127.2 127.3 87.5 314.1 279.0 146.0 131.9 183.7 227.5 94.3 109.9 126.2 167.9 376.9 242.9 143.7 149.6 127.4 171.8 197.3 114.1 355.9 219.5 223.0 270.2 255.3 209.6 254.8 102.8 239.1 235.5 284.5 195.9 268.2 180.0 169.0 169.8 210.0 221.2 151.7 127.0 155.9 351.3 164.8 275.9 256.1 244.5 309.0 60.0 67.6 67.0 62.8 61.1 64.1 67.0 65.1 66.9 65.6 68.5 76.1 88.7 64.1 50.0 23.5 73.1 53.2 84.4 214.2 50.1 33.6 111.9 123.6 41.6 118.7 131.4 104.8 33.3 233.8 97.5 218.9 66.5 213.4 475.6 89.5 93.5 68.2 36.5 57.2 16.7 258.4 321.8 94.3 71.9 118.8 44.3 76.5 82.1 233.5 217.9 37.0 16.8 158.6 122.1 104.3 73.2 464.0 82.6 99.9 62.2 15.9 126.1 97.0 114.4 19.1 25.8 256.4 195.4 76.0 145.1 142.5 238.7 119.6 136.3 62.6 111.7 60.9 141.6 291.4 145.2 103.4 67.1 467.9 74.3 159.0 162.0 141.0 RFC2 "A1, RFC40" ENSG00000049541 "Replication factor C subunit 2" P35250 7 74231499-74254458 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029493 Approved Supported "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus" "HPA029493: AB_10603991" "unprognostic (1.25e-1)" "prognostic favorable (9.91e-4)" "unprognostic (1.44e-1)" "unprognostic (7.66e-3)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (2.08e-2)" "unprognostic (5.74e-2)" "unprognostic (2.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.09e-7)" "unprognostic (2.22e-1)" "unprognostic (6.65e-2)" "unprognostic (3.61e-2)" "unprognostic (2.59e-1)" 12.2 9.5 10.6 13.4 10.9 27.4 15.5 11.4 11.5 12.6 11.1 13.4 9.0 9.6 8.4 18.6 10.1 8.6 10.1 10.5 10.9 14.7 21.2 11.3 23.5 11.7 11.3 11.3 13.3 11.8 7.9 18.4 11.4 11.5 15.0 8.8 12.2 7.6 18.8 20.3 11.2 12.6 11.5 14.2 13.6 10.0 10.7 20.2 9.2 12.2 30.8 11.5 12.6 11.8 74.3 55.6 65.2 64.6 13.1 15.2 29.4 42.5 46.7 85.2 101.4 62.6 67.3 69.2 11.5 30.7 78.7 49.7 53.3 69.2 87.5 49.6 91.5 42.9 76.4 46.7 10.1 64.6 25.3 15.4 15.9 79.8 55.0 18.5 46.0 63.9 89.4 41.9 66.4 87.2 65.1 124.7 74.1 116.3 47.4 95.0 72.0 85.8 45.7 58.1 52.4 65.5 50.7 94.8 34.7 79.2 68.7 58.0 17.4 83.4 54.9 64.6 96.3 25.1 35.1 120.6 42.4 98.4 89.3 33.4 36.7 27.3 18.0 42.3 18.1 31.6 15.5 16.5 31.9 36.8 19.5 14.3 46.4 42.9 40.1 17.1 23.9 29.1 10.6 10.9 11.4 11.5 10.5 10.9 11.7 11.3 11.4 11.5 10.7 11.8 15.4 12.8 11.1 2.6 19.0 23.8 24.3 24.3 19.9 13.2 12.6 17.4 6.1 5.7 16.5 5.5 2.1 68.6 17.5 12.4 5.9 21.0 2.8 8.1 13.3 13.5 4.8 38.3 3.0 19.0 65.0 17.4 10.7 11.5 23.4 25.1 13.6 14.0 37.7 3.3 2.6 13.1 20.3 14.4 28.2 2.5 8.7 18.2 21.4 1.9 26.3 16.1 23.7 1.5 2.2 13.8 6.9 10.9 17.5 11.0 13.2 13.8 8.8 9.5 6.6 14.6 17.5 33.8 44.6 20.1 17.0 46.1 16.9 12.9 19.1 15.3 RHEB RHEB2 ENSG00000106615 "Ras homolog, mTORC1 binding" Q15382 7 151466012-151520120 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 724.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019436 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "CAB019436: AB_2178777" "unprognostic (2.22e-2)" "unprognostic (2.29e-2)" "unprognostic (2.25e-2)" "unprognostic (9.47e-2)" "unprognostic (2.65e-2)" "unprognostic (3.08e-3)" "prognostic unfavorable (9.08e-5)" "unprognostic (9.37e-2)" "unprognostic (4.76e-3)" "unprognostic (9.76e-3)" "unprognostic (1.85e-3)" "unprognostic (3.67e-2)" "unprognostic (2.36e-3)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.91e-1)" "unprognostic (3.15e-1)" 118.6 136.8 124.2 62.0 127.4 108.1 100.9 124.3 173.8 77.1 108.4 130.2 52.9 116.2 160.1 73.0 90.2 56.3 134.4 136.9 133.0 103.7 98.4 93.1 44.3 124.5 129.1 87.0 86.5 81.6 84.3 104.9 130.2 83.0 60.5 106.8 72.4 97.0 193.5 66.9 62.6 114.5 121.5 63.6 85.2 47.3 130.2 71.8 98.9 160.8 47.6 117.2 76.8 125.3 335.9 100.3 173.3 165.7 211.5 172.3 131.3 241.7 211.1 198.0 240.4 145.0 354.0 86.4 370.3 215.2 517.4 111.6 126.3 116.8 255.5 91.7 96.9 73.7 113.2 109.5 329.6 137.7 115.2 132.7 183.1 158.1 211.1 207.7 155.2 128.6 231.7 387.1 276.5 216.7 196.0 195.7 285.7 241.5 145.0 94.1 152.6 173.9 233.1 118.4 166.3 208.6 245.4 235.0 283.0 167.7 88.0 169.9 171.0 156.1 65.5 271.9 395.5 145.2 212.2 123.8 376.9 252.7 432.0 39.5 34.1 47.0 24.8 30.5 41.0 23.6 34.2 31.5 26.7 23.9 24.5 30.5 33.9 36.5 34.4 47.0 37.3 39.6 124.2 127.4 124.3 173.8 136.9 133.0 124.5 129.1 130.2 121.5 130.2 125.3 230.5 60.9 45.8 72.5 87.3 398.2 611.3 272.9 114.4 72.8 187.7 179.2 102.0 81.5 169.0 108.5 18.8 207.0 111.9 126.2 416.7 211.7 53.4 107.7 102.6 168.8 98.2 122.9 64.7 213.3 384.1 179.0 40.8 160.8 106.1 95.0 103.9 137.6 233.9 121.1 49.6 76.3 290.9 111.1 384.6 33.2 112.2 174.5 318.4 29.0 114.3 473.6 65.9 30.2 30.6 271.5 109.2 151.6 119.9 620.3 87.8 296.6 85.0 68.7 124.9 149.4 312.2 355.1 173.4 144.7 405.6 421.1 110.4 86.9 79.7 724.9 RHOT1 "ARHT1, FLJ11040, MIRO-1, MIRO1" ENSG00000126858 "Ras homolog family member T1" Q8IXI2 17 32142454-32253374 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 128.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010687, CAB068223, CAB068224" Supported NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 5: Muller glia cells - Visual perception" "CAB068223: AB_2665691, CAB068224: AB_2665692, HPA010687: AB_1079813" "unprognostic (3.28e-2)" "unprognostic (4.02e-3)" "unprognostic (6.85e-2)" "unprognostic (3.53e-1)" "unprognostic (1.57e-2)" "unprognostic (5.49e-2)" "unprognostic (1.59e-3)" "unprognostic (1.59e-2)" "unprognostic (7.02e-3)" "unprognostic (1.29e-1)" "unprognostic (1.38e-1)" "unprognostic (5.05e-1)" "unprognostic (1.01e-2)" "unprognostic (2.97e-2)" "unprognostic (2.58e-1)" "unprognostic (3.90e-1)" "unprognostic (4.08e-2)" 19.1 26.9 19.9 9.6 20.8 19.7 19.5 20.5 29.4 16.6 12.5 19.8 11.4 16.3 15.0 14.9 14.4 11.4 24.8 22.0 18.5 17.6 16.8 17.3 10.9 18.1 17.5 17.7 15.5 38.1 14.2 18.6 19.8 17.1 11.3 50.9 17.3 19.1 28.4 28.5 12.2 16.0 18.7 12.2 17.3 12.3 19.9 19.4 25.0 34.5 11.2 16.6 15.5 24.8 14.1 26.2 21.9 22.8 25.8 28.9 13.2 22.7 18.2 24.2 26.0 13.8 9.0 18.2 22.3 18.7 26.5 24.9 34.3 13.8 29.1 14.4 25.9 21.4 15.8 21.0 35.4 28.1 15.3 15.3 40.7 20.7 23.8 40.5 21.1 36.7 48.1 14.9 21.5 10.6 52.1 23.0 18.0 16.7 12.6 28.6 32.4 32.2 17.5 8.4 20.0 18.1 22.8 14.1 38.4 26.1 31.9 38.1 16.3 17.0 17.5 19.6 16.2 22.0 22.9 19.9 20.5 26.7 28.9 3.0 5.8 5.4 2.1 4.9 2.3 2.1 2.3 2.1 5.3 4.0 1.8 2.3 3.6 3.4 5.2 1.8 1.3 2.8 19.9 20.8 20.5 29.4 22.0 18.5 18.1 17.5 19.8 18.7 19.9 24.8 16.5 28.9 38.8 88.8 17.8 25.9 13.5 14.4 27.9 61.5 21.4 18.0 38.1 14.3 18.7 16.5 70.9 28.4 14.1 12.3 33.2 17.0 19.6 14.5 15.5 17.9 16.9 31.5 97.3 13.1 20.3 19.3 15.3 13.9 27.3 24.8 18.9 18.3 33.7 57.2 89.9 9.3 22.4 46.4 29.1 20.6 30.1 33.2 16.0 76.8 45.1 128.9 29.9 68.3 65.9 13.5 14.4 24.0 11.6 13.7 22.8 21.3 15.1 58.7 26.3 24.8 21.9 63.0 40.3 24.3 53.0 22.7 18.9 24.5 13.9 11.4 RNF114 "PSORS12, ZNF313" ENSG00000124226 "Ring finger protein 114" Q9Y508 20 49936336-49953885 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Early spermatids: 1500.7;Late spermatids: 923.4;Spermatocytes: 558.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 561.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021184 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane, Cytosol" "HPA021184: AB_1859185" "unprognostic (8.38e-2)" "unprognostic (3.56e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (8.10e-6)" "unprognostic (1.56e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (2.50e-2)" "unprognostic (1.03e-2)" "unprognostic (2.12e-1)" "unprognostic (3.99e-1)" "unprognostic (2.70e-2)" "unprognostic (2.54e-3)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.36e-2)" 32.8 32.0 43.3 29.7 48.2 51.6 31.2 46.6 45.1 37.2 41.0 45.0 42.8 28.7 32.8 30.8 34.7 28.8 37.6 40.4 44.9 48.6 49.0 37.9 39.3 47.3 46.5 39.0 52.2 30.2 28.1 35.1 46.6 33.9 40.0 16.7 41.0 34.1 83.3 24.2 40.8 25.4 47.1 52.4 35.9 166.1 47.2 39.1 37.9 52.8 37.3 28.9 28.7 49.9 83.9 80.5 42.9 43.7 84.3 57.8 118.0 73.0 86.2 153.2 64.4 241.7 67.6 39.9 142.9 40.1 91.6 66.3 62.5 74.7 90.6 73.5 44.3 51.5 50.1 173.2 73.3 95.3 59.5 51.5 68.8 58.4 39.9 52.6 36.8 69.7 98.0 46.7 45.5 281.0 82.6 98.0 42.3 67.4 114.3 85.7 45.5 73.6 83.4 67.9 63.2 45.4 88.8 561.6 118.5 45.4 149.7 86.6 47.8 134.6 62.3 71.6 87.0 93.6 107.1 79.2 76.4 63.2 76.1 112.2 97.8 86.1 48.1 92.5 53.1 63.9 52.6 48.6 75.3 71.2 61.6 50.2 100.5 57.8 112.5 61.9 68.9 92.7 43.3 48.2 46.6 45.1 40.4 44.9 47.3 46.5 46.6 47.1 47.2 49.9 47.1 48.1 53.7 13.4 69.9 107.2 127.8 103.4 63.2 24.4 50.7 55.8 46.1 41.5 101.4 69.9 12.5 91.3 61.0 61.7 72.4 107.5 1500.7 72.2 36.3 55.3 60.4 45.4 22.8 101.1 77.4 61.9 41.3 71.4 45.0 31.9 46.1 63.7 110.6 40.4 24.4 79.5 42.7 76.6 146.5 923.4 70.5 66.0 71.2 27.2 96.3 38.0 56.7 10.6 26.2 92.1 77.9 59.8 81.9 122.5 96.4 120.9 75.8 22.6 39.5 45.5 59.2 558.0 138.4 45.8 87.1 124.8 69.2 46.5 80.4 113.3 RNF181 HSPC238 ENSG00000168894 "Ring finger protein 181" Q9P0P0 2 85595725-85597708 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 851.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046112, HPA062121" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA046112: AB_2679542, HPA062121: AB_2684687" "unprognostic (3.79e-1)" "unprognostic (8.31e-2)" "unprognostic (5.08e-2)" "unprognostic (2.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.67e-2)" "unprognostic (3.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.22e-2)" "unprognostic (5.85e-2)" "unprognostic (1.11e-1)" "unprognostic (4.96e-2)" "prognostic unfavorable (1.06e-6)" "unprognostic (3.24e-1)" "unprognostic (2.04e-1)" "prognostic favorable (4.59e-5)" "unprognostic (1.49e-2)" 110.4 135.0 87.6 60.2 92.4 76.7 109.8 93.3 101.9 105.5 85.7 101.3 75.1 85.2 85.0 118.0 87.4 50.2 141.1 88.9 93.2 174.3 169.5 114.0 69.1 92.8 91.5 90.7 168.5 80.1 61.9 82.9 91.8 111.0 69.0 36.0 110.0 73.0 172.1 102.6 91.4 65.2 93.7 101.2 121.8 107.6 94.5 59.5 93.8 105.1 89.6 107.5 98.7 97.7 125.7 120.4 96.3 103.8 94.3 113.4 152.2 104.7 195.4 207.7 199.7 185.2 132.2 118.8 196.8 150.6 206.2 117.5 83.5 164.8 223.8 133.9 104.0 91.6 58.5 224.7 168.0 104.8 122.1 122.0 208.5 144.5 237.1 166.2 175.4 110.8 109.1 119.7 282.7 193.0 97.8 235.6 68.6 164.9 180.2 105.1 202.5 171.7 200.8 109.3 57.2 74.5 88.4 126.2 171.7 114.8 125.4 136.2 160.1 104.9 77.2 218.4 149.6 170.3 143.5 143.1 166.4 144.9 95.5 213.9 418.5 339.7 176.1 326.0 164.6 251.9 181.4 169.2 321.4 214.8 156.4 153.0 356.6 195.5 254.9 360.4 262.0 439.0 87.6 92.4 93.3 101.9 88.9 93.2 92.8 91.5 91.8 93.7 94.5 97.7 89.3 147.4 104.8 7.8 89.3 116.9 102.5 343.7 75.7 27.1 92.8 95.4 122.8 124.4 200.2 150.8 2.1 237.1 104.2 148.1 416.7 236.5 365.7 70.5 63.6 102.8 70.2 85.2 2.2 290.4 260.2 113.7 55.0 93.2 102.7 59.0 99.6 214.4 263.4 18.5 2.2 138.4 185.1 154.0 182.3 250.6 88.3 147.6 170.7 3.7 188.7 80.4 94.7 2.0 6.9 304.0 201.5 78.2 113.8 123.8 271.9 851.7 141.7 29.1 59.2 66.3 108.8 121.3 33.1 97.9 118.6 221.2 86.7 62.6 102.0 115.6 RNF2 "BAP-1, BAP1, DING, HIPI3, RING1B, RING2" ENSG00000121481 "Ring finger protein 2" Q99496 1 185045526-185102603 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026803 Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 28: Placenta - Pregnancy" "Cluster 5: NTERA-2 - Transcription" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA026803: AB_10602086" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (1.35e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (5.85e-2)" "unprognostic (3.56e-3)" "unprognostic (1.62e-2)" "unprognostic (2.01e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.94e-7)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.89e-3)" "unprognostic (2.52e-1)" 9.5 8.1 5.4 10.2 6.7 13.8 12.5 6.1 7.0 10.3 3.7 9.3 8.4 10.7 8.5 8.4 8.6 9.4 7.4 7.0 7.5 9.6 8.3 8.3 11.5 4.0 4.8 9.3 9.6 8.7 5.6 21.7 4.8 8.5 9.7 11.8 9.6 10.4 8.2 6.4 6.5 10.9 4.5 10.4 9.6 21.9 7.9 12.3 10.8 9.0 12.3 16.5 8.7 5.1 34.0 18.6 62.8 25.4 17.8 30.3 65.3 24.0 28.4 35.5 28.3 29.9 53.3 10.2 29.2 29.0 24.4 11.5 43.7 32.7 41.7 31.1 28.4 54.9 10.2 25.8 27.5 56.1 29.7 29.7 19.6 29.6 36.4 27.9 36.6 34.4 44.7 22.5 25.1 21.2 48.5 17.6 86.3 27.4 11.0 55.1 41.3 9.8 25.7 23.6 18.9 33.4 17.3 9.9 46.7 67.8 19.7 27.5 28.4 25.4 33.6 25.1 29.8 39.0 26.2 36.3 16.1 25.7 28.9 31.0 22.4 27.7 17.1 27.7 24.4 20.1 15.5 15.8 25.7 21.9 15.1 15.6 9.8 24.4 29.9 13.4 17.8 16.3 5.4 6.7 6.1 7.0 7.0 7.5 4.0 4.8 4.8 4.5 7.9 5.1 22.6 3.2 6.4 11.4 23.6 23.2 27.6 10.2 26.7 10.3 18.2 11.8 8.4 7.2 6.6 9.2 4.2 25.4 24.5 11.2 23.5 11.5 6.1 11.2 10.8 20.3 29.5 29.4 23.1 12.6 53.0 17.9 12.8 10.3 12.7 16.9 23.2 8.8 20.1 6.7 20.5 9.2 8.2 21.4 55.2 5.6 9.6 22.0 21.4 20.6 25.4 13.3 10.3 18.6 15.1 11.3 16.9 11.7 15.5 30.2 4.1 16.4 8.8 7.2 0.0 11.7 13.4 35.6 83.1 15.8 20.3 28.5 20.7 15.6 11.3 38.0 RNF25 "AO7, FLJ13906" ENSG00000163481 "Ring finger protein 25" Q96BH1 2 218663892-218672002 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036420, HPA036421" Uncertain Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Nucleoplasm, Actin filaments" "HPA036420: AB_2675114, HPA036421: AB_10669604" "unprognostic (3.22e-2)" "unprognostic (7.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (3.46e-1)" "unprognostic (2.04e-3)" "unprognostic (8.82e-2)" "unprognostic (1.26e-3)" "unprognostic (2.50e-1)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.69e-2)" 10.9 11.4 18.5 8.9 18.6 7.3 10.9 18.3 21.0 12.2 17.1 12.0 6.2 12.7 15.8 11.7 12.4 10.8 13.9 18.6 19.7 10.4 11.1 10.4 14.5 18.4 18.4 14.5 11.5 15.1 11.4 11.4 19.0 11.8 8.2 7.0 11.0 13.9 15.0 14.5 7.9 13.6 18.5 10.3 9.4 14.3 19.2 15.1 14.1 17.1 11.9 14.0 9.7 19.0 18.8 20.4 22.1 24.6 27.6 17.5 20.4 27.3 43.5 58.0 53.6 32.4 13.2 11.6 17.6 42.3 35.2 19.5 22.1 33.9 31.0 16.4 27.3 22.7 21.3 34.6 33.6 19.3 20.6 33.9 30.9 55.5 44.7 21.4 31.0 40.9 27.4 24.3 41.1 45.3 20.6 20.4 32.9 16.2 23.4 23.2 15.5 15.9 36.3 21.8 19.5 23.8 18.1 17.2 28.4 21.9 20.6 25.6 26.6 40.2 20.5 19.2 31.1 23.7 13.7 23.5 33.4 19.1 25.7 58.6 21.5 32.6 26.0 21.3 24.8 25.7 25.7 27.2 17.1 30.4 29.0 23.2 17.1 30.5 25.2 15.0 25.9 24.8 18.5 18.6 18.3 21.0 18.6 19.7 18.4 18.4 19.0 18.5 19.2 19.0 4.2 0.0 0.5 5.2 7.8 6.2 4.8 16.3 6.8 7.7 3.4 3.7 4.0 10.0 8.9 1.8 8.4 12.3 4.5 7.4 15.6 12.3 16.8 6.3 8.1 7.6 1.2 2.1 6.2 12.9 9.7 7.5 9.7 4.8 7.0 5.9 8.9 7.1 13.2 5.0 5.8 5.5 8.2 5.0 4.0 5.3 7.2 5.5 8.8 2.8 8.9 7.9 9.2 3.5 4.9 12.7 9.6 12.8 8.5 3.8 7.2 14.8 8.2 5.0 26.3 5.6 9.2 19.3 12.8 5.9 6.8 10.0 8.0 8.5 6.1 3.6 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 98.5 123.0 122.2 43.1 124.5 61.7 94.6 126.7 159.0 73.5 115.9 117.1 43.5 65.5 31.5 94.2 65.6 19.3 114.6 121.2 119.7 123.1 158.5 80.4 48.0 126.5 124.2 68.9 109.6 47.1 66.5 30.2 123.7 108.1 19.2 23.9 94.4 42.8 104.7 80.0 78.3 19.7 124.8 100.5 101.5 65.8 128.4 40.5 96.7 45.4 34.6 99.9 73.7 123.9 94.8 117.6 54.5 80.4 60.7 39.7 110.8 102.0 87.3 92.5 74.0 131.1 62.1 118.9 107.4 64.5 74.8 73.8 87.8 111.3 32.2 163.8 261.5 110.0 105.5 118.0 88.2 166.8 142.3 60.1 83.1 80.3 96.8 49.4 64.9 87.6 128.0 83.8 61.0 108.0 80.6 164.1 95.1 210.9 209.5 127.3 70.0 182.0 99.7 95.8 121.2 66.9 85.8 137.3 203.1 33.6 98.8 134.8 74.0 77.5 168.8 85.7 141.7 140.3 145.4 188.4 103.3 116.8 183.1 126.8 147.4 187.3 133.0 141.6 123.5 159.7 135.1 140.6 122.4 173.9 129.9 132.8 168.7 128.9 119.4 193.1 165.1 138.3 122.2 124.5 126.7 159.0 121.2 119.7 126.5 124.2 123.7 124.8 128.4 123.9 113.6 44.8 51.4 13.1 109.5 137.1 94.3 124.3 84.2 98.0 178.6 205.7 73.8 105.8 83.0 97.5 52.1 152.9 114.7 205.5 217.2 174.9 23.6 68.6 69.8 121.0 142.6 83.5 8.7 192.2 231.9 92.0 76.0 81.6 69.8 62.0 116.0 184.8 204.3 35.3 10.9 207.5 130.2 116.4 233.3 40.3 137.0 110.8 108.5 8.4 147.8 139.1 162.7 5.5 18.7 233.5 202.2 126.0 193.3 206.8 274.9 362.2 54.0 103.7 78.9 74.4 100.9 61.6 138.0 87.6 147.9 131.6 115.2 103.1 165.9 132.4 RRBP1 "ES/130, hES" ENSG00000125844 "Ribosome binding protein 1" Q9P2E9 20 17613678-17682295 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 497.7" "Cell type enhanced" "Detected in all" "Distal enterocytes: 588.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 37.8;plasmacytoid DC: 44.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009026, HPA011924" Enhanced Enhanced "Endoplasmic reticulum" NA NA 320000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 25: Pancreas - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" "HPA009026: AB_1079852, HPA011924: AB_1856476" "unprognostic (1.56e-3)" "unprognostic (2.26e-3)" "unprognostic (8.46e-2)" "prognostic favorable (1.41e-4)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (6.63e-2)" "unprognostic (9.21e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.38e-4)" 64.2 72.3 27.0 62.8 41.9 28.1 54.6 41.1 32.2 69.1 52.3 98.3 76.1 59.5 55.0 67.8 45.1 71.5 59.1 27.5 35.3 77.4 219.0 80.2 28.2 49.3 42.2 48.3 497.7 72.4 63.4 107.9 45.5 66.5 65.9 17.7 228.2 63.4 21.9 43.6 82.7 46.0 37.7 57.7 123.1 48.4 40.9 14.4 130.4 14.7 27.0 57.6 55.2 49.2 173.5 121.0 35.7 80.4 160.3 172.2 186.2 264.3 221.3 110.0 148.2 271.2 159.3 66.5 87.3 252.2 113.4 170.4 38.7 215.4 89.1 30.9 29.7 76.2 34.9 283.6 229.4 29.0 93.0 228.9 63.8 178.7 104.3 161.7 109.7 23.4 32.6 62.9 167.6 78.8 11.4 65.5 41.6 383.3 115.8 20.1 94.2 231.3 93.0 58.4 18.2 13.7 151.1 353.2 108.4 75.0 62.0 43.5 198.7 232.7 85.9 122.1 88.5 114.6 93.6 21.6 88.1 30.7 121.1 11.7 8.4 37.8 4.3 5.5 3.2 1.0 1.4 2.6 4.6 1.4 1.4 1.6 7.8 10.7 8.4 44.4 1.5 3.1 27.0 41.9 41.1 32.2 27.5 35.3 49.3 42.2 45.5 37.7 40.9 49.2 146.8 96.1 197.1 15.0 72.5 59.1 92.3 90.3 55.2 21.9 127.0 76.3 46.4 144.4 158.2 95.6 31.3 262.0 180.6 588.9 45.0 199.7 47.2 117.5 228.4 155.8 97.0 31.6 3.0 414.6 235.8 219.7 294.6 322.8 118.9 78.1 118.9 279.9 117.4 25.2 4.9 507.9 50.8 62.0 85.7 44.3 127.1 91.6 71.2 17.8 75.1 144.3 79.3 23.1 27.6 357.7 452.3 83.1 570.6 145.6 221.6 57.2 121.8 35.5 32.9 165.1 169.8 77.5 139.9 73.2 55.8 532.9 56.9 114.6 329.3 218.5 RSRP1 "C1orf63, DJ465N24.2.1" ENSG00000117616 "Arginine and serine rich protein 1" Q9BUV0 1 25242249-25338213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058992, HPA067651" Uncertain Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA058992: AB_2683873, HPA067651: AB_2685879" "unprognostic (1.03e-1)" "unprognostic (4.52e-2)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (3.65e-2)" "unprognostic (3.81e-2)" "unprognostic (5.77e-3)" "unprognostic (3.67e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.02e-2)" "unprognostic (7.51e-3)" "unprognostic (1.73e-3)" "unprognostic (4.84e-2)" "unprognostic (1.87e-1)" "unprognostic (7.87e-2)" "prognostic favorable (2.91e-5)" 31.1 31.2 19.6 3.5 27.1 12.8 18.6 25.7 29.4 54.5 25.8 34.0 4.7 29.6 4.4 39.3 38.9 16.3 42.9 20.7 18.1 53.5 35.1 42.4 5.8 37.3 23.6 47.8 19.6 0.9 59.9 8.8 26.0 56.3 2.0 8.5 39.1 18.2 18.8 22.4 26.0 2.1 22.9 37.6 27.2 24.4 25.0 24.4 41.3 21.2 11.4 33.4 52.7 34.8 7.7 16.8 2.2 2.4 18.3 2.7 6.6 7.1 1.3 8.2 9.2 13.7 8.5 6.1 23.0 1.0 3.0 11.4 14.7 1.3 2.8 14.4 8.9 21.0 20.5 17.9 3.9 9.7 11.3 1.8 8.9 3.8 0.0 3.2 4.8 6.3 17.7 49.9 2.3 7.6 2.2 18.5 9.1 17.1 9.7 9.2 6.9 9.1 6.1 0.3 8.9 1.9 4.7 4.7 5.1 1.4 3.9 10.6 10.7 5.7 5.6 5.0 4.1 29.1 24.0 6.3 4.3 24.1 4.5 149.6 57.0 87.4 25.5 38.0 26.7 24.8 26.8 21.6 60.4 23.5 25.3 17.3 130.4 36.6 54.5 37.9 37.6 30.9 19.6 27.1 25.7 29.4 20.7 18.1 37.3 23.6 26.0 22.9 25.0 34.8 351.6 60.9 77.0 121.1 332.7 0.0 229.7 0.0 338.6 86.9 200.1 217.0 47.7 45.8 37.8 93.8 141.8 80.3 456.5 385.9 21.5 43.0 29.8 115.2 142.0 150.0 130.6 140.9 172.6 21.1 82.8 169.0 183.0 146.4 217.1 140.1 71.4 19.6 61.9 84.1 125.4 200.1 0.0 72.2 0.0 16.5 140.1 197.5 0.0 140.5 160.6 69.3 200.8 93.0 278.8 43.6 340.3 90.3 248.4 130.3 397.9 15.2 59.0 138.8 124.9 214.1 141.8 107.6 102.8 283.0 0.0 121.2 346.7 123.8 159.6 196.8 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.0;kidney: 36.4;liver: 36.5" "Cell type enhanced" "Detected in some" "Astrocytes: 15.3;Cone photoreceptor cells: 25.0;Endometrial stromal cells: 17.5;Glandular and luminal cells: 14.3;Hepatocytes: 30.1;Microglial cells: 26.2;Oligodendrocytes: 47.6;Proximal tubular cells: 20.3" "Cancer enhanced" "Detected in many" "glioma: 19.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 29.5;BJ hTERT+: 25.3;NTERA-2: 48.0;RPTEC TERT1: 40.4;U-87 MG: 46.2" "Region enhanced" "Detected in all" "olfactory bulb: 52.6" "Low region specificity" "Detected in all" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 21: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: AB_2680902, HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favorable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favorable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.3 0.0 18.0 0.6 29.2 0.1 0.3 29.7 21.3 19.6 2.1 2.6 1.0 17.4 0.0 0.3 11.0 0.4 0.8 17.9 21.7 36.4 36.5 0.0 0.0 41.0 32.2 4.5 1.0 6.5 6.5 3.9 36.6 0.8 2.6 4.6 0.2 1.6 0.0 0.2 1.3 8.4 31.1 0.0 2.5 1.7 26.6 0.1 23.7 0.2 0.0 2.8 7.2 40.2 0.0 1.7 29.5 0.2 0.8 0.6 0.0 10.0 25.3 0.6 1.4 0.0 0.0 0.0 11.2 14.1 8.8 0.0 18.6 0.0 0.9 0.0 11.3 0.0 0.0 18.5 0.7 0.0 8.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 48.0 0.0 0.0 3.8 1.9 0.0 40.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 46.2 0.0 10.0 0.2 0.6 0.5 0.1 0.4 0.1 0.2 0.2 0.1 0.4 0.2 0.1 0.1 0.3 0.0 0.3 0.4 0.2 0.3 18.0 29.2 29.7 21.3 17.9 21.7 41.0 32.2 36.6 31.1 26.6 40.2 0.0 0.0 0.0 15.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 1.4 10.0 0.0 9.2 25.0 0.0 0.0 0.0 11.7 0.5 0.7 8.9 17.5 0.9 0.0 2.7 0.2 0.0 0.0 1.6 0.0 14.3 0.0 0.0 0.7 30.1 0.1 0.0 8.2 0.0 0.0 1.0 0.3 0.1 0.0 0.4 0.0 26.2 0.0 0.5 0.0 5.0 47.6 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 1.0 0.0 0.0 0.5 0.2 2.3 0.0 0.1 0.0 0.3 0.6 0.0 0.1 SAP18 "2HOR0202, MGC27131, SAP18p" ENSG00000150459 "Sin3A associated protein 18" O00422 13 21140514-21149084 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011352, CAB012273" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" Cytosol "CAB012273: , HPA011352: AB_1856563" "unprognostic (5.08e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-3)" "unprognostic (2.84e-1)" "unprognostic (5.21e-2)" "unprognostic (3.02e-1)" "unprognostic (3.18e-1)" "unprognostic (8.15e-2)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (4.14e-2)" "unprognostic (2.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.70e-2)" "unprognostic (3.70e-3)" "unprognostic (2.78e-2)" 125.7 164.3 140.9 122.9 152.2 242.3 121.6 149.6 198.9 120.4 137.8 141.8 137.4 123.8 97.5 159.2 112.9 82.4 195.8 147.4 160.7 190.4 171.1 106.5 118.0 154.7 153.8 109.5 134.6 114.2 129.6 111.7 157.7 109.7 58.5 89.5 126.3 73.0 297.9 119.5 127.5 51.7 164.1 107.6 119.5 194.3 155.7 115.5 110.7 156.3 64.8 131.7 118.5 170.7 182.1 99.3 159.5 173.1 169.0 140.5 246.9 227.1 167.2 205.5 151.3 181.1 342.4 187.3 272.0 189.1 223.4 186.5 198.1 142.4 231.5 288.0 100.4 267.6 121.2 305.9 191.8 367.1 207.5 143.0 159.7 157.5 187.1 158.4 157.3 223.1 128.8 103.6 188.2 231.0 417.0 599.0 200.7 501.5 109.7 261.1 251.4 187.1 295.7 160.7 185.0 161.1 145.7 213.8 296.5 176.5 206.8 528.0 192.6 126.0 141.9 230.1 268.9 159.6 243.6 536.7 122.5 214.9 236.4 433.0 431.5 540.0 344.1 485.0 349.3 493.7 418.2 410.9 427.8 443.6 405.9 402.9 430.5 395.3 547.4 568.8 517.5 909.3 140.9 152.2 149.6 198.9 147.4 160.7 154.7 153.8 157.7 164.1 155.7 170.7 638.0 134.6 143.5 15.0 291.7 458.6 336.3 640.9 310.7 101.5 298.9 594.9 592.9 194.5 383.8 233.6 41.7 566.2 397.4 353.6 759.2 396.5 1259.5 334.1 231.1 273.1 234.5 214.4 20.8 365.6 528.0 374.0 170.2 256.2 258.6 176.6 180.2 242.0 396.0 119.5 23.4 364.5 468.0 189.5 440.9 206.0 342.3 260.4 407.4 17.8 385.0 370.8 233.8 19.6 26.2 401.9 417.6 303.6 182.3 325.9 475.0 1100.6 446.8 132.3 203.8 362.5 438.3 547.7 319.9 271.7 422.2 908.3 338.8 254.2 344.7 419.9 SARNP "CIP29, Hcc-1, THO1" ENSG00000205323 "SAP domain containing ribonucleoprotein" P82979 12 55752463-55817724 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030902, HPA030903" Supported Supported "Nuclear speckles" NA NA 150000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nuclear speckles" "HPA030902: AB_10669872, HPA030903: AB_10964180" "unprognostic (1.83e-2)" "unprognostic (1.58e-2)" "unprognostic (2.22e-1)" "unprognostic (2.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.10e-1)" "unprognostic (2.36e-4)" "unprognostic (2.02e-2)" "unprognostic (4.29e-3)" "unprognostic (1.21e-2)" "unprognostic (5.03e-2)" "unprognostic (6.48e-2)" "unprognostic (2.31e-6)" "unprognostic (8.50e-2)" "unprognostic (1.31e-1)" "unprognostic (5.29e-3)" "unprognostic (1.19e-1)" 48.0 59.1 52.9 45.8 53.7 88.8 58.0 56.4 88.2 52.6 55.0 53.7 31.1 48.2 57.2 61.9 42.3 34.8 81.5 53.4 60.8 62.5 49.4 46.4 67.2 54.8 56.8 48.5 31.6 45.7 43.7 55.1 55.3 48.0 53.6 31.6 39.4 47.7 98.9 43.3 38.5 53.4 53.5 47.9 44.1 55.4 55.8 83.0 41.6 84.0 84.5 59.8 48.3 56.2 118.8 106.6 251.5 107.9 114.9 162.9 119.7 160.5 126.2 196.7 163.6 151.4 129.1 191.3 108.7 131.8 77.2 66.5 223.7 158.2 209.8 151.2 140.5 192.5 181.6 132.9 166.9 162.0 142.4 121.1 115.7 129.0 99.7 206.0 210.4 169.1 141.3 137.9 198.0 100.5 204.1 257.8 221.4 107.0 97.8 186.5 131.6 159.3 265.9 133.0 108.2 87.8 138.1 88.1 144.8 143.3 134.1 216.3 146.1 79.0 79.3 101.3 128.3 87.0 122.8 258.5 94.9 163.8 101.9 246.1 137.9 218.7 110.5 156.2 101.1 125.3 115.8 119.0 153.7 114.0 91.7 103.0 107.2 134.2 138.8 146.8 170.6 153.9 52.9 53.7 56.4 88.2 53.4 60.8 54.8 56.8 55.3 53.5 55.8 56.2 14.7 32.1 35.6 27.7 26.6 25.2 24.5 24.0 46.1 11.2 12.9 9.9 0.2 10.0 41.0 22.0 16.7 16.1 17.9 11.8 25.4 28.8 16.3 9.1 8.8 16.5 14.9 34.1 32.8 29.8 19.8 30.5 33.6 11.4 27.8 8.9 8.9 7.4 14.6 8.4 33.8 13.3 24.4 19.2 36.3 35.9 18.0 25.1 21.4 27.2 32.4 10.6 16.5 37.7 46.6 32.1 13.1 17.3 37.0 14.8 14.8 19.1 45.2 10.0 6.6 12.6 23.3 36.4 32.8 50.9 26.6 16.8 29.9 12.2 11.5 20.4 SCAMP2 ENSG00000140497 "Secretory carrier membrane protein 2" O15127 15 74843730-74873365 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014699, HPA019194" Approved Supported "Golgi apparatus,Vesicles" NA NA 71000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "HPA014699: AB_1856605, HPA019194: AB_1856604" "unprognostic (1.74e-1)" "unprognostic (1.27e-2)" "unprognostic (2.05e-1)" "unprognostic (5.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.53e-2)" "unprognostic (7.23e-2)" "unprognostic (9.73e-3)" "unprognostic (7.26e-2)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.40e-1)" "unprognostic (1.79e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-2)" 43.1 46.7 27.8 40.3 32.8 51.5 40.7 31.9 31.2 40.5 38.8 76.0 75.7 36.9 36.9 103.4 47.4 35.4 32.4 26.1 29.8 44.9 42.0 49.6 47.9 40.7 30.9 26.5 54.5 85.6 29.4 48.9 36.7 35.5 72.7 4.7 92.7 32.4 34.2 68.3 80.1 33.6 33.6 66.8 64.9 36.2 33.3 33.0 38.3 18.9 53.4 38.1 49.4 35.4 44.7 57.3 24.2 37.6 72.0 37.2 72.0 45.0 56.6 46.9 50.1 83.0 102.6 36.5 57.8 68.1 67.7 157.8 72.3 55.9 19.4 145.8 71.1 92.8 31.2 57.6 54.3 48.0 170.9 48.0 97.6 44.4 32.0 37.0 46.0 42.0 31.3 67.5 33.3 68.1 24.6 55.3 24.1 111.0 36.6 42.6 22.3 126.4 54.0 63.1 24.9 25.0 36.7 64.3 42.4 35.4 88.5 76.3 43.4 40.2 23.9 43.8 53.0 46.1 73.2 37.6 37.8 112.2 30.2 118.3 111.3 90.0 94.1 106.9 76.1 80.8 85.3 95.9 81.8 70.9 69.4 75.8 74.4 83.8 119.3 128.7 105.3 120.8 27.8 32.8 31.9 31.2 26.1 29.8 40.7 30.9 36.7 33.6 33.3 35.4 36.0 73.7 31.7 17.9 49.5 17.5 41.7 40.5 19.4 6.8 28.0 24.8 14.4 24.3 53.1 40.5 2.1 156.9 63.4 116.8 15.6 67.4 132.3 30.8 22.0 36.2 37.3 29.0 7.7 92.8 61.9 37.2 54.0 40.6 79.2 31.3 26.4 27.7 164.7 6.7 6.1 77.5 42.7 78.3 44.5 56.2 32.0 77.0 32.0 21.5 56.9 41.4 63.8 12.1 17.9 96.1 75.5 23.0 73.1 54.0 105.7 48.1 52.6 8.4 26.3 25.6 35.8 47.1 35.3 39.6 22.3 136.4 55.1 40.0 64.2 58.5 SCAND1 "RAZ1, SDP1" ENSG00000171222 "SCAN domain containing 1" P57086 20 35953617-35959472 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 241.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071335 Approved "Nuclear speckles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear speckles" "HPA071335: " "unprognostic (3.88e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (1.28e-3)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-1)" "unprognostic (1.21e-2)" "unprognostic (4.09e-3)" "unprognostic (2.67e-2)" "unprognostic (1.56e-2)" "unprognostic (7.15e-3)" "unprognostic (3.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.48e-2)" 67.4 92.4 25.8 20.2 24.5 44.3 66.2 30.2 51.7 54.9 34.4 61.5 35.4 62.4 4.7 63.1 58.1 5.3 72.6 27.5 31.9 96.0 117.9 51.7 13.8 39.8 29.6 61.1 76.8 9.7 69.6 9.5 28.7 83.7 3.9 2.7 61.0 11.1 85.0 69.4 61.8 5.5 26.8 78.5 66.4 56.7 28.2 10.3 65.7 6.3 4.9 55.5 49.5 26.4 57.0 41.6 14.6 30.1 8.0 9.0 102.2 38.1 14.5 16.0 18.3 37.2 41.0 44.2 96.8 5.7 20.4 52.3 3.3 17.3 1.8 15.8 93.3 105.9 23.5 86.2 28.1 33.7 41.8 16.9 14.3 13.0 2.9 8.9 26.3 42.9 47.7 34.4 9.9 58.6 95.5 241.1 52.9 20.3 162.5 70.8 48.6 73.6 16.4 22.7 78.8 114.4 63.7 100.4 89.2 2.0 67.8 62.7 52.2 54.5 49.7 53.3 37.5 99.6 55.0 64.2 63.8 35.7 42.3 401.5 267.5 274.6 149.3 191.8 120.8 172.0 149.7 134.2 208.6 192.2 124.2 120.8 241.8 149.4 196.2 278.5 224.0 213.7 25.8 24.5 30.2 51.7 27.5 31.9 39.8 29.6 28.7 26.8 28.2 26.4 114.4 32.1 61.9 11.1 115.7 60.0 164.0 188.6 96.2 67.6 118.8 112.0 43.1 133.0 126.9 165.5 43.8 158.3 123.3 410.8 311.0 241.4 336.3 159.6 98.0 123.0 281.3 131.1 5.5 337.3 159.7 105.6 159.0 127.2 69.7 122.4 185.6 292.4 205.9 52.2 7.1 269.8 201.4 197.4 91.5 79.8 118.7 134.5 104.9 6.5 202.2 154.6 148.3 7.1 14.3 283.0 418.6 100.1 137.2 162.4 378.8 596.9 149.1 88.0 111.7 83.9 117.4 96.0 38.2 110.3 75.0 163.8 131.0 153.8 200.8 217.3 SDHD "cybS, PGL, PGL1" ENSG00000204370 "Succinate dehydrogenase complex subunit D" O14521 11 112086824-112120016 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Transport, Tricarboxylic acid cycle" "Cancer-related genes, Disease variant, FDA approved drug targets, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 530.2;Proximal tubular cells: 449.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045727 Approved "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" "HPA045727: AB_10963114" "unprognostic (9.13e-2)" "unprognostic (3.51e-2)" "unprognostic (4.47e-3)" "unprognostic (4.21e-2)" "unprognostic (1.93e-1)" "unprognostic (4.98e-2)" "unprognostic (5.69e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-3)" "unprognostic (7.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.99e-10)" "unprognostic (5.14e-2)" "unprognostic (1.58e-2)" "unprognostic (1.56e-2)" "unprognostic (7.51e-2)" 117.5 95.7 60.0 84.5 63.1 72.9 102.6 68.6 76.3 92.5 65.1 185.2 208.1 88.2 96.7 126.7 92.6 85.6 254.7 60.1 65.4 319.9 391.8 79.3 131.7 63.4 62.5 91.6 77.8 152.4 37.0 95.0 63.2 87.9 190.8 37.4 112.6 100.9 354.7 64.3 175.6 98.1 64.7 85.1 101.1 34.1 63.7 102.5 136.8 449.6 124.8 117.9 76.4 68.2 84.0 67.3 58.1 89.4 212.0 170.7 97.3 97.5 147.6 106.8 132.2 244.8 222.1 155.5 288.4 131.0 156.1 203.5 175.4 139.8 129.8 129.9 92.4 142.8 51.9 140.1 165.6 222.4 107.5 189.6 160.2 110.5 189.1 124.6 153.0 109.6 156.0 208.7 135.0 95.2 143.9 215.0 77.4 333.8 211.6 126.2 145.8 294.4 221.6 175.2 83.5 55.8 135.3 194.8 107.0 81.8 198.9 164.2 108.0 103.8 132.3 114.7 95.0 59.1 73.2 270.7 58.8 297.0 100.5 233.7 293.3 208.8 158.4 390.1 173.1 235.2 170.8 168.8 308.7 198.1 204.3 191.8 257.5 207.9 322.9 151.7 189.9 348.9 60.0 63.1 68.6 76.3 60.1 65.4 63.4 62.5 63.2 64.7 63.7 68.2 104.3 80.1 51.1 12.4 78.0 81.6 102.2 262.2 83.6 12.2 61.0 78.4 216.5 120.1 108.1 90.1 8.4 154.3 55.2 203.8 530.2 82.9 9.9 41.6 67.6 76.4 50.4 70.2 9.6 58.9 124.1 104.6 75.4 41.2 65.9 32.3 76.8 169.7 162.9 11.8 11.2 129.1 154.6 97.1 74.4 37.0 104.1 94.2 76.5 9.4 118.6 52.9 75.2 8.0 9.7 54.1 134.2 99.6 80.9 61.6 253.1 449.9 60.5 18.9 92.1 78.3 110.7 70.4 55.8 127.1 74.4 179.0 71.4 86.2 176.0 98.6 SEC23B "CDA-II, CDAII, CDAN2, HEMPAS" ENSG00000101310 "SEC23 homolog B, COPII coat complex component" Q15437 20 18507520-18561415 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008216, HPA069974" Uncertain Supported Vesicles NA Yes 16000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA008216: AB_1079895, HPA069974: AB_2686223" "unprognostic (4.47e-2)" "unprognostic (2.67e-2)" "unprognostic (3.52e-1)" "prognostic favorable (8.25e-4)" "unprognostic (1.24e-1)" "unprognostic (1.33e-1)" "unprognostic (5.44e-3)" "unprognostic (6.01e-2)" "unprognostic (1.39e-1)" "unprognostic (8.75e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-2)" "unprognostic (3.91e-2)" "unprognostic (1.72e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-2)" "unprognostic (8.21e-2)" 19.6 38.3 18.7 32.0 27.1 36.0 37.8 24.7 25.9 36.2 27.4 31.6 23.8 17.2 53.8 28.4 29.5 23.1 8.5 19.5 22.4 37.4 30.6 29.7 30.5 27.2 23.8 16.9 57.1 50.6 32.6 24.2 27.2 34.8 32.7 40.7 70.9 35.9 4.1 18.2 23.3 18.5 24.5 25.5 38.2 34.8 23.2 27.6 59.5 6.2 38.0 30.5 12.6 38.9 85.0 93.9 49.8 48.7 32.3 36.6 116.0 69.8 45.3 80.0 68.7 84.9 73.8 37.5 44.9 50.4 107.0 88.5 88.5 120.7 86.2 47.5 43.1 64.9 35.6 130.6 70.5 90.2 78.7 28.0 71.8 118.0 151.4 47.6 50.6 34.0 74.8 82.4 55.1 90.7 59.8 49.5 48.0 118.9 101.6 62.4 77.7 122.1 83.0 85.6 78.8 58.0 83.6 188.9 80.6 62.6 82.3 94.4 45.3 53.1 29.8 58.4 87.1 104.2 155.9 60.1 45.3 47.8 74.4 147.9 94.1 106.0 57.2 95.6 78.7 67.2 56.8 61.4 107.9 61.2 51.3 54.0 48.0 78.8 94.9 80.7 75.4 103.7 18.7 27.1 24.7 25.9 19.5 22.4 27.2 23.8 27.2 24.5 23.2 38.9 8.5 16.0 43.5 15.3 24.7 11.5 21.0 34.3 10.2 21.0 21.5 15.6 3.0 20.0 42.5 31.3 16.7 34.3 36.0 26.2 58.7 36.1 95.6 25.4 12.4 11.3 19.7 7.4 17.9 33.4 30.0 11.7 25.0 31.3 15.9 13.6 11.0 25.6 42.9 13.5 20.5 34.7 26.4 38.7 21.0 11.3 14.3 30.3 23.2 15.0 33.1 23.9 9.2 23.1 27.0 31.8 24.2 10.5 59.0 30.1 11.8 53.2 45.4 20.4 19.7 12.4 12.2 48.7 22.1 15.8 14.2 65.8 21.0 16.0 21.5 28.3 SELENOT SELT ENSG00000198843 "Selenoprotein T" P62341 3 150602875-150630445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 215.1;Extravillous trophoblasts: 230.6;Hofbauer cells: 238.8;Pancreatic endocrine cells: 206.0;Proximal tubular cells: 176.8;Syncytiotrophoblasts: 489.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039780 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA039780: AB_10805594" "unprognostic (1.13e-1)" "unprognostic (4.03e-2)" "unprognostic (2.78e-1)" "unprognostic (1.92e-1)" "unprognostic (3.31e-1)" "unprognostic (1.34e-2)" "unprognostic (2.65e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-3)" "unprognostic (6.30e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-3)" "unprognostic (4.91e-2)" "unprognostic (4.08e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" 49.2 73.5 44.0 56.4 47.2 100.0 47.8 49.8 58.9 44.0 44.8 49.1 51.2 39.2 62.7 41.0 49.1 38.9 51.9 46.0 52.2 75.4 72.4 51.0 80.5 46.9 46.9 36.0 45.4 84.2 45.6 60.6 49.9 49.5 56.6 69.7 45.5 48.8 44.9 28.3 50.3 54.1 50.5 46.4 45.1 39.7 47.7 58.3 67.2 54.0 73.2 63.4 32.0 53.9 232.1 94.9 57.1 51.8 86.7 84.0 111.3 174.3 127.3 120.7 79.6 145.9 129.1 125.6 192.2 128.7 107.5 76.1 89.6 110.3 177.7 124.8 77.3 130.9 48.4 68.1 94.6 77.1 102.5 74.1 86.5 107.6 92.1 86.7 132.2 58.2 31.0 359.9 173.4 137.6 107.5 46.1 65.4 134.2 99.0 79.0 73.8 215.4 102.6 132.7 64.2 39.8 106.4 64.4 74.8 71.2 133.6 96.2 125.7 65.1 41.1 121.1 172.6 261.3 151.4 176.1 88.8 142.1 56.9 218.1 163.8 142.5 133.7 138.4 148.5 119.6 111.3 125.4 126.5 102.3 87.4 110.1 198.8 106.3 155.7 90.7 132.3 324.7 44.0 47.2 49.8 58.9 46.0 52.2 46.9 46.9 49.9 50.5 47.7 53.9 80.6 60.9 67.9 0.0 53.4 0.0 0.0 0.0 0.0 0.0 97.2 66.5 0.0 0.0 29.1 108.5 0.0 215.1 114.7 0.0 97.8 166.8 0.0 63.9 46.8 35.5 0.0 0.0 0.0 135.0 230.6 30.9 0.0 64.7 45.4 31.5 0.0 0.0 238.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 0.0 0.0 123.5 0.0 0.0 0.0 0.0 206.0 0.0 0.0 21.0 0.0 0.0 176.8 32.8 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 489.3 48.1 63.4 0.0 0.0 SERF2 "4F5REL, FAM2C, H4F5rel, HsT17089" ENSG00000140264 "Small EDRK-rich factor 2" P84101 15 43777087-43804427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056613 Uncertain Nucleoplasm,Nucleoli NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA056613: " "unprognostic (3.29e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.33e-4)" "unprognostic (1.40e-1)" "unprognostic (3.91e-2)" "unprognostic (6.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (2.50e-1)" "unprognostic (3.04e-1)" "unprognostic (1.36e-1)" "unprognostic (3.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.35e-2)" "unprognostic (2.76e-2)" "unprognostic (9.42e-2)" 760.6 1067.4 704.4 446.7 726.4 944.9 619.4 750.2 906.3 650.8 1027.1 728.4 443.4 509.9 776.2 887.9 456.8 469.4 1187.9 698.1 712.2 1002.2 1328.7 700.8 686.4 737.1 725.3 474.3 795.1 490.9 569.3 484.2 734.7 794.5 631.9 72.8 823.7 312.8 636.9 631.1 593.2 507.4 739.4 745.3 784.3 400.2 759.4 450.7 706.6 723.6 628.9 595.0 634.1 758.8 497.5 770.8 573.8 792.9 1963.2 1431.3 438.9 844.8 1042.5 540.4 682.7 991.5 470.0 250.4 694.7 1429.2 698.7 641.1 454.6 623.8 271.1 699.6 526.2 610.9 1074.9 1936.8 934.7 581.8 1235.8 1349.9 810.5 425.8 452.1 836.1 783.5 680.7 630.2 1593.5 1067.4 1441.8 758.6 1337.2 501.5 1849.7 885.1 743.9 382.6 1147.2 1462.5 1695.7 450.6 481.1 458.9 1871.5 463.9 488.4 1574.7 2363.9 682.9 920.0 469.0 1409.4 669.3 593.3 886.2 1837.8 989.2 1032.8 980.4 4033.8 5391.9 5884.9 2716.6 5055.2 2481.3 3853.8 2938.5 2784.5 4649.4 3901.8 2713.3 2731.7 3154.6 2568.8 4495.9 6486.5 3793.5 12856.7 704.4 726.4 750.2 906.3 698.1 712.2 737.1 725.3 734.7 739.4 759.4 758.8 1269.2 506.4 789.0 0.0 1149.8 1151.3 1379.1 3393.0 861.6 53.9 2373.1 2483.2 2229.8 1338.2 2099.5 1736.1 54.2 2660.9 1475.6 2388.2 3897.3 1707.6 576.8 1243.6 1343.1 1283.3 1167.5 1310.8 0.5 2255.2 3410.2 1489.3 1403.7 1261.0 785.9 775.2 1532.4 2884.5 3545.2 47.1 0.5 2862.6 2278.6 2262.1 2298.5 319.2 1225.3 2102.8 1817.8 0.0 2626.4 544.5 1881.6 1.5 0.3 1804.7 2363.9 992.2 1546.7 2188.9 3013.2 5083.6 1950.6 148.4 604.8 680.1 1737.3 750.2 381.1 1725.5 1556.5 3275.8 1216.9 1446.6 2042.5 2819.5 SERINC3 "AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1" ENSG00000132824 "Serine incorporator 3" Q13530 20 44496221-44522085 "Predicted membrane proteins, Transporters" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 558.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048116 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "HPA048116: AB_2680269" "unprognostic (3.16e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (2.60e-1)" "unprognostic (2.74e-1)" "unprognostic (7.34e-2)" "unprognostic (1.85e-3)" "unprognostic (6.26e-2)" "unprognostic (7.41e-2)" "unprognostic (3.11e-1)" "unprognostic (8.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-3)" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (1.27e-1)" "unprognostic (1.64e-2)" 81.6 91.6 50.1 49.3 60.0 48.7 61.8 57.8 80.4 73.3 22.4 56.6 47.2 62.4 48.9 65.2 54.8 68.9 72.8 66.1 60.3 49.2 92.7 67.7 46.4 57.6 56.7 67.6 50.3 107.0 44.6 115.8 61.5 57.7 63.2 47.9 66.3 63.5 81.6 63.9 53.3 70.1 56.8 57.1 54.1 110.2 55.7 60.0 81.5 81.1 50.3 63.3 50.1 67.9 70.3 73.9 34.8 44.1 297.4 211.8 53.7 140.8 243.1 111.5 101.3 167.3 169.2 51.0 187.5 168.8 127.1 123.0 41.9 144.9 117.3 59.5 47.1 59.7 71.9 85.7 161.4 74.2 124.5 152.1 207.4 109.7 163.3 135.3 110.0 81.6 67.5 146.2 117.7 88.2 76.5 58.9 20.5 91.6 110.9 38.1 51.9 78.5 88.7 79.5 43.4 32.9 135.2 129.8 91.8 47.9 93.0 82.6 141.5 262.1 43.3 117.0 99.1 86.2 102.0 38.9 195.3 51.7 83.9 217.1 92.6 119.4 96.5 96.7 98.4 57.6 82.9 94.5 95.4 63.4 84.7 85.0 177.3 111.0 113.5 87.4 104.4 137.7 50.1 60.0 57.8 80.4 66.1 60.3 57.6 56.7 61.5 56.8 55.7 67.9 139.7 73.7 70.7 20.5 52.1 54.8 75.3 96.5 60.3 39.2 55.3 44.4 75.9 78.6 84.7 47.8 35.5 85.8 86.1 84.4 15.6 77.2 239.8 44.5 76.2 115.1 66.4 94.9 58.7 69.9 85.6 97.5 41.3 65.1 102.5 32.9 122.4 105.7 57.7 45.4 52.4 60.4 71.2 93.5 50.0 558.0 105.0 79.7 39.2 34.7 44.2 47.4 37.0 27.6 63.8 100.4 63.8 114.0 76.1 75.3 55.6 24.6 65.4 36.6 98.6 69.5 88.9 210.9 99.3 54.6 84.1 165.4 72.0 85.9 54.7 82.2 SERP1 "FLJ43424, RAMP4" ENSG00000120742 "Stress associated endoplasmic reticulum protein 1" Q9Y6X1 3 150541998-150603228 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 542.5;U-266/70: 735.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA038970: AB_2676296" "unprognostic (8.81e-3)" "unprognostic (2.35e-3)" "unprognostic (1.91e-1)" "unprognostic (7.29e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.57e-2)" "unprognostic (2.35e-3)" "unprognostic (6.16e-2)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (2.55e-2)" "unprognostic (2.75e-2)" "unprognostic (4.75e-2)" "unprognostic (1.78e-1)" 74.6 94.0 52.9 64.4 56.5 86.8 103.9 51.5 67.7 104.3 55.1 78.5 63.4 51.0 158.0 80.6 80.2 48.2 39.0 54.2 56.1 73.9 157.7 82.3 66.1 54.3 51.2 80.7 255.6 57.2 84.6 60.2 53.2 92.4 67.8 26.1 185.5 69.8 16.9 52.8 64.2 45.0 56.1 87.8 114.8 37.5 56.0 66.4 113.3 17.0 74.5 64.6 64.2 58.8 216.1 46.3 68.9 52.5 99.7 116.0 152.9 150.4 98.7 82.2 96.5 121.6 93.7 175.8 274.8 111.7 67.7 102.2 113.6 79.5 108.6 104.7 93.3 187.1 38.4 123.9 193.9 170.8 117.4 69.6 139.4 47.7 236.7 89.2 97.7 118.1 92.7 241.0 70.8 95.3 144.5 143.3 128.1 138.5 115.1 181.2 52.5 542.5 100.4 69.7 116.8 99.3 57.8 128.4 244.5 83.2 112.8 165.0 93.8 38.9 69.6 84.4 117.0 735.1 230.5 236.0 70.9 165.2 36.8 347.2 410.6 375.2 237.4 399.6 304.5 239.7 250.3 238.5 317.6 222.1 244.0 227.3 299.9 188.5 456.8 321.1 268.0 508.0 52.9 56.5 51.5 67.7 54.2 56.1 54.3 51.2 53.2 56.1 56.0 58.8 168.0 67.3 162.7 66.0 468.4 538.0 677.4 277.8 363.7 74.5 500.8 451.2 44.5 158.7 246.5 172.9 58.4 284.6 337.7 351.1 365.9 231.3 361.1 246.5 198.9 189.5 254.0 157.5 51.6 304.3 553.8 213.0 218.2 359.7 219.7 135.4 249.5 480.7 373.5 42.1 48.0 563.2 168.9 662.6 477.8 627.0 219.6 512.6 348.6 25.3 558.1 174.5 279.1 63.3 60.6 349.0 564.2 190.3 923.0 744.8 326.1 293.7 218.5 69.6 111.7 98.1 192.4 208.0 91.3 347.4 592.7 944.7 335.5 94.2 404.3 1101.9 SF3B1 "Hsh155, Prp10, PRPF10, SAP155, SF3b155" ENSG00000115524 "Splicing factor 3b subunit 1" O75533 2 197388515-197435079 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050275 Approved Enhanced "Nuclear speckles" NA NA 94000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" "HPA050275: AB_2681071" "unprognostic (6.86e-2)" "unprognostic (2.78e-1)" "unprognostic (2.14e-1)" "unprognostic (3.51e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-3)" "unprognostic (2.44e-3)" "unprognostic (3.31e-3)" "unprognostic (1.25e-2)" "unprognostic (2.20e-1)" "unprognostic (6.79e-2)" "unprognostic (1.78e-2)" "unprognostic (2.57e-2)" "unprognostic (9.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (3.41e-2)" 183.8 173.9 101.7 132.7 112.4 304.8 180.7 120.5 126.1 222.8 136.8 170.9 110.4 195.8 200.0 136.8 183.8 123.2 135.7 98.2 100.8 135.4 168.5 162.8 203.0 105.7 101.9 226.5 200.7 154.9 147.8 165.3 111.0 163.2 147.3 138.4 180.4 133.2 172.4 156.5 231.6 116.5 107.5 287.8 169.2 91.4 104.9 221.9 167.8 144.8 199.3 154.4 167.1 135.8 134.9 105.4 288.6 155.9 222.8 219.2 237.8 172.6 196.7 163.2 205.9 233.0 147.2 247.5 116.6 193.1 165.8 133.7 273.4 151.2 271.8 196.5 154.8 237.5 257.4 294.3 155.4 270.1 198.6 232.1 163.0 175.9 209.3 278.6 205.9 171.0 210.2 174.0 192.3 134.2 251.1 285.6 231.4 167.5 163.8 234.4 197.9 182.9 245.8 286.4 154.2 186.7 174.7 118.2 139.2 345.1 115.2 242.5 186.8 126.9 109.4 123.3 145.8 168.7 238.8 342.0 123.7 174.8 146.5 49.8 50.4 57.5 54.5 51.7 55.4 46.1 46.2 50.9 60.5 44.1 48.7 49.2 60.8 56.7 52.5 37.5 71.3 56.2 101.7 112.4 120.5 126.1 98.2 100.8 105.7 101.9 111.0 107.5 104.9 135.8 175.6 179.5 222.9 92.4 187.4 119.0 172.0 127.1 125.7 103.4 96.4 83.3 129.2 72.9 194.0 92.0 73.0 116.8 224.1 90.1 56.7 104.8 9.2 123.9 191.0 143.1 110.5 109.0 55.5 94.8 102.3 151.6 132.0 179.0 246.9 171.1 107.1 74.4 100.6 94.2 59.7 108.1 89.5 124.7 144.1 20.6 120.2 166.1 76.5 75.9 163.9 111.1 116.4 87.0 121.1 112.0 68.3 104.6 195.6 103.8 84.2 70.5 221.5 98.5 118.3 159.5 227.9 104.6 100.5 94.3 118.8 142.7 216.2 119.4 91.4 156.1 SF3B6 "CGI-110, Ht006, P14, SAP14a, SF3B14a" ENSG00000115128 "Splicing factor 3b subunit 6" Q9Y3B4 2 24067586-24076373 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034829, HPA034830" Enhanced Supported Nucleoplasm NA NA 11000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "HPA034829: AB_10673104, HPA034830: AB_10669680" "unprognostic (6.37e-2)" "unprognostic (1.38e-1)" "unprognostic (3.59e-1)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (5.35e-3)" "prognostic unfavorable (5.57e-5)" "unprognostic (1.74e-2)" "unprognostic (8.75e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (2.80e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (5.44e-2)" "unprognostic (2.91e-1)" 79.0 86.5 82.4 65.1 84.1 211.2 137.9 86.4 125.3 99.1 82.5 106.2 91.1 84.7 141.9 123.5 89.2 78.2 89.3 82.7 85.7 111.5 132.6 67.3 102.8 85.9 84.2 93.7 63.7 103.0 62.9 88.3 86.3 81.2 108.7 64.4 71.6 84.2 74.7 76.4 84.7 89.0 88.6 65.1 70.4 66.6 82.0 138.6 104.9 106.2 123.3 117.2 85.2 92.4 307.2 152.4 231.6 207.9 182.7 292.8 139.3 233.6 253.8 279.1 284.2 329.9 197.0 236.6 117.3 213.1 265.4 187.7 245.2 293.7 345.5 218.0 263.4 256.6 197.2 299.4 324.4 314.3 151.3 268.5 342.5 281.3 319.3 286.4 288.8 199.4 290.2 181.3 294.2 250.3 234.1 486.1 194.7 362.8 264.0 170.6 327.7 239.1 334.6 189.0 214.4 320.7 123.6 268.3 570.9 195.4 122.7 309.4 173.9 159.6 213.6 157.3 384.4 171.2 239.1 655.3 215.4 515.8 224.5 225.0 118.9 185.7 96.0 133.5 108.1 153.9 122.9 117.8 138.9 114.7 118.0 130.0 173.5 133.7 124.3 129.6 179.6 143.8 82.4 84.1 86.4 125.3 82.7 85.7 85.9 84.2 86.3 88.6 82.0 92.4 207.4 70.5 91.5 11.8 125.1 0.0 280.4 0.0 208.3 50.7 194.3 320.5 120.8 133.0 55.1 138.0 16.7 296.5 149.2 217.1 389.4 206.1 195.9 226.4 208.1 149.0 180.3 164.7 9.2 167.4 413.2 153.0 85.6 210.7 100.1 185.1 142.1 167.1 232.7 18.5 10.2 253.5 0.0 129.3 0.0 49.4 210.3 132.6 0.0 10.3 227.4 175.4 149.3 11.6 19.4 205.4 314.5 180.5 134.0 327.5 381.2 423.1 78.0 68.4 118.3 155.0 158.9 272.4 173.7 257.8 0.0 271.7 126.6 344.4 242.7 438.1 SFT2D1 "C6orf83, MGC19825, pRGR1" ENSG00000198818 "SFT2 domain containing 1" Q8WV19 6 166319728-166342576 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014677 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA014677: AB_2238986" "unprognostic (8.45e-2)" "unprognostic (1.43e-3)" "unprognostic (2.29e-1)" "unprognostic (1.41e-2)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.47e-4)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.68e-1)" "unprognostic (6.53e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (4.20e-2)" "unprognostic (5.05e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.75e-2)" 40.8 43.9 55.0 35.6 61.7 35.8 45.9 62.3 76.2 35.4 54.0 52.1 39.2 26.5 68.2 36.6 33.8 34.4 30.5 54.5 59.0 51.0 24.5 37.0 50.9 64.0 59.0 31.9 51.1 36.1 17.3 48.9 65.3 47.5 50.1 12.9 70.7 28.0 22.2 24.7 39.0 24.8 62.9 41.9 50.7 26.9 57.2 41.7 46.3 27.5 47.9 40.4 29.4 72.4 47.1 39.9 41.9 86.3 76.1 65.9 56.4 70.7 69.6 56.8 85.5 80.2 103.3 43.9 55.7 68.8 90.2 59.7 62.5 67.0 88.3 58.8 88.4 53.0 35.4 133.4 65.9 134.9 106.5 61.1 78.9 65.5 58.3 81.8 31.3 73.1 96.1 46.8 90.3 68.5 42.1 241.5 40.2 154.5 36.2 28.6 45.0 105.4 141.6 46.1 8.0 34.3 45.6 87.8 73.0 48.1 46.4 252.3 28.6 33.4 60.4 87.4 79.7 40.7 32.3 50.6 70.4 84.8 85.5 141.1 90.7 126.3 62.1 98.6 38.7 88.1 47.3 52.3 103.4 72.5 50.3 51.7 166.0 58.9 107.3 204.9 79.4 92.7 55.0 61.7 62.3 76.2 54.5 59.0 64.0 59.0 65.3 62.9 57.2 72.4 45.6 41.7 66.5 25.1 103.4 86.5 127.8 262.4 59.2 10.0 136.0 103.6 25.0 51.5 143.9 108.5 0.0 153.0 154.2 109.3 90.1 154.5 70.3 52.0 49.9 55.8 28.8 63.3 15.6 126.8 259.4 81.5 61.2 73.9 149.0 31.3 65.3 30.6 211.6 15.2 13.6 162.5 168.9 178.5 178.4 25.2 85.1 143.5 99.6 21.5 198.3 31.7 111.2 16.6 71.5 155.4 146.5 47.4 108.5 239.2 115.5 140.4 96.0 9.1 85.5 69.5 64.0 159.0 93.4 72.9 102.9 131.2 74.9 63.2 131.4 194.0 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 302.1;tongue: 218.2" "Cell type enhanced" "Detected in all" "Early spermatids: 173.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoli, Cytosol" Nucleoplasm "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 43.2 44.0 101.6 11.5 137.5 17.4 39.7 141.1 123.0 41.5 79.4 49.2 12.6 37.2 10.4 42.5 37.2 15.0 76.9 100.7 111.2 35.9 51.5 38.2 13.7 151.0 129.6 49.0 33.4 18.2 31.2 10.5 144.7 32.7 10.2 11.9 41.5 14.9 302.1 48.8 32.4 18.3 121.3 40.1 41.4 43.5 127.6 13.1 34.5 218.2 13.0 41.3 37.8 173.5 16.1 9.8 8.4 20.6 46.7 31.8 5.8 11.3 20.2 17.8 22.7 17.1 10.2 5.4 23.7 21.3 13.2 8.3 14.6 25.1 10.9 25.2 15.6 10.1 10.9 10.9 33.0 7.0 22.4 33.5 29.7 14.4 16.9 21.4 31.9 17.7 10.1 42.0 28.2 8.9 15.4 6.2 1.2 27.6 13.6 19.9 22.8 15.3 14.8 14.9 20.7 9.0 12.9 17.8 13.0 7.0 8.0 19.2 28.9 24.0 5.1 37.2 17.0 16.9 8.8 12.6 18.1 19.0 22.0 48.9 54.7 59.8 44.9 69.1 28.5 24.9 21.9 31.0 42.9 28.9 14.3 23.6 42.7 36.5 56.7 44.0 33.1 51.9 101.6 137.5 141.1 123.0 100.7 111.2 151.0 129.6 144.7 121.3 127.6 173.5 39.5 16.0 19.4 26.1 21.0 51.6 30.3 35.1 35.3 29.7 28.8 29.7 42.1 14.3 27.2 12.9 35.5 36.5 90.8 28.4 37.2 29.0 173.0 24.7 15.4 31.1 17.5 27.1 31.2 17.6 15.2 30.3 44.9 26.5 25.4 29.5 28.5 19.7 66.3 30.3 27.2 24.1 97.6 38.3 51.7 74.8 31.1 37.1 46.2 11.2 20.0 22.6 85.5 76.4 110.8 26.5 23.9 41.0 39.7 14.9 54.0 38.8 30.1 28.2 19.7 113.5 27.9 15.3 7.2 30.1 60.1 42.3 45.8 31.3 18.2 21.5 SLC25A11 "OGC, SLC20A4" ENSG00000108528 "Solute carrier family 25 member 11" Q02978 17 4937130-4940053 "Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 233.6;skeletal muscle: 314.5;tongue: 450.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021167 Approved NA NA 25000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "HPA021167: AB_1857021" "unprognostic (8.58e-2)" "unprognostic (4.06e-3)" "unprognostic (9.43e-2)" "unprognostic (2.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (4.86e-1)" "unprognostic (9.48e-2)" "prognostic favorable (6.41e-6)" "unprognostic (2.84e-1)" "prognostic favorable (2.84e-9)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" "unprognostic (1.70e-2)" "unprognostic (1.09e-1)" 35.6 52.5 69.2 33.8 70.7 31.7 32.0 77.7 79.8 35.3 70.8 46.7 47.5 36.7 22.1 50.5 41.6 30.7 233.6 76.8 73.6 66.6 66.7 30.0 40.7 69.2 72.7 30.7 27.9 70.8 36.4 27.6 69.6 34.0 36.1 23.2 41.6 38.4 314.5 48.7 40.2 33.4 70.2 37.5 39.9 10.9 77.0 45.1 38.5 450.4 33.9 38.5 33.3 71.5 51.1 134.6 67.3 66.3 64.7 39.9 47.3 56.2 57.2 96.2 79.3 85.1 24.7 78.3 74.5 55.3 46.8 99.6 88.1 101.5 37.8 99.6 113.8 86.4 70.9 74.5 66.0 37.6 100.7 57.7 65.1 85.4 71.7 46.7 67.8 83.2 38.7 74.1 82.7 91.2 121.6 38.3 35.6 56.1 89.6 108.6 41.4 71.0 74.8 52.6 59.9 62.1 70.9 79.0 65.2 33.6 73.3 58.7 46.0 43.0 28.1 58.8 109.7 39.3 25.4 30.7 84.8 62.6 108.4 126.0 170.3 132.3 98.8 176.8 90.8 87.5 75.1 87.8 160.4 74.3 74.1 81.2 111.8 151.6 165.1 107.0 97.3 186.2 69.2 70.7 77.7 79.8 76.8 73.6 69.2 72.7 69.6 70.2 77.0 71.5 39.7 25.6 23.3 12.7 32.9 38.1 47.1 92.7 25.6 60.3 47.5 51.3 150.6 51.5 40.0 66.2 16.7 132.2 39.0 67.0 185.9 60.7 15.2 30.3 29.7 41.0 27.6 50.3 8.0 53.6 138.7 40.2 30.5 28.2 39.3 45.6 33.5 61.5 109.1 47.1 10.5 51.6 99.7 45.3 44.4 19.6 30.4 56.2 51.6 9.4 106.9 59.2 47.4 9.5 10.4 47.4 58.7 38.4 45.8 43.1 99.9 202.5 26.5 56.0 52.6 43.1 48.4 15.1 31.3 46.9 44.3 102.5 38.4 57.5 88.3 42.1 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856926-48898904 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 148.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 42.2;Hepatocytes: 64.2;Proximal enterocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 96.1;RPMI-8226: 138.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 20.7 29.9 16.3 11.9 18.2 10.7 17.9 18.6 16.4 8.3 15.3 26.5 65.6 10.4 4.6 9.1 12.8 15.7 62.8 15.5 17.9 25.6 148.3 15.6 14.6 17.7 17.4 5.9 30.4 17.3 11.6 7.3 17.8 11.7 23.5 4.5 19.9 9.0 66.5 10.4 52.7 15.1 17.4 20.6 21.0 9.1 17.5 17.3 11.4 61.1 16.1 11.3 8.4 18.4 4.1 12.8 9.7 13.8 30.1 11.8 1.9 22.3 11.8 15.2 15.8 16.3 19.1 19.0 15.6 35.1 18.7 4.1 24.5 9.8 11.6 47.9 11.8 26.4 19.2 20.4 14.0 27.8 48.1 14.9 11.2 20.6 3.8 6.1 20.2 28.1 24.1 96.1 20.2 10.9 30.4 13.7 5.1 22.9 27.6 10.6 5.9 138.4 16.4 10.1 3.9 13.6 20.7 0.2 11.4 13.6 30.5 12.9 16.6 17.2 3.2 25.5 16.4 35.6 27.0 21.8 24.5 19.5 23.3 60.8 101.1 215.2 97.4 79.7 62.2 36.8 53.1 71.2 97.5 33.0 41.2 69.1 48.6 64.6 83.7 120.5 60.7 112.3 16.3 18.2 18.6 16.4 15.5 17.9 17.7 17.4 17.8 17.4 17.5 18.4 7.5 6.4 2.7 13.1 7.0 1.8 2.5 4.6 3.4 1.1 4.0 3.6 42.2 4.3 4.4 0.0 6.2 2.3 13.6 28.4 3.9 3.5 1.3 2.3 4.6 5.5 7.3 16.4 2.2 4.3 2.3 6.1 9.2 2.1 1.3 3.8 7.5 64.2 16.9 0.0 3.8 12.7 2.0 13.4 4.5 1.8 10.5 10.0 1.8 1.0 31.3 2.9 32.0 1.0 6.0 3.7 16.4 12.4 12.6 3.9 51.8 16.7 5.9 1.3 0.0 5.4 5.3 8.3 7.1 4.1 1.3 1.2 14.4 27.7 16.6 2.9 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108531-36129385 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Breast glandular cells: 307.0;Prostatic glandular cells: 197.9" "Group enriched" "Detected in all" 4 "breast cancer: 361.9;prostate cancer: 127.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 35: Glandular cells - Unknown function" Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: AB_2677968" "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 27.3 25.9 23.3 21.6 28.5 11.6 147.2 28.6 26.1 34.5 48.9 13.9 9.6 56.9 56.2 17.0 63.6 24.2 14.0 20.0 28.8 28.2 16.5 18.9 17.3 28.8 33.6 43.1 37.7 86.5 23.9 31.7 30.6 129.0 13.4 50.2 30.9 114.3 12.7 51.3 8.9 30.2 28.6 15.5 16.4 19.3 26.7 18.5 37.3 16.6 28.4 52.6 16.1 34.2 43.7 54.0 127.1 75.1 131.4 96.6 33.0 116.2 137.3 76.5 88.7 30.3 47.5 47.1 57.3 113.1 53.1 104.1 112.4 109.2 115.5 105.4 40.7 20.6 69.5 44.4 83.2 69.8 49.6 88.7 236.1 116.2 100.5 69.9 11.7 38.6 10.7 92.1 108.9 67.0 69.0 15.6 30.6 24.0 30.4 70.6 72.8 61.4 84.4 145.2 132.8 116.8 143.5 41.5 200.6 52.1 56.7 32.4 18.9 184.9 30.5 35.5 59.2 85.9 90.0 35.7 64.0 48.3 99.8 29.2 13.3 31.2 16.3 19.7 19.7 16.7 13.8 14.7 16.4 17.3 12.0 17.7 10.2 18.1 19.4 33.6 17.0 14.2 23.3 28.5 28.6 26.1 20.0 28.8 28.8 33.6 30.6 28.6 26.7 34.2 13.3 38.5 18.7 8.8 22.5 45.9 58.2 79.6 59.2 41.5 307.0 132.2 19.6 10.0 66.4 42.3 33.3 6.6 36.7 4.0 1.9 53.1 21.3 37.1 76.1 12.9 25.6 4.6 13.0 37.8 56.7 45.6 9.2 73.8 23.5 18.9 8.9 11.0 20.4 23.5 23.9 7.4 38.7 20.1 30.0 18.1 37.3 26.0 67.6 1.9 25.7 38.2 10.3 34.2 36.5 39.5 1.9 47.8 24.4 197.9 2.7 13.6 44.3 41.3 39.5 40.4 38.6 43.9 27.8 32.6 74.4 23.8 23.2 23.0 5.7 69.3 SLC4A1AP "HLC3, kanadaptin" ENSG00000163798 "Solute carrier family 4 member 1 adaptor protein" Q9BWU0 2 27663471-27694976 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 143.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036679 Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 21: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Vesicles, Plasma membrane" "HPA036679: AB_2675244" "unprognostic (5.63e-2)" "unprognostic (1.01e-1)" "unprognostic (4.62e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (2.21e-1)" "unprognostic (7.89e-3)" "prognostic unfavorable (3.76e-7)" "unprognostic (1.32e-1)" "unprognostic (7.74e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-1)" "unprognostic (9.66e-2)" "unprognostic (9.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.79e-4)" 13.7 16.6 15.3 16.1 16.2 15.8 14.5 17.9 20.9 11.8 12.7 12.3 12.6 13.4 12.4 15.1 12.7 10.4 20.6 16.4 16.2 16.0 16.2 13.9 17.4 15.7 15.6 15.5 14.4 21.1 12.7 15.7 15.7 12.9 12.9 19.8 12.9 12.0 30.6 16.4 13.3 13.2 13.3 15.0 13.9 33.9 15.6 17.1 15.3 22.1 16.9 12.6 12.0 16.4 44.6 25.4 25.1 23.6 25.3 23.2 36.8 36.1 24.8 37.2 30.3 37.4 31.7 28.0 32.7 29.1 39.2 31.0 40.6 28.0 33.2 39.2 33.2 32.2 26.2 41.5 30.7 46.6 29.5 20.9 34.8 37.1 34.8 31.2 38.4 27.1 47.5 29.7 34.7 27.1 31.5 45.4 25.4 29.3 24.7 25.9 54.9 32.4 38.5 20.4 27.2 26.8 28.1 37.9 36.0 25.2 23.0 30.1 39.3 34.5 31.3 24.2 42.7 48.5 73.8 88.4 37.4 36.8 28.2 104.8 33.4 48.9 31.6 32.6 31.8 26.1 28.6 28.0 25.8 36.7 34.5 29.1 31.9 43.7 37.6 20.8 34.9 28.0 15.3 16.2 17.9 20.9 16.4 16.2 15.7 15.6 15.7 13.3 15.6 16.4 17.1 32.1 28.9 14.7 17.3 11.9 12.3 27.1 14.8 19.9 13.3 11.0 30.1 11.5 29.1 18.4 18.8 24.5 21.0 11.4 5.9 28.4 47.2 22.0 20.3 21.9 16.3 11.8 25.5 36.9 20.3 17.4 13.3 20.4 38.6 18.5 15.4 13.9 24.4 25.2 23.7 11.5 16.2 13.9 8.2 7.9 17.4 18.9 17.8 8.4 31.5 21.6 19.6 12.5 18.2 30.5 9.3 19.2 22.1 8.7 11.5 16.1 24.4 21.1 32.9 23.3 21.7 143.4 82.4 15.7 11.9 24.4 21.8 21.5 10.1 10.8 SMAP1 "FLJ13159, SMAP-1" ENSG00000112305 "Small ArfGAP 1" Q8IYB5 6 70667776-70862011 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 325.7;Late spermatids: 281.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030574 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 34: Spermatids - Unknown function" "Plasma membrane, Cytosol" "Golgi apparatus" "HPA030574: AB_10601589" "unprognostic (1.55e-1)" "unprognostic (2.66e-3)" "unprognostic (1.01e-3)" "unprognostic (2.98e-3)" "unprognostic (7.06e-2)" "unprognostic (2.90e-2)" "unprognostic (1.66e-3)" "unprognostic (3.46e-1)" "unprognostic (6.50e-2)" "unprognostic (3.75e-2)" "unprognostic (7.80e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-1)" "unprognostic (4.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.85e-1)" "unprognostic (1.22e-1)" 17.0 12.8 24.4 16.1 27.8 18.6 13.6 19.5 44.8 15.2 13.3 27.5 26.8 14.1 18.0 28.4 10.2 17.4 23.1 27.6 24.3 14.1 16.6 14.9 15.4 22.7 25.3 11.1 37.2 28.5 8.6 16.1 23.7 17.6 28.3 24.8 18.0 15.2 32.9 20.4 26.7 19.7 20.1 13.7 20.9 30.9 24.4 24.8 21.1 20.1 22.4 18.1 16.1 29.2 60.3 18.6 28.5 35.3 26.0 33.9 46.4 26.6 29.5 21.4 20.9 27.9 17.4 31.4 28.1 32.0 30.5 18.5 27.4 28.1 35.5 36.3 39.4 34.7 16.5 23.6 17.2 25.5 28.0 22.3 31.3 24.2 29.2 39.6 34.2 16.1 33.8 36.9 33.8 35.0 19.2 31.4 21.3 30.9 21.9 36.0 107.9 51.8 38.1 36.0 40.7 28.7 16.9 23.3 17.1 24.2 31.0 37.3 33.6 17.2 29.7 11.4 23.5 34.3 32.9 16.0 13.0 29.4 24.2 35.0 16.4 18.4 18.2 18.3 20.7 14.8 24.3 21.0 14.0 12.7 12.1 15.7 22.6 25.6 20.0 13.7 25.3 23.4 24.4 27.8 19.5 44.8 27.6 24.3 22.7 25.3 23.7 20.1 24.4 29.2 45.0 38.5 39.4 58.1 39.3 66.9 37.7 66.9 33.0 51.8 39.6 47.2 38.8 52.9 46.0 38.6 37.5 26.2 47.6 111.3 54.8 78.9 325.7 26.1 46.8 43.2 41.9 28.8 120.1 151.0 48.8 40.3 64.7 52.1 48.2 42.9 58.5 41.3 56.6 55.5 104.3 82.3 61.1 61.2 59.8 281.1 50.7 53.0 32.0 60.0 64.1 69.7 64.9 115.6 72.7 108.2 99.5 67.0 51.8 76.3 92.6 69.6 21.1 38.6 65.7 36.3 53.3 105.2 84.2 89.3 77.3 31.7 64.9 44.1 75.8 51.6 SMIM12 "C1orf212, FLJ90372" ENSG00000163866 "Small integral membrane protein 12" Q96EX1 1 34712737-34859755 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065331 Approved Approved Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA065331: AB_2685470" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.64e-1)" "unprognostic (2.05e-1)" "unprognostic (5.71e-2)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "prognostic favorable (1.15e-5)" "unprognostic (7.33e-2)" "unprognostic (6.70e-2)" "unprognostic (3.58e-2)" "unprognostic (2.52e-2)" 40.2 56.6 31.7 26.5 32.1 24.8 33.5 29.5 35.3 20.9 29.2 34.0 30.1 26.0 17.7 41.3 23.5 17.3 53.8 31.5 35.7 42.3 87.9 31.6 25.0 32.6 32.7 17.1 26.4 31.8 26.9 24.8 33.1 19.9 28.0 12.8 24.1 20.5 56.2 29.7 30.8 31.5 29.6 31.9 30.4 28.0 31.9 30.3 24.9 51.1 27.3 29.2 25.7 33.3 52.9 39.8 43.3 31.6 55.2 43.3 30.1 55.8 48.1 70.2 60.3 40.0 65.0 55.1 49.2 57.6 55.5 51.7 55.5 74.7 53.5 67.3 41.6 98.1 65.6 49.1 51.3 107.9 55.4 66.2 71.9 76.5 61.3 25.3 72.9 47.0 71.0 72.3 63.0 38.6 52.6 55.4 70.1 40.8 52.7 44.1 42.7 71.7 62.2 54.6 41.5 32.9 52.0 48.1 81.5 53.9 32.8 29.9 69.9 47.8 49.3 74.3 66.7 40.4 60.2 56.9 45.2 63.7 32.1 104.2 76.0 126.4 65.8 82.0 77.9 57.7 60.4 72.0 86.0 59.2 50.1 64.3 50.2 62.6 67.5 62.4 76.2 87.5 31.7 32.1 29.5 35.3 31.5 35.7 32.6 32.7 33.1 29.6 31.9 33.3 51.2 25.6 13.1 4.9 37.0 68.2 26.3 49.8 23.3 14.4 36.4 30.1 33.9 42.9 30.4 22.0 10.4 50.7 38.5 46.7 86.1 78.7 58.3 17.1 19.0 56.2 21.8 53.9 10.4 83.7 60.2 24.9 20.9 20.6 23.5 18.9 48.2 89.3 83.8 20.2 9.5 23.4 46.8 41.7 61.6 32.7 14.9 41.0 39.2 7.5 89.8 24.9 54.6 6.6 7.0 87.5 41.0 23.3 27.5 40.8 62.9 90.6 26.8 17.3 13.1 21.8 52.3 37.6 23.0 41.4 75.6 58.0 40.8 33.7 39.6 41.7 SMIM3 "C5orf62, MSTP150, NID67" ENSG00000256235 "Small integral membrane protein 3" Q9BZL3 5 150778757-150796734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 161.0" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 85.5;Basal squamous epithelial cells: 80.8;granulocytes: 90.0;Macrophages: 79.3;Sertoli cells: 138.1;Smooth muscle cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 409.9;ASC TERT1: 200.1;LHCN-M2: 193.8;U-87 MG: 291.5" "Low region specificity" "Detected in all" HPA075345 Approved Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "HPA075345: AB_2686744" "unprognostic (2.33e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "unprognostic (9.45e-2)" "unprognostic (5.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.47e-1)" "unprognostic (3.90e-1)" "unprognostic (2.05e-2)" "unprognostic (9.71e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.15e-8)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.46e-3)" 161.0 36.2 20.5 25.5 20.3 89.5 71.5 20.9 26.4 21.9 42.1 26.8 13.4 16.2 22.6 16.8 30.2 25.7 36.8 20.5 22.1 34.9 12.2 30.9 11.7 23.3 21.5 25.9 33.7 26.9 15.1 46.0 23.6 27.6 19.1 20.4 14.0 24.1 15.0 12.5 23.0 28.3 20.7 25.2 21.6 4.1 23.5 17.7 21.0 15.5 8.8 29.0 18.7 19.6 13.8 4.5 7.3 60.8 409.9 200.1 15.9 52.3 114.6 19.2 77.2 21.5 35.3 0.0 3.1 55.1 12.7 10.7 12.5 11.8 28.6 0.2 3.8 20.0 2.8 9.9 72.4 19.7 130.0 167.9 23.6 54.2 25.1 122.3 6.4 46.6 5.5 0.4 193.8 10.5 28.5 27.0 3.8 10.7 12.5 15.2 1.2 0.0 20.6 10.2 1.8 4.7 7.8 1.1 16.1 8.1 25.4 120.6 10.1 84.2 15.2 65.9 27.5 0.0 0.4 0.2 291.5 75.0 10.8 68.7 41.0 72.4 20.8 17.2 12.7 1.3 14.5 14.4 19.4 0.2 14.1 12.1 42.7 13.0 16.2 57.3 2.3 38.0 20.5 20.3 20.9 26.4 20.5 22.1 23.3 21.5 23.6 20.7 23.5 19.6 53.7 6.4 8.6 2.6 3.2 0.0 85.5 0.0 80.8 0.8 12.0 16.6 9.9 7.2 2.5 7.3 0.0 8.5 22.8 4.0 13.7 6.4 0.8 1.3 11.1 25.4 4.8 8.4 1.0 31.3 5.0 53.5 2.6 1.1 90.0 1.7 13.2 1.0 45.2 0.0 2.0 36.8 0.0 34.2 0.0 0.6 14.0 79.3 0.0 16.9 30.2 62.1 11.3 5.5 0.1 18.2 1.1 36.9 3.5 15.9 3.9 8.8 0.0 1.9 138.1 72.3 77.2 0.1 0.5 20.1 0.0 8.1 28.8 3.0 7.4 40.1 SMIM7 "C19orf42, MGC2747" ENSG00000214046 "Small integral membrane protein 7" Q9BQ49 19 16630751-16660442 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043127 Uncertain Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "HPA043127: AB_10806378" "unprognostic (6.61e-2)" "unprognostic (1.61e-2)" "unprognostic (1.90e-1)" "unprognostic (3.71e-2)" "unprognostic (2.52e-1)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "unprognostic (1.79e-2)" "unprognostic (6.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.75e-1)" "unprognostic (1.76e-3)" "unprognostic (8.29e-3)" "unprognostic (2.94e-1)" "unprognostic (2.29e-1)" "unprognostic (8.38e-2)" "unprognostic (7.64e-2)" 41.6 39.5 39.6 24.8 41.8 19.9 47.2 41.4 48.5 36.7 39.8 34.1 34.4 32.5 72.9 30.0 36.9 30.5 35.8 37.8 41.3 52.7 66.7 33.5 33.7 42.9 41.1 32.2 47.7 54.1 16.1 34.7 42.2 46.5 42.0 18.6 52.3 39.3 18.7 32.1 25.4 36.4 43.0 26.7 38.2 21.0 41.7 29.3 50.0 21.0 34.0 32.8 17.9 44.2 60.6 52.1 48.7 42.3 74.4 64.4 48.9 50.4 69.4 70.7 68.8 45.2 111.8 44.4 67.7 69.3 50.5 48.0 44.5 69.8 86.7 38.1 34.4 42.4 34.9 48.5 43.3 64.2 46.5 49.3 49.8 51.5 52.9 43.0 68.9 40.3 59.9 53.7 81.6 120.2 42.4 55.1 45.2 121.5 77.4 41.3 32.9 43.4 83.4 66.3 26.0 48.2 37.8 41.0 51.2 26.8 59.9 80.5 41.5 55.4 35.7 130.3 83.2 46.4 72.6 56.0 56.3 75.6 71.2 47.5 73.3 38.3 37.1 65.8 35.3 49.6 38.0 37.0 58.8 44.3 37.0 33.6 31.0 42.8 78.3 79.2 44.9 45.3 39.6 41.8 41.4 48.5 37.8 41.3 42.9 41.1 42.2 43.0 41.7 44.2 63.5 67.3 64.5 29.0 75.5 34.2 62.8 114.3 70.6 70.1 69.0 84.6 38.5 57.2 68.8 57.0 95.9 144.1 68.5 67.6 129.1 85.2 18.4 58.2 60.8 61.5 73.0 54.7 35.3 86.3 105.2 74.9 57.1 51.5 50.1 42.3 66.0 85.7 115.6 63.9 32.1 78.3 77.3 77.2 43.9 21.6 88.9 64.6 48.0 21.5 102.4 101.3 98.9 21.6 44.8 87.6 87.0 83.1 76.5 77.6 85.1 140.0 54.6 121.4 72.3 42.3 64.8 84.0 81.0 74.7 35.8 156.4 54.7 66.7 62.7 57.7 SMUG1 "FDG, HMUDG, UNG3" ENSG00000123415 "Single-strand-selective monofunctional uracil-DNA glycosylase 1" Q53HV7 12 54121277-54189008 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 98.9;Syncytiotrophoblasts: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026804, HPA065892" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA026804: , HPA065892: " "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.58e-2)" "unprognostic (7.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.82e-1)" "unprognostic (6.12e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.67e-3)" "unprognostic (3.35e-1)" "unprognostic (2.41e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.46e-1)" "unprognostic (1.73e-1)" 20.5 29.2 21.9 13.9 22.4 10.7 26.3 20.7 24.2 17.3 22.6 20.8 17.1 17.1 39.9 38.6 24.5 16.9 19.4 22.3 21.1 28.9 49.6 14.7 18.9 23.7 21.4 18.8 30.0 23.9 16.9 19.1 22.1 24.0 18.7 14.3 29.7 18.1 27.4 29.4 21.3 16.3 22.1 21.8 32.2 15.9 22.7 17.8 21.9 21.8 18.6 20.3 20.1 24.8 31.9 57.5 22.2 23.2 40.4 31.3 37.7 24.2 31.4 37.2 33.8 58.0 69.5 19.0 60.4 35.1 34.8 40.3 15.7 63.7 23.5 19.7 33.3 28.6 47.4 42.3 48.2 19.3 34.0 35.7 97.7 43.9 43.2 40.4 30.2 33.3 48.2 40.3 41.4 60.8 24.3 37.2 27.7 54.3 51.7 17.5 22.6 34.3 46.6 46.2 33.1 39.2 27.6 47.3 43.5 44.9 73.7 35.9 14.3 24.7 27.5 22.5 28.1 37.3 32.1 13.1 35.8 15.0 38.4 89.6 46.2 57.1 28.5 39.5 28.4 49.7 27.3 30.7 40.3 36.6 24.6 24.6 45.5 27.1 31.5 45.5 41.0 33.9 21.9 22.4 20.7 24.2 22.3 21.1 23.7 21.4 22.1 22.1 22.7 24.8 6.6 6.4 16.0 2.9 13.3 7.5 14.4 40.2 11.4 10.5 25.5 22.5 17.7 22.8 26.4 25.8 8.4 87.5 8.8 28.4 60.7 37.1 5.2 15.3 8.9 11.0 11.5 7.4 6.8 40.2 98.9 13.6 16.3 11.0 2.5 10.1 18.2 49.4 46.1 6.7 6.1 25.8 32.6 19.2 5.8 11.8 18.6 14.0 5.4 3.7 34.0 16.3 19.6 5.0 8.1 41.4 24.6 17.7 12.6 20.7 58.4 56.6 27.1 11.9 32.9 8.5 13.8 26.2 28.0 20.8 10.4 100.0 9.5 19.4 23.7 19.6 SNAP29 "CEDNIK, SNAP-29" ENSG00000099940 "Synaptosome associated protein 29" O95721 22 20859007-20891214 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" "Ichthyosis, Neuropathy, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 524.1;Late spermatids: 191.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 220.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031823, CAB037092, HPA056492" Supported Supported Nucleoplasm,Cytosol NA NA 110000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol Nucleoplasm "CAB037092: AB_477491, HPA031823: AB_10602407, HPA056492: AB_2683151" "unprognostic (1.76e-1)" "prognostic favorable (6.99e-4)" "unprognostic (3.72e-3)" "unprognostic (3.26e-2)" "unprognostic (7.83e-3)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (2.05e-2)" "unprognostic (1.34e-2)" "unprognostic (2.60e-2)" "unprognostic (3.68e-2)" "unprognostic (6.85e-2)" "unprognostic (1.22e-1)" "unprognostic (2.52e-1)" "unprognostic (1.45e-1)" "unprognostic (4.51e-3)" "unprognostic (6.08e-2)" 18.3 18.0 10.8 17.1 11.5 18.9 15.9 12.8 18.0 15.3 11.7 19.9 17.4 14.5 11.1 23.1 12.8 13.7 18.9 12.0 11.4 16.8 35.8 13.9 17.0 12.6 11.7 13.6 17.3 18.7 11.0 19.1 12.4 13.5 17.8 14.4 15.8 14.1 31.2 19.0 16.6 18.1 11.2 16.8 18.6 56.5 11.0 24.1 12.3 27.4 19.7 15.6 15.7 12.5 48.4 19.4 27.1 22.3 30.0 43.5 35.0 44.8 40.3 49.5 49.5 26.8 16.7 30.1 27.9 42.2 50.0 27.8 35.8 30.4 53.2 43.5 27.3 50.0 20.9 29.2 42.7 44.6 38.8 34.6 42.2 51.9 37.2 34.0 35.1 25.5 220.8 41.5 46.2 33.1 40.7 42.9 8.9 55.9 20.2 38.9 60.6 12.1 29.1 25.5 22.0 26.2 48.0 29.9 51.0 33.3 46.8 35.3 30.7 50.1 45.5 34.6 35.6 42.4 74.0 55.3 37.5 29.8 36.7 49.0 43.7 52.4 21.7 61.5 22.7 23.7 21.2 23.7 38.0 22.6 19.3 19.8 49.0 60.0 77.9 43.6 34.5 34.6 10.8 11.5 12.8 18.0 12.0 11.4 12.6 11.7 12.4 11.2 11.0 12.5 24.4 12.8 29.0 8.8 19.0 16.7 24.5 34.7 17.6 12.4 26.4 22.5 22.5 21.5 22.9 23.9 12.5 80.1 35.9 40.0 43.0 40.3 524.1 26.3 28.2 30.1 22.1 36.4 9.6 50.0 146.0 28.4 26.5 22.3 29.2 25.0 29.6 46.5 74.4 20.2 7.2 27.6 32.6 49.4 23.1 191.7 33.2 46.7 35.6 2.8 51.4 30.6 48.4 10.6 12.1 59.4 21.4 36.5 44.1 26.7 38.8 36.8 37.4 13.2 39.5 21.9 27.9 113.5 81.1 28.2 15.5 98.2 26.5 70.3 25.3 29.7 SNRNP27 "RY1, U4/U6.U5-27K" ENSG00000124380 "Small nuclear ribonucleoprotein U4/U6.U5 subunit 27" Q8WVK2 2 69893956-69905575 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034541 Approved Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA034541: AB_10602408" "unprognostic (2.24e-1)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.61e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-1)" "unprognostic (3.18e-1)" "unprognostic (4.35e-3)" "unprognostic (9.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.26e-1)" "unprognostic (1.86e-1)" 31.0 33.4 25.3 23.9 26.6 43.2 26.1 28.0 40.1 19.9 21.5 18.2 17.4 23.5 24.3 19.8 19.1 21.5 39.5 27.3 27.6 23.5 24.6 19.2 32.8 23.6 26.5 21.7 18.5 32.1 16.3 30.3 25.2 23.7 20.9 25.3 21.8 19.3 62.2 19.5 20.4 24.0 26.0 22.6 18.4 14.2 25.3 31.7 26.9 71.8 27.7 24.8 13.4 30.7 27.9 16.2 52.0 31.4 44.7 49.0 41.7 38.5 45.4 54.2 42.9 34.0 31.3 29.6 30.5 31.5 56.0 15.3 34.9 16.1 67.3 33.3 34.1 34.2 14.4 42.2 40.1 43.6 57.9 36.0 38.6 35.4 30.4 44.4 42.0 41.6 49.0 46.6 72.1 15.6 59.4 73.9 38.1 30.1 16.2 46.0 42.9 31.1 60.0 18.5 53.0 41.9 28.7 30.8 42.7 39.0 28.1 35.4 24.6 37.1 51.3 53.7 58.5 28.5 29.9 45.7 33.2 52.4 71.7 43.2 25.1 38.9 23.6 23.5 25.2 37.9 25.7 23.4 22.2 32.2 27.8 27.7 13.7 32.2 25.2 40.8 30.3 25.1 25.3 26.6 28.0 40.1 27.3 27.6 23.6 26.5 25.2 26.0 25.3 30.7 45.3 54.5 39.3 6.5 57.1 49.1 40.5 47.0 44.9 31.6 53.0 32.4 60.7 47.1 36.1 62.5 14.6 49.2 69.9 40.5 74.3 57.7 37.4 37.0 44.8 42.0 38.9 82.7 14.1 55.1 70.1 50.5 18.8 44.6 60.0 24.5 56.4 78.8 57.4 23.5 11.6 52.7 22.4 57.7 46.6 12.4 51.3 48.5 37.4 8.4 50.6 41.8 68.0 4.0 7.6 70.4 42.8 57.9 60.2 34.3 33.9 63.8 47.2 31.2 39.5 32.4 45.2 76.2 61.7 33.9 46.0 52.5 51.7 20.3 37.5 37.7 SNRNP35 U1SNRNPBP ENSG00000184209 "Small nuclear ribonucleoprotein U11/U12 subunit 35" Q16560 12 123458088-123473154 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059145, HPA067031" Supported Supported Nucleoli NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoli "HPA059145: AB_2683926, HPA067031: AB_2685766" "unprognostic (3.80e-2)" "unprognostic (1.17e-2)" "unprognostic (6.16e-2)" "unprognostic (1.35e-3)" "unprognostic (6.78e-2)" "unprognostic (1.96e-1)" "unprognostic (7.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.75e-1)" "unprognostic (6.24e-2)" "unprognostic (2.56e-3)" "unprognostic (7.24e-2)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (7.10e-2)" "unprognostic (2.30e-2)" "unprognostic (1.31e-3)" 19.0 20.0 33.1 16.0 34.8 17.6 18.7 36.2 46.3 24.2 33.4 20.8 15.4 22.2 15.1 26.2 19.0 10.3 41.2 32.7 35.3 29.2 26.4 19.1 20.1 34.6 34.0 17.1 19.2 20.5 24.5 16.8 34.1 24.9 17.8 18.3 23.7 12.7 79.5 26.5 23.3 16.2 32.0 30.8 22.9 16.4 34.8 18.7 23.3 43.3 19.3 18.4 21.4 37.2 22.8 23.7 28.1 14.4 20.0 18.6 24.6 19.5 28.4 20.1 14.6 14.9 15.3 45.0 14.0 28.4 14.5 23.0 24.3 34.9 17.2 33.0 19.7 21.1 22.0 34.6 14.0 21.8 32.5 22.7 24.0 18.0 17.1 36.3 27.8 14.0 27.5 8.9 28.4 48.0 23.6 49.1 19.6 30.5 22.4 18.0 12.3 24.0 46.8 45.2 23.9 35.3 17.3 36.1 28.2 27.8 43.6 29.1 32.4 13.3 24.3 16.9 17.7 22.0 23.8 26.6 21.7 21.1 18.6 81.0 45.6 74.3 43.3 48.5 43.0 71.5 54.3 49.2 47.0 66.2 41.9 45.2 70.2 47.9 47.0 47.8 79.3 36.8 33.1 34.8 36.2 46.3 32.7 35.3 34.6 34.0 34.1 32.0 34.8 37.2 21.4 51.3 20.1 14.0 25.0 14.0 19.1 57.3 13.1 30.9 16.3 19.3 29.5 18.6 36.7 33.1 12.5 51.6 31.3 26.9 50.9 35.2 38.3 26.1 21.2 22.5 14.9 29.2 8.4 33.6 34.8 19.3 27.0 22.9 13.3 19.9 23.9 27.1 33.1 15.2 12.1 22.4 44.7 17.0 10.2 10.9 24.2 19.3 16.0 11.2 35.9 37.1 39.1 12.1 27.1 35.0 33.4 25.9 15.9 20.6 37.4 48.9 32.5 28.6 32.9 19.0 24.1 25.3 24.2 18.9 14.5 42.0 24.4 18.3 18.1 25.4 SNW1 "Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1" ENSG00000100603 "SNW domain containing 1" Q13573 14 77717599-77761207 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 300.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002457, CAB009931, HPA017370" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 6: T47d - Mammary gland" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339" "unprognostic (1.24e-3)" "unprognostic (2.02e-1)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (4.27e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.07e-1)" "unprognostic (8.09e-3)" "unprognostic (2.88e-2)" "unprognostic (3.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.47e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-3)" "unprognostic (1.22e-2)" 47.1 33.3 27.6 33.6 29.5 91.2 42.7 30.6 35.9 39.2 29.1 38.4 32.6 39.0 28.4 38.4 38.3 26.7 39.5 27.0 29.0 38.7 33.6 37.1 46.2 29.5 28.6 41.4 38.6 31.3 30.3 33.0 29.8 32.2 32.1 43.3 34.0 21.9 64.8 50.7 38.5 30.9 28.6 44.6 36.6 48.5 28.4 49.0 33.9 35.9 41.9 38.8 38.0 32.9 91.0 66.6 67.0 70.8 54.5 60.6 76.5 61.3 54.6 66.8 61.2 66.0 81.0 88.3 54.5 46.1 50.8 88.2 81.8 58.9 90.3 71.1 63.5 71.8 59.1 66.7 77.7 50.5 81.0 46.8 76.1 60.0 82.8 71.5 65.8 83.7 103.9 64.7 51.9 93.1 90.7 85.4 74.2 103.1 87.8 97.3 85.5 61.7 61.4 82.6 71.2 76.5 84.7 73.6 87.3 68.1 106.6 95.5 69.9 71.6 81.7 64.9 73.9 62.9 95.5 98.7 65.5 79.8 80.9 94.5 71.0 95.6 57.5 76.9 65.5 59.2 64.5 65.9 72.6 67.0 67.6 63.9 67.8 94.5 92.1 43.2 94.5 76.1 27.6 29.5 30.6 35.9 27.0 29.0 29.5 28.6 29.8 28.6 28.4 32.9 86.5 93.0 49.3 13.1 64.2 56.5 80.4 89.1 33.6 56.0 40.1 50.0 49.9 47.1 77.9 53.3 35.5 79.4 75.4 38.0 76.3 79.0 43.5 97.2 81.3 69.9 43.6 85.0 17.9 70.1 100.1 64.9 26.5 80.5 92.3 61.5 55.6 33.7 76.4 38.7 18.6 50.8 54.9 53.6 52.0 24.0 77.9 70.7 39.2 30.0 95.6 66.7 65.9 15.6 31.9 71.3 43.8 74.1 46.3 48.9 48.8 57.3 88.1 72.2 65.7 60.9 89.5 300.5 140.7 39.7 54.3 109.0 76.8 54.4 47.9 70.9 SNX1 "HsT17379, MGC8664, SNX1A, Vps5" ENSG00000028528 "Sorting nexin 1" Q13596 15 64094123-64146090 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 177.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA047373, HPA052761" Approved Enhanced Endosomes,Lysosomes NA NA 6100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" "Endosomes, Lysosomes" "HPA047373: AB_2680018, HPA052761: AB_2681939" "unprognostic (3.99e-2)" "unprognostic (8.65e-3)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (7.13e-2)" "unprognostic (2.73e-1)" "unprognostic (7.15e-2)" "unprognostic (6.49e-3)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.47e-2)" "unprognostic (3.26e-1)" "prognostic favorable (9.88e-6)" "unprognostic (2.27e-1)" "unprognostic (3.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.95e-1)" 63.4 69.0 47.1 59.0 64.1 34.8 46.2 60.9 49.8 52.8 44.5 60.2 49.8 47.6 67.7 60.6 37.5 42.9 50.4 46.2 51.4 56.8 69.3 54.7 67.1 67.5 63.6 39.0 44.3 72.1 32.0 57.8 66.4 51.9 47.6 27.0 55.4 64.4 69.1 48.5 52.4 53.0 62.5 61.0 54.8 34.2 57.2 79.5 102.9 36.8 66.8 62.1 51.2 76.8 75.4 93.5 69.1 60.8 116.4 81.3 23.0 93.5 91.5 81.4 94.5 64.6 115.6 74.4 100.5 86.7 79.7 113.8 102.6 95.2 63.5 136.1 56.0 101.2 110.4 98.2 63.6 94.7 108.0 102.9 62.6 65.2 50.2 59.7 86.1 77.0 74.0 29.2 85.1 107.8 111.4 80.2 54.5 103.2 52.1 100.0 65.3 118.1 127.1 170.5 56.3 56.4 91.4 61.1 86.3 59.5 87.0 86.6 103.0 80.1 120.2 50.8 52.5 93.4 220.5 120.1 72.9 123.5 85.8 144.1 149.1 162.1 83.4 143.1 70.9 101.1 70.4 82.2 127.3 101.9 67.0 66.6 113.7 98.1 144.2 86.1 95.8 156.0 47.1 64.1 60.9 49.8 46.2 51.4 67.5 63.6 66.4 62.5 57.2 76.8 34.4 115.4 74.2 35.6 32.9 26.5 38.1 39.3 29.0 18.9 29.7 29.2 50.6 34.3 52.8 18.4 22.9 51.5 51.6 32.1 33.2 40.9 3.7 36.4 36.7 34.2 26.5 26.5 44.2 37.2 35.1 36.2 27.5 44.9 39.2 44.9 35.3 34.2 72.2 15.2 39.3 28.3 28.5 46.8 27.4 4.0 32.3 42.7 32.0 44.0 56.3 19.7 35.0 121.7 177.7 34.6 30.3 37.6 34.0 32.7 39.2 53.6 31.9 16.5 46.0 36.0 64.0 33.3 23.4 33.8 27.1 47.7 35.0 39.3 28.8 33.9 SNX6 ENSG00000129515 "Sorting nexin 6" Q9UNH7 14 34561093-34630160 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049374 Approved Supported Endosomes,Lysosomes NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 10: Non-specific - Unknown function" "Endosomes, Lysosomes" "HPA049374: AB_2680734" "unprognostic (1.89e-1)" "unprognostic (6.49e-2)" "unprognostic (1.46e-1)" "unprognostic (3.06e-2)" "unprognostic (1.12e-1)" "unprognostic (2.36e-3)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.23e-1)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (1.91e-1)" "unprognostic (3.48e-2)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (8.82e-2)" "unprognostic (2.10e-2)" 50.0 36.5 38.0 46.8 44.4 42.0 36.7 41.2 62.9 40.4 40.2 50.4 74.2 33.6 30.1 40.0 31.2 39.7 33.7 35.4 41.0 44.4 38.9 33.4 56.5 45.4 42.9 31.3 25.1 78.3 14.9 74.5 44.9 25.8 49.1 14.8 27.2 29.5 30.5 30.3 49.1 43.9 44.8 49.2 39.6 36.0 42.1 45.1 34.1 29.2 47.8 50.2 29.6 51.4 112.3 65.3 73.5 48.9 114.5 224.7 99.4 113.1 124.0 110.4 95.4 61.6 115.4 73.2 79.0 153.2 44.1 67.8 81.1 85.8 187.9 93.5 31.7 44.6 34.9 115.9 108.5 77.2 46.8 154.1 98.9 80.7 109.7 100.4 151.7 53.3 48.8 56.3 146.9 68.4 69.9 41.4 40.2 97.7 73.0 74.3 84.4 64.1 135.2 84.6 56.7 61.1 89.9 72.9 94.6 65.0 77.6 47.5 150.8 74.6 52.6 67.8 72.0 55.9 95.9 82.9 37.6 41.6 86.1 73.5 74.2 93.4 73.1 97.4 95.8 71.5 97.0 84.8 66.5 68.0 73.3 79.2 126.5 74.0 101.3 47.6 102.0 109.0 38.0 44.4 41.2 62.9 35.4 41.0 45.4 42.9 44.9 44.8 42.1 51.4 130.2 86.6 49.7 17.6 77.5 51.4 63.0 109.7 69.4 43.4 51.1 67.8 73.4 27.1 87.2 80.9 22.9 166.7 108.9 73.0 125.2 88.1 6.6 74.9 110.1 87.5 52.0 55.5 25.5 64.7 126.3 88.0 68.8 114.3 85.4 93.5 124.6 36.8 251.1 21.9 31.2 62.7 67.1 196.1 73.0 15.3 64.3 155.7 62.2 26.2 155.4 69.6 88.6 21.1 52.5 74.1 77.9 94.8 51.2 84.0 54.8 127.0 73.3 39.4 59.2 74.2 133.8 164.6 167.9 90.0 65.8 254.6 109.4 346.2 82.0 76.8 SPOP "BTBD32, TEF2" ENSG00000121067 "Speckle type BTB/POZ protein" O43791 17 49598884-49678163 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 21: OE19 - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (1.96e-2)" "unprognostic (1.43e-2)" "unprognostic (8.83e-2)" "unprognostic (3.23e-1)" "unprognostic (2.15e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (1.89e-2)" "unprognostic (7.20e-2)" "unprognostic (1.17e-2)" "unprognostic (1.51e-2)" "unprognostic (1.24e-3)" "unprognostic (7.67e-2)" "unprognostic (2.81e-1)" "unprognostic (3.45e-2)" "unprognostic (1.10e-2)" "unprognostic (3.29e-1)" 32.3 26.8 33.4 28.7 37.6 13.6 30.2 49.8 39.8 45.7 35.9 92.2 27.4 50.1 35.8 56.9 42.2 29.8 41.0 36.1 37.3 29.5 37.1 33.1 38.9 33.1 34.0 40.9 25.1 30.9 22.7 32.5 34.6 64.8 39.2 38.2 32.8 81.7 57.2 26.5 34.0 77.8 31.8 32.8 35.0 17.0 38.4 43.6 35.2 52.4 42.8 46.7 30.6 42.8 33.7 30.9 40.9 18.3 49.0 51.8 28.0 44.1 47.6 57.6 62.8 71.1 36.8 56.4 84.2 41.3 38.5 29.2 49.3 29.1 68.8 111.4 57.6 70.6 38.9 47.8 54.6 45.9 50.3 39.0 41.4 42.9 46.2 43.1 60.9 39.6 73.3 54.2 42.4 33.3 79.2 44.0 11.4 80.9 46.3 48.8 64.5 79.9 32.9 21.0 65.2 26.7 29.7 14.1 37.2 22.5 54.2 45.8 55.4 65.9 41.0 49.9 39.5 52.3 51.7 50.6 37.6 41.0 32.9 145.3 71.2 93.0 61.3 68.7 59.8 76.4 66.0 68.9 91.8 80.2 98.2 78.9 107.9 74.9 88.8 67.9 63.9 92.4 33.4 37.6 49.8 39.8 36.1 37.3 33.1 34.0 34.6 31.8 38.4 42.8 54.5 48.1 41.6 80.6 59.2 42.8 36.2 26.7 34.7 72.7 44.5 38.7 51.6 35.8 30.4 29.5 43.8 23.3 47.3 25.9 29.4 36.5 24.4 30.3 38.8 57.5 51.5 53.2 50.5 28.2 23.3 55.9 18.8 28.4 31.0 39.2 66.8 47.3 38.5 75.7 50.1 46.2 30.5 62.2 59.4 8.9 56.2 49.0 39.2 45.9 67.7 100.2 33.0 54.3 49.3 25.6 30.5 73.4 61.4 30.6 40.1 29.6 32.4 58.7 72.3 37.1 59.2 36.6 45.8 28.2 43.9 36.1 46.7 50.1 33.3 22.8 SRP14 "ALURBP, MGC14326" ENSG00000140319 "Signal recognition particle 14" P37108 15 40035690-40039181 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053738, HPA065118" Approved Nucleoplasm,Nucleoli NA NA 440000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA053738: , HPA065118: " "unprognostic (2.52e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-3)" "unprognostic (1.01e-2)" "unprognostic (1.04e-1)" "unprognostic (5.39e-3)" "unprognostic (2.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (7.99e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.31e-4)" "unprognostic (2.20e-1)" "unprognostic (8.03e-3)" "unprognostic (1.41e-3)" "unprognostic (4.94e-2)" 309.1 307.5 330.1 118.1 327.1 252.7 300.4 323.8 426.0 301.7 320.4 272.5 121.5 311.2 282.1 257.7 270.7 155.8 390.1 317.9 349.3 391.5 229.5 220.8 168.0 357.0 402.7 323.5 192.4 324.3 306.8 143.8 339.7 264.4 158.9 212.8 237.8 158.9 354.7 201.2 215.7 163.4 321.1 219.7 247.6 165.6 326.2 276.9 275.6 338.5 172.9 266.7 253.9 355.1 131.8 163.7 399.5 301.4 300.0 275.5 189.4 232.4 265.0 213.4 223.3 297.8 113.7 107.9 245.0 305.1 319.5 216.6 322.8 260.9 207.0 257.5 230.3 258.3 530.2 364.0 231.4 238.2 211.8 276.0 298.3 177.8 213.3 391.0 360.6 297.7 280.2 204.2 356.3 204.5 370.2 291.4 217.6 520.1 301.3 247.6 176.8 192.6 477.5 401.7 287.2 255.0 231.2 243.2 171.2 243.7 332.8 448.6 290.9 240.4 160.3 229.4 171.1 161.8 494.7 291.0 234.7 255.4 229.7 729.8 525.0 875.7 484.5 485.8 473.9 600.9 547.9 549.0 562.5 509.0 522.0 510.2 452.7 525.9 459.5 1148.0 755.1 1262.6 330.1 327.1 323.8 426.0 317.9 349.3 357.0 402.7 339.7 321.1 326.2 355.1 1378.8 461.6 415.0 83.2 577.0 667.1 861.7 1395.7 427.4 432.9 617.7 914.5 880.3 649.1 906.9 995.0 125.1 867.3 812.5 742.7 2551.3 1366.9 353.1 1215.7 729.8 957.7 554.0 619.4 39.4 1087.2 1100.4 699.1 324.7 1513.6 564.0 669.5 654.7 819.4 1022.1 348.3 56.1 676.9 1226.8 631.1 882.8 377.3 1039.8 645.8 789.8 36.5 1174.3 1262.8 619.0 39.2 76.0 1240.7 894.4 986.9 610.9 826.3 874.5 2276.2 935.5 477.3 624.5 651.9 749.3 779.9 643.1 631.5 710.3 758.8 644.1 831.9 673.2 975.0 SRSF10 "FUSIP1, FUSIP2, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR1, TASR2" ENSG00000188529 "Serine and arginine rich splicing factor 10" O75494 1 23964347-23980927 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053805, HPA053831" Uncertain Supported Nucleoplasm NA Yes 49000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA053805: AB_2682269, HPA053831: AB_2682275" "unprognostic (2.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.34e-2)" "unprognostic (1.77e-1)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (2.05e-2)" "unprognostic (1.68e-3)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.74e-4)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.69e-2)" "unprognostic (1.59e-1)" "unprognostic (2.76e-1)" "unprognostic (2.40e-2)" 57.0 59.9 22.5 46.3 23.3 119.6 46.9 26.5 30.1 51.7 29.9 48.8 38.0 49.6 40.7 43.8 56.3 29.2 40.0 23.2 24.4 56.3 56.7 49.6 61.0 23.3 23.5 61.1 50.1 37.2 43.6 42.2 24.3 47.9 45.0 46.5 45.4 32.1 37.7 40.1 50.2 41.3 25.0 49.0 47.9 34.7 23.1 55.8 61.3 24.4 57.1 43.0 45.0 28.6 110.7 89.6 142.9 92.9 88.6 68.2 98.0 133.4 53.5 116.8 102.3 83.5 112.8 239.5 82.7 63.5 73.8 99.7 163.4 89.7 140.7 140.9 122.7 134.5 160.3 115.1 62.2 164.3 107.9 44.2 68.5 74.3 72.9 66.8 89.1 92.1 187.2 83.4 99.3 77.2 167.9 118.1 196.2 139.6 84.4 162.9 99.7 127.6 102.1 86.4 104.9 85.5 98.7 88.2 100.1 97.4 94.2 129.5 89.2 94.7 99.5 89.2 126.4 94.6 134.6 189.1 83.4 185.9 112.8 112.8 67.7 74.0 51.3 84.1 65.1 80.2 58.5 60.3 58.1 68.8 62.9 55.8 43.9 74.5 82.0 69.6 75.9 72.3 22.5 23.3 26.5 30.1 23.2 24.4 23.3 23.5 24.3 25.0 23.1 28.6 115.8 112.2 112.1 39.2 188.4 42.6 115.5 23.2 183.2 159.1 104.4 103.4 59.1 97.2 85.5 79.1 160.6 116.8 150.5 85.6 78.2 94.2 115.4 96.7 138.3 109.8 122.0 154.2 54.7 89.2 164.1 111.3 93.8 106.7 93.6 181.0 86.0 63.8 82.0 99.3 50.9 92.4 36.7 51.2 41.3 118.5 127.7 83.4 26.6 44.0 101.5 131.6 111.2 54.8 67.2 78.6 85.9 110.6 169.4 122.6 67.4 74.6 94.6 287.5 105.2 121.8 125.8 188.1 150.5 140.0 45.5 63.3 142.6 335.7 106.3 100.1 SSNA1 "N14, NA14" ENSG00000176101 "SS nuclear autoantigen 1" O43805 9 137188660-137190370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (6.70e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-2)" "prognostic favorable (8.94e-4)" "unprognostic (1.73e-1)" "unprognostic (4.44e-1)" "unprognostic (1.12e-3)" "unprognostic (2.15e-1)" "unprognostic (2.10e-2)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (9.07e-2)" "unprognostic (8.35e-2)" "unprognostic (2.68e-2)" "unprognostic (1.67e-2)" "unprognostic (7.72e-2)" "unprognostic (1.66e-1)" 46.3 48.2 64.5 41.7 67.8 61.6 45.3 66.5 89.0 38.8 62.4 52.7 42.1 39.5 18.4 77.6 38.8 24.4 81.5 64.2 66.4 60.8 66.5 38.7 54.6 67.0 66.8 30.3 75.9 30.2 27.9 29.1 66.8 48.6 19.2 10.1 61.5 27.8 78.7 62.0 45.9 26.0 65.4 52.2 68.3 124.8 67.4 48.5 37.4 41.9 34.9 48.8 43.8 72.3 79.1 167.4 54.9 86.6 52.0 45.8 56.8 71.8 63.9 96.9 53.5 82.6 108.2 77.0 89.3 60.8 84.2 128.2 65.6 99.2 14.7 140.7 44.9 62.7 128.8 89.0 70.8 104.6 64.5 46.2 86.2 64.5 56.3 45.7 87.8 112.5 69.4 141.9 66.7 225.2 138.8 107.0 86.5 167.7 73.6 91.6 75.2 223.0 83.1 67.5 96.7 54.8 56.9 156.0 82.3 21.3 167.2 122.3 63.8 94.3 53.5 141.6 98.2 34.9 140.3 76.7 103.6 103.3 79.0 117.4 96.7 161.1 99.6 143.8 90.3 118.0 91.6 100.9 90.6 117.9 84.0 85.1 85.0 107.7 136.9 146.1 140.6 93.7 64.5 67.8 66.5 89.0 64.2 66.4 67.0 66.8 66.8 65.4 67.4 72.3 72.4 41.7 44.2 7.5 83.7 63.7 58.0 78.3 63.2 39.1 96.1 115.6 49.9 94.4 59.4 62.5 16.7 150.7 109.9 200.5 113.5 144.6 76.3 80.3 54.4 64.8 77.7 97.4 14.2 233.1 170.5 51.5 65.2 75.0 57.2 57.8 49.6 84.0 156.3 40.4 13.6 131.0 71.2 78.0 82.8 56.6 60.3 82.6 119.2 7.5 186.1 86.7 107.1 8.0 39.7 207.0 166.2 50.8 83.4 88.6 210.2 194.3 52.7 40.3 32.9 27.8 67.1 320.6 114.2 113.5 84.0 111.1 89.9 67.0 130.2 72.7 STAMBP AMSH ENSG00000124356 "STAM binding protein" O95630 2 73828916-73873659 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "LHCN-M2: 1108.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035800, HPA035801" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 18000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Plasma membrane, Cytosol" "HPA035800: AB_10670591, HPA035801: AB_2732470" "unprognostic (1.86e-2)" "unprognostic (1.14e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (4.70e-5)" "unprognostic (6.13e-2)" "unprognostic (2.08e-3)" "unprognostic (3.73e-2)" "unprognostic (1.71e-1)" "unprognostic (6.58e-2)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.79e-4)" "unprognostic (1.01e-1)" "unprognostic (2.29e-1)" "unprognostic (7.72e-2)" "unprognostic (2.63e-1)" "unprognostic (1.43e-1)" "unprognostic (2.89e-1)" 15.6 11.6 21.7 14.6 30.6 13.3 20.2 29.7 23.8 19.3 19.3 21.5 20.7 20.6 15.5 25.4 18.3 16.9 22.3 20.6 24.5 21.9 19.0 15.7 19.3 31.3 28.0 17.7 12.2 24.3 9.3 17.3 30.4 22.1 23.2 14.6 21.5 15.6 37.4 16.7 20.4 21.3 27.9 14.9 18.2 15.8 27.1 23.2 22.6 42.8 21.6 16.8 16.0 38.6 39.0 44.0 34.0 31.6 31.1 37.2 39.1 23.3 31.7 42.1 40.3 73.7 35.9 32.2 35.8 19.8 55.7 30.0 36.6 81.7 47.6 56.6 41.3 43.3 29.1 58.1 43.4 35.8 50.0 30.1 57.6 49.6 70.7 53.5 25.1 43.7 47.9 47.8 1108.9 46.8 55.9 32.4 54.9 55.1 22.7 38.6 89.4 46.1 45.2 43.0 62.0 45.8 28.4 34.6 49.1 36.4 32.3 21.4 22.0 37.5 44.5 22.9 41.9 44.8 46.9 24.9 46.4 38.1 44.7 30.7 18.9 34.2 15.9 21.4 17.2 21.5 18.3 15.6 19.9 19.3 18.9 14.4 27.6 22.3 19.9 19.5 25.8 14.9 21.7 30.6 29.7 23.8 20.6 24.5 31.3 28.0 30.4 27.9 27.1 38.6 22.1 19.2 17.7 22.9 21.5 16.3 28.9 61.7 31.3 22.3 28.8 27.7 41.1 28.6 34.4 25.8 12.5 43.0 27.4 48.7 49.0 37.9 80.8 35.6 37.3 21.4 10.3 34.9 18.5 36.3 32.5 26.0 18.8 45.8 52.6 21.2 17.5 41.1 33.0 26.9 22.1 36.4 40.7 27.7 16.2 125.0 32.6 25.2 7.2 16.9 34.1 24.9 25.7 26.2 67.2 44.5 41.8 34.6 21.5 40.9 57.2 68.8 24.5 21.0 39.5 28.2 27.2 33.1 44.2 44.5 21.6 44.5 21.4 27.5 34.3 27.1 STARD3NL "MENTHO, MGC3251" ENSG00000010270 "STARD3 N-terminal like" O95772 7 38178245-38230670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019204 Enhanced Supported Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 34: Spermatids - Unknown function" Vesicles "HPA019204: AB_2197800" "unprognostic (1.55e-3)" "unprognostic (2.80e-3)" "unprognostic (2.22e-1)" "unprognostic (2.58e-1)" "unprognostic (4.37e-2)" "prognostic unfavorable (2.20e-4)" "prognostic unfavorable (1.44e-5)" "unprognostic (9.64e-2)" "unprognostic (1.89e-1)" "unprognostic (5.37e-2)" "prognostic favorable (8.48e-4)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" "unprognostic (8.09e-3)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 26.8 21.8 35.5 23.1 37.6 37.8 22.0 39.6 41.7 31.4 29.8 21.5 18.5 32.6 27.1 12.3 27.5 22.0 27.1 35.7 44.1 34.0 17.4 32.8 21.3 42.0 46.8 24.2 16.4 17.9 25.5 49.4 48.4 40.6 23.5 26.3 14.9 21.6 17.3 6.6 20.3 33.1 40.5 27.1 17.6 32.7 41.8 22.3 32.7 17.5 15.3 29.4 14.8 42.9 40.9 42.7 92.6 60.4 62.8 62.2 32.4 65.2 67.2 63.2 82.4 34.3 63.0 31.9 64.0 59.9 192.0 42.9 51.4 49.5 95.2 29.0 45.1 64.8 22.1 47.4 55.3 71.5 72.7 58.8 24.0 67.0 53.0 72.0 116.7 86.1 75.0 53.7 98.4 25.1 40.9 115.2 65.5 33.7 33.9 49.6 85.9 14.9 89.0 37.5 36.9 86.7 22.4 58.8 64.1 127.0 40.9 93.8 80.0 43.0 61.0 67.8 93.5 57.4 62.2 12.1 87.0 125.6 142.4 33.5 46.8 56.2 52.2 43.3 23.9 30.8 21.6 39.3 42.3 28.4 18.1 35.6 53.1 71.8 47.0 30.3 24.8 47.1 35.5 37.6 39.6 41.7 35.7 44.1 42.0 46.8 48.4 40.5 41.8 42.9 45.8 19.2 47.3 15.0 33.2 20.8 57.3 43.4 20.5 8.7 26.8 15.0 18.2 14.3 25.9 31.3 12.5 48.3 67.2 15.5 31.3 31.4 125.3 37.0 42.5 45.5 21.5 28.2 21.9 34.3 91.2 34.2 19.9 33.1 23.5 36.0 51.0 12.4 65.8 5.0 24.5 20.9 32.6 63.2 77.9 115.2 18.3 56.8 26.6 17.8 24.2 34.6 114.4 27.6 26.0 34.0 21.6 25.9 34.3 55.2 19.4 50.1 22.8 13.0 13.1 23.4 38.4 48.8 37.3 12.2 16.2 42.3 47.5 24.5 19.5 46.4 STAT1 "ISGF-3, STAT91" ENSG00000115415 "Signal transducer and activator of transcription 1" P42224 2 190908460-191020960 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 533.6;BJ hTERT+ SV40 Large T+ RasG12V: 595.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000931, HPA000982, CAB004049" Approved Enhanced Nucleoplasm,Cytosol NA NA 92000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 58: T-cells - T-cell receptor" Nucleoplasm Cytosol "CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099" "unprognostic (6.90e-2)" "unprognostic (6.47e-2)" "unprognostic (4.27e-2)" "unprognostic (2.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.91e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-2)" "unprognostic (1.35e-1)" "prognostic favorable (1.75e-4)" "prognostic unfavorable (4.23e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.22e-5)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (3.35e-3)" "unprognostic (3.93e-2)" 41.2 35.6 8.0 113.3 7.7 35.1 27.1 5.1 10.2 33.9 5.6 43.4 51.3 27.5 15.1 35.8 25.1 66.6 35.6 11.1 14.7 45.3 66.0 69.1 145.6 18.8 9.4 33.0 40.7 39.0 23.8 28.9 13.4 34.8 40.6 20.0 107.4 24.2 29.8 24.9 41.8 47.5 27.3 114.5 55.7 31.2 17.4 104.3 33.4 29.7 59.0 62.2 25.1 13.2 54.8 58.6 26.8 41.4 105.7 158.8 79.3 82.4 257.1 533.6 595.5 95.1 62.8 21.7 48.1 180.8 173.9 45.9 29.8 62.0 108.6 179.6 24.6 99.0 43.8 47.3 72.2 48.4 58.3 94.7 36.8 100.4 31.0 56.5 63.5 38.4 56.8 103.9 93.6 42.5 38.0 41.1 36.6 34.2 95.3 31.4 71.4 27.9 58.9 70.1 37.9 35.0 100.3 35.7 236.5 37.5 38.6 59.9 56.2 105.1 57.5 90.0 51.4 202.1 330.7 21.0 80.8 40.3 47.8 50.0 143.9 104.9 51.6 191.1 71.4 38.3 129.3 77.4 61.4 31.7 128.2 94.2 203.9 77.3 117.3 28.9 227.8 210.2 8.0 7.7 5.1 10.2 11.1 14.7 18.8 9.4 13.4 27.3 17.4 13.2 46.8 73.7 34.3 14.0 48.8 22.2 17.5 32.3 22.2 13.3 27.6 26.0 44.6 51.5 40.3 53.3 25.0 13.6 48.0 44.4 7.9 47.5 18.5 30.9 43.9 42.1 21.0 15.5 9.0 37.8 53.9 44.1 51.5 39.3 51.4 38.5 28.5 54.1 92.6 3.3 12.2 26.7 16.2 72.0 26.2 5.2 21.8 96.9 17.8 31.9 107.3 13.7 62.8 25.1 11.9 36.0 21.7 29.7 69.4 26.7 24.7 44.0 47.7 19.3 39.5 35.4 31.1 25.4 24.6 28.8 31.3 8.3 78.1 37.9 29.2 26.9 STX4 "p35-2, STX4A" ENSG00000103496 "Syntaxin 4" Q12846 16 31032889-31042975 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001330 Approved Enhanced "Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" "Plasma membrane" "HPA001330: AB_1080167" "unprognostic (2.31e-3)" "prognostic favorable (3.65e-4)" "unprognostic (3.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "unprognostic (5.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.01e-2)" "unprognostic (3.12e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (2.88e-9)" "unprognostic (6.90e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.26e-2)" 38.3 44.0 33.1 34.2 36.2 22.3 33.9 37.4 36.4 36.3 32.3 37.5 38.3 31.4 24.4 35.8 29.8 27.7 39.8 33.2 37.8 33.5 35.8 36.2 31.1 38.0 36.6 30.4 27.7 38.4 23.2 32.3 37.7 29.9 28.6 8.5 29.9 26.5 45.8 44.3 35.9 31.6 36.1 43.7 32.4 14.9 36.2 28.4 29.5 33.8 37.1 38.1 32.6 39.0 51.9 70.6 16.0 36.1 51.1 52.1 33.8 47.7 79.2 47.5 48.7 22.1 53.2 35.4 58.9 80.8 54.4 36.6 15.2 52.6 45.6 60.3 43.8 25.3 48.7 59.7 58.3 29.2 80.1 50.2 36.1 82.1 61.1 58.5 64.3 22.3 29.9 38.6 84.9 80.3 28.0 44.8 33.1 36.9 36.7 24.0 47.1 46.1 45.9 38.7 13.1 24.6 40.6 41.1 17.4 20.7 33.7 38.7 74.4 48.3 21.8 55.8 26.6 41.2 37.0 14.6 73.3 46.4 29.7 21.3 21.7 27.3 17.6 23.8 15.4 12.7 14.7 17.9 18.8 17.5 11.0 14.2 23.0 24.6 21.9 11.1 9.0 11.2 33.1 36.2 37.4 36.4 33.2 37.8 38.0 36.6 37.7 36.1 36.2 39.0 34.9 44.8 22.7 7.8 32.6 65.1 34.6 56.3 31.9 7.4 22.3 20.6 23.6 48.6 35.2 22.0 12.5 31.1 35.9 69.7 29.4 60.6 12.9 22.1 26.6 46.0 25.7 11.1 4.8 67.7 35.7 51.7 43.3 29.0 60.3 42.1 33.9 20.0 89.5 5.0 3.6 39.5 38.7 49.6 149.9 15.7 38.5 83.2 30.2 2.8 51.7 24.1 42.2 3.0 16.0 73.4 58.5 35.3 23.0 61.6 77.7 50.8 31.3 6.9 39.5 40.6 36.4 9.4 6.7 27.0 65.1 33.1 35.4 39.0 47.9 36.2 STYXL1 "DUSP24, MK-STYX" ENSG00000127952 "Serine/threonine/tyrosine interacting like 1" Q9Y6J8 7 75996338-76048004 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 91.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050261 Uncertain NA No "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" "HPA050261: AB_2681066" "unprognostic (6.24e-2)" "unprognostic (1.12e-1)" "unprognostic (7.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.88e-3)" "unprognostic (9.33e-2)" "unprognostic (1.50e-3)" "unprognostic (4.77e-2)" "unprognostic (8.01e-2)" "unprognostic (4.02e-2)" "unprognostic (4.47e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "unprognostic (5.45e-2)" "unprognostic (3.17e-2)" "unprognostic (2.28e-1)" "prognostic favorable (8.22e-4)" 8.7 15.4 21.9 11.5 22.5 15.1 17.4 21.3 26.5 15.3 24.6 15.9 11.2 10.5 20.7 18.9 28.7 9.8 11.5 21.7 19.7 16.8 19.4 11.9 16.1 21.0 20.8 15.2 22.5 16.3 11.9 17.3 22.0 16.5 20.4 13.1 16.2 10.1 10.5 20.4 9.1 14.4 20.2 14.4 14.8 21.9 21.3 13.2 14.8 9.6 21.6 14.2 13.4 23.8 50.3 26.2 20.3 27.2 31.4 33.6 21.1 22.1 31.3 35.1 34.7 30.6 44.2 11.7 10.9 29.4 55.6 21.6 33.3 44.3 50.5 37.4 14.5 14.2 12.2 27.5 44.3 19.9 24.7 33.2 51.0 42.1 104.8 45.0 34.5 17.4 46.4 34.1 31.8 40.8 7.9 84.6 17.1 48.2 62.5 30.1 16.9 31.1 45.2 32.2 26.5 27.6 20.7 46.7 57.6 50.4 51.5 38.0 17.3 29.9 12.6 33.3 31.8 36.6 24.9 39.5 26.7 37.5 47.8 70.8 52.9 50.0 23.8 48.2 26.3 36.3 22.5 26.6 42.1 29.7 19.8 22.2 44.9 49.7 47.0 28.1 41.4 34.1 21.9 22.5 21.3 26.5 21.7 19.7 21.0 20.8 22.0 20.2 21.3 23.8 7.7 22.4 13.2 16.6 10.7 7.4 14.8 24.2 13.1 6.7 17.9 18.5 18.1 10.0 31.4 11.0 0.0 34.8 7.3 24.6 39.2 15.6 91.4 42.7 10.2 11.1 20.3 9.0 18.8 25.6 24.5 9.4 18.3 19.7 10.8 13.9 11.7 18.2 30.9 3.3 11.6 29.1 24.4 21.0 9.6 62.1 11.5 19.7 3.6 11.2 31.1 20.2 9.2 8.0 15.8 23.9 40.3 10.1 23.0 17.0 14.6 25.2 60.7 10.4 6.6 7.6 9.0 39.3 12.6 13.0 9.9 45.0 10.8 9.5 18.8 17.9 SUB1 "p14, p15, PC4" ENSG00000113387 "SUB1 regulator of transcription" P53999 5 32531633-32604079 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 1838.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 1427.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001311, CAB015351" Supported Supported Nucleoplasm,Nucleoli NA NA 120000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Nucleoli" "CAB015351: AB_2197157, HPA001311: AB_1080123" "unprognostic (5.19e-2)" "unprognostic (1.58e-1)" "unprognostic (5.25e-2)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.25e-6)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.46e-3)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (1.02e-3)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (2.43e-1)" "unprognostic (2.45e-1)" 142.0 98.7 88.7 130.4 100.7 251.7 122.1 72.7 152.6 109.7 69.4 110.0 88.7 85.4 83.3 108.9 66.0 74.1 113.3 104.3 98.7 129.2 135.3 91.2 159.8 80.7 87.2 68.3 62.0 107.3 88.4 103.2 94.7 73.2 107.1 83.6 76.6 65.4 105.2 69.6 83.7 79.4 86.0 144.9 97.3 71.1 92.6 204.2 69.2 108.9 137.3 124.0 73.2 85.3 199.9 161.8 315.3 295.8 187.5 329.1 197.7 340.3 245.4 300.8 275.4 236.9 307.3 101.2 231.0 236.5 307.3 132.4 266.9 278.9 402.9 420.2 244.1 337.8 365.8 450.5 264.4 594.6 441.4 233.3 235.6 321.0 228.0 166.0 228.9 378.5 399.4 1427.8 269.5 178.6 566.8 942.9 207.8 235.9 326.9 247.8 409.9 645.7 303.0 178.2 170.4 141.1 526.9 244.9 251.9 198.2 272.0 544.9 238.7 324.7 351.5 275.8 261.0 556.0 1035.0 180.5 297.7 634.9 202.4 650.7 135.8 326.2 164.7 142.3 151.4 330.4 215.9 219.8 265.1 214.8 168.2 195.2 163.7 155.2 133.4 390.1 344.6 326.1 88.7 100.7 72.7 152.6 104.3 98.7 80.7 87.2 94.7 86.0 92.6 85.3 298.9 144.2 163.4 27.1 638.2 584.9 588.7 709.9 324.4 118.1 459.2 383.9 196.7 244.5 320.1 310.8 43.8 493.0 613.5 342.1 1009.5 711.4 131.6 319.0 263.7 280.2 281.4 379.5 71.5 327.2 785.0 323.6 227.9 329.9 307.5 188.6 223.1 375.4 500.5 85.8 60.9 362.9 484.2 319.0 721.3 68.1 239.9 422.5 528.3 37.5 587.5 223.7 500.5 64.3 50.4 416.3 516.6 344.6 1838.8 536.0 342.4 921.2 291.9 79.7 203.8 224.0 468.5 447.2 439.9 411.8 565.4 836.8 575.5 357.7 394.6 645.5 SUMO1 "GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1" ENSG00000116030 "Small ubiquitin like modifier 1" P63165 2 202206182-202238599 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 7.6" "CAB004269, HPA056956" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear membrane" "Nucleoli, Nuclear bodies" "CAB004269: AB_628300, HPA056956: AB_2683285" "unprognostic (7.15e-2)" "unprognostic (2.34e-2)" "unprognostic (1.49e-1)" "unprognostic (2.52e-3)" "unprognostic (2.89e-1)" "unprognostic (9.56e-3)" "unprognostic (1.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.78e-3)" "prognostic favorable (7.93e-4)" "unprognostic (7.06e-3)" "unprognostic (1.16e-1)" "unprognostic (4.64e-3)" "unprognostic (1.31e-2)" "unprognostic (7.58e-2)" "unprognostic (2.82e-2)" "unprognostic (2.19e-1)" 77.5 99.1 79.4 62.7 84.9 133.7 83.6 89.0 99.9 68.9 84.4 82.7 72.0 65.1 86.3 71.6 65.7 71.7 79.8 85.6 85.3 118.1 174.1 66.5 86.4 79.9 80.1 54.5 55.8 91.6 56.7 75.6 81.1 75.3 82.8 80.2 66.8 61.9 107.5 57.1 80.5 71.5 78.9 68.1 73.8 54.7 81.4 112.1 102.3 103.3 95.4 77.9 54.9 86.6 164.1 82.4 291.4 155.8 159.3 168.5 129.7 171.0 214.6 209.0 274.6 178.1 203.7 111.6 153.5 199.0 193.5 117.1 242.2 237.9 325.0 104.8 185.7 207.6 159.0 211.2 114.9 237.2 188.5 130.9 225.2 164.0 123.9 195.1 197.3 219.0 194.2 176.0 226.4 141.1 298.3 391.6 351.7 168.5 172.2 190.9 163.2 197.9 255.5 134.3 201.7 219.3 140.3 133.6 236.4 313.9 120.0 223.2 139.9 152.5 153.0 141.4 152.8 151.7 322.9 285.8 170.2 165.4 137.2 242.2 220.0 284.2 169.2 226.5 179.6 276.3 206.8 200.0 223.6 231.6 193.8 202.3 256.5 246.5 239.7 187.8 329.0 394.7 79.4 84.9 89.0 99.9 85.6 85.3 79.9 80.1 81.1 78.9 81.4 86.6 182.7 112.2 61.1 10.7 143.1 422.1 204.4 448.6 177.6 99.6 196.8 170.2 58.1 130.1 215.3 189.4 64.6 259.4 162.3 136.6 481.3 250.4 91.3 148.3 115.1 170.7 142.4 140.1 31.4 173.3 297.8 161.8 89.7 115.2 92.6 114.7 142.8 202.1 205.3 87.5 27.8 156.4 319.4 140.7 330.2 28.0 129.8 137.7 211.7 15.9 241.3 182.3 176.1 16.6 21.2 208.1 191.1 127.9 130.5 258.5 272.2 534.4 185.5 87.8 111.7 92.5 221.9 212.0 141.5 183.9 424.5 209.7 174.5 134.9 157.5 254.1 SUMO2 "SMT3B, SMT3H2" ENSG00000188612 "Small ubiquitin like modifier 2" P61956 17 75165586-75182959 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037314, HPA042123, HPA048064" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear bodies" "CAB037314: AB_796170, HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (6.49e-2)" "unprognostic (1.01e-2)" "unprognostic (4.23e-2)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.32e-1)" "unprognostic (1.23e-3)" "prognostic unfavorable (2.12e-4)" "unprognostic (9.80e-2)" "unprognostic (6.02e-3)" "unprognostic (2.58e-3)" "unprognostic (5.07e-2)" "unprognostic (2.29e-2)" "prognostic unfavorable (5.23e-6)" "unprognostic (2.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.14e-2)" "unprognostic (4.89e-3)" 198.2 205.1 176.2 203.6 186.9 229.8 174.5 214.2 239.9 219.3 168.5 190.1 161.4 205.5 158.5 240.9 186.8 134.0 156.7 185.4 193.4 205.6 185.8 171.5 214.6 175.5 177.3 231.1 161.0 130.6 146.5 130.1 177.5 158.1 143.9 205.9 160.3 122.2 229.4 182.6 169.2 154.8 187.4 174.7 205.3 182.2 187.2 271.9 149.2 152.0 228.6 188.2 205.1 191.5 742.5 299.1 1035.7 534.4 296.8 283.6 486.1 571.2 276.9 384.5 354.5 343.6 396.0 641.8 398.1 327.9 503.0 353.4 470.3 351.7 451.6 373.6 712.4 644.0 282.1 597.4 194.1 856.1 555.7 290.1 195.9 343.9 187.2 615.6 403.8 628.3 540.7 508.7 288.3 317.8 1310.8 734.0 632.8 552.5 445.5 903.2 987.1 539.5 391.9 612.0 633.4 739.0 691.1 566.8 481.4 796.9 614.6 663.0 458.1 557.2 581.7 429.4 931.3 355.4 348.1 986.8 351.2 500.6 457.3 831.1 436.4 781.2 390.9 498.9 408.8 515.7 486.8 456.8 451.6 443.6 444.0 437.1 380.1 452.3 548.3 616.0 701.6 851.5 176.2 186.9 214.2 239.9 185.4 193.4 175.5 177.3 177.5 187.4 187.2 191.5 522.1 163.5 160.6 25.5 453.3 705.4 647.4 717.6 602.2 216.4 492.1 524.1 62.3 337.5 368.2 355.0 50.1 522.8 485.0 278.1 968.5 602.7 281.8 348.6 429.0 458.5 441.9 519.9 35.7 531.7 948.9 451.1 274.2 343.5 349.0 465.0 491.2 273.4 616.3 233.9 33.0 397.9 472.0 676.9 637.0 488.6 604.9 481.5 462.4 21.5 743.4 535.4 517.0 25.1 42.6 666.5 397.3 605.2 443.0 822.3 348.7 847.5 322.6 161.3 571.9 409.5 716.6 872.2 683.2 795.2 742.7 565.2 480.3 476.1 437.0 977.2 TAF9 "AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32" ENSG00000273841 "TATA-box binding protein associated factor 9" Q16594 5 69364743-69370013 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 550.8;Late spermatids: 924.3;Spermatocytes: 370.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028930, HPA053429, HPA058961, HPA072658" Approved Enhanced Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: " "unprognostic (1.25e-3)" "unprognostic (9.52e-2)" "unprognostic (1.76e-3)" "unprognostic (8.38e-3)" "unprognostic (5.40e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.48e-5)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.66e-1)" "unprognostic (9.45e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.58e-1)" "unprognostic (1.97e-1)" "unprognostic (3.02e-2)" "unprognostic (1.79e-1)" 42.1 43.5 35.5 31.9 38.6 108.2 46.0 35.4 41.4 28.3 34.4 42.5 34.2 31.5 50.4 37.4 31.1 28.8 52.7 39.2 43.0 38.4 55.7 27.7 46.6 37.1 36.4 37.8 40.8 35.5 50.6 38.0 40.5 33.7 47.5 47.2 34.7 27.7 58.0 36.1 33.2 35.9 36.6 35.0 38.0 140.4 37.7 50.9 28.7 41.7 52.3 50.6 30.3 36.1 107.0 109.3 67.7 121.6 114.4 143.5 179.3 100.1 159.8 172.3 227.0 109.7 135.1 135.9 70.2 146.7 322.2 82.2 92.4 208.1 227.4 65.6 111.0 120.4 154.0 157.8 261.3 118.7 168.3 159.4 137.4 117.1 247.7 122.5 143.1 121.4 122.4 119.8 165.9 147.7 126.1 189.5 82.0 42.6 81.6 83.0 119.7 169.0 152.7 120.7 118.1 82.6 108.3 64.3 192.8 111.3 100.9 175.7 103.3 65.9 98.2 78.2 173.1 93.2 118.3 175.6 101.3 145.7 82.8 149.3 107.8 122.5 52.8 101.3 81.2 90.1 79.7 64.2 83.9 75.4 89.6 73.6 16.0 58.7 88.4 47.0 95.5 134.4 35.5 38.6 35.4 41.4 39.2 43.0 37.1 36.4 40.5 36.6 37.7 36.1 67.4 19.2 29.3 0.0 55.2 174.0 151.4 238.7 39.3 24.1 49.9 81.4 69.3 42.9 108.8 23.9 14.6 118.0 45.1 33.8 90.1 67.1 550.8 47.6 44.9 58.6 30.7 93.2 0.0 80.4 166.7 57.3 36.7 38.1 38.6 53.5 34.6 41.9 107.7 20.2 0.0 49.5 146.5 42.8 99.8 924.3 65.3 55.2 99.6 0.0 66.9 35.1 35.0 0.0 0.0 85.1 37.2 34.3 76.5 87.3 47.4 90.2 85.2 43.0 32.9 49.1 95.5 370.7 78.0 60.7 163.2 104.5 50.7 75.0 64.2 149.6 TANGO2 "C22orf25, DKFZp761P1121" ENSG00000183597 "Transport and golgi organization 2 homolog" Q6ICL3 22 20017014-20067164 "Disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 78.9" "Cell type enhanced" "Detected in all" "Erythroid cells: 111.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003080 Approved NA NA 200000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "HPA003080: AB_1078350" "unprognostic (4.05e-1)" "unprognostic (1.90e-3)" "unprognostic (2.16e-1)" "unprognostic (1.06e-1)" "unprognostic (3.48e-1)" "unprognostic (1.37e-1)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (6.13e-2)" "unprognostic (6.76e-2)" "prognostic favorable (3.01e-4)" "unprognostic (2.21e-1)" "unprognostic (1.83e-3)" "unprognostic (3.95e-2)" "unprognostic (5.49e-2)" "unprognostic (2.60e-1)" "unprognostic (2.62e-2)" 17.0 26.7 20.9 13.8 19.2 50.5 13.4 19.1 23.8 10.9 15.9 14.9 9.8 13.0 9.2 11.5 10.9 10.9 78.9 21.8 22.4 21.3 20.0 19.2 17.7 24.7 26.6 7.9 15.4 27.7 19.7 11.6 30.2 17.1 11.3 6.4 12.2 12.2 27.7 12.8 16.2 12.0 20.6 34.0 21.2 7.5 25.7 12.4 24.3 29.0 11.7 15.1 9.7 20.5 15.6 14.2 4.8 9.6 33.6 10.9 8.7 15.7 20.8 14.5 12.8 10.0 12.1 6.2 11.1 42.4 20.2 18.9 11.2 17.5 9.2 36.8 11.4 16.9 11.9 12.0 24.6 15.7 29.1 15.6 12.9 21.0 11.6 14.5 21.6 10.4 44.0 13.1 20.8 17.7 10.3 10.7 2.3 37.7 9.5 9.5 12.9 4.0 11.7 19.9 8.4 4.7 16.1 27.7 35.3 10.3 7.0 14.3 14.7 19.0 14.4 25.2 11.0 6.7 4.1 6.4 25.9 12.9 13.6 76.3 44.1 77.8 14.9 53.4 16.2 20.5 15.9 19.2 41.6 15.7 10.0 13.1 55.8 31.3 70.1 14.3 28.7 39.6 20.9 19.2 19.1 23.8 21.8 22.4 24.7 26.6 30.2 20.6 25.7 20.5 5.8 16.0 5.8 10.7 11.9 3.8 3.9 4.2 2.2 4.9 3.9 3.4 17.1 10.0 4.6 7.3 4.2 10.6 10.2 11.5 19.6 11.5 5.5 2.7 3.4 5.7 6.6 111.4 20.6 9.7 17.4 5.9 9.2 4.9 15.2 4.5 6.4 6.4 39.4 10.1 13.3 7.0 8.2 21.6 7.1 15.9 5.0 24.0 19.6 15.9 24.8 7.6 19.6 3.0 30.9 11.6 9.2 4.9 7.2 4.8 13.8 7.7 6.1 2.9 19.7 3.0 6.6 4.8 3.1 5.3 4.5 11.5 9.7 13.0 6.3 3.5 TANK "I-TRAF, TRAF2" ENSG00000136560 "TRAF family member associated NFKB activator" Q92844 2 161136908-161236230 "Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010345, HPA037675, HPA037676" Approved Supported Nucleoli,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 41: Macrophages - Immune response" Cytosol Nucleoli "CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601" "unprognostic (1.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.53e-1)" "unprognostic (5.27e-2)" "unprognostic (3.98e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.71e-1)" "unprognostic (2.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (2.78e-6)" "unprognostic (2.13e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (2.30e-2)" 42.9 36.2 20.9 46.2 23.6 84.2 57.7 22.1 24.7 30.5 25.3 32.4 28.0 30.7 27.0 29.8 35.0 43.0 27.1 20.1 24.1 29.1 66.5 39.7 52.8 24.0 25.5 30.8 22.9 27.8 19.7 36.9 23.5 24.6 35.8 32.1 26.6 24.7 52.3 26.7 29.1 32.5 21.4 43.2 30.2 22.3 21.9 42.1 36.4 43.3 51.4 49.0 25.0 25.1 39.2 24.5 31.7 36.3 91.3 124.9 45.2 58.0 86.4 39.3 57.7 30.8 50.5 53.1 38.7 67.6 28.2 27.5 19.2 43.4 59.5 126.6 20.5 29.8 22.5 79.1 72.4 51.1 32.2 98.3 66.6 59.6 46.6 73.5 101.7 32.0 30.5 68.7 77.7 29.3 31.4 50.7 18.2 40.9 21.5 17.9 45.5 35.2 86.3 62.1 26.4 30.7 37.4 40.6 60.4 43.2 17.5 64.9 108.2 50.4 29.3 25.7 34.0 46.6 46.1 80.9 66.9 40.3 40.8 122.2 71.4 97.1 36.0 78.5 55.9 63.8 58.8 53.1 66.5 66.7 39.9 39.6 189.4 42.4 94.0 43.4 100.7 55.0 20.9 23.6 22.1 24.7 20.1 24.1 24.0 25.5 23.5 21.4 21.9 25.1 34.7 57.7 79.6 82.3 108.9 59.9 106.3 82.7 21.6 32.7 73.0 71.5 27.3 42.9 69.2 46.0 12.5 43.1 54.8 50.4 60.7 58.8 18.0 47.2 42.3 46.7 47.4 63.8 49.9 40.5 82.9 67.8 28.5 52.4 59.5 17.0 28.2 58.1 45.6 21.9 60.9 29.3 71.2 71.5 194.0 10.0 52.8 106.8 72.9 120.9 177.7 33.5 40.2 63.3 87.4 56.0 43.9 26.4 57.1 81.8 34.4 46.5 66.2 37.4 26.3 52.1 40.3 54.3 33.9 29.3 60.9 134.9 109.3 33.0 32.2 158.4 TATDN3 ENSG00000203705 "TatD DNase domain containing 3" Q17R31 1 212791828-212816830 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032092 Approved Approved "Nucleoplasm,Golgi apparatus,Focal adhesion sites" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Golgi apparatus, Focal adhesion sites" "HPA032092: AB_10671086" "unprognostic (9.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.80e-1)" "unprognostic (3.88e-2)" "unprognostic (3.34e-3)" "unprognostic (5.02e-3)" "prognostic favorable (1.59e-4)" "unprognostic (1.93e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-3)" "unprognostic (2.96e-3)" 13.0 11.3 10.1 10.4 12.4 12.2 10.0 10.1 12.7 6.5 9.3 8.3 6.1 7.1 13.3 7.3 7.7 7.4 19.3 10.6 12.4 16.6 10.3 8.0 12.2 12.2 10.5 8.6 9.4 18.2 8.2 7.3 12.4 6.9 7.7 17.7 8.5 6.9 29.9 6.3 7.2 7.7 10.5 11.1 11.1 10.0 10.4 11.2 11.7 24.1 10.3 8.2 5.5 15.8 12.2 11.9 10.3 15.1 16.7 26.0 23.5 12.9 14.3 10.8 13.1 3.1 17.2 27.4 12.3 12.4 6.0 7.6 13.0 18.2 11.5 17.1 17.0 13.4 10.3 6.3 19.0 33.3 16.3 20.6 12.8 14.3 37.3 11.2 16.1 37.7 28.2 21.7 11.7 5.9 28.4 10.9 13.9 14.9 7.6 16.0 19.3 49.4 11.3 6.3 21.6 18.5 14.5 25.1 30.6 19.2 26.6 19.6 10.1 7.9 10.3 16.4 13.0 19.4 32.9 44.9 20.6 26.8 12.0 26.1 37.2 60.2 12.7 59.3 11.5 39.7 15.8 15.4 45.6 31.0 12.5 14.9 42.8 13.8 64.4 74.6 16.1 22.9 10.1 12.4 10.1 12.7 10.6 12.4 12.2 10.5 12.4 10.5 10.4 15.8 9.1 6.4 16.2 17.3 18.5 4.5 8.1 14.2 3.4 16.1 8.5 8.3 36.6 8.6 8.0 3.7 18.8 14.3 39.7 3.4 41.1 18.1 12.2 10.8 7.6 8.9 10.2 6.5 35.1 16.5 17.5 10.0 6.1 7.8 7.0 10.8 5.3 7.0 18.8 15.2 43.9 5.1 12.2 27.6 8.3 4.0 5.3 20.4 14.2 17.8 31.0 17.8 8.2 23.1 53.6 12.0 6.2 4.9 9.3 6.2 7.3 26.4 12.5 29.6 6.6 8.8 9.2 24.2 17.9 6.6 4.4 9.3 11.1 11.0 5.2 7.0 TBC1D23 FLJ11046 ENSG00000036054 "TBC1 domain family member 23" Q9NUY8 3 100260992-100325251 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038151, HPA038152" Approved Enhanced "Golgi apparatus" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA038151: AB_10672405, HPA038152: AB_10672620" "unprognostic (9.23e-3)" "unprognostic (6.01e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (1.79e-2)" "unprognostic (6.18e-2)" "unprognostic (7.87e-3)" "unprognostic (6.16e-2)" "unprognostic (7.92e-2)" "unprognostic (2.02e-2)" "unprognostic (2.98e-3)" "unprognostic (3.66e-3)" "unprognostic (1.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.51e-1)" "unprognostic (5.64e-2)" "unprognostic (2.32e-1)" 15.1 17.4 4.8 12.7 7.0 23.0 14.8 10.8 6.7 13.5 5.0 15.1 17.9 14.3 10.2 16.2 9.3 13.9 14.3 5.9 6.4 17.1 22.7 12.6 12.5 6.6 5.4 16.2 18.2 17.9 5.1 21.6 7.1 11.7 15.5 16.8 15.2 9.9 17.2 13.5 18.4 14.1 7.0 12.5 15.2 17.1 6.7 14.4 14.1 15.3 15.5 15.6 8.2 10.9 72.9 15.0 17.4 9.8 34.4 44.3 17.5 40.4 45.7 46.6 53.6 28.6 13.3 18.3 20.6 46.9 26.0 25.5 64.5 29.4 72.4 9.0 15.1 49.9 16.6 19.3 33.9 23.2 39.1 35.9 23.7 23.3 38.1 39.0 25.2 14.1 41.0 26.8 30.1 16.3 17.9 11.4 20.3 26.2 27.8 14.8 37.9 21.6 27.3 16.3 24.8 13.5 23.4 18.4 29.8 22.7 19.6 22.0 24.1 32.9 30.9 15.5 26.9 25.6 28.1 31.8 42.1 21.2 27.4 27.8 17.8 22.7 12.2 20.5 12.4 12.0 11.7 10.7 18.7 12.7 10.3 10.9 10.2 21.8 24.8 8.2 17.4 17.4 4.8 7.0 10.8 6.7 5.9 6.4 6.6 5.4 7.1 7.0 6.7 10.9 24.0 41.7 12.6 19.6 24.5 31.5 18.6 14.8 16.5 18.6 17.9 11.7 26.1 11.5 20.5 12.9 14.6 20.1 19.1 24.8 31.3 26.8 46.8 17.5 28.4 22.5 7.2 54.1 50.9 29.5 19.3 31.9 13.7 31.7 29.8 19.0 13.9 19.0 13.9 35.3 42.4 17.5 18.3 17.1 20.2 44.2 20.5 21.9 24.9 48.7 14.0 18.7 12.3 41.7 56.4 36.1 16.9 14.3 34.5 22.3 21.1 19.9 19.3 30.2 13.1 27.6 25.9 20.8 15.2 20.4 38.8 65.8 21.1 21.8 14.3 30.2 TBPL1 "STUD, TLF, TLP, TRF2" ENSG00000028839 "TATA-box binding protein like 1" P62380 6 133952170-133990432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 126.7" "Group enriched" "Detected in all" 5 "Early spermatids: 407.5;Spermatocytes: 557.4;Syncytiotrophoblasts: 244.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071810, HPA071813" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA071810: AB_2686451, HPA071813: AB_2686452" "unprognostic (2.21e-3)" "unprognostic (1.95e-2)" "unprognostic (5.11e-2)" "unprognostic (6.67e-3)" "prognostic favorable (7.22e-4)" "unprognostic (5.16e-3)" "prognostic unfavorable (7.91e-5)" "unprognostic (1.19e-1)" "unprognostic (3.94e-2)" "unprognostic (4.66e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.82e-1)" "unprognostic (8.16e-2)" 12.1 11.7 16.9 12.0 18.9 37.5 10.5 19.0 23.0 10.4 12.7 11.7 13.3 12.3 8.1 11.7 13.1 11.8 11.9 19.3 19.4 9.2 13.7 9.7 21.3 14.2 12.9 12.5 8.1 10.4 11.7 14.8 14.2 12.2 14.3 15.0 9.1 12.3 6.4 9.0 12.9 11.1 11.7 12.6 11.7 126.7 20.0 19.8 16.8 9.2 16.9 15.1 9.8 16.5 16.5 19.6 43.9 28.5 32.6 33.3 24.5 29.9 31.5 39.1 51.1 23.0 13.0 49.8 20.2 24.1 43.8 21.2 28.0 32.3 46.8 38.3 35.9 87.8 11.5 25.5 33.0 46.4 32.8 20.8 32.2 43.8 47.1 30.7 37.6 43.3 129.3 33.4 28.1 37.0 39.2 27.8 49.2 23.6 25.1 26.7 26.4 19.5 23.2 14.3 56.5 56.2 17.7 23.2 37.8 36.9 10.5 18.5 34.4 22.5 32.4 50.0 33.6 27.2 31.5 32.8 37.7 30.0 27.4 133.1 31.7 81.8 62.7 33.3 69.8 67.6 53.1 67.1 29.8 60.2 50.6 59.5 74.8 52.5 38.3 35.4 60.5 64.0 16.9 18.9 19.0 23.0 19.3 19.4 14.2 12.9 14.2 11.7 20.0 16.5 35.6 6.4 12.2 10.7 43.2 70.7 27.0 46.7 46.1 22.8 29.8 34.2 12.8 28.6 21.1 7.3 18.8 40.7 59.1 16.8 29.4 29.1 407.5 20.6 17.1 40.8 71.0 51.4 35.3 25.2 69.7 30.8 36.7 14.8 40.0 13.5 22.9 11.2 24.4 15.2 25.2 26.5 48.8 14.8 43.2 75.1 21.1 38.3 32.0 22.5 21.3 23.3 42.2 27.2 27.7 31.4 24.2 18.4 35.2 39.7 17.9 28.4 28.2 12.3 19.7 27.3 35.1 557.4 72.8 36.7 65.8 244.9 50.0 11.0 24.3 37.6 TDG ENSG00000139372 "Thymine DNA glycosylase" Q13569 12 103965822-103988874 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052263 Supported Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Plasma membrane" "HPA052263: AB_2681777" "unprognostic (3.15e-1)" "unprognostic (1.36e-1)" "unprognostic (9.89e-3)" "unprognostic (6.93e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.27e-5)" "unprognostic (1.56e-2)" "prognostic unfavorable (6.90e-5)" "unprognostic (5.37e-2)" "unprognostic (1.82e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (1.90e-10)" "unprognostic (3.68e-1)" "unprognostic (2.90e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" 10.8 13.6 5.8 15.9 6.4 18.1 12.0 6.7 7.2 10.0 7.2 13.2 11.4 11.6 9.5 17.8 8.7 12.2 9.8 6.3 6.0 8.5 12.1 9.6 21.0 5.3 5.5 9.7 9.5 10.4 9.5 17.5 5.5 9.6 15.6 10.5 9.2 7.3 9.5 12.8 13.4 10.9 4.6 11.9 11.2 4.9 5.5 25.7 10.6 9.6 19.1 17.1 11.2 7.3 42.6 21.4 64.4 37.2 15.5 13.7 69.4 32.4 12.3 42.6 23.6 39.1 18.2 99.4 18.8 26.3 6.9 27.9 76.8 36.5 32.6 42.8 66.8 76.4 31.8 17.5 14.8 95.4 55.8 16.3 48.0 31.5 24.6 25.9 42.3 58.4 91.1 15.8 20.6 45.2 107.6 53.6 76.7 33.0 34.0 107.9 32.8 35.0 46.4 61.4 84.2 58.0 38.9 42.7 28.4 37.7 70.7 52.2 26.5 13.3 21.5 14.3 37.5 34.5 49.5 81.8 14.2 52.0 25.3 55.0 53.0 45.8 28.9 39.2 22.0 43.4 28.1 24.3 34.6 39.8 28.5 25.5 35.5 33.6 40.1 92.5 30.5 17.6 5.8 6.4 6.7 7.2 6.3 6.0 5.3 5.5 5.5 4.6 5.5 7.3 35.4 38.5 23.8 12.1 54.6 79.0 49.1 63.0 38.7 51.3 61.2 54.9 25.9 37.1 49.4 33.1 27.1 66.7 68.7 35.2 37.2 68.6 6.2 44.7 44.7 45.2 81.7 69.4 30.3 53.9 82.6 38.5 47.4 45.7 40.4 27.0 39.3 36.4 44.1 35.3 30.0 55.7 87.5 44.8 42.1 3.8 27.4 42.4 16.0 23.4 41.1 24.4 43.3 20.6 20.9 79.7 39.0 30.1 52.6 52.4 28.4 30.5 40.8 39.0 46.0 37.4 38.0 11.0 23.1 52.8 102.9 156.7 49.8 25.0 42.6 61.8 TFCP2 "CP2, LBP-1C, LSF, TFCP2C" ENSG00000135457 "Transcription factor CP2" Q12800 12 51093656-51173135 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 73.0;Inhibitory neurons: 75.9;Microglial cells: 69.3;Oligodendrocyte precursor cells: 79.4;Oligodendrocytes: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070247 Supported Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 5: NTERA-2 - Transcription" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Cytosol "HPA070247: AB_2686239" "unprognostic (6.27e-2)" "unprognostic (6.77e-2)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (4.68e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (9.69e-2)" "unprognostic (4.91e-3)" "unprognostic (1.01e-1)" "unprognostic (3.20e-1)" "unprognostic (5.58e-2)" "unprognostic (5.31e-2)" 16.7 12.9 12.4 18.5 14.7 9.8 16.9 13.9 16.4 18.4 10.1 17.0 14.9 18.0 16.1 13.5 19.6 13.5 17.7 13.2 13.1 16.1 11.3 13.5 21.0 12.4 13.0 18.6 13.8 25.0 14.2 18.8 12.6 18.5 20.3 32.1 16.3 15.0 26.7 14.3 15.1 18.1 12.6 18.5 15.2 9.1 12.8 27.3 17.1 22.1 26.0 15.5 13.4 16.9 17.3 29.5 43.0 40.4 25.2 31.3 64.1 30.7 18.6 29.8 17.4 52.4 37.6 1.5 27.9 29.4 21.9 33.8 56.0 35.2 29.4 35.5 28.3 47.4 26.6 23.8 20.3 57.9 48.4 21.3 33.3 29.4 47.8 34.0 28.4 15.1 54.1 0.1 32.0 0.0 55.2 39.5 64.0 39.9 55.3 41.2 23.6 0.4 39.2 39.4 41.1 36.0 38.8 34.6 28.1 41.7 13.0 49.0 24.3 27.1 27.9 27.8 28.4 30.8 53.3 0.1 25.8 35.3 19.5 7.4 6.1 6.6 2.3 5.4 3.8 2.8 2.4 2.6 5.6 1.8 3.1 2.4 2.1 6.9 7.2 2.2 3.8 3.3 12.4 14.7 13.9 16.4 13.2 13.1 12.4 13.0 12.6 12.6 12.8 16.9 9.3 9.6 16.4 57.8 11.0 6.6 6.9 10.7 9.1 21.6 11.5 10.5 23.8 8.6 8.7 12.9 20.9 13.2 19.6 11.4 5.9 9.2 0.8 11.0 14.1 10.2 10.8 5.9 73.0 7.7 10.5 9.7 10.7 14.6 10.8 22.5 12.5 9.3 13.7 10.1 75.9 13.2 10.2 21.1 10.8 0.7 12.2 17.0 10.6 69.3 36.8 9.8 24.7 79.4 103.6 12.2 11.0 10.9 7.3 11.1 8.7 9.4 9.2 27.3 0.0 14.0 13.1 6.7 11.3 9.9 5.3 16.7 10.7 12.2 13.4 6.4 TIMM17B "DXS9822, JM3" ENSG00000126768 "Translocase of inner mitochondrial membrane 17B" O60830 X 48893447-48898143 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029093 Approved Approved Microtubules,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Microtubules Mitochondria "HPA029093: AB_10600913" "unprognostic (7.87e-2)" "prognostic favorable (6.63e-4)" "unprognostic (8.44e-2)" "unprognostic (3.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-3)" "unprognostic (1.44e-1)" "unprognostic (2.01e-1)" "unprognostic (1.14e-2)" "unprognostic (2.04e-1)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (9.40e-2)" "unprognostic (5.24e-3)" "unprognostic (8.67e-2)" "prognostic favorable (7.88e-4)" 24.0 42.0 49.8 18.8 51.1 28.2 25.9 50.6 60.6 29.2 47.0 40.3 25.5 27.7 21.0 38.2 29.1 17.6 75.3 50.1 49.6 47.5 48.7 28.1 27.8 49.5 48.9 27.3 33.4 47.6 45.1 23.0 48.9 36.4 19.4 26.2 25.3 27.7 99.1 35.4 32.2 18.0 50.5 37.9 40.5 18.7 50.6 40.7 30.4 83.2 26.8 35.5 28.7 53.1 71.0 127.8 78.7 78.1 24.2 19.3 65.4 31.3 47.7 81.1 52.9 113.3 93.4 51.8 47.4 27.2 131.1 52.5 125.1 68.3 30.4 111.2 140.1 37.6 69.2 101.4 68.3 56.5 35.0 24.9 67.3 60.9 80.8 40.3 37.6 90.1 56.5 118.2 37.8 183.5 89.4 136.7 102.8 93.2 118.3 62.1 51.0 187.8 80.9 41.1 77.6 69.7 48.6 77.0 47.0 98.5 168.7 97.4 26.2 37.1 72.4 89.8 54.9 107.8 137.1 64.3 51.4 100.3 44.6 178.2 123.4 179.9 67.2 123.9 77.4 113.4 67.1 76.3 121.1 113.4 64.8 59.7 139.6 75.7 104.8 127.6 74.4 124.3 49.8 51.1 50.6 60.6 50.1 49.6 49.5 48.9 48.9 50.5 50.6 53.1 23.8 25.6 34.9 4.9 56.5 30.2 52.4 99.0 21.1 40.4 52.9 62.2 40.0 41.5 59.4 73.5 16.7 94.4 45.0 40.2 185.9 94.5 5.6 42.4 25.5 24.6 81.5 48.8 4.3 73.1 94.3 31.0 34.1 37.8 52.0 50.3 24.7 56.0 99.6 35.3 5.6 68.3 91.6 37.6 49.8 7.4 23.9 48.9 44.4 3.7 85.9 48.7 55.6 2.5 9.1 89.9 92.7 23.0 103.7 63.3 102.4 160.0 56.6 43.8 32.9 21.2 45.0 29.0 39.9 52.0 34.4 79.6 48.2 52.7 59.8 61.2 TIMM8B "DDP2, FLJ21744, MGC102866, MGC117373, TIM8B" ENSG00000150779 "Translocase of inner mitochondrial membrane 8 homolog B" Q9Y5J9 11 112084800-112086798 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 577.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041173 Approved NA NA 11000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA041173: AB_10796340" "unprognostic (1.36e-1)" "unprognostic (8.82e-2)" "unprognostic (1.19e-2)" "unprognostic (1.56e-3)" "unprognostic (6.45e-2)" "unprognostic (2.79e-2)" "unprognostic (4.38e-2)" "unprognostic (5.54e-2)" "unprognostic (1.19e-2)" "unprognostic (2.40e-3)" "unprognostic (8.17e-2)" "unprognostic (4.81e-2)" "unprognostic (3.48e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (2.44e-2)" 35.2 55.8 35.0 23.3 36.1 34.9 30.9 37.5 49.0 27.3 36.4 31.2 19.0 22.0 25.2 65.7 19.6 9.0 137.9 35.8 36.3 38.0 51.2 21.2 21.2 36.3 35.6 18.2 21.9 24.1 22.1 17.5 35.6 25.1 23.7 15.6 28.3 17.7 106.5 34.6 23.3 20.1 36.3 27.6 27.8 31.9 36.4 29.6 21.4 97.9 22.5 27.2 32.3 36.5 43.4 56.0 105.5 89.6 45.0 27.7 50.6 43.8 29.3 55.4 54.6 198.2 53.4 19.3 96.0 53.5 46.9 57.9 82.6 61.5 29.0 55.0 116.0 86.7 77.4 125.6 70.1 98.8 45.3 53.5 28.3 59.4 20.6 20.6 84.9 84.4 74.5 86.2 52.5 114.8 75.9 113.9 52.3 126.0 97.4 65.5 49.5 121.6 107.5 118.6 85.1 61.9 71.6 100.9 33.5 47.5 123.5 75.1 62.5 58.6 77.8 48.6 54.1 30.7 73.5 137.7 21.0 97.6 55.9 100.8 146.8 157.0 54.5 156.2 52.6 91.1 55.8 53.0 157.2 85.8 64.7 54.4 80.3 93.2 133.4 213.2 91.1 113.6 35.0 36.1 37.5 49.0 35.8 36.3 36.3 35.6 35.6 36.3 36.4 36.5 83.5 54.5 41.1 6.8 66.3 82.7 69.3 247.1 66.6 44.6 136.2 167.3 577.5 178.7 142.1 101.2 31.3 222.2 78.9 257.3 360.0 229.6 96.1 103.4 141.4 94.0 142.7 118.9 7.7 227.3 184.5 100.0 95.3 124.8 60.9 90.5 110.3 444.8 297.2 33.7 8.8 166.9 185.1 138.9 76.3 181.0 98.8 115.3 168.9 2.8 185.5 125.6 116.4 4.5 12.0 220.0 210.3 88.8 106.0 107.4 195.8 515.8 96.2 69.0 72.3 63.4 132.8 193.9 158.9 224.2 148.6 129.7 54.8 185.9 208.6 94.0 TIPRL "dJ69E11.3, MGC3794, TIP41, TIPRL1" ENSG00000143155 "TOR signaling pathway regulator" O75663 1 168178962-168202109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027995, HPA054282" Approved Supported Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Vesicles, Cytosol" "HPA027995: AB_10602900, HPA054282: AB_2682435" "unprognostic (3.18e-2)" "unprognostic (1.05e-1)" "unprognostic (5.05e-2)" "unprognostic (3.17e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-3)" "prognostic unfavorable (1.60e-4)" "unprognostic (5.82e-2)" "unprognostic (3.32e-2)" "unprognostic (1.12e-2)" "unprognostic (4.30e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.45e-8)" "unprognostic (3.23e-1)" "unprognostic (1.57e-1)" "unprognostic (5.55e-2)" "unprognostic (8.61e-2)" 16.3 14.9 15.5 19.6 16.3 33.8 21.0 15.0 20.1 17.7 12.8 22.2 19.0 23.2 16.8 20.1 14.3 16.8 23.7 16.8 17.0 17.8 22.5 14.9 22.2 14.0 13.4 17.4 15.9 27.4 13.6 17.5 14.4 18.4 22.0 14.7 12.0 17.3 24.4 16.3 18.5 22.7 13.4 16.3 15.4 18.2 15.1 30.1 17.4 23.0 19.9 18.7 13.6 15.7 69.4 31.0 45.9 41.6 36.7 53.1 27.5 50.5 53.0 54.6 48.4 48.3 50.1 49.0 68.2 48.7 40.1 81.8 34.5 49.3 52.6 47.2 36.4 47.3 29.2 22.9 64.5 94.7 62.0 43.2 62.8 47.4 62.7 36.0 58.1 75.4 69.0 66.3 47.7 25.4 84.9 49.0 37.0 96.7 54.2 41.1 47.0 66.4 49.7 33.9 29.6 66.1 39.3 54.6 102.2 51.6 59.9 96.3 53.4 45.6 52.4 43.6 69.7 72.2 80.5 108.1 29.8 61.4 53.4 71.6 26.7 36.8 22.0 32.1 22.1 27.3 25.7 23.8 31.6 27.6 22.8 22.4 34.5 29.6 33.9 23.4 36.0 28.2 15.5 16.3 15.0 20.1 16.8 17.0 14.0 13.4 14.4 13.4 15.1 15.7 52.1 25.6 20.4 9.4 39.7 48.2 42.1 70.4 50.1 27.3 31.3 36.2 46.3 22.8 40.7 22.0 16.7 44.2 49.0 37.1 29.4 68.5 53.4 36.0 50.1 43.4 24.0 32.6 41.6 88.9 62.8 47.3 24.5 30.8 40.0 35.2 36.0 33.5 65.1 52.2 37.9 33.9 44.7 26.6 41.1 15.4 37.6 42.6 30.2 19.7 61.0 43.9 51.5 22.1 21.3 69.7 27.7 38.0 37.1 43.3 35.9 77.2 36.1 20.8 26.3 35.4 51.1 151.5 51.6 56.0 41.8 29.0 48.0 84.5 38.5 37.5 TM2D1 BBP ENSG00000162604 "TM2 domain containing 1" Q9BX74 1 61681046-61725423 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046058, HPA055621" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Vesicles "HPA046058: AB_2679519, HPA055621: AB_2682865" "unprognostic (1.80e-1)" "unprognostic (1.99e-3)" "unprognostic (1.68e-1)" "unprognostic (2.20e-2)" "unprognostic (5.79e-1)" "unprognostic (5.23e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (1.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.00e-1)" "unprognostic (2.28e-2)" "unprognostic (1.15e-2)" "unprognostic (4.60e-2)" "unprognostic (1.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" 30.9 36.3 25.4 16.5 26.0 23.2 35.8 27.3 36.5 29.4 27.6 27.7 20.5 30.3 45.3 21.4 29.9 26.0 45.4 25.2 27.0 38.8 29.3 27.4 26.5 26.7 27.0 36.4 21.8 41.6 20.4 35.7 26.8 33.3 28.5 26.2 30.1 22.5 40.9 19.8 25.0 29.3 27.1 23.9 24.4 34.9 25.9 25.1 40.6 35.3 20.3 30.1 20.7 28.4 31.3 15.0 22.8 18.2 68.1 66.2 29.2 54.5 55.2 26.4 35.0 9.7 39.0 25.3 70.9 45.9 52.7 34.8 29.2 39.7 40.5 41.3 34.4 28.2 23.0 21.8 66.7 40.9 48.0 74.2 67.0 30.5 38.0 64.4 50.5 33.6 32.7 47.7 64.7 10.1 20.9 32.0 24.9 27.5 21.4 17.9 43.1 31.5 78.4 24.3 25.4 30.9 32.5 64.1 102.6 30.5 35.1 43.2 45.3 35.3 17.8 19.8 41.9 40.0 39.4 30.8 61.3 39.4 31.8 52.8 18.7 44.9 16.1 23.7 16.6 24.2 18.6 19.7 18.6 20.1 17.2 19.9 12.2 23.3 26.8 36.4 24.3 19.4 25.4 26.0 27.3 36.5 25.2 27.0 26.7 27.0 26.8 27.1 25.9 28.4 49.5 41.7 40.2 32.3 49.0 78.3 91.9 205.2 59.2 60.3 67.7 56.6 40.5 48.6 99.9 79.1 60.5 51.2 47.4 46.5 39.2 50.3 6.5 43.3 34.7 59.2 43.9 42.1 42.3 45.3 60.0 84.3 29.0 42.2 61.5 37.6 80.7 54.2 50.3 69.0 46.9 41.3 158.7 58.7 53.8 9.9 79.9 48.1 90.7 43.1 54.1 99.2 63.8 50.3 63.4 54.2 60.4 53.0 51.4 110.0 45.9 67.6 100.0 70.1 39.5 75.3 60.0 172.1 72.5 58.6 76.4 53.5 47.3 42.0 43.0 110.1 TM9SF2 P76 ENSG00000125304 "Transmembrane 9 superfamily member 2" Q99805 13 99446311-99564048 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005657 Supported NA NA 2100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 43: THP-1 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA005657: AB_1080303" "unprognostic (9.77e-3)" "unprognostic (3.51e-2)" "unprognostic (2.85e-2)" "unprognostic (1.09e-2)" "unprognostic (3.76e-1)" "prognostic unfavorable (6.40e-4)" "unprognostic (5.96e-2)" "unprognostic (1.54e-1)" "unprognostic (1.97e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.19e-2)" "prognostic favorable (5.21e-7)" "unprognostic (6.49e-2)" "unprognostic (8.55e-2)" "unprognostic (2.20e-2)" "unprognostic (2.21e-1)" 66.6 67.2 34.4 66.7 37.4 64.6 90.6 35.9 41.4 100.2 62.5 115.8 119.4 63.6 119.0 56.1 76.6 73.6 51.0 35.8 40.3 108.4 169.4 78.6 62.1 35.9 35.1 53.2 90.2 126.8 41.5 98.2 36.6 97.8 123.7 41.9 109.6 73.2 36.3 56.6 119.3 65.7 39.8 62.4 104.1 59.6 36.9 49.7 121.2 48.3 71.3 90.0 44.4 44.9 187.3 56.7 75.8 107.8 223.2 134.8 108.2 124.1 154.5 86.6 134.8 93.1 234.7 72.1 100.0 150.1 88.4 183.1 81.1 108.7 117.8 80.8 57.8 89.6 90.9 100.2 118.0 235.8 100.0 106.2 132.4 75.1 76.8 133.2 110.4 72.8 90.7 70.0 103.0 62.8 59.1 91.9 66.3 335.7 70.0 49.3 61.0 78.7 178.9 137.3 71.7 87.5 71.7 285.6 94.8 145.5 174.0 280.5 109.1 69.6 50.7 70.5 77.8 96.6 120.8 29.0 163.8 120.0 103.0 192.4 156.4 174.9 57.7 180.5 72.8 86.9 68.4 65.3 139.6 60.1 62.8 58.4 251.3 76.0 182.1 159.6 109.6 178.1 34.4 37.4 35.9 41.4 35.8 40.3 35.9 35.1 36.6 39.8 36.9 44.9 68.9 83.3 76.3 29.0 72.5 40.9 57.3 132.8 48.9 20.6 82.9 40.5 44.0 70.1 170.7 86.5 18.8 99.3 94.5 141.1 11.7 98.6 149.2 101.0 75.6 65.4 83.0 47.9 36.6 102.7 122.8 74.6 89.2 93.9 54.5 35.2 87.4 172.9 116.0 21.9 44.4 167.9 128.1 137.6 57.2 41.8 50.1 100.7 72.9 44.0 97.4 42.7 42.2 34.2 44.8 83.4 116.7 52.3 143.1 69.0 123.5 70.8 187.7 25.3 19.7 44.1 104.1 109.7 56.3 69.8 52.1 171.4 53.2 43.2 119.4 104.0 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favorable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 252.5 276.8 498.7 220.7 507.8 434.6 241.9 504.6 588.9 236.5 500.2 253.3 192.8 179.4 344.5 310.5 181.7 117.9 355.4 502.2 514.7 317.6 273.2 208.0 279.3 511.7 510.0 259.6 230.3 309.8 302.0 146.6 505.9 239.6 229.3 295.4 215.9 142.7 511.6 215.1 220.4 132.7 513.0 272.9 235.5 216.0 511.9 388.3 232.4 287.4 297.7 213.3 239.3 514.5 565.0 398.8 634.2 456.6 514.0 497.1 435.6 454.1 355.7 425.1 419.3 326.3 395.9 365.2 315.3 397.8 553.6 215.5 559.8 512.5 471.6 452.6 475.5 689.4 910.3 845.8 399.0 792.2 443.0 459.7 538.2 402.6 388.8 414.2 546.0 641.1 376.6 379.0 615.3 581.2 929.4 1071.2 847.1 607.0 637.3 262.2 397.0 620.4 746.0 748.7 207.8 526.1 511.0 369.3 736.1 583.6 356.7 1156.3 412.1 358.0 650.8 560.5 902.6 626.1 1001.6 902.8 459.1 754.2 379.9 1923.2 1058.7 2195.0 1127.1 1022.5 1237.6 1412.6 1486.0 1377.1 1150.8 1172.2 1464.7 1408.1 2036.5 943.8 1028.9 1521.6 1652.1 2663.7 498.7 507.8 504.6 588.9 502.2 514.7 511.7 510.0 505.9 513.0 511.9 514.5 518.8 240.4 370.4 20.9 615.0 716.3 534.0 1308.9 618.6 219.6 866.8 1111.2 633.4 513.3 616.2 901.2 106.3 785.4 797.4 948.2 1717.8 566.9 653.6 524.8 511.4 474.5 635.3 609.1 25.8 1032.9 830.9 443.7 356.3 646.1 454.4 376.5 574.7 1098.6 854.5 119.5 25.4 985.5 695.8 652.4 790.5 1123.9 646.8 544.3 777.3 18.7 850.3 522.8 1080.3 10.1 28.3 872.9 980.3 464.6 593.9 584.6 1211.0 1438.8 466.4 321.9 355.0 393.6 448.4 547.4 689.4 805.5 898.4 440.1 757.1 351.9 937.2 572.2 TMEM179B ENSG00000185475 "Transmembrane protein 179B" Q7Z7N9 11 62787402-62790400 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016585, HPA062068" Enhanced "Nuclear speckles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear speckles" "HPA016585: AB_1844357, HPA062068: AB_2684676" "unprognostic (1.18e-2)" "unprognostic (2.83e-1)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.68e-1)" "unprognostic (6.11e-3)" "unprognostic (1.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.44e-1)" "unprognostic (1.25e-2)" "unprognostic (4.61e-3)" "unprognostic (2.76e-2)" "unprognostic (4.56e-1)" "unprognostic (1.64e-1)" "unprognostic (2.16e-1)" "unprognostic (5.74e-3)" "unprognostic (3.60e-2)" 52.1 60.3 32.4 22.0 34.7 21.5 55.0 33.7 36.4 50.5 41.8 48.7 34.7 44.4 71.2 47.9 46.7 28.4 34.0 30.8 32.9 54.3 64.3 51.0 26.9 35.3 33.3 39.6 58.7 34.1 31.0 30.0 35.6 45.8 40.1 10.4 59.1 26.4 27.2 58.2 49.8 26.3 33.7 48.1 53.9 41.6 33.0 33.0 55.4 21.6 29.8 43.3 46.0 36.9 35.6 68.8 17.7 35.7 136.3 34.3 22.6 38.2 47.5 29.8 34.2 39.3 82.9 16.5 53.1 78.0 44.2 64.8 33.4 35.4 23.2 48.6 44.9 24.1 29.2 36.3 90.8 30.9 32.2 65.8 55.8 57.1 70.0 60.0 30.3 46.9 33.2 46.3 34.5 81.1 40.2 59.5 26.5 76.8 74.6 26.5 28.8 86.1 57.7 42.6 24.4 26.7 49.3 65.3 70.4 35.8 76.2 37.8 42.2 39.6 29.4 73.3 32.2 51.2 32.5 22.6 57.0 19.0 47.3 302.9 300.4 332.7 149.4 305.0 147.9 169.2 135.5 144.9 198.2 140.6 118.2 117.3 224.3 140.2 305.9 366.1 146.6 282.5 32.4 34.7 33.7 36.4 30.8 32.9 35.3 33.3 35.6 33.7 33.0 36.9 119.6 60.9 59.2 15.3 52.7 68.7 73.9 175.6 86.0 12.4 108.0 122.2 1.3 65.8 121.1 60.7 0.0 174.5 71.7 91.2 37.2 138.1 5.8 75.2 54.5 83.7 65.2 40.4 9.9 149.0 160.5 76.8 54.6 66.5 54.6 43.8 69.9 81.9 133.2 8.4 9.0 103.5 128.1 63.7 83.0 11.0 75.8 76.5 106.7 12.2 98.3 74.4 91.6 16.1 28.1 124.0 137.1 45.9 93.9 97.1 179.4 87.5 122.9 14.7 65.7 50.5 57.8 120.8 100.5 93.2 76.0 185.1 60.0 90.4 94.8 97.5 TMEM199 "C17orf32, MGC45714, VMA12, VPH2" ENSG00000244045 "Transmembrane protein 199" Q8N511 17 28357642-28363683 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027051 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 3: Monocytes - Immune response regulation" "HPA027051: AB_10600915" "unprognostic (3.01e-1)" "unprognostic (3.45e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.55e-4)" "unprognostic (9.98e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.78e-1)" "unprognostic (6.38e-3)" "unprognostic (1.09e-1)" "unprognostic (9.25e-2)" "unprognostic (2.75e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-3)" "unprognostic (5.95e-2)" 8.3 11.9 9.2 10.3 10.4 13.3 8.6 10.1 13.0 9.1 9.6 9.0 7.4 9.5 9.6 10.6 8.0 6.2 9.3 9.5 10.5 12.9 14.4 8.5 12.7 10.2 10.1 8.0 8.9 15.5 11.7 9.5 10.1 9.8 7.9 13.9 9.5 6.8 7.2 11.6 9.0 6.2 9.5 13.2 8.9 7.8 10.4 12.8 10.8 7.5 11.2 8.8 8.8 12.0 12.2 20.4 19.6 16.7 7.9 6.8 16.5 14.8 9.5 20.6 18.5 48.9 9.6 17.6 14.8 11.0 26.4 20.6 21.8 13.9 18.0 32.8 19.6 13.0 17.7 23.6 15.9 18.7 22.0 9.7 12.6 19.6 13.0 12.2 10.2 16.1 21.6 21.8 15.4 24.1 21.3 25.6 16.2 21.0 13.9 17.2 24.4 16.3 15.5 20.2 24.8 26.0 17.8 45.6 27.1 20.1 28.7 16.9 14.0 17.4 13.5 15.0 25.3 29.3 38.9 16.2 21.6 11.4 22.2 28.5 24.2 20.0 15.1 25.2 16.6 17.1 13.1 13.4 20.0 16.0 16.4 14.5 18.9 15.6 23.0 14.0 14.9 19.1 9.2 10.4 10.1 13.0 9.5 10.5 10.2 10.1 10.1 9.5 10.4 12.0 12.4 32.1 8.6 8.8 21.0 5.7 10.5 34.3 15.4 13.8 14.3 14.4 5.6 12.8 23.5 9.2 8.4 40.2 15.5 21.1 43.0 40.2 3.7 12.0 11.4 14.6 15.6 12.2 11.0 31.4 38.1 10.6 7.7 10.9 7.6 11.9 17.5 26.8 51.3 11.8 10.5 15.7 32.6 22.9 9.5 4.5 11.5 22.4 21.4 6.5 45.0 19.1 25.7 7.5 13.7 35.4 19.4 6.4 15.1 13.1 20.3 54.0 15.1 14.0 13.1 8.6 14.2 26.5 35.4 14.0 8.8 48.4 15.2 14.7 13.0 11.4 TMEM219 IGFBP-3R ENSG00000149932 "Transmembrane protein 219" Q86XT9 16 29940885-29973050 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 637.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059185 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 25: Spermatids - Spermatogenesis" "HPA059185: AB_2683941" "unprognostic (4.13e-2)" "unprognostic (1.94e-3)" "unprognostic (1.51e-1)" "prognostic favorable (5.79e-4)" "unprognostic (2.62e-1)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (9.83e-2)" "unprognostic (8.53e-2)" "unprognostic (1.71e-1)" "unprognostic (4.18e-1)" "unprognostic (1.19e-1)" "unprognostic (3.10e-2)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-3)" 119.7 181.1 246.7 50.2 256.4 79.4 117.6 241.4 280.2 103.6 249.0 130.4 121.9 85.0 164.7 119.1 130.0 89.8 130.4 234.5 239.8 173.7 194.7 125.0 75.3 252.4 244.6 107.9 161.6 109.3 105.2 55.9 243.8 139.5 88.2 39.7 175.9 97.7 101.4 121.4 127.7 65.6 252.5 138.3 170.6 140.6 251.1 62.5 114.0 89.3 73.4 110.7 100.6 247.5 58.8 70.2 60.1 77.8 157.0 161.8 68.5 59.7 123.2 87.7 113.3 34.4 168.4 46.3 111.2 151.1 63.9 34.0 35.5 82.0 43.3 81.6 68.0 44.3 53.3 114.2 181.1 29.8 108.5 146.5 124.0 63.0 55.2 166.7 142.6 126.2 30.9 95.4 115.5 63.8 41.1 98.2 34.8 119.3 45.4 81.8 37.6 107.5 158.8 38.4 33.8 67.1 20.5 40.7 110.7 81.0 66.6 109.7 79.5 69.9 41.7 36.0 28.3 74.0 24.2 39.5 93.9 99.0 59.2 471.8 333.2 450.9 146.6 253.1 151.0 213.7 205.9 154.2 274.5 206.2 191.3 149.2 154.9 132.7 187.3 298.5 246.2 328.3 246.7 256.4 241.4 280.2 234.5 239.8 252.4 244.6 243.8 252.5 251.1 247.5 174.0 70.5 122.2 16.0 82.3 67.0 134.0 207.4 84.8 23.7 239.3 258.4 73.2 167.3 158.1 176.6 10.4 80.4 85.6 309.2 252.4 183.3 181.0 107.8 67.0 143.2 180.4 39.3 10.8 238.7 225.3 97.1 87.7 97.1 142.5 84.1 213.5 165.7 269.2 16.8 13.4 273.1 154.6 260.8 149.8 524.8 86.6 189.8 167.2 6.5 192.0 119.6 114.4 12.5 23.8 213.7 333.7 100.4 95.8 136.2 637.1 371.1 183.7 30.7 52.6 54.8 92.5 101.1 117.5 119.1 78.6 71.1 89.4 118.7 227.9 215.0 TMEM258 "C11orf10, Kud, Kuduk" ENSG00000134825 "Transmembrane protein 258" P61165 11 61768501-61792802 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044602 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Plasma membrane" "HPA044602: AB_10961423" "unprognostic (6.35e-2)" "unprognostic (1.70e-1)" "unprognostic (7.49e-2)" "unprognostic (4.99e-3)" "unprognostic (9.95e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.24e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.37e-4)" "unprognostic (1.34e-3)" "unprognostic (7.39e-2)" "unprognostic (4.75e-3)" "unprognostic (2.59e-2)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.58e-1)" 116.4 158.4 125.5 66.1 128.7 128.4 120.8 130.8 162.2 142.2 123.0 112.4 80.9 116.0 350.1 122.8 123.1 59.3 170.8 122.6 128.7 123.5 160.6 110.0 83.0 130.0 125.6 154.9 300.3 80.5 128.9 80.4 130.3 105.5 107.6 44.0 183.9 88.7 146.7 95.3 99.8 81.5 131.1 124.4 142.8 79.1 126.8 111.7 109.1 120.6 108.9 107.5 111.7 140.1 144.3 254.9 194.9 173.3 329.0 308.4 117.1 113.9 177.1 104.5 124.8 223.5 265.5 103.9 205.9 272.1 196.1 154.8 186.7 222.7 149.1 141.7 168.6 86.8 258.3 347.6 310.7 186.9 96.3 272.5 339.6 137.1 364.8 267.9 210.9 207.4 221.7 394.5 185.4 501.1 131.2 318.8 267.1 315.6 172.9 142.1 144.6 673.0 241.5 243.7 169.3 173.1 103.8 221.7 211.5 179.6 244.5 347.3 108.0 129.2 111.7 166.1 78.3 248.6 201.7 173.6 183.8 112.6 135.7 507.9 225.6 287.6 169.5 200.4 216.5 233.2 198.8 190.1 177.8 187.1 167.1 166.7 182.4 151.7 204.4 496.4 236.8 244.9 125.5 128.7 130.8 162.2 122.6 128.7 130.0 125.6 130.3 131.1 126.8 140.1 211.3 102.5 224.1 6.8 323.6 228.9 220.5 794.5 170.8 41.3 525.1 608.3 491.3 403.2 445.9 318.2 18.8 409.5 279.8 306.2 295.4 534.8 234.4 369.2 304.7 254.8 311.1 197.7 7.4 654.4 667.7 314.8 210.5 305.6 226.7 261.8 335.2 572.9 461.4 37.0 8.2 631.5 441.5 401.7 396.9 142.8 335.5 265.7 569.2 3.7 430.0 418.6 270.8 6.0 25.8 469.4 432.6 214.4 821.3 296.6 392.2 553.8 470.9 73.9 170.9 192.3 248.5 399.4 433.8 297.4 279.0 508.0 245.2 135.3 442.1 274.9 TMEM59 "C1orf8, HSPC001" ENSG00000116209 "Transmembrane protein 59" Q9BXS4 1 54026681-54053504 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075447 Approved NA NA 27000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA075447: " "unprognostic (2.63e-1)" "unprognostic (9.88e-2)" "unprognostic (2.63e-2)" "unprognostic (2.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (8.28e-2)" "unprognostic (4.10e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (4.49e-2)" "unprognostic (6.34e-3)" "unprognostic (9.84e-2)" "unprognostic (1.70e-1)" "unprognostic (6.83e-3)" "unprognostic (7.38e-2)" 257.6 359.7 181.9 164.6 220.8 259.7 341.4 240.3 253.8 343.6 379.5 488.3 364.1 208.7 415.5 241.8 403.2 299.3 275.7 178.4 202.0 473.7 505.7 264.0 162.6 240.6 205.0 225.4 586.1 532.5 170.2 325.8 239.1 350.2 485.3 254.2 550.3 279.9 194.5 194.7 369.1 219.8 235.7 188.7 433.0 174.9 204.6 186.9 341.3 247.6 189.2 289.2 202.6 286.8 188.9 122.3 142.8 185.2 844.1 371.1 182.8 347.9 499.1 211.5 276.0 99.1 391.9 96.7 322.6 595.6 257.7 281.1 166.2 237.5 221.9 237.7 177.4 133.5 266.6 166.1 317.8 165.7 268.7 408.3 411.2 207.5 219.2 566.9 246.6 127.8 158.9 326.3 245.1 91.6 97.9 137.3 201.0 528.3 226.3 94.0 251.6 403.2 257.6 248.0 208.2 173.3 381.5 386.0 398.3 266.2 184.9 348.4 259.3 259.8 90.7 193.3 187.8 289.0 338.7 114.5 349.4 275.4 222.3 1183.5 654.6 831.5 439.7 532.9 461.8 449.3 465.9 480.4 520.9 405.2 430.3 426.4 1196.5 430.4 595.9 527.1 576.1 1153.8 181.9 220.8 240.3 253.8 178.4 202.0 240.6 205.0 239.1 235.7 204.6 286.8 355.3 233.9 181.3 49.6 221.3 404.2 637.0 1214.2 237.3 150.2 409.0 325.1 155.1 479.0 991.8 437.7 118.9 477.7 244.5 905.2 160.4 527.8 357.1 348.5 201.9 279.5 408.2 277.0 44.3 352.5 528.7 410.6 226.8 217.2 155.2 89.5 334.4 413.2 320.2 132.9 42.1 672.8 1131.1 302.9 290.3 183.1 432.7 225.4 690.1 27.2 209.3 473.5 190.5 60.3 176.6 329.3 1064.8 354.0 692.8 583.2 1015.8 468.8 977.4 183.6 368.1 198.6 350.4 488.9 210.1 245.5 414.3 687.1 227.2 185.8 534.9 750.4 TMEM60 "C7orf35, DC32" ENSG00000135211 "Transmembrane protein 60" Q9H2L4 7 77793728-77798434 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062625 Approved NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "HPA062625: AB_2684811" "prognostic favorable (3.09e-4)" "unprognostic (1.06e-1)" "unprognostic (1.42e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-3)" "unprognostic (3.91e-2)" "unprognostic (5.28e-3)" "unprognostic (2.73e-3)" "unprognostic (3.46e-1)" "unprognostic (4.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (2.72e-2)" "unprognostic (9.44e-2)" "unprognostic (2.07e-3)" "unprognostic (4.43e-3)" 15.9 23.9 17.5 17.6 17.4 10.6 29.6 18.4 21.4 21.7 19.5 24.9 17.7 16.6 29.7 15.3 18.9 18.6 17.1 17.4 19.3 30.4 35.5 18.9 29.2 18.0 17.5 23.3 18.2 39.8 17.5 23.5 18.2 17.4 24.3 14.1 21.2 19.9 22.9 16.5 17.0 19.6 18.9 20.4 16.4 24.1 17.8 20.4 25.8 20.3 27.7 16.9 13.1 19.1 45.7 30.3 46.2 54.4 61.6 54.5 21.2 41.8 79.9 44.2 69.9 28.4 56.8 35.1 10.0 39.4 150.6 46.8 44.0 24.6 49.7 27.5 41.9 19.0 26.9 39.9 43.4 26.9 33.9 39.9 35.1 32.8 39.6 42.8 31.9 32.0 45.7 68.2 70.4 49.3 20.4 68.7 32.3 55.3 39.4 24.1 36.6 50.7 52.9 33.9 23.2 37.4 31.4 43.7 66.0 48.7 52.8 49.0 21.2 55.6 38.7 49.2 31.4 27.6 46.6 51.1 42.3 55.8 50.2 208.6 51.3 100.2 29.2 58.7 32.4 88.9 51.0 36.9 40.3 72.5 42.9 36.6 52.7 32.3 54.7 52.6 79.4 41.2 17.5 17.4 18.4 21.4 17.4 19.3 18.0 17.5 18.2 18.9 17.8 19.1 16.5 9.6 11.5 2.9 33.5 30.0 34.6 61.7 25.6 7.6 37.5 42.4 8.0 20.0 29.0 44.1 8.4 56.4 17.6 22.0 52.8 28.4 9.4 17.7 13.7 20.1 9.1 14.5 6.1 29.8 40.2 26.9 11.7 14.5 24.7 21.1 24.7 26.3 70.8 13.5 6.5 30.6 61.1 43.5 38.9 10.9 45.7 39.1 28.4 7.5 42.6 21.5 21.6 3.0 7.9 27.6 31.4 35.3 15.4 35.4 30.3 50.5 31.4 12.4 52.6 12.6 50.5 49.8 40.3 31.0 33.4 43.9 20.8 16.4 23.6 39.3 TMEM9B C11orf15 ENSG00000175348 "TMEM9 domain family member B" Q9NQ34 11 8947202-8965011 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037784 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA037784: AB_10671886" "unprognostic (3.18e-1)" "unprognostic (4.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.84e-3)" "unprognostic (1.13e-1)" "unprognostic (8.48e-3)" "unprognostic (2.56e-2)" "unprognostic (6.34e-2)" "unprognostic (1.52e-1)" "unprognostic (3.78e-2)" "unprognostic (1.89e-2)" "unprognostic (5.06e-1)" "prognostic favorable (4.26e-5)" "unprognostic (1.83e-1)" "unprognostic (1.82e-1)" "unprognostic (5.51e-3)" "unprognostic (9.56e-2)" 34.2 40.0 67.6 33.8 70.5 78.0 47.9 70.1 80.8 37.0 62.3 63.6 54.6 22.2 59.0 62.4 31.4 39.5 53.3 65.1 69.3 60.2 39.8 50.7 40.5 70.6 69.5 24.1 41.4 63.9 38.5 45.2 71.5 34.2 67.0 42.3 51.4 26.0 47.4 45.5 54.8 22.2 70.8 41.7 59.3 27.5 72.0 35.6 75.0 42.9 43.3 47.3 35.9 75.2 63.0 42.4 23.7 46.0 117.1 65.9 41.1 78.4 69.3 45.2 46.3 32.4 96.7 39.1 40.3 81.6 53.2 81.9 22.3 57.5 47.3 72.7 45.0 26.2 36.8 31.0 66.3 53.2 79.5 61.1 94.6 27.9 56.0 61.7 54.5 26.4 21.0 58.0 87.2 43.9 16.6 33.9 7.4 90.1 49.5 18.8 30.4 31.6 67.7 72.4 26.4 22.5 44.8 92.3 40.6 29.7 55.7 35.1 59.4 55.0 24.9 93.7 48.6 24.1 44.7 27.8 69.0 35.0 47.5 178.7 104.5 151.8 98.5 134.7 101.7 103.2 94.3 109.8 112.6 89.3 77.7 109.0 50.5 93.3 150.2 80.7 136.8 159.8 67.6 70.5 70.1 80.8 65.1 69.3 70.6 69.5 71.5 70.8 72.0 75.2 61.5 41.7 52.0 17.9 65.7 65.0 65.5 155.5 58.6 61.0 67.5 35.9 28.6 70.1 104.1 95.6 20.9 104.8 69.6 124.0 70.5 84.5 16.4 29.2 28.0 49.3 31.2 111.6 21.9 80.7 112.9 48.0 34.7 43.8 88.1 21.1 55.0 30.5 109.3 43.7 23.2 78.8 213.6 79.0 109.8 13.4 38.2 70.1 60.5 15.9 58.1 82.6 77.2 24.1 33.8 70.9 103.9 28.6 53.6 59.2 114.7 45.7 53.2 49.2 19.7 41.6 26.2 56.4 58.2 83.7 87.4 160.8 66.8 40.3 82.8 80.6 TNFAIP8L2 FLJ23467 ENSG00000163154 "TNF alpha induced protein 8 like 2" Q6P589 1 151156649-151159749 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.2" "Cell type enhanced" "Detected in some" "Hofbauer cells: 70.4;Kupffer cells: 65.4;Macrophages: 35.8;monocytes: 34.7;NK-cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 29.8;HL-60: 17.6;HMC-1: 44.1;NB-4: 25.2;THP-1: 95.2;U-937: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062742 Approved Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "HPA062742: " "unprognostic (3.19e-3)" "unprognostic (1.02e-2)" "unprognostic (6.63e-3)" "unprognostic (2.27e-2)" "unprognostic (1.29e-1)" "unprognostic (6.49e-3)" "unprognostic (1.05e-1)" "unprognostic (9.15e-3)" "prognostic favorable (3.64e-4)" "unprognostic (9.54e-2)" "unprognostic (3.32e-2)" "unprognostic (9.03e-2)" "prognostic unfavorable (3.53e-7)" "unprognostic (1.78e-1)" "unprognostic (3.91e-2)" "unprognostic (4.87e-2)" "unprognostic (2.23e-1)" 4.7 4.3 4.9 19.6 5.4 6.1 3.4 5.1 7.5 2.3 5.7 4.5 5.3 1.5 1.4 2.5 2.2 5.5 2.3 4.7 5.2 2.0 5.6 10.8 32.0 6.5 5.7 1.0 1.4 1.2 1.2 6.9 7.0 2.1 6.1 0.9 2.6 1.8 0.8 3.8 7.6 5.4 6.4 39.2 3.4 0.8 6.3 19.2 1.3 2.2 17.7 7.8 1.4 8.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 29.8 0.4 0.0 0.0 17.6 44.1 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.1 0.1 0.0 0.1 0.4 25.2 0.0 0.0 0.1 5.3 0.1 4.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 95.2 2.5 0.2 0.1 0.1 0.2 0.3 0.0 1.9 0.1 37.8 0.1 317.0 238.8 246.7 103.2 220.2 101.9 78.3 125.7 105.2 265.4 83.2 189.5 137.3 292.3 232.9 210.6 63.0 155.7 249.5 4.9 5.4 5.1 7.5 4.7 5.2 6.5 5.7 7.0 6.4 6.3 8.1 0.3 0.0 1.7 0.0 6.9 0.3 0.0 0.0 0.0 0.8 0.8 0.3 0.1 2.8 1.3 0.0 0.0 0.3 11.1 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 8.8 0.0 0.0 0.5 0.2 0.0 0.0 5.1 0.0 0.7 0.3 70.4 0.0 0.0 0.0 0.0 65.4 12.8 0.4 0.3 35.8 0.0 0.0 34.7 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.4 10.6 0.0 0.0 0.0 TOP1 ENSG00000198900 "DNA topoisomerase I" P11387 20 41028822-41124487 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 801.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009058, HPA019039" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center" No Yes 7600 "Cluster 31: Non-specific - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 36: HEL - Hemostasis" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Nucleoli fibrillar center" "CAB009058: AB_2303554, HPA019039: AB_1858187" "unprognostic (1.46e-1)" "unprognostic (8.65e-2)" "unprognostic (1.33e-2)" "unprognostic (1.92e-3)" "unprognostic (5.05e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.86e-2)" "unprognostic (1.51e-1)" "unprognostic (4.60e-2)" "unprognostic (3.74e-3)" "unprognostic (6.51e-2)" "unprognostic (8.65e-2)" "unprognostic (4.70e-2)" "unprognostic (5.14e-1)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" 37.9 36.7 17.4 49.9 18.6 74.9 27.9 21.8 25.1 26.9 25.3 36.9 42.6 27.9 34.4 36.7 22.4 37.2 19.1 18.0 18.9 39.0 47.5 40.0 59.9 18.5 18.4 24.3 28.6 26.7 22.4 50.2 18.1 31.8 37.3 25.5 26.7 24.2 21.3 26.5 42.6 23.9 18.7 38.5 36.5 18.9 18.8 58.9 37.6 20.2 60.6 42.7 28.8 19.2 105.2 71.7 131.4 108.2 52.2 61.8 129.8 92.6 81.0 105.0 94.8 190.5 127.6 296.4 96.4 48.5 112.3 98.9 159.1 147.2 153.0 64.9 81.6 378.6 54.9 139.0 135.4 165.1 124.0 69.8 76.4 102.4 166.8 94.0 111.5 98.1 167.8 98.7 120.9 233.2 235.3 119.7 106.3 104.1 131.6 197.7 123.1 157.7 121.4 95.2 108.6 75.4 145.4 88.3 95.0 94.2 98.6 146.4 109.9 84.7 71.3 78.8 100.9 62.7 75.6 338.3 113.7 91.1 82.0 12.6 9.9 16.8 6.6 10.3 8.3 10.5 7.3 7.0 9.5 10.1 7.7 6.9 19.1 6.3 13.2 18.8 9.0 5.4 17.4 18.6 21.8 25.1 18.0 18.9 18.5 18.4 18.1 18.7 18.8 19.2 116.9 118.6 201.5 66.0 117.6 245.9 338.0 90.3 153.7 98.2 90.5 75.7 49.7 78.6 170.3 99.3 60.5 192.1 137.1 194.1 74.3 94.4 10.0 151.3 167.4 115.1 91.8 486.5 86.9 65.8 175.4 121.4 84.1 259.2 78.6 119.1 67.1 131.7 99.2 72.3 77.4 126.9 69.2 101.2 109.1 12.8 59.7 151.6 72.9 74.9 95.4 88.0 78.2 87.4 90.7 119.2 169.8 69.6 234.1 162.3 94.1 136.2 68.3 87.0 85.5 135.5 130.8 116.8 54.6 129.4 214.2 801.5 111.5 123.7 117.8 237.7 TOR1A "DQ2, DYT1" ENSG00000136827 "Torsin family 1 member A" O14656 9 129812942-129824244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012473, HPA051195" Approved Supported "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA 20000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane, Vesicles" "CAB012473: AB_2240792, HPA051195: AB_2681382" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.95e-1)" "unprognostic (1.86e-3)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (2.10e-2)" "unprognostic (1.41e-1)" "unprognostic (4.10e-2)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (3.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.77e-1)" "unprognostic (1.99e-1)" 21.2 24.2 14.3 20.7 14.8 34.5 19.6 14.7 17.7 18.6 14.2 20.7 16.6 20.3 19.9 14.3 17.2 20.6 16.8 15.7 15.9 20.5 35.9 19.4 22.9 13.6 14.0 17.2 19.5 19.4 14.3 23.5 14.0 21.3 22.3 9.8 17.0 23.1 16.4 17.8 18.8 25.4 14.1 18.8 18.1 9.2 15.4 26.3 23.8 14.9 19.0 28.6 15.6 14.8 33.7 49.5 35.9 41.5 53.1 51.3 47.4 76.7 94.5 67.0 57.2 32.3 48.2 41.0 44.0 99.7 46.0 77.2 34.7 50.8 54.7 65.7 32.9 36.9 49.8 32.3 66.9 82.1 65.5 69.8 50.7 63.5 45.6 61.5 73.2 65.3 66.5 32.3 74.6 84.3 58.9 79.3 53.8 39.2 55.6 30.5 56.5 41.9 54.9 42.4 27.0 47.6 79.3 30.7 43.3 40.1 61.6 63.4 65.1 66.1 37.7 49.6 59.6 36.6 87.0 37.7 49.0 46.9 54.3 95.5 72.8 141.3 57.4 68.5 48.1 45.5 48.4 52.1 61.4 33.5 40.9 42.4 72.7 68.6 58.3 56.5 59.1 78.9 14.3 14.8 14.7 17.7 15.7 15.9 13.6 14.0 14.0 14.1 15.4 14.8 25.0 9.6 11.8 5.5 17.5 17.6 16.6 39.5 12.0 11.2 16.5 15.9 9.9 18.6 24.4 14.7 2.1 47.9 39.3 18.7 15.6 42.1 0.7 12.5 18.8 24.2 19.2 30.5 6.3 49.9 65.7 25.0 13.7 15.0 22.2 23.4 16.1 22.7 45.2 21.9 6.4 17.8 26.4 19.1 22.4 1.3 12.8 27.9 14.2 3.7 47.6 18.5 35.0 9.5 6.6 40.1 18.9 15.4 23.7 24.7 21.0 17.0 14.9 9.2 32.9 15.2 24.3 7.3 10.1 9.3 18.5 53.4 25.5 23.4 15.4 19.6 TP53I3 PIG3 ENSG00000115129 "Tumor protein p53 inducible protein 3" Q53FA7 2 24077433-24085861 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 119.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 175.8;Late spermatids: 213.9;Proximal enterocytes: 200.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "T-47d: 599.7" "Low region specificity" "Detected in all" "CAB017479, HPA022012, HPA028742" Enhanced Supported Vesicles NA NA 250000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456" "unprognostic (3.66e-2)" "unprognostic (1.41e-3)" "unprognostic (5.55e-2)" "unprognostic (8.04e-2)" "unprognostic (7.10e-3)" "unprognostic (4.47e-1)" "unprognostic (1.09e-2)" "unprognostic (1.53e-3)" "unprognostic (1.17e-1)" "unprognostic (2.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-1)" "unprognostic (3.67e-2)" "unprognostic (8.57e-3)" 20.2 24.6 8.6 16.1 9.8 20.0 17.2 8.4 9.6 29.6 11.2 54.4 51.5 17.3 4.5 119.2 16.5 26.3 15.4 7.5 9.0 46.8 15.2 29.9 7.2 9.4 11.1 8.2 40.1 7.0 11.7 10.6 8.5 15.0 40.8 2.0 25.3 11.2 6.2 8.0 69.1 16.9 7.7 11.9 25.3 38.4 13.0 14.2 23.6 5.9 10.1 22.3 63.8 9.7 27.5 86.8 50.6 21.1 38.8 85.3 37.2 27.3 32.3 22.6 31.1 22.1 48.4 3.5 15.0 44.0 6.1 8.0 13.1 46.5 13.8 21.6 2.0 8.7 33.3 57.5 25.2 4.1 15.3 92.3 72.3 60.2 14.7 46.1 102.0 16.3 7.3 23.4 95.5 18.1 5.0 0.6 39.2 30.8 36.0 10.1 45.7 0.9 38.1 41.4 7.2 32.9 35.1 7.8 6.1 40.5 599.7 5.6 80.6 26.9 63.8 18.5 13.7 10.6 7.4 3.0 8.9 0.4 7.0 11.8 19.1 16.9 0.2 12.6 0.2 4.9 0.2 0.6 16.0 5.5 0.1 0.4 4.1 0.3 5.6 7.1 0.5 6.1 8.6 9.8 8.4 9.6 7.5 9.0 9.4 11.1 8.5 7.7 13.0 9.7 19.2 28.9 38.4 3.9 6.8 4.7 24.7 69.7 6.8 0.8 25.8 33.0 9.0 50.1 51.9 42.3 0.0 41.9 1.1 175.8 109.5 93.5 127.8 50.4 47.4 20.3 79.4 7.2 0.4 134.7 31.9 30.6 83.6 68.2 12.7 85.8 23.9 12.9 45.0 0.0 0.4 63.9 57.0 22.9 11.1 213.9 7.8 20.9 14.2 4.7 23.9 9.5 0.0 5.0 0.3 91.1 138.5 9.1 8.0 11.4 200.9 104.7 19.2 1.9 19.7 14.1 36.8 56.6 14.3 38.8 7.0 28.9 3.4 16.2 75.2 49.9 TPI1 ENSG00000111669 "Triosephosphate isomerase 1" P60174 12 6867119-6870948 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Glycolysis" "Isomerase, Lyase" "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2470.8;tongue: 2005.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050924, HPA053568" Uncertain Approved Nucleoplasm,Vesicles NA NA 170000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Vesicles "HPA050924: AB_2681276, HPA053568: AB_2682193" "unprognostic (2.85e-1)" "unprognostic (5.58e-3)" "unprognostic (1.65e-1)" "unprognostic (1.62e-2)" "unprognostic (6.94e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (4.14e-3)" "unprognostic (7.49e-2)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (7.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" 340.4 588.6 446.2 269.7 480.2 334.8 274.5 476.5 541.9 314.1 446.9 425.6 421.0 240.5 220.2 764.4 248.2 216.8 819.8 481.0 462.0 609.0 536.1 308.6 253.9 459.2 460.4 269.9 238.1 496.4 236.8 287.2 467.2 272.1 435.3 625.0 377.6 273.3 2470.8 410.1 404.5 301.5 429.7 291.4 329.0 239.8 503.5 200.3 269.1 2005.8 410.4 363.8 440.6 454.4 1556.8 1350.5 706.1 1094.6 666.5 696.6 1236.3 1097.5 1184.9 1999.1 2407.5 1409.9 823.0 903.4 212.7 1069.7 1042.4 748.8 1671.0 1812.3 2189.4 1196.4 1265.1 1172.0 924.4 926.2 496.8 1351.5 924.0 764.0 739.7 1537.8 1305.0 2816.1 1233.3 451.0 615.0 336.5 1554.5 1130.0 709.6 1119.5 1741.0 1302.3 855.9 413.5 1156.1 930.7 1261.4 1061.1 497.2 830.0 953.3 977.8 542.7 1452.6 224.4 1003.2 778.2 1068.0 914.6 703.1 1631.7 653.4 285.7 1327.8 2153.1 821.2 784.9 1708.8 2304.1 2375.2 824.6 2402.3 845.7 863.3 820.0 808.0 2656.1 800.9 570.5 703.0 934.3 1387.7 2165.7 482.0 1106.3 4679.5 446.2 480.2 476.5 541.9 481.0 462.0 459.2 460.4 467.2 429.7 503.5 454.4 311.5 134.6 204.2 34.6 290.6 684.8 553.8 1756.4 414.9 284.6 294.3 303.3 552.5 391.7 673.0 389.9 110.5 1017.0 278.2 850.3 1508.5 1361.5 203.0 280.8 307.0 352.0 425.5 243.3 38.4 786.5 1824.0 386.5 408.3 343.9 362.8 364.8 276.6 547.3 937.3 297.8 33.7 567.2 1151.5 386.7 750.4 683.5 279.0 482.8 674.1 18.7 1129.8 739.6 312.0 17.1 26.7 1081.5 889.4 263.3 427.9 556.2 1595.9 1642.7 401.2 298.0 197.2 270.5 551.3 14.9 79.0 690.4 615.9 1530.4 352.9 869.2 827.0 652.5 TPST2 TANGO13B ENSG00000128294 "Tyrosylprotein sulfotransferase 2" O60704 22 26521996-26596717 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 398.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 171.0;NK-cells: 263.7;Plasma cells: 183.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 158.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021054 Enhanced "Intracellular and membrane" NA NA 88000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 25: Pancreas - Digestion" "Cluster 3: HMC-1 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA021054: AB_1858221" "unprognostic (2.24e-1)" "unprognostic (1.70e-1)" "unprognostic (1.74e-2)" "prognostic favorable (8.08e-5)" "unprognostic (8.88e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-2)" "unprognostic (9.70e-2)" "unprognostic (3.18e-2)" "unprognostic (3.38e-1)" "unprognostic (2.70e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (2.34e-6)" "unprognostic (9.68e-2)" "unprognostic (9.21e-3)" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" 24.4 31.0 24.4 15.2 20.8 23.1 21.8 19.1 29.9 17.4 26.9 11.5 13.6 18.0 111.6 18.7 17.0 12.2 27.5 23.4 22.9 24.9 74.9 45.7 19.1 22.0 24.2 9.2 398.8 5.3 9.9 41.8 20.8 16.0 8.8 3.3 10.9 17.8 38.5 18.4 13.4 12.1 23.1 36.4 11.7 20.6 34.2 10.7 38.8 22.6 17.0 17.1 17.3 20.7 12.8 9.1 11.7 6.0 24.4 18.7 16.4 27.9 49.9 22.2 20.3 6.2 6.5 21.4 7.3 50.4 11.6 19.5 8.8 19.2 12.7 8.8 16.9 51.8 5.6 13.1 10.2 6.0 158.7 20.1 30.3 22.5 7.7 22.5 41.6 9.6 52.6 65.2 17.2 14.3 24.3 40.7 15.4 10.0 9.1 22.5 15.8 60.2 6.7 14.3 8.8 6.1 12.9 11.2 16.0 17.0 5.2 24.7 33.2 27.3 61.2 22.5 27.3 20.9 31.5 20.6 20.7 23.1 25.3 490.4 77.0 111.9 249.2 86.3 70.5 23.6 57.0 187.2 48.3 25.6 27.8 163.6 163.0 354.9 94.3 115.3 71.9 240.7 24.4 20.8 19.1 29.9 23.4 22.9 22.0 24.2 20.8 23.1 34.2 20.7 37.3 16.0 12.6 13.7 30.8 38.1 82.5 29.9 14.2 9.0 10.8 13.1 15.5 47.1 14.4 22.0 6.2 171.0 120.8 6.7 27.4 12.9 15.2 31.1 14.8 66.1 0.0 64.6 23.4 65.1 49.8 10.7 5.1 39.5 53.7 13.9 113.6 79.3 123.9 6.7 20.3 9.3 12.2 55.9 48.6 4.5 5.3 70.1 28.4 47.8 32.4 1.9 263.7 5.0 1.9 53.1 8.7 4.1 183.7 36.4 16.5 7.6 18.6 5.3 6.6 9.9 15.3 2.9 13.2 15.1 35.9 143.0 64.4 42.0 11.8 83.7 TRAPPC1 "BET5, MUM2" ENSG00000170043 "Trafficking protein particle complex 1" Q9Y5R8 17 7930345-7932123 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052398 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 3: Monocytes - Immune response regulation" "HPA052398: AB_2681813" "unprognostic (1.07e-1)" "unprognostic (3.89e-3)" "unprognostic (1.49e-2)" "unprognostic (7.81e-3)" "unprognostic (1.20e-2)" "unprognostic (3.58e-2)" "unprognostic (1.93e-1)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (9.86e-2)" "unprognostic (1.83e-2)" "unprognostic (1.88e-1)" "unprognostic (1.31e-2)" "unprognostic (2.22e-2)" "unprognostic (1.71e-1)" "unprognostic (8.06e-2)" "unprognostic (2.64e-1)" 111.7 145.2 130.1 91.9 128.2 100.6 100.8 133.8 142.5 99.3 124.8 119.5 83.0 129.8 124.8 156.7 94.0 74.4 169.6 129.1 139.2 158.7 123.6 132.4 140.5 136.4 134.0 79.7 101.1 109.4 124.3 114.6 134.1 93.7 87.9 67.5 103.7 65.8 139.1 110.1 121.9 102.4 127.5 170.7 118.0 72.6 145.6 166.0 101.4 94.4 153.0 108.9 104.6 134.2 178.9 306.2 161.1 186.5 262.9 258.9 101.5 221.7 233.9 206.2 233.3 172.3 104.1 192.0 164.7 337.5 203.1 159.6 173.8 282.3 235.9 279.3 278.6 93.4 165.5 193.6 196.0 114.3 243.0 302.5 197.9 218.6 162.2 262.2 240.4 174.3 74.9 130.4 314.4 166.7 246.3 157.9 101.2 130.4 138.6 122.7 137.7 165.5 392.3 131.0 68.4 165.7 150.6 78.3 166.5 217.3 163.8 124.2 271.5 146.6 105.3 138.0 179.9 139.6 130.9 100.2 294.5 132.4 176.5 315.1 235.5 427.0 190.0 225.2 157.4 243.2 189.5 196.8 270.7 215.8 158.4 177.2 244.3 192.5 235.5 293.0 288.7 304.6 130.1 128.2 133.8 142.5 129.1 139.2 136.4 134.0 134.1 127.5 145.6 134.2 90.4 67.3 46.7 11.4 160.1 54.0 81.2 257.4 78.0 32.8 120.1 158.7 13.0 131.5 124.3 240.9 8.4 375.1 182.9 135.1 340.4 280.8 33.6 60.5 76.3 97.5 118.1 105.2 10.1 259.0 427.6 84.2 67.2 74.1 102.1 78.0 153.8 136.1 362.8 45.4 9.9 155.1 193.3 210.5 135.3 72.6 115.5 195.9 149.4 8.4 374.8 97.8 303.8 6.0 15.5 256.6 162.0 83.5 120.1 62.9 200.0 530.3 87.6 33.7 39.5 31.8 117.1 67.8 69.3 139.5 72.6 271.4 169.7 113.0 144.3 100.2 TRAPPC2B "MIP-2A, SEDLP, SEDLP1, TRAPPC2P1" ENSG00000256060 "Trafficking protein particle complex 2B" P0DI82 19 57363551-57365405 "Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063308 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum, Vesicles" Nucleoplasm "HPA063308: AB_2684982" "unprognostic (8.55e-2)" "unprognostic (1.07e-2)" "unprognostic (4.24e-1)" "unprognostic (5.27e-2)" "unprognostic (1.93e-1)" "unprognostic (6.69e-2)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (1.47e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.26e-1)" "unprognostic (4.49e-2)" "unprognostic (9.74e-2)" "unprognostic (1.39e-2)" 15.0 20.6 8.3 6.8 8.8 10.6 14.2 10.6 11.5 7.9 9.5 13.0 5.0 10.6 11.0 12.5 9.8 9.8 19.5 8.5 9.5 12.5 11.0 10.4 12.3 8.4 8.6 12.8 7.3 10.8 14.9 10.8 9.0 10.1 5.7 8.6 10.9 6.7 30.2 11.6 8.6 9.2 8.2 13.3 9.5 23.2 8.9 15.2 12.2 17.0 10.7 12.4 8.5 8.6 16.9 11.9 18.0 12.0 16.2 18.9 16.2 11.5 25.9 16.6 48.6 6.4 12.5 13.0 15.3 14.9 28.3 6.1 8.4 18.5 17.8 5.9 60.8 13.0 18.7 14.6 16.7 14.3 20.9 18.9 23.1 12.6 9.4 19.1 12.5 14.5 4.1 0.1 19.5 5.0 22.1 13.0 6.0 1.2 25.3 10.7 17.0 20.2 18.8 26.7 18.8 15.4 10.9 12.5 11.1 15.9 18.7 18.1 13.9 15.8 13.7 7.7 18.6 20.5 27.8 25.4 22.7 9.1 16.0 68.4 23.5 30.8 12.0 22.2 24.6 45.1 25.3 20.2 26.5 48.5 24.4 19.5 27.7 44.1 20.9 37.9 24.6 22.4 8.3 8.8 10.6 11.5 8.5 9.5 8.4 8.6 9.0 8.2 8.9 8.6 38.9 9.6 13.1 0.0 13.2 0.0 0.0 0.0 0.0 0.0 21.7 28.2 26.1 0.0 9.9 18.4 0.0 38.1 16.3 0.0 25.4 32.9 0.0 29.3 13.4 15.4 0.0 0.0 0.0 22.1 18.3 10.3 0.0 25.7 21.5 18.2 0.0 0.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 11.9 0.0 0.0 0.0 0.0 28.7 0.0 0.0 4.4 0.0 0.0 17.0 13.1 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 91.9 11.7 32.7 0.0 0.0 TRAPPC3 BET3 ENSG00000054116 "Trafficking protein particle complex 3" O43617 1 36136570-36156053 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028408 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" Cytosol "Golgi apparatus" "HPA028408: AB_10601826" "unprognostic (3.54e-3)" "unprognostic (1.17e-1)" "unprognostic (1.36e-1)" "unprognostic (4.94e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (7.39e-3)" "unprognostic (1.15e-1)" "unprognostic (7.12e-3)" "unprognostic (7.38e-2)" "unprognostic (2.94e-1)" "unprognostic (9.25e-3)" "unprognostic (2.61e-2)" "unprognostic (9.47e-2)" "unprognostic (2.10e-3)" "unprognostic (6.53e-2)" 43.7 74.7 42.5 31.2 43.0 28.8 46.6 47.0 50.7 38.5 53.7 57.0 33.6 41.1 60.7 61.6 37.0 32.6 51.1 43.1 44.9 55.3 51.2 36.4 38.3 48.0 45.1 28.2 46.0 54.4 47.0 37.8 47.2 39.2 42.5 39.9 46.4 45.4 48.9 51.5 38.5 49.9 48.3 41.6 48.2 53.1 46.3 51.3 59.9 44.6 54.4 46.2 41.2 48.9 95.7 65.6 44.9 70.2 114.2 91.4 87.9 85.2 109.0 100.0 97.0 55.9 90.0 40.4 79.0 95.0 79.6 68.8 69.9 114.1 113.8 79.8 103.7 75.8 77.2 81.7 132.6 80.0 76.7 78.3 98.5 93.8 91.5 103.6 126.7 101.2 93.2 67.0 122.0 71.4 95.6 74.6 60.5 79.5 93.7 65.8 63.8 90.9 128.4 76.1 67.8 49.7 69.2 78.5 140.1 115.2 50.2 59.6 95.6 59.1 66.7 116.0 116.3 80.1 87.0 67.3 100.7 88.7 60.5 161.9 130.2 148.7 85.0 142.5 89.4 93.6 100.4 90.4 132.6 89.0 96.0 86.9 134.3 95.8 116.3 109.4 135.4 155.3 42.5 43.0 47.0 50.7 43.1 44.9 48.0 45.1 47.2 48.3 46.3 48.9 41.9 25.6 27.6 12.1 45.6 101.1 111.5 152.1 52.3 41.8 97.8 78.5 57.8 55.8 75.7 38.6 16.7 145.7 43.0 55.1 170.2 157.0 286.1 51.8 38.3 59.1 48.3 63.3 15.4 188.5 146.0 52.1 29.0 55.6 45.7 40.5 33.2 49.8 145.0 53.8 16.9 51.2 132.2 56.1 74.7 131.0 42.9 60.6 96.0 10.3 104.4 68.0 61.8 8.5 17.9 178.4 72.1 51.9 80.7 196.9 73.3 115.9 49.2 30.7 32.9 37.4 69.2 172.5 89.4 63.4 123.6 191.4 50.4 50.3 54.3 134.1 TRAPPC5 "MGC52424, TRS31" ENSG00000181029 "Trafficking protein particle complex 5" Q8IUR0 19 7680833-7687703 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 57.5;Gastric mucus-secreting cells: 86.2;Plasma cells: 76.9;Squamous epithelial cells: 80.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 314.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042221, HPA049064" Uncertain Approved Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" Vesicles "HPA042221: AB_2677907, HPA049064: AB_2680618" "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.12e-2)" "unprognostic (1.14e-1)" "unprognostic (3.21e-3)" "unprognostic (1.80e-1)" "unprognostic (2.86e-1)" "unprognostic (6.28e-2)" "unprognostic (2.55e-2)" "unprognostic (2.12e-2)" "unprognostic (6.82e-2)" "unprognostic (4.86e-8)" "unprognostic (3.09e-1)" "unprognostic (1.11e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-1)" 58.9 86.8 65.7 25.6 68.7 62.7 58.4 67.1 112.6 55.6 60.6 53.0 27.6 52.1 8.1 85.6 44.7 13.8 105.1 69.4 74.7 75.7 99.7 35.9 23.4 64.5 68.9 50.1 67.1 19.9 58.4 19.1 70.5 71.1 8.4 9.0 64.8 17.2 112.4 90.6 48.5 11.5 64.3 60.6 57.5 181.4 65.9 16.8 56.0 27.3 12.2 55.5 56.2 64.4 61.0 129.4 20.7 56.9 16.3 24.1 62.1 47.1 33.8 45.3 46.1 76.9 41.2 62.9 92.0 32.7 25.8 55.2 13.0 47.2 8.9 48.3 199.2 23.7 86.7 163.7 56.8 42.1 45.3 40.0 61.9 34.6 15.8 15.4 57.6 64.3 34.3 89.3 22.3 190.7 72.3 148.8 66.1 27.1 314.1 46.6 28.8 91.1 50.7 142.8 54.1 47.0 40.1 74.6 69.1 7.1 60.1 44.3 58.8 54.2 44.9 103.3 47.7 80.8 44.2 44.3 75.3 51.2 74.2 207.5 373.4 151.4 116.7 394.1 112.3 313.7 145.0 129.3 442.0 289.2 141.7 124.7 518.4 97.4 365.5 188.8 222.5 329.3 65.7 68.7 67.1 112.6 69.4 74.7 64.5 68.9 70.5 64.3 65.9 64.4 1.8 3.2 3.6 15.3 36.1 1.9 1.2 2.4 57.5 5.1 6.3 4.2 1.0 1.5 5.1 5.5 2.1 3.5 1.2 26.7 0.0 26.9 13.3 3.8 4.8 5.6 11.4 41.0 13.5 19.3 5.3 14.3 86.2 3.7 1.3 2.0 8.2 13.4 9.9 8.4 16.4 15.7 0.0 18.8 3.3 44.4 1.5 52.2 1.8 11.2 17.0 1.5 4.1 11.6 22.8 19.8 26.3 3.4 76.9 1.9 28.0 9.2 2.6 4.8 0.0 1.4 8.4 5.0 1.2 80.1 1.7 3.4 18.0 2.7 14.1 1.5 TSR3 "C16orf42, MGC24381" ENSG00000007520 "TSR3 ribosome maturation factor" Q9UJK0 16 1349240-1351878 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040760, HPA046265" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Golgi apparatus" "HPA040760: AB_2677122, HPA046265: AB_10963942" "unprognostic (4.04e-1)" "unprognostic (2.00e-2)" "unprognostic (2.36e-1)" "unprognostic (4.59e-2)" "unprognostic (4.74e-2)" "unprognostic (4.44e-1)" "unprognostic (1.40e-2)" "unprognostic (1.12e-2)" "unprognostic (5.36e-2)" "unprognostic (3.81e-2)" "unprognostic (6.07e-2)" "unprognostic (8.32e-2)" "unprognostic (3.92e-2)" "unprognostic (9.72e-2)" "unprognostic (3.72e-1)" "unprognostic (2.82e-1)" "unprognostic (1.14e-1)" 44.0 47.6 47.7 18.9 50.4 17.4 40.4 47.9 54.6 35.5 43.3 60.7 25.6 38.6 11.1 51.2 33.5 12.6 72.8 46.1 44.5 51.8 58.3 34.4 20.4 52.7 50.0 32.2 57.2 18.5 35.0 15.2 46.8 42.6 9.0 8.3 42.6 19.8 86.8 46.5 38.3 11.6 48.7 43.0 49.1 30.5 49.6 15.9 35.0 27.9 11.7 48.9 38.1 47.7 60.0 65.2 26.6 35.7 30.8 37.3 44.7 54.3 23.8 38.1 35.3 72.7 59.6 37.8 70.8 36.7 40.5 61.6 24.2 45.2 13.1 73.8 110.8 16.7 56.3 58.2 56.0 36.2 31.8 39.5 63.8 34.3 33.0 29.5 41.7 60.2 54.1 32.6 31.8 107.4 53.6 61.1 44.6 34.4 78.0 93.5 32.3 103.0 33.5 23.7 41.9 53.9 41.9 52.3 73.0 20.8 50.3 44.8 45.9 63.0 67.3 54.2 67.4 67.8 49.2 51.3 31.9 43.5 43.6 13.8 4.0 12.0 4.7 3.6 5.9 7.4 5.9 4.4 3.4 10.0 6.2 5.7 10.4 2.6 3.9 5.2 4.8 1.7 47.7 50.4 47.9 54.6 46.1 44.5 52.7 50.0 46.8 48.7 49.6 47.7 45.2 19.2 16.2 3.3 33.7 28.2 44.9 7.4 18.8 27.1 54.3 48.9 9.4 44.3 12.1 25.8 12.5 48.6 37.8 43.1 103.7 36.5 3.5 30.7 30.9 30.7 24.0 32.4 4.3 46.6 48.7 28.5 18.3 26.9 8.2 45.0 33.9 54.1 48.8 18.5 5.2 35.3 10.2 42.4 26.7 4.9 28.0 38.0 48.0 1.9 34.6 53.9 49.4 3.5 9.2 38.5 32.6 32.0 47.3 53.8 41.5 125.6 11.1 33.6 6.6 27.7 40.4 15.7 39.7 50.3 41.5 29.8 34.7 38.4 35.7 49.2 TTC1 TPR1 ENSG00000113312 "Tetratricopeptide repeat domain 1" Q99614 5 160009113-160065543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036557, HPA057502" Approved Enhanced Cytosol NA NA 17000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA036557: AB_10670112, HPA057502: AB_2683450" "unprognostic (4.34e-3)" "unprognostic (2.26e-2)" "unprognostic (3.05e-2)" "unprognostic (7.38e-2)" "unprognostic (6.62e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (8.29e-2)" "unprognostic (2.38e-1)" "unprognostic (5.50e-2)" "unprognostic (2.31e-1)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (6.16e-2)" 37.0 46.5 77.6 35.6 79.7 26.2 39.4 84.2 111.7 31.5 71.2 44.5 27.3 32.2 58.1 37.4 32.2 26.2 59.9 79.4 83.1 49.5 45.5 33.0 47.8 90.6 85.4 32.6 27.4 45.1 29.8 35.5 88.7 33.4 45.4 42.9 39.4 37.2 91.2 34.8 30.9 41.8 80.3 36.6 34.6 33.8 83.8 48.7 35.7 77.0 55.9 35.7 27.6 84.1 83.2 85.1 62.2 104.4 71.9 51.6 70.5 90.8 80.4 97.7 115.6 120.2 94.0 84.5 172.7 78.2 132.9 63.9 83.5 124.7 156.6 157.7 88.4 75.9 63.0 87.3 102.0 127.2 61.2 48.7 81.0 86.5 71.8 71.8 118.8 74.2 73.6 81.7 112.3 65.0 92.8 99.8 70.7 67.3 85.8 88.4 87.0 93.6 124.2 76.8 51.2 57.7 63.1 74.4 175.1 58.3 117.6 121.5 84.4 64.8 55.8 58.5 141.9 58.4 114.8 82.3 89.6 143.3 85.9 109.8 72.8 105.7 57.6 80.9 73.4 92.6 68.3 68.0 73.5 86.0 62.5 69.1 103.0 87.7 80.6 65.4 90.2 113.1 77.6 79.7 84.2 111.7 79.4 83.1 90.6 85.4 88.7 80.3 83.8 84.1 48.6 67.3 50.8 20.9 55.0 47.0 33.6 89.2 28.5 38.4 40.4 47.0 237.0 40.0 67.4 46.0 20.9 108.7 36.0 58.0 162.4 114.2 115.3 62.8 46.5 61.3 35.3 89.2 54.0 106.5 77.9 57.4 23.4 54.8 83.4 41.3 52.1 72.8 90.0 35.3 47.6 51.4 83.4 48.1 34.7 39.9 46.9 52.4 28.4 23.4 70.1 99.1 68.0 43.7 57.0 98.5 54.7 63.9 42.9 37.6 53.7 144.9 89.4 50.2 59.2 55.7 59.2 142.9 101.5 37.8 47.3 99.9 50.8 53.6 53.7 21.9 TTC17 FLJ10890 ENSG00000052841 "Tetratricopeptide repeat domain 17" Q96AE7 11 43358920-43494933 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038508 Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Plasma membrane" Cytosol "HPA038508: AB_10671744" "unprognostic (2.71e-1)" "unprognostic (4.04e-3)" "unprognostic (6.48e-2)" "unprognostic (2.64e-1)" "unprognostic (1.17e-1)" "unprognostic (5.66e-2)" "unprognostic (1.74e-1)" "unprognostic (9.03e-2)" "unprognostic (5.01e-3)" "unprognostic (2.62e-1)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (1.04e-2)" "unprognostic (4.40e-1)" "unprognostic (1.18e-1)" "unprognostic (1.54e-2)" 20.7 18.7 11.0 16.1 11.3 15.5 28.6 16.7 12.2 22.0 22.0 21.2 21.6 26.9 25.0 14.2 28.4 22.3 13.5 11.1 12.2 19.4 38.6 24.2 20.2 11.9 12.5 40.9 49.5 27.7 12.3 29.2 11.7 25.4 22.9 25.1 40.7 21.4 16.4 19.5 25.5 23.0 11.0 23.4 27.4 24.8 12.4 24.6 36.9 20.0 22.4 18.8 15.6 13.0 15.0 30.4 31.3 49.3 77.2 63.6 22.1 35.6 47.6 29.3 35.1 21.1 21.7 31.6 34.9 35.9 33.7 31.1 22.3 23.5 35.2 24.5 29.0 24.2 19.5 20.8 95.3 36.6 29.9 59.5 69.8 21.3 68.4 66.2 29.5 22.7 35.5 26.2 29.8 18.1 27.1 20.3 46.8 58.0 25.0 25.1 33.3 36.9 37.2 21.4 16.7 39.7 27.7 73.1 44.6 31.4 68.6 40.8 39.6 41.7 18.4 47.1 52.1 51.1 44.5 29.8 26.9 21.6 45.3 20.0 21.7 19.0 14.9 22.4 15.9 16.4 16.2 14.5 16.9 14.8 16.3 15.1 18.5 16.5 20.8 17.6 16.1 18.0 11.0 11.3 16.7 12.2 11.1 12.2 11.9 12.5 11.7 11.0 12.4 13.0 43.0 64.1 62.7 159.6 53.3 42.1 35.0 36.4 30.7 44.1 40.3 35.7 20.5 31.5 51.9 22.0 60.5 32.6 43.8 30.7 3.9 23.1 52.6 35.8 44.5 40.9 22.3 44.0 204.6 43.4 28.8 44.4 40.2 48.6 36.6 56.2 40.0 57.5 26.2 47.1 203.2 42.1 34.6 48.0 32.3 18.4 57.2 37.1 28.4 181.8 47.8 24.8 37.0 192.0 200.6 29.7 31.5 36.5 48.9 50.1 47.7 15.5 54.3 47.3 52.6 45.5 36.2 51.8 35.0 34.6 43.2 30.8 45.6 33.5 35.8 42.7 TXNDC12 "AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19" ENSG00000117862 "Thioredoxin domain containing 12" O95881 1 52020131-52055191 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 160000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (6.54e-2)" "unprognostic (5.46e-2)" "prognostic favorable (4.44e-4)" "unprognostic (2.33e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.61e-4)" "prognostic unfavorable (1.28e-5)" "unprognostic (1.25e-1)" "unprognostic (3.28e-2)" "unprognostic (1.17e-1)" "unprognostic (6.14e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.40e-12)" "unprognostic (2.13e-1)" "unprognostic (5.83e-2)" "unprognostic (1.73e-2)" "unprognostic (1.17e-1)" 49.6 47.7 39.7 45.7 40.7 51.3 50.8 41.2 48.0 49.2 44.2 60.8 47.0 40.8 62.9 31.2 56.8 46.5 36.6 40.1 47.0 54.0 74.1 46.9 50.1 42.5 41.6 47.8 56.5 46.7 21.9 54.5 43.1 40.8 66.1 28.6 57.6 36.5 18.2 29.9 48.4 40.8 44.1 46.4 56.4 38.9 42.8 52.3 52.6 30.2 54.4 57.5 18.0 46.1 97.1 88.9 96.0 135.4 160.1 83.9 76.4 143.5 143.8 132.7 150.7 99.8 78.2 73.0 93.8 118.1 141.1 127.3 134.5 112.9 178.2 94.1 124.2 93.1 73.3 163.2 165.7 176.8 181.8 120.5 132.0 134.0 203.3 99.0 135.4 89.1 87.1 48.2 111.9 91.4 89.3 233.6 208.0 138.8 85.9 94.2 143.3 207.1 178.6 85.3 68.3 97.3 143.9 123.5 138.7 187.7 69.6 228.1 86.5 93.9 100.1 106.7 166.1 107.2 183.6 84.2 131.0 164.9 108.2 355.3 224.0 356.5 135.3 215.0 170.8 160.1 164.3 145.3 169.2 146.0 156.7 151.1 393.2 150.0 234.2 180.6 220.0 273.3 39.7 40.7 41.2 48.0 40.1 47.0 42.5 41.6 43.1 44.1 42.8 46.1 89.8 9.6 12.3 9.4 50.4 44.1 63.1 78.9 35.3 18.3 53.6 57.0 13.6 62.9 30.4 44.1 14.6 115.5 58.9 35.3 17.6 75.4 13.3 42.5 54.7 62.3 48.5 25.7 15.0 89.4 170.9 52.1 23.4 49.2 33.0 106.3 55.6 31.0 120.8 21.9 14.7 70.5 50.8 59.1 55.7 7.2 55.9 66.0 51.6 19.7 66.6 39.2 50.4 10.1 15.9 73.0 57.0 30.9 68.7 68.7 65.4 36.1 32.3 17.0 32.9 40.7 47.1 60.4 9.7 36.0 45.5 118.5 52.3 75.4 71.2 60.4 TXNDC17 "MGC14353, TRP14, TXNL5" ENSG00000129235 "Thioredoxin domain containing 17" Q9BRA2 17 6640985-6644541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 182.9" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 785.8;Proximal tubular cells: 814.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022931 Approved NA NA 820000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA022931: AB_1858479" "unprognostic (8.94e-2)" "unprognostic (6.03e-2)" "unprognostic (5.33e-2)" "unprognostic (2.97e-2)" "unprognostic (5.02e-2)" "unprognostic (5.06e-2)" "unprognostic (7.65e-3)" "unprognostic (3.88e-1)" "unprognostic (1.51e-2)" "unprognostic (2.21e-3)" "unprognostic (1.15e-2)" "unprognostic (9.97e-2)" "prognostic unfavorable (1.15e-5)" "unprognostic (8.86e-2)" "unprognostic (2.27e-1)" "unprognostic (3.09e-2)" "unprognostic (9.01e-2)" 25.9 45.3 16.7 22.6 17.3 21.8 28.0 17.7 24.0 35.5 18.5 54.1 56.8 20.4 40.3 182.9 16.1 27.0 31.3 17.8 18.5 62.3 69.8 23.2 22.1 17.3 17.3 13.3 40.4 24.5 27.6 15.0 17.5 32.2 44.7 7.4 47.5 14.6 21.7 27.7 38.8 20.4 18.2 41.9 54.5 15.5 17.2 25.8 20.7 10.1 27.0 68.7 58.5 18.7 130.8 154.4 62.1 134.1 38.1 54.4 29.1 65.4 56.4 59.2 57.0 84.8 44.0 27.8 62.4 50.6 62.3 200.0 67.6 223.5 73.2 93.0 109.3 33.1 138.6 153.3 43.3 54.1 70.7 55.1 83.6 72.7 72.3 58.2 79.8 88.2 45.1 13.3 83.1 91.8 55.1 69.7 90.3 91.9 123.9 53.2 41.4 69.5 126.7 253.3 28.8 74.9 65.9 66.7 54.6 42.1 63.3 48.2 59.8 48.8 61.7 55.7 117.2 20.0 47.8 43.1 98.9 56.9 57.1 77.2 105.0 93.6 35.3 117.3 37.2 54.9 41.7 42.4 115.8 47.5 32.2 37.8 180.9 35.5 120.9 109.3 66.9 56.7 16.7 17.3 17.7 24.0 17.8 18.5 17.3 17.3 17.5 18.2 17.2 18.7 91.8 93.0 157.2 3.9 66.9 189.3 185.3 785.8 330.6 18.1 141.5 162.6 110.3 175.8 236.4 125.0 2.1 180.7 76.6 560.2 389.4 326.8 362.5 110.0 81.6 99.6 135.1 70.7 3.9 451.8 291.6 84.9 181.0 126.9 50.0 92.2 88.2 371.7 245.0 40.4 3.6 316.4 221.8 114.9 83.7 303.2 74.9 118.9 113.8 1.9 170.2 86.8 80.3 4.0 5.3 534.5 378.6 67.0 112.5 169.9 420.3 814.9 142.9 26.8 26.3 58.5 103.9 34.6 116.4 500.1 143.3 104.9 67.7 151.0 332.1 300.0 TXNDC9 APACD ENSG00000115514 "Thioredoxin domain containing 9" O14530 2 99318982-99340702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031844, HPA031845, HPA031846" Approved Enhanced Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916" "unprognostic (3.63e-3)" "unprognostic (4.26e-2)" "unprognostic (7.28e-2)" "unprognostic (3.12e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (9.63e-7)" "unprognostic (2.06e-2)" "unprognostic (9.09e-2)" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.32e-1)" "unprognostic (2.47e-3)" "unprognostic (2.03e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" 18.7 17.9 10.0 21.3 10.8 17.5 28.7 11.0 13.2 19.3 10.4 24.6 18.4 16.6 25.9 26.1 18.1 18.6 28.6 10.8 11.7 28.8 27.2 20.1 29.2 11.6 11.5 10.7 10.9 15.4 11.3 23.5 11.9 19.6 26.3 11.0 15.1 16.1 18.2 19.0 17.6 24.4 11.8 18.6 18.5 17.8 10.9 26.1 24.8 16.2 34.0 24.9 14.1 12.5 78.3 27.6 55.0 27.7 55.8 57.8 65.8 83.1 79.5 88.5 85.0 71.1 55.5 58.0 66.9 72.6 77.0 52.7 55.2 88.2 102.6 44.0 53.5 60.4 34.5 77.0 54.2 71.8 44.2 53.0 76.7 74.3 53.8 46.1 101.9 32.1 73.0 51.1 103.7 41.5 43.4 63.6 43.4 46.4 68.7 32.5 53.0 56.4 123.9 62.6 37.1 31.5 41.7 56.2 93.7 69.8 64.3 60.9 69.4 65.1 62.7 40.6 62.6 21.2 37.1 65.6 51.9 76.8 58.6 110.6 54.1 61.1 56.7 60.5 70.2 69.1 66.6 64.4 60.3 57.6 61.9 62.5 53.5 77.7 82.6 60.9 91.2 87.0 10.0 10.8 11.0 13.2 10.8 11.7 11.6 11.5 11.9 11.8 10.9 12.5 46.6 9.6 13.4 8.8 33.4 35.2 29.7 137.1 25.0 11.3 21.5 26.3 27.6 25.8 67.0 36.8 8.4 75.7 31.3 26.2 84.1 79.8 75.7 37.3 29.9 46.2 20.9 47.8 13.3 69.4 82.5 29.2 22.4 25.5 17.7 21.0 38.2 24.4 56.9 13.5 12.8 25.7 91.6 25.4 31.3 21.1 27.7 30.2 26.6 4.7 55.5 26.9 44.3 12.5 16.7 84.5 21.6 23.3 31.8 24.0 21.9 121.5 72.8 19.8 26.3 17.8 89.3 52.8 42.7 29.4 38.9 81.3 35.1 40.1 26.6 21.9 UBE2F NCE2 ENSG00000184182 "Ubiquitin conjugating enzyme E2 F (putative)" Q969M7 2 237966827-238042782 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 282.2;monocytes: 215.5;NK-cells: 193.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA037444 Approved Approved Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol "HPA037444: AB_10672491" "unprognostic (1.73e-1)" "unprognostic (1.65e-1)" "unprognostic (3.80e-2)" "unprognostic (6.92e-3)" "unprognostic (3.39e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (3.43e-3)" "unprognostic (6.64e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.59e-7)" "unprognostic (2.04e-2)" "unprognostic (6.39e-2)" "unprognostic (3.60e-2)" "unprognostic (2.51e-1)" 26.7 29.7 33.0 25.5 33.7 41.8 22.8 35.9 40.6 27.7 32.5 29.6 24.7 23.1 53.0 43.1 18.8 28.7 56.7 33.4 38.0 28.2 44.2 22.6 32.1 37.5 37.7 12.6 70.5 41.8 21.0 39.9 38.7 25.4 33.7 16.0 25.2 30.3 60.7 18.8 26.9 35.6 35.5 23.7 26.5 26.0 36.1 34.5 35.4 69.1 33.1 40.7 23.5 38.3 42.9 23.9 53.6 55.1 69.2 83.0 74.8 38.9 55.5 43.3 44.4 26.0 26.4 22.0 13.7 88.7 93.7 35.1 62.3 84.9 67.9 33.7 22.7 31.6 28.5 86.6 86.2 13.1 70.1 48.1 137.7 57.9 87.1 40.1 78.1 100.8 94.2 13.7 80.1 64.0 35.1 55.9 59.8 60.9 33.8 41.8 35.0 39.1 66.3 17.8 36.0 53.0 45.2 36.2 77.0 89.4 31.0 52.8 49.7 47.6 41.7 54.9 43.1 17.1 14.3 43.6 57.1 38.4 35.8 112.4 50.0 63.8 66.3 68.2 26.2 26.2 44.8 40.4 45.0 25.4 40.7 41.4 37.3 102.3 78.5 56.4 51.6 63.6 33.0 33.7 35.9 40.6 33.4 38.0 37.5 37.7 38.7 35.5 36.1 38.3 17.6 6.4 18.4 0.0 26.4 32.5 24.1 33.0 11.4 24.2 37.7 24.9 48.1 30.0 21.6 27.6 8.4 84.9 87.3 38.6 56.7 49.7 23.6 15.0 23.9 27.1 41.8 102.5 0.0 79.4 282.2 24.9 15.8 13.8 21.5 13.1 22.1 41.7 152.7 26.9 0.0 58.1 32.6 72.2 105.7 61.3 25.7 67.6 35.6 0.0 215.5 28.3 193.6 0.0 0.0 71.8 31.9 30.9 25.7 46.0 49.7 62.2 23.4 21.7 39.5 14.8 31.4 123.5 79.4 19.0 40.3 65.7 36.2 16.0 35.5 34.6 UBE2I UBC9 ENSG00000103275 "Ubiquitin conjugating enzyme E2 I" P63279 16 1308880-1327018 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003909, CAB009021, CAB079920" Approved Supported Nucleoplasm,Nucleoli NA NA 130000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (2.88e-3)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (7.60e-3)" "unprognostic (3.56e-1)" "unprognostic (7.28e-2)" "unprognostic (9.30e-2)" "unprognostic (1.57e-1)" "prognostic favorable (5.68e-4)" "unprognostic (1.15e-3)" 62.5 76.3 42.5 60.3 44.0 81.6 62.0 46.1 49.3 64.7 37.1 63.8 45.1 72.7 48.7 74.2 67.3 34.3 68.2 45.2 45.2 63.4 40.8 53.1 76.0 39.3 42.3 93.1 49.1 72.0 61.6 58.1 40.2 53.4 47.3 31.7 56.4 46.7 58.0 68.0 61.1 53.8 42.2 71.9 52.9 47.6 47.1 110.3 53.2 57.0 89.3 66.6 63.1 42.1 121.3 161.1 269.0 157.7 112.7 135.8 114.4 170.0 121.7 154.3 152.9 191.8 190.1 208.2 137.7 148.1 140.7 142.4 193.2 159.2 197.9 151.2 133.4 130.6 136.6 188.4 178.6 194.9 148.0 127.1 100.7 152.1 180.0 149.0 170.0 169.9 190.3 124.3 148.0 254.4 349.6 193.0 219.0 136.0 118.5 434.0 170.9 238.4 145.7 106.6 150.3 159.8 149.3 164.1 177.7 152.8 167.5 234.4 139.4 149.2 172.6 134.0 155.5 132.1 170.4 423.4 85.3 142.9 164.7 278.7 214.3 327.1 165.9 256.6 200.9 297.8 167.8 170.3 214.7 241.1 148.2 149.6 149.5 202.6 249.5 186.3 196.5 260.9 42.5 44.0 46.1 49.3 45.2 45.2 39.3 42.3 40.2 42.2 47.1 42.1 109.5 51.3 67.0 16.3 172.8 178.6 186.4 275.6 97.3 64.6 101.9 105.7 89.1 84.4 140.9 62.5 50.1 312.8 153.9 77.4 105.7 211.9 64.4 66.6 100.6 118.3 102.3 127.4 17.2 148.2 293.1 134.4 55.5 104.6 109.5 149.7 94.2 43.7 213.5 47.1 16.8 97.1 162.8 104.8 182.1 37.8 129.8 124.8 128.1 15.9 220.2 104.7 209.1 16.6 26.7 212.3 91.8 107.6 144.1 294.8 90.4 117.7 65.7 63.1 78.9 82.1 185.4 139.6 145.7 158.4 206.7 418.1 144.7 134.9 134.7 304.5 UBE2K "HIP2, HYPG, UBC1" ENSG00000078140 "Ubiquitin conjugating enzyme E2 K" P61086 4 39698109-39782792 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028869, CAB033212, CAB033515" Supported Approved "Plasma membrane,Cytosol" NA NA 390000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol "Plasma membrane" "CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487" "unprognostic (1.14e-2)" "unprognostic (6.02e-2)" "unprognostic (2.42e-3)" "unprognostic (3.06e-1)" "unprognostic (6.81e-2)" "unprognostic (2.05e-1)" "unprognostic (5.05e-3)" "unprognostic (1.44e-2)" "unprognostic (2.71e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.60e-4)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "unprognostic (6.88e-2)" "unprognostic (1.22e-1)" "unprognostic (4.10e-3)" 29.9 19.4 13.5 23.4 17.5 21.4 21.7 20.9 24.5 16.0 9.2 35.8 31.2 17.8 17.7 26.2 12.7 12.9 18.4 18.3 14.9 26.7 45.4 16.4 20.1 12.9 14.0 13.6 13.2 20.4 15.8 24.4 13.1 19.8 24.2 21.0 16.9 14.9 37.3 22.6 24.8 17.2 7.8 18.0 31.8 16.5 14.2 22.4 23.8 25.6 18.0 20.2 17.2 16.0 91.3 90.7 49.3 45.6 29.8 28.7 82.8 122.8 26.4 32.8 34.0 138.0 91.1 114.3 105.2 35.0 79.8 39.0 95.4 54.7 51.9 76.1 70.0 145.7 88.9 121.6 38.4 159.0 79.6 27.1 60.2 46.0 49.0 35.2 43.3 49.3 152.9 39.6 33.9 86.6 111.5 89.9 67.7 54.4 69.8 66.3 144.0 44.2 46.0 123.9 103.9 47.4 91.7 34.5 58.9 54.1 44.4 58.2 116.9 49.9 105.7 60.0 114.5 55.3 174.0 121.4 26.9 101.4 59.5 19.6 18.1 24.8 14.4 16.9 13.4 20.7 15.0 13.8 19.7 14.7 11.2 12.6 15.1 14.0 25.4 27.6 16.0 10.5 13.5 17.5 20.9 24.5 18.3 14.9 12.9 14.0 13.1 7.8 14.2 16.0 63.2 57.7 63.1 69.2 53.0 122.9 65.5 74.3 59.7 62.2 65.3 52.5 72.3 52.9 66.7 49.7 29.2 84.5 76.5 143.7 66.5 83.5 144.9 72.0 82.3 65.6 59.7 85.8 115.9 89.4 168.7 59.2 68.3 90.9 34.8 40.1 63.5 113.6 80.2 104.3 113.8 74.5 65.1 77.1 91.8 202.4 65.3 76.5 56.9 89.0 104.0 87.1 56.7 87.0 118.2 139.6 94.3 56.4 55.5 111.4 75.3 98.0 60.7 42.9 39.5 61.8 121.1 145.2 55.1 74.3 137.9 147.5 61.3 54.8 74.1 107.0 UBE2L3 UBCH7 ENSG00000185651 "Ubiquitin conjugating enzyme E2 L3" P68036 22 21549447-21624034 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 544.4" "HPA045609, HPA062415" Approved Approved Nucleoplasm,Cytosol NA NA 5800000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (4.90e-2)" "unprognostic (3.05e-1)" "unprognostic (1.92e-2)" "unprognostic (1.07e-2)" "unprognostic (2.74e-2)" "unprognostic (9.99e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.28e-2)" "unprognostic (3.65e-2)" "prognostic favorable (3.82e-6)" "unprognostic (3.53e-2)" "unprognostic (4.55e-2)" "unprognostic (3.18e-2)" "unprognostic (4.66e-2)" "unprognostic (5.09e-2)" "unprognostic (2.77e-1)" "unprognostic (3.15e-3)" 41.5 46.0 63.7 37.1 64.8 54.4 33.9 65.0 72.0 35.5 54.4 45.5 39.6 35.0 41.0 49.1 38.5 34.0 51.5 65.4 65.3 40.1 40.9 33.9 48.8 67.8 64.7 33.9 30.3 43.2 31.2 42.7 66.8 39.1 45.6 28.1 33.9 36.8 63.5 36.2 40.7 48.6 62.3 37.6 37.5 28.5 66.7 51.9 36.4 53.1 52.5 46.8 32.3 65.5 121.9 68.9 98.3 77.4 105.1 93.1 56.6 100.0 113.6 125.8 118.7 79.0 57.0 114.2 49.0 133.5 94.7 101.4 132.1 108.6 124.3 114.4 142.9 132.1 63.3 94.8 70.0 190.9 91.0 82.7 93.1 91.2 65.7 90.6 143.4 69.4 544.4 59.3 137.9 89.6 100.0 137.6 72.8 134.8 71.6 80.5 147.6 31.2 118.8 96.2 88.0 65.4 79.9 99.1 95.6 89.4 61.7 104.0 103.8 88.6 113.5 75.5 103.6 57.3 99.7 103.7 120.0 87.5 86.0 84.4 87.8 105.7 84.9 102.2 79.7 77.3 79.9 91.6 109.2 73.6 69.0 82.9 73.2 81.2 89.0 106.3 106.1 141.1 63.7 64.8 65.0 72.0 65.4 65.3 67.8 64.7 66.8 62.3 66.7 65.5 102.6 109.0 83.9 26.1 110.7 125.5 171.6 318.5 51.2 54.5 76.9 72.8 64.9 101.5 180.3 71.7 16.7 312.1 159.0 215.1 197.6 288.2 79.9 133.1 104.6 125.9 126.0 173.0 25.6 385.0 406.5 102.6 60.1 124.9 129.3 79.3 109.6 159.8 298.5 69.0 24.3 153.1 193.3 126.9 159.7 61.1 87.3 140.9 126.3 19.7 257.9 98.4 200.8 22.6 30.4 432.1 222.1 103.8 98.4 186.7 213.5 257.2 173.9 45.5 105.2 81.0 205.4 202.8 121.2 87.6 129.7 372.1 130.1 133.7 154.0 208.4 UBL5 ENSG00000198258 "Ubiquitin like 5" Q9BZL1 19 9827892-9830115 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 3183.1" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (2.53e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (4.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.96e-1)" "unprognostic (7.30e-2)" "unprognostic (7.85e-2)" "unprognostic (8.51e-2)" "unprognostic (3.14e-3)" "unprognostic (2.04e-2)" "unprognostic (4.79e-2)" "unprognostic (1.05e-2)" "unprognostic (3.64e-1)" "unprognostic (1.07e-2)" "unprognostic (3.19e-2)" "unprognostic (2.23e-3)" 303.2 450.0 486.9 202.3 501.8 323.7 287.0 503.9 613.4 291.0 537.1 331.2 218.5 263.8 513.6 375.8 261.5 213.8 648.9 493.9 514.4 476.6 401.6 263.1 280.8 495.3 488.5 269.5 227.0 486.4 439.5 215.7 497.7 300.7 264.1 274.7 278.8 284.9 533.4 261.1 259.7 248.4 515.9 303.6 303.5 275.3 492.8 427.3 304.3 567.0 322.2 297.8 278.2 534.1 609.5 633.1 536.4 508.8 755.8 589.0 320.0 434.9 519.8 557.0 687.0 800.0 338.5 374.8 745.6 651.7 475.1 380.9 562.1 634.2 532.7 629.4 1032.4 1110.5 783.3 1328.0 508.8 1105.1 471.2 612.2 658.5 406.4 437.8 569.2 630.0 798.3 697.9 888.0 669.8 1016.8 758.8 3183.1 534.7 758.8 1046.3 444.4 435.8 972.4 1054.9 1138.9 474.9 616.1 380.3 358.4 568.1 612.2 397.3 1029.3 517.3 608.9 277.1 787.5 579.1 1046.1 1812.3 800.4 540.0 713.6 370.6 865.4 497.7 1271.3 424.7 488.1 410.8 445.4 468.2 464.3 466.7 352.4 395.3 430.8 818.7 395.9 529.2 780.2 618.9 756.0 486.9 501.8 503.9 613.4 493.9 514.4 495.3 488.5 497.7 515.9 492.8 534.1 387.5 256.4 330.2 8.1 329.4 397.7 342.1 779.0 236.2 177.4 479.0 535.4 763.9 446.1 491.5 662.1 62.6 549.6 422.1 970.8 1486.9 574.3 168.8 613.3 370.8 335.4 433.4 400.4 6.8 519.7 598.4 336.7 284.4 523.3 400.8 305.2 327.7 932.9 705.0 126.2 6.7 693.1 571.7 447.8 548.4 130.6 472.5 423.9 499.8 8.4 729.1 591.6 503.6 6.6 11.9 645.8 1081.0 495.0 427.5 460.5 1117.0 1610.2 642.1 230.1 355.0 284.4 417.4 622.6 596.8 420.5 519.0 585.7 395.1 235.8 555.7 495.3 UBR7 C14orf130 ENSG00000012963 "Ubiquitin protein ligase E3 component n-recognin 7" Q8N806 14 93207241-93229215 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 300.9;Late spermatids: 372.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000861 Approved Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 63: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA000861: AB_1078321" "unprognostic (9.60e-2)" "unprognostic (5.12e-3)" "unprognostic (1.11e-1)" "unprognostic (9.20e-2)" "unprognostic (3.30e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.12e-5)" "unprognostic (1.14e-1)" "unprognostic (9.83e-2)" "unprognostic (1.04e-2)" "unprognostic (4.30e-2)" "unprognostic (5.94e-2)" "prognostic favorable (9.76e-5)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" 12.7 10.4 16.9 13.2 19.1 21.1 19.1 16.3 20.2 17.6 17.7 16.9 11.8 14.4 14.0 13.0 14.4 13.1 22.0 18.8 15.9 16.6 15.1 12.7 22.2 15.3 16.1 17.6 22.9 25.7 8.9 10.3 16.0 14.6 18.3 24.3 12.7 15.3 17.5 15.7 13.2 15.3 17.1 14.1 14.2 19.0 17.3 34.0 16.8 25.9 27.3 13.6 10.9 18.8 26.1 33.0 52.2 44.2 24.2 24.0 18.6 54.0 38.6 57.1 43.9 23.5 28.2 60.9 42.6 28.3 26.0 30.7 55.8 30.1 60.7 46.4 29.2 45.7 33.1 23.7 11.2 65.7 47.5 15.5 20.7 33.8 21.2 21.7 33.1 54.8 41.5 60.5 57.7 77.3 104.5 35.7 24.1 69.4 61.9 81.9 92.9 33.6 20.6 42.0 65.3 45.4 39.5 32.1 16.3 31.1 58.4 44.6 24.0 43.1 23.0 37.0 56.3 69.0 103.4 61.1 37.0 49.8 38.7 34.5 11.3 18.2 17.8 14.2 19.5 26.4 16.4 16.4 11.4 20.4 13.6 15.1 16.6 18.1 18.3 15.0 26.7 13.4 16.9 19.1 16.3 20.2 18.8 15.9 15.3 16.1 16.0 17.1 17.3 18.8 13.8 16.0 6.4 9.4 16.1 19.9 8.3 8.0 6.8 6.1 11.6 11.0 19.7 11.5 8.5 11.0 10.4 12.3 15.1 15.6 11.7 9.9 300.9 8.2 8.5 11.0 5.4 20.2 16.3 12.9 15.2 12.0 9.7 9.1 5.1 8.8 12.8 11.3 14.0 3.3 12.7 8.4 12.2 10.7 10.9 372.2 9.3 9.0 14.2 7.5 9.3 13.5 13.4 10.6 13.9 8.9 5.4 12.4 26.0 4.7 10.3 9.3 5.5 13.9 6.6 11.2 10.1 38.7 23.2 10.7 13.5 6.6 12.4 6.2 12.4 6.0 UBXN6 "UBXD1, UBXDC2" ENSG00000167671 "UBX domain protein 6" Q9BZV1 19 4444999-4457794 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Late spermatids: 1342.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040906, HPA041313, HPA061872" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Cytosol" "HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.50e-2)" "prognostic favorable (5.68e-5)" "unprognostic (1.67e-1)" "unprognostic (2.65e-3)" "unprognostic (1.83e-2)" "unprognostic (1.41e-2)" "unprognostic (1.09e-1)" "unprognostic (3.48e-1)" "prognostic favorable (6.95e-4)" "unprognostic (3.93e-2)" "prognostic favorable (2.78e-5)" "unprognostic (4.61e-2)" "unprognostic (2.67e-1)" "unprognostic (1.43e-1)" "unprognostic (1.79e-1)" 99.7 188.7 60.5 35.0 60.9 85.8 89.4 53.3 91.6 94.9 64.0 93.6 49.2 94.5 21.1 89.7 89.1 33.7 116.1 72.3 53.1 118.4 122.2 72.0 35.2 64.0 64.8 115.2 100.3 64.7 146.1 34.8 64.1 93.8 14.1 23.8 86.1 50.7 216.6 113.8 67.7 23.2 52.9 77.8 88.5 174.8 55.1 26.9 111.8 84.3 18.1 91.8 85.3 57.5 71.7 49.4 23.3 50.6 57.7 70.6 35.1 71.3 84.3 50.9 54.1 30.8 58.8 31.8 63.5 70.8 26.3 40.8 18.2 54.8 18.6 56.3 39.4 26.4 53.5 41.4 94.5 33.6 51.1 65.2 70.4 40.1 38.7 62.3 62.9 42.7 55.6 83.6 38.3 45.4 67.2 56.8 37.6 27.4 42.9 30.4 33.3 76.0 48.3 43.9 67.1 97.3 40.1 40.9 116.7 10.8 48.5 54.4 76.8 67.4 51.4 145.0 47.7 186.6 80.7 33.2 128.7 62.5 61.4 6.4 6.6 10.4 3.8 8.0 6.2 5.3 4.5 5.2 6.7 6.0 5.3 4.2 6.7 2.7 4.9 10.2 5.5 4.9 60.5 60.9 53.3 91.6 72.3 53.1 64.0 64.8 64.1 52.9 55.1 57.5 26.7 41.7 30.1 13.7 25.1 37.2 44.9 26.7 15.9 37.2 36.3 25.1 47.2 64.3 21.2 44.1 27.1 54.5 31.9 105.0 80.3 58.1 297.0 29.1 35.6 30.5 46.8 172.0 14.4 65.0 43.1 39.0 28.5 32.2 34.3 50.0 47.5 61.6 54.8 13.5 11.9 66.2 20.3 52.8 35.9 1342.0 100.0 37.5 53.4 1.9 49.0 60.1 25.7 5.5 10.3 65.6 90.1 73.0 16.4 50.9 136.9 112.2 21.4 35.2 72.3 38.8 29.5 139.9 68.9 20.4 41.1 79.6 18.5 41.4 58.4 48.5 UMAD1 "RPA3-AS1, RPA3OS" ENSG00000219545 "UBAP1-MVB12-associated (UMA) domain containing 1" C9J7I0 7 7640711-7968020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 96.7;Inhibitory neurons: 114.3;Microglial cells: 79.6;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044806 Approved Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA044806: AB_10961141" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" "unprognostic (9.08e-3)" "unprognostic (9.24e-2)" "unprognostic (6.86e-3)" "unprognostic (4.87e-1)" "unprognostic (2.56e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "prognostic favorable (1.73e-8)" "unprognostic (6.66e-3)" "unprognostic (8.34e-2)" "unprognostic (7.69e-2)" "unprognostic (3.58e-1)" 9.2 16.5 5.5 11.2 5.8 9.5 10.3 5.6 6.2 10.1 7.0 12.8 15.4 10.3 11.4 8.9 10.2 10.7 13.7 4.9 8.3 17.2 14.3 12.0 15.7 6.9 7.3 13.6 36.1 29.7 10.3 9.2 7.5 18.9 11.6 11.5 20.6 11.7 11.3 7.0 16.6 9.8 6.1 10.3 23.0 5.8 7.0 18.4 24.6 10.5 13.4 12.3 8.4 7.1 24.7 17.9 9.0 10.5 12.7 14.9 10.3 14.9 17.2 11.5 17.4 7.6 17.9 13.4 15.4 9.4 46.3 15.7 10.4 15.0 14.3 10.1 8.1 7.3 12.4 8.9 14.2 13.6 16.3 14.2 18.6 16.6 12.7 13.5 7.1 17.2 15.1 40.0 15.4 19.9 12.4 7.4 16.2 16.5 14.8 13.6 21.3 21.3 20.9 11.1 3.6 14.8 21.0 26.7 21.6 26.5 20.8 16.3 7.8 11.7 27.2 23.3 15.2 28.6 34.2 15.5 26.4 19.2 36.8 51.8 16.0 43.5 19.3 21.5 23.9 28.8 27.2 24.2 13.8 26.0 31.8 23.8 46.1 18.5 24.1 16.3 38.7 17.9 5.5 5.8 5.6 6.2 4.9 8.3 6.9 7.3 7.5 6.1 7.0 7.1 12.1 25.6 11.9 58.8 22.8 0.0 27.7 0.0 12.0 6.5 13.8 12.3 10.9 11.5 9.9 14.7 14.6 16.7 7.7 7.6 39.2 8.4 7.1 9.7 7.6 7.1 6.1 6.7 96.7 14.5 23.6 11.4 33.1 10.6 15.2 3.8 6.4 9.5 16.8 15.2 114.3 13.3 0.0 13.2 0.0 3.7 13.4 12.9 0.0 79.6 8.9 11.4 16.5 80.9 119.3 10.4 9.0 7.9 28.4 19.3 16.8 34.2 9.5 9.8 26.3 12.0 9.6 4.8 5.0 12.6 0.0 21.2 17.0 7.6 7.7 21.2 UNC50 "GMH1, UNCL, URP" ENSG00000115446 "Unc-50 inner nuclear membrane RNA binding protein" Q53HI1 2 98608579-98618515 "Predicted membrane proteins" "Protein transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 215.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027009 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA027009: AB_1858620" "prognostic unfavorable (4.79e-4)" "unprognostic (3.28e-2)" "unprognostic (1.23e-1)" "unprognostic (1.74e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (5.31e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.14e-1)" "unprognostic (4.38e-1)" "unprognostic (7.12e-3)" "unprognostic (4.82e-3)" 36.6 49.1 46.3 34.2 48.2 36.8 45.8 48.8 57.3 38.1 53.6 35.0 37.9 46.3 69.2 30.9 42.7 36.2 38.7 46.2 48.3 52.5 46.9 38.6 41.4 48.5 46.6 44.2 42.0 82.4 41.4 52.2 49.1 41.3 43.2 60.0 56.0 45.4 31.6 39.9 34.4 38.7 49.0 39.3 45.5 48.9 47.2 36.6 64.1 35.9 42.6 37.8 30.5 54.3 55.2 35.6 65.2 44.3 95.7 82.6 73.0 51.2 71.8 61.9 54.2 54.5 64.0 16.6 75.2 44.1 94.0 52.0 45.9 41.5 50.9 56.4 46.2 37.5 47.3 89.4 103.0 71.7 56.7 54.6 92.5 33.1 60.4 71.5 55.1 43.3 61.2 50.2 63.5 39.2 31.7 80.3 49.6 46.1 41.7 20.1 47.3 58.8 68.9 48.6 24.2 35.6 35.9 47.3 86.5 75.8 40.7 91.9 42.7 67.4 41.3 34.5 35.0 76.1 63.2 44.2 63.6 51.7 60.1 61.6 54.3 66.7 50.6 54.9 43.9 52.8 42.2 47.9 54.9 48.1 46.2 52.9 45.3 58.5 51.4 51.3 37.4 44.2 46.3 48.2 48.8 57.3 46.2 48.3 48.5 46.6 49.1 49.0 47.2 54.3 45.3 25.6 31.0 13.7 35.7 47.2 51.2 139.4 42.7 36.7 46.7 40.8 39.5 38.6 85.8 35.0 16.7 118.6 41.2 27.4 33.2 52.3 47.7 38.3 35.3 48.3 21.6 19.1 21.2 53.2 77.1 58.9 19.4 30.7 27.3 23.7 47.2 33.9 73.2 33.7 24.1 34.1 85.5 31.3 33.3 29.9 54.7 33.0 44.4 19.7 41.7 84.6 48.4 19.1 25.8 40.7 33.0 74.9 51.0 75.7 29.0 46.6 73.8 49.8 46.0 45.0 58.9 215.1 58.7 34.6 49.7 152.6 29.2 39.1 30.1 44.6 UQCR11 "QCR10, UQCR" ENSG00000127540 "Ubiquinol-cytochrome c reductase, complex III subunit XI" O14957 19 1597169-1605473 "Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 297.7;skeletal muscle: 311.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1792.1;Hepatocytes: 2200.3;Proximal enterocytes: 2007.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (1.90e-1)" "unprognostic (6.67e-3)" "unprognostic (1.78e-1)" "prognostic favorable (1.23e-4)" "unprognostic (5.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (5.42e-3)" "unprognostic (9.10e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.86e-4)" "unprognostic (1.03e-1)" "prognostic favorable (1.65e-4)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (1.06e-2)" 71.0 80.2 74.9 20.6 79.6 39.7 60.5 79.4 103.7 46.8 78.6 91.7 59.7 46.4 18.4 71.6 43.6 25.0 297.7 76.4 76.7 103.4 136.4 48.7 27.4 76.5 77.7 35.5 49.5 46.8 62.7 24.1 76.6 62.0 22.8 13.8 53.9 30.9 311.8 50.4 62.6 22.6 75.6 60.9 77.2 24.7 78.3 24.1 52.6 109.7 19.3 60.9 51.4 79.0 68.9 75.7 34.7 74.5 60.8 40.7 79.9 54.3 45.4 55.5 48.8 121.5 47.3 47.4 51.8 41.8 12.3 46.8 55.5 61.0 26.5 65.0 163.1 40.6 87.3 114.0 60.6 66.1 57.9 62.8 62.6 35.2 41.6 28.6 50.8 66.9 94.8 73.1 36.2 111.5 67.7 72.4 94.8 59.2 176.0 40.4 36.2 148.9 74.6 158.4 69.6 65.9 39.3 86.4 99.7 27.9 59.3 65.1 66.7 44.3 30.0 129.9 57.7 110.4 101.2 54.4 82.6 69.9 64.8 619.6 421.3 521.9 282.7 367.9 287.1 390.0 341.7 316.6 360.5 333.8 324.3 314.1 496.7 273.7 354.9 448.4 407.7 872.4 74.9 79.6 79.4 103.7 76.4 76.7 76.5 77.7 76.6 75.6 78.3 79.0 300.4 269.2 379.1 20.5 287.6 0.0 189.6 0.0 206.6 135.2 715.6 798.8 1731.6 529.0 159.7 634.5 39.6 481.8 380.1 834.6 1792.1 665.4 178.2 290.5 220.2 282.4 452.6 451.6 17.8 811.6 632.1 262.0 342.0 243.5 199.3 152.6 463.3 2200.3 962.9 89.2 17.6 681.7 0.0 783.5 0.0 474.8 252.8 472.2 0.0 10.3 866.6 418.8 568.5 9.5 25.1 855.3 727.0 259.5 384.1 365.5 2007.4 1742.3 267.5 164.4 223.5 192.6 291.3 159.2 145.3 520.3 0.0 512.8 304.3 188.0 717.0 290.3 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866630-132868847 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1301.6" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 3312.4;Hepatocytes: 5039.2;Proximal tubular cells: 3336.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria NA NA 18000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA046693: AB_10968453, HPA053323: AB_2682112" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 226.5 378.7 277.6 91.8 283.7 132.6 189.2 309.6 391.9 151.7 293.2 313.0 220.8 147.9 211.2 332.4 138.6 78.3 1301.6 283.6 315.5 460.7 1036.6 149.0 69.1 291.2 285.6 120.0 269.4 318.5 222.8 89.0 294.9 272.9 232.2 187.4 253.8 122.2 1024.7 182.3 244.5 98.5 286.6 151.8 372.3 128.9 294.7 130.3 167.3 873.5 92.3 219.9 193.3 302.3 300.9 391.1 246.7 599.9 364.2 292.2 209.3 216.3 310.6 341.7 424.9 556.4 353.8 126.5 433.4 291.5 424.5 302.7 229.5 536.6 300.7 222.9 466.0 169.4 606.3 459.9 312.7 188.8 276.2 314.0 366.5 247.4 341.6 229.6 274.1 258.3 219.2 398.6 369.7 547.5 450.5 442.1 175.3 568.1 367.0 288.4 271.7 541.7 460.9 573.4 410.7 335.8 269.1 302.7 493.9 170.4 451.9 422.5 168.3 316.0 392.1 257.2 438.7 423.1 616.3 236.6 417.9 350.0 320.6 474.1 528.3 355.5 245.6 431.0 251.8 317.2 280.3 280.2 472.0 260.6 273.5 263.6 258.8 322.9 410.0 516.7 326.1 658.2 277.6 283.7 309.6 391.9 283.6 315.5 291.2 285.6 294.9 286.6 294.7 302.3 252.0 250.0 349.3 17.6 258.1 348.3 334.0 1046.6 235.6 97.8 575.5 657.7 3312.4 993.7 556.9 787.2 120.9 720.4 200.6 1678.3 1813.7 685.6 470.0 424.1 308.5 288.4 549.3 319.4 13.9 947.7 484.1 330.2 438.3 467.5 294.5 277.0 333.8 5039.2 771.4 72.3 17.0 1047.6 807.7 421.1 448.6 1116.6 282.4 301.6 715.1 11.2 394.7 459.2 260.6 13.6 23.5 705.7 1460.8 288.9 416.2 537.1 2476.1 3336.0 512.5 271.5 184.1 217.8 388.7 308.1 174.7 570.1 514.0 562.7 205.0 235.9 1205.6 500.2 VIPAS39 "C14orf133, hSPE-39, SPE-39, SPE39, VIPAR, VPS16B" ENSG00000151445 "VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog" Q9H9C1 14 77426675-77457952 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003589, HPA003593" Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA003589: AB_10599707, HPA003593: AB_10601879" "unprognostic (1.30e-1)" "unprognostic (7.56e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (5.79e-3)" "unprognostic (5.76e-2)" "prognostic unfavorable (1.06e-6)" "unprognostic (2.53e-2)" "unprognostic (1.67e-1)" "unprognostic (5.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-3)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (5.91e-2)" "unprognostic (1.09e-2)" 12.4 11.8 15.3 9.4 16.0 9.1 12.2 15.4 17.9 12.1 15.6 14.3 10.1 12.1 14.7 13.2 10.8 9.1 14.8 15.7 15.6 11.2 13.6 9.9 12.4 15.2 15.3 18.5 11.9 14.6 13.4 15.5 15.6 11.8 12.7 14.4 10.0 13.7 13.7 13.7 11.1 14.6 15.6 13.2 11.6 15.9 15.9 16.5 11.7 15.0 14.7 13.9 11.6 17.7 10.6 17.8 18.3 26.6 32.5 26.5 18.3 17.5 16.1 20.8 20.2 11.9 24.7 18.4 15.1 14.3 10.8 20.4 17.0 15.5 24.9 15.8 5.8 13.7 10.7 14.7 26.3 8.6 23.2 25.4 24.2 17.8 24.2 27.7 36.3 25.5 10.9 17.4 19.9 25.1 17.7 18.4 16.5 31.0 19.3 17.6 23.0 12.7 20.9 15.3 13.0 15.0 22.7 16.7 20.2 21.7 39.1 18.1 25.9 14.1 12.5 15.5 9.8 14.8 15.1 14.6 15.3 15.9 17.0 1.8 9.4 17.6 5.0 15.6 6.5 4.8 6.5 5.6 10.8 5.6 5.7 5.6 7.8 13.0 20.3 5.5 7.8 6.1 15.3 16.0 15.4 17.9 15.7 15.6 15.2 15.3 15.6 15.6 15.9 17.7 6.0 3.2 1.5 16.0 6.3 3.2 3.0 4.7 2.8 8.5 5.3 5.3 9.0 4.3 3.4 9.2 20.9 20.7 6.3 7.2 7.9 9.3 5.7 4.0 7.4 6.8 5.4 11.2 14.6 6.3 16.6 8.2 5.1 6.2 2.5 12.2 8.2 6.6 13.3 10.1 14.4 5.4 2.0 17.6 3.8 3.8 11.5 8.3 0.0 13.1 17.6 7.4 9.2 15.1 17.2 9.1 9.4 15.4 4.0 2.5 10.7 5.8 3.6 13.3 6.6 5.5 6.8 11.0 9.2 6.3 4.3 19.2 6.3 15.5 7.2 2.8 VPS25 "DERP9, EAP20, MGC10540" ENSG00000131475 "Vacuolar protein sorting 25 homolog" Q9BRG1 17 42773449-42779599 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004978, HPA021992, HPA052217, HPA057284" Uncertain Supported Vesicles NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 10: Non-specific - Unknown function" Vesicles "CAB004978: AB_426095, HPA021992: , HPA052217: AB_2681765, HPA057284: AB_2683397" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-4)" "unprognostic (7.37e-2)" "unprognostic (7.57e-2)" "unprognostic (9.83e-3)" "unprognostic (2.76e-3)" "unprognostic (5.84e-2)" "unprognostic (1.25e-1)" "unprognostic (2.90e-1)" "unprognostic (8.10e-3)" "unprognostic (3.88e-1)" "unprognostic (2.39e-3)" "unprognostic (1.15e-1)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" 36.6 40.3 32.8 32.5 33.0 44.3 53.3 34.8 36.8 41.6 36.6 61.9 53.8 35.5 65.3 91.4 58.9 33.4 43.5 32.9 33.2 70.1 68.6 31.8 37.8 32.9 32.8 33.2 49.0 72.3 27.6 46.7 33.5 40.2 68.4 31.2 48.7 36.5 51.3 50.5 45.4 42.8 33.5 37.1 50.0 27.4 33.8 51.3 40.9 41.3 57.2 44.8 44.3 34.0 67.2 136.6 101.8 62.1 126.9 86.5 94.5 83.0 117.1 167.5 116.3 117.9 77.0 66.8 135.8 122.0 88.5 68.7 142.2 181.8 107.9 61.2 178.7 50.6 87.0 177.5 131.0 95.7 64.6 118.2 115.4 148.9 158.0 99.1 106.7 79.0 175.6 65.5 102.1 96.5 138.8 105.2 78.9 152.0 95.3 51.1 123.3 108.7 202.6 75.8 86.3 66.7 46.8 60.1 129.6 155.8 138.4 100.2 58.0 105.7 68.4 60.0 90.3 64.0 39.4 97.9 92.7 64.5 79.6 85.1 76.9 106.7 38.8 89.0 39.9 48.8 42.4 46.4 80.3 46.6 42.3 40.7 44.9 78.9 82.7 54.1 43.1 59.6 32.8 33.0 34.8 36.8 32.9 33.2 32.9 32.8 33.5 33.5 33.8 34.0 26.3 25.6 36.3 4.2 25.3 13.9 41.0 88.3 16.5 24.1 44.4 46.6 26.9 51.5 65.7 62.5 14.6 136.1 22.0 74.3 133.1 135.9 2.6 61.8 48.5 35.4 41.0 47.9 3.5 152.4 186.5 40.8 40.8 55.9 29.2 21.5 29.6 46.4 102.3 23.5 3.5 70.5 85.5 34.5 12.7 5.6 27.7 33.0 42.7 0.0 46.7 56.1 44.3 2.5 4.7 134.4 75.7 30.5 40.9 44.4 83.5 93.6 74.9 29.5 32.9 13.5 69.9 42.8 46.7 61.9 22.9 121.6 22.8 69.9 63.4 53.5 WASHC3 "CCDC53, CGI-116" ENSG00000120860 "WASH complex subunit 3" Q9Y3C0 12 102012840-102062149 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 125.2;Hofbauer cells: 73.1;Proximal tubular cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038339 Uncertain Approved Vesicles NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA038339: AB_2675966" "unprognostic (4.25e-2)" "unprognostic (1.61e-2)" "unprognostic (2.28e-1)" "unprognostic (3.45e-3)" "unprognostic (1.21e-2)" "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.63e-2)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "unprognostic (7.81e-2)" "unprognostic (7.41e-2)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" 27.3 32.2 41.3 14.2 41.9 13.2 24.7 42.8 57.2 26.4 38.3 33.7 13.6 27.5 35.7 28.4 18.0 17.7 35.0 42.8 44.9 41.6 41.1 20.6 22.8 44.6 43.9 20.3 17.4 37.8 33.4 20.0 45.2 26.1 20.7 25.3 19.8 34.9 34.5 20.1 20.5 29.3 43.4 22.7 27.3 98.1 43.5 31.2 25.7 42.2 26.2 28.8 23.4 44.2 17.1 23.3 20.1 12.6 75.2 90.9 18.9 23.3 48.0 33.6 37.3 18.8 16.0 18.0 16.4 52.9 34.2 32.1 21.4 57.0 44.5 41.8 12.9 25.3 15.9 29.5 67.0 22.4 13.9 55.9 72.4 42.1 42.2 92.1 46.3 43.5 15.3 19.6 88.4 23.1 23.6 39.9 6.1 32.7 41.0 13.6 30.4 27.2 59.4 27.7 19.6 10.8 32.6 22.9 50.2 36.5 29.1 12.8 25.5 41.5 9.9 24.7 16.3 49.5 32.7 22.7 59.0 15.6 17.8 125.7 41.3 95.3 37.5 66.6 45.4 61.9 56.3 50.7 56.1 49.4 41.2 49.4 18.2 59.9 70.9 54.9 118.5 52.8 41.3 41.9 42.8 57.2 42.8 44.9 44.6 43.9 45.2 43.4 43.5 44.2 55.4 28.9 41.5 0.0 18.5 0.0 0.0 0.0 0.0 0.0 36.4 55.4 0.0 0.0 14.2 33.1 0.0 60.3 28.4 0.0 125.2 47.9 0.0 40.5 49.2 15.0 0.0 0.0 0.0 38.8 48.5 24.8 0.0 27.4 40.4 36.1 0.0 0.0 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 46.5 0.0 0.0 0.0 0.0 35.5 0.0 0.0 5.4 0.0 0.0 98.9 22.6 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 39.4 18.8 60.9 0.0 0.0 WDR41 FLJ10904 ENSG00000164253 "WD repeat domain 41" Q9HAD4 5 77425970-77620611 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 178.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043124 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Golgi apparatus, Cytosol" "HPA043124: AB_10793990" "unprognostic (1.81e-1)" "unprognostic (9.42e-2)" "unprognostic (2.52e-3)" "unprognostic (9.69e-2)" "unprognostic (1.52e-1)" "unprognostic (4.56e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.28e-3)" "unprognostic (1.43e-1)" "unprognostic (1.68e-2)" "unprognostic (2.30e-3)" "unprognostic (1.49e-1)" "unprognostic (4.15e-3)" "unprognostic (6.11e-2)" "unprognostic (4.90e-1)" "unprognostic (1.85e-1)" "unprognostic (2.90e-3)" 16.3 9.4 13.5 13.7 15.1 19.3 15.7 13.3 18.3 13.4 8.5 12.8 8.9 10.9 12.3 19.6 16.6 11.7 17.1 13.8 13.7 12.9 14.8 14.0 15.2 15.0 13.6 7.6 21.0 13.8 6.9 11.4 14.8 11.3 13.1 20.6 12.1 10.9 21.4 12.1 8.8 19.1 12.4 11.8 11.3 27.6 14.0 11.7 22.4 21.0 17.2 14.8 10.8 17.0 17.7 29.8 42.6 62.1 41.9 60.1 32.2 55.5 59.6 26.3 47.5 28.1 28.7 54.1 24.6 53.1 44.4 22.3 31.6 77.8 27.6 65.5 37.1 21.6 32.0 24.7 63.7 46.1 50.0 38.5 96.1 30.1 63.1 28.3 42.0 29.6 21.7 56.8 42.2 39.1 24.7 29.7 15.4 17.8 11.7 58.1 56.1 38.7 27.9 14.8 23.5 29.7 48.2 31.0 47.9 49.9 29.4 57.8 38.2 34.3 28.0 19.1 41.3 51.3 44.8 96.7 48.1 20.7 59.4 25.4 28.5 50.1 11.3 33.8 10.9 19.0 6.5 10.2 51.0 13.3 4.4 8.0 13.7 31.8 38.5 23.2 5.8 16.5 13.5 15.1 13.3 18.3 13.8 13.7 15.0 13.6 14.8 12.4 14.0 17.0 10.2 38.5 12.3 63.3 12.6 12.0 25.2 31.0 14.2 34.8 11.6 12.3 17.3 12.8 16.5 18.4 20.9 8.8 16.4 4.4 37.2 22.7 178.8 17.7 25.6 11.3 6.0 13.5 41.3 20.9 25.5 23.7 9.2 8.3 15.8 11.7 8.9 11.5 26.3 23.5 46.7 8.5 14.2 20.2 29.5 87.5 9.6 23.9 17.8 36.5 16.4 14.9 15.5 56.8 78.9 15.2 7.4 8.2 25.6 26.8 5.0 18.7 17.0 19.2 6.6 12.7 22.3 56.4 44.5 23.9 14.2 6.3 11.4 35.5 10.9 28.0 WDR45 "JM5, NBIA5, WDRX1, WIPI4" ENSG00000196998 "WD repeat domain 45" Q9Y484 X 49074433-49101170 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Autophagy "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027562 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA027562: AB_10610565" "unprognostic (1.39e-1)" "prognostic favorable (1.21e-4)" "unprognostic (1.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (4.30e-2)" "unprognostic (6.66e-3)" "unprognostic (7.12e-2)" "unprognostic (3.57e-1)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (5.06e-3)" "unprognostic (2.85e-1)" "unprognostic (5.27e-1)" "unprognostic (3.60e-2)" "unprognostic (1.11e-3)" 58.0 74.7 53.3 22.4 59.1 43.2 54.3 56.1 57.8 54.8 59.4 52.3 27.6 51.5 208.4 38.5 45.7 29.7 79.6 53.6 55.3 61.8 68.5 46.6 25.7 63.8 61.1 49.0 58.6 54.8 43.4 21.9 58.1 48.9 19.6 21.2 50.8 34.4 115.9 48.5 38.2 24.7 57.8 45.0 59.0 10.0 61.0 32.3 52.9 87.5 23.2 45.9 43.0 52.7 36.3 41.9 23.4 23.7 50.1 63.7 45.7 39.0 80.6 30.1 42.1 22.1 51.5 25.1 21.6 77.1 38.6 30.8 35.3 31.6 21.6 27.6 61.0 15.6 79.5 33.5 114.2 12.1 34.5 57.2 54.9 49.4 52.1 47.8 30.7 23.8 33.3 42.8 40.3 40.9 25.6 31.0 23.8 15.9 36.3 20.4 34.8 85.7 53.2 32.8 31.3 46.8 49.2 37.5 120.5 29.9 23.9 43.4 41.8 32.8 29.4 65.6 16.6 66.2 48.9 18.1 60.1 19.5 24.1 125.4 89.0 82.0 54.5 81.6 54.3 49.1 41.0 51.4 67.1 48.4 32.0 36.5 88.9 83.7 97.9 68.0 65.3 72.0 53.3 59.1 56.1 57.8 53.6 55.3 63.8 61.1 58.1 57.8 61.0 52.7 36.5 32.1 34.6 15.0 34.0 46.5 54.2 49.3 36.5 18.8 43.7 41.8 35.8 35.8 42.6 35.0 12.5 30.6 56.5 37.9 56.7 71.3 1.3 22.5 35.0 30.5 28.8 71.8 8.9 98.5 56.8 50.8 43.3 26.1 27.3 27.5 35.0 49.7 42.1 26.9 9.3 32.2 10.2 38.8 44.1 3.8 40.4 47.1 35.6 6.5 74.8 38.7 68.0 4.5 11.0 109.6 44.0 32.4 86.5 67.9 68.5 131.2 23.4 24.0 19.7 42.4 44.5 2.6 5.0 24.8 47.3 62.1 33.4 48.3 28.7 73.4 WDR83OS "Asterix, C19orf56, PTD008" ENSG00000105583 "WD repeat domain 83 opposite strand" Q9Y284 19 12668073-12669415 "Predicted membrane proteins, Transporters" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065685 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Endoplasmic reticulum" "HPA065685: AB_2685531" "unprognostic (1.73e-1)" "unprognostic (5.37e-3)" "unprognostic (1.03e-1)" "unprognostic (4.86e-2)" "unprognostic (1.27e-1)" "unprognostic (3.29e-2)" "unprognostic (7.47e-2)" "prognostic favorable (2.09e-4)" "unprognostic (1.71e-1)" "prognostic favorable (8.84e-4)" "unprognostic (4.17e-3)" "unprognostic (1.09e-1)" "unprognostic (7.87e-3)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" 152.2 219.2 204.0 80.1 213.4 203.3 156.9 213.2 226.5 164.0 199.2 138.5 103.9 146.9 276.1 174.0 223.2 138.0 206.8 198.6 212.5 194.9 189.2 133.3 128.7 209.9 205.9 226.2 210.0 204.7 164.8 119.7 211.1 160.6 151.4 50.2 180.9 135.9 226.7 175.1 128.5 169.6 216.9 146.5 164.7 80.4 210.8 129.8 190.1 234.1 174.2 164.4 144.8 223.7 190.9 204.4 223.1 252.8 338.2 267.0 96.4 135.3 230.3 211.6 181.7 170.0 161.1 86.2 310.0 390.4 143.5 150.9 242.7 255.9 175.2 180.9 333.0 107.4 170.3 259.6 262.1 183.5 148.5 287.1 343.2 208.0 243.7 309.9 265.2 161.2 196.2 196.3 253.5 661.5 136.8 399.3 187.7 254.4 584.9 110.0 117.7 310.1 241.7 217.2 182.3 278.6 155.2 162.4 193.5 148.2 197.6 295.1 156.7 289.8 78.2 317.2 205.8 342.4 428.4 126.5 245.4 313.2 189.0 612.8 502.8 492.3 329.2 469.3 312.0 445.2 308.6 336.5 466.7 394.4 280.0 305.8 485.8 451.4 503.7 319.2 396.0 635.4 204.0 213.4 213.2 226.5 198.6 212.5 209.9 205.9 211.1 216.9 210.8 223.7 198.5 80.1 54.6 11.8 156.8 171.7 193.7 391.7 272.0 42.3 310.7 424.2 129.4 168.7 204.5 342.1 27.1 435.7 153.8 233.0 401.1 255.5 7.9 128.6 184.0 185.7 195.3 126.4 10.5 255.8 333.8 205.2 162.6 162.7 147.9 239.7 183.1 314.3 287.5 50.5 10.6 282.6 301.1 212.5 230.2 22.7 170.6 209.3 297.1 13.1 254.5 264.8 179.2 13.0 39.4 243.4 295.7 144.8 256.0 230.9 398.1 586.3 103.6 55.7 98.6 140.9 187.6 87.3 98.4 353.6 221.3 405.1 172.2 279.8 262.4 241.1 XRCC5 "KARP-1, KU80, Ku86, KUB2" ENSG00000079246 "X-ray repair cross complementing 5" P13010 2 216107464-216206303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004468, HPA025813, HPA064685" Supported Enhanced Nucleoplasm NA NA 940000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322" "unprognostic (4.23e-2)" "unprognostic (1.75e-1)" "unprognostic (9.07e-3)" "unprognostic (3.44e-3)" "unprognostic (2.44e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.10e-7)" "unprognostic (4.42e-3)" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (3.38e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-1)" "unprognostic (2.88e-2)" "unprognostic (3.58e-2)" "unprognostic (6.01e-2)" 79.6 74.0 52.8 102.4 58.4 112.0 114.6 56.0 69.9 96.4 38.1 91.0 82.2 103.3 85.3 96.8 95.8 83.2 77.1 58.1 56.4 100.2 140.6 76.6 127.8 52.4 50.7 104.0 71.7 118.4 61.4 87.1 54.4 84.7 106.6 102.0 71.6 91.3 103.1 91.6 82.3 100.1 59.1 83.9 77.0 69.5 51.0 176.8 129.2 92.7 140.9 131.7 72.7 65.6 234.4 194.9 427.0 230.5 185.5 210.9 256.6 269.9 279.2 307.1 328.5 421.0 225.7 225.6 214.8 239.1 269.2 203.5 425.2 329.5 469.7 215.0 291.0 488.5 282.9 398.0 229.2 437.1 230.0 193.5 172.1 361.2 156.6 218.4 368.0 272.1 314.4 199.7 405.9 225.9 496.7 221.7 498.0 236.0 170.6 429.8 376.7 186.5 331.9 262.6 372.6 314.6 217.8 159.9 201.1 428.5 196.7 325.8 264.2 287.3 241.5 190.6 312.3 240.0 311.4 493.6 223.4 339.5 290.0 253.2 172.7 175.0 153.6 177.1 165.3 121.2 148.1 157.0 168.0 121.6 147.6 149.1 192.7 172.9 217.4 102.1 167.5 330.4 52.8 58.4 56.0 69.9 58.1 56.4 52.4 50.7 54.4 59.1 51.0 65.6 129.0 105.8 126.3 65.6 131.0 113.7 174.0 242.4 90.5 136.7 93.6 87.1 163.0 105.8 190.0 101.2 45.9 210.5 141.6 79.8 97.8 304.3 103.0 147.4 175.4 142.4 133.3 159.4 73.9 235.8 238.8 134.1 74.5 159.1 146.7 140.2 82.8 222.5 157.3 89.2 82.4 90.7 173.0 100.5 85.3 30.0 101.5 130.7 69.4 108.7 310.9 142.0 138.0 93.0 111.4 247.9 70.3 129.4 132.5 137.4 82.8 139.9 160.1 114.0 111.7 142.9 161.3 252.2 179.2 114.7 120.3 165.5 149.7 165.3 112.0 161.2 YPEL5 CGI-127 ENSG00000119801 "Yippee like 5" P62699 2 30146941-30160533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 438.1" "Cell type enhanced" "Detected in all" "Late spermatids: 548.0;Plasma cells: 545.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042809 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Cytosol Nucleoplasm "HPA042809: AB_2678179" "unprognostic (7.22e-3)" "unprognostic (6.50e-3)" "unprognostic (9.16e-2)" "unprognostic (5.47e-2)" "unprognostic (4.88e-2)" "unprognostic (1.83e-2)" "unprognostic (3.60e-2)" "unprognostic (3.39e-2)" "unprognostic (1.95e-1)" "unprognostic (5.73e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (7.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.67e-3)" 65.2 67.0 61.5 44.9 65.6 438.1 55.2 58.0 81.2 61.3 68.2 70.3 40.5 51.4 84.3 55.6 51.3 64.0 56.7 66.0 64.7 87.4 64.4 61.1 62.7 64.0 57.2 60.3 44.8 101.5 45.6 64.6 63.0 68.8 45.5 77.2 63.3 95.5 54.1 51.9 44.4 65.1 61.8 58.9 49.4 71.4 60.8 77.2 61.8 48.7 62.8 78.1 47.0 61.6 35.9 18.1 42.5 20.9 113.3 109.4 35.0 50.7 152.6 28.5 43.3 16.3 36.7 21.4 32.7 100.7 65.0 19.1 9.9 50.5 40.2 94.1 19.1 11.0 8.0 26.0 98.3 3.7 24.9 114.1 100.7 53.0 67.6 122.5 53.8 13.5 15.5 36.8 77.2 18.5 11.3 26.3 23.9 41.2 22.7 7.0 56.8 20.9 96.4 69.6 16.7 51.1 24.6 24.4 65.2 77.1 27.3 20.5 70.6 77.4 29.5 21.2 14.2 86.5 34.9 28.7 55.1 9.9 31.7 229.3 82.4 190.7 53.3 95.4 54.7 89.9 65.8 64.2 78.0 74.0 62.2 55.8 306.9 56.5 149.5 152.9 95.8 146.6 61.5 65.6 58.0 81.2 66.0 64.7 64.0 57.2 63.0 61.8 60.8 61.6 83.8 83.3 90.5 13.4 398.6 134.0 162.9 184.8 122.3 70.7 142.5 105.5 73.2 47.1 119.3 101.2 47.9 172.8 300.4 104.1 138.9 90.9 253.9 178.0 71.0 74.3 208.9 93.7 30.9 78.8 140.4 84.2 126.9 213.7 81.3 46.4 56.0 43.3 103.3 63.9 25.9 94.5 114.0 132.1 168.7 548.0 57.8 214.9 170.7 15.9 321.0 103.4 50.4 19.6 28.3 110.2 108.6 82.8 545.7 143.3 84.8 137.0 101.4 63.5 52.6 87.4 114.9 133.8 78.0 97.4 142.6 408.0 358.5 53.5 46.8 281.2 YY1AP1 "HCCA2, YAP, YY1AP" ENSG00000163374 "YY1 associated protein 1" Q9H869 1 155659443-155689000 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006986, HPA064249" Uncertain Approved "Nucleoli fibrillar center" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 43: THP-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" "Nucleoli fibrillar center" "HPA006986: AB_1080620, HPA064249: AB_2685226" "unprognostic (1.96e-2)" "unprognostic (2.80e-1)" "unprognostic (1.09e-2)" "unprognostic (5.67e-2)" "unprognostic (3.91e-2)" "unprognostic (1.77e-1)" "unprognostic (2.86e-3)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (8.13e-2)" "unprognostic (6.87e-2)" "unprognostic (8.65e-2)" "prognostic unfavorable (2.01e-6)" "unprognostic (6.81e-2)" "unprognostic (2.10e-1)" "unprognostic (3.39e-1)" "unprognostic (5.84e-2)" 41.9 36.1 35.4 28.1 38.6 77.2 42.8 51.1 41.6 47.1 20.7 56.6 23.5 41.5 38.6 53.0 44.2 26.7 48.1 33.5 32.7 42.3 38.3 49.3 38.6 32.6 35.2 47.5 37.6 35.4 47.1 32.0 32.4 46.3 35.6 41.3 41.0 37.6 113.8 54.0 39.7 42.6 31.7 47.9 41.8 74.6 38.8 50.4 39.9 73.2 49.8 45.8 45.8 41.3 63.5 32.0 40.3 45.9 44.9 40.4 86.5 39.9 58.0 70.4 59.9 49.3 65.7 50.1 38.4 58.6 35.8 60.5 61.3 55.7 66.2 46.7 30.5 41.6 36.2 31.2 47.5 66.7 54.2 43.0 56.1 53.7 68.5 48.8 44.3 47.5 55.8 69.9 52.2 56.0 68.5 32.4 63.7 86.5 46.4 53.7 34.9 80.4 42.7 45.5 40.3 47.8 52.6 75.0 51.5 72.5 82.3 108.7 36.0 39.4 34.6 41.4 53.5 87.7 62.8 123.2 38.9 43.0 46.4 40.3 27.6 50.3 34.7 27.5 36.8 26.7 29.6 36.4 34.0 20.9 25.5 25.5 29.5 45.0 27.7 15.9 40.1 35.1 35.4 38.6 51.1 41.6 33.5 32.7 32.6 35.2 32.4 31.7 38.8 41.3 18.3 19.2 26.7 28.7 26.0 34.7 30.5 20.2 38.7 24.5 27.4 21.3 23.2 22.8 22.9 12.9 43.8 23.6 24.5 25.7 13.7 17.3 68.0 20.0 21.8 24.5 34.9 42.9 33.8 19.1 27.9 24.7 25.0 25.5 25.3 16.6 15.7 23.1 21.5 16.8 34.8 23.8 12.2 20.8 36.3 81.0 28.0 28.5 19.6 37.5 27.4 20.8 15.5 38.7 48.3 18.4 16.2 25.6 36.9 29.2 22.5 11.7 17.3 24.9 6.6 24.9 22.3 77.6 25.5 38.8 35.7 45.0 26.7 26.6 24.4 33.8 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type palmitoyltransferase 12" Q96GR4 9 128720870-128724127 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 224.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Intermediate filaments" "HPA059339: AB_2683985" "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 18.8 23.9 7.8 15.5 7.7 41.3 19.3 7.5 9.9 16.8 8.4 40.5 26.3 12.9 7.1 67.8 12.0 14.1 13.7 7.4 8.8 30.6 52.3 23.3 20.0 9.6 7.8 7.4 67.1 9.8 11.3 16.3 8.4 26.6 13.7 0.5 43.2 12.5 15.6 42.4 36.8 6.3 8.4 31.7 49.2 24.7 10.5 12.4 16.2 4.1 13.7 18.7 30.5 9.7 53.5 127.6 6.0 31.3 17.6 12.1 59.4 32.8 28.8 34.5 22.9 109.6 61.5 37.3 29.6 25.5 62.9 139.8 13.0 65.0 3.8 65.0 31.7 20.1 92.7 49.1 34.7 33.1 87.1 19.9 44.7 29.6 11.0 17.7 25.6 65.6 18.8 93.6 7.1 187.3 45.9 66.2 26.8 118.8 107.6 21.0 21.0 108.4 28.7 43.4 42.1 30.4 46.2 64.1 18.3 9.6 98.9 35.6 27.5 0.1 36.9 25.9 45.8 58.1 106.8 17.3 61.3 38.4 41.4 231.1 122.3 385.6 105.1 123.9 91.2 94.6 95.9 101.5 100.1 111.0 99.2 91.4 269.5 90.5 150.0 244.7 130.9 101.0 7.8 7.7 7.5 9.9 7.4 8.8 9.6 7.8 8.4 8.4 10.5 9.7 10.0 16.0 12.0 1.3 31.8 16.2 43.3 94.0 10.8 1.2 55.5 30.4 14.8 77.2 59.0 46.0 0.0 183.9 39.1 171.0 13.7 106.8 73.2 20.7 11.5 21.1 51.2 51.1 0.6 200.0 224.0 14.2 38.7 52.5 18.4 13.7 35.7 55.3 137.0 0.0 0.5 108.5 67.1 62.2 20.9 30.0 9.6 46.5 42.7 6.5 115.3 18.4 81.4 0.5 2.0 133.8 167.7 7.2 43.3 56.5 186.0 48.5 20.1 2.0 6.6 5.4 16.3 36.0 18.6 55.2 28.1 134.1 34.1 22.0 110.0 77.5 ZFAND2A AIRAP ENSG00000178381 "Zinc finger AN1-type containing 2A" Q8N6M9 7 1152071-1160759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 490.1;Paneth cells: 310.4;Prostatic glandular cells: 255.2;Urothelial cells: 322.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 179.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019469 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 22: Epithelial cell types - Mixed function" "HPA019469: AB_1859009" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (6.85e-2)" "unprognostic (1.63e-2)" "unprognostic (3.08e-2)" "unprognostic (1.03e-2)" "unprognostic (7.12e-2)" "unprognostic (1.10e-2)" "unprognostic (2.10e-3)" "unprognostic (7.52e-2)" "unprognostic (8.78e-2)" "unprognostic (6.48e-2)" "prognostic unfavorable (5.47e-7)" "unprognostic (5.44e-3)" "unprognostic (7.60e-2)" "unprognostic (6.46e-2)" "unprognostic (2.59e-2)" 27.0 26.0 57.7 10.6 58.9 80.5 24.1 62.8 98.9 18.1 52.7 26.4 17.8 20.7 14.7 21.5 18.8 18.1 18.5 63.0 61.3 30.8 81.1 32.5 15.4 58.7 60.4 20.9 33.8 16.4 22.4 21.1 60.8 23.2 18.1 15.1 19.6 12.1 13.2 20.3 19.9 14.4 60.3 24.3 32.5 26.9 59.3 13.4 27.0 7.9 11.8 25.2 21.7 66.2 44.7 50.6 12.8 29.3 28.6 20.3 20.3 40.1 32.6 40.1 30.6 35.7 35.4 14.5 15.8 33.5 63.3 59.8 10.2 10.6 40.5 11.9 21.1 9.8 22.7 179.8 54.4 29.2 19.3 19.1 34.2 32.9 58.3 28.2 14.0 32.8 56.0 33.0 29.6 69.6 8.3 32.8 51.8 105.8 69.3 25.3 2.4 23.0 16.5 19.0 18.6 19.0 14.3 39.1 50.5 26.7 40.1 58.5 18.2 29.6 23.2 34.3 54.7 40.0 51.2 27.3 29.1 32.5 64.3 71.6 25.8 34.2 31.3 24.7 28.8 32.3 28.1 33.0 18.7 34.5 26.9 23.4 31.8 33.2 25.3 34.6 39.5 30.0 57.7 58.9 62.8 98.9 63.0 61.3 58.7 60.4 60.8 60.3 59.3 66.2 65.4 32.1 17.2 4.2 40.6 22.6 490.1 27.6 46.7 15.6 39.8 34.7 17.9 22.8 17.4 7.3 16.7 18.9 49.1 211.8 23.5 21.6 9.7 46.3 33.4 40.7 126.9 17.2 5.6 39.5 46.6 50.8 54.0 83.8 116.4 9.7 20.3 50.3 40.6 11.8 5.8 207.9 18.3 29.2 119.6 12.6 13.4 121.1 32.0 1.0 31.6 23.7 21.6 2.5 7.4 65.7 310.4 18.0 89.7 255.2 29.3 34.1 13.1 25.6 0.0 16.6 40.5 47.1 39.0 64.8 27.7 65.9 156.4 13.3 123.6 322.2 ZNF28 "DKFZp781D0275, KOX24" ENSG00000198538 "Zinc finger protein 28" P17035 19 52797408-52857600 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "prognostic unfavorable (9.29e-4)" "unprognostic (2.11e-1)" "unprognostic (7.05e-2)" "unprognostic (3.40e-2)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-2)" "unprognostic (6.91e-3)" "unprognostic (5.38e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (6.57e-2)" "unprognostic (1.06e-2)" "unprognostic (7.09e-2)" "unprognostic (1.11e-2)" "unprognostic (2.22e-1)" "unprognostic (5.68e-2)" 4.4 3.7 2.6 5.0 2.5 1.5 7.2 5.4 2.4 6.0 3.0 7.3 6.5 4.9 5.4 5.6 7.5 5.6 3.7 2.0 2.7 6.8 2.1 5.2 6.3 3.1 2.5 5.3 4.3 6.5 1.8 6.6 2.9 6.6 8.5 8.0 3.3 5.2 1.1 3.8 6.3 4.8 2.5 6.2 6.6 5.9 2.8 7.7 10.6 2.5 6.8 6.4 3.4 3.0 11.7 1.4 6.7 12.6 10.5 8.3 23.5 10.2 7.9 9.9 13.7 9.7 11.0 19.4 11.5 7.8 10.1 8.7 11.1 6.7 13.7 0.1 11.6 15.8 6.4 2.8 10.7 0.1 15.4 7.0 10.1 13.1 12.9 7.4 10.0 10.7 18.4 0.2 11.8 3.6 16.2 6.6 8.4 12.6 9.6 10.4 16.6 11.5 10.6 39.5 10.9 8.3 21.8 10.2 7.5 17.5 15.0 14.3 8.6 5.0 10.0 4.5 10.5 4.0 18.0 21.0 0.3 2.4 20.1 20.9 5.9 9.3 9.3 4.3 8.2 5.8 6.5 7.7 7.7 6.1 7.3 8.7 2.9 25.1 5.0 4.0 5.9 7.6 2.6 2.5 5.4 2.4 2.0 2.7 3.1 2.5 2.9 2.5 2.8 3.0 4.9 3.2 4.7 0.0 6.3 3.2 3.8 5.5 4.6 1.4 7.7 5.2 6.7 11.5 11.5 11.0 2.1 7.1 6.3 13.7 7.9 7.0 0.9 10.2 5.9 6.8 14.5 5.5 0.0 5.1 9.7 3.4 3.6 13.5 8.2 6.5 6.4 6.5 9.6 5.0 0.0 12.8 8.2 10.6 3.0 1.3 2.5 6.1 3.6 0.0 5.7 2.2 9.2 0.0 0.0 6.9 14.0 1.9 5.6 7.8 17.8 8.2 9.8 1.6 0.0 3.4 3.4 2.0 3.9 7.6 2.3 7.0 6.2 4.2 10.4 8.8 ZNF410 "APA-1, APA1" ENSG00000119725 "Zinc finger protein 410" Q86VK4 14 73886617-73932521 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002871 Approved "Nuclear bodies" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Nuclear bodies" "HPA002871: AB_1080712" "unprognostic (5.84e-2)" "unprognostic (5.04e-2)" "unprognostic (9.29e-2)" "unprognostic (6.36e-3)" "unprognostic (5.86e-4)" "unprognostic (4.91e-2)" "unprognostic (2.83e-3)" "unprognostic (2.10e-2)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.79e-2)" "unprognostic (2.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.19e-1)" 29.0 33.0 26.8 18.7 30.4 57.7 29.4 30.9 33.9 30.0 28.9 30.6 19.0 27.5 43.7 33.4 28.1 22.6 21.0 26.3 28.0 33.0 28.8 27.6 25.6 29.1 27.5 38.7 20.6 27.1 27.0 32.2 29.6 29.5 24.4 22.8 24.4 27.3 21.1 37.6 25.2 28.4 26.7 26.1 25.7 44.7 28.3 29.9 24.6 18.3 30.7 29.1 28.7 37.0 46.7 35.8 42.4 45.2 44.8 39.8 52.4 51.4 56.9 88.2 82.0 37.6 40.1 38.4 21.7 65.7 28.2 42.1 42.9 52.8 83.2 56.2 26.9 36.2 31.6 29.9 67.4 30.6 45.6 37.0 72.4 44.5 83.1 39.5 47.5 43.9 38.2 33.0 43.3 88.6 45.8 51.2 15.5 56.3 41.7 40.7 48.5 24.7 57.0 43.7 39.0 50.3 57.2 52.5 54.6 35.5 48.3 52.2 30.7 62.7 59.0 37.1 47.2 45.2 83.4 48.0 40.1 34.1 53.7 65.9 45.3 74.8 47.5 43.1 51.9 37.7 49.0 49.0 45.6 43.0 42.3 43.5 34.4 60.5 50.1 30.8 46.7 55.9 26.8 30.4 30.9 33.9 26.3 28.0 29.1 27.5 29.6 26.7 28.3 37.0 4.3 0.0 3.1 27.7 10.8 0.6 1.5 1.0 10.8 1.5 2.2 1.7 1.1 0.0 2.9 0.0 4.2 1.8 5.0 1.7 0.0 1.0 3.8 4.7 5.6 2.6 0.0 5.9 22.7 0.9 1.5 5.3 10.7 6.7 10.8 2.9 1.8 0.4 1.2 1.7 23.8 1.1 0.0 2.2 3.1 1.1 1.2 5.4 1.8 18.7 1.1 2.4 2.1 18.1 31.0 1.3 1.4 0.4 13.4 1.0 2.4 0.7 0.2 4.7 0.0 4.0 5.1 3.3 1.9 10.1 1.1 2.6 10.5 4.1 0.8 1.4 ZNHIT1 "CG1I, H_DJ0747G18.14, ZNFN4A1" ENSG00000106400 "Zinc finger HIT-type containing 1" O43257 7 101218165-101224190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 905.3;Proximal tubular cells: 889.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019043 Uncertain Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA019043: AB_1859481" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.52e-3)" "unprognostic (1.24e-1)" "unprognostic (4.26e-2)" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (3.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-2)" "unprognostic (1.05e-2)" "unprognostic (2.02e-2)" "unprognostic (2.10e-3)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (3.36e-1)" "unprognostic (7.24e-3)" 67.1 58.3 142.9 34.3 149.3 59.5 53.7 153.0 173.5 51.9 149.9 65.4 66.8 38.4 54.1 45.4 60.8 46.5 67.6 141.2 146.9 82.3 199.3 38.1 48.5 152.3 148.5 32.5 62.3 77.8 45.0 44.1 149.5 49.1 43.2 21.0 73.6 52.8 90.8 46.3 58.0 39.8 148.5 48.7 62.8 20.7 148.6 55.8 49.2 70.0 38.8 44.8 39.1 158.1 100.1 92.5 61.8 128.6 114.4 147.4 63.0 113.8 112.8 111.2 111.2 97.6 120.9 70.1 154.6 132.7 87.8 80.2 56.5 159.8 49.1 76.7 221.5 37.8 83.0 116.6 142.7 75.4 82.9 137.8 190.5 97.6 49.8 94.0 166.4 102.4 121.4 126.8 99.9 280.8 145.0 411.2 121.8 151.5 239.7 73.5 47.7 222.1 154.4 46.6 79.6 176.0 79.8 166.2 197.7 70.5 44.6 99.8 121.8 109.0 94.0 190.6 91.0 95.8 136.8 95.3 101.7 142.5 138.7 231.5 214.5 220.2 121.3 202.7 126.5 130.9 133.6 124.4 186.6 142.4 107.9 114.7 181.3 121.4 205.5 202.3 195.2 234.5 142.9 149.3 153.0 173.5 141.2 146.9 152.3 148.5 149.5 148.5 148.6 158.1 203.1 93.0 81.8 6.8 85.3 100.7 121.1 214.6 76.2 30.8 146.0 163.3 77.6 183.0 139.4 191.3 16.7 204.4 115.8 358.1 361.9 200.5 30.5 177.2 153.2 158.5 241.4 195.5 4.6 254.5 199.9 124.7 121.3 169.9 78.6 110.4 174.9 905.3 205.9 11.8 5.0 315.6 166.8 205.4 133.7 59.9 135.2 126.3 129.9 5.6 222.1 89.9 176.1 5.0 17.3 271.4 389.9 124.8 119.4 89.4 432.8 889.4 139.4 37.4 151.2 71.7 150.1 70.6 42.0 109.1 116.5 163.5 104.5 153.8 287.1 138.8